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Abstract 
Peroxisome proliferator-activated receptor alpha (PPARa) is an important 
ligand-activated transcriptional factor which mediates the peroxisome proliferators 
(PPs)-induced liver cancer in rodents. In addition to its toxicological role, PPARa 
also plays an important physiological role in regulating fatty acid metabolism and 
homeostasis during energy deprivation. PPARa mediates its key roles by regulating 
the transcription of target genes in response to its ligands, such as PPs and fatty acids. 
This regulation is achieved by heterodimerization of PPARa with retinoid X receptor 
and direct binding of the heterodimer to the peroxisome proliferator response element 
(PPRE), which presents either in the promoter or intronic region of its target genes. It 
is known that PPARa regulates its target gene transcription in this manner, but the 
complete spectrum of PPARa target genes is still not fully known. 
Peroxisome proliferator and starvation-induced gene (PPSIG) is a novel PPARa 
regulating gene which was identified in our laboratory by fluorescent differential 
display (FDD) method and PPARa-niill mouse model. PPSIG was so named because 
this gene was significantly induced by PPs, or under short-term 72 h starvation. Such 
induction was only observed in wild-type but not in PPARa knockout mice, 
suggesting that PPSIG is a potential PPARa target gene. Gen Bank database search of 
the PPSIG cDNA sequence indicated that PPSIG was 100% similar to the 3，end of a 
Riken cDNA 0610039N19 (NM—026159) and a mouse all-trans-13,14-dihydroretinol 
saturase (RetSat) with unknown physiological function. Further characterization of 
PPSIG is required to understand its physiological function. 
In the present study, the full-length cDNA sequence of PPSIG was obtained by 
the rapid amplification of cDNA ends (RACE) method. The PPSIG cDNA existed as 
i 
multiple transcripts (1962, 2845 and 2989 bp) which were generated by 
polyadenylation. Two in-frame start codons (ATG) were found in PPSIG cDNA at 27 
and 1089 bp, respectively, whereas the transcription start site was 27 bp upstream of 
the first start codon. The stop codon was located at 1856 bp. The PPSIG full-length 
cDNA sequence displayed an extension in both 5' and 3' untranslated regions when 
compared to the Riken cDNA 0610039N19 and RetSat sequences. 
Examination of the PPSIG genomic sequence indicated that it contained 11 
exons and 10 introns which spanned 9825 bp. The two start codons were located in 
exons 1 and 6, while the stop codon was found in exon 11. Comparison of the 
genomic sequence of PPSIG with that of Riken cDNA 0610039N19 and RetSat 
revealed that PPSIG genomic sequence showed an extension in both 5' and 3’ ends. 
The PPSIG promoter and PPRE activities were also studied. Transient 
transfection experiments showed that the PPSIG 5'-flanking region from -375 to +119 
bp possessed promoter activity. Two putative PPREs (PPRE 1: +375 to +387; PPRE 2: 
+402 to +414) were predicted and studied in the intron 1 of PPSIG. Transient 
transfection experiments revealed that the PPSIG fragment from +94 to +435, which 
contained both PPREs 1 and 2，was responsible for the transcription activation by the 
PPARa/RXRa heterodimer. This result was further supported by the PPRE-deletion 
experiments from which removal of the PPSIG fragment (+191 to +435) abolished 
such transcriptional activation. Furthermore, site-directed mutagenesis studies showed 
that either deletion or mutation of PPRE 1 completely abolished the transactivation by 
PPARa/RXRa heterodimer, while deletion or mutation of PPRE 2 retained such 
activation, suggesting that only PPRE 1 was functional. In agreement to the site-
directed mutagenesis results, electrophoretic mobility shift assay indicated that 
PPARa/RXRa heterodimer only bound to PPRE 1 but not PPRE 2，further 
ii 
confirming that PPRE 1 was the functional PPRE of the PPSIG gene. Taken together, 
it is clear that PPSIG is a novel PPARa target gene which contains a functional 
intronic PPRE. Further characterization of this gene might increase our 
understandings on how PPSIG is involved in the PPARa-regulated toxicological as 




















的不同位置 ’ PPSIG有多個轉錄本（1962 ’ 2 8 4 5以及2 9 8 9 bp )。在P P S I G 
cDNA中有兩個同框的翻譚起始密碼子（ATG)，分別位于27和1089 b p � 而 
轉錄起始位點位于第一個ATG上游27bp °終止密碼子位于1856 b p � 相對于 
iv 
Riken cDNA 0610039N19 和 RetSat，PPSIG 的 5’和 3’的非翻譯區都更長一些。 
對PPSIG基因組序列的分析顯示它有11個外顯子和10個內含子，總共9852 
b p。兩個A T G分別位于外顯子1和外顯子6，而終止子位于外顯子1 1。將 
PPSIG基因組對比Riken cDNA 0610039N19和RetSat的基丨大 1組序列，顯示 
PPS1G基因組含有PPSIG更長的5’和3’的非翻譯區。 
本硏究也分析 / PPSIG的啓動子和其PPRE的活性。瞬時轉染實驗顯示 
PPSIG 5 ’ 端一 375至+119 bp片段具有啓動子活性。而兩個潜在的PPRE元件 
(PPRE 1: +375 至 +387; PPRE 2: +402 至 +414)位于 PPSIG 的內含子 1 範圍 
內。瞬時轉染實驗表明，同時含有PPRE 1和PPRE 2的P P S I G片段（+ 9 4至+ 
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Chapter 1 Introduction 
1.1 Peroxisome proliferators (PPs) 
Peroxisome proliferators (PPs) are a broad class of chemicals that are able to 
cause peroxisome proliferation in rats and mice, by significant increases in both 
number and size of peroxisomes (Gonzalez et al. 1998) and augment enzymatic 
activity associated with this organelle. Peroxisomes are single, membrane 
cytoplasmic organelles that are present in a wide variety of cells and perform several 
important metabolic functions, including H2O2 derived respiration, (3-oxidation of 
fatty acids and cholesterol metabolism (Lock et al. 1989). In addition to cause 
proliferation of peroxisomes, rodent exposure to PPs results in hepatocellular 
hypertrophy, hyperplasia and transcriptional induction of fatty acid-metabolizing 
enzymes regulated in parallel with peroxisome proliferation (Lock et al. 1989). 
Since 1976, it has been reported that chronic exposure to many PPs causes an 
increased incidence of liver tumors in rodents (Bull 2000; Hayashi et al. 1994; Hays «-
et cil- 2005; Lalwani et al. 1981; Laughter et al. 2004; Reddy et al. 1980; Reddy et al. 
1976) and this effect raises the concern of whether PPs also cause cancers in human, 
as PPs are environmentally abundant. 
Several pharmaceutical drugs and industrial chemicals are classified as PPs. 
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Medical examples include hypolipidemic drugs such as clofibrate and gemfibrozil 
and the experimental drug Wy-14,643 which is very potent (Kliewer et al 1994). 
Industrially, phthalate ester plasticizers and trichloroethylene are examples of PPs 
which are widespread environmental contaminants (Maronpot et al. 1995). It can be 
seen that PPs are environmentally abundant compounds and commonly exposed to 
human. Although PPs consist of a diverse group of chemicals, they have a structure 
similar to endogenous fatty acids, with a carboxylic acid functional group and a 
large hydrophobic domain (Vanden Heuvel 1999). Interestingly, treatment of rodents 
with starvation also induce peroxisomal enzyme expression which is similar to the 
effect of PPs, probably due to an induction in endogenous fatty acid in mice during 
fasting (Leone et al. 1999). From these results, it can be seen that the effects of 
elevated endogenous fatty acid level and PPs are similar. It is worth noting how 
these structural similar compounds elicit their biological responses, including 
peroxisome proliferation, hepatocellular hypertrophy and hyperplasia, 
transcriptional induction of fatty acid-metabolizing enzymes and most importantly, 
carcinoma formation. 
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1.2 Peroxisome proliferator-activated receptors (PPARs) 
1.2.1 What are PPARs? 
It was reported that a gene within the steroid receptor superfamily was 
activated by PPs (Issemann and Green 1990). The nuclear receptor encoded by this 
gene was given the name peroxisome proliferator-activated receptor (PPAR). 
Besides PPs, high fat diets, starvation, diabetes mellitus and vitamin E deficiency 
were also found to activate PPAR (Gottlicher et al. 1992; Schoonjans et al. 1996b). 
Similar to other members of the nuclear steroid superfamily, PPARs exist in three 
distinct isoforms, named PPARa, PPARp (or PPARa) and PPARy, encoded by 
separate genes (Dreyer et al. 1992). 
1.2.2 PPAR isoforms 
It is found that each PPAR isoform is differentially expressed in different 
tissues (Braissant et al. 1996). Their distinct tissue distributions suggest that the 
PP^R subtypes play different biological roles (Vanden Heuvel 1999). 
1.2.2.1 PPARp/a 
PPARp (or named as PPARa) is expressed ubiquitously, with relatively higher 
levels in the brain, adipose tissue and skin (Berger and Moller 2002; Braissant et al. 
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1996). The biological mechanisms of PPARp/a are found to be related to 
hyperlipidemia, athersclerosis, obesity (Dressel et cil. 2003; Tanaka et al. 2003; Wolf 
2003), fertility (Ding et al. 2003; Lim et al. 1999), inflammation (Schmuth et al. 
2004), cancer (Barak et al. 2002; Harman et al. 2004; He et al. 1999) and nervous 
system (Basu-Modak et al. 1999; Moreno et al 2004; Saluja et al. 2001; Smith et al. 
2004; Xing et al. 1995). As the functional identity of PPARp/a remains unclear, 
further investigations are required to study its biological roles. 
1.2.2.2 PPARy 
The PPARy gene contains three promoters that yield three isoforms, namely 
PPARyl, PPARy2 (Fajas et al. 1997) and PPAR丫3 (Fajas et al. 1998). Their mRNA 
levels are tissue-specific, in which PPARyl is found in a broad range of tissues, 
PPARy2 is restricted to adipose tissue and PPARyS is abundant in macrophages, 
large intestine and white adipose tissue (Braissant et al. 1996). PPARyl and PPARyB 
R^ NA transcripts are both translated to the identical PPARyl protein, while PPAR丫2 
transcript translates to PPARyZ protein. The biological mechanisms of PPARy are 
relevant to adipocyte differentiation (Shao and Lazar 1997), insulin sensitization 
(Miles et al. 2000; Olefsky 2000; Shibasaki et al. 2003; Shimaya et al. 1997), cancer 
(Bull 2003; Demetri et al. 1999; Heaney 2003; Koeffler 2003; Leibowitz and 
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Kantoff 2003; Tsujie et al. 2003)，inflammation, atherosclerosis (Kota et cil. 2005) 
and retinal disorders (Aoun et al. 2003; Murata et al. 2000). 
1.2.2.3 PPARa 
PPARa has been the best characterized one among the three PPAR isoforms. 
It is highly expressed in liver and well expressed in kidney, heart, skeletal muscle 
and brown fat (Auboeuf et al. 1997; Braissant et al. 1996). PPARa is-reported to 
play an important role in a variety of biological pathways, including lipid 
metabolism, glucose metabolism, urea cycle, biotransformation, inflammation and 
acute phase response (Mandard et al. 2004). 
1.2.3 PPARa target genes 
1-2.3.1 Transcriptional regulation 
Recent evidence demonstrates that PPARa regulates its biological roles 
through modulating gene expression in a manner similar to that of other nuclear 
receptors (Gorton et al. 2000; Mandard et al. 2004). Once PPARa is activated by its 
ligands including PPs and endogenous fatty acids, it forms heterodimer with retinoid 
X receptor alpha (RXRa), which is the receptor for 9-cis retinoic acid (Gearing et al. 
1993). The PPARa/RXRa heterodimer binds to a specific DNA sequence on target 
5 
genes and thus regulates the target gene transcriptions. This specific DNA sequence 
is called peroxisome proliferator response element (PPRE), containing a direct 
repeat of 6 nucleotides spaced by 1 nucleotide (DRl) with a consensus sequence of 
AGGTCA-N-AGGTCA (Palmer et al. 1995). 
1.2.3.2 PPRE 
PPREs were found in many of PPARa target genes (Table 1.1) (Mandard et al. 
2004). The first identified PPARa target gene was acyl-CoA oxidase (ACO) which 
contained a functional PPRE in its promoter region (Tugwood et al. 1992). Since 
then, many PPREs were identified in the promoter regions of PPARa-regulating 
genes (Gorton et al. 2000). In 2002, a PPRE was identified in intron 1 of rat 
acyl-CoA binding protein (Helledie et al. 2002) and a PPRE was also found in intron 
3 of rat peroxisomal thiolase B gene afterward (Hansmannel et al. 2003). 
Furthermore, a PPRE was identified downstream of mouse PEXl l a gene which is a 
protein involved in peroxisome biogenesis (Shimizu et al. 2004). From these results, 
• , . 
It IS possible that PPREs could be present in the promoter, intronic or even 
downstream regions of PPARa target genes. Although PPREs are reported to share a 
common core sequence AGGTCA (or TGACCT) spaced by a single nucleotide 
(Palmer et al. 1995), PPRE sequences showing variation to the consensus 
6 
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Gene Organ Species Function PPRE sequence Location Reference 
of PP RE 
AcyJ-CoA binding Adipose Rat Fatty-acyl-CoA (Hell edie et at. 
GGGACA G AGGTCA I"tron I 
protein tis ue Human ester transport 2002) 
Rat Lipid metabolism TGACCT T TGTCCT (Yaranasi et al. 
Acy l-CoA ox idase Liver Promoter 
Human p-ox idation AGGTCAA TGGTA 1996) 
Acy l-CoA synthetase 
Liver Rat 
Lip id metabolism 
TGACTGA TGC CT Promoter 
(Sc hoonjans et 
(ACS) p-oxidation al. 1995) 
Apolipoprotein-A I Liver Rat Lipid metabolism TGACCC C TGCCCT Promoter 
(Yu-Dac et (fl. 
1994) 
Apolipoprotein-A I I Liver Human Lipid metabolism CAACCT T TACCCT Promoter 
(Yu-Dac et al. 
1995) 
Mouse (Yu-Dac et at. Apol ipoprotein-AY Liver Li pid metabolism AGGTTA A AGGTCA Promoter 
Human 2003) 
Apolipoprotein-C III 
Liver Human Lipid metabolism TGGGCA A AGGTCA Promoter 
(Krey et at. 
(apo CIII ) 1993) 
Bifunctional enzyme 
Liver Rat Lip id metabolism TGAACT A TTACCT Promoter 
(Zhang et al. 
(BE) 1992) 
Ca rnitine palmitoyl Skeletal Fatty acid (Mascaro et at. Human TGACCT T TTCCCT Promoter 




TGACCT T CAG AC Promoter 
(Ban'ero et at. 
-tran lerase II (C PT-II) metabolism 2003) 
Choles terol 70.- Mouse Regulate bile acid TCACCC A AGTTCA (Cheema and Liver Promoter hydroxyla c (C YP7 A I) Human synthesis TCAACC A AGCTCA Agellon 2000) 
Choles tcryl es ter Intracellular Macro- (Ghosh and Human cho lestero l CTGGGC TT CAGT Promoter hydrolase phage 
homeostasis Natarajan 200 I) 
Activate PPRE I: 
Cytoc hrome P450 1 A 1 
olon 
procarcinogen TGA CTC TG : C (Seree et al. Human Promoter (CY PIAI) ratty acid PPR 2: 2004) 
metabolism TGACCT C AGGG T 
Cytoc hrome P450 4A I 
Liver Rat 
Fatty acid 
AGGGTA A AGTTCA Promoter (.Johnsoll et (It. (CY P'+AI) metabo lism 1996) 
Cytochrome P450 4A6 Liver and Fatty acid (Muerhorr et al. Rabbit TGGGC A A GGGTC A Promoter (CYP4A6) kidney metabolism 1992) 
Cytoso lic fatty acid 
binding protein Liver Rat Fatty acid binding AGGCCA T AGGTC A Promoter (Poirier et al. 
(L- FAB P) 200 1) 
Desaturation of (Tang et al. Del ta -6-dcsa turase Liver Human AGGGAG G AGGTCG Promoter 
fatty-acyl CoA 2003) 
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Table 1.1 PPARa target genes with identified PPREs 
— Location „ 
Gene Organ Species Function PPRE sequence of PPRE Reference 
F a u y a a d t丨慕 p « n 丨 而 ^ o u s e a a d c c C G C A A A G C C C A Promote,- ~ " 
protcin-1 (FATl)-l) metabolism � … � 
Glyoxylate reductase [ 丽 Mouse � y o x y l a t e c G G T T A A A G G T C A P 酬 咖 . Z T ^ ^ ' " ' 
(GRHl)R) ‘ metabolism 2005) 
nydmxystemici ^iver Human Hepatic cholesterol 八沉丁0八 A AGGTAA Promoter ( F a n g e , " / . 2005) 
SLillbiransferase homeostasis 
Ileal b n e a u d - b � d i n g [ 而 Human ^ e acid x G A C C C T G C T G G C 
protein (1-BABP) homeostasis 
11 � 1 I Human A G G C C A G A G G T C A Prommer (Jung et al. 2002) 
transporter (1-13AT) intestinal transport 
Mitochondrial (Rodriguez et al. 
Liver Rat Lipid metabolism A G A C C T T TGGC'CC Promoter …八^ 亡 
l lM(i -CoA synthase 1994) 
Mcdium-chain � . , , . 
Fatly acid (Gulick et al. 
acyl-CoA Liver Ral GGGCAA AGGTC A Promoter 
oxidation � W4> 
dehydrogenase 
Hally acid (Hansniannel et al. 
I 'croxisomal thiolase B Liver Ral . ^ . TCCAGT T T T C A G T I n t r o n 3 
oxidation 200 3) 
Bioeenesis of Down- (Shimizu e( al. 
I)HX11« Liver Mouse ^ JCACCJJJCACCC ，如^ peroxisomes stream 2004) 
Repressor of (Gervois et al. 
Kev-erba Liver Human GTGTTA CT GGGGCA l)mmoter 
gene transcription 1999) 
Slcamyl-C'oA Desaturation of " � T . , � ’� (Miller and Ntambi 
, Liver Mouse ACiAlCiF G AACJI 1A l)mmota. 
uesaUiiase 1 (S("D-1) fatty-acyl CoA 1996) 
胁 >1 12a-hyciroxylase 匕 而 Mouse Bi leac id A G G T C C A A G G G C A Promoter ( H u n t e , « / . 2000) 
(CYP8B1) biosynthesis 
PPRE B: 
Sterol carrier protein-X Fatty acid GTGGAT T A C A G G A , � ，， ，，,、,、， 
,, ‘ Liver Rat Promoter (Lopez el al. 2003) 
(SCL)-X) metabolism PPRE A: 
T C C T G T A AC'TC'CXJ 
Tiansten-in Liver Human Iron transport TGAC'CT T TGACC'C" Promoter (HerV/. et al. 19%) 
,丨I�,� Metabolism of 
' J i J l -g lucuronosyl - , ',、，.， 
endoeenous and (Barbier el al. 
transferase 1A9 Liver Mouse ^ T C A C C T C T G A C C T Promoter ' ^^^ 
(UGT1A9) exogenous 2003) 
compounds 
Brown , , 
, (Barbera et al. 
^ Uncoupling prolein-l adipose Mouse Thermogenesis T C A C C C T TGAC'CA Promoter 2OOI) 
tissue 
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sequence were also found to be functional. Therefore, the functionality of a PPRE 
within a PPARa target gene must be confirmed experimentally. 
1.2.4 Physiological roles of PPARa 
1.2.4.1 Lipid metabolism 
Most research study focus on the role of PPARa and its target genes involved in 
lipid metabolism. The target genes identified could be divided into several aspects, 
including uptake of fatty acid, oxidation of fatty acid, fatty acid transport, 
hydroxlyation of fatty acids, ketogenesis, hepatic lipogenesis, lipoprotein metabolism, 
uncoupling proteins and hepatic bile acid metabolism (Table 1.2) (Mandard et al. 
2004). 
1.2.4.1.1 Cellular fatty acid uptake and fatty acid activation 
Hepatic fatty acid catabolism consists of several distinct pathways. The first 
step is their transport across the cell membrane. Fatty-acid transport protein-1 gene 
(FATP-1) which is an identified PPARa target gene is involved in uptake of 
long-chain fatty acids and oxidized low-density lipoproteins (Frohnert et al. 1999; 
Martin et al. 1997). PPARa is able to induce the transcription of FATP-1, suggesting 
that PPARa can activate the fatty acid uptake process. The inactive fatty acids 
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Table 1.2 PPARa target genes involved in lipid metabolism 
PPARa-regulated biological . . 
PPARa target genes involved 
process in lipid metabolism 
Cellular fatty acid uptake and fatty acid activation Fatty-acid transport protein-1 
Long-chain fatty acyl-CoA synthetase 
Intracellular fatty acid transport Fatty acid bind protein 
Acyl-CoA binding protein 
Mitochondrial fatty acid uptake Carnitine palmitoyltransferase enzyme I 
Malonyl-CoA decarboxylase 
Mitochondrial fatty-acid P-oxidation Medium-chain acyl-CoA dehydrogenase 
Peroxisomal fatty acid uptake ATP binding cassette half-transporter type 2 
ATP binding cassette half-transporter type 3 
Peroxisomal fatty acid oxidation Acyl-CoA oxidase 
Bifunctional enzyme 
3- Ketoacyl-CoA thiolase 
Sterol carrier protein X gene 





Ketogenesis 3-Hydroxy-3-methylglutaryl-CoA synthase gene 
Uile acid metabolism Sterol-12a-hydroxylase (CYP8B1) 
Sterol-27-hydroxylase 
Cholesterol 7a-hydi"0xylase (CYP7A1) 
Hydroxy steroid sulfotransferase 
Apical sodium-dependent bile acid transporter 
Ileal bile acid-binding protein 
Lipoprotein metabolism Apolipoprotein A-1 
Apolipoprotein A-II 
Rev-erba 
Hepatic lipogenesis Malic enzyme 
Stearoyl-CoA desaturrase 1 
A5-Desaturase and A6-desatuiase 
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molecules are required to be activated into their fatty acyl-CoA derivatives in order to 
be further metabolized. It is found that the long-chain fatty acyl-CoA synthetase 
which is necessary for the activation step, is transcriptionally induced by PPARa in 
liver (Martin et al. 1997; Schoonjans et al 1995). Thus, it could be seen that 
PPARa regulates cellular fatty acid uptake and fatty acid activation. The activated 
fatty acyl-CoA derivatives are either transported to mitochondria or peroxisomes for 
degradation into acetyl-CoA via p-oxidation. Mitochondria oxidize short-, medium-
and mostly long-chain fatty acids, while peroxisomes oxidize some long-chain but 
mostly very long-chain fatty acids (Mandard et al. 2004). 
1.2.4.1.2 Intracellular fatty acid transport 
The next step of hepatic fatty acid catabolism is the intracellular fatty acid 
transport between the plasma membrane and nucleus. This process is performed by 
liver fatty acid bind protein (Tan et al, 2002; Wolfrum et al. 2001) which is 
upregulated by benzafibrate and fatty acids in a PPARa-dependent manner, 
suggesting that the transport process is enhanced (Poirier et al. 2001). PPARa is also 
capable of inducing the transcription of the acyl-CoA binding protein (ACBP). 
ACBP specifically binds acyl-CoA esters (Helledie et al. 2002), which can function 
both as acceptor and donar of acyl-CoA esters and is able to transport acyl-CoA esters 
11 
(Rasmussen et al. 1993). 
1.2.4.1.3 Mitochondrial fatty acid uptake 
PPARa up-regulates target genes for the transport of activated long-chain fatty 
acids into the matrix of mitochondria, including 2 isotypes of the carnitine 
palmitoyltransferase (CPT) enzyme 1, named as CPT-la and CPT-ip (Brandt et al. 
1998; Mascaro et al. 1998; Yii et al 1998). Besides up-regulating CPT-I, PPARa is 
also reported to promote the transcription of malonyl-CoA decarboxylase which 
degrade malony-CoA to acetyl-CoA (Lee et al. 2004). As malony-CoA is an inhibitor 
of CPT-I (McGarry and Brown 2000; Rasmussen et al. 2002), PPARa increases the 
mitochondrial fatty acid uptake process through promoting the CPT-I transcription, as 
well as inducing degradation of CPT-I inhibitor malonyl-CoA. 
1.2.4.1.4 Mitochondrial fatty-acid P-oxidation 
PPARa up-regulates the expression of genes involved in mitochondrial (3-
oxiation of fatty-acids, including the short-, medium-, long- and very long-chain 
acyl-CoA dehydrogenase genes encode four different chain-length-specific enzymes 
that catalyze the first step in mitochondrial fatty acid P-oxidation (Mandard et al. 
2004). However, so far a functional PPRE has only been identified for the medium 
12 
chain acyl-CoA dehydrogenase (Gulick et al. 1994). 
1.2.4.1.5 Peroxisomal fatty acid uptake 
PPARa up-regulates the ATP binding cassette half-transporter type 2 (ABCD2) 
and type 3 (ABCD3) genes, which are thought to participate in the entry of very long 
chain fatty acids into the peroxisome (Borst and Elferink 2002; Fourcade et al. 2001). 
Though expressions of ABCD2 and ABCD3 were found to be PPARa-dependent and 
highly sensitive to PPARa agonists, however, no functional PPRE has been identified 
to date (Fourcade et al. 2001). 
1.2.4.1.6 Peroxisomal fatty acid oxidation 
PPARa up-regulates the expression of genes involved in peroxisomal 
P-oxiation of mainly very long chain polyunsaturated fatty acids. Acyl-CoA oxidase, 
which is the first PPARa target gene identified, is involved in catalyzing the 
conversion of acyl-CoA to enoyl-CoA (Tugwood et al. 1992). The enoyl-CoA 
hydratase produces hydroxyacyl-CoA from enoyl-CoA, which is then oxidized to 
ketoacyl-CoA by hydroxyacyl-CoA dehydrogenase. A single protein is capable of 
carry out these two enzymatic activities and is named as bifunctional enzyme (BIEN) 
which is transcriptionally induced by PPARa (Bardot et al. 1993; Zhang et al. 1992). 
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The ketoacyl-CoA formed is degraded to acetyl-CoA and an acyl-CoA shorten by 2 
carbons, by the action of 3-ketoacyl-CoA thiolase (thiolase B). The transcription of 
thiolase B is found to be induced by PPARa (Hansmannel et al. 2003). The sterol 
carrier protein X gene which encodes a thiolase enzyme involved in the peroxisomal 
P-oxidation of branched-chain fatty acids, is also reported as a PPARa target gene 
(Lopez et al. 2003). 
1.2.4.1.7 Micorsomal co-hydroxylation of fatty acids 
A minor pathway of hepatic fatty acid catabolism under basal conditions is the 
0) -hydroxylation that occurs in smooth endoplasmic reticulum and this pathway is 
governed by P450 4A (CYP4A) enzymes (Johnson et al. 1996) and enhanced by the 
condition of diabetes mellitus or fasting (Mandard et al. 2004). PPARa up-regulates 
CYP4A1 (Aldridge et al. 1995; Kroetz et al. 1998) and CYP4A6 (Muerhoff et al. 
1992; Palmer et al. 1994) in liver which are responsible for mediating the 
w-hydroxylation of fatty acid. Other CYP4A enzymes, including CYP4A3 (Kroetz et 
al. 1998), CYP4A10 and CYP4A14 (Barclay et al. 1999) were also reported to be 




Hepatic ketogenesis produces ketone bodies as fuel for the brain and peripheral 
tissues during prolonged fasting, in which the plasma glucose level is not enough to 
provide energy (McGarry and Foster 1980). The rate of ketone bodies synthesis in 
liver is enhanced by starvation as well as high fat diet in accordance to an increase in 
hepatic fatty acid oxidation and large amounts of acetyl-CoA are generated. It is 
reported that PPARa plays an important role in ketogenesis, by inducing the 
transcription of mitochondrial 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) 
synthase gene (Rodriguez et al. 1994). The hypoglycemia effect in fasted PPARa-null 
mice may be also related to ketogenesis. During fasting ketone bodies are produced as 
fuel for the brain and peripheral tissues during prolonged fasting, in which the plasma 
glucose level is not enough to provide energy (McGarry and Foster 1980). An 
increase in ketone bodies produced can be used to replace glucose as fuel to provide 
energy, hence maintaining the plasma glucose level to prevent hypoglycemia. 
1-2.4.1.9 Bile acid metabolism 
Bile acid synthesis is regulated by PPARa, which is important in four aspects. 
First, as bile acid is synthesized from cholesterol, it aids in preventing 
over-accumulation and abnormal deposition of cholesterol, especially in the coronary 
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arteries which eventually leads to atherosclerosis. Second, bile acids help to solubilize 
cholesterol in the bile, thereby preventing the precipitation of cholesterol in the 
gallbladder, preventing gallstone formation (Rodriguez et al. 1994). Third, bile acids 
enhance triacylglycerols digestion by emulsification that render fats accessible to 
pancreatic lipases. Fourth, they facilitate the intestinal absorption of fat-soluble 
vitamins and this is likely to be related to PPARa activation by vitamin E deficiency. 
It is found that several enzymes involved in bile acid biosynthesis pathway are 
regulated by PPARa. Sterol-12a-hydroxylase (CYP8B1) which is also involved in 
bile acid homeostatsis, is reported to be transcriptionally up-regulated by 
PPARa (Hunt et al. 2000), while sterol-27-hydroxylase is down-regulated (Post et al. 
2001). Moreover, PPARa also up-regulates the liver X receptor a (LXRa) during 
fasting, in which LXRa is responsible for regulating CYP7A1 transcription (Tobin et 
al. 2000). Interestingly, the key enzyme cholesterol 7a-hydroxylase (CYP7A1) 
involved in bile acid biosynthesis, showed opposite regulation by PPARa from the 
result of two different research groups. One group showed that CYP7A1 is 
叩-regulated by PPARa during fasting and treatment with hypolipidemic drugs 
(Cheema and Agellon 2000; Hunt et al. 2000), while another group reported that 
PPARa down-regulate CYP7A1 by PPARa agonist (Marrapodi and Chiang 2000; 
Patel et al. 2000). The reasons for presence of discrepancy among the results of these 
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studies are unclear at this moment. Moreover, human hepatic hydroxysteroid 
siilfotransferase (SULT2A1) which plays an important physiological role in the 
maintenance of hepatic bile acid homeostasis, is also reported to be transcriptional 
induced by PPARa (Fang et al. 2005). Since basal bile formation is not affected in 
PPARa-null mice, the role of PPARa in bile acid metabolism is thought to be 
dominant only under conditions of increased free fatty acids levels, for example, 
during prolonged fasting (Kok et al. 2003a; Kok et al. 2003b). 
PPARa is also implicated in playing roles in bile salts reabsorption. It is 
reported to induce the transcription of apical sodium-dependent bile acid transporter 
(ASBT) which is important for enterohepatic circulation (Jung et al. 2002). PPARa 
also up-regulates the expression of the ileal bile acid-binding protein (1-BABP), which 
might be a negative regulator of bile acid absorption, but the physiological role of 
I-BABP remains elusive (Landrier et al. 2005). 
1.2.4.1.10 Lipoprotein metabolism 
Fibrates are used as hypolipidemic drugs in human due to their ability to 
decrease plasma triglyceride and increase plasma high-density lipoprotein (HDL). 
Epidemiological studies have shown the inverse correlation between high plasma 
HDL level and cardiovascular diseases (Mandard et al. 2004). Since hypolipidemic 
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drugs are strong ligands of PPARa, it has been studied whether PPARa plays a role in 
lipoprotein metabolism. Human apolipoprotein A-I (ApoA-I) and apolipoprotein A-II 
(ApoA-II) which are involved in plasma HDL level, are up-regulated by 
PPARa (Vu-Dac et al 1998; Vu-Dac et al. 1995; Vu-Dac et al. 1994). PPARa also 
down-regulates the transcription of rev-erba, which is a negative transcription factor 
and believed to repress the apoA-I transciption (Gervois et al. 1999). 
1.2.4.1.11 Hepatic lipogenesis 
Besides playing roles in fatty acid catabolism, PPARa also up-regulates some 
genes involved in lipogenesis. One of the examples is malic enzyme, which catalyses 
the oxidative decarboxylation of malate into pyruvate, generating NADPH required 
for fatty acid biosynthesis (Castelein et al. 1994). Besides, PPARa are also reported to 
up-regulate the transcription of stearoyl-CoA desaturase 1 (A9-desatLirase) (Miller and 
Ntambi 1996), which is involved in fatty acid biosynthesis. Moreover, A5-desaturase 
and A6-desaturase were probably regulated by PPARa, although no PPRE has yet 
been identified (Guillou et al. 2002; Tang et al 2003). It is found that PPARa plays 
roles in both fatty acid oxidation and fatty acid biosynthesis, which seems to be 
opposite. Two explainations have been proposed. Firstly, PPARa mediates fatty acid 
biosynthesis in order to counteract the excessive fatty acid breakdown. Secondly, 
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biosynthesis of fatty acid ensures an ample supply of endogenous ligands PPARs 
activation (Guillou et al. 2002). 
1.2.4.2 Glucose metabolism 
The plasma glucose level is very important, as very low blood glucose 
concentrations can result in brain dysfunction, coma and death. Studies showed that 
PPARa-null mice suffer from significant hypoglycemia after fasting (Kersten et al. 
1999; Leone et al. 1999)，suggesting that PPARa is also implicated in playing roles in 
glucose metabolism, yet its role in glucose metabolism is not as well studied as that in 
lipid metabolism. 
1.2.4.2.1 Glycogenolysis 
Some research groups reported that under basal conditions, hepatic glycogen 
stores are strongly decreased in PPARa-null mice compared with wild-type mice 
(Kersten et al 1999; Xu et al. 2002), suggesting that PPARa might regulate the 
hepatic glycogen level by mediating the hepatic glycogen breakdown, glycogen 
synthesis or storage (Mandard et al. 2004). However, no PPARa target genes involved 
in these pathways have been identified. 
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1.2.4.2.2 Glycolysis 
Increased glucose utilization (glycolysis) is also another reason for 
hypoglycemia in fasted PPARa-niill mice (Mandard et al. 2004). During fasting, 
PPARa is found to up-regulate pyruvate dehydrogenase kinase isoform 4 {PDK4), 
which phorsphorylates and inactivates pyruvate dehydrogenase, thus limiting the rate 
of glycolysis (Holness et al. 2002; Sugden et al. 2001; Wu et al. 1999; Wu et al. 
2001). In PPARa-null mice, the lack of induction of PDK4 during fasting fails to 
inactivate pyruvate dehydrogenase and thus results in increased glycolysis. This 
explanation suggests that PPARa plays a role in glycolysis by regulating PDK4 
transcription, though no PPRE has been identified for PDK4 yet. 
1.2.4.2.3 Gluconeogenesis 
The gluconeogenesis is an important step to provide energy during fasting, by 
biosynthesis of glucose. It is found that glyoxylate reductase and hydroxypyruvate 
reductase (GRHPR) which plays a key role in directing the carbon flux to 
gluconeogenesis by converting hyroxypyruvate into D-glycetate (Holmes and 
Assimos 1998), is up-regulated by PPARa (Genolet et al. 2005). Moreover, 
alanine:glyoxylate aminotransferase (AGT) is also up-regulated by PPARa during 
fasting (Kersten et al. 2001), which is responsible for the conversion of glyoxylate 
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into glycine and serine into hydroxypyruvate and hydroxypyruvate enters the 
gluconeogenesis pathway. 
1.2.4.3 Urea cycle 
During fasting, PPARa represses amino acid catabolism and the urea cycle 
(Kersten et al 1999). This mechanism is important for maintaining the plasma 
glucose level. By repressing the amino acid catabolism during fasting, less glycine 
supplied by the glyoxylate cycle enters the urea cycle and can be reserved for 
biosynthesis of glucose through gluconeogenesis (Genolet et al. 2005). The urea cycle 
is catalyzed by five enzymes: arginino succinate lyase, arginino succinate synthase, 
carbamoyl phosphate synthase 1, ornithine transcarbamoylase and arginase. PPARa 
has an inhibitory effect on the expression of urea cycle enzymes in mice, with the 
exception of arginase, whose regulation is more complex (Kersten et al. 2001). No 
PPRE has been identified for these genes to date and the precise molecular 
mechanism of how PPARa regulates urea cycle requires further investigation. 
1.2.4.4 Biotransformation 
PPARa is reported to play roles in biotransformation, by both up- and 
down-regulating expression of xenobiotic metabolizing enzymes. Biotransformation 
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usually consists of three phases (Mandard et al. 2004). In phase 1, the xenobiotics is 
made more reactive by introducing a polar group. In phase II, the modified 
xenobiotics are conjugated with a polar molecule such as glucuronic acid or 
glutathione. In phase III, conjugated xenobiotics are excreted into the bile or urine via 
specific transporters, mainly by members of the superfamily of ATP-binding cassette 
transporter proteins (Borst and Elferink 2002). 
PPARa is reported to down-regulate several phase I enzymes involved in 
hydroxylation (CYP2A4, CYP2A1, CYP3A11 and CYP17) as well as 
dehydrogenation (3a, l i p and 17p hydroxysteroid dehydrogenase) of steroids 
(Gorton et al 1997; Fan et al. 1998; Heimanowski-Vosatka et al. 2000). The 
mechanisms involved still need to be investigated. Different peroxisome proliferators 
are able to decrease the expression of various glutathione-S-transferase involved in 
phase 11 biotransformation (Voskoboinik et al. 1996), resulting in decreased biliary 
excretion of glutathione conjugates. In addition to glutathione conjugation, PPs also 
affect phase II glucuronidation by inducing the UDP-glucuronsyltransferase 1A9 gene 
transcription through PPARa (Barbier et al. 2003). •• 
1.2.4.5 Inflamniation 
PPARa plays a critical role in inflammation by the evidence that prolonged 
duration of inflammation in PPARa-null mice (Devchand et al 1996), suggesting that 
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PPARa down-regulates the inflammatory response (Gorton et al. 1998). 
Cyclooxygenase 2 (C0X2) is identified as a PPARa target gene that is strongly 
up-regulated in mammary epithelial cells by fatty acids and PPARa agonists (Meade 
et al. 1999). C0X2 is believed to be responsible for much of the prostaglandin 
production in inflamed tissues and is found to be overexpressed in several human 
cancers (Mandard et al. 2004). 
1.2.4.6 Acute phase response 
PPARa is implicated to play a role in hepatic acute phase response, which is a 
variety of systemic changes in response to tissue injury and infection associated with 
endotoxemia or liver regeneration (Mandard et al. 2004). PPARa gene expression is 
down-regulated during the hepatic acute phase response (Beigneux et al. 2000; Su et 
al. 2002). PPARa down-regulates one of the acute phase protein, transferrin, which 
functions as an iron transporter and a growth factor (Hertz et al. 1996). PPARa 
agonists were also found to repress two other acute phase proteins, fibrinogen and a-1 
acid glycoprotein, through PPARa regulation (Gorton et al. 1998; Gervois et al. .2001; 
Kockx et al. 1999). 
1.2.5 Toxicological roles of PPARa 
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1.2.5.1 PPs induce hepatocarcinoma formation through PPARa 
Researchers are highly concerned with PPs-induced cancer formation. Since 
1983, several hypolipidemic drugs and industrial chemicals classified as PPs have 
been found to cause tumors in laboratory animals (Reddy and Lalwai 1983). The most 
convincing data regarding PPARa-mediated hepatocarcinoma formation comes from 
the development ofPPARa-null mice (Lee et al 1995). It was reported that mice that 
lacking PPARa expression do not display the PPs-induced pleiotropic responses, 
including peroxisome proliferation, hepatomegaly and transcriptional-regulation of 
target genes (Lee et al. 1995). More importantly, after 11 months treatment of 
Wy-14,643, all wild-type mice developed hepatocellular neoplasms, such as 
adenomas and carcinomas, while the PPARa-null mice were unaffected (Peters et al. 
1997). These studies prove that PPARa is required in mediating carcinogenicity of 
Wy-14,643, one of the most potent PPs. 
Further evidences that PPARa mediates PPs-induced carcinomas are provided 
by David et al. and Laugther et al" In their studies, it is reported that PPARa played a 
dominant role in mediating hepatocarcinogenesis in rodents upon exposure to 
di(2-ethylhexyl)phthalate (DEHP) (David et al. 1999) and trichloroethylene (TCE) 
(Laughter et al. 2004)，in which both DEHP and TCE are kinds of PPs. From these 
results, it is widely believed that all PPs cause liver tumors in rodents through PPARa 
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activation (Bosgra et al. 2005). 
1.2.5.2 Mechanism of PPARa-mediated PP-induced hepatocarcinoma 
1.2.5.2.1 Oxidative stress 
Several peroxisomal oxidases that could lead to increased generation of H2O2 
are induced by PPs activation (Yeldandi et al. 2000). An important example is 
acyl-CoA oxidase (ACO) expression, which is well-known to be induced by PPARa 
ligands through PPARa regulation (Tugwood et al. 1992). During the P-oxidation 
pathway in fatty acid metabolism, ACO produces H2O2 as a by-product, which in 
normal state is detoxified by catalase to form H2O. The marked induction of ACO and 
only slight increase of catalase following exposure to PPs have been postulated to 
cause increase in cellular H2O2 and hence oxidative stress, thus results in DNA 
damage in hepatocytes (Conway et al. 1989; Reddy and Rao 1989). Also, increased 
cellular H2O2 could potentially react with metals to generate highly reactive hydroxyl 
radicals or react with lipids to product lipid peroxides that could damage DNA or 
proteins (Yeldandi et al. 2000). •• 
The hypothesis that PPs-induced cancer formation is due to oxidative DNA 
damage resulting from transcriptional induction of ACO and thus subsequent H2O2 
generation, is agreed with the observation of Rusyn et al which introduced base 
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excision repair system (BER) as marker of oxidative stress (Rusyn et al. 2000). Their 
study reported that all genes involved in BER for 8-OH-dG removal including OGGl, 
AP endonuclease (APE), polymerase (3 and ligase (Bohr and Dianov 1999; Tomkinson 
and Mackey 1998) are induced in both rat and mouse liver in response to Wy-14,643, 
providing evidence for the role of oxidative stress in PPs-mediated carcinogenesis 
(Rusyn et al. 2000). 
1.2.5.2.2 Hepatocellular proliferation and inhibition of apoptosis 
Hepatocarcinoma formation in rodents fed with PPs is associated with the 
proliferation of cells with DNA damage and gene mutations, which eventually form 
tumors (Vanden Heuvel 1999). Proliferation of cells is a balance between mitosis and 
apoptosis. The hypothesis that PPARa is responsible for PPs-induced liver cancer 
formation is supported by the fact that activation of PPARa mediates induction in 
hepatocellular proliferation and inhibition of apoptosis (Peters et al. 1997; Vanden 
Heuvel 1999). This evidence is strongly supported by observations in PPARa-null 
mice that are refectory to all of these changes in response to long-term ligand-feeding 
studies (Hays et al. 2005; Peters et al. 1997; Vanden Heuvel 1999). These studies 
clearly showed that PPARa agonists lead to increased cell proliferation and inhibition 
of programmed cell death, however, no specific target genes mediating these events is 
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identified. Though the precise mechanisms how PPARa mediates mitosis and 
apoptosis are unclear, the strength of the evidence is strong that causally link changes 
in cell proliferation and apoptosis to PPARa agonist-induced hepatocarcinogenesis 
(Klaunig et al. 2003). 
1.3 Discovery of novel PPARa target genes 
It is clear that PPARa plays important roles in different biological functions 
(Kota et al. 2005; Mandard et al. 2004) as well as PP-induced hepatocarcinoma 
formation in rodent (Bosgra et al. 2005; Hays et al. 2005; Laughter et al 2004; Peters 
et al. 1997; Vanden Heuvel 1999). PPARa mediates its biological and toxicological 
effects through transcriptional regulation of a diverse spectrum of target genes 
(Corton et al. 2000; Mandard et al. 2004). However, the full spectrum of these 
PPARa target genes is still not fully known. Identification of novel PPARa target 
genes might help in understanding the mechanism of PPARa-mediated physiological 
and PP-induced toxicological pathways. 
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1.3.1 Peroxisome proliferator and starvation-induced gene (PPSIG) 
1.3.1.1 PPSIG is a putative P P A R a target gene 
A 580 bp cDNA fragment (D3#3), which was displayed at higher levels in 
wild-type mice fasted for 72 h, was recovered from the fluorescent differential display 
gel (Figure 1.1), reamplified and used as a probe on Northern blot of liver RNA from 
wild-type and PPARa-null mice either fed or fasted for 72 h. The cDNA hybridizes to 
two transcripts o f - 2 0 0 0 and -3000 bp, which are all expressed at significantly higher 
levels in wild-type but not in PPARa-null mice fasted for 72 h (Figure 1.2). Similarly, 
D3#3 C D N A hybridizes to two transcripts of -2000 and -3000 bp, which are all 
expressed at significantly higher levels in wild-type but not in PPARa-null mice 
following 11 -month Wy-14,643 treatment (Figure 1.3). Since the expression of D3#3 
Was induced by both PP and starvation, we named this gene as peroxisome 
proliferator and starvation-induced gene (PPSIG). The fact that the up-regulation of 
PPSIG by PP and starvation was absent in PPARa-null mice, suggesting that PPARa 
is a transcription regulator of PPSIG and that PPSIG is a putative PPARa target gene. 
1-3.1.2 Examination of PPSIG FDD fragment cDNA sequence 
A GenBank database search of the PPSIG FDD cDNA sequence was performed 
to identify whether it is matched to any known gene. The blast search result indicated 
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Figure 1.1 Fluorescent differential display of D3#3 
Total liver RNA from wild-type and PPARa-null mice either fed with a control diet 
(Fed) or starved for three days (Starved) was reverse transcribed using an anchored 
primer AP3 (5 ‘ -ACGACTCACTATAGGGCT12GA-3 ‘). Two mice were used in each 
treatment group and PGR reactions were performed in duplicate for each mouse using 
TMR fluorescent-labeled anchor primer AP3 and arbitrary primer ARP12 
(5'-ACAATTTCACACAGGAGGTAACTAAGG- 3，）. The TMR-labeled fluorescent 
PCR products were resolved on a 5.6% denaturing polyacrylamide gel. A cDNA 
fragment of about 580 bp was significantly induced by starvation in wild-type but not 
in PPARa-null mice, suggesting that this gene was a putative PPARa-target gene. M, 
TMR-labeled molecular weight DNA marker. (Adapt from From Lo Kam Chun, 






















































































































































































































































































































































































































































































































































































































































































































































































































thai PPSIG is 100% similar to the 3，end of a Riken cDNA 0610039N19 with 
unknown function under accession number NM—026159 (Figure 1.4). In addition, 
PPSIG has high similarity to rat hypothetical protein RMT-7 mRNA (AF465614) and 
human cDNA FLJ90780 fis, clone THYR01001237 (AK075261) (Figure 1.5), 
indicating that PPSIG is conserved in mammals. In 2004 Moise et al. identified Riken 
cDNA 0610039N19 as mouse all-trans-13,14-dihyroretinol saturase (RetSat) and this 
gene is also conserved in rat and human (Figure 1.6). In their study, they found that 
RetSat is related to the retinoids family. Retinoids are essential for many important 
biological functions including development, immunity, cellular differentiation and 
vision of vertebrates. The expression of RetSat in transfected cells revealed that it 
catalyzes the saturation of all-trans-retinol at the 13-14 double bond. However, the 
biological function of the saturated product, all-trans-13,14-dihydroretinol is unknown. 
Therefore, it is still an open question about the functional role of PPSIG in 
PPARa-regulated biological functions. 
1.4 Obj ectives of the present study 
As PPSIG is a putative novel PPARa target gene with unknown biological 
function, further characterization of this novel gene might provide valuable 
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Score = 833 bits (420}, Expect = 0.0 
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D3#3 23 AAQGQCAAGCGTGGTGTTGACTATQAGACCCTCAAAAATGCCTTCGTGGAAGCCTCTATG 82 
M 丨 M I M M M H 川 ⑴ M M U : iM<.m"m I M M M L 
Riken 1432 AAGGGCAAGCGTGGTGTTGACTATGAGACCCTCAAAAATGCCTTCGTGGAAGCCTCTATG 1491 
B3 TCGGTOATCATGAAACTQTTCCCACAOCTQCUMWaCAAaOTOOAQAOTQTQACTQGAGGG 142 
M 1 i i i i M i H M M I H i 11 n 11 M • I i I - M 1, 11 h I! 1" M M M i 1 i: 
Riken 14 92 TCGGTGATCJ^GAAACTGrrCCCACAOCTaaAOaGaUMjaTOOAaAaTGTa&CTaaXOaa 1551 
I>3#3 14 5 TCACCACTCJACCAACCAGTACTATCTQGCTaCACCCCGAQGAGCTACCTATGGAQCTGAC 202 
m I m 丨 I m 1 m 111 m m : m " m : m . : m m m I 丨丨…卜 
Siken 15S2 TCACCAOTGACCAACCAGTACTATCTGGCTaCACCCCGAGaAGCTACCTATOGAOCTGAC 1611 
D3#3 203 CATQACTraaCTCaOCTGCATCCTCATGCAATGGCTTCCATAAGAGCCCAAACCCCCATC： 262 
mmimii丨mmmmmh;m:.⑴： im m丨 ‘ i i u � . 
Riken 1612 CATGACTTQGCTCGGCTGCATCCTCA'XGCAAIGGCTTCCATAAGAGCCCAAACCCCCATC 1671 
D3#3 263 CCCAACCTCTACCTGACAaGCCAAaWfAUCTTCXCCTOTGGOCTaMroaoaOCCCTOCAG 322 
M M m m � I m 1111 m H � ： � i 丨；：m ; i I h q 1": m ” m 
Riken 1672 CCCAACCTCTACCTtaCAOaCCAAOMATCTTCACCTGTGGGCTGATGaGGGCCCTGCAG 1731 
I>3#3 323 GQOGCCTTGCTCraCAOCAaTGCCATCCTaAAACaaAACTTGTAOTCAGATCTGCAGGCT 382 
m m 11 m 丨丨 1: m m! m m m m 丨；m : 11 r�111:. m 丨 M 丨 
Silten 1732 a<300CCTT<3CTOTGCAOaMnOCCATCCT<»AAC:GGAACTTGTACTCAGATCTGCAGGCT 1791 
D3#3 383 CTTGGCTCAAAGGTCAAGGCACAAAAGAAGAAGATGTAGTCCGTTCAGAGAAGAGCCAGA. 442 
HiiniiMnihii iMMiiiMiiri i i： Ml i i r d i n Ml 111. Riken 17 92 CTTOaCTCAAAOOTCAIlOaCACWUIkAOAAaWUaATGTAGTCCGrCAaAGAAGAGCCAGA 1851 V-
Figure 1.4 Alignment of the cDNA sequence of PPSIG FDD fragment with the 
3' end of Riken cDNA 0610039N19 
(A) The cDNA sequence of PPSIG FDD fragment (D3#3). The sequences of AP3 and 
ARP12 that were used to amplified the PPSIG FDD fragment are bolded. The gene 
specific sequence of FDD fragment was 555 bp. (B) Blast search result of PPSIG 
FDD fragment cDNA sequence in GenBank. It was shown that D3#3 cDNA fragment 
sequence from 23 to 442 bp was 100% similar to the 3’ end of Riken cDNA 
0610039N19 (NM—026159) from 1432 to 1851 bp. 
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Mouse ATGGTTCGAGGAGTGGCAOGAGGAGCCAAAGGGCAAOCGTGGTOTTGACTATGAGACCCT 1 4 6 3 
R a t ATGGTTCGAGGAQTGGCAGOAGGAGCCTAAGGGCAAOCGAGGTGTTGACTATGAGACCCT 1463 
Huinan GTGGTTTGAGGAGTOGCAGGCGGAGCTGAAGGGAAAGCGOGGCAGTGACTATGAGACCTT 1479 
D3#3 ACAATTTCACA CAGGAGGTACT-AAGGGCAAGCGTGGTGTTGACTATGAGACCCT 54 
喻賣 * * * * * 喻賣 • * * * * * * * * * * * * * * * * * * * * * * * • 
Mouse CWU^AATGCCTTCGTGGAAGCCTCTATGTCGGTGATCATGAAACTGTTCCCACAGCTGGA 1523 
R a t CAAAAATACCTTCCGGGAAGCCTCTATGTCGGTGATCATGAAACTGTTCCCACAGCTGGA 1 5 2 3 
Huioan CAAAAACTCCTTTGTGGAAGCCTCTATGTCAGTGGTCCTGAAACTGTTCCCACAGCTOGA 1539 
D3#3 CAAAAATGCCTTCGTGGAAGCCTCXATGTCGGTGATCATGAAACTGTTCCCACAGCTGGA 114 
Mouse GGGCAAGGTGGAGAGTGTOACTGGAGOGTCACCACTGACCAACCAGTACTATCTGGCTOC 1583 
Rat AGGCAAGGTGGAGAGTGTGACTGGAGGATCCCCACTGACCAACCAGTACTATCTGGCTQC 1583 
Human GGGGAAGGTGGAGAGTGTOACTGCAGGATCCCCACTCACCAACCAGTTCTATCTGGCTGC 1599 
GGGCAAGGTOGAGAOTGTGACTGGAGGGTCACCACTGACCAACCAGTACTATCTGGCTGC 174 
Mouse ACCCCGAGGAGCTACCTATGGAGCTGACCATGACTTGGCTCGGCTGCATCCTCATGCAAT 1643 
R a t ACACCaAGGAGCTACTTATGGGOCTGa^CCATGACCrGGCTCGTCTGCATCCTCATGCAAT 1 6 4 3 
Human TCCCCGAQGTGCCTGCTACGGGGCTGACCATGACCTGGOCCGCCTGCACCCTTGTGTGAT 1659 
ACCCCGAGGAGCTACCTATGGAGCTGACCATGACTTGGCTCGGCTGCATCCTCATGCAAT 234 
* •俞 * • * « « * « * * * * * * « • « * * « • « « « 喻 * 貪 * « 
Mouse GGCTTCCATAAGAGCCCAAACCCCCATCCCCAACCTCTACCTGACAGGCCAAGATATCTT 1703 
R a t GGCTTCCCTAAGAGCCCAAACCCCCATCCCCAACCTCTACCTGACAGGCCAAGATATCTT 1 7 0 3 
Human GGCCTCCTTGAGQGCCCAOAGCCCCATCCCCAACCTCTATCTGACAGGCCAGGATATCTT 1719 
D3#3 GGCTTCCATAAGAGCCCAAACCCCCATCCCCAACCTCTACCTGACAGGCCAAGATATCTT 294 
Mouse CACCTGTGOQCTGATGGGOOCCCTGCAOOGGGCCTTGCTGTGCAOCAGTGCCATCCTGAA 1763 
Rat CACCTGTGGOCTGATGGQGGCCCTGOU^GGGGCCCTGCTGTGCAGCAGTGCCATCCTGAA 1763 
Human CACCTGTGGACTGGTCGGGOCCCTGCAAGGTGCCCTGCTGTGCAOCAGCGCCATCCTGAA 1779 
D3#3 CACCTGTOGOCTGATGGOGGCCCTOCAGGGGOCCTTGCTGTGCAGCAGTOCCATCCTGAA 3 54 
Mouse ACGGAACTTGTACTCAGATCTGCAGGCTCTTGGCTCAAAGGTCAAGGCACAAAAGAAGAA 1823 
Rat ACGGAACCTGTACTCAGATCTOCAGGCTCTTGGCTCAAAGGTCAGGGCACAAAAGAAGAA 1823 
Human GCGGAACTTGTACTCAGACCTTAAGAATCTTGATTCTAGGATCCGGGCACAGAAGAAAAA 183d 
ACGGAACTTGTACTCAQATCTGCAGGCTCTTGGCTCAAAGGTCAAGGCACAAAAGAAGAA 414 
Mouse GATGTAGTCCGTTCAGAGAAGAOCCAGA 1 8 5 1 
^ ^ t GAAGTAGTCTATTCAGAGATGAGCTAGAGGAA - - 1 8 5 5 
Human GAATTAGTTCCATCAGGGAGGAGTCAGAGGAATTTGCCCAATGGCTGGOGCATCTCCCTT 1899 
GATGTAGTCCGTTCAGAGAAGAGCCAGAGGAAA GGCACCTCCCCAAC 4 6 1 
* * * * * * * * * * * * * * 
Mouse 
Rat 
Human GACTTACCCATAATCTCTTTCTGCATTAGTrCCTTGCACGTATAAAGCACTCTAATTTOG 1959 
啡 3 TTCTCGTGGTGTCCTCCCTCCTACAGCAATTCCTTGCACATATAAACAAAAACCATTTTG 5 2 1 
Mouse 
Rat 
Human TTCTGATGCCTGAAGAGAGGCCTAGTTTAAATCACAATTCCGAATCTGGGGCAATGGAAT 2019 
妇 T T - T C C C A J I A A A A A A A A A O C C C T A T A G T O A G T C G T 555 .. 
Figure 1.5 The cDNA sequence of PPSIG FDD fragment is conserved in mouse， 
rat and human 
GenBank database search of cDNA sequence of PPSIG FDD fragment D3#3 showed 
similarity to mouse Riken cDNA 0610039N19 (NM_026159), rat hypothetical protein 
mRNA (AF465614) and human cDNA FU90780 fis, clone THYR01001237 
(AK075261). 
The matched nucleotides are indicated by *. 
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This is a blank page 
Jtouse -Riken ATCTGGAT--CACTGCT-CTGCTGCTGXaCCGTGCTGCTG 36 
ftouse -RetSat ATGTGGAT- -CACTGCT-CTGCTGCTSGCCGTGCTGCTG 36 
Rat-RetSat ATGTGGAT- -CACTGCT-CTGCTGCTOGTCGTaCTGCTTG 3.6 
miman-RetSat ACrcrCGACCCQAOGCCGGOGiTaATSTGGCTrCCaCTGGTGCTGCTCCTaaCTGTaCTGSCrG 60 
Mouse-Riken CTXaGTGATCCTCCACAGOGTCTACGTGOGCCTTTACGCTGCAAGTTCCCCGAACCCCTTC 96 
Mouse-RetSat CTaGTGATCCTCCACAGaGTCTACGTGQGCCTrrACGCTGCAAOrTCCCCGAACCCCTTC 96 
Rat - R ©tSat CTOGrGGTCGTTCACAGOGSTTTATGTGCSGCCTTTTCACCGGAAGrTCCCCGAACCCCTTC 9 6 
Human-RetSat CTOGCCGTCCTTCTrGCAAAGTTTACTTGaGACTATTCTCTGGCAGCTCCCCGAATCCITTC 120 
Mouse-Riken GCOGSAGGATGTCAAGCGACCGCCTGAACCCCTOGTGACCGACAAGGAOGCTAOCSAAGAAA 156 
Mouse -RetSat GCOGAGGATGTCAAGCGACCGCCTGAACrCCCTOSrGACCGACAAGGAaaCTAaaAAGAAft^  156 
Rat - RetSat GCTOAGGATGTCAAGCGGCCACCTGAACCCCTAGTGACCGACAAGGAaGCTAOaAAGAAA 156 
Human-Retsat TCCGAAGJiTGTCAAACGGKrCCCCAGCGCCCCTOaTAACTGACAAGGAQSCCAaaAAGAAa 180 
食 * 貪 •• *食 « * • 食食會喻亩 # * •會 贪 • • • K l 食 會 食 俞 
Mouse -Riken GTTCTCAAACAAGCTTTCTCi^GTCAGCCGAGTJVCCAGAaAAGCTGGATaCAGTOGTGATC 216 MOUSG - R e t s a t GTTCTCAAACAAGCTTTCTCAGTCAGCOGlAGTACCAGACAAGCTGGATGCAGTaGTGATC! 2 1 6 
Rat-R©tSat GTTCTCAAACAAGCrTTCTCAGTCAGCCGAGTACCAGAGAAGCTGGAOGCAGTGGTGATr 216 
Human-Retsat GTrCTCAAACAAGCTTTTTCAGCCAACCAAGTGCCGGAGAAGCTGGATGTGGTGGTAATT 240 
MDUSe -Riken GGCAGCGGCATTOGGGGACTGGCCTCAGCTGOQSTTCTAGCTAAAGCTGGCAAGAGACTC 276 
Mouse -RetSat GGCAGCGGCA/TTOGGGGACTGGCCTCAGCTGOOGTTCTAGCTAAAGCraGCAAGAGACTC： 276 Rat-RetSat GGCAGCQGCATTaGGGGACTGOCCrCAGCTGCOaTTCTAGCTAAAGCTOGCAAGAGACTC 276 
Human-Retsat GGCAGTGGCTVTTOGGGGCCTGGCrGCAGCTGCAATTCTAGCTAAAGCTGGCAAGCGAGrC 300 
MDU3G -Riken CTTGTGerGGAACAACATiVCCAAGGCGaGCGGCrGTTGTCMrJkCCa^TTaGGGAAAATOSC 336 
Mouse -RetSat CTTGTGCTaGAACAACATACCAAGGCG<3GCGGCTGTTCTCATACCTTT<3GGGAAAATaaC 336 
Rat -RetSat CTTGTGCTGGAACAACACACCAAGGCAOGCGGCTGTTGTCATACCTTTGGGGAAAATOGC 336 
Human-Retsat CTaaTGCTaGAACAACATACCAAGGCAOGGGGCTGCTCTCATACrCTTTCGAAAaAATOaC 360 
Mouse -Riken CTTGAATTTGACACTGGAATTCATrATATTGGACGAATGCGGGAGGGCAACATTGOCCGr 396 
Mouse -RetSat CTTGAA/nTGACACTGGAATTCATTrATATTGGACGAATaCGGaAGGGCAACATTGGCOar 396 
Rat-RetSat CTTOAAlTTGACACTGGAATrTCATTATATTGGACGAATGCGGGAGGGCAACATTGGCCQT 396 
Human-RetSat CTTGAATrGACACAGGAATCCATTACATTGGGCGmTGGAAGAGGGCAGCATTGGCOGT 420 
Mouse -RIken TTrATCTTaGACCAGATCACTGAAGGGCAACTOaRCTOGGCCCCCATOOCCTCCCCmTr 456 
Mouse-R6tsat TTTATCTTGGACCAGATCACTGAAGGGCAACroGACTaGGCCCCCATaGCCTCCCCTTTT 456 
Rat-RetSat TTCATCTTGGACGAGATCACCGAAGGGCAACTOaACTOaGCCCCrATaGCCTCCCCTTTr 456 
Human-R©tsat TTTATCTTGOACCAGATCACSTGAAGGGCAGCTaaACTaaGeTCCCCTGrrCCTCTCCTTTr 480 
MOUS© -Riken GACTTGATCA/rACTAGAAGGGCCCAATOGCCGAAAGGAOTTCCCCATaTACACTGGGAGG 516 
Mouse -RetSat GACTTGATGATACTAGAAOGOCCCAATaaCCGAAAGGAGTTCCCCATOTACACTGGGAGG 516 
Rat - RetSat GACTTGATGATiVCTAGAAOGACrCCAATaGCICGAAAaGAGT^TGCCCATGTACAOTGaOJVGa 516 
Human-RetSat GACATCATaGTACTGGAAGGGCCCAATaaCCGAAAGGAGTACCCCATOTACAOTGGAGAG &40 
會會會 • 囔會 * 省噢食食 耆食會貪會 會 龠 會 * 食 會 會 * 夤 會 食 會 會 會 食 食 食 會食會會喻食會會 *會會會 *贪《 舍 Mouse -Riken AAAGAATACATCCAGGGCCTTAAGAAGAAGTTCCCCAAGGAAGAAGCraTCATTGACAAG 576 Mouse-RetSat AAAGAATACATCCAGGGCCTTAJWSAAGAAGTTCCCCAAGGAAGAAGCTGrCATTGACAACS 576 
Rat _RetSat AAAGAATACATCCAGGGCCTTAAGGAGAAGTTCC*CCAAGGAAGAGG<rGTCATTGACAAA 576 
Human-Retsat AAAGCCTACAa*TCAGGGCCTCAAGaAGAAGTTrCCACAaGAG<3AAGCTATCATTGACAAG 600 
MDUSG -Riken TACATGGAGTTGaTTAAQGTGGTGGCCOGTGGAGTCTCTCATGCAGTTCTACTCAAGTTC 6B6 
Mouse -Retsat TACATGGAGTTGCTTAAOGTGOTGGCCCGTGGAaTCTCTCATGCAaTTCTACTCAAGTTC 636 
Rat - RetSat ^TACATGGAGCTaaTTAAOSTGGTGaCCCArGGAaTCTCTCATaCCATCCTACTOAAGTTC €36 
Human-Rets at 了 JVrATAAAGCTGGTTAAaGTGGTATCCAGTOGAOCICCCTCATGCCATCCTaTTaAAATTC 660 ** * * 會會 • 會 • 食 會 • ITR 會會•喻會會 itir • , * ••會 Mouse -RikiSn CTCCCATTOCCCTTGACTCAGCTCCTCAGCAACTTTGOaCT^ACTGACTCGITrCTCTCCA 696 Mouse -RetSat CTCCCATTGCCCrTGACrCAGCTCCTCAGCAACTTTGOaCTACTGACTCGTTTCTCTCCA 696 Rat-RetSat CTCCCA/rrSCCCrrGACTCAGCTCCTCAACAAOTTTGOaCTGCTGACTCGTTTrTCTCCA 696 Human-Retsat CTCCCATTGCCOGrGGTTCAGCTCCTOaACAGCTGTGOaCTGCTGACTCGTTTCTCTCCA 720 
Mouse -RiKen TTCTGCOGAGCGTCTACGCAGAGCCTAGCTGAAOTCCraCAOCAOCTraGQCCTrTCCCGT 75G 
Mouse -RetSat TTCTGCOOAGCGTCTiVOGCAGAGCCrTAacrGAAGTCCTGCAGCAGCTrGGGGCTTCCCGT 756 
Rat-R©tSat TTCTGCOaAGCGTCTACTCAGAGCCTAGCrGAAGTCCTGAAACAGCTTGGGGCTTCCCCT 756 
Human-R&ts SL t TTCCTTCAAGCATCCACCCAGAaCCTaGCTOAaGTCCraCAGCAGCTaKSGGGCCTCCTCT 780 * ** * ** * ** ******** *** ** * » * « # ‘** * 
Mouse -Ri kan GAaCTCCAGGCTGfTTCTCAGCTACATCTTCCCCACTTACGGAarAACTCCCAGCCACACC 816 
Mouse -Rets at GAGCrCCAGGCTGriTCTCAGCTACATCTTCCCCACTTACOGACTAACTCCCAGCCACACC 81G 
Rat _ RetSat GAGCTCCAGGCTCTrCTTAGCTACATTTTACCCACTTACGGAOTAACCCCCAGCCATACC 816 
Human-Retsat GAGC^TCCAGGCAOT及CTCAGCTACATCTTCCCCACTTACGGTOrCACrCCCGAACCIACrAGI： 640 
• $ftr * * » * * » * * 龠 會 • 贲 * 會會會 * 會 會 * 
Mouse-Riken GCCTTTTCCTTGCATGCTCTGCTGGTTGACCACTACATACAAOGGGCATATTACCCTCGA 876 
MOfUS©-Re tSa t (iCCTTTTCCrTGCArGCTCrGCTrGGTTaACCACTACATACAAaaGGCATATTACCCITOaA 8 7 6 
Rat-Retsat iXrCTTTTCCrTGCACGCTCTGCTraGTTSACCACTACATACAAaGGGCATJVTTACCCCCGA 876 
Human-Retsat GCCTTTTCCATGCACGCCCTGOTaGTCAACCACrACATGAAAOaAGGCTTTTATCCCCaA 900 
Mouse -Riken GGOGGTTCCAGTGAGATOaCCTTCCATACCATCCCTTTGATTCAGCGOaCOSaGGGCGCT 956 
MDUSO-RotSat GGOGGTTCCAGTaAGATOGCCTTCCATACCATCCCTTrrGATTCAGCGGaCCGOGGacaCT 936 
R a t - R e t s a t CGOGGCTCCAGTGlAGA/nXSCTTTCCATACCATCCCTrrGaVTTCAGCaOGCCGOGGGCacr 9 36 
Human-RetSat GGOGGTTCCAGTCAAATTGCCITTCCACACCATCCCTGTGATTCJVGCGaGCTGaGGGOacr 960 
‘ 35 
Mouso-Rikon GTCCTCACCAGGGCCACTCTACAOAGTarGCTGCrGGACTCAGCTGGGAGAGOGTGTaGT 996 
MOU£Q-RetSat GTCC:rCAC:CAGGGCCACTGTACAGAGTCTGC:TGCTGGAC:TCAGCTGG<3AGAGCaTGT>33T 996 
Rat-RetSat GTCC:TCAC:CAGGaCCAC?0G*rACJW3AGTCTGCTGCTGGACTCAaCTGGGAGAG0GrGO3GT 996 
Human-RetSat GTCCTCACAAAGGCCACraTGCAGAGTCTGTTSCTGGACTCAGCTGGOAAAGCCTGTOGT 1020 
MDUBG-Riken GTCAGTGTGAAGAAGGGACAAGAGCTGOTGAACATCTACTGCCCAGTTOTCATCTCCAAT 1056 
M:yus«-R©tsat aTCAGTGTaAAGAAGGaACAAGAaCTGCTaAACATCTACITGCCrCAGTrGTCATCTCCAAT 1056 
Rat-R©tsat aTCAGTGTOAAGAAGQCACAACJAQCTGCTaAACATCTACTGCCCAGlTCrCATCTCCAAT 1056 
Human-Retsat GTCAGTGTGRAGAAGGOGCATGACSCrTOarGAACATCTATTGCCCrCATOarGGTCrTCCAAC： 1080 
Mouse -Riken GOaaaAATarTCAArACCTATCAaCACTrGTTGCCAGAOACTCTCCGCCATCTGCCAaAr 1116 
MOUS© -RetSat G03GGAATGrTCAATAC:CT;^TCAGC?ierGTTGCCAGAGACTCTCC<3CaVTCTGCCAGAT 1116 
Rat - RetSat GCOaGAATarTCAATACCTATCAGCACCTGTTOCCAGAGTCTCTCCGSCTACCTraCCAaAT 1116 
Human-Retsat GCAGGACTGTTCAACACCTATGAACACCTACTGCCGGaGAAOaCCCGCTGCCTaCCAGSGT 1140 
* « 會食* 會會食 • 會喻夤 , * * * « • » , 會 噢 * 會 會 • 《 * * 
MCXIS© -Rl)c©n GTGAAGAAGCAGCrGGOaATGGTAAGGCCTGGTCrGAGCATGCTCTCAATCTTCATCTGT 1176 
MDU^ C-RetSat GTGAAGAAGC^AGCTGGOaATaGTAAGCCCrGGlTTGAGCWGCTC^rCAArCTrCATCTGT 1176 
Rat-Retsat GTaAAOAAGCAGCTGACAATGGTAAAGCrCTGGTTTGAGCATGCTGTCAArTITCATCTGT 1176 
Human-Retsat GTaAAGCAGCAACTGOaaACGGTaCGGCCCGGCTTAGaaVTGACCTCrGrTTTCATCTGC 1200 
• •龠••嘸 • •龠喻 « * * * « 會 ••會•翕會會 Mouse -Riken CTOAAAGaCACCAAGGAOOACCTaAAGdTCACTCCACCAACTACXATarTTATT了TCAC 1236 
Maus©-Retsat CTOAAAGaCACCAAGaAaaACCTOAAGCTTCAOTCCACCAACTACTATGrTTATriTOAC 1236 
Rat-Ret sat CTOAAGGGCACCAAGOAQSAGCTCAAGCTTCACTCCACCAACTACTJVTarTTATTTTaAC 12S6 
Human -RetSat CTGCGAGGCACCAAGGAACyVCCrGCATCTGCCG?rCCACCAACTACTATarTTACTATC2AC 1260 
«•會會 •• • • 食 會食夤會會•會會會*會會會會會*食夤會會會《 * •••• Mouse -RlkQn ACAaACATaaACAAAGCaATG<;AaCGCTATGTCTCTATaCCCAAGaAAAAaaCTCCAGAA 1296 
Mouse -Rotsat ACAOACATGGACAAAGOGAraGAGCaCTilTGTCTCTATCCCCAAGGAAAAGGCTCCAaAA 1296 
Rat- Retaat ACAGACATGGACAAAGOGATQGAGrGCTATGTCrCTATOCCCAAGGAAAAGGCTCCAOAA 1296 
Human-Rets at J^COtSACATOGACCAAGCIOATGGAGCGCTACGTCTCCATOCCCAGGGAAGAGGCTGCGaAA 1320 
Mouse -Riken CACArTCCCCTTCTCTTCATTGCCrTCCCATCAAGCAACJGATCCAACCTGGGAGGAGOSA 1356 
MDUe©-RetSat CACAT^rCCCCTTCTCTTCATTGCCrTCCCATCAAGCAAGGATCrCfiACCTGGGAGGAGOGA 1356 
Rat - RetSat CACATTCrCCCTTCTCTTCAT•了 CCCrTCrCCATCAAGCAAGGATCCAAdCTCGGAGGACCGA 1356 Human-RstSat CACATCCCTCTTCTCTTCTrCGCTrTCCCATCAGCCAAAGATCCaACCTGaGAaGACOOA 1380 
MOUSO -Ri kon TTCCCAGACCGATC:CACAATGACTGC:GCTGGT;VCCCATaGCCrTTGAATGGTTCGAG<3AG 1416 
Mouse-RetSAt TTCCCAGACCGATCCACAATGACTGCGCTGGTACCCMXSGCCTrTGAATGGTrCGAGaAG 1416 
Rat-R etsat TTCCCAG ACCGATCCACAATGACTGICCrGGTACCC/^TOGCCTTTGAATGCyrCGAGaAG 1416 
Human-RetSat TrCCCAGaCCGaTCCACCArGATCATGCTCATACCCACTGCCTACGACTGGTTTGAGGAG 1440 
Mouse-Riken TGGGAGGAGGAGCCAAAOGGCAAGCGTOOTGTTGACTATGAGACCCTGAAAAATGCCTTC 1476 
Mouse -RetSat IGaCAOGAGGAaCCAAAOaGCAAGCGTaGTGTraACTATaAGACCCTCAAAAATGCCTTC： 14 76 Rat-Retsat TGGCAGGAGGAGCCTAAaaGGAAGCGAaGTGTrOACTATGAGACCCTCAAAAATACCTTC 1476 Human-Retsat TOGCAQGCGGAGCTGAAOGQAAAGCGOaSCAGTaACTATGAGACCTTCAAAAACrCCTTT 1500 
Itousd -Riken GTOSAAGCCrCTATGTOGJSTGATCATGAAACTCTTCCCACAGCTGGAOCWCAAGGTGCAG 1536 
muso-RetSat GTaOAAGCCrCTATGTCaaTGATCATGAAACrCTTCCCACAGCTrGaAaaGCAAaaTGaAG 1536 
Rat-Rstsat CGaaAAGCCrCTATGTCaaraATCATGAAACTCTTCCCACAGCTGGAAGGCAAaaTGGAG 1536 
Human-Retsat G*raaAAGCCrCTATGTCAGrGC3TCCTGAAACTaTrCCCACAGCTGaAOGGaAAaGTaGSAa 1560 
MDUSe -Ri ken AGTGTQACTGaAaaGTCACCACTGACCAACCACTACTATCTGGCTGCACCCOGAGGAGCT 15 9 € 
Mouse-RetSat AGTOTGACTaGAOGGTCACCACTaACCAACCAOTACTATCTaaCTCCACCCCaAGGAaCT 1596 
Rat-RetSat .AGTGrGACTGGAOaATCCCCACTaACCAACCACTACTATCTGaCTGCACACCaAGGAaCT 1596 
Human-RetSat AGTGTGACTGCAQaATCCCCACTCACCAACCAGTTCTATCTGGCTGCTCCCOaAGGTGCC 1620 
Mouse -Rikon ACCTATGGAGCTGACCATaACraGCTCGGCTGCATCCTCATaCAATOSCl^TCCATAAaA 1656 
Mouse -RetSat ACCTATOGAGCTGACCATGACTTaaCTCGOCTGCATCrCTCATGCAATaaCTrcaVTAAGA 1656 
Rat-Rotsat ACTTATGOSaCTCACCATCACCTCGCTCGTCTOCATCCTCATGCAATOaCTTCrCCTAAGA 1656 
Human-RetSat •TGCrACGOaGCTOACCATGACCTCGGCCacrCTGCACCCTTGTOrGATaaCCTCCTTGAGG 1680 
Maus©-Rikon aCCCAAACCCCCATCCCCAACCTCrACCTOACAaGCCAAGATATCTTCACCTOrGGaCTG 1716 
Mouse -RetSat GCCCAAACCCCCATCCCCAACCTCrJ^CCTGACAaaCCAAaATATCTTCACCrOTGaGCTG 1716 
Rat - RetSat GCCCAAACCCCCATCCCCAACCTCrACCTGACAGGCGAAGATATCTTCACCTCTGGGCTG 1716 
Human-R©tsat GCCCAGAGCCCCATCCCCAACCrcrATCTGACAGGCCAGGATATCTTCACCTOrGGACTG 1740 
Mouso -Riken ATOaGGGCCCTGCAGGGOaCCTTCCTGTGCAOCAGTGCCATCCTGAAACGGAACTTGTAC 1776 
Mouse-RetSat ATQGGQGCCCrGCAGGGaGCCTrGCTGTSCAGCAGTGCCATCCTGAAACGGAACrTTGTAC 1776 
Rat-RetSat ATOGGGGCCCTGCAAGGOGCCCTGCrTGTGCAGCAGTGCCATCCrGAAACGGAACCrGTAC 1776 
Human-RetSat gtoggggccctgcaaggtsccctgctgtgcagcagcgccatcctgaagcggaacttgtac leoo 
« • 食 食 f t 夤會龠 *眘會曾會會* « « « •食食 喻會•會會會銜會•喻« 會 會 食 • 舍 舍 會 夤 Moxibg -Rikon TOWSATCTGCAaaCTCTTaOCTCAAAaarCAAaaCACAAAAGAAGAAGATGTAGTCOTrT 1836 
Mouse -RetSat TCAGATCraCAGGCrCTTCGCTCAAAGarCAAaGCACAAAAGAAGAAaArGTAGTCOGnrT 183€ 
‘ Rat-RetSat TCAGATCraCAGGCTCTTGGCTCAAAGCTCAGOGCACAAAAGAAaAAGAAGTAGTCTATr 1836 
Human-RetSat TCAOACOTTAAGAATCTTOATTCTAaGATCCaaaCACAaAAGAAAAAaAATTAGTTCCAT 1860 
•••»» «龠 •• 會•會會食 會 食 食會 會*龠噢•會 會會锚龠會 會《會貪 會食會* 食 muse -Riken cagagaagagccaga - - 1851 •• 
Mouse -RetSat CAGAGAAGAGCCAGA - 1851 
Rat - RetSat CAGAGATCAGCTAOAGGAA 1855 
Human - Rotsat CAOOGAaGAGTCAGAGGAATTTaCCCAATGGCTCGGG CATCTCCCTTGACTTACCCATAA 1920 
Figure 1.6 Alignment of Riken cDNA 0610039N19 and all-trans-13,14-
dihydroretinol saturase 
Riken cDNA 0610039N19 was identified as a mouse all-trans-13,14-dihydroretinol 
saturase (RetSat) and this gene is conserved in mouse, rat and human. The matched 
nucleotides are indicated by *. 
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The main goal of this research project was to confirm that PPSIG is a novel 
PPARa target gene by the identification of a functional PPRE in this gene. There are 
four objectives to achieve in this project: (1) clone the full-length cDNA of PPSIG 
using the rapid amplification of cDNA ends technique (RACE) in order to determine 
whether PPSIG is 100% similar to the Riken cDNA 0610039N19; (2) obtain the 
genomic clones of PPSIG in order to study its genomic organization and to identify 
the functional PPRE(s); (3) prepare reporter constructs and perform transactivation 
aasays to study the promoter region and putative PPRE(s) of PPSIG; (4) perform 
electrophoretic mobility shift assays (EMSAs) to study the binding of PPARa/RXRa 
heterodimer to the PPRE sequence of PPSIG. 
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Chapter 2 Materials and Methods 
2.1 Cloning of the full-length mouse PPSIG cDNA 
2.1.1 Rapid amplification of cDNA ends (RACE) 
2.1.1.1 Total R N A extraction 
2.1.1.1.1 Materials 
TRIzol® reagent was purchased from Invitrogen corporation (Carlsbad, CA, 
USA). Chloroform, ethanol and isopropanol were obtained from BDH (UK). 
Nuclease-free water was consumed from Promega (Madison, WI, USA). 
2.1.1.1.2 Methods 
To prepare animal samples for RNA extraction, wild-type and PPARa-null 
mice (strain SV129/ter, male, 3 months old) were treated with a control diet or diet 
containing 0.1% Wy-14,643 for 11 months. Following decapitation of mice, the livers 
w缺ere immediately removed, weighed, wrapped in aluminium foil and stored in liquid 
nitrogen until use. 
• {紀 
Mouse liver RNA was extracted using TRIzol reagent according to the 
manufacturer's instructions. Around 1 g of liver sample was added to 10 ml TRIzol® 
I'eagent in a 50 ml Falcon tube. The tissue was homogenized and the resuspension was 
38 
aliquoted into 1 ml aliquots in 1.5 ml microcentrifuge tubes. Two hundred fil 
chloroform was added to each tube, mixed vigorously and centrifuged at 14,000 rpm 
at 4°C for 15 min. The supernatant was transferred to a new 1.5 ml microcentrifuge 
tube and 0.5 ml isopropanol was added. The mixture was incubated at room 
temperature for 10 min and centrifuged at 14,000 rpm at 4°C for 10 min. The 
supernatant was discarded and the RNA pellet was washed twice with 1 ml 70% 
ethanol and then air-dried. For performing RACE, one RNA pellet from a wild-type 
mouse treated with control diet and one from a wild-type mouse treated with 0.1% 
Wy-14,643 diet were dissolved in 100 nuclease-free water. The remaining RNA 
pellets were stored in 1 ml absolute ethanol at -80�C. The RNA concentration was 
measured by the absorbance at 260 nm using a Beckman DU640 UV-VIS-NIR 
scanning spectrophotometer. 
2.1.1.2 Primers design 
To perform 5’ and 3’ RACE, one 5，-GSPl and one 3,-GSPl PPSIG 
分. 
gene-specific primers (GSPs) were designed based on the known cDNA sequence 
obtained from the 555 bp PPSIG FDD fragment D3#3 and the instructions of 
GeneRacer™ kit (Invitrogen) (Table 2.1 and Figure 2.1). The primer oligonucletoides 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.1.1.3 5，and 3' c D N A ends amplification 
2.1.1.3.1 Materials 
GeneRacer™ with S u p e r S c r i p t ™ II reverse transcriptase and platinum^ Taq 
DNA polymerase high fidelity were purchased from Invitrogen corporation (Carlsbad, 
CA, USA). 
2.1.1.3.2 Methods 
To obtain the 5' and 3，ends of cDNA sequences of PPSIG, RACE was 
performed according to the manufacturer's instructions. Total liver RNA extracted 
from a wild-type mouse treated with a control diet and a wild-type mouse treated with 
0.1% Wy-14,643 for 11 months prepared in Section 2.1.1.1 were used as the RNA 
templates. 
The first step of RACE was to dephosphorylate RNA. Five |ag of total RNA 
from each sample, 1 …of 40 U/|al RNaseOUT™, 1 |il of lOX calf intestinal alkaline 
phosphatase (CIP) buffer and 1 of 10 U/|il CIP were mixed in a 1.5 ml 
V� 
microcentrifuge tube and were made up to 10 with DEPC water. The CIP reaction 
was incubated at 50°C for 1 h. The dephosphorylated RNA products were then 
precipitated following the ethanol precipitation method as described in the following. 
Ninety |al of DEPC water and 100 \x\ phenol:chloroform were added. They were 
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mixed and centrifuged at 14,000 rpm at room temperature for 5 min. The supernatant 
was transferred to a new 1.5 ml microcentrifuge tube. Two of 10 mg/ml mussel 
glycogen, 10 fil of 3 M sodium acetate (pH 5.2) and 220 95% ethanol were added 
and mixed thoroughly. The RNA was precipitated on dry ice for 20 min and pelleted 
by centrifugation at 14,000 rpm at 4°C for 20 min. The RNA pellet was washed with 
500 pj of 70% ethanol and air-dried for 2 min. The RNA pellet was resuspended in 7 
Ml DEPC water and proceeded to next step as indicated below. 
The second step of RACE was to remove the cap structure from 
dephosphorylated mRNA. One of 40 U/|al RNaseOUT™, 1 |LI1 of lOX tobacco acid 
pyrophosphatase (TAP) buffer and 1 [i\ of 0.5 U/|al of TAP were added to the 1.5 ml 
microcentrifuge tube containing 7 CIP-treated RNA obtained from step 1 above 
and the reaction mixture was incubated at 37°C for 1 h. TAP-treated RNA was 
precipitated from the reaction mixture by the ethanol precipitation method as 
described in the previous paragraph. 
The third step of RACE was to ligate the dephosphorylated and decapped 
niRNA to the GeneRacer™ RNA oligo. Seven of TAP-treated RNA obtained from 
step 2 above was added to the tube containing 250 ng GeneRacer^ ^ RNA oligo (Table 
l l ) and mixed by pipetting up and down for 5 times. The mixture was incubated at 
for 5 min and was then put on ice for 2 min. One |al of 40 U/|_il RNaseOUT™, 1 
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I^Ll of 1 OX T4 RNA ligase buffer and 1 of 5 U/|al T4 RNA ligase were added to the 
mixture. The reaction mixture was mixed, centrifuged briefly and then incubated at 
37°C for 1 h. The ligation products were precipitated from the reaction mixture by the 
ethanol precipitation method as described in the previous paragraph, but this time the 
pellet was resuspended in 10 instead of 7 of DEPC water. 
The fourth step of RACE was to reverse transcribe the mRNA to cDNA. One |_il 
of 50 |.iM GeneRacer™ oligo-dT primer (Table 2.1) and 1 of 10 mM dNTP mix 
were mixed with the ligation products obtained from step 3 above. The mixture was 
incubated at 65°C for 5 min and was then stood on ice. Four |al of 5X first strand 
buffer, 1 |al of 40 U/^il RNaseOUT™，2 |al of 0.1 M DTT and 1 … o f 200 U/^l 
Superscript IM II reverse transcriptase were added to the mixture. Reverse 
transcription (RT) was performed by incubation at 4 2 � C for 50 min, 7 0 � C for 15 min 
and kept at 4 � C . One of 2 U/|li1 Rnase H was added to the RT product and the 
mixture was incubated at 3 7 � C for 20 min. 
The fifth step of RACE was to amplify the 5’ cDNA (5, RACE) and 3，cDNA 
0 ’ RACE) ends from the RT product obtained from step 4 above. The upstream and 
downstream primers for 5' RACE were GeneRacer 5' primer and PPSIG 5'-GSPl 
(Table 2.1), respectively, whereas for 3，RACE were PPSIG 3 '-GSPl and GeneRacer 
3，primer (Table 2.1), respectively. For both the 5' and 3’ RACE PCR, 5 |al of lOX 
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high fidelity PCR buffer, 1 of 10 mM dNTP mix, 1 |al of 50 mM MgS04, 3 …of 10 
laM of GeneRacer primer, 1 of 10 iiM PPSIG gene specific primer, 1 of RT 
template and 0.5 i^l of 5 U/|il platinum® Taq high fidelity were mixed in a 0.2 ml 
microcentrifuge tube and was made up to 50 [L\ with nuclease-free water. Three 
negative controls including no RT template or no PPSIG GSPl or no GeneRacer 
primer were set-up in parallel for comparison. PCR was done in a themiocycler 
(Applied Biosystem GeneAmp PCR 9700) set at 94°C for 2 min in the first cycle, 
followed by 5 cycles at 94°C for 30 s and 7 2 � C for 3 min, another 5 cycles at 9 4 � C for 
30 s and 70°C for 3 min, then 25 cycles at 94°C for 30 s, 65°C for 30 s and 68 °C for 
3 min and a final step at 68°C for 10 min. 
2.1.2 Subcloning of 5' and 3，RACED products 
2.1.2.1 Ligation and transformation 
2.1.2.1.1 Materials 
TOPO TA cloning® kit for sequencing was obtained from Invitrogen 
corporation (Carlsbad, CA, USA). Ampicillin was purchased from Sigma chemical 
company (St. Louis, MO, USA). B a c t o ™ tryptone, yeast extract and agar were 
provided by BD Bioscience (San Jose, CA, USA). Sodium chloride was purchased 
from USB corporation (Cleveland, Ohio, USA). 
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2.1.2.1.2 Methods 
The PCR products were ligated in a pCR®II-TOPO® vector (Figure 2.2) 
according to the company's instructions. Four |al PCR products, 1 jal of 6X salt 
solution and 1 of 2 ng/|al vector were mixed in a 0.2 ml microcentrifuge tube. The 
ligation reaction was incubated at room temperature for 30 min and the ligation 
products were transformed in TOP 10 competent cells following the standard 
transformation protocol as described in the following. 
To perform transformation, the ligation products were mixed with 100 |il 
TOPIO competent cells, incubated on ice for 30 min, heat shocked at 42°C for 1 min 
and placed on ice for 2 min. Eight hundred jiil Luric Broth (LB) medium was added 
and incubated at 37°C with shaking for 1 h. The cells were pelleted by centrifugation 
at 2,500 rpm at 4°C for 8 min. Two hundred supernatant was removed and the 
pellet was resuspended again in the remaining culture and spreaded on pre-wann LB 
agar plates containing 100 |Lig/ml ampicillin. The plates were incubated at 37°C for 
18-24 h inverted. The subclones on the LB/ampicillin plates were grown up in 2 ml 
LB/amp medium and incubated at 37°C with shaking for 16 h. 
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Figure 2.2 Map of pCR®II-TOPO® vector 
^coK I sites on both sides of the ligated PGR product were used to check for the size 
of insert by EcoR I digestion. Ml3 reverse and M13 forward primers were used as 
sequencing primers to determine the sequence of the subcloned insert. (Adapted from 
the manual of TOPO TA cloning® kit, 
Invitrogen) 
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2.1.2.2 Screening of the recombinants 
2.1.2.2.1 Phenol:chloroform test 
2.1.2.2.1.1 Materials 
UltraPure phenol:chlorofonn:isoamyl alcohol (25:24:1) was purchased from 
Invitrogen (Carlsbad, CA, USA). Mini-M® plasmid DNA extraction system was 
obtained from Viogene (Sunnyvale, CA, USA). 
2.1.2.2.1.2 Methods 
Phenolxhlorofonn test was used to screen subclones containing plasmids of 
expected sizes. Twenty |al overnight bacterial culture was mixed with equal volume of 
phenol:chloroform:isoamyl alcohol and mixed vigorously. The 丨nixture was 
centrifuged at 14,000 rpm for 1 min and the supernatant which containing the 
plasmids were resolved by electrophoresis to check for the sizes of plasmids. 
Subclones containing plasmids of desired size were grown up in 5 ml LB/amp culture. 
Plasmid DNA was extracted from the culture using the mini-M暮 plasmid DNA 
extraction system. 
2.1.2.2.2 Restriction enzyme digestion 
2.1.2.2.2.1 Materials 
EcoK I enzyme and its buffer were purchased from New England Biolabs 
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(Beverly, MA, USA). 
2.1.2.2.2.2 Methods 
Restriction enzyme digestions were performed to screen for the recombinants 
which carry the recombinant inserts. The sizes of inserts were checked by digesting 
the pi asm ids with EcoR I enzyme, as EcoR I sites were present in both upstream and 
downstream sequence close to the insert cloning site (Figure 2.2). For each selected 
subclone, 400 ng plasmid DNA, 2 … o f lOX EcoR I buffer and 0.2 of 20 U/|al 
ECOR I restriction enzyme were mixed in a 1.5 ml microcentrifuge tube and were 
made up to 20 |LI1 with autoclaved water. The digestion reactions were incubated at 
overnight and resolved on 1% agarose gel in 0.5X TBE buffer. 
2.1.3 DNA sequencing of the 5' and 3' RACED subclones 
Subclones screened by phenolxhlorofonn test and confirmed by restriction 
enzyme digestion were selected for DNA sequencing. The nucleotide sequences of 5' 
and 3' RACED subclones were determined by DNA sequencing using the Ml3 
reverse primer, M l 3 forward primers and PPSIG gene-specific sequencing primers 















































































































































































































































































































































































































































































































































































































































GCGGTCTTCCGAGCC CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 90 
GCCTTTACGGTGCRA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AaCCJACCGCCTGAAC CCCTGGTGACCGACA AGGAGGd'AGGAAGA 180 
AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTGAG 270 
PPSiG-SEQ413 — 一 PPSIG.RP2635 
CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTG7GGTG'3AAC AACATACCAAGGCGG GCGGCTGTTGTCATA CCTTTGGGGAAAATG 360 
GCCTTGAATTTGACA CTGGAATTCATTATA TTGGACGAATCCGGG AGGGCAACATTGGCC GTTTTATCTTGGACC AOATCACTGAAGGGC 4&0 
—PPSIG-SEQ594R 
AACTGGACTGGGCCC CCATGGCCTCCCCTT TTGACTTGATGATAC TAGAAGGC-CCCAATG GCCGAAAGGAGTTCC CCATGTACAGTGGGA 540 
PPSIG.SEQ684 — 
GCJAAAGAATACATCC ASGGCCTTAAGAAGA AGTTCCCCAAG'3AAG AAGCTGTCATTGACA AGTACATGGAGTTGG TTAAGGTGGTGGCCC 630 
GTGGAGTCTCTCATG CAGTTCTACTCAAGT TCCTCCCATTGCCCT TGACTCAGCTCCTCA GCAAGTTTGGGCTAC TGAGTCGTTTCTCTC 720 
CATTCTGCCGAGCGT CTACGCAGAGCCTAG CTGAAGTCCTGCAGC AGCTTGGGGCTTCCC GTGAGCTCCAC-GCTG TTCTCAGCTACATCT 810 
PPSIG-SEQ968 
iCCCCACTTACGGAG TAACTCCCAGCCACA CCGCCTTTTCCTTGC ATQCTC7C-CTGGTTG ACCACTACATACAA.G G3GCATA7TACCCTC 900 
OAGGGGCTTCCAGTC； AGATCGCCTTCCATA CCATCCCTTTGATTC AGCGGGCCGGGGGCG CrrGTCCTCACCAGGG CCACTGTACAGAGTG 9 9 0 
PPSIG-SEQ1205-» 
TGCTGCTGGACTCAG CTG3GAGAGC0TGTG GTGTCAGTGTGAAGA AGGGACAAGAGCTGG TGAACAT'CTACTGCC CAGTTGTCATCTCCA 1080 
鄉？鄉 A•？ A T A C C T A T C A G C A C T TGTTC-CCAGAGACTG TCCGCCATCTGCCAG ATGTGAAGAAC-CAGC TGGCGATGGTAAGGC 1170 
CTGGTCTGAGCATGC TCTCAATCTTCATCT GTCTGAAAGGCACCA ASGAGGACCTGAAGC TTCAGTCCACCAACT ACTATGTTTATTTTG 1260 
ACACAGACATGCJACA AAGCGATGGAGCGCT ATGTCTCTATGCCCA AGGAAAAGGCTCCAG AACACATTCCCCTTC TCTTCATTGCCTTCC 1350 
PPSIG-SEQ1547 一 
CATCA/iGCAAGGATC CAACCTGGGAGGAGC GATTCCCAGACCGAT CCACAATGACTGCGC TGGTACCCATGGCCT TTGAATGGTTCGAGG 1440 
3'-GSP1 —• 
AGTGGCAGGAGGAGC CAAAGGGCAAGCGTG GTGTTGACTATGAGA CCC7CAAAAATGCC7 TCGTGGAAGCCTCTfi TGTCGGTGATCATGA 1530 
AACTGTTCCCACAGC TGGAGGGCAAGGTGG AGAGTGTGACTGGAG GGTCACCACTGACCA ACCAGTACTATCTGG CTGCACCCCGAGGAG 1620 
CTACCTATGGAGCTG ACCATGACTTCXJCTC GGCTGCATCCTCATG CAATGGCTTCCATAA GAGCCCAAACCCCCA TCCCCAACCTCTACC 1710 
TGACAGGCCAAGATA TCTTCACCTGTGGGC TGATGGGGGCCCTGC AGGGGGCCTTGCTG? GCAGCAGTACCATCC TGAAACGGAACT7GT 1800 
PPSIG-SEQ1948R 
ACTCAGATCTGCAGG CTCTTGGCTCAAAGG TCAAGGCACAAAAGA AGAAGATGTAGTCCG TTCAGAGAAGAGCCA GAGGAAAGGCACCTC 1890 
5'-GSP1 
CCCAACTCCGTTCAG AGAAGAGCCAGAGGA AAOGCACCTCCCCAA CTTCTCG7GGTGTCG TCCCTCCTACAGCAA TTCCTTGCACATATA 1980 
AACAAAAACCATTTT GTTTCTGAATAGTGT TGTTAAGTCAAGAGT TCTTTACCTTGCATT CTACTTAAGGCCTAG TGTGAACTACATAGC 2070 
CTTGATGCCTCATGA AGAATGCTCCCATGC CTTTCCTACACCCAA CTCCYJvGCTATGGTC AGGCACCCAGAACCC CTGGGGTGTTGGCTA 2160 
CTGGAATAGGTTGGT TCAGTCCTACCCTGA AGCTTTTTGTTCCTC CTCACTCTCGTGTTG TGATGCTCTATACAT GGAAAAGTGTGGGCT 2250 
… PPSIG-SEQ9382 —^ 
TGGAGTAGCAACTCT CTGAAAGTGCCAGAC CTAAGAAAACCCTCA GGTCTAAGTTTTATC CTGATAGAAGTGGGT TAAAGGAACACACCA 2340 
^GATACCACTGCC GATGAACCAAGCCTA GACACGGCATTTGTA GTTGCTGGCACATAG TCA/ACTGAGTTACG AGGCTC-GCAAGTCCA 2430 
GGGCAGCCAGACTCTC TC?TTATACRGAGAAA CCCTGTCTTGAAAAA OAAAACAAAACAAAA CAARACCTGAGTATT G T T T T C T A A A A T G C T 2520 
fCSGAGTCAGAATTCT TTCAGATTTTGTGGT ATTTGCATACACATG AGATAACCTGGGGAA TGGGTCCCAGAACTA AACCACAAATTCATT 2610 
TGTTTCATATGTATA GACCAGCrCACAACAT CTTATGTAATACTTT GAAAAACTGAGCATT CTGACCTGTCACATG AGTCCATGCTATAAT 2700 
^"I'AAAAAGCTTGCTT TGATTTCAGAATAGG GATGCTTTACCTATA T3AGTAAATGAGAAG GTGGATAAAAATTAA AAACCTTTCGCT'ITVT 2790 
"TTAAACAAGTGCTA ATTTTAGTCTGTTTA AATATAGTATTAA.TA CATGTARTC7TTCAA AAAAAAAAAAAAAAA AAAA 2869 
figure 2.3 Locations of PPSIG gene-specific primers designed for sequencing 5， 
and 3 'RACEDcDNAs 
To walk the full-length 5' and 3’ RACED cDNAs, PPSIG gene-specific sequencing 
primers (bolded and underlined sequences) were designed based on the cDNA 
sequence obtained from the sequencing results of 5’ and 3' RACED subclones using 
Ml3 forward and reverse primers. The primer sequences of 5'-GSPl and 3，-GSPl are 
underlined for reference. 
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2.1.4 Northern blot analysis using PPSIG 5' and 3’ RACED cDNA 
as probes 
2.1.4.1 RNA sample preparation 
2.1.4.1.1 Materials 
Formamide was purchased from USB corporation (Cleveland, Ohio, USA). 
2.1.4.1.2 Methods 
Liver RNA was extracted from four groups of mice, including wild-type mice 
fed with a control diet or a 0.1% Wy-14,643 diet for 11 months and PPARa-null 
mice fed with a control diet or a 0.1% Wy-14,643 diet for 11 months. For each group, 
KNA samples from three different mice were used to increase the reliability of the 
data. The RNA extraction method has been described in Section 2.1.1.1 For 
performing Northern blot analysis, the RNA pellets were dissolved in 100 \x\ 
formamide. 
2.1.4.2 Formaldehyde-agarose gel electrophoresis and blotting of RNA 
2.U.2.1 Materials 
Positively charged nylon membrane was purchased from PALL corporation 
(East Hills, NY, USA). Gel-blotting paper and 3 MM chromatography paper were 
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provided by Whatman® (UK). Scott® paper towel was provided by Kimberly-Clark 
Corporation (Roswell, GA, USA). DIG-labeled RNA molecular weight marker I 
(0.39-6.9 kb) was purchased from Roche (Germany). Sodium chloride and MOPS 
were obtained from USB corporation (Cleveland, Ohio, USA). Formaldehyde (37%) 
was provided by RDH (Germany). Sodium citrate tribasic dihydrate was obtained 
from Sigma chemical company (St. Louis, MO, USA). 
2-1.4.2.2 Methods 
A 1% formaldehyde-agarose gel was prepared by mixing 0.75 g agarose, 7.5 
ml of lOX MOPS, 1.35 ml of 37% formaldehyde and made up to 75 ml. To prepare 
the RNA sample, 10 f.il of 3 |ag/|j.l total RNA sample obtained from Section 2.1.4.1 
Was mixed with 10 of core mix A (5 of nuclease-free water, 3 of 37% 
formaldehyde and 2 i^l of lOX MOPS). To prepare the RNA size marker, 2.5 i^l of 
IQ ng/|al DIG-labeled RNA molecular weight marker I was mixed with 7.5 jal 
fonnamide and 10 \x\ core mix A. RNA samples and marker were denatured at 68°C 
for 15 mill and immediately chilled on ice for 10 min. After incubation, 2.3 of 
core mix B (2 of 6X loading dye and 0.2 of 1 mg/ml ethidium bromide) was 
added. RNA samples and marker were loaded entirely onto 1% 
fonnaldehyde-agarose gel and electrophoresed at lOOV for 2-3 h in IX MOPS buffer. 
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After electrophoresis, the gel was washed in lOX SSC (3 M sodium chloride and 0.3 
M sodium citrate, pH 7.0) for 45 min with shaking at room temperature. 
To blot the RNA sample onto a positively charged nylon membrane, the gel 
was inverted and placed on top of a stack of gel blotting paper which were soaked in 
lOX SSC in a plastic box. The nylon membrane was put on top of the gel. Two 
pieces of pre-wetted 3 MM papers were put on top of the membrane, followed by 2 
pieces of dry 3 MM papers and then a stack of paper towel ( -10 cm high). A glass 
plate was put on top and the whole set-up was wrapped with Saran wrap. Finally, a 
Weight of 500-1000 g was placed on top and the RNA was allowed to transfer to the 
nylon membrane by upward capillary action overnight. After the transfer, the 
positions of wells were marked on the membrane with a pencil. The membrane was 
washed in 2X SSC [diluted from 20X SSC stock (3 M NaCl and 0.3 M sodium 
citrate)] for 5 min and then air-dried briefly on a large filter paper. RNA was then 
fixed onto the membrane by baking at 80°C for 2 h in an oven (Memmert UM300). 
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2.1.4.3 Probe preparation 
2.1.4.3.1 DIG labeling of RNA probe from 5，RACED PPSIG cDNA subclone 
5，#32 
2.1.4.3.1.1 Materials 
Spe I enzyme and its buffer were purchased from New England Biolabs 
(Beverly, MA, USA). T7 RNA polymerase together with its transcription buffer and 
lOX DIG RNA labeling mix were obtained from Roche (Germany). UltraPure 
phenol:chloroform:isoamyl alcohol (25:24:1) was supplied by Invitrogen 
corporation (Carlsbad, CA, USA). Ethanol was purchased from BDH (UK). 
2-1.4.3.1.2 Methods 
To prevent continuous in vitro RNA transcription, firstly, PPSIG 5' RACED 
CDNA from subclone 5’#32 was linearized by Spe I digestion. Ten \ig of plasmid 
DNA, 15 |al of lOX NEBuffer 2, 15 |il of 1 mg/ml BSA and 20 |.il of 3 U/|ul Spe I 
enzyme were mixed in a 1.5 ml microcentrifuge tube and filled up to 150 with 
nuclease-free water. The reaction mixture was incubated at 37°C overnight. 
The linearized DNA was purified by ethanol precipitation method. Firstly, 150 
I^LI of phenol:chloroform:isoamyl alcohol was added to the digestion product, mixed 
and centrifuged at 14,000 rpm at 4°C for 10 min. The supernatant was transferred to 
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a new 1.5 ml microcentrifuge tube. One-tenth volume of 3 M sodium acetate and 2.2 
volume of absolute ethanol were added and mixed thoroughly. It was then incubated 
at -80°C overnight. After incubation, the mixture was centrifuged at 14,000 rpm at 
4°C for 40 min. The supernatant was then removed and the pellet was washed twice 
with 70% ethanol. After air-drying, the pellet was dissolved in 30 \x\ nuclease-free 
water and the DNA concentration was measured by the absorbance at 260 nm using 
a Beckman DU640 UV-VIS-NIR scanning spectrophotometer. 
DIG-labeled RNA probe was prepared by using T7 RNA polymerase. One jig 
of linearized 5'#32 DNA, 2 |il of lOX transcription buffer, 2 of lOX DIG RNA 
labeling mix and 2 \x\ of 20 U/)LL1 T 7 RNA polymerase were mixed in a 1.5 ml 
microcentrifuge tube and was made up to 20 |al with nuclease-free water. The 
labeling reaction was incubated at 37°C for 2 h and stopped by adding 2 of 0.2 M 
EDTA (pH 8.0). 
21.4.3.2 PCR DIG labeling of 3，RACED PPSIG cDNA subclone 3’#12 
2-1.4.3.2.1 Materials •“ 
PCR DIG labeling mix was purchased from Roche (Germany). Taq DNA 
polymerase, PCR buffer and MgCb solution were obtained from Genesys (UK). 
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2.1.4.3.2.2 Methods 
3’ RACED PPSIG cDNA from subclone 3'#12 was PGR DIG-labeled using the 
forward (PPSIG-SEQ9382) and reverse (PPSIG-RP9534) primers (Figure 2.4). 
Briefly, 20 ng of subclone 3'#12 template DNA, 5 |al of lOX PCR buffer, 3 of 25 
mM MgClz, 5 of lOX PCR DIG labeling mix, 2 of 10 i^M forward primer 
PPSIG-SEQ9382, 2 |al of 10 laM reverse primer PPSIG-RP9534 and 0.2 of 5 U/|al 
Taq DNA polymerase were mixed in a 0.2 ml microcentrifuge tube. PCR DIG-
labeling reaction are performed in a themiocycler (Applied Biosystem GeneAMP 
PCR 9700) set 9 4 � C for 2 min for the first cycle, followed by 30 cycles at 94°C for 30 
s, 65°C for 30 s and 72°C for 3 min and a final step at 72°C for 10 min. reaction. 
2.1.4.4 Hybridization 
1.4.4.1 Materials 
Hybridization bag was purchased from Kapak corporation (Minneapolis, MN, 
USA). DIG-Easy hyb buffer was purchased from Roche (Germany). 
2 .U.4 .2 Methods 
Hybridization of RNA samples was performed using DIG-labeled RNA or 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































membrane was put in a hybridization bag and was rinsed thoroughly in 20 ml of 2X 
SSC. The 2X SSC was poured out and the membrane was pre-hybridized in 10 ml 
DIG-Easy hyb buffer and shaken gently at 60°C (RNA probe) or 4 2 � C (DNA probe) 
for 2 h. The pre-hybridization buffer was then transferred into a 50-ml Falcon tube 
and the probe was added into the tube, mixed thoroughly and then transferred into 
the hybridization bag. Hybridization was earned out at 60°C (RNA probe) or 42°C 
(DNA probe) overnight with gentle shaking in a hybridization incubator (FinePCR®, 
combi-SV12). 
2.1.4.5 Post-hybridization washing and colour development 
2-1.4.5.1 Materials 
Blocking reagent, anti-digoxigeiiin-AP Fab fragments, nitroblue tetrazolium 
chloride (NBT) and 5-bromo-4-chloro-3-indolyl-phosphate-4-toluidine salt (BCIP) 
Were purchased from Roche (Germany). Tween® 20 was obtained from USB 
corporation (Cleveland, Ohio, USA). 
2.1.4.5.2 Methods 
Post-hybridization washing was performed to reduce the non-specific signal 
the membrane. The membrane was transferred to a baked clean glass tray and 
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washed in low stringency buffer [2X SSC and 0.1% sodium dodecylsulfate (SDS)] 
at room temperature for 5 min twice, followed by high stringency buffer (0.5X SSC 
and 0.1% SDS) at 68°C for 5 min twice. It was then washed in washing buffer [0.3% 
(v/v) Tween 20® in 0.1 M maleic acid and 0.15 M sodium chloride (pH 7.5)] at room 
temperature for 5 min. The membrane was blocked in IX blocking buffer [1% (g/v) 
blocking reagent in 0.1 M maleic acid and 0.15 M sodium chloride (pH 7.5)] at 
room temperature for 1 h and incubated in an antibody solution (anti-digoxigenin-
AP 1:10000 diluted in IX blocking buffer) at room temperature for 1 h. After 
incubation, the membrane was washed in washing buffer again at room temperature 
for 15 min twice and then equilibrated in detection buffer [0.1 M Tris-Cl and 0.1 M 
NaCl (DH 9.5)] for 5 min. Signal was developed by incubating the membrane in 
NBT/BCIP substrate solution (125 )il NBT and 93.8 BCIP in 25 ml detection 
buffer). Colour development was stopped with autoclaved distilled water. The image 
on membrane was captured with an Epson expression 1600 pro flatbed scanner SCSI 
using an Adobe® photoshop® 6.0 program. 
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2.2 Cloning of the PPSIG genomic DNA 
2.2.1 Screening of bacterial artificial chromosome (BAC) clones 
2.2.1.1 Screening of a mouse genomic library 
A female mouse spleen genomic DNA (129S6/SvEvTac) BAC library was 
screened using a purified PPSIG 5' RACED cDNA (5'#32) insert by hybridization 
screening (Invitrogen corporation, Carlsbad, CA). The BAC vector used was 
pBACe3.6 (Figure 2.5). 
2.2.1.2 Purification of BAC DNA by solution I，II，III 
2.2.1.2.1 Materials 
Chloramphenicol, glucose and potassium acetate were purchased from Sigma 
chemical company (St. Louis, MO, USA). Tris, ethylene diaminetetraacetic acid 
(EDTA) and sodium dodecyl sulfate (SDS) were obtained from USB corporation 
(Cleveland, Ohio, USA). Hydrochloric acid (HCl) was provided by BDH (England). 
么cetic acid was purchased from Merck (Whitehouse Station, NJ, USA). Sodium 
hydroxide was obtained from RDH (Germany). 
2.2.1.2.2 Methods 
• BAC DNA was purified from an overnight culture as suggested by the 
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Figure 2.5 Map of pBACe3.6 vector 
(Adapted from http://bacpacxhori.Org/pbace3.6) 
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company's instructions (Invitrogen). Each BAC clone glycerol stock was streaked 
on a LB plate containing 12.5 |ig/ml chloramphenicol (LB/chloramphenicol) and 
incubated at 37°C for 16 h. From each BAC clone, one single colony was picked 
and re-streaked on a LB/chloramphenicol plate and incubated at 37°C for 16 h. On 
each plate, 10 colonies were picked and each grown in 2 ml LB/chloramphenicol 
medium by incubation at 37°C with shaking for 16 h. 
To extract the BAC DNA, 1.5 ml of each bacterial culture was transferred to a 
2 ml microcentrifuge tube and centrifuged at 14,000 rpm for 30 s. The supernatant 
was discarded and the pellet was resuspended in 100 chilled Solution I [50 mM 
glucose, 20 mM Tris-HCl (pH 8.0), 10 mM EDTA (pH 8.0)]. The tubes were 
incubated on ice for 5 min and 200 fil freshly prepared Solution II (0.2 M NaOH, 
lo/o SDS) was added into the mixture. The solution was mixed by inverting up and 
down 8 times and 150 [i\ Solution III [potassium acetate (pH 4.8)] was added and 
mixed by inverting up and down 8 times again. The cell debris was pelleted by 
centrifugation at 14,000 rpm for 6 min and the supernatant was transferred to a new 
1.5 ml microcentrifuge tube. One ml ethanol was mixed with the supernatant and 
centrifuged at 14,000 rpm for 6 min to precipitate the BAC DNA, The supernatant 
Was removed. The DNA pellet was washed with 500 of 70% ethanol, air-dried 
completely and resuspended in 20 TE [Tris-EDTA (pH 8.0)] buffer. 
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2.2.2 Confirmation of PPSIG genomic BAC clones 
2.2.2.1 Genomic Southern blot analysis 
2.2.2.1.1 Agarose gel electrophoresis and blotting of BAC DNA 
2.2.2.1.1.1 Materials 
Positively charged nylon membrane was purchased from PALL corporation 
(East Hills, NY, USA). Gel-blotting paper and 3 MM chromatography paper were 
provided by Whatman® (UK). Scott® paper towel was purchased from 
Kimberly-Clark Corporation (Roswell, GA, USA). Hydrochloric acid (HCl) was 
obtained from BDH (England). Sodium hydroxide was provided by RDH 
(Germany). 
2-2.2.1.1.2 Methods 
Fifteen jiig BAC DNA was resolved in a 0.5% agarose gel in 0.5X TBE 
(Tris-Borate-EDTA) buffer. The gel was then denatured by incubating in 0.25 M 
HCl with gently shaking for 20 min, rinsed twice with autoclaved water and agitated 
slowly in 0.4 M NaOH for 40 min. To blot sample DNA onto positively charged 
nylon membrane, the gel was inverted and placed on top of a stack of gel-blotting 
V. 
paper which were soaked in 0.4 M NaOH in a plastic box. The nylon membrane was 
put on top of the gel. Two pieces of pre-wetted 3 MM papers were put on top of the 
64 
membrane, followed by 2 pieces of dry 3 MM papers and then a stack of paper 
towel (-10 cm high). A glass plate was put on top and the whole set-up was wrapped 
with Saran wrap. Finally, a weight of -500-1000 g was placed on top and the DNA 
was allowed to transfer to the nylon membrane by upward capillary action overnight. 
After the transfer, the positions of wells were marked on the membrane with a pencil. 
The membrane was washed in 2X SSC for 5 min and then air-dried briefly on a 
large 3 MM filter paper. DNA was then fixed onto the membrane by baking at 80°C 
for 2 h in an oven (Memmert UM300). 
2.2.2.1.2 DIG labeling of DNA probe by random priming 
2-2.2.1.2.1 Materials 
DIG DNA labeling mix, hexanucleotide mix and klenow enzyme were 
purchased from Roche (Germany). QIAquick gel extraction kit was obtained from 
Qiagen (Germany). 
2.2.2.1.2.2 Methods 
The first step was to purify the PPSIG cDNA insert from PPSIG 5' RACED 
subclone 5,#32 by EcoR I digestion. Ten i^g plasmids, 10 of lOX EcoR I buffer 
and 5 of EcoR I restriction enzyme were mixed in a 1.5 ml microcentrifuge tube 
65 
and were made up to 100 \x\ with autoclaved water. The digestion reaction was 
incubated at 37°C overnight and PPSIG cDNA insert was electrophoresed in 0.7% 
agarose gel, excised and purified using the QIAquick gel extraction kit. 
The second step was to DIG-label the PPSIG probe. One ^g purified PPSIG 
C D N A insert was pipetted in a 1.5 ml microcentrifuge and filled up to 15 with 
nuclease-free water. The mixture was boiled for 15 min and then chilled on ice for 5 
min. Two of lOX DIG DNA labeling mix, 2 of lOX hexanucleotide mix and 1 
of 2 klenow enzyme were then added and mixed briefly. The labeling 
reaction was incubated at 3 7 � C for 20 h. After incubation, 1 |al of 0.2 M EDTA (pH 
8.0) was added to stop the reaction. The probe was stored at -20°C until use. 
2.2.2.1.3 Hybridization 
Hybridization was performed as described in Section 2.1.4.4. 
2.2.2.1.4 Post-hybridization washing and colour development 
Post-hybridization washing and colour development was performed as 
described in Section 2.1.4.5. 
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2.2.2.2 EcoK I digestion 
2.2.2.2.1 Materials 
EcoK I restriction enzyme and its buffer were purchased from New England 
Biolabs (Beverly, MA, USA). 
2.2.2.2.2 Methods 
The BAC DNA from different BAC clones was digested by EcoR I enzyme 
and followed by Southern blot analysis as indicated in Section 2.2.2.1. Twenty-five 
l-Lg of BAC DNA, 2 |al of lOX EcoK I buffer and 1 of 20 U/|al o f £ c o R I enzyme 
was mixed in a 1.5 ml microcentrifuge tube and filled up to 20 with autoclaved 
Water, The reaction mixture was incubated at enzyme-specific temperature overnight 
and resolved in 0.5% agarose gel in 0.5X TBE buffer. Genomic Southern blot 
analysis was then performed according to the method as described in Section 
2.2.2.1. 
2.2.2.3 
Large scale preparation of BAC DNA 
^•2.2.3.1 Materials 




The glycerol stock of BAC clone was streaked on LB/chloramphenicol agar 
plate and incubated at 37°C for 16 h. A single colony was picked and inoculated in 
500 ml LB/chloramphenicol medium. BAC DNA was extracted from the culture 
using the NucleoBond® BAC maxi kit according to the manufacturer's instruction. 
2.2.3 Determination of PPSIG genomic sequences 
2.2.3.1 Primers design 
Eleven pairs of primers were designed to amplify the PPSIG genomic 
fragments from the BAC DNA (Table 2.3 and Figure 2.6). The primers were 
designed in such a way that there were overlapping regions between the amplified 
fragments (Figure 2.7). The primers were designed with high annealing temperature 
(54-58°C) to increase the primer binding specificity. The annealing temperatures 
between two primers were not differed for more than 4°C so that they were 
compatible in a PCR reaction. The dimer and duplex formation, as well as 
non-specific binding of primers were also checked. The primer oligonucletoides 
Were synthesized by Invitrogen corporation (Carlsbad, CA, USA). 
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Table 2.3 Primers designed for amplifying PPSIG genomic 
sequences 
Expected P( R 
Length GC T m 
r, •瞭丨• Location Scuenee 肿）（％ ) (。（,） 
(bp) 
PPS1(;,-FP(U76) Upstream 5 ,-TCG CGC TAG AAC TAC ATT T-3’ 19 42.1 54 
of PPS IG 爪 2 
PPS1G-RP2635 Exon 2 5 ' -GCC CGC CTT GGT ATG TTG-3' 18 61.1 58 
PPS1G-FP2574 Exon 2 5,-CTG C G G TTC T A G (T A AAG-3, 18 50.0 54 川 
PPSIG-RP3184 Exon 3 5 ' -GGC CCT GGA TGT ATT CTT-3' 18 50.0 54 
PPSKi-l:l)3040 Exon 3 5'-GGC C G T T T T A T C TTG GAC-3 ' 50.0 54 ^^^^ 
PPSIG-R1M376 Exon 4 5'-TGG GGA AG A TGT AGC TGA-3 ' 18 50.0 54 
1)1)S1U-FP4259 Exon 4 5'-GGG CTA CTG ACT C O T TTC-3' 18 55.6 56 卯& 
l>l)SKi-RI)5244 Exon 5 5,-CC�C TTG TAT GTA GTG GTC-3’ 18 50.0 54 
I)I)S1C�-F1)519X Exon 5 5'-CCG CCT TTT CCT TGC ATG-3' 18 55.6 56 1^ 40 
l)l)SI(i-m)()437 Exon 6 5'-GGG CAG TAG ATG TTC ACC-3 ' 18 55.6 56 
I)1)S1G-F1)()433 Exon 6 5'-TGC CCA GTT GTC ATC" TCC-V 18 55.6 56 � ( ） 
1^1^S1G-R1'7571 Exon 7 5 , -GGT GCC TTT C A G ACA GAT-3’ 18 50.0 54 
I^PSIG-FP7523 Exon 7 5.-AAG GCC TGG TCT GAG〔、AT-3’ 18 55.6 56 ^口 
l)l)SI(i-|�i)7939 Exon 8 5’-CC’T TGG GCA TAG AGA CAT-3’ 18 50.0 54 
l)l)Sl(i-FP7()l6 Hxon 8 5'-AGC GCT ATG TCT CTA TGC-3' 18 50.0 54 ^^ ^ 
I)1)S1CI-RP81()7 Exon 9 5"-GGG TCT CAT AGT CAA CAC-3 ' 18 50.0 54 
>'1^S1G-FP8167 Exon 9 .V-AAG GCX' A AG CGT GC.T GTT-3' 18 55.6 56 3 站 
lM^SKj-Rl>8534 Hxon 10 5'-GGT TTU GUC TCT TAT GGA-3' 18 50.0 54 
''•^ Sia-|:p8454 Exon 10 5'-CCC CO A GGA GCT ACC TA-3' 17 64.7 56 ^^ ^ 
l)l)SK.i-Ri)8S()8 Exon 11 5'-AGC CTG CAG ATC TGA GTA-3' 18 50.0 54 
l ) l )S IG- l�8841 Exon 11 5'-ACG GAA C T T GTA CTC AGA T-3' 1() 42.1 54 
l)l)SK:i-Rl)(D263) Dowiistveam 5'-TTC CCA GTT AGA TTG C'TA C-3' 19 42.1 54 1418 
of PPSIG 
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This is a blank page 
PPSIG-FP(D76)—• 
tcgcgctagaactac atttcccattaggca attgaactcctgctc t^gcaaagatcatacg gaggtccataatgga caatcttcatcagtt 
ttfjagcaggcgtgag tcaaaatgcttcggc tcctcxraagtctggt: attactccaaggacg aactagaggggcggg occtcagctar.aaaa lao 
Kxon 1 
Start codon 
9ccgagctcagcgg9 gaaaqgacgcggtct tccgagccctggcag caacATGTGGATCAC TGCTCTGCTGCTGGC CGTGCTGCTGCTGGT 270 
GATCCTCCACAGGGT CTACGTGGGCCTTTA CGCTCCAACTTCCCC: GAACCCCTTCGCCGA GGATGTCAAGCGACC GCCTGAACCCCTGOT 3G0 
GACCG?iCAAGGAGGC TAGGAAGAAAGTTCT CAAACAAGgtcaact gatgggtttcaggcc tgctctcgggccttc tgctcatgtctcccc 4 SO 
attagtaaagtgctg ggaaaacttctcttg cacacagaggrtcca taatt.tagtgt:tctt tgcttctgaaagggt gcaggcattaccctt b40 
ggcacgccaaattcc agccccgccagtrtgg aatctcttcagctca cggctr.acacagaat aagagacctr.tcccc tacttgggtctggag 630 
ccaacttttccctat acttctgtgcatgct cgggggcacagggaa gcagcactgaaagtt ttcctaacaagcggg ttgcaggcaaaatgt 720 
agtccagttcataga actgaagcttgataa taacttcggaatttc agtactggctaggga taagaactccactct ccagtgaaccatctc 810 
taaagcacgtgtaga gtgctcccaaggttt gtgtttttgagactg gtctcacttttgtac tggagttggctttga actctcttcgcagcc 900 
caggctcaaacccgg agcagccctcttctt ctgtccccagcatga tgagatagattacaa gcatgcaccagcatg tctgcctttcaacgt 990 
tttacggaagtgctg gagctgggcatagtg gtgcaacaatttaat. tccagtttggactac acaatgagaccctgt ctaaatgcacacatc 'JC80 
aaaccccaaaacaac caaaacccccaaatg caaaactttcaaaaa acaaacaaggaccac ctctttgacctccag gagcctctgacttgt 1170 
aaattttagccaagc ctaggctagccttaa ctgcactattttttg gggactgactttgaa ctcctgatccttgtg cctctacttcctaag 1260 
aggcaccacacccag ttatttcattattgt cattgtttgcggatc gggggagaggcaggt: ctcatacctgtagcc caggctagcttataa 1350 
cttgctatacaggac aagt.gtgtctcaaat tcacagtgattctcc aaccaccatcagcaa gagattacaaatggr, gggattacagatgtg 1440 
agccaccatggcttg gatggagattttttt ttfcatttfcatttttt ttagttt.ttagttgt ttgagacagtgtttc tctctatagttctag 15^ 30 
atgrcctggaactcg ctattgctatataga ccaggctggccttga actcactgagatcct cccacctcagcctcc tgagtgctgagacta 1620 
aagctgtgaacactt ggccttgggcaatga tgtttaatgagcaga tr.tactg9acar.agt ggcacattcctgtga tcccagcgctgggga 1710 
ggaaaagacaggtgg atctctacataggga gttccagcccagtta gggctacatgtgtag tgaaaccgtgtgtct taaaaaacacgaatc 1800 
aataaaatcaaagaa agcaagcaaataaag gaggaaaggaagtaa aagactgggagaaaa caacaaatcccaggt ctcgtgttgaccgtg 1890 
cattccagtttggtt ctgtgaggttcccgg cacaccaaccttcct ccttttctgaggctg gtgctgtgacctctc agagtagcagcctct 1980 
gagcagctctgcctg ctccacctccgttgg cactcagagaccttg cttcttccaaagaaa cccagt.tccctgaac caccagcgtccccag 2070 
cccccaccctgagcc ttattgccttttctt tcctcgcttgcatt-c acagaactgacgtta cagccctgtgcagtt gccatctttctggtt 2160 
Ltgttctacagcagc tagctgagtcagtcc tacttcctttgaaag gcatcaaatccctca agtacactgtagggg ttaagactcatcact 2250 
gctr.aaccr.gcctgt ctggtccgaggtatt ccctggtagaatgtc ttgagacatcttagt caagagtaaataaac taccttaaaagaaag 2340 
gtctgccctccctct. tgttttgagactggg tctaacgagcccagg ctggcctcctgtggg atgatcttggcctcc taatgcacctttcaa 2430 
gtgctcccatcacag gagtacaccaccatg cccagcagccc|taga gactitcttaccgagt acacgttagagaagg accccggcttctttg 2520 
Exon 2 
acttgacttfccctgc cctcgtctgagaagc tcaccctt.ctcct.cc cttctacacfCTTTCT CAGTCAOCCGAGTAC CAGAGAAGCTGGATG 2610 
PP3IG-FP2574—• ^ PPSIG-RP2635 
CAGTGGTGATCGGCA GCGGCATTGGGGGAC TGGCCTCAGCTQCGG TTCTAGCTAAAGCTG GCAAGAGAGTCCTTG TGCTGGAACAACATA 2700 
GTTGTCATACCTTTG GGGAAAATGGCCTTG AATTTGACACTGgta aggcttgtgcgggaa agggttaggagcatg 2790 
gccttgtctttagat ggctaataacacaca ctattgagtgacatg ggggcattttaatgt ttggaggtctcaact tctctctgggcacct 2880 
ccatttctgtccgat ggcctagctacfcggg caagcattgggcggt atatgttctgatttg tttcttatagaaagg gtgggcagcccccct 2970 
ctggacatgaacata gccaagcaggacaac ctcttccttacttgg catatttccagggcc caatcccttctatcr. ctatatctcctttcc 3060 
Exon 3 PPSIO-FP3040 — • 
tttgcacctcccaac agGAAlTCATTATAT TGGACGAATGCGGGA GGGCAACATTggggG rryr*i:yrC?TTQG^ pCA GATCACTGAAGGGCA 3ISO 
ACTGGACTGGGCCCC CATGGCCTCCCCITT TGACrrOATGATACT AGAAGGCJCCCMTCG CCGAAAGGAGTrCCC CATGTACAGTGGGAG 3240 
PPSIO-RP3184 
Gi^QAATACATCCA GGQCCITAAGAAGAA GTTCCCCAAGGAAGA AGCTGTCATTGACAA GTACATGGAGTTGGT TAAGgtagtatgcac 3330 
catgattagcatccc tagtttatttccaac aagactggccttttc attagfcgaagaaact ggtggggtaggagga gagggctgagttggg 3420 
gaggcaggaaggaat ggtcatgtctgtcct ggttccagtgtaagc ttgtgtttgcctgtg ccctgcttggctccc cagctgcagtcctca 3510 
cactggcctctagat ggtacccttgctaag tcaggctttgaggaa gctagatgtcctctg agatatgccagactc ttgtgtatttgaggt 3600 
agagtctcacaatgc tgccctggctggtct ggaactcagcagaga tccacctgcctctgc cgagcatatgaaatc ataacctgctttctg 3690 
gaccaggatgtttgg aaggaatctgaatgc tggggatgtggctca ggcttagcacataca actctgaattatatc ccaagcaccttagca 3780 
tctggatatgatggt gtagcctgtaatccc agcattggggaggca gaagcaggaagctca ggagttcaaggtcac tggaatattcggaac 3870 
tctccatat:aaaaga aaaacaatacttttt ggagcatgaaatgga agagcaaatagtctc atctgagrgcgaaga atgagaaaaactcag 3960 
gacccattttgttgt tgttttgtggtgagg aagacagctctacta catagtcctggcttc tatgtcagtgtatag ctctggttgccctta 4050 
aactcatggcaatcc tcctgctgtagcatc tcaactgttgggatc acaggcctgagtctg atcacacacaccatg cctaaaaaaaatttt 4140 
caagrccaaaaattc tgagtaagtgttgct gggctggcagccagc gctgactgctgcagc agcaactaggctcca gcaccccagagctga 4230 
Exon 4 
gacticactttacctt ttttatcccagGTGG TGGCCCGTGGAGTCT CTCATGCAGTTCTAC TCAAGTTCCTCCCAT TGCCCTTGACTCAGC 4320 
PPSia-FP4259 — 
TCCTCAGCAAGTTTg_GqCTACTGACTCGTT TCTCTCCRTTCTGCC GAGCGTCTACGCAGA GCCTAGCTGAAGTCC TGCAGCAGCTTGGGG 4410 
PPSIG-RP4376 
CTTCCCGTGAGCTCC AGGCTGTTCTCAGCT ACATCTTCCCCACTr ACGgtgggtggctat agcccaggcttttct aggctactgctctcc 4500 
cagctttggtctttc tttcccatctgccta actgagacaggctag aatagccccaggcct gcaggagrtcgtgga tcagggctgagaagt 4590 
ctgacccatgttgga ctctggtaaaaatga tttattatttacttt atggaacgttatctt ttgttcttctctctt gtatcttttcttctt 4680 
cttctgttttgtttt ctcttccttttcgaa gacaaggtcttccag gcaagctttgaactc tugtagttgaggatg tccttaaattcctta 4770 
tccttctgcctctac cttcctagtgctagg tatgtgccaccatgt ctggggtatgtggtg ctggagatcaaatcc aggctttcatgcatg 4860 
ttaggaagacatcca gcr.gagcccacccaa gtgcattttctccct. gtcccctacacctcc aggaaaagttttgac tttgctcaggctggc. 49S0 
ctagatctctccgta gctCagtatggcttt gaatcaatgatcctt ctggtgtagcttttg agtgtgagattatag gcatgtacactgctc 5040 
aaggttgatttttct ctttagccaacagtg tcagtgact.tctttg gtcttggaagcataa tggttttatattcca ctaagctcattacct S130 
accctgggcctttgg gagcattctcatcct aggatggactctngfc ggtccctcacaggaa gccctatttcttcct gaatggtgccaaatg 5220 
Exon 5 PPSIO-PP5198—• PPSIO-Rf'5244 
accactatgctcatc ttctttccttcatcc t:gtagGAGTAACTCC CAGCCACACCGCCTT TTCCTTGCATGCTCT GCTGGTrGACCACTA S310 
TTACCCTCGAGGGGG TTCCAGTGAGATCGC CTTCCATACCATCCC TTTGATTCAGCGGGC CGGGGGCGCTGTCCT 5400 
CACCAGGGCCACTGT ACAGAGTGTGCTGCT GGACTCAGCTGGGAG AGCGTGTGgtaagag atctgtactgggctg tggggtcagtgggct 5490 
99ggtggaagccagc ctgtttatgcacggt aagaggctggcgtcc gagccggtgagatag ctcagtggataaatg gtctagtcactcact 5^80 
70 
aaacctgatgatccc cacagcctacatggt ggaaggagagaactx: ccggacaagttgtca ctactgacctccaca catgggctgtagcac 5670 
tcctacccccacccc ccccacacacacaca caatgaaggaatcaa actacaattcttaca aaaggtcaggtctga cataatggttttgtg 5760 
agtggccagagar.ga ggr.tggaoacacagg cttcagtacatcaca gaagcottggtgf-tt catgaaggttgagt.c atctggggagtact.g 5650 
tagatgtggaacttg gcagcagggaaggag gggctgggactccat agagccagrgttctt gggacggcagggcgt ggctaaggtaagtcc 5940 
atatgggtcjggtaag aagagctagagagqg caagcacagaagcat ttgaggcaagggcta agtgactttgcagtg tgcctgggacctgct €030 
trggctagaggaact tctaggtctgagaaa acagggcct.acccta ggagacatctggata gtgtggctatagaca gaactaatattttga 6120 
99C^iggatttcat;gt gt.r,tcaggctatcct caaactcactagcta gctgaggctgacctt cgaattcctgattat atggcgtctacctcc 6210 
tacatgctaggattg caggaacatgtcatc atgctgcgactacag ctaatgcttugagag aaatgtatttcacac tctcctgggttgtgt 6300 
1.1g111tatggt.ggg tatggggtgcacgga acctagggcttcata catgttagacaagcg ctttccacctgagct gt.attcctagccctt 6390 
Exon 6 
^sigagggatctagag aatggtataggtcrc tttcgtttccacaga gctcatagaagctca gccanattcttgtgc ctgcagGTGTCAGTG 6460 
^ PPSIO-RP6437 PPSTG-FP6433 — 
TGAAGAAGGGACAAG AGCTGOTOAACATCT ACTqCCCAGTTGTCA TCTCCAATGCGGGAft. TGTTCAATACCTATC AGCACTTGTTGCCAG 6570 
AGACTGTCCGCCATC TGCCAGgtaaaagac tgaccttttgaacta atatttcatctgtga agcttacatgcccag ctgggtgggctcccc €660 
tctccttgggcagtc ccjctagctgtctctc tctagtctgtgctac caggaacatagcatt tatatttggggaatc taggactacagggga 6750 
agaggagcccttcac agaggcagtggcaga gctctgaggactctg ttr.tgtcagatgcaa atgtctatcttgtac 11ccgggctgaaaaa 6840 
cacaaccctgtatat 11get11ccx11gcc agagaaaccagggcc ttaatagaaaagact cagttaaatggcaga caagagctagggatg 6930 
aagttcagttggtta gagtgcttgcaticag ccctgggtttaccta yagccaggtaagaca actagagtggatttg gctgcaatcccagca 7020 
ctcaagaggtgttgg cgggaagataagaaa ttcaaggtcaccgtt ggctacacaagaccc tgcctcaacaaacaa aggccactgagatgg 7110 
ttcagagtgtaaagt c 111 g c t gc t a a a t. c cccagagtggaagaa gatagttgtcttctg gcttcctgcacatct agacagacctttatc 7200 
catatacatctataa ttaacgaaacatcta aatgtataaagagga gggttggaacagcct gattgtccagaggtg ctgtgagttagctct 7290 
gctctgaatcagcag gaagccagcacctat gactaaggggacatg gggcagaggtggtag agttggaaagaatct gaggctacatctcac 7380 
ata9ccag9acgaga cttaagagcaggtct ctgccaggatcctat agaaatagttataaa dccggccaggtctct gtcccagctggcagc 7470 
tgaggatcgagctac aaatcagaaaaggga acatcctgaggctat cctgacaggggtggc tgtctggctgtaact cctgcacagcaatcc 7560 
Exon 7 PPSIG-FP7523 —• PPSIG-RP7571 
tcactggctctctgc agATGTGAAGAAGCA GCI'GGCGATGGTAAG QCCTGGTCTGAGCAT GCTCTCAATCri'CAT CTGTCTGAAAqGCAC 76S0 
CAAOGAGGACCTGAA GCTTCAGTCCACCNA CTACTATGTTTA^ TGACACA0ACATG<3A CAAAGCgtaagatgt gaggggtggqgaa^ 7740 
ctgatagtgttgggc ctcatcccacaaggt cctgcttccaccctc cacacgg11ctagga ataagaaggatgtgt. tttgagggaggaggt 7830 
goagtctctaatgga ct.tctagaaaggcct tctacaccaaagccg tgctgttttctccct tgtgggaagtccctg gagatgagcccttgt 7920 
Exon 8 PPSIG-PP7916—• 
tt^ jggtiagtgctggt: ggctttgaggaagag gcctaaagattggca gtcacgccccctccc tcatccacagGATGG AGCOCTATOTCTCTA 8010 
PPS1G-RP7939 " …... 
TggCCAAQQAAAAGG CTCCAGAACACATTC CCCTTCTCTTCATTG CCTTCCCATCAAGCA AGGATCCAACCTGGG AGGAGCGATTCCCAG 8X00 
Exon 9 
^tagggcttgaagtc cagggaagttgggtg tagggcaaggcaggg ccaaatagcaataac atggccttat.accca cagACCGATCCACAA 8190 
PPSIG-PP8167 ••-PPSIG-RP8197 
TGACTGCaCTGGTAC CCATGGCCTTTGAAT GGTTCGAGGAGTGGC AGGAGGAGCCAjj^gg ggj^ggg^jf^ggJg^G ACTATGAQACCCl'CA 8280 
AAAATGCCTTCGTGG AAGCCTCTATGTCGG TGATCATGA^iACTGT TCCCACAGCTGGA<X3 G C A A G g t a g ^ " ^ g acatacagtgctgga 8 3 7 0 
99tgacaatgcatcc cttaactgtcttctt ccatacagggacaaa gcctgcggtaacaag agtcccacagtccct tgttcacccttgcct 8460 
Exon 10 PPSIG-FP8454-^ 
tgcccLtttgtttcC tcagGTGGAGAGTGT GACTGGAGGGTCACC ACTGACCAACCAGTA CTATCTGGCTGCACC CCGAGQAQCTACCTA 8550 
•"PPSIG-RP8534 
TGaAGCTGACCATGA CTTGGCTCGGCTGCA TCCTCATGCAATGGC TTCCATAAGAGCCCA AACCCCCATCCCCAA CCTCTACCTGACAGg 8640 
tacactgcctcactt tgccagaatctggac ttccctggcatagtc trctgttctcgtcct caagcctacaccagg agctgggctgcc11g 8730 
gctattgtcctgggt. tct-.atctgaggctgt ctctctt:t9ggtggc cttgatatggaggga tgaacacaagaaccc ttgttacccccatct 8820 
Exon 11 
tcatgggtcactgct tttgctttctagGCC AAGATATCTTCACCT GTGGGCTGATGGGGG CCCTGCAGGGGGCCT TGCTGTGCAGCAGTG 8910 
PPSIG-FP8841"^ •"PPSIG-RP8868 Stop codon 
CCATCCTGAAACGGJ^ —jlffg^ gg辟g^ jfgj^ g^ g^C TQCAQGCTCl'TGGCT CAAAGGTCAACtGCAC AAAAGAAGAA5ATGT AGTCCGTTCAGAGAA 9000 
GAGCCAGAggaaagg cacctccccaacttc tcgtggtgtcctccc tcctacagcaattcc ttgcacatataaaca aaaaccattttgttt 9090 
CTGATTAGTGTTGTT AAGTCAAGAGTrCTT TACCTTGCATTCTAC TTAAGGCCTAGTGTG AACTACATAGCCTTG ATGCCTCATGAA3AA 9180 
TGCTCCCATGCCTTT CCTACACCCAACTCC AAGCTATGGTCAGGC ACCCAGAACCCCTGG GGTGTTGGCTACTGG AATAGGTTGGTTCAG 9270 
TCCTACCCTGAAGCT TTTTGTTCCTCCTCA CTCTCGTGTTGTGAT GCTCTATACATGGAA AAGTGTGGGCTTGGA GTAGCAACTCTCTCA 9360 
AAGTGCCAGACCTAA GAAAACCCTCAGGTC TAAGTTTTATCCTGA TAGAAGTGGGTTAAA GGAACACACCAAAAG ATACCACTGCCGATG 9450 
ACCCAAGCCTAGACA CGGCATTTGTAGTTG CTGGCACATAGTCAA ACTGAGITACGAGGC TGGGCAGTCCrGGCA CCGGCCTTTAACCCC 9540 
AGCACTCAGAAGGCA GGGGCAGACAGAGCT CTGTGAATCTGAAGC CAGAACTAGTTTATG AAGCAAGTCCAGGGC AGCCAGAGCTCTGTT 9630 
ATACAGAGAAACCCT GTCTTGAAAAACAAA ACAAAACAAAACAAA ACCTGAGTATTGTTT TCTAAAATGCTTGGA GTCAGAATTCTTTCA 9720 
^ATTTTGTAGTATTT GCATACACATGAGAT AACCTGGGGAATGGG TCCCAGAACTAAACC ACAAATTCATTTGTT TCATATGTATAGACC 9810 
AGGCACAACATCTTA TGTAATACTTTGAAA AACTGAGCATTCTGA CCTGTCACATGAGTC CATGCTATAATTTAA AAAGCTTGCTTTGAT 9900 
'n^CAGAATAGGGATG CTTTACCTATATGAG TAAATGAGAAGGTGG ATAAAAT^TTAAAAAC CTTTTACTTATGTTA AACAAGTGCTAATTT 9990 
TAGTCTGTTTAAATA TAGTATTAATACATG TAATGTTTCAATGCT TTGATATCTGAAATT TATTGATTTCTGTTC AATAATGACATGAAA 10080 
CTATGCTATGATTCC ATTTACAGAAGCTCA GTAAAATATACTGAA AAATACTTACTATAC CACAGTAAGCTTTAA AAAAAATAAAATTAA 10170 
•4- PPSIO-RP(D263) 
OCCATTACAGTTAAG TTACAAAAAAGGTGA CAATACCAAACATGG CTAACAGTAGCAATC TAACTQGGAA 10240 
Figure 2.6 Locations of primers designed to amplify the PPSIG genomic 
fragments 
PPSIG primers were designed based on the genomic sequence of Riken cDNA 
0610039N19. Eleven pairs of primers (bolded and underlined) were designed to 



























































































































































































































































Platinum Taq DNA polymerase high fidelity kit was purchased from 
Invitrogen corporation (Carlsbad, CA, USA). 
2.2.3.2.2 Methods 
PGR was performed to amplify the PPSIG genomic fragments. Twenty ng 
template, 5 i^l of lOX high fidelity PGR buffer, 2 |il of 50 mM MgS04, 1 of 10 
inM dNTP, 2 of 10 |aM forward primer, 2 jiil of 10 f,iM reverse primer and 0.2 
of 5 U/|al Taq were mixed in a 0.2 ml microcentrifuge tube and was filled to 50 
with nuclease-free water. PCR was done in a theimocycler (Applied Biosystem 
GeneAmp PCR 9700) set at 95°C for 2 min for the first cycle, followed by 35 cycles 
at 94°C for 30 s, 65°C for 30 s and 6 8 � C for 3 min and a final step at 68°C for 10 
min. 
2.2.3.3 Subcloning of the PPSIG genomic fragments 
2.2.3.3.1 Ligation and transformation 
The PPSIG genomic fragments were subcloned in pCR®II-TOPO*^ vector. The 
ligation and transformation protocols were described in Section 2.1.2.1. Subclones 
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were picked from the LB/ampicillin agar plate and grown up in 1 ml LB/ampicillin 
medium. They were incubated at 3 7 � C with shaking overnight. 
2.2.3.3.2 PCR screening 
2.2.3.3.2.1 Materials 
Taq DNA polymerase, PCR buffer and MgCl? solution were purchased from 
Genesys. Mini-M�” plasmid DNA extraction system was obtained from Viogene 
(Sunnyvale, CA, USA). 
2.2.3.3.2.2 Methods 
PCR screening was performed to select subclones containing the target inserts, 
by primers which were used to generate that PPSIG genomic fragment. Seven |al of 
overnight culture, 1 i^ il of lOX PCR buffer, 0.6 i^l of 25 mM MgCb, 0.2 |al of 10 mM 
dNTP, 0.5 |al of 10 \xM forward primer, 0.5 |al of 10 |iM reverse primer and 0.2 of 5 
U/^il Taq DNA polymerase were mixed in a 0.2 ml microcentrifuge tube. PCR was 
done in a themiocycler (Applied Biosystem Gene Amp PCR 9700) set at 95°C for 2 
min for the first cycle, followed by 35 cycles at 94°C for 30 s, 65°C for 30 s and 72°C 
for 3 min and a final step at 72°C for 10 min. All PCR products were resolved by 
electrophoresis. For each PPSIG fragment, one subclone showing positive result was 
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chosen to grown up in 5 ml LB/ampicillin culture. Plasmid DNA was extracted from 
the culture using the Mini-M® plasmid DNA extraction system. 
2.2.3.4 DNA sequencing 
The plasmids were sequenced using M13-reverse primer, M13-forward primer 
and PPSIG gene-specific sequencing primers designed as shown in Table 2.4 and 
Figure 2.8. . 
2.3 Cloning of PPSIG-promoter reporter constructs 
2.3.1 Amplification of PPSIG 5'-flanking fragment by PCR 
2.3.1.1 Materials 
Platinum Taq DNA polymerase high fidelity kit was purchased from 
In vitro gen corporation (Carlsbad, CA, USA). QIAquick gel extraction kit was 
obtained from Qiagen (Germany). Restriction enzymes and their buffer and BSA 
were purchased from New England Biolabs (Beverly, MA, USA). The primer 
oligonucletoides were synthesized by Invitrogen corporation (Carlsbad, CA, USA). 
2.3.1.2 Methods 
A -3000 bp PPSIG 5'-flanking fragment spanning from —2936 to +119 with 
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Table 2.4 Primers designed for DNA sequencing of subclones of 
PPSIG genomic fragments 
Primer Sequence Orientation PPSIG genomic fragments 
Ml3-Reverse 5 ' -CAG GAA ACA OCT ATG AC-3 ' - All subclones 
M 1 3-Forvvard 5'-GTA AAA CGA CGG CCA GT-3' - All subclones 
PPS1G-SEQ138 5'-GAG CCC TGG CAG CAA CAT-3' Forward PPSIG-FP{IJ7())/PPS1G-RP2635 
P1\SIG-SEQ(11)586 5'-GGG GGC ACA GGG AAG CA-3’ Forvvaid PPS1G-FP(1176)/PPS1G-RP2635 
1)I)S1G-RP76() 5'-CTT GGG AGC ACT CTA CAC-3' Reverse PPSIG-FP(U76)/PPS1G-RP2635 
PPSIG-Si:-;0(11 )1492 R 5'-CAG C C T GGT CTA TAT AGC-3' Reverse PPSIG-FP(IJ76)/PPS1G-RP2635 
l 'PSIG-SHQ(l l )1680 5'-GGG CTA CAT GTG TAG TGAA-3' Forward PPSIG-FP(U76)/PPS1G-RP2635 
l)PSi(i-Rl)l 845 5'-GCC GGG AAC CTC ACA GAA-3' Reverse PPSIG-FP(1)7())/PPS1G-RP2635 
1)PS1G-SEQ(11 )2186R 5'-GGC AGG TTA AGC AGT GAT G-3' Reverse PPSIG-FP(U76)/PPSIG-RP2635 
PI'S1G-SEQ34() 5 ' -CTC GGC TGA CTG AGA AAG-3' Reverse PPSIG-FP(IJ7())/PPSIG-RP2635 
l'l\SICi-RP3031 5’-CCT CCC GCA T I C GTC CAA-3’ Reverse PPSIG-FP2574/PPS1G-RP3184 
Pl)SIG-m)3184 5'-GGC CCT GGA TGT ATT CTT-3' Reverse PPSIG-FP2574/PPS1G-RP3184 
H)SIG-SEQ(I3)3 198 5 ' -CTC CAA GGA AGA AGC TGT-3' Forward PPSIG-FP3040/PPSIG-RP4376 
Pl)SrG-Rl)3545 5'-AGG GCA GCA TTG TGA GAC-3' Reverse PPSIG-FP3040/PPSIG-RP4376 
I)l)SlG-m)3971 5'-GGG CAA CCA GAG CTA TAC-3' Reverse PPSIG-FP3040/PPSIG-RP4376 
即SIG-I:1M25() 5 ' -GGG CTA CTG ACT CGT TTC-3’ Forward PPSlG-FR259/PPSICi-RP5244 
PI)SIG-m)4376 5'-TGG GGA AGA TGT AGC TGA-3 ' Reverse PPS1G-FP3040/PPS1G-RP4376 
P1'SIG-SEQ(!4)5063R 5'-G(’C CAG G G T AGG TAA TGA-3' Reverse F'PSIG-F1M259/PPS1G-RP5244 
PI'S1G-SHQ5368 5'-AGA GCG TGT G G T AAG AGAT-3’ Forward PPSIG-FP5198/l^PSlG-RF'6437 
l 'I 'SIG-RP56()0 5 '-GGG GGT AGG AGT GCT AC-3' Reverse PPSIG-FP31 ' )8/PPSlG-RP6437 
' ' l 'SIG-SEQ(I5)6214R 5'-CCC AGG AAA GTG TGA AAT A-3' Reverse PPS1G-FP5198/l)l)SIG-RP64:;7 
' 'l 'S^iG-RP6437 5'-GGG CAG TAG ATG TTC ACC-3 ' Reverse PPS1G-FP51 ()8/Pl)SICi-Rl)()437 
16)6749 5'-CGG G C T GAA AAA CAC AAC-3' Forward PPSIG-FP6433/FPS1G-RP7571 
' '1'S1G-RP7571 5 '-GGT GCC I T T CAG ACA GAT-3' Reverse PPS1G-FP6433/PPSIG-RP7571 
' ' I 'SIG-SEQ(E 12)9382 5'-TGC CAG ACC TAA GAA AAC C-3' Forward PPSIG-FP8841/PPS1G-RP(D263) 
P1)SIG-W)9534 5'-TGC CCA GCC TCG TAA CTC-3' Reverse PPS1G-FP8841 /PPS1G-RP( 1)263) 
' ' l 'SIG-RP( 1)263) 5'-TTC CCA GTT AGA TTG CTAC-3 , Reverse PFS1G-FP8841/PPS1G-RP(D263) 
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tcgcgctagaactac at11cccattaggca attgaactcctgctc r:gcaaagatcatac9 gaggtccataargga caatcttcatcagtt 90 
tt9agca9gc9tgag tcaaaatgctt,cggc tcctccaagtctgqt attact,ccaaggacQ aactagaggggcygg gcctcagctataaaa 180 
Bxon 1 
PPSIG-SEQ138—• Start codon 
gccgagctcagcggg gaaaggacgcggtct tccgagccctggcag caacATGTGOATCAC TGCTCTGCTGCTGGC CGTGCTGCTGCTGGT 270 
GATCCTCCACAGGGT CTACGTQGGCCTTTA CGCTGCAAGTTCCCC GAACCCCTTCGCCGA GGATGTCAAGCGACC GCCTGAACCCCTGGT 360 
OACCGACAAGGAGGC TAGGAAGAAAGTrCT CAAACAAGgtcaact. gatgggtttcaggcc tgctctcgggccttc tgctcatgtctcccc 4 
at.ta9taaa9t9Ct.9 gga^iaacttctcttg cacacagaggttcca t:aar.11agtg1.1ctt. tgcttctgaaagggt. gcaggcattaccctt S40 
ggcacgccaaactcc agccccgccagttgg aatcttttcagctca cggctracacagaat aagagacctttcccc tacttgggtctggag 630 
PPSIG-SEQ(II) 
ccaacttttccctat acttctgtgcatgct c:筋乡朋giji!jp^gcactgaaAgt.t: ttcctaacaagcggg ttgcaggcaaaatgt 720 
a 91； c c a 911 c a t a g a a c t g a a g c r： t g a t a a taacttcggaatttc agt ac t ggc r； a ggga t： aagaactccactct ccagtgaaccatctc 810 
^PPSIQ-RP760 
taaagcacgtgtaga gtgctcccaagqttt gtgtttt.cyagact9 gcctcacttttgtac tggagttggctttga actctcttcgcagcc 900 
caggctcaaacccgg a9cagccctct.tctt otgtccccagcat.ga r. 9 ag a t a g a 11 a c a a gcat.gc<5c;cagcatg t. c t g c c 1.1.1. c a a 091 990 
tttacggaagtgttg gagctgggcatagtg gtgciiacraatttiaiU： tccagtttggactac acaatgagaccctgt ctaaatgcacacatc 1080 
aaaccccaaaacaac caaaacccccaaatg caaaactttcaaaaa acaaacaa^gat cac ctctttgacctccag gagcctctgacttgt 1170 
a aa 1111 ag c c a ag c ctaggctagccttaa ctgcactattttttg gggactgactttgaa ctcctgatccttgtg cctctacttcctaag 1260 
aggcaccacacccag ttattttar.tatt.gt tatr.gttrt.gtggar,r. gggggagaggcaggt. ctcatacttatagcc caggctagcttataa 13S0 
cttgctatacaggac aagtgtgtctcaaat tcacagtgattctcc aaccaccatcagcaa gagattacaaatggt gggatcacagatgtg 1440 
agccaccatggcttg gatggagaccttttt tttattttattttct titagttitttagtitgt. ttgagacagtgtttc tctctatagctctag 1530 
•-PPSXQ-SEQdl) 1492R 
^tgtcctggaacttg ctattgctatataga cc&ggctggcc11ga actcactgagatcct cccacctcagcct.ee tgagtgctgagacta 1620 
^^^ctgtgaacactt ggccttgggcaatga tgt ttaatgagcaga tttactggacatagt ggcacattcctgtga tcccagcgccgggga 1710 
PPSIG-SEQ(Il)1680 — 
atctctacatciggga gttccagcccagtta gggctacatg tgrtag t g aa a c eg 1: g t g t. c t t aaa a a a c acg a a t c 1800 
aataaaatcaaagaa agtaagtcsaataaag gaggaaaggaagtaa aagactgggagaaaa caacaaatcccaggt cttgtgttgaccgtg 1890 
—PPSIG-RPIMS 
ca11cca91.1111 ctgtgaggttcccgg cacaccaaccttcct ccctttctgaggctg gtgetgtgacctctc agagcagcagcctcc 1930 
gagcagctctgcctg ctccacctccgttgg cactcagagacctxg ctt.ct.tccaaagaaa cccagttcccr.gaac caccagcgtccccag 2070 
cccccaccctgagcc ttattgccttttctt tcctcgcttgcattc acagaactgacgtta cagccctgtgcagtt gccatccttctggtt 2160 
—J»PSIG-SBQ(I1)2186R 
ttgttctacagtage tagctgagtcagtcc tacttcctttgaaag gtatcaaatccctca agtacactgtagggg ttaagacts，^!^，；^!：； 2250 
gcttaacctcfCGtqt ctggtccgaggtatt ccctggtagaatgtt ttgagacatcttagt caagagtaaataaac taccttaaaagaaag 2340 
gtctgccctccctct tgttttgagactggg r.ctaacgagcccagg ctggcctcctgtggg atgatcttggcctcc taatgcacccttcaa . 2-130 
？3tgctcccatcacag gagtacaccaccatg cccagcagccgtaga gacttcttaccgagt acacgttagagaagg accccggcttctttg 2520 
Exon 2 •-PPSIG-SEQ340 
acttgactttcctgc cctcgtctgagaagc tcacccttctcctcc cttctacagCTTTCT CAGTCAGCCGAG丁AC CAGAGAAGCTGGATG 26.10 
CAGTGGTGATCGGCA OCGGCATTGGGGGAC TGGCCTCAGCTGCGG TTCTAGCTAAAGCTG GCAAGAGAGTCCTTG TGCTGGAACAACATA 2 7 0 0 
CCAAGGTOGGCGGCT GTTCTCATACCTTTG GGGAAAATGOCCTTG AATTTGACACTGgta aggctt^tgtgggaa agggttaggagcatg 2790 
9ccttgtctttagat ggctaataacacaca ctattgagtgacatg ggggcattttaatgt ttggaggtctcaact tctctctgggcaccc 2880 
ccii111ctgt.ccgat ggcctagttactggg caagca11gggt.ggt atatg11.ctga1.11g t.ttcttatagaaagg gtgggcagcccccct 2970 
'^ B^S^ k^Catgaacata gccaagcaggacaac ctcttcc11ac11gg catatr.tccagggcc caatcccttttatct ctaratctcctttcc 3060 
Exon 3 PPSIG-RP3031 
tttgcACCtCCCaac a^GAATTCATTATAT TQGACGAATGCGQGA GQGCAACATTGi'SCCG TTTTATCTTGGACCA GATCACTGAAGGGCA 3150 
ACTGGACTGGGCCCC CATGGCCrCCCCTTT TGACTTGATGATACT AGAAGGGCCCAATGG CCGAAAGOAGTTCCC CATGTACAGTGGGAG 3 2 4 0 
。 鄉 G T R Q Q Q 鄉 J ^ F I S ^ F ? 办 职 A T T G A C A A GTACATGGAGTTGGT T^AGGTAGCACGCAC 3330 
catgattagcatccc tagtttatttccaac aagactggccttttc attagtgaagaaact ggtggggtaggagga gagggctgagttggg 3420 
gaggcAggaaggaat: ggtcatgtctgtcct gg 11 ccag r.g t a age tt.gr,gt.ttgcctgr.g ccctgcttggctccc eager, gcagtcctca 3510 
cactggcctctagat ggcaccctcgctaag tcagactttgaggaa attagatgtcctctg agatatgccagactt ttgcgtattcgaggt 3600 
'^PPSIO-RP3545 
^^^SL^ctcacaatgc tgccctqqctqf^tct ggaactcagcagaga t;. c cac c t. 9 c c t c 19 c cgagca t a t gaaa t c a t. a a c c t. g c 11.1 c t g 3e>90 
gaccaggatgtttgg aaggaatctgaatgc tggggatgtggctca ggcttagcacataca actctgaattatatc ccaagcaccrtagca 3780 
tctggatatgatggt gtagcctgtaatccc agcattggggaggca gaagcaggaagttca ggagttcaaggtcac tggaacatttggaac 3870 
tctctatataaaaga aaaacaatacttttt ggagcatgaaatgga agagcaaaLagtctc atttgagtgcgaaga atgagaaaaactcag 3960 
PPSIO-RP3971 
gaccca1111g11.gt tgttttgtggtgagg aAgacagctctacta catagtcctggcttc tatgtcagtgtatag ctctggttgccctta 4050 
eiactcatggcaatcc tcctgctgcagcarc tcaactgttgggarc acaggcctgagtctg atcacacacaccatg cctaaaaaaaatttc 4140 
c a a g t c ca a a a a 11. c t ga g t a a 91. g 11 g c t gggctggcagl.cagc gctgactgct.gcagc agtaactaggctcca gcaccccagagctga 4230 
£xon 4 
g a c t c a c t t t a c c t t t t r t a t C C C a g G T G G TGGCCCGTGGAGTCT CTCATGCAGTTCTAC TCAAGTTCCTCCCAT TGCCCTTGACTCAGC 4 3 2 0 
- PPSIG-FP4259 — 
TCCTCAQCAAG'ITTG GGCTACTGACTCGTT TCTCTCCATTCTGCC GAGCGTCTACGCAGA GCCTAGCTGAAGTCC TGCAGCAGCITGGGG 4 4 1 0 
—PPSIG-RP4376 “ 
CTTCCCGTGAGCTCC AQGCTOTTCTCAGCT ACATCTTCCCCACTT ACGgtgggtggctat agcccaggcttttct aggctactgctctcc 450(3 
c^gctttggtctttc tttcccatctgccta actgagacaggctag aatagccccaggcct gcaggagt11gtgga tcagqgctgagaagt 4S9C 
^tgacccatgttgga ctctggtaaaaatga tttattatttacttt atggaacgtuatctt. ttgttcttctctctt gtatcctttcttctt 4680 
cttctgttttgtttt ctcttcctttttgaa gacaaggccttccag gcaagctttgaactc txgtagr.tgaggatg tccttaaattcctta 4770 
tccttctgcctctac cttcctagtgctagg tacgtgccaccatgt ctggggtatgtggtg ctcjgagaccaaatcc aggctttcatgcatg 4860 
^taggaagacatcca gctgagcccacccaa gtgcattttctccct gtcccctacacctcc aggaaaagttttgac tttgctcaggccggt 4950 
ctagatctctccgta gcttagtatggcttt gaatcaatgatcctt ctggtgt.agct.r.ttg agtgtgagattatag gcatgtacactgctc 5040 
和 PPSIG-SEQ(I4)5063R 
®^99ttgatttttct ctttagccaacagtg tcagtgacttctttg gtcttggaagcataa tggttttatatrcca ctaagctcattacct 5130 
*££ctg[22cct11gg gagcattctcatcct aggatggactcttgt ggtccctcacaggaa gccctatttcttcct gaatggtigccaaatg 5220 
Exon 5 
^ c c a c t a t g c t c a t c t t ' c r ' t t c c t t c a t c c tgr.agOAGTAACTCC CAGCCACACCGCCTT TTCCTTGCATGCTCT GCTGGTTGAC^CTA 5310 
^ATACAAGGGGCATA TTACCCTCGAGGGGG TTCCAGTGAGATCGC CTTCCATACCATCCC TTTGATTCAGCGGGC CGGGGGCGCTGTCCT 5 4 0 0 
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PPSIG-SEQ5368— 
CACCAGGGCCACTGT ACAGAGTGTGCTGCT GGACTCAGCTGGf;各^JJ^q^TGl纽納3叹碎ct..gtact:gggct.g t.ggggtcagtgggct 5490 
999gt99aagccagc cr.gtttatgcacggt aagaggctggcgtct gagccggtgagatag ctcagrggataaatg gtctagtcactcact S^BO 
和 PPSIG-RP5600 
aaacctgatgatccc cacagcctacatggt ggaaggagagaactn ctggacaagttgtca ctactgacctccaca catgggctgtageac 5670 
tcctacccccacccc ccccacacacacaca caatgaaggaatcaa actacaattcl.tvaca aaaggtcaggtctga cataatagttttgtg 5760 
agtgaccagagatga ggttggacacacagg cttcagtacatcaca gaagccttggtgttt catgaaggttgagtc atctggggagtactg 5B50 
tagatgtggaacttg gcagcagggaaggag gggctgggactccat agagccagtgttctt gggacggcagggcgt ggctaaggtaagtcc 5940 
at at99919 ggt a ag aagagcta^agaggg caagcaca9aagcat ttgaggcaagggcta agtgacl.ttgcagtg tgcctgggacctgct 6030 
ttggctggaggaact tctaggtctgagaaa acagggcctacccta ggagacatctggata gtgtggctatagaca caaccaatar.tttga 6120 
Qgcagoa111catgt gtttcaggctatcct caaactcactagcta gctgaggctgacctt cgaatccctgattat atggcgt-ctacctcc €210 
PPSIG-SEQ(I5)6214R 
tacatgctagaat-tg caggaacatgtcatc atgctgcgactacag ctaatgctttgagag aaatgtatttcac&c 11tcctgggt.tgtgt 6300 
ttgttttatggtggg catggggtgcacgga acctagggcttcata catgttagacaagcg ctttccacctgagct gtattcctagccctt G390 
aagagggatctagag aatggtataggtcct 11c.tg11.1ccacaga gctcatagaagctca gccanattctt.gtgc ctgcagGTGTCAGTG 6480 
和PPSIG-RP6437 
TGAAGAAGGGACAAG AGCTGGTqAACATCT ACTGCCCAGTTGTCA TCTCCAATGCGGGAA TGTTCAATACCTATC AGCACTTGTTGCCAG €570 
AGACTGTCCGCCATC TGCCAGgtaaaagac tgatcttttgaacta atatttcatctgtga agcttacacgcccag ctgggtgggctcccc 6660 
t c t. c c 11 g g 9 c a g t c cgctagctgrctctc tctagtctgtgctac caggaacat.agcatt t a r. a 1.11 g g g 9 a a t. c taggactacagggga 6750 
PPSIG-SEQ(I6) 6749—• 
agaggagcccttcac acfaggcagtggcaga gctctgaggaetctg ttttgtcagatgcaa atgtctatcttgtac ttccgggctgaaaaa fS40 
ca^^cctgtatat. ttgcttccctttgcc agagaaaccagggct ttaatagaaaagact cagt.taaatggcaga caagagctagggatg 6930 
aagttcagttggtta gagtgtttgcatcag ccctgggtttaccta gagccaggtaagaca actagagtggatttg gctgtaatcctagca 7020 
ctcaagaggtgttgg cgggaagataagaaa ttcaaggtcaccgtt ggctacacaagaccc tgcctci^acaaacaa aggccactgagatgg 7iio 
ttcagagtgtaaagc ctttgctgctaaatc cccagagtggaagaa gatagtr.gtcttctg gcttcttgcacatct agacagacccttatc 7200 
ca t a t a c a t c t a t a a ttaacgaaacatcta gggttggaacagccc gattgtccagaggtg ctgtgagttagct.ct 7290 
gctctgaatcagcag gaagccagcacctat gactaaggggacatg gggcagaggtggtag agttggaaggaatcc gaggctacacctcac 7330 
atagccaggacgaga cc.taagagcaggtct ctgccaggatcctat agaaatagtcataaa accggccaggtctct gtcccagctggcagc 7470 
孜ggatcgagctac agatcagaaaaggga acatcctgaggctat cctgacaggggtggc tgtctggctgtaact cctgcacagcaatcc 7560 
和 PPSIG-RP7571 
tcactggctctctgc agATGTGAAGAAGCA GCTGGCGATGGTAAG GCCTGGTCTGAGCAT GCTCTCAATCTTCAT CTGTCTGAAXGGCAC 7650 
CAAGGAGGACCTGAA GCTTCACTCCACCNA CTACTATGriTATrr TGACACAGACATCGA CAAAGCgtaagatgt gaggggrggggaaga 7740 
ctgatagtgttgggc ctcatcccacaaggt cctgcttccaccctc cacacggttctagga atgagaaggatgtgt tttgagggaggaggt 7830 
gcagtctctaatgga cttctagaaaggctt tctacaccaaagccg tgctgccttctccct tgtgggaagtccctg gagatgagccttegt 7920 
ttgggtagtgctggt ggctttgaggaagag gcctaaagattggca gtcacgccccctccc tcatccacagGATGG AGCGCTATGTCTCTA 8010 
TGCCCAAGGAAAAGG CTCCAGAACACATTC CCCTTCTCTTCATTG CCTTCCCATCAAGCA AGGATCCAACCTGGG AGGAGCGATTCCCAG 8X00 
gtaggqcttgaagtc cagggaagttgggcg tagggcaaggcaggg ccaaatagcaataac atggccttataccca cagACCGATCCACAA 8190 
TGACTGCGCTGGTAC CCATGGCCTTTGAAT GGTTCGAGGAGTGGC AGGAGGAGCCAA;VGG GCAAGCGTGGTGTTG ACTATGAGACCCTCA 8280 
AAAATCCCTTCGTC5C, AAGCCTCTATOTCGG TGATCATGAAACTGT TCCCACAGCTGGAGG GCAAG9taggggctg acatacagtgctgga 8370 
99tgacaatgcatcc crtaactgtcttctt ccatacagggacaaa gccrgcggtaacaag aatcccacagtccct tgttcacccttgcct 8460 
tycccttttgtttcc tcagGTGGAGAGTGT GACTGGAGGGTCACC ACTGACC/vACCAGTA CTATCTGGCTGCACC CCGAGGAGCTACCTA 8S50 
TGGAGCTGACCATGA CrrGGCTCGGCTGCA TCCTCATGCAATGGC ITCCATAAGAGCCCA AACCCCCATCCCCAA CCTCl'ACCTGACAGg 8 6 4 0 
tacactgcctcactt cgccagaatctggac ttccctggcatagtc ttcrgttctcgtcct caagcctacaccagg agctgggctgccctg 8730 
9Ctattgtcctgggt tctatctgaggctgt ctctctttyggtggc cttgatatggaggga tgaacacaagaaccc ttgctacccccatct 8S20 
tcatgggtcactgct tttgctttCtagGCC AAGATATCTTCACCT GTGGGCTGATtKJGOG CCCTGCAGGGGGCCT TGCTGTCCAGCAGTG 8910 
Stop codon 
CCATCCTGAAACGGA ACTTQTACTCAGATC TGCAGGCTCTTGGCT CAAAGGTCAAGGCAC AAAAGAAGAAGATGT AGTCCGTTCAGAGAA 9COO 
OAGCCAGAygaaagg cacctccccaacctc tcgtggtgtcctccc tccuacagcaattcc ttgcacatataaaca aaaaccattttgctt 9090 
CTGATTAGTGTTGTT AAGTCAAGAGTTCTT TACCTTGCATTCTAC TTAAGGCCTAGTGTG AACTACATAGCCTTG ATGCCTCATGAAGAA 9180 
TGCTCCCATGCCTTT CCTACACCCAACTCC AAGCTATG-STCAGGC ACCCAGAACCCCTGG GGTGTTOGCTACTGG AATAGGTTGOTTCAG 9270 
TCCTACCCTGAAGCT TTTTGTTCCTCCTCA CTCTCGTGTTGTGAT GCTCTAT^VCATGGAA AAGTGTGGGCTTGGA GTAGCAACTCTCTCA 9360 
PPS1G-SEQ(E12)9382 — 
TAAGTTTTATCCTGA TAGAAGTGGGTTAAA GGAACACACCAAAAC- ATACCACTGCCGATG 9450 
•-PPSIG-RP9534 
ACCCAAGCCTAGACA CGGCATTTGTAGTTG CTGGCACATAOTCAA ACTQAGTTACGAOqC TGGGCAGTGCTi'GGCA CCGGCCTTTAACCCC 9B40 
AGCACTCAGAAGGCA GGGGCAGACAGAGCT CTGTGAATCTGAAGC CAGAACTAGTTTATC AAGCAAGTCCAGGGC AGCCAGAGCTCTGTT 9 6 3 0 
ATACAGAGAAACCCT GTCTTGAAAAACAAA ACAAAACAAAACAAA ACCTGAGTATTGTTT TCTAAAATGCTTGGA GTCAGAATTCTTTCA 9720 
GATTTI^ GTAGTATTT GCATACACATGAGAT AACCTGGGGAATCGG TCCCAGAACTAAACC ACAAATTCATTTOTT TCATA'fGTATAGACC 9810 
AGCCACAACATCTTA TGTAATACTTTGAAA AACTGAGCATTCTGA CCTCTCACATGAGTC CATGCTATAATTTAA AAAGCTTGCTTTGAT 9900 
'^TCAGAATAGGGATG CTTTACCTATATGAG TAAATGAGAAGGTGG ATAAAAATTAAAAAC CTTTTACTTATGTTA AACAAGTGCTAATTT 9990 
TAGTCTGT'rAAATA TAGTAn'AATACATG TAATGTTTCAATCCT TTGATJVrCTGAAATT TATTGATTTCTGTTC AATAATGACATGAAA 10080 
CTATGCTATGATTCC ATTTACAGAAGCTCA GTAAAATATACTGAA AAATACTTACTATAC CACAGTAAGCTTTAA AWvAAATAAAATTAA 10170 
PPSIG-l!JP(r)2€3) 
OQCATTACAGTTAAG TTACAAAAAAGGTGA CAATRCOVVACATGG • … 稱 I G 搜 1 0 2 4 0 
Figure 2.8 Locations of primers designed for DNA sequencing of subclones of 
PPSIG genomic fragments 
PPSIG sequencing primers were designed based on the genomic sequence of Riken 
CDNA0610039N19. 
78 
reference to the start codon in exon 1 was amplified by a forward primer 
PPSIG-FP(-2936) containing a Nhe I site (5 '-CTAGCTAGCTAGCGGGTGAAGA-
GGACAACTTT-3') and a reverse primer PPSIG-RP(+119) containing a Xho I site 
(5 ' -CCGCTCGAGCGGGGCGGTCGC TTGACATCC-3’）(Figure 2.9). Five i^l of 
lOX high fidelity PCR buffer, 2 of 50 mM MgS04, 1 of 10 mM dNTP mix, 2 
1 of 10 |LLM forward primer, 2 )il of 10 )j.M reverse primer, 20 ng BAC DNA 
purified from BAC clone 458 C 12 # 3 and 0.2 |al of 5 U/ ).il platinum Taq DNA 
polymerase high fidelity were mixed in a 0.2 ml microcentrifuge tube and filled up 
to 50 |al with nuclease-free water. PCR was performed in a themiocycler (Applied 
Biosystem GeneAmp PCR 9700) set at 94®C for 2 min for the first cycle, followed 
by 35 cycles at 94'-C for 30 s, GOT for 30s and 68''C for 3.5 min and a final step at 
for 10 min. The PCR products were electrophoresed in a 0.6% agarose gel, 
excised and purified using the QIAquick gel extraction kit. 
The gel purified � 3 0 0 0 bp PCR product (-2936/+119) was digested with Nhe I 
and Xho I restriction enzymes to produce cohesive ends for directional ligation into 
the pGL3-Basic vector. The reaction was set up as follows: 10 |j,g template DNA, 10 
l-tl of lOX NEBuffer 2, 10 … o f l mg/ml BSA, 4 of 10 U/|.il Nhe I and 6 of 20 
Xho I were mixed in a 1.5 ml microcentrifuge tube and filled up to 100 with 
autoclaved water. The digestion reaction was incubated at 37"C overnight and the 
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PPSIG-FP (-2936)—• 
GTTGTTCCTCAGGCT CTGTTCGCCTTAATT TTTTCQGGTGAAGAG GACAACTTTTGCCTG GAACCAGATGAGCAG GTTAGGATGGCCAGC -2881 
CAGTGAGCTTTAGAG AGCTGCCCATTCTCC TTCCTAATGTTGGGC TTACAAGTATGTGCT ACCACACCCAATTTT TTAAAAAGTGTATTA -2791 
TTTTCATTTGTGTAC TCCTCTGTGTGTGTG TGGGTGTGTGTGGGT GTGTGTGGGTGTGTC TGCCATGTATGTGCA GATGTCCATAACACA -2701 
TTGGATTCCCTGGAG CTGGAGTTACACATG GTTGAGAGCTGCCAT GTAGGTGCAGAGAGC CAAATTCTGGTCCTC TGCAAGATGTTCTTA -2611 
AGTGAGCATCTCTCC AGCCCTTCTCTCTCT CCCCCTCTCTCTCTC CCTCTCTATAAGGAC TCAGATATACAGAGA AGTTCTTATGGACGT -2521 
TCTTCAGCCTGGCCT CATCCTTGCTATGTA GCTGAGGCTTGCTTC TACTTCTCAAGGGTG GAGACAAAAGTCCTG TTCTTTCATCTTATG -2431 
GTGCCTGCCTCAGGA AGAGGGCTGGACAAA GACCCCATCACATCA AAAGTCTGTGTCACG AGGAGACAGCCTTCT CATGAGCGAGCACCT - 2 3 4 1 
CTAGGTCTTAGGGGG ACGGATTGATGTGAG AGAGTCAAAACAAAA CACAAGGCCTGGGAT ACAGATCAGAGGTAA AGCTATTGCTTACCA -2251 
CAAGTGACATCTGGG TTCAAGGCCTGGGAT ACAGATCAGAGGTAA AGCTATTGCTTACCA CAAGTGACATCTGGG TTCAGTCCCCACAAC -2161 
TGAAAAAAAAAAAAT AAAAACCAGAGATCA TCCTCAACATGGTGG TGTATGCCCGCATGA ATGTATGCCCAGATT CCTAGAAATCTGGAA -2071 
GCAGAGGCAGGAGAA TCACTGTGTATTTGA GGGCAGCCTGATCTA CATAGAGTTCCAGGT CAGTTAAGACTACCT AGCAAGACTCTGTCT -1981 
CAACAGAAAACAAAG CAAGGGCAGGTGAAA TGGCTCAGTGGGTCG AGGTGCTTGCCAGCA AACTTGATGACCTAA GTTCAGTCCCTAGAG -1891 
GGACCTAGAAGACTG GTAGAAATAAAGAAG CAATTGTCTTCTGAC CTCCACACACGCACC ATGGCACACACCGCT CTGCTCACCCAGATA -1801 
AAAACCAAAAAAAAA AAAAAAAAAAAACAC ACACACACACAAGGG GCTGGGAAGATGACT CAGTGGGCAGGAGGG CTTGCTTCAGGGTAA -1711 
AAACCTGAGTTTGGC TCCCTAGCACTCTGG TCGATGGAATTAAAA GGATTGCTGGTTGCT GGGCCTAGTTCCACA TTCAGTCAGAGAAGC -1621 
AATTCTACCAACTTC AAAGGTAGAAGGCAC AGAGTGACAGAACAG GCAATTTACAGTCCC CCTGATCTTTCTGTT CCTATATGGGCATGC -1531 
ATGCTCACACCCACA CACCAGAGAGTCAGT GTGGAAAGGCTGGGA CTGTAACCTAGTGGC AGCAAAGGAGGCTCA ACCCCTGATATCGAG -1441 
GGGGAAAATGAGAGT GGATGGTTCTCACAC AACTGACAGTCATAC TTCACAGACTCAGAG GACTAAGTCAGTGGG GAGGCCCTCCACGGA -1351 
GCCAGTCCTCCACTA GGGGACTATGATTTA CATTCCCCAAGGACT GACTGCCAGTAACAA ACAGCTTTTGGGCTC GACGCCTGGCTGCCT -1261 
GTGATCTAGAGAGGA TGGTGGTAACGTCCT CCCTGAAACACCCCA GGGACTAGCTCCCCC CCCCCCTCCCCAGAA CCTCAGCATCTACCT -1171 
CTCTTTTCCTTTCCT TCCATCTCGGCCTAA ATGACAGCATAAGAT ACACACACATCAGAT AACCTGGCAGGGTCA CAGGTAGGACTGACA -1081 
AAGTCTCGGGAAGGC TCTCCTGTTACTGTG GGGAAAACGAACCAA GTAGCATAGAAGCAT GACCTGCTTTACATA CCGGACTGGAGCACC -991 
GCTGGGGCCTAAAAC AAGGACAAAACACTC AAAGTTACGAAGTCA TTCCTCCTGATAGTG GGTACCTGAGGAAAT GGGCCTCCTATACAA -901 
ACAAATCCCTCTTAA GTCAAGTACGTATTT CAGACCTACTTTCCT CAAAGGGCAACATTA AGATGGTAGGATATC TAGACTGTCTGCTGG -811 
AGCTTAAACTCTCTG AAAAGCTGATTTAGA AGCTGGTGCGTCCTT AAATGCAAATAAACA CACAGGATGATCCTT GACTTAGTCTTTCTT -721 
GAGGCTTGTCCTAGG TGGCTTGCACTTTGA GAGCCTGATAGAGTA GTTACGATTAGGGGA ATCCACCTAGGGATA ACGTCGGTGTGAGGC -631 
TGCCAGTCCTGGGCT GACACAGGTTTAGGA GAGCTCCTGTGCAGG TCTCAACAAGGTCTC AACTCAGATACCCAG ACAGAGGCTGTGTGG -541 
GCACAGAAACTTTGT CACTGCTTGGAAGAG GAGAGGGGAGGAAAG CAATGAACTGCCTCC GAGGTTCCAGCGAAT CCAACACGGAAAAGG -451 
CACCAGAACCCAGGT CTTCTCTGCCTCCCA GACAGGATCTCTCTC AGACCTGCAACTTTC ATCCTTGTTGTGGTC CCGCGGTGACCATTT -361 
CCACCAGACATCGTC CTCCTCACCCTCACC TCCCTCACCAGACCC CTTGCTCACCGGACG CGTCCCCAGCGTTCC GGTAAGGGGGGGATC -271 
CCACATCCCCCTTTT CGCGCAGCCGTGCAG TGTCGCCTGTCTCGC GCTAGAACTACATTT CCCATTAGGCAATTG AACTCCTGCTCTGCA -181 
AAGATCATACGGAGG TCCATAATGGACAAT CTTCATCAGTTTTGA GCAGGCGTGAGTCAA AATGCTTCGGCTCCT CCAAGTCTGGTATTA -91 
CTCCAAGGACGAACT AGAGGGGCGGGGCCT CAGCTATAAAAGCCG AGCTCAGCGGGGAAA GGACGCGGTCTTCCG AGCCCTGGCAGCAAC -1 
Exon 1 
otar t codon 
ATGTGGATCACTGCT CTGCTGCTGGCCGTG CTGCTGCTGGTGATC CTCCACAGGGTCTAC GTGGGCCTTTACGCT GCAAGTTCCCCGAAC 90 
—PPSIG-RP(+119) 
CCCTTCGCCGAGGAT GTCAAQCQACCGCCT GAACCCCTGGTGACC GACAAGGAGGCTAGG AAGAAAGTTCTCAAA CAAGGTCAACTGATG 180 
Figure 2.9 Locations of primers designed to amplify the PPSIG 5'-flanking 
fragment (-2936/+119) 
The 5'-flanking sequence of Riken cDNA 0610039N19 is shown and the position of 
start codon (bolded and underlined) was regarded as +1. PPSIG-FP(-2936) and 
PPSIG-RP(+119) primers which are bolded and underlined were used to amplify the 
-3000 bp 5'-flanking fragment of PPSIG. 
80 
Nhe I IXho I digested DNA fragment was purified using the QIAquick gel extracion 
kit. 
2.3.2 Preparation of pGL3-Basic vector DNA 
2.3.2.1 Materials 
pGL3-Basic vector and JM109 competent cells were purchased from Promega 
(Madison, WI, USA). Plasmid midi kit was obtained from Qiagen (Germany). 
Restriction enzymes and alkaline phosphatase, calf intestinal phosphatase (CIP) and 
their buffers were purchased from New England Biolabs (Beverly, MA, USA). 
QIAquick gel extraction kit was purchased from_Qiagen (Germany). 
2.3.2.2 Methods 
pGL3-Basic vector DNA (Figure 2.10) was prepared to produce the PPSIG 
promoter reporter constructs. One j^ il of 1 |ig/|al vector DNA was transformed in 
JM109 competent cells following the standard transformation protocol. Briefly, the 
plasmids were pipetted to the competent cells and incubated on ice for 30 min. The 
cells were heat shocked at 42°C for 1 min and then immediately placed on ice for 2 
min. The cells were added with 800 [i\ LB medium and incubated at 37°C with 
































































































































































































































































































agar plate and was incubated at 37°C for 18 h. Five colonies were picked from the 
plate and each inoculated in 2 ml LB/ampicillin culture and checked by 
phenolxhlorofonn test as described in Section 2.1.2.2.1. One subclone containing the 
vector was grown up in 100 ml LB/ampicillin medium by shaking at 37°C for 16 h. 
The vector DNA was extracted from the overnight bacterial culture using the Qiagen 
plasmid midi kit. 
The pGL3-Basic vector was digested with Nhe I and Xlio I restriction 
enzymes to create cohesive ends for ligation. The reaction was set up as follows: 10 
lag vector DNA, 10 \x\ of lOX NEBuffer 2, 10 |al of 1 mg/ml BSA, 4 ).tl of 10 U/|al 
Nhe I and 6 |LI1 of 20 U/)LI1 Xho I were mixed in a 1.5 ml microcentrifuge tube and 
were filled up to 100 |al with autoclaved water. The digestion reaction was incubated 
at 3TC overnight. 
To prevent self-ligation, 0.5 of 10 U/jul CIP was added to remove 5' 
phosphate group from the linearized vector. The CIP reaction was incubated at 37°C 
for 1 h. The Nhe VXho I digested and CIP-treated DNA fragement was 
electrophoresed in a 0.7% agarose gel, excised and purified using the QIAquick gel 
extraction kit. 
83 
2.3.3 Ligation and transformation 
2.3.3.1 Materials 
T4 DNA ligase and its buffer were purchased from New England Biolabs 
(Beverly, MA, USA). Midi-VlOO"^ ultrapure plasmid extraction system was 
obtained from Viogene (Sunnyvale, CA, USA). 
2.3.3.2 Methods 
The DNA insert (-2936/+119) was ligated into the Nhe I and Xlio I sites of 
pGL3-Basic vector and the resulting recombinants were transformed in JM109 
competent cells. The ligation reaction was set up as follows: 300 ng insert, 100 ng 
vector, 1 )al T4 DNA ligation buffer and 1 T4 DNA ligase were mixed in a 0.2 ml 
microcentrifuge tube. The ligation reaction was filled up to 10 |al with autoclaved 
water and incubated at 16"C for 16 h. After incubation, the ligation products were 
transformed in JM109 competent cells according to the standard transformation 
method as mentioned in Section 2.1.2.1. The subclones were picked from the 
LB/ampicillin plates and inoculated in 2 ml LB/ampicillin medium at 2>TQ with 
shaking for 16 h. 
f > 
84 
2.3.4 Screening and confirmation of recombinants 
2.3.4.1 Materials 
Not I and Hind III enzymes and their buffer and BSA were purchased from 
New England Biolabs (Beverly, MA, USA). Midi-VlOO™ ultrapure plasmid 
extraction system was obtained from Viogene (Sunnyvale, CA, USA). 
2.3.4.2 Methods 
Phenolxhlorofonn test was used to screen subclones containing plasmids of 
expected sizes. Twenty |al overnight bacterial culture was mixed with equal volume 
of phenol:chlorofomi:isoamyl alcohol and mixed vigorously. The mixture was 
centrifiiged at 14,000 rpm for 1 min and the supernatant which containing the 
plasmids was resolved by electrophoresis to check for the sizes of plasmids. 
Subclones containing plasmids of desired size were grown up in 5 ml LB/amp 
culture. Plasmid DNA was extracted from the culture using the mini-M" plasmid 
DNA extraction system. 
Not I and Hind III enzyme digestions were used to determine the size of the 
subcloned insert in reporter construct pGL3-PPSIG (-2936/+119) (Figure 2.11). 
Briefly, 200 ng plasmid DNA, 2 …of lOX NEBuffer 2, 1 [il of 1 mg/ml BSA, 0.3 











































































































































































































1.5 ml microcentrifuge tube and filled up to 20 \x\ with autoclaved water. The 
digestion reaction was incubated at 37°C for overnight and the digestion products 
were electrophoresed in a 0.7% agarose gel. One confirmed subclone was grown up 
in 100 ml LB/ampicillin medium and the reporter construct was extracted from the 
bacterial culture using plasmid extraction system. 
The sequence of the reporter construct pGL3-PPSIG (-2936/+119) was 
confirmed by DNA sequencing using pGL3-RV3 (5’-CTAGCAAAATAGGCTGTC-
CC-3’）and pGL3-GL2 (5'-CTTTATGTTTTTGGCGTCTTCCA-3') primers of the 
pGL3-Basic vector sequence. 
2.4 Cloning of PPSIG 5'-deletion promoter constructs 
2.4.1 Deletion of target fragments by restriction enzyme digestion 
2.4.1.1 Materials 
Restriction enzymes, 丁4 DNA ligase and their buffer and BSA were purchased 
from New England Biolabs (Beverly, MA, USA). QIAquick gel extraction kit and 
QlAquick PCR purification kit were obtained from Qiagen (Germany)._T4 DNA 
polymerase together with the buffer and BSA were provided by New England 
Biolabs (Beverly, MA, USA). 
87 
2.4.1.2 Methods 
Three deletion constructs including pGL3-PPSIG (-1534/+119), pGL3-PPSIG 
(-879/+119) and pGL3-PPSIG (-375/+119) were produced from the parental 
pGL3-PPSIG (-2936/+119) construct by Nhe VNsi I, Nhe HSna'Q I and Nhe MSac II 
digestions, respectively (Figure 2.12). The parental construct pGL3-PPSIG 
(-2936/+119) was firstly digested with Nhe I. Twenty fag of pGL3-PPSIG 
(-2936/+119) DNA, 10 |al of lOX NEBuffer 2, 10 |al of 1 mg/ml BSA and 10 |al of 
10 lJ/|al Nhe I enzyme were mixed in a 1.5 ml microcentrifuge tube and filled up to 
100 jjJ with autoclaved water. The reaction mixture was incubated at 37°C overnight 
and the digestion products were purified using the PGR purification kit. The purified 
product was then digested with the second restriction enzyme {Nsi 1, SnaB I or Sac 
II). Three DNA, 5 |al of lOX appropriate reaction buffer, 5 of 1 mg/ml BSA 
where appropriate and 5 |il restriction enzyme were mixed in a 1.5 ml 
microcentrifuge tube and filled up to 50 with autoclaved water. The reaction was 
incubated at 37°C overnight and the restriction enzyme digested DNA fragments 
were electrophoresed in a 0.7% agarose gel, excised and purified using the 
QIAquick gel extraction kit. 
The sticky ends of the restriction enzyme digested DNA fragments were then 































































































































































































































































































































DNA polymerase buffer, 2.5 |al of 1 mg/ml BSA, 2 |LI1 of 10 mM dNTP and 1 |al of 
3U/fil T4 DNA polymerase were mixed in a 0.2 ml microcentrifuge tube and filled 
up to 50 \.i\ with autoclaved water. The reaction was incubated at 12°C for 15 min 
and stopped by adding 1.5 [i\ 0.5 M EDTA and heated at 75°C for 20 min. The 
blunt-ended products were purified by the PCR purification kit. 
2.4.2 Ligation and transformation 
2.4.2.1 Materials 
丁4 DNA ligase and its buffer were purchased from New England Biolabs 
(Beverly, MA, USA). Mini-M(� plasmid DNA extraction system was obtained from 
Viogene (Sunnyvale, CA, USA). 
2.4.2.2 Methods 
The blunt-ended plasmids were self-ligated to produce the deletion constructs. 
Eight 111 DNA, 1 |al of lOX T4 ligation buffer and 1 of 400 U/|al T4 DNA ligase 
were mixed in a 0.2 ml microcentrifuge tube and incubated at 25°C overnight. The 
ligation products were transformed in JM109 competent cells following the standard 
transformation protocol as mentioned in Section 2.1.2.1. 
90 
2.4.3 Screening and confirmation of recombinants 
The subclones were screened by phenol xhloroform test and restriction 
enzyme digestions (Figure 2.13) as described in Section 2.3.4. One confirmed 
subclone was grown in 100 ml LB/ampicillin medium and the DNA was extracted 
from the overnight bacterial culture using the midi-VlOO'^ ultrapure plasmid 
extraction system. 
The sequences of the deletion constructs including pGL3-PPSIG (-1534/+119), 
pGL3-PPSIG (-879/+119) and pGL3-PPSIG (-375/+119) were confirmed by DNA 
sequencing using the pGL3-RV3 and pGL3-GL2 primers of the pGL3-Basic vector 
sequence. 
2.5 Cloning of PPSIG-PPRE reporter constructs 
2.5.1 Amplification of PPSIG-PPRE fragments 
2.5.1.1 Materials 
Platinum Taq DNA polymerase high fidelity kit was purchased from 
Invitrogen corporation (Carlsbad, CA, USA). QIAquick gel extraction kit was 
obtained from Qiagen (Germany)•一Restriction enzymes and their buffer and BSA 
were provided by New England Biolabs (Beverly, MA, USA). The primer 

































































































































































































































































































































































































































Four PPSIG intron 1 fragments of different lengths including (-229/+435), 
(+94/+435), (-229/+3031) and (+94/+3031) were amplified by PPSIG gene-specific 
primers PPSIG-FP(-229)/PPSIG-RP(+435), PPSIG-FP(+94)/PPSlG-RP(+435), 
PPSIG-FP(-229)/PPSIG-RP(+3031) and PPSIG-FP(+94)/PPSIG-RP(+3031)’ 
respectively (Table 2.5 and Figure 2.14). PCR was performed as mentioned in 
Section 2.3.1. 
The PCR amplified DNA fragments including (-229/+435), (+94/+435), 
(-229/+3031) and (+94/+3031) were digested with Kpn I and Xho I to produce 
cohesive ends for directional ligation into the pGL3-Basic vector. The reaction was 
set up as follows: 10 template DNA, 10 |il of lOX NEBuffer 1, 10 |al of 1 mg/ml 
BSA, 4 |al of 10 U/|J Kpn I and 6 of 20 U/^il Xho I were mixed in a 1.5 ml 
microcentrifuge tube and filled up to 100 |LI1 with autoclaved water. The digestion 
reaction was incubated at 37®C overnight and the digestion products were 



































































































































































































































































































































CCACATCCCCCRRRR CC;CGCAGCCGTGCAG TOTCGCCTGTCTCQC QCTAGAACTACATTT CCCA'RRKOCRCAAR-TG AACICCTCJCTCIX;CA - I S I 
AAaATCATACGGAGG TCCATAATGGACAAT CTTCATCAGTTTTGA GCAGGCGTGAGTCAA AATGCTTCGGCTCCT CCAAGTCTGGTATTA -91 
CTCCAAGGACQAACT AaAGGGGCGGGGCCT CAGCTATAAAAGCCG AGCTCAGCGGGGAAA GGACGCGGTCTTCC3 AGCCCTG-3CAGCAAC -1 
Exon 1 
Start codon 
ATQTGGATCACTaCT CTGCTGCTGOCCGTG CTOCTGCTGGTGATC CTCCACAGGGTCTAC GTOGGCCTTTACGCT GCAAGTrCCCCGAAC 90 
PPSIG-FP( + 94) — • Intron 1 鄉£91 各明继GAACCrCTGGTGACC GACAAGGAGGCTTACTG AAGAAAGTTCTCA从 CAAGGTCAACTr,ATG 1ft D 
OJTTTCAGaCCTGCl' CTCOGGCCrTCTGCT CATGTCTCCCCAITA GTAAAGTOCTOGGAA AACTTCTCTTGCACA CAOAGCrTCCATAAT :7� 
TTAGTriTTCTTTGCT TCTGAAAOGGTOCAG OCATTACCCTTaOCA CGCCAAATTCCAGCC CCGCCAGTTGGAATC TTTTCAGCTCACGGC 360 
Putative PPRE 1 Putativ® PPRK 2 PPSIG-RP(+435) 
XL'ACACAGAALAAGA GACCTTTCCCCTACT TVJGGTCIGGAGCCAA CTTTTCCCTATACTT CTQTGCATQCTCQGG GCJCACAGGGAAUCAG 4&0 
CACTGAAAGTTTTCC TAACAAGCGOGTTGC AGGCAAAATQTAGTC CAGTrCATAGAACTG AAGCTTGATAATAAC TTCGGAATTTCAaTA 540 
CraCTAGGGATAAG AACTCCACTCTCCAG TOAACCATCTCTAAA GCACaTGTAGAGTGC TCCCAACGTTTGTGT rTTTGAGACTCASTCT 630 
CACTTTTGTACTGGA GTTGGCTTTGAACTC TCTTCQCAGCCCAGG CTCAAACCCGGAGCA GK:CCTCTTCTTCTGT CCCCAGCATGATGAG 7 二 0 
ATAGArrACAAOCAT GCACCAGCATGTCTG CCTTTCAACG'rm'A CGGAAOTGTTOGAGC TGGOCATAGTGGTGC AACAATTIAAITCCA S丄0 
OTVrGGhCTACACkA TOAGACCCTOTCTAA ATGCACACATCAAAC CCCAAAACAACCAAA ACCCCCAAATGCAAA ACTTTCAAAAAACAA 900 
ACAAG<iA1'CACCTCT ITGACCTCCAGGAGC CTCTGACnGTAAAT 'ITTAGCCAAGCCTAG GCrAGCCTTAACTGC ACI'ATTmTGGOGA 990 
CPGACrXTGAACTCC TGATCCTrGTGCCl'C TAC'n'CCIAAGAGJOC ACCACACCCAGTTAT TlTAl'^ 'AI'TGlTATl' GTrGTGOATTGGGG 1080 
GAGAGGCAGGTCTCA TACTTOTAGCCCAGG CTAGCTTATAACTTG CTATACAGGACAAGT GTGTCTCAAATTCAC AGTGATTCTCCAACC 1170 
ACCATCAGCAAGAGA TTACAAATGGTGCX^A TThCkOk'TOTOAGCC ACCATGGCTTGGATa GACJiTTTTTTTTTTA TTTTATTmiTTAG 1260 
TTTTTAGTTGTTTGA GACAGTGTTTCTCTC TATAGTTCTAyATGT CCTGGAACTTGCTAT TGCTATATAGACCAG GCTGGCCTTGAACTC 1350 
ACTCSAGATCCTCCCA CCTCAGCCTCCTGAC? TGCTGAGACTAAAOC TGTGAACACTTGGCC TTGGGCAATGATGTT TAATGAGCAGATTTA 1440 
CTGCJACATAGTGGCIA CATirCl'GTGATCCC AGCGCTGGGGAGGAA AAOACAGGTuGATCT CTACATAGGGAGTTC CAGCC'AGTTAGGGC 1530 
TAC:ATGTGTAGTGAA ACCGTGTGTCTTAAA AAACACGAATCTAATA AAATCAAAGAAAGTA AGTAAATAAA3GAGG AAAGGAAGTAAAAGA 1620 
CTGGGAGAAAACAAC AAATCCCAGGTCTTG TCJTTGACCGTGCATT CCAGTTTGGTTCTGT GAOGITCCCGGCACA CCAACCTTCCTCCTT 1710 
ITCTGAGGCTGGTGC TGTGACCTCTCAGAG TAGCAGCCTCTGAGC AGCTCTCJCCTGCrCC ACCTCCGTI^GGCACr CAGAGACCITGCTTC 1600 
TTCCAAAGAAACCCA GTTCCCTGAACCACC AGCGTCCCCAGCCCC CACCCTGA3CCTTAT TGCCTTrCTTTCCT CGCTTGCATTCACAG 1890 
AACTGACGTTACAGC CCTGTGCAGTTGCCA TCTTTCTGGTTTTGT TCTACAGTAGCTAGC TOAaTCAGTCCTACT TCCTTTGAAAGaTAT 1080 
CAAATCCCTCAAGTA CACTGTAGGGGTTAA GACTCATCACTaCTT AACCTGCCTGTCTGO TCCQAGGTATTOCCT GGTAGAATGTTTTGA 2070 
GACATCTTAGTCAAG AGTAAATAAACTAC:C TTAAAAGAAAOTi�C'r aCCTTCC'CrCTTGIT 'nXJAGACTGGaTCI'A ACGAGCCCAGGCTGG 2160 
CCTCCraTGGGATGA TCTTGGCCTOCTAAT C;CACCTTTCAAC5TGC TCCCATCACAOGAGT ACACCACCATSCCCA GCAGCCGiTAGAGACT 22S0 
TCFTACCGAGTACAC GTTAGAGAAGGACCC CGGCTTCTTTGACTT CACnrCCTGCCCTC GTCTGAGAAGCrCAC CCTTCTCCTCrCCTrC 2340 
Exon 2 
TACAGCrXl'CTCAGT CAOCCGAGJTACX-AGA GAAGCTGC5AT0CAGT GGTaATOT3CAGCG-;3 CATrCJCJGGGACTCjGC CTCAGClXSCGG'n'Cr 24J0 
AGCTAAAGCTGGCAA GAOAGTCCTTGTGCT GGAACAACATACCAA GGCGGGCG-C^CTGTTG TCATAC-CnTGGGGA AAATGGCCTTGAATT 2520 
Intron 3 
TGACACTGOTAAGGC TTGTCTGGGAAAGGG TTAGGAGCATCTGCCT TGTCTTTAGATGGCT AATAACACACACTAT TGAGTGACATGGGGG 2 6 1 0 
CATTTTAATGTTTC3G AaGTCTCAACTTCTC TCTGGGCACCTCCAT TTCTGTCCGATGGCC TAGTTACrGGGCAAG CATTGGGTGGTATAT 2700 
GTTCTGATTTOTTTC TrATAGAAAGGCSTOG GCAGCCCCCCTCTGG ACATGAACATAGCCA AGCAGGACAACCTCT TCCTTACTTGGCATA 2790 
Exon 3 
TTTCCAGGGCCCAAT CCCTTTTATCTCTAT ATCTCCTTTCCTTTG CACCTCCCAACAGGA ATTCATTATATTGGA CGAATGCGGGASGGC 2680 
AACATTGGCXGrrrr ATCTTGGAGCAGATC ACTGAAGGGCAACTO (;ACIYiGGCCCCCATG GCCTCCCCT-n-TGAC TTGATGATACTACSAA 2970 
和 PPSIQ-RP{ + 3031} GGGCCCAATGGCCaA AAGGAGTTCGCCATG TACAGTGGGAGGAAA GAATACATCCAGGGC CTTAAGAAGAAGTTC CCCAAGGAAGAAOCT 3060 
Figure 2.14 Locations of primers designed to amplify PPSIG intronic 
fragments which contained putative PPREs 1 and 2 
The PPSIG genomic sequence of Riken cDNA 0610039N19 is shown and the 
position of start codon was regarded as +1. PPSIG primers (bolded and underlined) 
including PPSIG-FP(-229), PPSIG-FP(+94), PPSIG-RP(+435) and PPSIG-
RP(+3031) were designed to amplify the different PPSIG fragments which 
contained the putative PPREs 1 and 2. 
95 
2.5.2 Preparation of pGL3-Basic vector DNA 
2.5.2.1 Materials 
Restriction enzymes and alkaline phosphatase, calf intestinal phosphatase 
(CIP) and their buffers were purchased from New England Biolabs (Beverly, MA, 
USA). QIAquick gel extraction kit was obtained from Qiagen (Germany). 
2.5.2.2 Methods 
The pGL3-Basic vector (prepared in Section 2.3.2) was digested with Kpn I 
and Xho I restriction enzymes to create cohesive ends for ligation. The reaction was 
set up as follows: 10 昭 template DNA, 10 |al of lOX NEBuffer 2, 10 of 1 mg/ml 
BSA, 4 of 10 U/|al Kpn I and 6 |il of 20 U/|al Xho I were mixed in a 1.5 ml 
microcentrifuge tube and filled up to 100 |al with autoclaved water. The digestion 
reaction was incubated at 37"C overnight. 
To prevent self-ligation, 0.5 of 10 U/|J,1 CIP was added to remove 5’ 
phosphate group from the linearized vector. The CIP reaction was incubated at 37°C 
for 1 h. The Kpn l/Xho I digested and CIP-treated DNA fragement was 
electrophoresed in a 0.7% agarose gel, excised and purified using the QIAquick gel 
extraction kit. 
96 
2.5.3 Ligation and transformation 
2.5.3.1 Materials 
T4 DNA ligase and its buffer were purchased from New England Biolabs 
(Beverly, MA, USA). Midi-VlOO'^ ultrapure plasmid extraction system was 
obtained from Viogene (Sunnyvale, CA, USA). 
2.5.3.2 Methods 
The DNA inserts of (-229/+435), (+94/+435), (-229/+3031) and (+94/+3031) 
were ligated into the Kpn I and Xho I sites of pGL3-Basic vector and transformed in 
JM109 competent cells following the protocols described in Section 2.1.2.1. 
2.5.4 Screening and confirmation of recombinants 
The subclones were screened by phenolxhlorofonn test as described in 
Section 2.1.2.2.1 and Not MHind III digestions as mentioned in Section 2.3.4 (Figure 
2.15). The sequence of the reporter constructs including pGL3-PPSIG (-229/+435), 
PGL3-PPSIG (+94/+435), pGL3-PPSIG (-229/+3031) and pGL3-PPSIG (+94/ 
+3031) were confirmed by DNA sequencing using the pGL3-RV3 and pGL3-GL2 





















































































































































































































































































































































































































































































































































































































































































































CCACATCCCCCTTTT CGCGCAGCCGTGCAG TGTCGCCTGTCTCGC GCTAGAACTACATTT CCCATTAGGCAATTG AACTCCTGCTCTGCA -181 
AAGATCATACGCiAGG TCCATAATGGACAAT CTTCATCAGTTTTCA GCAGGCGTCAGTCAA AATGCTrCGCSCTCCT CCAAGTCTT-^GTATTA -9i 
PPSIG-SEQ138 — • 
CTCCAAGGACGAACT AGAGGOaCGGGGCCT CAGCTATAAAAaCCG AGCTCAGCGG3GAAA GGACGCGGTCTl'CCG AQCCCTQQCAGCXAC -1 
Start codon 
ATOIGGATCACTGCT CTGCTGCTGGCCGTG CTGCTGCTGGTQATC CTCCACAGGGTCTAC GTGGGCCTTTACGCT GCAAGTTCCCCGAAC 9C 
CCCTTCGCCGAGGAT GTCAAGCGACCGCCT GAACCCCTGGTC^ACC GACAAGGAGGCTAGG AAGAAAGTTC^CAAA CAAG<?TCAACTGATG 18C 
GGTTTCAGGCCTGCT CTCGGGCCTTCTGCl' CATGTCTCCCCA'ITA GTAAAGTGCTGGOAA AACTTCTCTTGCACA CAOAGGTTCCATAAT 27C 
TTAGTGTTCTTTGCT TCTGAAAGGGTGCAG GCATTACCCTTGGCA CGCCAAATTCCAGCC CCGCCAGXrOGAATC TTTTCAGCTCAC5GC i6C 
Putatlvtt PPRE 1 PutAtiv® PPRK 2 PPSIG-SBQUl>586 
TTACACAGAATAAG冬…鄉口！；；；^ .^；；；.!；；.嘴•^ACT T C 3 G G T C T G � ; ; M | ; ? _ 5 : j ! ^ … C T O T G C A T C C T C Q G G GGCACAQGGAAqCAC； 45C 
CACTGAAAG'rrrrCC I-AACAAGCGGGITGC AaCCAAAATGTAGTC CAGTICATAGAACTG AAGCTTGATAATAAC TTCGGAATTTCAGTA 54C 
PPSIG-RP760 
CTGGCTAGGGATAAG AACTCCACTCTCCAG TGAACCATCTCTAAA GCACGTqTAGAQTQC TCCCAAQGnTGTGT TTTTGAGACrGGTCT 63C 
CIACrrrTGTACTGGA GTTGGCTTTGAACTC TCTTCGCAGCCCAGC； CTCAAACCaSGIAGCA C5CCCTCTTCTTCTGT CCCCAGCATGATGAG 72C 
ATAGATTACAAGCAT GCACCAGCATGTCrG CC'LTTCAACGTRRRA CGGAAGTGTTGGAGC TGGGCATAGTGGTGC AACAATTTAATTCCA 81C 
GTTTGGAC:TACACAA TGAGACCCTGTCTAA ATGCACACATCAAAC CCCAAAACAACCAAA ACCCCCAAATGCAAA ACTTTCAAAAAAC:AA 90C 
ACAAGGATCACCTCT TTGACCTCCAGOAGC CTCTGACTTGTAAAT TTTAGCCAAGCCTAG GCTAGCCTTAACTGC ACTATTTTTTG^GGA • 
CTGACriTGAACrCC TGATCCTTCT(5CCTC TACTTCCTAAGAGGC ACCACACCCAGITAT TTTATTATRCJTTATT GTTTGTCJGATTGGGG I08C 
GAGAGGCAGGTCTCA TACTTGTAGCCCAGG CTAGCTTATAACTTG CTATACAGGACAAGT GTGTCTCAAATTCAC AGTGATTCTCCAACC 117C 
ACCATCAGCAAC5AaA 'ITACAAATGC3TaaGA TTACAGATGTGAGCC ACCATC5GCTTGGATG GAGATTTTTTTrrTA rirrATTTTTTTTAG i26C 
和 I>I>SI(3-SKQUm492R 
1TITTA3TTGTTTGA GACAGTG'ITTCTCTC TATAGTTCTAGAT'GT CCTGGAACl'TGCrrAT 绍 养 1 3 5 C 
ACTGAGATCCTCCCA CCTCAGCCTC:CTGAG TGCTGAGACrTAAAGC TGTC3AACACTTGGCC TTGGGCAATaATGTT TAATGAGCAGATTTA 144C 
CTOGACATAGTGGCA CATTCCTGTGATCCC AGCGCTGGGGAGGAA AAGACAGGTGGATCT CTACATAGGGAGTTC CAGCCCAGTTAGGGC 153C 
TACATGTGTAGTGAA ACCGTOTGTCITAAA AAACACGAATCAATA AftATCAAAGAAAGTA AGTAAATAAAGGAGG AAAGGAAGTAAAAOA 1620 
PPSIQ-RP1845 
CTGGGAGAAAACAAC AAATCCCAGGTCTTG TGTTGACCGTGCATT CCAGTTTGGTTCTGfT QAGGTTCCCOGCACA CCAACCTTCCTCCTT i71C 
TTCTGAGGCTGGTGC TGTGACCTCTCAC5AG TAO-CAGCCTCTaAGC AGCTCTGCCTGCTCC ACCTCCGTTGGCACT CAGAGACCTTGCTTC I80C 
rrCCAAAGAAACCCA GTTCCCTGAACCACC AGCGTCCCCAGCCCC CACCCTGAGCCITAT TGCCTTTTCTTTCCT CGCTTGCATTCACAG i89C 
AACTGACGTTACAGC CCTGTGCAGTTGCCA TCTTTCTOGTTTTGT TCTACAGTAGCTAGC TGAGTCAGTCCTACT TCC?TTGAAAG3TAT I98C 
CAAATCCCTCAAGTA CACTGTAGGGGTTAA GACTCATCACTGCTT AACCTGCCTGTCTGG TCCaAGGTATTCCCT GGTAGAAT3TTTTaA 207� 
GACAT'CITAGTCAAG AGTAAATAAACTACC TTAAAAGAAAGOTCT CJCCTTCCCTCTTGTT TTGAGACl'GGGTC^'A ACGAGCCCAGGCTOO 216C 
CCTCCTOTOGGATGA TCTTGOCCTCCTAAT aCACCTTTCAAGTGC TCCCATCACA3GAGT ACACCACCATGCCCA GCAGCCGTAGAGACT 2250 
TCTTACCGAGTACAC GTTAGAaAAGGACCC： CCSGCTTCTTTGACTT C^ACTTTCCTGCCCTC GTCTGAGAAGCTCAC CCTTCTCCTCCCTTC 2340 
TACAGCITTCTCAGT CAGCCGAGTACCAGA GAAGCrGGATGCAGT GGTGATCGGCAGCGO CATrOGGGGACTGaC CTCAGCTGCGGTI'Cr 2430 
PPS1Q-RP2635 
AGCTAAAGCTOGCA^. GAGAGTCCTTGTGCT GGAACAACATACCAA GGCGGGCGCrCTGTTG TCATACCTTTGGGGA AAATGGCCTTGAATT 252C 
TGACACTGGTAAaaC TTOTGTGGGAAACXXS TTA0GAGCATGC5CCrr TGTCTTTAGATGGCT AATAACACACACTAT TGAGTGACATGGGGG 261C 
CAlTTlAATGTTTfSG AOaTCTCAACrrCTC TCTOG-CJCACCTCCAT TTCL'GTCCOATGGCC TAGTTACTGAGCAAG CATROGGTOGTATAT 270C 
GTTCTGATTTGrrrC TTATAGAAAGGGTGG GCAGCCCCCCTCTOG ACATGAACATAGCCA AGCAGGACAACCTCT TCCTTACTTGGCATA 279C 
TTTC:CAGGaCCCAAT CCCTTTTATCTCTAT ATCTCCTTTCCTTTG CACCTCCCAACJ^GCiA ATTCATTATATTGCJA CGAATGCGGGAGGGC 2880 
‘ AACATTGaCCGrrrr ATCTTGGACCAGATC ACTGAAGGGCAACTO GACTGGGCCCCCATCJ GCCTCCCCnTTGAC TTGATGATACTAGAA 297C 
GGGCCCAATGGCCGA AAQGAGXTCCCCATG TACAGTGGGAGGAAA GAATACATCCAGGGC CTTAAGAAGAAGTTC CCCAAGGAAGAAGCT 30枕 
Figure 2.16 Locations of PPSIG gene-specific primers designed for DNA 
sequencing of PPSIG-PPRE reporter constructs 
The PPSIG genomic sequence of Riken cDNA 0610039N19 is shown and the 
position of start codon was regarded as +1. PPSIG gene-specific primers (bolded 
and underlined) were designed to perform DNA sequencing of reporter constructs, 
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2.6 Cloning of PPSIG-PPRE deletion construct 
2.6.1 Deletion of PPRE fragment by Stu l/Xho I digestion 
2.6.1.1 Materials 
Restriction enzymes together with their buffer and BSA were purchased from 
New England Biolabs (Beverly, MA, USA). QIAquick gel extraction kit and 
QIAquick PCR purification kit were obtained from Qiagen (Germany). 
2.6.1.2 Methods 
The deletion construct pGL3-PPSIG (+94/+190) was prepared from the 
parental construct pGL3-PPSIG (+94/+435) in which a 245 bp fragment (+191/+435) 
containing the putative PPREs 1 and 2 was removed by Stu I and Xho I digestions 
(Figure 2.17). The pGL3-PSIG (+94/+435) was firstly digested with Stu I enzyme. 
Ten lag ofpGL3-PPSIG (+94/+435) DNA, 10 …of lOX NEBuffer 2 and 6 i^l of 10 
U/jLil Stu I enzyme were mixed in a 1.5 ml microcentrifuge tube and filled up to 100 
Ml with autoclaved water. The reaction mixture was incubated at 37°C overnight and 
the Stu I digested DNA fragment was purified using the PCR purification kit. The 
purified product was then proceeded to Xho I digestion. Five |ag DNA, 5 jal 
NEBuffer 1 ,5 of 1 mg/ml BSA and 3 |il Xho I enzyme were mixed in a 1.5 ml 




























































































































































































































reaction was incubated at 37°C overnight and the Stu UXho I digested DNA 
fragment was electrophoresed in a 0.7% agarose gel, excised and purified using the 
QIAquick gel extraction kit. 
2.6.2 Ligation, transformation, screening and confirmation of 
recombinants 
The gel purified DNA fragment was treated with 丁4 DNA polymerase to form 
blunt ends as described in Section 2.4.1. Then the blunt-ended DNA fragment was 
self-ligated in the presence of T4 DNA ligase and transformed in JM109 competent 
cells as mentioned in Section 2.4.2. The recombinant subclones were screened by 
phenolxhlorofonn test and Not VHind III digestions (Figure 2.18) as stated in 
Section 2.4.3. The DNA was purified from the recombinant clone by Qiagen 
midi-VlOQiM ultrapure plasmid extraction system and its sequence was confirmed 




Kpn I Stu I Xho I 
PGL3-PPSIG A , 
(+94/+435) t Parental J 




stu I ；r/7o I 5 3 
4 6 5 1 丨 丨 / 
PGL3-PPSIG 
(+94/+190) f Not I Hind III \ 
4894 bp V Deletion J 
construct 
> ^ 一 
4598 bp 
Figure 2.18 Not l/Xho I digestions for screening the recombinants of deletion 
construct pGL3-PPSIG (+94/+190) 
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2.7 Construction of PPSIG-PPRE-deletion and PPSIG-
PPRE-mutation constructs by site-directed 
mutagenesis 
2.7.1 Primers design 
Several pairs of PCR primers were designed according to the strategy of 
(Allemandou et al. 2003) to produce three PPSIG-PPRE-deletion constructs 
including pGL3-PPSIG (APPRE 1)，pGL3-PPSIG (APPRE 2) and pGL3-PPSIG 
( A PPREs 1 and 2) and three PPSIG-PPRE-mutation constructs including 
pGL3-PPSIG (mutPPRE 1), pGL3-PPSIG (mutPPRE 2) and pGL3-PPSIG 
(nuitPPREs 1 and 2). (Table 2.7, Figures 2.19 and 2.20). Briefly, two pairs of 
primers were used to amplify the left and right halves of PPRE-deletion or 
PPRE-mutation constructs in which specific PPRE deletion or mutation was 
introduced. The BamW I site on the vector was mutated to EcoK I site by the 
designed primers for screening of PPRE-deletion or mutation constructs produced. 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.7.2 Amplification of the left and right halves of the PPRE-
deletion and PPRE-mutation constructs by PCR 
2.7.2.1 Materials 
Pfu DNA polymerase and its reaction buffer were purchased from Promega 
(Madison, WI, USA). QIAquick PCR purification kit was obtained from Qiagen 
(Germany). EcoK I enzyme and its buffer were provided by New England Biolabs 
(Beverly, MA, USA). 
2.7.2.2 Methods 
PCR was performed to amplify the left and right halves of the PPRE-deletion 
and PPRE- mutation constructs to produce the constructs pGL3-PPSIG (A PPRE 1), 
pGL3-PPSIG ( A PPRE 2), pGL3-PPSIG ( A PPREs 1 and 2), pGL3-PPSIG 
(mutPPRE 1)，pGL3-PPSIG (mutPPRE 2) and pGL3-PPSIG (miitPPREs 1 and 2). 
The primer and template combinations for each construct are shown in Table 2.7 and 
Figures 2.19 and 2.20. Five of lOX buffer with MgS04 for Pfu DNA polymerase, 
1 |LI1 of 10 mM dNTP mix, 2 fil of 10 )iM forward primer, 2 \x\ of 10 mM reverse 
primer, 200 ng of parental construct DNA [pGL3-PPSlG (+94/+435) or 
PGL3-PPS1G (mutPPRE 1)] and 0.25 i^l of 2-3 U/|il Pfu DNA polymerase were 
mixed in a 0.2 ml microcentrifuge tube and filled up to 50 |j.l with nuclease-free 
109 
water. PCR was done in a themiocycler (Applied Biosystem GeneAmp PCR 9700) 
set at 94°C for 2 min in the first cycle, followed by 12 cycles at 94°C for 30 s, 60°C 
for 30 s and 11�C for 7 min and a final step at 7 2 � C for 10 min. The PCR products 
were purified using the QIAquick PCR purification kit. 
The purified PCR products were digested with EcoK I restriction enzyme to 
generate cohesive ends for ligation. For each purified PCR product, 3 fig of PCR 
products, 5 |al of lOX EcoR I buffer and 3 }j.l of 20 U/|al EcoR I enzyme were mixed 
in a 1.5 ml microcentrifuge tube. The tube was incubated at 37°C overnight and the 
EcoR I digested products were purified using the QIAquick PCR purification kit. 
2.7.3 Ligation, Dpn I digestion and transformation 
2.7.3.1 Materials 
T4 DNA ligase, Dpn I enzyme and their buffer were purchased from New 
England Biolabs (Beverly, MA, USA). 
2.7.3.2 Methods •• 
For ligation, four [i\ purified PCR product of the left half (200 ng) and 4 |al of 
the right half (200 ng) of the deletion or mutation construct, 1 |al of lOX T4 DNA 
ligation buffer and 1 \i\ of 400 U/|il T4 DNA ligase were mixed in a 0.2 ml 
110 
microcentrifuge tube. The ligation reaction was incubated at 25°C overnight. 
The next day, Dpn I enzyme was used to digest the parental construct in the 
ligation mixture. Briefly, 8.5 ligation product, 0.5 |LI1 of lOX NEBuffer 4 and 1 i^l 
of 20 U/|jJ Dpn I were mixed in a 1.5 ml microcentrifuge tube. The reaction mixture 
was incubated at 37°C overnight and then transformed in JM109 competent cells 
following standard transformation protocol as mentioned in Section 2.1.2.1. 
2.7.4 Screening and confirmation of recombinants 
2.7.4.1 Materials 
EcoR I enzyme and its buffer were purchased from New England Biolabs 
(Beverly, MA, USA). Midi-VlOO'^ ultrapure plasmid extraction system was 
obtained from Viogene (Sunnyvale, CA, USA). 
2.7.4.2 Methods 
The subclones were firstly screened by phenolxhlorofonn test as mentioned 
in Section 2.3.4 and EcoR I digestion was further used to distinguisH the 
PCR-generated PPRE-deletion and PPRE-mutation constructs from the parental 
construct as EcoR I site was only present on PCR-generated pi asm ids. For each 
construct, 200 ng plasmid DNA, 2 of lOX EcoR I buffer and 1 … o f 20 U/^il 
111 
EcoR I enzyme were mixed in a 1.5 ml microcentrifuge tube and were filled up to 
20 |al with autoclaved water. The digestion reaction was incubated at 37°C for 
overnight and the EcoR I digested products were electrophoresed in a 0.6% agarose 
gel. The confirmed subclones for each construct were grown up in 100 ml 
LB/ampicillin medium and the plasmid DNA was extracted from the overnight 
bacterial culture using the midi-VlOO"^ ultrapure plasmid extraction system. 
The sequences of the deletion constructs including pGL3-PPSIG (A PPRE 1), 
pGL3-PPSIG ( A PPRE 2)，pGL3-PPSIG ( A PPREs 1 and 2) and mutation 
constructs including pGL3-PPSIG (mutPPRE 1)，pGL3-PPSIG (mutPPRE 2) and 
pGL3-PPSIG (mutPPREs 1 and 2) were confirmed by DNA sequencing using the 
pGL3-RV3 and pGL3-GL2 primers of the pGL3-Basic vector sequence. 
2.8 Cloning of mouse malonyl-CoA decarboxylase (MCD) 
and rat acyl-CoA binding protein (ACBP) PPRE 
reporter constructs 
2.8.1 Preparation of mouse and rat genomic DNA 
2.8.1.1 Materials 
Tris, EDTA, SDS and sodium chloride were obtained from USB corporation 
(Cleveland, Ohio, USA). Hydrochloric acid (HCl) was provided by BDH (England). 
112 
Proteinase K was purchased from Roche (Germany). 
2.8.1.2 Methods 
Genomic DNA was extracted from the tail of a wild-type mouse (SV129/ter, 
male, 3 months old) and a rat (Spragiie-Dawley, male, 3 months old) by a tail DNA 
extraction method. Briefly, about 1 cm tail tips from mouse and rat were excised and 
put separately into two 15 ml Falcon tubes each containing 2.5 ml lysis buffer [100 
mM Tris-HCl (pH 8.5), 5 mM EDTA (pH 8.0)，0.2% SDS, 200 mM NaCl and 100 
|Lig/ml proteinase K]. The tails were digested at 55()C overnight and centrifuged at 
3,000 rpm for 10 min on the next morning. The supernatant was transferred to 1.5 
ml microcentrifuge tubes in 750 |al aliquots and centrifuged at 14,000 rpm for 20 
min. The supernatant was transferred to a new set of 1.5 ml microcentrifuge tubes. 
Equal volume of isopropanol was added and mixed until the DNA strands were 
precipitated. The genomic DNA was transferred to a new 1.5 ml microcentrifuge 
tube, air-dried and dissolved in 500 |il TE buffer. 
2.8.2 Amplification of MCD and ACBP PPRE fragments by PCR 
2.8.2.1 Materials 
Platinum Taq DNA polymerase high fidelity kit was purchased from 
113 
Invitrogen corporation (Carlsbad, CA, USA). QIAquick gel extraction kit was 
obtained from Qiagen (Germany)._The primer oligonucletoides were synthesized by 
Invitrogen corporation (Carlsbad, CA, USA). 
2.8.2.2 Methods 
A � 3 5 0 bp MCD DNA fragment which contained two functional PPREs in its 
promoter region (Lee et al. 2004) and a -1400 bp ACBP DNA fragment which 
consisted of a functional PPRE in its intronic region (Helledie et al. 2002) were 
amplified by MCD-FP(-311 )/MCD-RP(+36) and ACBP-FP (-392)/ACBP-RP (+979) 
primers, respectively (Table 2.8 and Figure 2.21). Briefly, 5 of lOX high fidelity 
PCR buffer, 2 of 50 mM MgSCU, 1 \.i\ of 10 mM dNTP mix, 2 |il of 10 |iM 
forward primer, 2 |AL of 10 |LLM reverse primer, 200 ng template (mouse DNA for 
MCD and rat DNA for ACBP) and 0.2 of 5 U/|al Platinum Taq high fidelity were 
mixed in a 0.2 ml microcentrifuge tube and filled up to 50 \jl\ with nuclease-free 
water. PCR was performed in a thermocycler (Applied Biosystem GeneAmp PCR 
9700) set at 95°C for 2 min for the first cycle, followed by 35 cycles at 94''C for 30 s, 
60X： for 30 s and 6 8 T for 2 min and a final step at 6 8 T for 10 min. The PCR 
products were electrophoresed in a 0.7% agarose gel, excised and purified using the 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The amplified MCD and ACBP fragments were digested with Kpn I and Xho I 
enzymes to create sticky ends for ligation following the methods described in 
Section 2.5.1. 
2.8.3 Ligation and transformation 
The Kpn l/Xho I digested MCD and ACBP fragments were ligated to Kpn 
\/Xho I sites of pGL3-Basic vector (prepared in Section 2.5.2) and transformed in 
JM109 competent cells according to the protocol as mentioned in Section 2.5.3. 
2.8.4 Screening and confirmation of recombinants 
Subclones were screened by phenolxhloroform test and Not MHincl III 
digestion (Figure 2.22) as mentioned in Section 2.3.4. The confirmed subclones of 
MCD and ACBP constructs were grown up in 100 ml LB/ampicillin medium and the 
plasmid DNA was extracted from the overnight bacterial culture using the 
midi-VlOO'^ ultrapure plasmid extraction system. 
The sequences of the MCD and ACBP PPRE-reporter constructs were 
confirmed by sequencing using the pGL3-RV3 and pGL3-GL2 primers of the 




Kpn I Xho 丨 53 
4651 L / MCD 
P G L 3 - M C D X ^ 




Kpn I Xho I 棚 Y ACBP 
P G L 3 - A C B P A , h ^ A 
6 1 8 9 b p I J 
> ^ 乂 
4598 bp 
Figure 2.22 Not l/Hind III digestions for screening the recombinants of 
positive control reporter constructs pGL3-MCD and 
pGL3-ACBP 
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2.9 Cloning of mPPARa and mRXRa expression 
plasmids 
2.9.1 RT-PCR of mouse PPARa and RXRa cDNAs 
2.9.1.1 Materials 
Oligo-dT primer, SuperScripF'^ II reverse transcriptase kit and platinum Taq 
» 
DNA polymerase high fidelity kit were purchased from Invitrogen corporation 
(Carlsbad, CA, USA). QIAquick gel extraction kit was obtained from—Qiagen 
(Germany). Restriction enzymes together and their buffers were provided by New 
England Biolabs (Beverly, MA, USA). The primer oligonucletoides were 
synthesized by Invitrogen corporation (Carlsbad, CA, USA). 
2.9.1.2 Methods 
The liver mRNA from a wild-type mouse (SV129/ter, male, 3 months old) 
was reverse transcribed to cDNA using oligo dT primer. Briefly, 0.2 of RNA 
�extracted in Section 2.1.1.1, 1 |al of 10 [iM oligo-dT primer and 1 fil of 10 mM 
dNTP were mixed in a 0.2 ml microcentrifuge tube, filled up to 13 with 
nuclease-free water and incubated at 65°C for 5 min in a themiocycler (Applied 
Biosystem GeneAmp PCR 9700). Four of 5X first strand buffer, 2 of 100 mM 
DTT and 1 of 200 U/|dl reverse transcriptase were then added and the RT reaction 
119 
was performed in a thermocycler set at 42°C for 50 min in the first step and then 
heat at 70°C for 15 min. The RT products were stored at -20°C until use 
PCR was performed to amplify the mouse PPARa and RXRa cDNAs from 
the RT product using PPARa-FP423/PPARa-RPl 849 (Figure 2.23) and 
RXRa-FP171/ RXRa-RP1759 (Figures 2.24) primers, respectively. Four f,il of RT 
product, 5 |al of lOX high fidelity PCR buffer, 2 |il of 50 mM MgSO*’ 1 …of 10 
mM dNTP mix, 2 of 10 |LIM forward primer, 2 of 10 |LIM reverse primer and 0.2 
[il of 5 U/|.il platinum Taq DNA polymerase high fidelity were mixed in a 0.2 ml 
microcentrifuge tube and filled up to 50 with nuclease-free water. The PCR 
reaction was performed in a thermocycler (Applied Biosystem GeneAmp PCR 9700) 
set at 94°C for 2 min in the first cycle, followed by 35 cycles at 94°C for 30 s, 60°C 
for 30s and 68°C for 2 min and a final step at 68°C for 10 min. The PCR products 
were electrophoresed in a 0.7% agarose gel, excised and purified using the 
QIAquick gel extraction kit. 
The purified PPARa and RXRa PCR products were digested with BamW I 
and Bgl II enzymes, respectively, to create cohesive ends for ligation. Five fig 
purified PCR products, 10 |j.l of lOX appropriate reaction buffer, 10 of 1 mg/ml 
BSA and 100 U restriction enzyme were mixed in a 1.5 ml microcentrifuge tube and 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































37°C overnight and the digested products were electrophoresed in a 0.7% agarose 
gel, excised and purified using the QIAquick gel extraction kit. 
2.9.2 Preparation of pSG5 vector DNA 
2.9.2.1 Materials 
pSG5 vector and AGl competent cells were purchased from Stratagene (La 
Jolla, CA, USA). Restriction enzymes and alkaline phosphatase, calf intestinal 
phosphatase (CIP) and their buffers were obtained from New England Biolabs 
(Beverly, MA, USA). QIAquick gel extraction kit was provided by Qiagen 
(Germany). 
2.9.2.2 Methods 
pSG5 expression vector (Figure 2.25) DNA was prepared as described in 
Section 2.3.2 using AGl instead of JM109 competent cells. The pSG5 vector DNA 
was firstly digested with BamW I (for PPARa) or Bgl II (for RXRa) to create 
‘ cohesive ends. Ten |ig of pSG5 vector, 10 |il of lOX appropriate reaction buffer, 10 
of 1 mg/ml BSA and 5 restriction enzyme were mixed in a 1.5 ml 
microcentrifuge tube, filled up to 100 with autoclaved water and incubated at 
37°C overnight. 




























































































































































































group from vector to prevent self-ligation. The CIP reaction was incubated at 37°C 
for 1 h. The products were electrophoresed in a 0.7% agarose gel, excised and 
purified using the QIAquick gel extraction kit. 
2.9.3 Ligation and transformation 
2.9.3.1 Materials 
丁4 DNA ligase and its buffer were purchased from New England Biolabs 
(Beverly, MA, USA). 
2.9.3.2 Method 
The BamW I digested mPPARa and the Bgl II digested mRXRa cDNAs were 
ligated to the BamR 1-CIP and Bgl II-CIP pSG5 vector, respectively. The resultant 
recombinants were transformed in AGl competent cells following the protocol 
described in Section 2.1.2.1. 
2.9.4 Screening and confirmation of recombinants 
2.9.4.1 Materials 
Stu I enzyme and its buffer were purchased from New England Biolabs 
(Beverly, MA, USA). Midi-VlOO™ ultrapure plasmid extraction system was 
125 
obtained from Viogene (Sunnyvale, CA, USA). 
2.9.4.2 Methods 
Subclones were firstly screened by phenolxhlorofomi test as described in 
Section 2.3.4. The confirmed subclones for mPPARa and mRXRa expression 
constructs were grown up in 100 ml LB/ampicillin medium and the plasmid DNA 
was extracted from the overnight bacterial culture using the midi-VlOO™ ultrapure 
plasmid extraction system. 
Stu I enzyme was used to screen the mPPARa and mRXRa expression 
plasmids with correct orientations (Figure 2.26). For each plasmid, 200 ng plasmid 
DNA, 2 of lOX NEBuffer 2 and 1 i^l of 10 U/^il Stu I enzyme was mixed in a 1.5 
ml microcentrifuge tube and filled up to 20 with autoclaved water. The digestion 
reaction was incubated at 37°C for overnight and the Stu I digested products were 
electrophoresed in a 0.7% agarose gel. One subclone that carrying insert in forward 
orientation was grown up in 100 ml LB/ampicillin medium and the mPPARa and 
mRXRa plasmid DNAs were extracted from the overnight bacterial culture using 
the midi-VlOQiM ultrapure plasmid extraction system. 
The sequences of the pSG5-mPPARa and pSG5-mRXRa expression plasmids 










































































































































































































































































































































































primers of the pSG5 vector (Figure 2.25) and mPPARa and mRXRa gene-specific 
primers (Figure 2.27). 
2.10 Transient transfection and reporter assays 
2.10.1 Cell culture and transient transfection 
2.10.1.1 Materials 
L i p o f e c t a m i n e T M PLUS reagent and all cell culture products unless otherwise 
specified were purchased from Invitrogen corporation (Carlsbad, CA, USA). 
Wy-14,643 ([4-chloro-6-(2,3-xylindino)-2-pyrimidinylthio]acetate) was obtained 
from Chemsyn Science Laboratories (Lenexa, KS, USA). 9-cis-retinoic acid was 
provided by Sigma Chemical Company (St. Louis, MO, USA). NIH-3T3, HepG2 
and AML-12 cell lines were purchased from American Type Culture Collection 
(Manassas, VA, USA). 
2.10.1.2 Methods 
NIH-3T3, HepG2 and AML-12 cells were maintained in complete medium 
[Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal 
bovine serum (FBS), 1 mM MEM sodium pyruvate, 100 \.iM MEM non-essential 
amino acids, 100 ^ig/ml penicillin and 100 |ag/ml streptomycin] at 37°C in a 
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A 
S t a r t c o d o n 
GCCACATCCATCCAA CMQGTGGACACAGA GAGCCCCATCTGTCC TCTCTCCCCACTGGA GGCAGATGACCTGGA AAaTCCCTTATCTGA 90 
AGAATTCTTACAAGA AATGGGAAACATTCA AGAGATTTCTCAGTC CATCGaTGAGGAGAG CTCTaGAAGCTTTGa mTGCAGACTACCA 160 
PPXRa-SKQ667 
GTACTTAaaAAGCTG TCCGGGCTCCGAGGO CTCTGTCATCACAGA CACCCTCTCTCCAGC TTCCAQCCCTTCCTC AOTCXqCTGCCCCQT 270 
GATCCCCGCCAGCAC GGACGAQTCCCCCGG CAGTGCCCTGAACAT CGAGTGTCGAATATG TGGGGACAAGGCCTC AGGGTACCACTACGG 360 
AGTTCACGCATGTGA AGC5CTGTAAGGGCTT CTTTCGCSCCIAACTAT TCCK3CTGAAGCTGGT GTACGACAAGTGTAA TCGGAGCTGCAAGAT 4 50 
TCAGAAGAAGAACCG '3AACAAATGC:CAOTA CTGCCGTTTTCACAA GTGCCTGTCTGTCGG GATGTCACACAATGC AATTCOCTTTGGAAG 540 
AATGCCAAOATCTGA AAAAGCAAAACTGAA AGCAGAAATTCTTAC CTGTGAACAC'GACCT GAAAGATTCGGAAAC TGCAGACCTCAAATC 630 
TCTGGGCAAGAGAAT CCACGAAOCCTACCT GAAGAACTTCAACAT GAAC^AGGTCAAGGC CCGGGTCATACTCQC QQQAAAAACCAQCAA 720 
CAACCCGCCrm^aT CATACATGACATQGA GACCITGTGTATGGC CUAGAAGACGCITGT GGCCAAGATGGTGGC CAACGOCGTCGAAGA 810 
CAAAasiGGCAGAGGT CCaATTCTTCCACTG CTGCCAGTGCATGTC CGTGGAGACCGTC-AC GGAGCTCACAGAATT TGCCAAGGCTATCCC 900 
AGGCTTTaCAAACTT GGACTTGAACGACCA AGTCACCTTGCTAAA GTACGGTGTGTATGA AOCCATCTTCACGAT GCTGTCCTCCTTGAT 990 
PPARa-SEQ1440 — 
GAACAAAGACGGaAT GCTGATCGCGTACQO CAATOGCTTTATCAC ACGCGAGTTCCTTAA GAACCTGAGGAAGCC GTTCTGTGACATCAT 1060 
GGAACCCAAGTITGA CTTCGCTATGAAGIT CAATGCCTTAGAACT GGATGACAGTGACAT TTCCCTGTTTaTGGC TGCTATAATTTGCTG 1170 
TO-aAGATCOGCCTGG CCTTCTAAACATAuG CTACATTGAGAAGIT GCAGaAGGGaATTGT GCACGTGCTTAAGCT CCACCTGCAGAGCAA 1260 
CCATCCAaATGACAC CTTCCTCTTCCCAAA GCTCCTTCAAAAAAT aCTGGACCTTCGGCA GCTGGTCACGGAGCA TGCGCAGCTCGTACA 1350 
S t o p c o d o n GGTCATCAAGAAGAC CGAGTCCGACGCAGC OCTGCACvCCACTGTT GCAAGAGATCTACAG AGACATGTACT<^TC TT 1427 
B 
S t a r t c o d o n 
CGCAGACATQC^ACAC CAAACATTTCCTGCC GCTCGACTTCTCTAC CCAGGTGAACTCTTC： GTCCCTCAACTCTCC AACGGGTCGAGGCTC 90 
CATGGCTGTCCCCTC GCTGCACCCCTCCTT GGGTCCC3AGAATCGG CTCTCCACTGGGCTC GCCTGGGCAGCTOCA CTCTCCTATCAGCAC 180 
CCTOAGCTCCCCCAT CAATGGCATGGGTCC GCCCTTCTCTGTCAT CAGCTCCCCCATGGG CCCGCACTCCATGTC GOTACCCACCACACC 270 
CACATTGGGCTTCGG GACTGGTAGCCCCCA GCTCAATTCACCCA? GAACCCTOTGAGCAG CACTGAGGATATCAA GCCGCCACTAGGCCT 360 
RXR<):-SKQ533 — 
CAATGGCgTCCTCAA QOTTCCTGCCCATCC CTCAGGAAATATGGC CTCCITCACCAAGCA CATCTGTCCTATCTG TGaGGACCGCTCCTC 4SC 
AGGCAAACACTATGG GGTATACAGTTGTGA GGGCTGCAAGGGCTT CTTCAAGAGGACAGT ACGCAAAGACCTGAC CTACACCTGCCGAGA 54C 
CAACAAGGACTGCCT GATCGACAAGAOACA GC GG A AC C50TGTCA GTACTGCCGCTACCA GAAGTGCCTGGCCAT GGGCATGAAGCGGOA. €^ 30 
AGCTGTGCAGGAGGA GCGGCAGCGGGGCAA GGACCOGAATGAGAA COAGGTGGAGTCCAC CAGCAGTGCCAACGA GGACATGCCTGTAGA 720 
RXR«-SEQ921—^ 
GAAGATTCTGGAAGC CQAGCTTGCTGTCGA qCCCAAgXCTQAQAC ATXCaTGGAGGCAAA CATGGGGCTGAACCC CAGCTCACCAAATGA 81C 
CCCTGTTACCAACAT CTGTCAAGCAGCAGA CAAGCAGCTCrrCAC TCTTGTGGAGTGGGC CAAGAGGATCCCACA CTTTTCTGAGCTGCC 900 
CCTAGACGACCAGGT CATCCTACTACC3GGC AGGCTAGAACGAGCT GCTGATCGCCTCCTT CTCCCACCGCTCCAT AGCTGTGAAAGATGO 990 
RXRnt-SSQ1220 
GATTCTCCTGGCCAC CGGCCTGCAC3TACA CCGGAACAGCGCTCA CAGTGCTGGGGTGGG CGCCATCTTTGACAG QQTGCTAACAGAGCT 1080 
GGTGTCTAAGATGCO TGACATGCAGATGGA CAAGACGGAGCTOGG CTGCCTGCGAGCCAT TGTCCTGTTCAACCC TGACTCTAAGGGOCT 1170 
CTCAAACCCTGCTGA GGTGGAGGCGTTGAG GGAGAAGGTGTATGC GTCACTAGAAGCGTA CTGCAAACACAAGTA CCCTGAOCAGCCOGO 1260 
CAGOTTl'GCCAAGCT GCTGCTCCGCCTGCC TGCACTCJCGTTCCAT CGGGCTCAAGTGCCr GGAGCACCTG'rTCTT CTTCAAGCTCATCGG 13S0 
S t o p c o d o n 
GGACACGCCCATC:GA CACCTTCCTC-ATGGA GATGCTGGAGGCACC ACATCAAGCCACCTA GGCCCCCGCCGCCGT GTGCCGGTCCCGTGC 1440 
CCTGCCTGGACACAG CTGCTCAGCTCCAGC CCTGCCCCTGCCCTT TCTGATGOCCCGTGT GGATCTTTGGGGTGC AOTGTCCTTATGGGC 1530 
CCAAAA3ATGCATCA CCATCCTCGCCATCT TTACTCATGCTTGCC TTTGGCC 1582 
Figure 2.27 Locations of primers designed for DNA sequencing of 
pSG5-PPARa and pSG5-RXRa expression plasmids 
(A) mPPARa cDNA sequence subcloned in pSG5 vector. (B) mRXRa cDNA 
sequence subcloned in pSG5 vector. The sequencing primers are underlined and 
bolded. The start and stop codons are underlined and bolded. 
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humidified 5% CO2 atmosphere. For NIH-3T3 cells, 1 x lO"^  cells were seeded per 
well of 24-well plate. For HepG2 and AML-12 cells, 5x10"^ cells were seeded. The 
cells were allowed to grow at 37°C in a humidified 5% CO2 atmosphere for 24 h. 
Transient transfections were performed using the L i p o f e c t a m i n e T M PLUS 
reagent and according to the transfection seating plans (Appendix A). For each well 
of the 24 well culture plate, 200 ng reporter constructs, 20 ng of pRL-TK vector as a 
transfection control and 100 ng pSG5-PPARa and/or 100 ng pSG5-RXRa were 
mixed in a 1.5 ml microcentrifuge tube. pSG5 vector DNA was used to adjust to 
equal DNA load. The mixture was filled up to 23 i^l with DMEM. Two jiil Plus 
reagent was added, mixed and incubated at room temperature for 15 min. After 
incubation, 0.5 |al Lipofectamine diluted in 24.5 |il DMEM was added, mixed and 
incubated at room temperature for another 15 min. During the incubation, the cells 
were washed with 1 ml Dulbecco's phosphate buffered saline (D-PBS) and added 
with 0.2 ml DMEM. After incubation, the transfection mixtures were added to the 
cells and incubated at 37°C in a humidified 5% CO2 atmosphere for 3.5 h. One ml 
complete medium was added to each well and incubated 37°C in a humidified 5% 
CO2 atmosphere for 24 h. The medium was then replaced with complete medium 
containing 50 |aM Wy-14,643 in DMSO and 1 |aM 9-cis-retinoic acid in ethanol or 
their vehicles (1:1 mixture of DMSO and ethanol). The cells were incubated at 37°C 
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in a humidified 5% CO2 atmosphere for 24 h. After 24 h of culture, cells were lysed 
and assayed for luciferase activity. 
2.10.2 Assay for reporter construct luciferase activity 
2.10.2.1 Materials 
Dual-luciferase assay reagent was purchased from Promega (Madison, Wl, 
USA). Rimless luminometer tubes (12 X 75 mm) were obtained from Iwaki glass 
Co., Ltd (Japan). 
2.10.2.2 Methods 
The cells were lysed according to the company's instruction with some 
modification. Briefly, the medium was aspirated off from the 24-well plate and the 
cells were washed once with 1 ml IX PBS per well. The cells in each well were 
lysed with 80 |LI1 (instead of 100 \x\ suggested by instruction) IX passive lysis buffer 
‘ with shaking for 45 min. The lysates were resuspended by pipetting up and down 10 
times and then transferred to a new set of 1.5 ml microcentrifuge tubes. Cell debris 
was collected by centrifugation at 6,000 rpm for 2 min. Twenty |al supernatant was 
transferred to a 12 X 75 mm luminometer tube. 
Dual-luciferase assay reagent was used to measure the luciferase activity of 
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the reporter constructs according to the company's instruction with some 
modification. Prior to measure the luciferase activity, luciferase assay reagent 11 
(LAR II) for measuring firefly luciferase activity (which was the luciferase activity 
from reporter construct) and Stop and Glo reagent for measuring Ren ilia luciferase 
activity (which was the activities from pRL-TK) were prepared according to the 
company's instruction. For each tube containing 20 )il lysates, 50 |_il (instead of 100 
|al suggested by instruction) LAR II was added, mixed gently and inserted into the 
liiminometer (Berthold Lumat LB 9501) to measure the firefly luciferase activity. 
The tube was then taken out and 50 \x\ Stop and Glo reagent was added. The mixture 
was vortexed briefly and then inserted into the luminometert to measure the Renillci 
luciferase activity. The ratio of firefly luciferase activity to Renillci luciferase activity 
in each sample was served as a measure of the normalized luciferase activity. 
Experiments were performed in triplicate for at least three times. 
2.11 Electrophoretic mobility-shift assay (EMSA) 
2.11.1 In vitro transcription/translation 
2.11.1.1 Materials 
TNT® quick coupled transcription/translation systems and Transcend™ 
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non-radioactive translation detection systems were purchased from Promega 
(Madison, WI, USA). 
2.11.1.2 Methods 
mPPARa, mPPAR(3, mPPARy and mRXRa proteins were produced by in 
vitro transcription/translation. pSG5-PPARa and pSG5-mRXRa expression 
plasmids were prepared in Section 2.9 while pSG5-mPPAR(3 and pSG5-mPPARy 
expression plasmids were gifts from Dr. Jeff Peters (Penn State University, 
Philadelphia, USA). In order to obtain an unprogrammed lysate as a negative control 
for EMSAs, translation products were also performed with pSG5 vector only. 
Translation products were labeled with Transcend^'^ biotin-lysyl-tRNA for detection 
of proteins. Parallel reactions were performed without biotin-lysyl-tRNA to yield 
translation products for use in EMSA. The in vitro transcription/translation reaction 
was set up as follows: 1.5 |ag plasmids, 0.5 |al of 1 mM methione, 20 ),il T7 master 
� m i x and 2 )al of bioin-lysyl-tRNA where appropriate were mixed in a 1.5 ml 
microcentrifuge tube and filled up to 25 with nuclease-free water. The reaction 
was incubated at 30°C for 90 min. After incubation, the reaction was stopped on ice 
and stored at -80°C until use. One |j.l labeled translation products were analyzed on a 
12% SDS-PAGE using TranscendTM non-radioactive translation detection systems 
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according to the company's instructions. 
2.11.2 Preparation of AML-12 nuclear extract 
2.11.2.1 Materials 
Trypsin-EDTA, D-PBS and dithiothreitol (DTT) were purchased from 
Invitrogen corporation (Carlsbad, CA, USA). BCA protein assay kit was obtained 
from Pierce (Rockford, IL, USA). HEPES sodium salt, sodium chloride, potassium 
chloride, EDTA and glycerol were provided by USB corporation (Cleveland, Ohio, 
USA). Magnesium chloride hexahydrate, potassium hydroxide and 
phenylmethylsulfonylfluoride (PMSF) were purchased from Sigma chemical 
company (St. Louis, MO, USA) 
2.11.2.2 Methods 
Nuclear extracts were prepared from AML-12 cells treated with 50 
Wy-14,643 or DMSO according to (Andrews and Faller 1991) with some 
modifications. Briefly, AML-12 cells were seeded on two 175 cm culture flasks. 
When the cells became 70% confluent, they were treated with complete medium 
containing 50 |aM Wy-14,643 or DMSO and incubated at 37°C in a humidified 5% 
CO2 atmosphere for,48 h. After 48 h incubation, the medium was aspirated and the 
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cells were washed with 10 ml PBS. Four ml typsin-EDTA was added to detach the 
cells from the flasks by incubation at 37°C in a humidified 5% CO2 atmosphere for 
4 min. Ten ml complete medium was added, resuspended and transferred to a 15 ml 
Falcon tube. The cells were pelleted by centrifugation at 1,000 rpm for 4 min and the 
supernatant was aspirated. After washing with 10 ml cold PBS by pipetting up and 
down 10 times, the cells were pelleted by centrifuging at 1,000 rpm for 4 min. The 
supernatant was aspirated and the cell pellet was resuspended in 5 cell volume of 
cold buffer A (10 niM HEPES-KOH pH 7.9 at 4°C, 1.5 mM MgCb, 10 mM KCl, 0.5 
mM DTT and 0.2 mM PMSF) by flicking the tube and transferred to a 2 ml 
microcentrifuge tube. The cells were allowed to swell on ice for 10 min and then 
vortexed for 10 s. The samples were centrifuged at 14,000 rpm for 2 min and the 
supernatant was discarded. The pellet was resuspended with 2 cell volume of cold 
buffer A, centrifuged at 14,000 rpm for 2 min and the supernatant was discarded. 
High salt extraction was performed by resuspending the cell pellet in 2/3 of cell 
volume of cold buffer C (20 mM HEPES-KOH pH 7.9, 25% glycerol, 420 mM 
NaCl, 1.5 mM MgCb, 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF) and incubated 
on ice for 60 min. During the 60 min incubation, the resuspension mixture was 
mixed gently at every 5 min-interval. The mixture was then centrifuged at 14,000 
rpm at 4°C for 2 min and the supernatant which containing the nuclear extracts was 
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stored in aliquots at -80°C until use. The concentration of nuclear protein was 
determined using the BCA protein assay kit according to the manufacturer's 
instruction. 
2.11.3 P r e p a r a t i o n of D I G - l a b e l e d P P S I G - P P R E o l igonuc leot ides 
2.11.3.1 Oligonucleotides design 
Oligonucleotides containing PPSIG-PPRE 1, PPSIG-PPRE 2 and PPSIG-
mPPRE 1 in which some of the PPRE 1 sequences were mutated, were designed to 
study their binding activity with mPPARa/mRXRa (Table 2.9). The oligonucleotide 
containing functional PPRE of acyl-CoA oxidase (AOX-PPRE) (Osada et al. 1997) 
was used as the positive control to monitor the EMS A system. The primer 
oligonucletoides were synthesized by Invitrogen corporation (Carlsbad, CA, USA). 
2.11.3.2 Annealing of single-stranded oligonucleotides to form double-
� stranded oligonucleotides 
2.11.3.2.1 Materials 
























































































































































































































































































































































































































































































































































































































































































Single-stranded oligonucleotides including SIG-EMSA-FPl, SIG-EMSA-FP2, 
SIG-EMSA-mFPl and AOX-EMSA-FP were annealed with their complementary 
oligonucleotides SIG-EMSA-RPl, SIG-EMSA-RP2, SIG-EMSA-mRPl and 
AOX-EMSA-RP, respectively to form double-stranded DNA. Briefly, 10 |al of 100 
|.iM of oligonucleotides, 10 of 100 )LIM of the complementary oligonucleotides 
and 30 TEN buffer (10 mM Tris, 1 mM EDTA and 0.1 M NaCl, pH 8.0) were 
mixed in 0.2 ml microcentrifuge tubes. The annealing reactions were performed in a 
thermocycler (Applied Biosystem GeneAmp PCR 9700) set at 95°C for 10 min, 
8 5 � C for 10 min, 7 5 � C for 10 min, 6 5 � C for 10 min, 55°C for 10 min, 45°C for 10 
min, 35°C for 10 min and finally kept at 25°C. 
2.11.3.3 3' end labeling of the double-stranded oligonucleotides 
2.11.3.3.1 Materials 
DIG gel shift kit, second generation was purchased from Roche (Germany). 
2.11.3.3.2 Methods � 
The double-stranded oligonucleotides were DIG-labeled using the 
components provided in the DIG gel shift kit (Roche). Twenty |al of 20 pmol/^1 
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double-stranded oligonucleotides were diluted to 4 pmol/|al with TEN buffer in a 
final volume of 100 ^il. One |al of 4 pmol/|il double-stranded oligonucleotides was 
mixed with 9 nuclease-free water in a 0.2 ml microcentrifuge tube. Four of 5X 
labeling buffer, 4 of 25 mM C0CI2 solution, 1 of 1 mM DIG-ddUTP and 1 i^l 
of 400 U/|al terminal transferase were added to the tube, mixed and incubated at 
TTC for 1 h. The labeling reactions were stopped by adding 2 )al of 0.2 M EDTA 
(pH 8.0) and incubated on ice. Three [i\ nuclease-free water was added and the 
probes were stored at -80°C. 
2.11.3.4 Testing the labeling efficiency of the double-stranded 
oligonucleotides 
2.11.3.4.1 Materials 
Positively charged nylon membrane was purchased from PALL corporation 
(East Hills, NY, USA). Gel-blotting paper was obtained from Whatman® (UK). NBT 
and BCIP were provided by Roche (Germany). Tween® 20 was purchased from USB 
corporation (Cleveland, Ohio, USA). 
2.11.3.4.2 Methods 
The labeling efficiency of the probes was tested before they were used in 
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EMSA. A series of dilutions of the probes were prepared as shown in Table 2.10. 
One |al of the probe at each dilution was applied onto a membrane. The DIG-labeled 
probes were fixed onto the membrane by baking at 80°C for 2 h in an oven 
(Memmert UM300). The membrane was washed in 20 ml washing buffer for 2 min 
in a small container, blocked in 10 ml IX blocking buffer at room temperature for 1 
h and incubated in 10 ml antibody solution (1 |il anti-digoxigenin-AP in 10 ml IX 
blocking buffer). After washing in washing buffer at room temperature twice for 5 
min, the membrane was incubated in detection buffer for 5 min. Signal was 
developed by incubating the membrane in detection reagent (25 fil NBT and 18.75 
BCIP in 5 ml detection buffer). Colour development was stopped with autoclaved 
distilled water. The image of membrane was captured with an Epson expression 
1600 pro flatbed scanner SCSI. 
2.11.4 Preparation of unlabeled oligonucleotides as competitors 
To prepare competitors in the binding reactions, two different concentrations 
(1.55 pmol/^l and 15.5 pmol/|al) of unlabeled oligonucleotides of PPSIG-PPRE 1 
atl0-fold and 100-fold excess of the probe, respectively, were obtained. Unlabeled 
oligonucleotides of 15.5 pmol尔 1 was prepared by diluting 7.75 of 20 pmol/|al 

































































































































































































oligonucleotides of 1.55 pmol/|al was obtained by diluting 7.75 f,il of 4 pmol/fil 
double-stranded oligonucleotides to 20 with TEN buffer. 
2.11.5 Binding reactions 
2.11.5.1 Perform with in vitro transcribed/translated proteins 
2.11.5.1.1 Materials 
DIG-gel shift kit, second generation was purchased from Roche (Germany). 
2.11.5.1.2 Methods 
111 the binding reactions, PPSIG-PPRE 1, PPSIG-PPRE 2 and AOX-PPRE were 
used as probes. Unprogrammed reticulocytes and in vitro transcribed/translated 
mPPARa and mRXRa were used to examine the binding activity of mPPARa/ 
mRXRa heterodimer on PPSIG-PPRE 1, PPSIG-PPRE 2 and AOX-PPRE. Binding 
reactions for PPSIG-PPRE 1 were also set in the presence of either PPARa or RXRa 
only to ensure that only PPARa/RXRa heterodimer binds to PPSIG-PPRE 1. 
Unlabeled PPSIG-PPRE 1 and PPSIG-mutPPRE 1 were included as competitors to 
examine whether PPARa/RXRa heterodimer specifically bound to PPSIG-PPRE 1 
only. Poly (dl/dC) and poly (dA/dT) were included to reduce non-specific binding on 
GC rich oligonucleotide (AOX-PPRE) and AT rich oligonucleotides (PPSIG-PPRE 1’ 
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PPSIG-PPRE 2 and PPSIG-mPPRE 1)，respectively. 
To set up the binding reactions using in vitro transcribed/translated PPARa and 
RXRa, 2 |il of 4 ng/^il DIG-labeled probes, 4 of 5X binding buffer, 1 |ag of 
poly(dI/dC) (for AOX-PPRE) or poly(dA/dT) (for PPSIG-PPRE 1’ PPSIG-PPRE 2 
and PPSIG-mPPRE 1), 0.1 jil of 0.1 jig/fil poly-L-lysin for improving binding 
efficiency and/or 4 of PPARa and/or 4 i^l RXRa were mixed. The total amounts of 
reticulocyte lysates were kept constant (8 |j,l) in each reaction through the addition of 
unprogrammed lysate. The total volume was made to 20 |al with autoclaved water. For 
competition experiments, 10- and 100-fold molar excess of the unlabeled 
PPSIG-PPRE 1 or PPSIG-mutPPRE 1 were added to the reaction mixtures. The total 
volume was made to 20 |LI1 with nuclease-free water. Binding reactions were incubated 
al 25°C for 20 min and stopped by placing on ice. 
In addition, binding reactions were performed using in vitro 
transcribed/translated PPARp, PPARy and RXRa. Briefly, 2 of 4 ng/|_il DIG-labeled 
probes, 4 |uil of 5X binding buffer, 1 |_ig of poly(dI/dC) (for AOX-PPRE) or 
poly(dA/dT) (for PPSIG-PPRE 1, PPSIG-PPRE 2 and PPSIG-mPPRE 1) and 0.1 of 
0.1 poly-L-lysin and/or 4 \x\ of mPPARp or mPPARy and/or 4 |al mRXRa 
proteins were mixed. The total amounts of reticulocyte lysates were kept constant (8 
|al) in each reaction through the addition of unprogrammed lysate. The total volume 
143 
was made up to 20 \x\ with nuclease-free water. The binding reactions were incubated 
at 25"C for 20 min and stopped by placing on ice. 
2.11.5.2 Perform with AML-12 nuclear extracts 
2.11.5.2.1 Materials 
DIG-gel shift kit, second generation was purchased from Roche (Germany). 
2.11.5.2.2 Methods 
AML-12 nuclear extracts as a source of nuclear mPPARa and mRXRa were 
used to perform EMSA. Nuclear extracts from AML-12 cells either treated with 
Wy-14643 or DMSO were used to compare the difference in binding activity. 
PPSIG-PPRE 1, PPSIG-PPRE 2 and AOX-PPRE were used as probes. 
Binding reactions were set in the presence or absence of AML-12 nuclear extracts to 
examine the binding of PPARa/RXRa heterodimer on PPSIG-PPRE 1, PPSIG-PPRE 
2 and AOX-PPRE. Unlabeled PPSIG-PPRE 1 and PPSIG-mutPPRE 1 were included 
as competitors to examine whether PPARa/RXRa heterodimer specifically bind to 
PPSIG-PPRE 1 only. 
For binding reactions using nuclear extracts, 5 |ig of nuclear extracts, 2 of 4 
ng/|jJ DlG-labeled probes, 4 of 5X binding buffer, 1 |j,g of poly(dI/dC) or 
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poly(dA/dT) and 0.1 |LI1 of 0.1 fj,g/|j.l poly-L-lysin were mixed. The total volume was 
filled to 20 |LIL with autoclaved water. For competition experiments, 10- and 100-fold 
molar excess of the unlabeled PPSIG-PPRE 1 or PPSIG-mutPPRE 1 was added to the 
reaction mixtures. The total volume was made up to 20 |al with nuclease-free water. 
Binding reactions were incubated at 25°C for 20 min and stopped by placing on ice. 
2.11.6 Detection of shift-up pattern 
2.11.6.1 Materials 
DIG-gel shift kit, second generation was purchased from Roche (Germany). 
Positively charged nylon membrane was obtained from PALL corporation (East Hills, 
NY, USA). Gel-blotting paper was provided by Whatman® (UK). NBT and BCIP 
were purchased from Roche (Germany). Tween® 20 was obtained from USB 
corporation (Cleveland, Ohio, USA). 
2.11.6.2 Methods 
The 6% non-denaturing polyacrylamide gel was pre-set one night before to 
ensure that the gel was completely polymerized. Before use, it was pre-riin in 0.5X 
TBE buffer at 80 V for 5 min. The binding reactions were resolved on the gel by 
electrophoresis at 112 V until the dye reached 2/3 of the gel. The resolved products 
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were transferred to nylon membranes by electroblotting at 400 mA for 30 min in 0.5X 
TBE buffer. Nucleic acid was fixed onto the membrane by baking at 80°C for 2 h in 
an oven (Memmert UM300). It was then washed with washing buffer (0.3% Tween 20 
in maleic acid) for 5 min, blocked in IX blocking solution [1% (g/v) blocking reagent 
in maleic acid buffer] for 1 h and incubated in an antibody solution (5 |al 
anit-Digoxigenin-AP in 50 ml IX blocking solution) overnight. Signal was developed 
in NBT/BCIP substrate (250 |al NBT and 187.5 BCIP in 50 m) detection buffer). 
Colour development was stopped with autoclaved distilled water. The image on the 
membrane was captured with an Epson expression 1600 pro flatbed scanner SCSI 
using an Adobe® photoshop® 6.0 program. 
2.12 Statistical analysis 
All statistical analyses were carried out using SigmaStat version 2.03 software 
system (Systat Software, Inc., USA). All data are presented as mean 土 standard error 
of mean. The Student's Mest was used to examine the difference between different 
groups as mentioned in the figure legend. A difference of P < 0.05 between different 
groups was considered significant. 
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Chapter 3 Results 
3.1 PPSIG cDNA sequence analysis 
3.1.1 Cloning of PPSIG full-length cDNA sequence 
RACE was performed to obtain the full-length cDNA of PPSIG in order to 
confirm full-length PPSIG was 100% similar to Riken cDNA 0610039N19. For 5’ 
RACE, a single predominant PCR product of � 1 9 0 0 bp was obtained which was 
matched to the expected size (Figure 3.1 A). It was found that this PCR product was 
up-regulated in liver sample which was extracted from mouse fed with a 0.1 % 
Wy-14,643 diet for 11 months. There was no PCR product obtained in all the negative 
controls including no RT template, no PPSIG 5' GSPl and no GeneRacer 5' primer, 
indicating that the PCR products observed in samples were specific. For 3’ RACE, 
four PCR products o f - 5 0 0 , 1200，1400 and 1700 bp were found (Figure 3.IB). The 
presence of the unexpected bands of � 1 2 0 0 , 1400 and 1700 bp was either due to 
unspecfic amplification of other genes or the presence of PPSIG isoforms. Except the 
� 5 0 0 bp PCR product, all the other products showed a higher intensity in liver RNA 
sample treated with a 0.1% Wy-14,643 diet for 11 months. The � 5 0 0 bp PCR product 
did not show any induction, probably due to the amount of this product in both 
samples reached the threshold of PCR. Minor bands were observed in negative 
147 
A PPSIG 5, amplified cDNAs 
T- OJ CO 
- I - J - J H H- H-
1 kb 二 2 
Marker Control diet ？? f 0.1% Wy-14,643 
9 B H 9 
3054 bp 
2036 bp j —1900 bp 
1636 bp 
B PPSIG 3，amplified cDNAs 
T- CM CO 
_J _ l _J 
h- K H 
1 kb O O O 
Marker Control diet > > > 0.1% Wy-14,643 
• • • P I 
1636 bp 斤 ; 丨 i — 700 bp 
j 一〜 i 400bp 
1018 bp �1200 bp 
506 bp ， — � 5 0 0 bp 
‘ Figure 3.1 PPSIG 5' and 3' RACE PCR products 
(A) PPSIG 5' RACE. A -1900 bp major product was observed for 5' RACE. This 
PPSIG 5' RACE cDNA was significantly induced in liver RNA sample extracted from 
mice treated with a 0.1% Wy-14,643 diet for 11 months. (B) PPSIG 3，RACE. Four 
PCR products of � 1 7 0 0 , � 1 4 0 0，� 1 2 0 0 and -500 bp were found in 3, RACE. Except 
for the � 5 0 0 bp PCR product, all other three products showed a higher intensity after 
treated with a 0.1% Wy-14,643 diet for 11 months. The PCR reactions with no RT 
templates (-ve CTL 1), no PPSIG GSPl (-ve CTL 2) and no GeneRacer primer (-ve 
CTL 3) were used as negative controls. 
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control with no PPSIG 3，-GSP primer. As mentioned in the manual of GeneRacer'^ 
kit, these bands were generated by nonspecific binding of the GeneRacer 3’ primer. 
There was no PCR product observed for the negative controls with no RT templates 
and no GeneRacer 3' primer, indicating the PCR products observed in samples were 
specific. 
Both the 5' and 3’ RACED PCR products were subcloned in a pCR®II-TOPO® 
vector and EcoR I digestion was performed to screen the subclones by checking their 
insert sizes in the recombinants. From the result of EcoR I digestion for 5' RACE, all 
the eight subclones including 5'#7, 5'#11, 5'#12, 5'#16, 5'#20, 5，#31, 5’#32 and 
5’#33 showed the same patterns (Figure 3.2), suggesting that these recombinants were 
identical. The existence of two bands (1500 and 400 bp) indicated that an EcoR I site 
was present within the insert. The total size of inserts was 1900 bp (1500 bp + 400 bp) 
which was matched with the expected size, showing that the 5' RACED cDNA was 
successfully subcloned. The EcoR I digestion result for 3’ RACED sublcones showed 
two different patterns, suggesting that there were different forms of recombinants 
(Figure 3.3). Except for subclones 3’#8，3’#12 and 3’#25，all the subclones showed 
single band of about 600 bp. These subclones appeared to carry recombinants 
containing the 3' RACE product of 500 bp. The EcoR I digestion product showed an 








































































































































































































































































































































































































































































































































































and the insert cloning site on the vector. For subclones 3’#8, 3，#12 and 3’#25, they 
showed two bands of � 5 0 0 and 1100 bp, indicating that there was an EcoR I site 
within the insert. The total size of insert was 1600 bp which was believed to be the 
1600 bp product in PPSIG 3’ RACE PCR. The sizes of inserts for all PPSIG 3’ RACE 
subclones were matched with RACED PCR product sizes, suggesting that the 3' 
RACED cDNA was successfully subcloned. 
DNA sequencing was performed to determine the nucleotide sequences of 5' 
RACED products from subclones 5’#7，5'#11, 5'#12, 5'#16, 5'#20, 5'#31, 5'#32 and 
5’#33 (Appendix B). The cDNA sequences obtained from different 5' RACE 
subclones were compared to determine if there were variations in their nucleotide 
sequences (Figure 3.4). The result showed that PPSIG 5' RACE only yield one 
product. There were some mismatched nucleotides and this might be due to PCR or 
sequencing errors. The size of 5' RACED cDNA was around 1920 bp which was 
matched with the expected size. Two ATG start codons were found at 27 and 1089 bp, 
respectively, and one TAG stop codon (TAG) was observed close to the 3’ end of 
PPSIG 5' RACED cDNA, showing that the cDNA of PPSIG 5' RACED subclones 
contained the full open reading frame (ORF). 
The transcription start site (TSS) of PPSIG was determined by 5' RACE. The 
sequencing result of all the eight 5' RACED subclones showed that the first 
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1 16 30 31 4 � < � C 今 1 76 " 50 
tn(> GOXrrCTTCCUAGCC CTCKjCAGCAACATgT cmiX-ACTCX'TCTCK- TGC'roriCCXiiriCKiC ACP^ 'XXrtZThlXrrCXi EfC 
accjGrrcrrcca/vGcc cT3GC7^ Gc;uvc:AT_aT o3九TCAcn^TTKac CXJCTCXJCCCTCSCTOC l o c K K n ^ r c c T c c ACAaa3TCTA<xn>3G so 
‘ ^12 GCrJCA7<:rnV.a:^ QCC 少;rrCD：： TCK.-I»3CKXXJKKrraC HI^-^Kmi^tTCXnrC ACAQGGTCTA0GTC3G 
5’^Ul Ga3CTrCTTCCGAGCC CTa3CAGCJUvqfcT<rr aOATCACTVXrrCTCK： TOCTGGCCGTGCTOC T3CI>33TGATCCTC:C ACAQ3GTCTACGTQG 90 
V 农 ( : ; a : x ; { T r r T ( : c G A G c : c o:v<rcjk<-nxxrrcixK： ro:^r.TJCty3TGCKr：: iKKriKXJtc^Tcc't^rc ACAtx; SS 
Oaxrrcri'CCGAOCC CIWCAGCAAC^I' OJATCACTCKTCKX： TOC"TO�CCOTGCT:K： T3CT:^ 5T3MCCTCC ACAi'i3:rrCTACX3T33 ？c 
5'47 aCG3TCTTC03AGCC CTQGCAGavAqy][•空T OGATCACT3CTCTX3C T\3CT30CCGT)3C7GC TOCTOTTGJ^TCCTCC ACAGCX3TCTA03T3G 分C 
H. ‘ Q'axin'cr'n'criitMc:;: c'r^xKAocAAcxTor a'jATCACT:xn'civjc. IKKTCX^ XXHOCTCK: •TiCOTOTOATCcra:: ACAocacrrcTAcoTGO -JO 
TSS of 5' RACE let start codon 
•ft 
lOS lUfc 1 a 150 1S3 1 6 1 6 C 
5 ‘ m QC;CTTTAa3CrrGCAA GTTCCCCGAACCCCT TCQCCGAaOATOTCA AOCGACCGCCTGAAC CCCTtXSTSACCGACA AQGAC33CTAa3AA<SC lec 
；j,吞:n cxxrinrrAcxKrixscAA <rrTcccxx^Accc<ri' 'ra:K::a:说aiiATorcA Acii^xiAcaxrraiAAC cccrairirsAcrx^CA ACX^ AC^ CK-TAC-KSAAGA lac 
GCCTTTACQCrrGCAA CTTCCCC3AACCCCT TOSCCOAGQATQTCA AGO^ACa^ CClUfcAC CCCTO3TGACCGACA AGGAOGCTAOmAGA 150 
GarmAOSriT:•；CAA GTT:’C;�Cr;»_ACrCCT X^XrCUAaSATSTCA AOCXSACtXrCCKJlAAC CCrnr^ TTGACOTACA AGGAO r^TAO^AGA 
fy'ftzo CKTCnTACGCTrtSCAA CSTTCCCCC-iAACCCCT TOGCrOaACmtXn'CA ACKXiAariCCTaAAC CCC-tXTToAamcrft ACyjACKJCTAOTiAACiA 17« 
OCCTTTACGCTOCAA CSTTeCCCCjAACCCCT TCQCCmOGATGTCA AQCaACTCGCCTaAAC CCCTO3TGACCGACA AQGAOGCTAOaA/vGA lac 
S- #17 GCC:了rTACrrCTGfCAA GTTCCCrCOAMTCd: TCXjCCXI^ACXSAIXrVCA Ai:KXiAC<X}CCli:iAAC CrCCTCXIilTiACXX^ iCA AC磁C:<3CTAC:<5AA<» 18 C 
5 G C C T r r A C G C V : S C A A OTTCCCCGAACCCCT TCGCOOAOSATGTCA AGC^ ACCQCCTGAAC CCCTOGT3AC03ACA AC5GAGQCTAQ3AA^  i«C 
19& 210 ：：1 2：；6 240 二43 2*>6 270 
5'f t l6 CAOTTCTCAAACAAQ CTTTCTCAQTCAGCC OAOTACCAGAOAAGC T33AT>3CA3TCX3T3A TCGrsCAGCOSCATTQ 033C^CT33CCTCAG 27C 
S.^m ivAGTTCTCAAACAAG CTTT-CTCAGTCAGCC OAGTACrCACyiaAAGC TX '^raCAGTCriTGA TCQ^ CAGCaOCATTG aCXiGkCTOGCCTCXa 27Q 
5'ft 1.2 AAGTTCTCAAACAAG CTTTCTCAGTCAGCC OAGTA CCAOAOAAGC "TOaATOTAG•？33TCA TCOTCAQCQQCATTG QGQQACTaQCCTCAG 270 
tr^fi u. AAcrrrcrcAAArAAG errrcTOiOTC'AGcc GAGTACCAGACAAG: IXXSAT二;cAGTocrKSA TcocoiaraxATTG gcxxsackx^CCTCAG 270 
'•I ‘ ttZi) AAOTVCrCAAACAAa CTTTCTCiU-VrCAGCC’ OAC^TACCACJACWUVCK： 'KXiATOCACnxixriXiA TCOOCACKXJ：.寬 
A.ACrn'CTCAAACAA<S Crn'CiX:!A<TrCACiCC CSAC^tACrCACiACIiAAriC： 'IXVjAT�3CACnr:SGT3A TCXatiCAijiyJC^ CATTC CX3I:JC3ACI\33CCI'CAO 270 
；UvGTTCrCARACAAG CTTTCTCAGTCAGCC GA^ TACCAOAG^ AGC 703ATGCAGTC3GT3A TCaC^AGCTiGC/lTTS OCXiOftCTXXSCCTCXG 27C 
AAGTTCTCAAACAAG CTTTCTCAGTCAGCC OAGTACCAGAOAAGC 103ATQCAGT<331>3A T-CGQCAQCOGCATTC OC?aQACT3QCCTCAG 270 
:!iOC ；iC] 31ft M6 i i l ‘ ^60 
y me (rixKxrjrrcrAC}!CTA AA^ CTOGCAAGA^ AG TccTOmKnxj^-iAAc AACATACX'aacjckx^ S OC-aixrTG'nxsrcrAT Accr-TT.txsGK'i^ ^AAA 
CTQCGGTTCTAGCTJ； A^AGCTGGCAAGAGACi TCCTTGTCKrTGSGAAC A^CATXCCAAOrjCOri GC-CiGCTGTTt3TC7iT ACCT-TTTiOGGAAXA 
5’ CTGCDGTTCTAGCTA AAGCTOSCAAGAGAG TCCTiaTOCTQaAAC AA-CATAOCAA<33a33 GC-OGCTGrrOTCAT A0CT-TTQG03AAAA 35« 
S ' ^ l l CTOCCXTTTCTAaCTA AAO-rTOOCAAGAGAC TCCTKHOCTCXSAAC AACATACCAA03CGC OC •OQCTG'nOTCAT ACCT- TTOQirSAAAA 
crXKr»3TTCTAc;5CTA AAacnXXK'AM^OAG TCCTOrPGCrTCKiAAC AACATACCAAOXXSG GC• (XKriHTTtrrCAT ACCT• TKKiOCiAAAA 
5‘ft:!^2 cnXK.'GSTTCTAGCTA AACf:.TO;3CAA<:$A;:iAO T<:CTTG7<K7<:rJAAC AACATACCAACXKO'.i a<:-'33CTQTVCm:AT ACCT-TI>:i333AAWi iS8 
5,冉？• CTCKXX-yTTfSTAGCTA ；UiGCTGOCAAGAGACi TCCTTCnOCTOGAAC /vACRTACCAAOIKXri 3C - CJ05CTCvTT3TCAT ACCT-TTGC^ XiAAJU 505 
{:nnaxn'TCTA«ClVL AACXn^ XiCAAOAOAG TCCrKnOClGGAAC: AACATACCAAar,aX4 GC.-CKK:TOni:rrCAT ACCT-Tr:3CX:^ 3RAAA 35« 
； r ? 6 ^90 A^iJ AOS 406 A20 421 & 4&0 
？i'fiilS. 'HlKK.nm^AATTTCiA CACrKrAATTCATTA TATTO'.5A03vA.TaCX5 CCGTrTTATCrTOSA CCrAGATlllAC?3AA33 443 
5 ' 叫 TGOCCrPGJAATTTGA CACT3GAATTCATTA TATT3aACGj;ATQ03 03/i03GC/tACXTT3a CCGnTTTATCTTQOA CCAGATCACTGAAQa 4iS 
ft'#12 诚 CACIXJ.5AA.Tl'CA'3"rA TAT^ H^ GACGitiAltSCG a:iAC9aGCAACATn3G CCGmTTATCrnxX从 eC:A<»iTCACT3RA<33 44a 
於 U 'IKXiCCrVOPJiTT'TOA CACKy^ AATTCATTA TATlOTAOTiAlOCG OCJAOGGCAACftTTOC CCGTTTTATCTIOaA CCAOATCACTGAACC 446 
5'ft:<>0 TX^ aCCTKiAATTTGA TATTTjWAOaAA^K i^ asAOaCAACATTOa C'aJTrTTATCTTXXiA CCACiATCACTOAAa'S 44ft 
？ i ， r o a C C r i X J A A T T T G A CACKmATTCATl^ A TATOrJACXiAAlXXXr. ::*5AGJ:XiCAACXT1X3:3 CCXSTTTTATCTTOtSA CCAG^ TCllACTKiAACaS 4 43 
#7 TOSCCrraAArrTGA CACrciGAATTCATTA T/iTTOOACGAATtSC-G OGk^ XXSCJiAChTTiXi CCGTTTTATCTT3G?； CCAGATCACTaAAC33 <4S 
S •#：!；?, :!>:3ac:'CrK"JAATTTGA CTArTCKJWkTTCATTA TAm^mCGAAlCTCG CaTrTTTATCrTT33A^ CCA<SATCACTaAA<33 
453 4^5 460 496 5i0 526 &<0 
？i'fti6 <5CAA(:” io3紅axrcArai i txr rcccc m"rGA<:rrt5ATC3AT acTrAGXA-^ c^ cKrcAA CCCCATOTACACSTOS S^S 
5'^iiJ CCCCATC3GCCTCCCC TTTTGACTTSATXaAT ACTAGXAGGCiCCCAA TGSCCOAAAOQAGTT CCCCAT3TACAQTQG 533 
CCCCATQCJCCTCCCC 'nTitsArrrciAiriAT ；ICTAGAAGX+SCCAA 
5.411 aCAACTrX3ACTO3GC CCCCATOGCCTCCCC TTTTOACTTGACTiT ACTACIAA033CCCAA T3GC03AAA<3GAGr：' CCCCAT3TACAC5TC33 
S'FR2E) CCCCATOX'CTCCCC 'K^CX5AAAC«A0N' CR:CCAT:;TACAOTCIC 
OC:AACT3aAC':'IOC>GC CCCCAT03CCTCCCC TrTTGACITCA-paAT ACTAQAA-303CCCAA TQC:iCCaAAA3aAGTT CCCCATOTACAGTOG 
5' #17 CCCCIATOSCCTCCCC TTTTGACTTaATaAT ACTAGAAGGCiC'CCAA T\3QC:CGAAAa3A3TT CCCCATOTACAQTOG 533 
5 ‘ ^ CCZCM.'KKKX'VCCCC TTUX^CTXik^iT tiCl'hCMaXiCCCAA TXJSeCGAAAOGAC+TT SS^ 
b'U r�SS> Sh^ 670 lias 6Cfi f^Ci 650 
5 • ftl(S 'r^ AOroiVAAGAATACAT CCACOGCCTTTUGAA CAA-lTTTCXICCAAGSA AGAAGCTSTCATTCiA CAAGTACATT^ .'aAGTT OGTTAAGGTfXTTCa fcSfi 
G'liyi GACaG^ AAOAATACAT CCAOQGCCTTAAG^ A OAAOTTCCXrCAAOjA AOAAGCTGTCATTOA CAAGTACATOQAGTT GGTTAAaG1X53To3C 623 
5'#12 G^ vGGAAAG/iATACAT CCAQSSCCTT/JkGAA GtJiGTTCCCCAhOO^ AGAAGCTC-7CATT3A CAAGTACAT03A3TT C33TTAA3GT03TO3C 623 
GAC3C5AAAGAATACAT CCAOTyCCTTAAGAA aAAGTn'CCCCAAtXW ACSAACK-IXHTCATTGA CAAaTACAlVJGAGII' GGa'i'AAGGIOSTaCJC 62« 
OACK^ AAOMTACAT CCAa^ CTTAACS/kA CJAACTTTCCCCAAOV^  ACiAAGCTCTTCATTXSA CAA0TACATrjl3AGTT 6：26 
fi.fti：! C-yKKiAAAGAATACAT CCAC03C:CTTAA3AA GAAC?TTCX:CCAA03A ；VOAAGCIXSTCATTXiA CAAGTACATC^ IAGTT •3^ TT/lACiG'IXKnr33C 
S'^ / OAGOtiAAOIAA'rACJn’ fXACiaX-CrUACJAA ACSAACXnCTCATTGA CAAOTACATOTAaTT CX3TTAACi:nXX:n\'3C5C 
5' G^ lCJGWiAGWiTACAT CCAOS3CCTTAAGRA GAAGTTCCCCAAOGA AGAAGCTGTCATTGA CAAGTACATOGAGTT OSTTAA-SGTOaiOT：' 62S 
64S *S76 f^与 1 "JOS "^ Oe 7i:0 
COTIOSAGTCTCTCA TOCAGTTCTACTCAA arrCCTCCCATiaCC CTTCACTCAQCTCCT C:AGCAAGTr:\33GCT ACTGACT0G7TTCTC 7i6 
� (TOKaSAGTiirrCTCA TCK'ACnn'n'A CTCAA Crn'CCTCtXATTtSCC CTTGACTCAGCTCCT CACSCAAGl'nXS^ GC^ ' ACTOACrTCGTrTCTC 71« 
CCGTGGAGTCTCTCA TGCAGTTCTACTCA7i GTrCCTCCCATlKSCC CTTGACTCAGCTCCT CAGCAAGTTTDOGCT ACTGACTCGTTTCTC 713 
CXX5TGCW3TCTCTCA TGCAGTTCTACTC-AA GITCCTCCCATltXC CTTGACTCAGCTCCT CAG-CAA<3Trit33GC" ACTv3J^ CTCGIlTCTC 7：« 
CCOITOAOTCTCTCA TQCAGTrCTACTOU OTTCCTCCCATOCC CTTGACTCAGCTCCT CT ACirjEACTOOTTTCTC 7X6 
C031\33AaTCTCTCA 1\3CAaTTCTACTCAA OrTCCTCC'CArKSCC CTTOACTCAGCTCCT CAGCAAQmOSSCT ACTGACTCGTTTCTC' 7:7 
COTIOCSACntrrCTCA TOCkCmCTTkCrrCAA arrCCTCCCATTCKC <nT3ACTCAC5CTCCT ACTGJt^ CTCOSTTTCTC 7IS 
5' CaSTSSAGTCTCTCA TGCAGTTCTACTCAA OTTCCTCCCATirsCC CTnSACTCAGCTCCT CAGCAAGTT-?33GCT ACTGACTCGTTTCTC 713 
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721 735 736 750 7&1 765 766 780 751 795 7SC BIC 
* 
IXXXTTC/KKKXHkGC CrTCfAasCAGA^CCT GCAGCrrOCXXKrTTC CrxnxSATCTC;:AC:>:X： lOTTCI'CAOCrrACAl' 7in 
1'CCA7'TCraCCGAGC CyiXTTACGCAGAGCTT AGCa^GTCCTGCA GCAOT^ lOT^ TiCTTC :03TGATCrCCA<riC T^ STTCTCAOCTACAT 办。石 
S' KIJS TCCATTCrKSCCOSAGC GTCTIiVCacAGAGOCT ACK-TXlAAGTCCTCiC/y aCA'SCTlXXXJCKTTTC CrCXnrSAGCTCCACOC TGTTCCCAaCTACAT fiOe 
TCCATTCIGCCCIIAQC GTCTAOSCAGAGCCT AGCTSkAGTCCTGCA GCAGCTT333aCTrC CCCTIVjAGCTCCAGSC TGTTCTCAGCTA"AT 5C5 
TCCATTC1X3C03AG-C OTCrkaSCAGk^CCr AGCTGAAGTCCTGCA QCAGCT1X3333CTTC COSTO^ G^CTCCAOSC T^TTCTCAGCTACAT 506 
TC'CA-i'TCK3ccK:avac AacTCAAGTCcracA rrcxjrjAGci'ccAo^r； TGrrrrcACKTArrAT 
TCCATTC1\-3CCG^CK- OTCTAOACAI-SA'VICCT AGCTCAACTCCIXXTA ACAGCTTA33ACTRC CCXTIVJAGCTCCAOSC TXTRTCTCAGCTACAT 
ftii TCCATTCTOCCCiAaC GTCTACGCXCSAGCCT AGCTCAAGTCCTC-JCA GCAGCT7t33G3CTTC CCOTGiiGCTCCAGGK： KTrTCTCAGCTACAT 5G6 
f<lX 525 640 ^ 41 ^bd tlQ S71 861? i^CO 
B'fti^v CTTCCCOiiCrTAOGG AGTAACTCCCA^ CCA CAC'CarCrTTTCCn (yckViKTC^XjCTCKrV TXiiACCA-CrTACJlTACA AOCXr3r;ATATXACCC 
！ C r r C C C C A C T T A C O G AOTAACTCCCAGCCA CACCGCCTTTrC'CTT GCATXSaVT^ CHXKS了 TUACCACTACATACA ACi30r5CATATTACCC 
& • CTTCCCCACTTACXTG AGTAACTCCCAGOCA CACCGCCTTTTC:CTT QCATOCTCTGC-IOGT TC5ACCACTACATACA Aa3G)GCATATTACCC fiOfi 
#11 CTTCeCCACTTACGG AGTAACTCCCAQCCA CACCGCCTTTTCCTT GCATGCTCTGC'?32-T l^CCACTACATACA AOaOGCATATTACCC CrCCCCACI'ACOG ACTAACirCCACJCCA CAC03CCr3"nrcrr GCAIXXIX-IXSCTOGT TGACCACTACATACA A-JGJGCATA'ITACCC 6S?6 
CrrCC'CCAClTA^ XSG A;3TAACTCCC*A0CCA CACC'CKrcrrrrcCTT OCAT3CTtrT:X-TfXrr- TCOACCACTACATACA AaXJGCATATTACCC 
‘ ft7 CTi'CCCCACTTACOG AGTAACrCCCAOCCA CACCOCCTTTTrjCTT ；'iCATtSCTCKSCItXTT iriACX'ACTACATACA ACTKSOCAI'ATTACCC 
fj'flBli CTTCOCCACTTACQG AGTAACTCCCA3(::CA C7*CCaCCTTrrCCTT CXTATCSCTCTOC'TCIGT ITiACCACTACATACA AG333c:ATATTACCC 
915 9X6 94 5? 946 960 975 976 390 
tr TCGAOOXXnTCCAC; lX;AGA;r�':XK:f:TTCCA TAri-CATCarrTTGAT TCrAGCDGGCCO^ O^G CGCTGTCCTCACOlC a^ rrCACTraTACAGAG 
点、1 TCGAOJORRGITCCAG 'IXAAO^TCOCCTTCCA TACCATCCCTTTGAT TCAOC-OCXICAXTXSG OXNXNCCTCACCAO OGCCACTOTACAGAG 
5 TCS^ AG33GGTTCC;iG TQ/^ GATOaCCTTCCA TACCATCCCTTTCSAT TCAQC033CO:3GG3G CGCrK57CCTCACCXG aTCCACTCTACAGAG 
TCGA33303TTCCAG TGAGATa3CCTTCCA TACCATCCCTTTaAT TCAG03G3CCa33aG OSCTOTCCTCACCAG GCKTCAC^TACAGAG & 
S TGAGATCXKTTTCCTit TC:AGaX5:K’CVX03G C-GCTOTCCTCACCAG OC^ CCrACTOTACIAGAG »««； 
'RCOAOCOTOTCCAG T^ACJATCORCTRCCA TACCATC'JCTTTGFTT 'RCAOOTGCOQORX3G RI^CTUTCCTCACCAG AXCACIXTTACAGA:; VS7 
1XSA<3ATXXJ'CCn'CCA TACCATCCCTTTOAT TCA0C033COT3:333 a3C^ «Tt:CTCACCAC? OOCCACTOTACAGAu 
TCQA.a3GQGTTCCAG TViAGATOJCCTTCCA TACC/^ TCCC'TTTGAT TCAGOQCX3CCaQ33G C3CTCTCCTCACCAG C33CCACTGTACAaAG 
lOOS 10 06 X02"X I'^Mi. 1 0 • OSO 106 5 0.066 1080 
B lK:riX>C1X3CTa;}ACTC AOCiXK3C:yiGAGCCnt;3 KCTirrCACrrC^ TC.'iAA CiAAOXyiCAAOAOCT 3:nUAAC:ATCTACTG CCCAGrrt3TCATCT<：' « 
(i'iUll TOC.TIXTI'CAG'tUTCii^ A GAAaJGACAAGAOCT O-TItSAACATCTACra CCCAGTIvrrCATCTC 10?杏 
5 l O T Q C T C i C r a - i A C T C AQCTt-KliSAaAQCGTVS T03TGTCAGTC5TC3?iA GA/V333AC:AAGA3CT GSim A CA TCTA CTVi CCCAOTTCTCATCTC 1078 
TOTGCTOCTXaOACTC A3C1033AGAGC3TG Ta^rGTCAaTOTGAA GAAGGSACAAOAGCT G3TC3AACATCTACrr3 CCCAGrK5TCATCTC 1075 
5 ； G A A G G G A C A A G A G C T CCCAGTT3TCATCTC .1076 
ixxrrcivAOTTixsAA c«3'raucArcTACTG cccAGnxrrcATCTC io?7 
S，fl7 TCOTCmCTOCMCTC AGCTOKSAGAGCXOT GAAGa^ACAAOAGCT aJTOAACATCTACTa CCCAOTTOTCATCTC 1076 
r^'i^iy TOnVlCTGCTXr^ ACTC A<3CTraC5AGAGCGTGJ lO^ TCiTOACnOTGiAA GhAOCKihCIshGAOCT 3:iT^ACATCTACTG CCCAGTTtSTCATCTC 1075 
2nd sturt codon 
.I0«;i 109S 1096 ： IIG 11,11 112^  1126 1140 2.141 3155 1156 1170 
ouTGOGcmxTgrr CAATACCTATCAOCA CTroritrcArjiaAc 'Kn:rcGrcATCTcx:c AGATOITAAGAAGCTA CKnxrrr:>G;ftT3GrrjtjvG IO7J? 
J1 CAATGCOTM^'RR CAATACCI'A'I'CACSCA CTTGRNT^CCAGAOAC： ICTCOSCCATCTOCC ACIATOITSAAGAACSC/I GCKJCSCXIARATTAAG 
S . m CAATACCTATCAQCA CTTOTraCCAGAGAC TGTCCOCeATCTGCC AGATGTVSAAOWvaC/i QCTOGCGATOSTAAG n66 
CAATCKXX^^Aa'T^ CAATACCTATCAG^ CA CTT3TTaCCA'3AGAC TGTCOSCCATCIXSCC AGATGlXSAAGAA'CiCA GCTOSCmTG3TAAG 1165 CAATGCXmAAWn- CAATACCTATCACICA CTltrnVSarAGACi&C -KrcCC^rCATCIXKrC AAATOItl^AAC-iAAGCA aCTOC^CGSVTGGTAAG 1166. 
C/TATGCTOOA^RR CAATACCTATCAGCA CNVMNCCAGAGAC CGTCOGCCATCITSCC AGATCTI^ AAGJVAOCA GCTCKXMTATTAAG 1167 
b'fl7 C:/UTGa::9aGA^ TT CAATACCTATCAGCA CriX.rnXX.'C:AGAGAC TGTCCOCCATCntKX AGAiaiXSAAOXAGCrA GCTOCKm'RXXrAACi 
Jj'flBi CAATQCQQGA^^GTT CAATACCTATCAGCA CT'iQTTQCCkGAGAC TGTCCGCCATC^SCC AGATVilUAAGAAGCA GCTCXSCOATGKSTAAG 1163 
II：-/1 118S 1.1(56 1200 1201 1215 L21<； 1230 1231 1245 1246 126 C 
fj'ftie OCCTO^TCTGAGCAT GCTCTCAATCrrCAT CTOTCTC^ kf^ CXiTAC C^ JVOGAO^ ACCTGAA OCTTCAaTCCACCAA CTACTATGTTTATTT 116， 
f)' it'ii Gccritxrrc'K^cjcAi' ocrcrrcAATcriTCAT cixyi'cnGAAAcxscAC cAA<macjiAccix3AA GCTTCACSTCCACOU crACTATtrnwm* 
5-#12 GKXTOGTCTaftaCAT CiCTCTC/^ ATCTTCAT CTGTCTGyUA33CAC CAAOGAG^ ACCIXSAA OCTTCAGTCCACCAA CTACTAIHTTTATTT 12Sfi 
S '#11 GCCTTGGTCTGAGOIT GCTCTCAATCTTCAT CTOi'C'ItiiWiA'GGCiKC CAAGGAGGACei^ IliAA GCTTCAGTCCACCAA CTACTA'KS'nTATTT liS-S 
GCC*nXiTCK3J£taCAT CKTCTCAATCTTCAT CTGT':T:SAAAG3CAC GCTTCAGTCCAC'-Am CTACTATSTTTATTT 
OCCTCXrrCTraft.OCAT OCTCTCAATCTTCAT CTGTCIOiEiAA<3GCAC CAiVSGAO^ i^CeTGAA 'GCTTCAGTCCA^ C^AA CTACTATCTTTATTT 12S7 
h ‘ fl.7 GccTorrcTc说ocA'r GcnxrrcAftTcrrcAc: CTCJTCTCSAAAOGCA?: cftAcxsAcx^ ActnTSAA Gcin'CAcvrccAcc^ A cTACTAiti'm'Arrr 
GCCTGGTCTOAQCAT (XTCTCAATCTTCAT CTOTCT3AAAGJCAC CAAGGAC33ACCIXIAA GCTTCAGTCCACCAA CTACTATGTTTATTT iSE^ti 
S'itlft 'IKaACACACiACATOSA CAAACXX谈CTA7t57*CTCTATGCC CAACKJAAAAa^fn'CC AC.5AACACATTCCCCT TCTCTTCATrGCCTT 
TOXICACAGACAra3A CAAAQCGJQ'KSQ/i.aCCi CTATOTCTCTATXSCC CAAGC3AAAAGGCTCC AGiAACACATTCCCCT TCTCTTCATTGCCTT 1246 
TGACACAGACA'rtaaA CAAAGOiJnaGAGCG CTATGTCTCTATGCC CAAOH^AAAOGCTCC AGAACACATTCCCCT TCrclTCATTOCCTT 1 
ftai CAAACSCGATOGftGCrj CTATOTCTCTATGCC： CAAGGIAAAAO^ CTCC AGAACACATTCCCCT TCTClTCAnx^CCTT 1344^  
S ‘社2Q TGACACAGACAraSA CAAAGCOATOT^ IAGCO CTATGTCTCTATOCC GAAOG/LAAAOGCTCC AGAACACATTCCCCT TCTCTTCATnXCTT 1>46 
KMCACAGA<Xi('lt:rjA 诚�K：^ CTATGTCI^ CTATGCC CAACKiAAAACKCTCrC AC:5AACACA1TCCCC:T TCmTCATiXXrCrr 1 
S'lfl7 TaACACAO/iCATOaG aUACJCmiOaAOCQ CTATGTCTCTAT3CC CAAGGAWiAOGCTCC AGAACACATTCCCXTT TCTCTTCATTGCCTT .U4S 
T�:yj^ CACA(:5ACA"KSGA CAAi^ GCXIJA'niKllAGa:; CTAT;t:,TCTCTA*K;CC C^ AAClOAftiUa^ JCrTCr ACIJAACACATTCCCCT TCTCTTCAriGCCTT 
� 13S1 1J65 i3«0 133& 1410 1411 142& 14^6 1«40 
� 5'436 �X’CATC:;UGCAAOGA TCCAACCTO^ GAOGiA GCXSATTCCCAGACCG ATCrCACAAKSAtnXX GCTOOTACCCATOCiC CTTTGAATOSTTCUA 
CCC-ATCAAGCAAa3A TCCMCCTGGGACm QCQ?*TTCCCAGACCG ATCCACAAimCTGC GCTOTTACCCATOaC CTTTGAATOOTTCOA 
SlliJ CCC:*AT(:AA‘,:5CAAGGA GO:进TTCCXIAGACCG ATCCACAATt:^ ACTGC GCTXJ:iTACa:ATa3C CTTTGJUTVtJCTrTCOA 
C*CCA'rt::AAC4CAAOC:iA 'rCCAA<:rTG;:X»C:K;A GCGATTCCCAGACO：； ATCCACIAAIXJACTGC： {X'"It3Cn'ACCCAT3C5C CTrTC:iAATX3GTTa:iA lAh.-? 
#20 CCCATCAAGCAAOQA TCCAACCTC333AOr3A. OOGATTOrCAGACC^ ATCCACAATJiACTCfC OCTOCTACCCAlXJiC" CTTTGAATOGTTOaA 14 S6 
H ^ N Z CCAVTCAAG<:AA03A TCCAAC::CTCL33AT3：诚 CICGATTDXAGACOG AT(XACAATOIACTGC OCK^TACCXJ^KJ^C CTTTCIAATOSTTCOA 1 4 ” 
CCCATCAAGCAAGQA TCCAACCTG33A-33A GCGATTC^ CCAOAeCO ATCCACriATl3ACTCC QCT03TACCCATGGC CTTTG^ATVSGTTCm 1436 
CCCATI:?AAC4CRA<3T:YI TRCAACCRTIXKJAGKSA C5CX-IATTCC:CA3A<X>5 ATCCACAAIXSACTCN'： C;CTC^ GFTACRCATO：^： 
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1441 libf^ a<70 147： 3 IS-OO UDl IbiO 
• S.^UiS GGAOTG^CAGGAOliA GCCAAAO-JGCAAGCo 'rOGTGTTGACrTATGA GACCCTCAA/lAATOC CTCOGraOAACKXTC TAl^^a'DXTTGATCAT Z-ilt � : n TOniarraACTATGA�5ACXCTCAAAAAnxX: CTTOQlVXJAAfSrCTC TATlirCCKTraATCAT 
！;、，<U2 CXV^OIOTCAOTvCm GCCAAA^jGCK'AAOilX； OACCCTCAAAAATCX. CTTCT^r^iAAG'CCTC TATOTCaTIXaATCAT 1626 aCCAAAOTrCAAOOG UXrGTRUCTA'rOA <,tACCCrCAAAAAir5C cnTCX;TC.i:5AAaCCTC TAItrCGnrOATCAT 5ft, 20 OriAGTOaCAOaACiOA GCCAAAGCXiCAAGCO TQGTOTTaACTATGA G/^CCCTCAAAAA'KiC CTTCGTX3QAAaCCTC TATtSTCOOTGiATCAT CSGAG^KJGCAGGAGriA GCCA.AGGGCAAGOG T>'JGlU'n\:iACTAl\:iA 3ACC-C7CAAAAAT3C CTTCGTGGAACKTCT；： TAICTCQ^TOAT-CAT 1527 GCCAAAC^CXJCAAGCX； •KXnGTTGAOTATGA GAiXXTCAAAAATOC CTTCGTXJAAGICCTC TATOTXy^TOATCAT 拟i • � aCCAAAOrXJCAAQCO 'KKiTOTrGACTA'K^A OACXXTCAA-AAAltiC CTTCXj'lXKiAAaari'C 
1S3： 154ft 1&46 l5fiC 1562 XS7Z> 1&76 3590 1591 1605 260€ 
• * �jAAArarrrcTCA::^ GCKmoo^KrAAoo:. ciGAGACTOiGAroG AOjrjTCAccACTrofcc CAACCASJTACTATCJ- rxJCKKAccraAo:; i:、，im G&MC'iPGTTCCCACA GCl�碰:xXK�AAOTr aiAC^GIOTOAC彻 AOT^iTCACCACTGAC CAACCA<5TACTATCT (SX'TCKfi^CCCiXSkCXy IhlH fOftAACTOTTCCrCACA CKTraOAOy^OlAOaT X^iki^hOmrc^CTOO Aa:OTCACC:AC1V5AC CAACCAGTACTATCI' a:4CTOCAaX03A33 S'^ ll <aAAACTGTTCCCACA GCTOaAa^^CAAQGT GGAGAGTairi;CT33 AC3GTCACCACTSAC CAACCAGTACTATCT a:iCTGCACCCCX3Aa3 二6�6 ：？'c:^AAC:T::-JTTCCC:ACrA CKiAGAGlVSTGACK^G AG33TCA CCACTXiAC CAACCAGTACTATCT ;:KKriX>CrACCCCt3AGG 1616 6 ‘ n y2 <X3AAC:TaTTCCCAaGt CiTCKiACSCKSCAAGGT X^iAOA^inTCrKi/CTQC； MTJCnTACCACKIAC CAACCAGTAC'TATCT CrJ-nrSTACCCCCi^C^G 1617 ；{i'«7 <aiVAACOTn'CCCACA C^crCKy^Cir^ijCAACrr kOi-.K^TCkCChCIX^C CAACCAcn'ACTATCT <T^CTOCACCX.�C:WCW Ifil^ t 
OftAACK^TTCCCACA C3CTCK说aXJCAAiXn* OS森CiACmTK«VCTQG ACKi:^TCACCACT:yvC CXACCAOTACTATCT a^ClXKrACCCCTiAQG 
3635 X6：^6 16^iO 1666 16SG 1661 .1695 1696 1710 TGAC:CAT:ytCT*KX:iC TCOGCtOCATCCTCA TGCAATGCSCTTCCAT AAGAG(:’CCAAA<rCCC CATCCCrAACCTCTA ^ -rtin ACK'I^ACCThTXmK： lOACCA'tSACTIOTC 1XX3GCr'rac；ATCCl CA TC^CAAITOCmrCAT AAC^AGCCCAAACCCC CATCCCCAACCTCTA 27 Ce t ‘ IJ12 AGCTACCTAnX：赚K： TGACCATaACTTCM: talGCTGCATCCTCA TCKrAAUKiCTTC'CAT AAOACCCCAAACCCC CATCCCCAACCTCTA l^ fid 
5'ftai ；TQTu二CATSACTTaOC TC.X3GCT0;:ATCCTCA 'KSCAA'raGCTTCCAT AXGAGCCCAAACCCC CATCCCCAACCTCTA 1706 ACXn^ACCTAIXri&GC TK:谈CrCATGACTIXXKr TCGGCTGCATCCTCA TOCRAHSGCTTCCAT AAGAGCICCAAACCCC CATCCCCAACCTCTA 1706 AGCTACCT&m-AGC raXCCftTOACTIXSGC TCOGCTT.CATCCTCA TC;CAA1XK>CTTCCAT AAaAGCCCA>.ACCCC CATCCCCAACCTCTA 1707 
Vrt? AC3C^rACCTA'lX^C:iAGC 'JXSACXAUSACraK: TCCKSCTinCATCCTC/； 1>3CAA1X,K>crCCAT AACSftGCrCCAAACCCC CATCCCCAACCTCTA I7i:-5 AGCTACCTATOQACiC -K^CCATXihCTTOOC TCOCSCVOCkTCCrCiK TGCAATOOrrcCAT AAGAGCCCAAAC^CCC CATCCCCAJkCCTCTA �7Cfi 
571.1 112^ rne i'V40 vrAi 1755 X756 nvc ITTI 1735 a766 laoo 
CCTmCAOGCCAAGA TATCTTCACCK?TO3 GCTGATGOS^GCCCT GCA03C?35CCnT5rT Q-rXXAOCAGTACCAT CrtAAACGOAACTr 1706 
CE;rt.?A<rAac;9t:cj\AG/i TAi'cn'<'ACc:'i>;nxK3 'jxxxcr-j- GTGCACJCAcsrcsrcAT arrxsAAAcxxiw^crr 
CCltSACAGGCCAAGA TATC:TTi:AC:CKtTac：^  GCTGATtXJCr-XiCCCT <K:ACX«:X3GCC'T'X5CT GlXJCAGCyvCTTGCCAT C<rCiAAAOXIfcACrTT 1756 
S'ftli CCl^CAGGCCAAOA TATCITCACCIOIXXJ C^CT-GATJCa^SCCCT GCAa3333CCn^-.T GltSCAGCAGTIXS-CCAT CCrZtSAAACGGWVCi^' 17 96 ！CCTt:yLCAa:ii::CAA<5A TATCTTCACCTGTGG GCTGATOXJO^CCCT 3CAQG$3aGCCTTGCT CnTiCAGCrAGTaCCAT CCTG;AAAC3G1AACTT ：7$6 
CCTGACAOoCCAAOA TATCTTCACCTGTas OrT3ATr3GC733CCCT GCAOT30GCCTTGCT OT3CAGCAG1>3CCAT CCTGAAACOOAACTT 1797 
Vrt? C<nx：^CAC:KiCCAAC5A 'JATC'I^CJ^CCTO'KK：； CCTtiATrXXJ：XX:C:CT GCAOXWGCCTTXXrT C31t5CAGC"J^Cr!X3CCAT CCTCyiAAa53AA<r?T 】？!Jfi 
iXTtfirAOGCXAAGA TATCTTCIACCTCTOa aCAC:X533C5CrCTTGt:T aTGCAGCAGlUCrCAT arUAAACOOAACTT 279« 
» Stop codon 
iJSiOi litis 1«.16 IfiiiO 186C l«ei 167!^  l^ Q^ 
S'Wie OTACTCACATCICCA O^CTCTTiGCTCAAA GGTCAAGGCACAAAA CGTTCAGAaAAGAGC CAGACXAAACXXZAC•‘ 丄757 
c:n'A<:^'IC:AOATCTO;A OGCTCT'nXKr'JCAAA <X5'rCWVO:JCAC:AAAA C,;AAC:yiAC:5A-IviTA0TC： CXrnCAGACSAAGAO I^IZ OTACTC森G&TCTOCA CKJCTCTTCJGCTC众AA vi:3TCAa:X3C:ACAAAA CJAAGAACSATCiTAOTC CGTTCA-^SAGAAOAa 1872 
•QTACTCAGATCl^XA GGCTCTl^XjCI'CAAA -331 CAa3GCACAAAA GAAGAAGA'JVJ^TC CGrCAOAGAAGAG- 1572 
GTACTCA<^TCiXiCA (XJCTCTIOGICTCAiU G^TCAAGISCACAilAA GJU^IiAAGAIKlT^TC CtSTTCACaAGAAGAGC CA^AOGAAAOCJCAC-
GTACTCAGATCTCCA OOCTCTTXTJCTCAAA CXl-TCAA33CACAAAA GAAGAAGAaCTAaTV CGTTCJVUAOAAGAGC CAGAQOAAACT^ CAC • 
G •绍7 CTACTCAC-iATClKXrA C5GCTCTTO3CTCAAA OAAOAAOA'IXJTAOTC CGTTCA(JAaJUGAOC CAGAG)yAAA�33CAC> lafi? OTAt^TCAGATCTGCA CGCTCTUiOCTCAAA aTrcrAAOQCACAAAA CiAAt^AAC^AK^TAq'TC CGTTCAOAO^ACiAGC： CAGAC3GAAAG3CAC-
S'Mie CaCCCCAACTTCTCq TOOTOTCCTCCCTCC TJIC 
- 二 “ 一-
£'(112 -..••- ……--•… 1(912 
.S'ftai 16^2 
f> ‘ tap 2 
� 7 Cn'CCCCrAJ^C'mi^O TW^CC^CCCTCC iih 1919 
S • • C T C r C C C T A A品5运远冠 ^ ^磁E•运 2 0 — 
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The cDNA length of 5’ RACE subclones was around 1920 bp. All the subclones 
showed identical nucleotide sequence except the presence of some mismatched 
nucleotide as indicated by * and highlighted in grey, suggesting that there was only 
one 5' RACE product. PPSIG 5' RACED cDNA contained the full open reading 
frame. The stop codon (TAG) in bold was found close to the 3’ end of 5’ RACED 
cDNA sequence. Two in-frame start codons (ATG) were observed. The position of 
5，-GSPl used to amplify the cDNA is underlined. This sequence was not observed in 
subclones 5，#31，5，#11 and 5，#32 and this might be due to sequencing problem. 
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nucleotide started at 'G' (Figure 3.4) and this appeared to be the TSS of PPSIG. To 
confirm this hypothesis, the 5' ends of another twenty-seven 5' RACED subclones 
were cloned and sequenced (Figure 3.5). From the sequencing results, all the other 34 
subclones showed similar result at which the first nucleotide was G. These results 
suggested that the TSS of PPSIG started at G. 
The nucleotide sequences of inserts in 3’ RACE subclones were determined by 
DNA sequencing (Appendix B). For 3’ RACE, twelve subclones were sequenced. 
Among them, nine subclones, including 3'#2, 3'#3, 3'#4, 3'#5, 3，#6, 3'#10, 3'#11, 
3’#16 and 3’#22 contained a smaller insert (-500 bp) while the remaining subclones 
(3#8, M\2 and 3#25) carried a larger insert (-1400 bp). The DNA sequencing results 
of recombinants were compared (Figure 3.6). The cDNA sequences of subclones 
carrying smaller insert were -500 bp while that with larger insert was � 1 4 0 0 bp, 
which were matched with the expected size. The alignment of cDNA sequences from 
different subclones showed that their cDNA sequences were identical in the first 481 
bp which was the whole nucleotide sequences of shorter insert and the TAG stop 
codon was present within this region. The cDNA sequence of shorter insert ended at 
nucleotide G that was about 100 bp downstream of the stop codon. The cDNA 
sequence of subclone 3’#8 ended at about 900 bp downstream of the stop codon, 
while the stop position of the cDNA sequences from subclones 3’#12 and 3’#25 were 
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5 ' # 7 GC-GCTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTCSCTC-TGCTG 4 7 
5 ' 1 1 1 GC-GGTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 7 
5 ' # 1 2 GC-GGTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 7 
S ' | 1 6 GC-GGTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA.CTGCTC-TGCTO 4 7 
# 2 0 GC-GGTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTS 4 7 
" S ' p l GC-GGTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCOG 4 7 
5 ' # 3 2 GC-GGfTC TTCCCGAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 8 
' 5 ' # 3 3 ^ GC-GGTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 7 
5 ' T 2 7 " GC-GGTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 7 
5 ' T 1 9 GC-GCTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 7 
5 ' T 2 1 GC-GTTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CAACTGCTC-TGCTG 4 8 
S ' T 2 5 GC-GCTC TTCC-GAGCCC-TGG CAGCA-CATGTGGAT CA-CTGCTC-TGCTS 4 6 
5 ' F 2 GC-GGTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTCK3TCTG 4 8 
5 ' 1 3 0 GC-GCTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 7 
S ' T 9 GC-GCTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 7 
5 ' T 2 GC-GCTC 'ITCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 7 
5 ' T 2 4 GC-GCTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 7 
5 ' T 3 5 GC-GCTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CR-CTGCTC-TGCTG 4 6 
5 ' T 1 5 GC-GCTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTS 4 7 
5 ' T I O GC-<3<3TC TTCC-GAGCCCCTGG CAGCAACATGTCGAT CA-CTGCTC-TGCTG 4 8 
5 ' T 1 7 GC-G<jrC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 7 
5 ' 2W1 GC-GCrC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCOS 4 7 
5 ' T i e GC-GGTC TTCC-GAGCCCCTGG CAGCAACATGTGGAT CA-CTGCTC-TGCTS 4 8 
5 ' F3 GC-GCTC TTCC-GAGTCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 7 
5 ' F7 GC-GCTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTC 4 7 
5 ' F l GC-GCTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTS 4 7 
5 ' 3 W 4 R GC-GCTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 7 
5 ' T 4 GC-GCTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 7 
5 ' T 6 GC-GGCC TTCC-GAGCCCCTGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 8 
5 ' F 5 GC-GGTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 7 
5 ' 1W3 GCTGOrC TTCC-GAGCTC-TGG CAGCAACATGTGGAT CA-CTGCTCGTGCTG 48 
5‘3WS GC-GCTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTC 4 7 
5 ' F 9 GC-GCTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTC 4 7 
S ' F S GC-GCTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CIX3CTC-TGCTC 4 7 
5 ' T 5 GC-GCTC TTCC-GAGCCC-TGG CAGCAACATGTGGAT CA-CTGCTC-TGCTG 4 7 
Figure 3.5 Transcription start site of PPSIG cDNAs 
The 5，end of thirty-five PPSIG 5，RACED cDNA are shown. cDNAs from all other 
. subclones started at 'G'. The mismatched nucleotides are indicated by * and location 
of the ATG start codon is bolded. The cDNAs of eight subclones shown previously 




1 IG 30 J1 4h -kf； 60 fl 7S 90 
i'fle AATOCCTTCGTOGAA OCCTCTATQTCG-r.TG ATCAT>3AAACTaTTC CCACAGCTGGAaGGC AAGCTOGAGAGTOTG ACT^ SaAOSOTCACCA 90 ：^ •封5 AATOCCTTCGTOGAA C^CTCTATOTaXTTG ATCATaAAA.CT;TTC CCACAGCT^AGaGC AAGGTSaAGAQTGTa ACTOOAOCCTCACCA 90 AATaCCTTCaTGOAA, OCCTCTATOTCGWIK! ATCA'T»?>A?i;'.CTGT'rC CCrACAGCTGOACJQGC AACOTGaArJACTOTT’ ？。 X'^ llI AATaCCTTTC(3TCJ<3AA GCCTCTATOTCXKHV：； ATCATTiAi^kACTCrTC CCtACAGCTODGCSGC AAGCrCSaA-:iA':rf<nX； 90 'a ' 1^22 AATOCCTTCGTOGAA OCCTCTATQTCGGTG ATCAT^AAACTGTTC CCACAGCTGGAGCSGC AAGGTOGAGAGTCTK； ACKiCJAnCiGTe^uTA ？0 AATGCCTTCGTGOAA OCCTCTATOTOSGTG ATCAHIAAACTCTTC CCACAG'TTOGAGGGC AAGGTGaAaASTGTG ACTaSACSGOTCACCA 50 3 •供4 AATGCCTTCGTOOAA OCCTCTATGTCGCrQ ATCAT3A?J^CTCTTC CCACAGCTGOAaQGC AAOGTaQAOA^CTS ACT3CSAC503TCACCA 90 詩:i AATOCCrCOTGGAA pCCTCTATQTOIiCTC；? ATCA'IXS?JI.A<:T-;:>TTC CX^ACACftlTCKJAC^'JCSC AAOOT^iCSAGAa-KTrG ACTO-riACXXiTCACX^A 
AATGCCTTCGTGQAA GCCTCTATaTD^ OTG ATCATCSAAA-rraTTC CCACAGCTGGAOGCJC AAGGTGGAGA3TGTG ACTGGAGGGTCACCA 50 AATGCCTTCGTGGAA OCCTCTATGTCXSaTa ATCATCAAACTGTTC CCACAGCTGGAaa-C AAGGTGaA;3AQT<?rG ACTGGAGGGTCACCA &0 AATQCCTTCGTOGAA OCCTCTATQTOSaTG ATCATt5iAAA^:r:TTC CCACAGtirOCrACKKSC AAGGTaAGAGTGT^； ACTaOAGGGTCACCA 90 AATGCCrCGTGCAA OCCTCTAtrGTOrOTt；? ATCATW.ZZiTOTC CCACTAGCTGGIS^CKKK： i^.O^rt^'MlP^Q^irVG ACTCKiAOCKiTOCCA 
91 IGS 106 120 121 135 136 ISO 151 165 166 180 CTGACCAACCAGTAC TATCTGGC?^3CACCC 03AaGAC,CTACCTAT AGAO^rGJACCATOAC TTGaCTCGOCTOCAT CCTCATGCAATOGCT i80 
y^'m <nr.rkccMQCMmd：. rhTcrmtrtiiChccc crGA-:K;iA«a，ACCTAT cctcatocaatcgct iso 
CTCtACCMCChm-AC TATCTGGCtGCACCC CGJAGOAGCTACC^TAT QCSAGCTGACCATOAC： TTGGCTCGGCTGICAT CCTCATGCAATGGCT 180 3*#U1 CTOACCAACCAGTAC TATCTGGCrQCACCC CXSASGAGCTACCTAT C^OAGCTOACCATQAC TTOGCTCGGCTaCAT CCTCATGOaATGGCT 180 •3,供2� CTOACCAACCACTAC TATCTGOCTaCACCC CGAOGAGCTTUrCTAT -SGAOCTaACCATaAC rTOOCTCaOCTaCAT CCTCATGCAATOOCT ibO CT:;ACCAACCA'7r?»C TATCTO7>CrG(CACCC 0:MGAGCTACCTAT •^JGAGCTOACXrATCSAC TTCXKrTCCJGCTCSCrAT C<rCATGCAATO~CT iSO 
；rr<3AC:<rAACC:ACrrA<： TATCTt^GCraCACCr-：： <XSAC3CtA-.-iCrACCTAT aiihOCTakCChTChC TVtXirVC^^^fCKV CCTClTfcTGCAATGGCT iBO 3 CTGACCAACCAOTAC TATCT(3GCTGCACCC CXSAaOAGCTACCTAT OOAGrnSACCATGAC TTOC5CTCOGCT3CAT CCTCATGCAATOGCT 160 CTGACCAACCAOTAC TATOT^OCTOOVCCC CGAnGAGCTACCTAT QCJAOCTaACCAT^AC TTO3CT03GCT<3CAT CCTCJVTOCAATilGCT 160 3!，游3 •jrXGACCAACCAOTAC TATCTnOCTC»CA.CCC OCS^u^GAGOTACCTAT O^OCTGJACCiVrvaAC TTOGCTCCKJCTOirAT ，^rCTr^VTGCAATCKKr IBO C'n:XAC!<rAA<X:A<rACr TATC-TdOC-rGCACCC tXJACSCJAC^CrACXrAT <KiPt<JCTX3A<rAT<iAC TTOaCTCCKJCTGCAT CCTC?vT<JCAATGGC7 iBO CTGACCAACCAOTAC TATCTGGCTQCACCC CGAGGAGCTACCTAT Qa^QCTOACCATGAZ TTQGCTCGGCTaCAT CCTCATGCAATGGCT 160 
Iftl ,196 2i0 211 240 255 25各 270 】••#*<； TCCATAA-WiGCarAA ACX'CrCCAl'CCCCAAC n^CTACXr;3ACA(3GC <J^AaATATrTTCACC TC;T03C!CTCUiTC30aG GCCCTGCACKKSOGCC 270 
”丨TCCATAA^ qAGCCCAA ACCrCCATCCOCAAC CTCTACCTaACAGGC CAAGATATCTTCACC T^TTCJC^aCTCyiTCKSrX； CJCCCTGCAOGCkSGfrC 持2 TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTCJACAGGC CAAGATATCTTCACC TOTWSCTGATaOGG GCCCTaCAOSaoaCC 270 TCCATAAOACJCOrAA ACCCCCATCCCCAAC CTCTACCTGACAaOC CAACSATATCTTCACC TGTOGC3Cir>ATCKK3G GCCCTOCACKJaOQCC 270 
；i'^：：/ ‘ At::C:CCCAir-:::CCCAAC CT<:TACCT<;ACA<3nC： ClViOATAT<7rtCACC TCTKXJ^SCTGi^TOCXK； 270 TCCJiTAACiAGCCCAA ACCCCCATCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC TOTOOrJCTGATGGGG aCCC7TC5CAG3GGGCC 270 #4 TCCATAAOAGCCCAA ACCCCCATCCCCAAC CTCTACCTaACAGGC CAAGATATCITCACC TGTOSaCTOATQOGG aCCCT<3CA03(3GGCC 270 3，种:i TCCATAAOAGCCTAA ACCCCCATCCCCAAC CTCTACCTaACAGOC CAAGATATCTTCACC Tn'50GCTGAT0<XiG GCCCTGCAGGJOOGCC i70 ：查 Ho IKTKVhJIhCfJ^CK^iyr.Ai^. A{:cri:C<:A'ir{X:cCA?^-.：： <:TCTAC:T<;ACA<SG；：： :*:‘\A0ATAT<:TTCACC TaTM:;CTO?iT<JGGG aO:r;rTaCAG30(XX:C ；:70 TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTaACAGGC CAA^GATATCTTCACC TOir^GGCTGATGIGGC’ GCCCTGCAOCSaGGCC Q?0 乏‘街25 TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTaACAOCC CAAGATATCTTCACC TGTOTGCTGATaGOG aCCCTGCAGSGGGCC 270 ”.12 TCCATAAGAQC'OCAA ACCCCCATCCCCAAC CTCTACCTOACAaGC CAAGATATCTtCACC TC3TC3O3CTGAT0CXKS SCCCTaCAGQOCKfCC 270 
271 265 286 300 31 它 330 34S 360 3’ TracraTGCAGCAGT GCCATCCimAAC-GQ AACTIOTACTCAGAT CraCAGacrCTTQGC TCAAASGTCAAaOCA CAAkAGAAGAAGATG 3€0 TTtJCrGiTGCMCA.rn" GCCATCCTGAAA園 AACXTTr?iCTCA3AT CT<3CAGa-CTCTTaC ?CrtAAGC3TCAA30CA CAWU^ OAAGA-355 
'n'CJCrJU'nSCACSCAaX CKXAyCCI*<iAAACW AACITKniACrCAOAT CT<iCAGC;CT<:TT(;C;C I'CAAACSGT<:A?iI3Gt:A CAAAAOAAaAAG^Po 3SO 
GaiATCCTCSAAAaiG AACrcrACirACWiT CrQCTOacrcrGGC TCAAAacrCAAGOCA CAAAAOAACiAAGATCS 360 TTCCTGTGCAaCAOT GCXATCCTC5AAACGG AACTTtSTA-CTCAGIAT CTaCAGaCTCTTOaC TCAAACJaTCAAOOCA CAAAAGAAGAAGATG 360 '#16 TTQCTOTOCAaCAQT OCCATCCTGAAACOG AACTTGTACTCAGAT CnaCAGGJCTCTTaGC TCAAAaGTCAAOGCA CAAAAUAAGAAOATG 360 TTGCTCfTCrCAO'CAGT OCCATCCTQAAACCSO? AACTTCSTACTCAGAT CTGCAaCiCTCTTOOIC T-.:AAA'3GTCfJi.0GCA CAAAJ^ARGAAGATG )右 0 
'#H TraCTCnXK-'AUeAOT AACTrcrrACTCAdAT crrCKrAOaCI^ rrTOCK： TChS^aQTZ^AOGCA CAAAAaAAaWirtAlXS 乏•flici TTGCTaTaCAQCAOT OCCATCCTGAXACaG AACTT^TACTCAGWvT CTGCAGaCTCTTGGC TCAXAaGTCAAOGCA CAAAAGAA-SAAORTG 3€0 
TTaCTOlX/CAaCAGfT OCCATCCTOAAACOG AACTTOTACTCAGAT CTaCAGGICTCTTOGC TCAAAdGITCAAOGCA CAAAACSAAOAAGATG 3€0 
TKJCTCHTacrAaCiW^T GCCATCCKiAAACGKi AACTTTT?.-TrCA3;a CTCKrAGCSirCTTO：：^： TCAAAGGT^CAj^TCKTA CTAAAAOAAGJkAG^i.T：； 350 
'viKvcrnmiiCAQCh.cir C S C C A T O T ^ ^ C T ; ARCNVRRIV二TOIOAT CTACAGGCTCRRCSGC TC:A^AC3CJTCA?U3G<:A CAW^AOAAGAAOATG 
361 375 .^ 76 405 4E>(：. • 420 421 435 436 450 於TAOTC=.OTTCAGArJs.. AOAGCCAGAaCAAAG OCACCTC^CCCAACTT CTCCmSGTGTCCTCC CtCCT.kCJtinC^TTC CTTi^CACATATAAAC 4SD TAGTt:C-:?nx:AaA(;?x A£3A(:!Cr<:A-.:i<KSAAA[；? GCATCTO:丨CXTtACTT CTeOTOi而rCCTCC CTOTACAGCAATTC CrTGCACATATAAAC 44? 
•拜2 TAGTCCOT-CAGAGA AQAr:iCCA-:^GaAAAG GCACCTCCCCAACTT C!TC<ra3TGTCCTCC CTCCTACAGCAATTC： CTTGiCACATATAAAC 449 TAOTCCGTrCAGAOA AGAGCCAGAQGAAAG GCACCTCCCCAACTT CTCG1XK3TGCCCTCC CTCCTACAGCAATTC CTTaCACATATAAAC 4SO 
AGAOCCA.rJACKiAAACl GCACCTCCCCAACTT CTCOTOaTGTCCTCC CTCCTACAGCAATTC CTTGCACATATAAAC 4&0 TAGTCCCi-nxrACSAG^k ACr>A(XCA-.:;A''jaAAAtH ‘:iCArCTO:!CCAACTT�reCTKKiJTaTCCTCC TCXTACAGCAATTC dTGCACATATr-^J^C 4&0 ，*毋今 TAOTCCXJTTCAGAGA AGAGCCACEnTSGAAAG GCACCTCCCCAACTT CTCGT:^TGTCCTCC CTCCTACAGCAATTC CTIV^CACAIV^TAAAC 4 50 TAOTCCGTTCAGAGA AGAaCCAOAOOAAAa GCACCTCCCCAACTT CTCCPTOSTCrCCTCC CTCCTACAGCAATTC CTKSCJvCATATAAAC 450 TAaTCCCrCAGAGA AGA(3CCA-3A<3AAAG GCACCTCCCCAACTT CrCCTOSTGTCCTCC CTCrTACAGCAATTC CTTGCACATATAAAC 450 
GCACCTCcccAAcrr CTCOTGCiTorccrcc crr<xrrACAi:jc:-2j\Trc crr;^ c7ACATAi^ AAAc ^so TAaTCCXrTCAC5A^:iA AGAOCCAaAGGAAAG GCACCTCCCCAACTT CTCCTri^TaTCCtrCC： CTCCTACAGCAATTC CTTGCACATATAAAC 450 
”封 12 TAOTCCGTTCAGAOA AOAaCCAGAQGAAGG GCACCTCCCCAACTT CTCCrTQ-QTOTCCTCC CTCCTACAGCAATTC CTTOCACATATAOAC 450 Stop codon 
451 4ft 5 480 4H1 A《外 SIO 511 ！ ? $ 4 C 种石 AAAAACOATTTTGTT TCT-OAAAAAAAWU；! AAAAA^A ^ ’ 持5 AXAAACCATTrGTr TCrartAAAAAAAAAA AAA- —- - 4 32 AAAAACCATTTTilTT Ti-TCJAAAAAAAAAAA AAAAA^iA- 4 So 
：”种 1X AAWiCCATTTOTr 'rcrGAAjftJCJlAAAAAA AAAAAAJ：. - 4H7 
AftAAACCATTTTCsrr 'KriTiAJyiAAAAAAAA AAftAAAAAA AAAAACCATTTTGTT TCTOftAAAAAAAAAA AAAAAAA 487 AAAAACCATTTTCTT TCTGAAA-WiAAAAA AAAAA^iA- 4S7 
•.料3 AAAAACCArrrrCSTT rCTOAAAAAAAWJiiA AAAAAAA?. - - - AB 
陶 AAAAA-::CArrT'rcrn' a'n'<aPiAAAAAAAAAA A^ AAAAAAAAAAAA 乏*姆& AAAAACCATTTTGTT TTraATTA<jT<rT3T TAAGTCAAtS入GTTCT TTACCTTaCATTCIA CTTAAaGCCTAaTGT OA^CrACATAaCTCTT S40 舞AAAAACCATTTTGTT TCTOATTAGTGTTG? TAAaTCAAGAGTTCT TTACCTTGCATTCTA CTTAASaCCT.VSTGT aAACTACATAGCCTr 540 们二 AAAAACCATTTTCXTr TCTGATTA叨CTT^T TAAaXCAAT^AaTTCT TTACCTTaCATTCTA CTTAACSaCCTAnTCST aAACTA.CATAX:?CCTT S40 End o£ 3*#22 3'#16, and 3»«10 
158 
This is a blank page 
542 5&5 556 570 E71 585 5d€ €00 601 615 630 
a <ite r^raccTCATGAAQA ATacrcccATaccrr TCCTACACCCAACTC c?A3CTAT3aTCA3a CACCCAGAACCCCTG aacncrT^GCTAcrG e30 
3 •.:y^TaCCTCATGAAGA ATaCTCCCATGCCTT TCCTACACCCAAirTC CAA7.CTATarJTCAG!3 CACCCftGAACCCCTCI -.^a-JTCTTGaCTACTa 6J0 3 ' ^  i r. •lATaCCTCATG.W.y^. ？vTirCTCCCATGCCTT TCCTAi^ACrCAACTC C;iAaCTATa:;TCAG：； CACCCrtOAACCCCTC f. lO 
631 • 6-4 6 €61 675 676 69C 69i 7G5 706 720 
3 GTCCTACCCTaAAGC TTTTraTTCCTCCTC ACrXCTCGTCmXITGA TaCTCTATACATCK^A WV?LTTGT:3C3GCTTCr^  7二0 GAATAGGTTGCTTCA GTCCTACCCTOAAGC TTTTTC^TrCCTCCTC ACrCTCGTGTT'GTOA TSCr-CTATACATaG;A AAAGTGI^aGCrGG 720 
?样12 GAATAGaTTOarCA GTCCTACCCTOAAGC TTTTraTTCCTCCTC ACTCTCCTOTTaTOA Tr»Cr-CTATACATCOi. AAAOTGraOGCTTGG 720 
rn. -yf^ e 7sc -rai ，沾"•<，<: sio Vita A-;:TA(3CAA',:rCTCTCr •、！AilAAftACCd'CAC^.-JT CTAAC^TTITATCCTG A'iXSAACACrACCAAAA 808 AGTAGCAA-rCTCTC AAAGTGCCAaACCTA AtiAAACCCTCAOGT CTAAaTTTTATCCTa ATA:;AAGTr^C;':;TTAA A<:;aAACACACCAAAA 810 AaTAGCAA-;rCTCTC AAAGT3CCAGACCTA AGAAAACCCTCAGCT CTACOTTrTATCCTG ATAGAAGTaGGTTAA A3SAACACACCAAA>t 610 
an BZS 626 641 85!：> 656 a70 Sft5 68€ 900 
3 vMACCACTGCCCSAT OAACCAAtlCCTAnAC PtCGGCJSiTra^JTACTT GCTi^CACATATTCA AACTOROTTACOAGG CT^lOCACrTOCTOGC BBB •i'it'jn -^iATACXACTGCrCCHAT GAACCAAiCXT^ilSAC AACiKSAGTTACr.AvX? CT^iJaOCA^JTGCTaOC 900 3 ' f^  12 ..:法TAeCACTGCXX认T A<XK;CAm�:>�:_Ai5T:r (:KrCC;-"ACATA<JTCA CTSCaGCAOTGCnKiC 900 
901 ，15 Bie ？30 931 945 5-46 960 961 91S 97€ 9今0 3 ACCOGCCTTTAACCC CAaCACTCAGAAQGC AaOOGCAGACAtlAGC TCTTCSTaAATCTGAAG CCAOrtACTACSTrXAT GAACICAAGTCCAX；^ ？88 轻2 & ACCCJGC.CTTTAACCC CAC3CACTCAG?JSiOGC AOGGaCAGACMAGC TCTGTGAATCTGAAG CCA'^AACTAaTTtAT CAAGTCCAGCIG &90 :i ‘ itl3 ACCC.GCCTTT?Ji.CCC CACSCACTCAG?Ji.<JGC AGGaUCAGJVCrMAGC TCT^nTJAATCTGAAa CCA<'i>JlCT?vC5TTTAT G^iAGCAP^TCCA^KlKJ 990 
9fiX i005 iD06 1020 1021 10.^5 1036 lOSC- 1C5I 1Q6G lOfe lOi^G 
3 '^ e CAGCCAOAQCTCTaT TATACACiAGAAACCC TaTCTTQAAAAACAA AACAAAACAAkACAA AACCTOACrATTCrT TTCTAAAATGCTTCSG 1078 CAaCCAGAQCTCTOT TATACAOAGAAACa'； TaTlTTTGAAAAACAA AACCAAACAAAACAA AACCTOAGTATTGTT TTCTAAAATGCTTOa 1080 CAGCCACyvGICTCrGT TATACAGAGA.2JiCCC TCSTCTTa^iAAACAA AACAAAACAAAACAA AACCTGAGTATTCnT TTCTAAAATaCTTClG 2060 
lO'fii 1095 109ft xixo • Hi iliis lue II&B li&e ii7a ：^ AdTCA.GAA'rcrTTC AOATTTTaTAaTATr TGCATACACAT^SAOA TAAeTGCJariAATOG OTCCCAOAACTAAAC CACAAATtCATTTGT 1166 5 AGTCAGAATTCrTTC AaATTTTaTACJTATT TGCATACACATGAGA TAACCTGQOCiAATOCi GTCCCA-SAACTAAAC CACAAATTCATirGT 1170 3 ACTTCAOAATTCTTTC ASATTTTaTGGTATT TQCATACACATCSAGA TAACCTOGaOAATCSG OTCCCAGAACTAAAC CACAAArTCATTTGT 1170 
1171 mS 1166 1200 1201 1215 1216 1210 ICm 12-45 1246 X ‘ TTCATATGTATA<:;AC CAaGCACAACATCTT- ATGTAATACTTTvTAA AAACTGAaCATTCTa ACrCTGTCACATGACTT CCATGCTAIAATTTA. 1258 
3 TTCATATCrATftQAC： CAGGCACAACATCTT ATaTAATACTTTGAA AWvCrnA-:;CATTCT3 ACCTGTCACAlXiAGT CCATGCThTAATTTA 1260 3'#12 TTCATATSTATAOAC CAGGCACAACATCTT ATGTAATACrTTGAA AAACTSAGCATTKTG； ACCTaTCACATOACTr CCATGCTATAAITTA liSO 
1261 li7$ 1276 1290 12DI 1^05 130C 1320 1321 1335 1336 13&0 ft • 
H'Jtfi AA&MCTTSIirn-rCSA T'rTCA<»ATA<:X»<:!AT CSCITTfl-.^CrTATA'K^A axWiATCiAGAAOOTO a?i??AAAATTAAAAA�XTTTasiCTTATOTT 1；348 AAAAGCTiaCTrTCJA TTTCA«AATAC53<yi.T CSCTTrACCTATATriR. GTAAATGACakAGKrTG GATAAAAATTAAAAA CCTTTCACTTATGTT X350 3'#12 AAAAGCTTGCrTTGA TTTTAGAATAOCjaAT rj^rTTACCTATATGA GTAAATGAOAA&CSTS GATAAAAATTAAAAf. CCTTrcaCTTATSTT 1350 
IJISl 15^5 1,366 1380 ：381 13 95 13<><； 1410 1411 1425 14；6 14<0 
3,#8 RAAAAAAAAAAfAAfc fMA- - - - -
fAACAA<3T<;C:VJi.Tr TTAaTCrtSTTTA^AT •ATAOTATTAATACAT aTJfkTSTTTCAAAAA ；iAAAAAAAAAAAA" - I42J H'trl2 AAAOAA;:TGCrAATT TTAGTCTCTrTAAAT ATAGTAriAfiTACAT CTAAr^iTITCAAAAA AAA.nAAAAAAAAAAA A 1-426 End ot End of 3'#12 and 3'#25 
Figure 3.6 Alignment of nucleotide sequences of PPSIG 3，RACE subclones 
There were different forms of PPSIG 3’ RACED cDNAs. The cDNA sequence 
obtained from nine subclones (3’#2，3，#3，3，#4, 3，#5’ 3’#6，3'#10, 3，#11, 3，#16 and 
3，#22) stopped at around 100 bp downstream of the stop codon, while the cDNA 
sequences of 3，#8，3，#12 and 3'#25 showed an extension in the 3’ end. Poly(A) tails 
were found at the 3' ends of different forms of cDNAs, suggesting that the presence of 
� different forms of cDNA were due to alternative polyadenylation sites. The 
mismatched nucleotides are indicated by * and highlighted in grey. The TAG stop 
codon is bolded. The PPSIG 3，-GSPl used for 3，RACE is underlined. 
159 
60 bp further downstream. From these results, it was found that there were three 
forms of PPSIG 3’ RACE products which showed variation after the stop codon in the 
3’ untranslated region (UTR). Poly(A) tails were found at the 3’ end of the different 
forms of 3' RACED cDNAs, suggesting that the presence of 3' RACED cDNAs of 
different sizes was due to polyadenylation. 
3.1.2 Northern blot analysis of PPSIG 
To analyse the different mRNA transcripts of PPSIG, Northern blot analysis 
was performed using the � 1 9 0 0 bp DIG-labeled 5'#32 RACED cDNA as a probe. It 
was found that two transcripts o f -2000 and 3000 bp were significantly induced by 11 
months Wy-14,643 treatment in the wild-type but not in PPARa-null mice (Figure 
3.7). This differential expression pattern was similar to that observed using the PPSIG 
FDD fragment as probe. 
The presence of multiple transcripts on Northern blots, in conjunction with the 
isolation of different 3’ PPSIG RACE subclones, suggested that alternative splicing or 
alternative polyadenylation was used to generate the different transcripts. To prove 
this hypothesis, Northern blot analysis was performed using a 153 bp DIG-labeled 
PPSIG fragment in the 3,-UTR as a probe. It was shown that only the 3000 bp 












































































































































































































































































































































































































































































































































































































































































































































































































































































































matched with the 3’ RACE result that the two transcripts observed in Northern blot 
was due to variation in the 3'-UTR. 
3.1.3 Comparison of PPSIG, Riken cDNA 0610039N19 and 
all-trans-13,14- dihydroretinol saturase cDNA sequences 
The full-length cDNA of PPSIG was firstly obtained by combination of the 
cDNA from 5' and 3，RACE (Figure 3.9). There were three forms of PPSIG cDNA 
sequences of 1962, 2845 and 2898 bp. The size of cDNA of 1962 bp was in good 
agreement with the transcript of -2000 bp observed on the Northern blots, while the 
cDNA sizes of 2845 and 2898 bp agreed with the 3000 bp transcript. From the PPSIG 
RACE results, it was found that the two transcripts were identifical except that the 
larger transcript showed an extension in the 3'-UTR compared to the shorter transcript. 
Poly(A) tails were found at the 3’ end of different PPSIG transcripts, suggesting that 
these transcripts were generated by polyadenylation sites. Two in-frame start codons 
were found in the PPSIG nucleotide sequence at 27 and 1089 bp downstream of the 
TSS while the stop codon was located at 1856 bp downstream of the TSS, thus PPSIG 
revealed two ORFs of 1830 and 786 bp. 
The PPSIG full-length cDNA was compared with cDNA sequences of Riken 
CDNA0610039N19 (NM_026159) and RetSat (AY704159) (Figure 3.9). U was found 
163 
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1st otart codon 
Riken - ATQT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 64 
RetSat ATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 64 
PPSIG 1,2 & 3 GCGGTCTTCCGAGCC CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 90 
M W I T A L L L A V L L L V I L H R V Y V 
Riken GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 154 
RetSat GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 1S4 
PPSIG 1,2 & 3 GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 180 
G L Y A A S S P N P F A E D V K R P P E P L V T D K E A R K 
Riken AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 244 
RetSat AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 244 
PPSIG 1,2 & 3 AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 270 
K V L K Q A F S V S R V P E K L D A V V I G S G I G G L A S 
Riken CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACXTAAGGCGG GCGGCTGTTGTCATA CCTTTGGGGAAAATG 334 
RetSat CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACCAAGGCGG GCGGCTGTTGTCATA CCTTTGGGGAAAATG 334 
PPSIG 1,2 it 3 CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACCAAGGCGG GCGGCTGTTGTCATA CCTTTGOGGAAAATG 360 
A A V L A K A G K R V L V L E Q H T K A G G C C H T F G E N 
Riken GCCTTGAATTTGACA CTGGAATTCATTATA TTGGACGAATGCGGG AGGGCAACATTGGCC GTTTTATCTTQGACC AGATCACTGAAGGGC 424 
RetSat GCCTTGAATTTGACA CTGGAATTCATTATA TTGGACGAATGCGGG AGGGCAACATTGGCC GTTTTATCTTGGACC AGATCACTGAAGGGC 424 
PPSIG 1,2 & 3 GCCTTGAATTTGACA CTGGAATTCATTATA TTGGACGAATGCGGG AGGGCAACATTGGCC GTTTTATCTTGGACC AGATCACTGAAGGGC 450 
G L E F D T G I H Y I G R M R E G N I G R F I L D Q I T E G 
Riken AACTGGACTGGGCCC CCATGGCCTCCCCTT TTGACTTGATGATAC TAGAAGGGCCCAATG GCCGAAAGGAGTTCC CCATGTACAGTGGGA 514 
RetSat AACTGGACTGGGCCC CCATGGCCTCCCCTT TTGACTTGATGATAC TAGAAGGGCCCAATG GCCGAAAGGAGTTCC CCATGTACAGTGGGA 514 
PPSIG 1,2 & 3 AACTGGACTGGGCCC CCATGGCCTCCCCTT TTGACTTGATGATAC TAGAAGGGCCCAATG GCCGAAAGGAGTTCC CCATGTACAGTGGGA 540 
Q L D W A P M A G P F D L M I L E G P N G R K E F P M Y S G 
Riken GGAAAGAATACATCC AGGGCCTTAAGAAGA AGTTCCCCAAGGAAG AAGCTGIXTATTGACA AGTACATGGAGTTGG TTAAGGTGGTGGCCC 604 
RetSat GGAAAGAATACATCC AGGGCCTTAAGAAGA AGTTCCCCAAGGAAG AAGCTGTCATTGACA AGTACATGGAGTTGG TTAAGGTGGTGGCCC 604 
PPSIG 1,2 & 3 GGAAAGAATACATCC AGGGCCTTAAGAAGA AGTTCCCCAAGGAAG AAGCTGTCATTGACA AGTACATGGAGTTGG TTAAGGTGGTGGCCC 630 
R K E Y I Q G L K K K F P K E E A V I D K Y M E L V K V V A 
Riken GTGGAGTCTCTCATG CAGTTCTACTCAAGT TCCTCCCATTGCCCT TGACTCAC3CTCCTCA GCAAGTTTGGGCTAC TGACTCGTTTCTCTC 694 
RetSat GTGGAGTCTCTCATG CAGTTCTACTCAAGT TCCTCCCATTGCCCT TGACTCAGCTCCTCA GCAAGTTTGGGCTAC TGACTCGTTTCTCTC 694 
PPSIG 1.2 & 3 GTGGAGTCTCTCATG CAGTTCTACTCAAGT TCCTCCCATTGCCCT TGACTCAGCTCCTCA GCAAGTTTGGGCTAC TGAGTCGTTTCTCTC 720 
R G V S H A V L L K F L P L P L T Q L L S K F G L L T R F S 
Riken CATTCTGCCGAGCGT CTACGCAGAGCCTAG CTGAAGTCTTGCAGC AGCTTGGGGCTTCCC GTGAGCTCCAGGCTG TTCTCAGCTACATCT 784 
RetSat CATTCTGCCGAGCGT CTACGCAGAGCCTAG CTGAAGTCCTGCAGC AGCTTGGGGCTTCCC GTGAGCTCCAGGCTG TTCTCAGCTACATCT 784 
PPSIG 1,2 t 3 CATTCTGCCGAGCGT CTACGCAGAGCCTAG CTGAAGTCCTGCAGC AGCTTGGGGCTTCCC GTGAGCTCCAGGCTG TTCTCAGCTACATCT 810 
P F C R A S T Q e L A E V L Q Q L G A S R E L Q A V L S Y I 
Riken TCCCCACTTACC3GAG TAACTCCCAGCCACA CCGCCTrTTCCTTGC ATGCTCTGCTGGTTG ACCACTACATACAAG GGGCATATTACCCTC 874 
RetSat TCCCCACTTACOGAG TAACTCCCAGCCACA CCGCCTTTTCCTTGC ATGCTCTGCTGGTTG ACCACTACATACAAG GGGCATATTACCCTC 874 
PPSIG 1,2 & 3 TCCCCACTTACOGAG TAACTCCCAGCCACA CCGCCTTTTCCTTGC ACGCTCTGCTGGTTG ACCACTACATACAAG GGGCATATTACCCTC 900 
F P T Y G V T P E H T A F S L H A L L V D H Y I Q G A Y Y P 
Riken GAGGGGGTTCCAGTG AGATCGCCTTCCATA CCATCCCTTTGATTC AGCGGGCCGGGGGCG CTGTCCTCACCAGX3G CCACTGTACAGAGTG S64 
RetSat GAGGGGGTTCCAGTG AGATCGCCTTCCATA CCATCCCTTTGATTC AGCGGGCCGGGGGCG CTGTCCTCACCAGGG CCACTGTACAGAGTG 964 
PPSIG 1,2 & 3 GAGGGGGTTCCAGTG AGATCGCCTTCCATA CCATCCCTTTGATTC AGCGGGCCGGGGGCG CTGTCCTCACCAGGG CCACTGTACAGAGTG 990 
R G G S S E I A F H T I P L I Q R A G G A V L T R A T V Q S 
Riken TGCTGCTGGACTCAG CTGGGAGAGCGTGTG GTGTCAGTGTGAAGA AGGGACAAGAGCTGG TX3AACATCTACTGCC CAGTTGTCATCTCCA 1054 
RetSat TGCTGCTGGACTCAG CTGGGAGAGCGTGTG GTGTCAGTGTGAAGA AGGGACAAGAGCTGG TGAACATCTACTGCC CAGTTGTCATCTCCA 1054 
PPSIG 1,2 t 3 TGCTGCTGGACTCAG CTGGGAGAGCGTGTG GTGTCAGTGTGAAGA AGGGACAAGAGCTGG TGAACATCTACTGCC CAGTTGTCATCTCCA 1080 
V L L D £ A G R A C G V S V K K G Q E L V N I Y C P V V I S 
2nd 0tart codon 
Riken ATGCGGGAATGTTCA ATACCTATCAGCACT TGTTGCCAGAGACTG TCCGCCATCTGCCAG ATGTGAAGAAGCAGC TGGCX3ATGGTAAGGC 1144 
RetSat ATGCGGGAATQTTCA ATACCTATCAGCACT TGTTGCCAGAGACTG TCCGCCATCTGCCAG ATGTGAAGAAGCAGC TGGCGATGGTAAGGC 1144 
PPSIG 1,2 t 3 ATGCGGGAATGTTCA ATACCTATCAGCACT TGTTGCCAGAGACTG TCCGCCATCTGCCAG ATGTGAAGAAGCAGC TGGCGATGGTAAGGC 1170 
N A G I T F N T Y Q H L L P E T Y R H L P D V K K Q L A M V R 
Riken CTGGTCTGAGCATGC TCTCAATCTTCATCT GTCTGAAAGGCACCA AGGAGGACCTGAAGC TTCAGTCCACCAACT ACTATGTTTATTTTG 1234 
RetSat CTGGTCTGAGCATGC TCTCAATCTTCATCT GTCTGAAAGGCACCA AGGAGGACCTGAAGC TTCAGTCCACCAACT ACTATGTTTATTTTG 1234 
PPSIG 1,2 & 3 CTGGTCTGAGCATGC TCTCAATCTTCATCT GTCTGAAAGGCACCA AGGAGGACCTGAAGC TTCAGTCCACCAACT ACTATGTTTATTTTV3 1260 
P G L S M L S I F I C L K G T K E D L K L Q £ T N Y Y V Y F 
Riken ACACAGACATGGACA AAGCSATGGAGCX5CT ATGTCTCTATGCCCA AGGAAAAGGCTCCAG AACACATTCCCCTTC TCTTCATTGCCTTCC 1324 
RetSat ACACAGACATGGACA AAGCGATGGAGCGCT ATGTCTCTATGCCCA AGGAAAAGGCTCCAG AACACATTCCCCTTC TCTTCATTGCCTTCC 1324 
PPSIG 1,2 & 3 ACACAGACATGGACA AAGCGATGGAGCGCT ATGTCTCTATGCCCA AGGAAAAGGCTCCAG AACACATTCCCCTTC TCTTCATTGCCTTCC 1350 
D T D M D K A M E R Y V S M P K E K A P E H I P L L F I A F 
Riken CATCAAGCAAGGATC CAACCTGGGAGGAGC GATTCCCAGACCGAT CCACAATGACTGCGC TGGTACCCATGGCCT TTGAATGGTTCGAGG 1414 
RetSat CATCAAGCAAGGATC CAACCTGGGAGGAGC GATTCCCAGACCGAT CCACAATGACTGCGC TGGTACCCATGGCCT TTGAATGGTTCGAGG 1414 
PPSIG 1,2 & 3 CATCAAGCAAGGATC CAACCTGGGAGGAGC GATTCCCAGACCGAT CCACAATGACTGCGC TGGTACCCATGGCCT TTGAATGGTTCGAGG 1440 
P 6 £ K D P T W E E R F P D R S T M T A L V P M A F E W F E 
Riken AGTGGCAGGAGGAGC CAAAGGGCAAGCGTG GTGTTGACTATGAGA CCCTCAAAAATGCCT TCGTGGAAGCCTCTA TGTOGGTGATCATGA 1504 
RetSat AGTGGCAGGAGGAGC CAAAGGGCAAGCGTG GTGTTGACTATGAGA CCCTCAAAAATGCCT TCGTGGAAGCCTCTA TGTCGGTCATCATGA 1504 
PPSIG 1,2 & 3 AGTGGCAGGAGGAGC CAAAGGGCAAGCGTG GTGTTGACTATGAGA CCCTCAAAAATGCCT CCGTGGAAGCCTCTA TGTCGGTGATCATGA 1530 
E W O E E P K G K R G V D Y E T L K N A P V E A S M S V I M 
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Riken AACTGTTCCCACAGC TGGAOGGCAAGGTGG AGAGTGTGACTGGAG GGTCACCACTGACCA ACCAGTACTATCTGG CTGCACCCCGAGGAG 1&94 
RetSat AACTGTTCCCACAGC TGGAOGGCAAGGTGG AGAGTGTGACTGGAG GGTCACCACTGACCA ACCAGTACTATCTGG CTGCACCCCGAGGAG 1B94 
PPSIG 1,2 & 3 AACTGTTCCCACAGC TGGAOGGCAAGGTGG AGAGTGTGACTGGAG GGTCACCACTGACCA ACCAGTACTATCTGG CTGCACCCCGAGGAG 1620 
K L F P Q L E G K V E S V T G G S P L T N Q Y Y L A A P R G 
Riken CTACCTATGGAGCTG ACCATGACTTGGCTC GGCTGCATCCTCATG CAATGGCTTCCATAA GAGCCCAAACTCCCA TCCCCAACCTCTACC 1664 
RetSat CTACCTA-TOGAGCTG ACCATGACTTGGCTC GGCTGCATCCTCATG CAATGGCTTCCATAA GAGCCCAAACCCCCA TCCCCAACCTCTACC 1684 
PPSIG 1 , 2 & 3 CTACCTATGGAGCTG ACCATGACTTGGCTC GGCTGCATCCTCATG CAATGGCTTCCATAA GAGCCCAAACCCCCA TCCCCAACCTCTACC 1710 
A T Y G A D H D L A R L H P H A M A E I R A Q T P I P N L Y 
Riken TGACAGGCCAAGATA TCTTCACCTGTGGGC TGATGGGGGCCCTGC AGGGGGCCTTGCTGT GCAGCAGTGCTATCC TGAAACGGAACTTGT 1774 
RetSat TGACAGGCCAAGATA TCTTCACCTGTGGGC TGATGGGGGCCCTGC AGGGGGCCTTGCTGT GCAGCAGTGOCATCC TGAAACGGAACTTGT 1774 
PPSIG 1 . 2 & 3 TGACAGGCCAAGATA TCTTCACCTGTGGGC TGATGGGGGCCCTGC AGGGGGCCTTGCTGT GCAGCAGTGCCATCC TGAAACGGAACTTGT 1800 
L T G Q D I F T C G L M G A L Q G A L L C S S A I L K R N L 
Stop codon 
Riken ACTCAGATCTGCAGG CTCTTGGCTCAAAGG TCAAGGCACAAAAGA AGAAGATGTACTCCG TTCAGAGAAGAGCCA GA - 1851 
RetSat ACTCAGATCTGCAGG CTCTTGGCTCAAAGG TCAAGGCACAAAAGA AQAAGATGTAgTCCG TTCAGAGAAGAGCCA GA 1951 
PPSIG 1 , 2 & 3 ACTCAGATCTGCAGG CTCTTGGCTCAAAGG TCAAGGCACAAAAGA AGAAGATGTACTCCG TTCAGAGAAGAGCCA GAGGAAAGGCACCTC 1890 
Y S D L 0 A L G S K V K A Q K K K M 
PPSIG transcript 1 •nd*d at this 
PPSIG 1 CCCAACTTCTCGTGG TGTCCTCCCTCCTAC AGCAATTCCTTGCAC ATATTAACAAAAACC 1962 
PPSIG 2 & 3 CCCAACTTCTCGTGG TGTCCTCCCTCCTAC AGCAATTCCTTGCAC ATATW^ACAAAAACC ATTTTCTTTCTOATT I I^L^SFSS^^GTCA 1980 
PPSIG 2 Sl 3 AGAGTTCTTTACCTT GCATTCTACTTAAGG CCTAGTGTGAACTAC ATAGCCTTGATGCCT CATGAAGAATGCTCC CATGCCTTTCCTACA 2070 
PPSIG 2 Sc 3 CCCAACTCCAAGCTA TGGTCAGGCACCCAG AACCCCTGGGGTGTT GGCTACTGGAATAGG TTGGITCAGTCCTAC CCTGAAGCTTTTTGT 2 1 6 0 
PPSIG 2 & 3 TCCTCCTCACTCTCG TGTTGTGATGCTCTA TACATGGAAAAGTGT GGGCTTGGAGTAGCA ACTCTCTCAAAGTGC CAGACCTAAGAAAAC 22B0 
PPSIG 2 & 3 CCTCAC3GTCTAAGTT TTATCCTGATAGAAG TGGGTTAAAGGAACA CACCAAAAGATACCA CTGCCGATGAACCAA GCCTAGACACC3GCAT 2 3 4 0 
PPSIG 2 & 3 TTGTAGTTGCTGGCA CATAGTCAAACTGAG TTACGAGGCTGGGCA GTGCTGGCACCGGCC TTTAACCCCAGCACT CAGAAOGCAGQGGCA 2430 
PPSIG 2 fit 3 GACAGAGCTCTGTGA ATCTGAAGCCAGAAC TAGTTTATGAAGCAA GTCCAGGGCAGCCAG AGCTCTGTTATACAG AGAAACCCTGTCTTG 2520 
PPSIG 2 Sl 3 AAAAACAAAACAAAA CAAAACAAAACCTGA GTATTGTTTTCTAAA ATGCTTGGAGTCAGA ATTCITTCAGATTTT GTCGTATTTGCATAC 2 6 1 0 
PPSIG 2 St 3 ACATGAGATAACCTG GGGAATGGGTCCCAG AACTAAACCACAAAT TCATTTGTTTCATAT GTATAGACCAGGCAC AACATCTTATGTAAT 2 7 0 0 
PPSIG 2 & 3 ACTTTGAAAAACTGA GCATTCTGACCTGTC ACATGAGTCCATGCT ATAATTTAAAAAGCT TGCTTTGATTTTAGA ATAGGGATGCTTTAC 2 7 9 0 
PPSIG transcript 2 •nd*d at this 
PPSIG 2 CTATATGAGTAAATG AGAAGGTGGATAAAA ATTAAAAACCTTTCA CTTATGTTAAAAAAA AAAAAAAAAAAAA- 284 5 
PPSIG 3 CTATATGAGTAAATG AGAAOGTGGATAAAA ATTAAAAACCTTTCA CTTATGTTAAAL5I5IR�65FXSF??FR6于CT GTTTAAATATAGTAT 2 8 8 0 
PPSIG trcmscript 3 ended at thlo �C' 
PPSIG 3 TAATACATGTAATGT TTCAAAAAFIAAAAAA AAAAAAAAA 2898 
Figure 3.9 Alignment of full-length cDNA sequence of PPSIG, Riken cDNA 
0610039N19 and RetSat 
There were three forms of PPSIG cDNA sequences of 1962 (PPSIG 1)，2845 (PPSIG 
2) and 2898 bp (PPSIG 3). The stop position of these three forms of PPSIG transcript 
is bolded, which was followed by a poly (A) tail. The comparison of PPSIG with 
Riken cDNA 0610039N19 and RetSat showed that they were identical, except PPSIG 
cDNA showed an extension in both the 5’ and 3’ UTR. The start (ATG) and stop 
� (TAG) codons of the three cDNA sequences are bolded and underlined. Both Riken 
cDNA 0610039N19 and RetSat identified the 1830 bp ORF using the ATG at 27 bp 
and TAG at 1856 bp downstream of the TSS. There was another in-frame ATG start 
codon at 1089 bp downstream of the TSS and no stop codon was found in between the 
two start codons, which revealed another 768 bp ORF using this start codon and the 
same stop codon. 
� 
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that the cDNA sequences of Riken cDNA 0610039N19 and RetSat were exactly the 
same and showed high similarity to PPSIG, indicating both PPSIG, Riken cDNA 
0610039N19 and RetSat were all referring to the same gene. These three cDNA 
sequences were identical from the 广 start codon to the stop codon, showing that their 
translation products were the same. Besides, the cDNA sequence of PPSIG showed an 
extension in both 5' and 3' ends when compared to the other two cDNA sequences, 
suggesting that the cDNA sequences of Riken cDNA 0610039N19 and RetSat were 
only partial of this gene, while the cDNA sequence obtained in PPSIG RACE was 
more likely the full-length of this gene. 
3.2 PPSIG genomic sequence analysis 
3.2.1 Screening of the PPSIG BAC clone 
To obtain the PPSIG genomic BAC clone, a female mouse spleen genomic 
DNA (129S6/SvEvTac) BAC library was screened by a probe prepared from the 
PPSIG 5' RACED cDNA (5,#32�by hybridization screening (Invitrogen corporation, 
Carlsbad, CA). Three PPSIG BAC clones glycerol stocks (31 D 21, 425 O 5 and 458 
C 12) were obtained from the hybridization screening and sent to our laboratory. To 
confirm that the three BAC clones contained PPSIG gene, BAC DNA were extracted 
from five subclones of each BAC clone and screened by genomic Southern blot 
166 
analysis using a DIG-labeled cDNA probe prepared from PPSIG 5' RACED subclone 
(5,#32). It was found that, except BAC clone 458 C 12 subclone #9 (458 C 12 # 9), 
all subclones showed a positive signal of similar sizes, indicating that the three BAC 
clones contained PPSIG gene (Figure 3.1 OA). One subclone from each genomic BAC 
clone including 31 D 21 #2, 425 O 5 #2 and 458 C 12 #3 were chosen for further 
screening with EcoK I digestion. To compare the PPSIG genomic fragments carried in 
the three BAC subclones 31 D 21 #2, 425 O 5 #2 and 458 C 12 #3, EcoK I digestion 
and Southern blot analysis were performed. As shown in Figure 3.1 OB, three identical 
bands were found in all the three BAC subclones, suggesting that these three 
subclones carried similar PPSIG genomic sequence. BAC subclone 458 C 12 # 3 was 
chosen randomly for determination of PPSIG genonimc sequence. 
3.2.2 Cloning of PPSIG genomic fragments 
To clone the PPSIG genomic fragments, firstly, PCR was performed to amplify 
PPSIG genomic fragments by eleven pairs of primers designed. The experimental 
sizes of PCR products were compared with the expected sizes based on the genomic 
sequence of Riken cDNA 0610039N19 (Figure 3.11). As shown in Figure 3.11, all of 
the PCR products showed expected sizes, indicating that all the PPSIG genomic �‘ 









































































































































































































































































































































































































































































































































































































































































































































































fragments were then subcloned in pCR®II-TOPO® vector by TA cloning. For each 
fragment, three to five recombinants subclones were screened by PCR screening. In 
the PCR screening, the subclones were screened by their respective PCR primers 
which were used to generate that PPSIG genomic fragment. It was found that all of 
the PPSIG genomic sub fragments were amplified with the expected sizes from their 
respective recombinants (Figures 3.12 and 3.13), indicating that they were 
successfully subcloned in the pCR®II-TOPO® vector. One subclone from each PPSIG 
genomic sub fragment (circled in Figure 3.12) was chosen for genomic organization 
analysis. 
3.2.3 Examination of PPSIG genomic organization 
The sequences of the eleven PPSIG genomic subfragments were aligned and 
combined to obtain the full-length genomic sequence of PPSIG (Appendix C). It was 
shown that the PPSIG genomic sequence consisted of 11 exons and 10 introns 
spanning 9825 bp (Figure 3.14). The introns contained the perfect consensus 3’ splice 
acceptor site (ag) and 5' splice donor site (gt) as indicated in the figure. There were 
two in-frame ATG start codons. The first start codon (ATG) was located in exon 1 and 
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Figure 3.14 Alignment of PPSIG cDNA and genomic sequence 
The PPSIG gneomic sequence was aligned with its cDNA sequence to identify the 
exonic (uppercase letter and highlighted in yellow) and intronic (lowercase letter) 
sequences. PPSIG genomic sequence consisted of 11 exons and 10 introns spanning 
9825 bp. The introns contained the perfect consensus 5' splice donar site (gt) as 
indicated by the red font and 3’ splice acceptor site (ag) as indicated by blue font. Two 
start codons (ATG) were found in exon 1 and exon 11，while a stop codon (TAG) was 
observed in exon 11. 
173 
Exon 1 lat start codon 
PPSIG-cDNA GCGGTCITCCGAGCC CTGGCAGCAACATOT GGATCACTGCTCTGC TGCTCGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTAOGTQG 90 
PPSIG-genomic gcggtcttccgagcc ctggcagcaacATOT GGATCACTGCTCTGC TGCTGGCOGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTA0E3TGG 90 
PPSIG-cDNA GCCTTTACGCTCCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGOCTGAAC CCCTGGTGACOGACA AGGAQGCTAGGAAGA 180 
PPSIG-genoraic GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAQGATGTCA AQOGACOGCCTQAAC CCCTGGTGACCGACA AOGAGOCTAQQAAOA 180 
PPSIG-cDNA AAGTTCTCAAACAAO - - - 19& 
PPSIG-genoraic AAGTTCTCAAACAAG gtcaactgatgggtc tcaggcctgctctcg ggccttctgctcatg tctccccattagtaa agtgctgggaaaact 270 
PPSIG-cDNA 195 
PPSIG-genoraic tctcttgcacacaga ggttccataatttag tgttctttgcttctg aaagggtgcaggcat tacccttggcacgcc aaattccagccccgc 360 
PPSIG-cDNA - 195 
PPSIG-genoraic cagttggaatctttt cagctcacggcttac acagaataagagacc tttcccctacttggg tctggagccaacttt tccctatacttctgt 450 
PPSIG-cDNA - 19& 
PPSIG-genoraic gcatgctcgggggca cagggaagcagcact gaaagttttcctaac aagcgggttgcaggc aaaatgtagtccagt tcatagaactgaagc 540 
PPSIG-cDNA - 195 
PPSIG-genoraic ttgataataacttcg gaatttcagtactgg ctagggataagaact ccactctccagtgaa ccatctctaaagcac gtgtagagtgctccc 630 
PPSIG-cDNA 195 
PPSIG-genomic aaggtttgtgccttt gagactggtctcact 11tgtactggagttg gctttgaactctctt cgcagcccaggctca aacccggagcagccc 720 
PPSIG-cDNA 195 
PPSIG-genoraic tcttcttctgtcccc agcatgatgagatag attacaagcatgcac cagcatgtctgcctt tcaacgttttacgga agtgtcggagctggg 810 
PPSIG-cDNA - 195 
PPSIG-genomic catagtggtgcaaca atttaaCtccagttt ggactacacaatgag accctgtctaaatgc acacatcaaacccca aaacaaccaaaaccc 900 
PPSIG-cDNA - - 195 
PPSIG-genoraic ccaaatgcaaaactt tcaaaaaacaaacaa ggatcacctctttga cctccaggagcctct gacttgtaaatttta gccaagcctaggcta 990 
PPSIG-cDNA - 195 
PPSIG-genoraic gccttaactgcacta tttttCggggactga ctttgaactcctgat ccttgtgcctctact tcctaagaggcacca cacccagttatttta 1080 
PPSIG-cDNA : 195 
PPSIG-genoraic ttattgttattgttt gtggaCtgggggaga ggcaggtctcatact tgtagcccaggctag cttataacttgctat acaggacaagtgtgt 1170 
PPSIG-cDNA - - 19S 
PPSIG-genomic ctcaaattcacagtg attctccaaccacca tcagcaagagattac aaatggtgggatCac agatgtgagccacca tggcttggatggaga 1260 
PPSIG-cDNA - 19& 
PPSIG-genoraic ttttttttttacttt attttttttagtttt tagttgtttgagaca gtgtttctctctata gttctagatgtcctg gaacttgctattgct 1350 
PPSIG-cDNA - 195 
PPSIG-genomic atatagaccaggctg gccttgaactcactg agatcctcccacctc agcctcctgagtgct gagactaaagctgtg aacacttggccttgg 1440 
PPSIG-cDNA - - 195 
PPSIG-genoraic gcaatgatgtttaat gagcagatttactgg acatagtggcacatt cctgtgatcccagcg ctggggaggaaaaga caggtggatctctac 1530 
PPSIG-cDNA 195 
PPSIG-genoraic atagggagttccagc ccagttagggctaca tgtgtagtgaaaceg tgcgtcttaaaaaac acgaatcaataaaat caaagaaagtaagta 1620 
PPSIG-cDNA - 195 
PPSIG-genoraic aataaaggaggaaag gaagtaaaagactgg gagaaaacaacaaat cccaggtcttgtgtt gaccgtgcattccag tttggctctgtgagg 1710 
PPSIG-cDNA 195 
PPSIG-genoraic ttcccggcacaccaa ccttcctccttttct gaggctggtgctgtg acctctcagagtagc agcctctgagcagct ctgcctgctccacct 1800 
PPSIG-cDNA - 195 
PPSIG-genomic ccgttggcacccaga gaccttgctCcttcc aaagaaacccagttc cctgaaccaccagcg tccccagcccccacc ctgagccttattgcc 1890 
PPSIG-cDNA - 195 
PPSIG-genomic ttttctttccCcgct tgcattcacagaact gacgttacagccctg tgcagttgccatctt tctggttttgtccta cagtagctagctgag 1980 
PPSIG-cDNA - 195 
PPSIG-genomic tcagtcctactCcct ttgaaaggtatcaaa tccctcaagcacact gtaggggttaagact catcactgcttaacc tgcctgtctggtccg 2070 
PPSIG-cDNA 195 
PPSIG-genomic aggtattccctggta gaatgttttgagaca tcttagtcaagagta aataaactaccttaa aagaaaggtctgccc tccctcttgttttga 2160 
PPSIG-cDNA - 195 
PPSIG-genoraic gactgggtctaacga gcccaggctggcctc ctgtgggatgatctt ggcctcctaatgcac ctttcaagtgctccc atcacaggagtacac 2250 
PPSIG-cDNA - - - - 195 
PPSIG-genomic caccatgcccagcag ccgtagagacttctt accgagtacacgtta gagaaggaccccggc ttctttgacttgact ttcctgccctcgtct 2340 
Bxon 2 
PPSIG-cDNA CTTTCTCAGTCAGC CGAOTACCAGAGAAG CTGGATGCAGTQGTG ATCOQCAGCOGCaTT 2&4 
PPSIG-genoraic gagaagctcaccctt ctcctcccttctaca gCTTTCTCAGTCAOC CQAOTACCAGAQAAQ CTOGATGCAGTGGTO AIXXSGCAGCOOCATT 2430 
PPSIG-cDNA GGGGGACTGGCCTCA GCTGCGGTTCTAGCT AAAGCTGGCAAGAGA GTCCTTGTGCTQGAA CAACATACCAAGOCG QOCGGCTGTTGTCAT 344 
PPSIG-genomic GGGGGACTGGCCTCA GCTGCGGTTCTAGCT AAAGCTGGCAAGAGA GTCCTTGTGCTQGAA CAACATAOCAAGOCO 0<XX5GCTGTTGTCAT 2520 
PPSIG-cDNA ACCTTTGGGGAAAAT GGCCTTOAATTTGAC ACTG 379 
� PPSIG-genoraic ACCTTTGGGGAAAAT GGCCTTQAATITGAC ACTGytaaggcttgc gtgggaaagggttag gagcatggccttgtc tttagatggctaata 2610 
PPSIG-cDNA ——， 379 
PPSIG-genomic acacacactattgag tgacacgggggcact ttaatgtttggaggt ctcaacttctctctg ggcacctccatttct gtccgacggoctagt 2700 
PPSIG-cDNA - 379 
PPSIG-genoraic tactgggcaagcatt gggtggtatatgttc tgatttgtttcttat agaaagggtgggcag cccccctctggacat gaacatagccaagca 2790 
Bxon ) 
PPSIG-cDNA - - ---GAATTC 3 84 
PPSIG-genomic ggacaacctcttcct tacttggcatatCtc cagggcccaatccct tttatctccatatct cctttcctttgcacc tcccaac«gQAATTC 2BB0 
PPSIG-cDNA ATTATATTQQACX3AA TQCOGOAGGQCAACA TTC300CGTTTTATCT TOGACCAGATCACTQ AAGOOCMCTOQACT OOQCCCCCATOOCCT 474 
PPSIG-genoraic MTATATrGGACGAA TGCGGGAGGGCAACA TTgGOCGTTTTATCT TOGACCAfiXTCACTG AAGGOCAACTGGXCT GQGCCCCCATGQCCT 2970 
PPSIG-cDNA CCCCrnTaACrraA TCUTACTACaAGGGC CCAATOGCCQAAAGO AOTTCCCCATGTACA QTGGQAOGAAAGMT ACATCCAGOOCCTTA 564 
PPSIG-genoraic CCCCTTTTGACTTOA TOATACTAOAAGGGC CCAATQGCCQAAAOQ AQTTCCCCATGTACA GTGOGAGGAAAGAAT AGATCCAGOGCCTTA 3060 
PPSIG-cDNA AGAAGAAGTTCCCCA AGGAAGAAGCTGTCA TTGACAAGTACATGG AGTTGGTTAAG- 622 
PPSIG-genomic AGAAGAAGTTCOCCA AGGAAGAAGCTGTCA TTGACAAGTACATGG AGTTGGTTAAGgtag catgcaccatgatta gcatccctagtttat 3150 
<i 
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PPSIG-cDNA - 622 
PPSIG-genomic ttccaacaagactgg ccttttcattagtga agaaactggtggggt aggaggagagggctg agttgggaggcagga aggaatggtcatgtc 3240 
PPSIG-cDNA 622 
PPSIG-genomic tgtcctggttccagt gtaagcttgtgtttg cctgtgccctgcttg gctccccagctgcag tcctcacactggcct ctagatggcaccctt 3330 
PPSIG-cDNA 622 
PPSIG-genomic gctaagtcaggcttt gaggaagctagacgt cctctgagatatgcc agacttttgtgtatt tgaggtagagtctca caatgctgccctggc 3420 
PPSIG-cDNA - 622 
PPSIG-genomic tggtctggaactcag cagagatccacctgc ctctgccgagcatat gaaatcataacctgc tttctggaccaggat gtttggaaggaatct 3510 
PPSIG-cDNA 622 
PPSIG-genomic gaatgctggggatgt ggctcaggcttagca catacaactctgaat tatatcccaagcacc ttagcatctggatat gatggtgtagcctgt 3600 
PPSIG-cDNA 622 
PPSIG-genomic aatcccagcattggg gaggcagaagcagga agctcaggagttcaa ggtcactggaatatt tggaactctctatat aaaagaaaaacaata 3690 
PPSIG-cDNA - 622 
PPSIG-genomic ctttttggagcatga aatggaagagcaaat agtcccatttgagtg cgaagaatgagaaaa actcaggacccattt tgttgttgttttgtg 3780 
PPSIG-cDNA 622 
PPSIG-genomic gtgaggaagacagct ctactacatagtcct ggcttctatgtcagt gtatagctctggttg cccttaaactcatgg caatcctcctgctgt 3870 
PPSIG-cDNA 622 
PPSIG-genomic agcatctcaactgtt gggatcacaggcctg agtctgatcacacac accatgcctaaaaaa aatttccaagtccaa aa a c t c tg agta agt 3960 
PPSIG-cDNA - 622 
PPSIG-genomic gttgctgggctggca gtcagcgctgactgc cgcagcagtaactag gctccagcaccccag agctgagactcactt taccttttttatccc 4050 
Exon 4 
PPSIG-cDNA --GTOGTOGCrCGTO OAGTCTCTCATGCAG TTCTACTCAAGTTCC TCCCATTGCCCTTQA CTCAGCTCCTCAOCA AQTrTQQGCrACTOA 708 
PPSIG-genomic agGTGGTGGCCCGTG OAGTCTCTCATGCAG TCCTACTCAAGTTCC TCCCATTGCCCTTGA CTCAGCTCCTCAQCA AGTTTGGGCTACTGA 4140 
PPSIG-cDNA GTOGTTTCTCTCCAT TCTGCCGAGCGTCTA CGCAGAGCCTJUSCTG AAGTCCTGCAGCAGC TTQGQGCTTCOCGTG AGCTCCAGGCrOTTC 798 
PPSIG-genomic CTCX3TTTCTCTCCAT TCTGCCGAOCGTCTA COCAOAGOCTAGCTG AAGTCCTGCAGCAGC rrOGOGCTTCOCOTG AGCTOCAGOCTCnTC 4230 
PPSIG-cDNA TCAGCTACATCTTCC CCACTTACQ- 823 
PPSIG-genomic TCAGCTACATCTTCC CCACTTACOgtgggt ggctatagcccaggc tcttctaggctactg ctctcccagccttgg tctttcttccccatc 4320 
PPSIG-cDNA 823 
PPSIG-genomic tgcctaactgagaca ggctagaatagcccc aggcctgcaggagtt tgtggatcagggctg agaagtctgaccca't gttggactctggcaa 4410 
PPSIG-cDNA - 823 
PPSIG-genomic aaatgatttattatt tactttatggaacgt tatcttttgttcttc tctcttgtatctttt cttcttcttctgttt tgttttctcttcctt 4500 
PPSIG-cDNA 823 
PPSIG-genomic tttgaagacaaggtc ttccaggcaagcttt gaacCcCtgCagttg aggatgtcctteiaat tccttatccttctgc ctctaccttcctagt 4S90 
PPSIG-cDNA 823 
PPSIG-genomic gctaggtatgtgcca ccatgtctggggtat gtggtgctggagatc aaatccaggctttca tgcatgttaggaAga catccagctgagccc 4660 
PPSIG-cDNA 823 
PPSIG-genomic acccaagtgcatttt ctccctgtcccctac acctccaggaaaagt tctgactttgctcag gccggtctagatctc tccgtagcctagtat 4770 
PPSIG-cDNA 823 
PPSIG-genomic ggctttgaatcaatg atccttctggtgtag c111tgagtgtgaga ttataggcacgcaca ctgctcaaggttgat ttttctctttagcca 4660 
PPSIG-cDNA 823 
PPSIG-genomic acagtgtcagtgact tctttggtcttggaa gcataatggttttat attccaccaagctca ttacctaccccgggc ctctgggagcattct 4950 
PPSIG-cDNA 823 
PPSIG-genomic catcctaggatggac tcttgtggtccctca caggaagccctattt cttcctgaatggtgc caaatgaccactatg ctcatcttctttcct 5040 
Bxon S 
PPSIG-cDNA -OAOT AACTCCCAQCCACAC COOCTTTTCCTTGCA OESCTCTGCTGOTTGA CCACTACATACAAGG GGCXTATTACCCTOG 901 
PPSIG-genomic tCAtcctgtagOAGT AACTCCCAQCCACAC COOCTTTTCCTTOCA TGCTCTOCTOGTTGA CCACTACATACAAOQ OGCATATTACCCTOO 5130 
PPSIG-cDNA AOOGQQTTCCAOTGA QATCGCCTTCCATAC CATCCCTTTOATTCA OCGQGCOOC9000CGC TOTCCTCACCAOOGC CACTOTACAGAQTOT 991 
PPSIG-genomic AGOOaGTTCCAGTOA OATCOCCTTCCATAC CATCCCTTTGATTCA QCQQQCOGQQQQCGC TGTCCTCACCAGOGC CACTQTACAGAGTQT 5220 
PPSIG-cDNA QCTGCTOOACTCAOC TOOGAOAOCQTGTG - 1022 
PPSIG-genomic GCTGCTGGiACTCAGC TGGGAGAGCGTQTGg taagagaCctgtact gggctgtggggtcag tgggctggggtggaa gccagcctgtttatg &310 
PPSIG-cDNA 1022 
PPSIG-genomic cacggtaagaggctg gcgtctgagccggtg agatagctcagtgga taaatggtctagtca ctcactaaacctgat gatccccacagccta 5400 
PPSIG-cDNA 1022 
PPSIG-genomic catggtggaaggaga gaactnctggacaag ttgtcactactgacc tccacacatgggctg tagcactcctacccc caccccccccacaca 5490 
PPSIG-cDNA 1022 
PPSIG-genomic cacacacaatgaagg aatcaaactacaatt cttacaaaaggtcag gtctgacataatggt tttgtgagtggccag agatgaggttggaca 5580 
PPSIG-cDNA 1022 
PPSIG-genomic cacaggc11cagtac atcacagaagccttg gtgtttcatgaaggt tgagtcatctgggga gtactgtagatgtgg aatttggcagcaggg 5670 
PPSIG-cDNA - 1022 
PPSIG-genomic aaggaggggc tggg a ctccatagagccagt gttcttgggacggca gggcgCggctaaggt aagcccatatgggtg ggtaagaagagcCag 5760 
PPSIG-cDNA 1022 
PPSIG-genomic agagggcaagcacag aagcatttgaggcaa gggctaagtgacttt gcagtgtgcctggga cctgctttggctgga ggaacttctaggtct 6850 
PPSIG-cDNA 1022 
PPSIG-genomic gagaaaacagggcct accctaggagacatc tggatagtgtggcta tagacagaactaata ttttgaggcaggatt tcatgtgtttCAggc 5940 
PPSIG-cDNA 1022 
� PPSIG-genomic tatcctcaaactcac tagctagctgaggct gaccttcgaattcct gattatatggcgtct acctcctacatgcta ggattgcaggaacat 6030 
PPSIG-cDNA - 1022 
PPSIG-genomic gtcatcatgctgcga ctacagcCaatgctt tgagagaaatgtatt tcacactttcctggg ttgtgtttgt11tat ggcgggtatggg^'tg 6120 
PPSIG-cDNA 1022 
PPSIG-genomic cacggaacctagggc ttcatacatgttaga caagcgctttccacc tgagctgtattccta gcccttaagagggat ctagagaatggtata 6210 
Sxon ( 
PPSIG-cDNA GTG TCAGTGTGAAGAAGQ GACAAGAGCTGGTGA 1053 
PPSIG-genomic ggtcttttttgtttc cacagagctcataga agctcagccanattc ttgtgcctgcagGTO TCAGTGTQAAGAAGG QACAAGAGCTGGTQA 6300 
2nd start codon 
PPSIG-cDNA ACATCTACTGCCCAG TTGTCATCTCCAATG CGGGAATOTTCAATA CCTATCAGCACTTGT TGCCAGAGACTGTCC GCCATCTGCCAG- - - 1140 
PPSIG-genomic ACATCTACTGCCCAG TTGTCATCTCCAATG CGGGAJlTOrrCAATA CCTATCAGCACTTGT TGCCAGAGACTGTCC GCCATCTOCCAGgta 6390 
PPSIG-cDNA - 1140 
PPSIG-genomic aaagactgatctttt gaactaatatttcat ctgtgaagcttacat gcccagccgggtggg ctcccctctccttgg gcagtccgctagctg 6480 
PPSIG-cDNA 1140 
PPSIG-genomic tctctctctagtctg tgctaccaggaacat agcatttatatttgg ggaatctaggactac aggggaagaggagcc cttcacagaggcagt 6B70 
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PPSIG-cDNA - - 1140 
PPSIG-genomic ggcagagctctgagg actctgttttgtcag atgcaaatgtctatc ttgtacttccgggct gaaaaacacaaccct gtatatttgctttcc 6660 
PPSIG-cDNA - 1140 
PPSIG-genomic tttgccagagaaacc agggctttaatagaa aagactcagttaaat ggcagacaagagcta gggatgaagttcagt tggttagagtgtttg 6750 
PPSIG-cDNA 1140 
PPSIG-genomic catcagccctgggtt tacctagagccaggt aagacaactagagtg gatttggctgtaatc ctagcactcaagagg tgttggcgggaagat 6840 
PPSIG-cDNA - - 1140 
PPSIG-genomic aagaaattcaaggtc accgttggctacaca agaccctgcctcaac aaacaaaggccactg agacggttcagagtg taaagtctttgctgc 6930 
PPSIG-cDNA 1140 
PPSIG-genomic taaatccccagagtg gaagaagatagttgt cttctggcttcCtgc acatctagacagacc tttatccatatacat ctataattaacgaaa 7020 
PPSIG-cDNA 1140 
PPSIG-genomic catctaaatgtataa agaggagggttggaa cagcctgattgtcca gaggtgctgtgagtt agctctgctctgaat cagcaggaagccagc 7110 
PPSIG-cDNA 1140 
PPSIG-genomic acctatgactaaggg gacatggggcagagg tggtagagttggaag gaatctgaggctaca tctcacatagccagg acgagacttaag*gc 7200 
PPSIG-cDNA - - - 1140 
PPfilG-genomic aggtctctgccagga tcctatagaaatagt tataaaaccggccag gtctctgtcccagct ggcagctgaggatcg agctacagatcagaa 7290 Kxon 7 
PPSIG-cDNA ATGTCAA 1147 
PPSIG-genomic aagggaacatcctga ggctatcctgacagg ggtggctgtctggct gtaactcctgcacag caatcctcactggct ctccgcagATQTQAA 7380 
PPSIG-cDNA QAAGCAOCTGGCGAT GOTAAGGCCrGGTCT GAQCATGCTCTCAAT CTTCATCTGTCTGAA AGOCACCAAQGAOGA CCTGAAGCTTCAGTC 1237 
PPSIG-genomic GAAGCAGCTGGCGAT GGTAAGGCCTGGTCT GAGCATCCTCTCAAT CTTCATCTGTCTGAA AGGCACCAAGGAOGA CCTGAAGCITCAGTC 7470 
PPSIG-cDNA CACCAACTACTATGT TTAXTTTGACACAGA CATGGACAAAGC 1280 
PPSIG-genomic CACGNACTACTATGT TTATTTTGACACAGA CATGGACaAAGCgta agatgtgaggggtgg ggaagactgatagtg ttgggcctcatccca 7560 
PPSIG-cDNA 1280 
PPSIG-genomic caaggtccCgcttcc accctccacacggtt ctaggaatgagaagg atgtgttttgaggga ggaggtgcagtctct aatggactcctagaa 7650 
PPSIG-cDNA 1290 
PPSIG-genomic aggctttctacacca aagccgtgctgtttt ctcccttgtgggaag Cccctggagatgagc ctttgtttgggtagt gctggtggctttgag 7740 
Exon 8 
PPSIG-cDNA -GATGGAGCGCTATG TCTCTATGCCCAAGG AAAAGGCTCCAGAAC 1323 
PPSIG-genomic gaagaggcctaaaga ttggcagtcacgccc cctccctcatccaca gQATGGAQCGCTATG TCTCTATGCCCAAOG AAAftGGCTCCAGAAC 7830 
PPSIG-cDNA ACATTCCCCrTCTCT TCATTGCCTTCCCAT CAAGCAAGGATCCAA CCTGGGAGGAGCGAT TCCCAQ 1389 
PPSIG-genomic ACATTCCCCTTCTCT TCATTGCCTTCCCAT CAAGCAAGGATCCAA CCTOGGAGGAGCGAT TCCCAGgtagggctt gaagtccagggaagt 7920 
Exon 9 
PPSIG-cDNA - - ACCGAT CCACAATGACTGCGC TOGTACCCATGGCCT 1425 
PPSIG-genomic tgggtgtagggcaag gcagggccaaatagc aataacatggcctta tacccacagACCGAT CCACAATGACTGCGC TOCTACCCATGGCCT 8010 
PPSIG-cDNA TTGAATQOTTCGAGQ AGTOOCAGQAGQAGC CAAAOGOCAAQCGTQ GTOTTOACTATGAOA CXXTTCAAAAATGCCT COGTOQAAOOCTCTA 1515 
PPSIG-genomic TTGAATGOITCGAGG AGTOGCAGGAGGAGC CAAAGQGCAAGCGTG GTGTTQACTATGAGA OCCTCAAAAATGCCT TCGTGGAAGOCTCTA 8100 
PPSIG-cDNA TGTOGGTQATCATGA AACTGTTCCCACAGC TGGAOGGCAAG 1558 
PPSIG-genomic TOTOGOTGATCATGA AACTGTTCOCACAOC T0QAQC3GCAA6gtag gggctgacatacagt gctggaggcg«caat gcatcccttaactgt 8190 
Bxon 10 
PPSIG-cDNA -GTGOA 1561 
PPSIG-genomic cttcttccatacagg gacaaagcctgcggt aacaagagtcccaca gtcccttgttcaccc Ctgccttgccctttt gtttcctcAgOTGOA 8280 
PPSIG-cDNA GAGTGTGACTOGAGO GTCACCACTGACCftA CCAGTACTATCTGQC TQCACCCCGAGGAOC TACCTATOGAOCTGA CCATCSACTTOGCTOG 1651 
PPSIG-genomic QAGTOTGACTOGAOO GTCACCACTOACCAA CCAOTACTATCTOOC TOCACCCCGAGQAOC TACCTATOCSAGCTGA CCATOACTTOGCTOQ 8370 
PPSIG-cDNA GCTGCATCCTCATGC AATGGCTTCCATAAG AGOCCAAACCCCCAT CCCCAACCTCTACCT GACAG 1717 
PPSIG-genomic GCTGCATCCTCATGC AATOOCITOCATAAG AGOCCAAACCCCCAT CCCCAACCTCTACCT GACAOgtacactgcc tcactttgccagaat 8460 
PPSIG-cDNA 1717 
PPSIG-genomic ctggacttccctggc atagtcttctgttct cgtcctcaagcctac accaggagctgggct gccttggctattgtc ctgggttctatctga 8550 
PPSIG-cDNA - 1717 
PPSIG-genomic ggctgtctctctttg ggtggccttgatatg gagggatgaacacaa gaacccttgttaccc ccatcttcatgggtc actgcttttgctttc 8640 
Bxon 11 
PPSIG-cDNA ---GCCAAGATATCr TCACCTGTGGGCTGA TGGGQQCOCTQCAQG QOGCCnTGCTGTOCA GCAOTGCCATCCTGA AACOQAACTTOTACT 1603 
PPSIG-genomic tagGCCAAQATATCT TCAOCTGTOGOCTGA TGGGQGCCCTOCAQG GGQCCTTGCTGTQCA GCAGTGCCATCCTQA AAOGGAACTTGTACr 8730 
Stop codon 
PPeiG-cDNA CAGATCTGCAGGCTC TTGGCTCAAAC3GTCA AGGCACAAAAGAAGA. AGATGTAOTCCGTTC AGAGAAGAGCCAGAG GAAAGGCACCTCCCC 1693 
PPSIG-genomic CAGATCTGCAOQCTC TTGOCTCAAAOQTCA AOGCACAAAAOAAQA AGATGTAOTCCGTTC AGAGAA6A6CCAQAG GAAAOGCACCTCCCC 8820 
PPSIG-cDNA AACTTCTCGTtaGTGT CCTOCCTCCTACAGC AATTCCTTGCACATA TAAACAAAAACCATT TTOTTTCTGATTAGT GTTGTTAAGTCAAGA 1983 
PPSIG-genomic AACTTCTCGTGGTGT CCTOCCTCCTACAGC AATTCCTTGCACATA TAAACAAAAACCATT TTGriTCTGATTAGT GTTGTTAAGTCAAGA 8910 
PPSIG-cDNA OTTCTTTACCTTGCA TTCTACTTAAGGCCT AGTOTOAACTACATA QCCTTGATGCCTCAT GAAGAATOCTCCCAT GCCTTTCCTACACCC 2073 
PPSIG-genomic OTTCTTTACCTTGCA TTCTACTTAAGGCCT AGT6TGAACTACATA GCCTTGATGCCTCAT GAAGAATOCTCCCAT OCCTTTCCTACXCCC 9000 
PPSIG-cDNA AACTCCAAGCTATGG TCAGGCACCCAGAAC CCCTOGGGTGTTGGC TACTGGAATAOGTTG GTTCAGTCCTACCCT GWWSCTTTrTGTTCC 2163 
PPSIG-genomic AACTCCAAGCTATQG TCAOGCACCCAGAAC CCCTGGGGTQTTGGC TACTOaAATAGGTTQ GTTCAGTCCTACCCT GAAOCTTTTTOTTCC 9090 
PPSIG-cDNA TCCTCACTCrCGTOT TQTGftTQCTCTATAC ATGGAAAAQTGTGOG CTTOGAGTAOCAACT CTCTCAAAQTQCCAfl ACCTAAGAAAACCCT 2253 
PPSIG-genomic TCCTCACTCTCGTGT TGTGATGCTCTATAC ATGGAAAAGTGTGGG CTTOGAGTAGCAACT CTCTCAAAGTGCCAG ACCTAAGAAAACCCT 9180 
PPSIG-cDNA CAGGTCTAAGTTTTA TCCTGATAGAAGTGG GTTAAAGGAACACAC CAAAAGATACCACTG CCGATGAACCAAGCC TAGACACGGCATTPG 2343 
PPSIG-genomic CAOGTCTAAOTTTTA TCCTOATAGAAGTGG GTTAAAGGAACACAC CAAAAGATACCACTG CCOATQACCCAAOCC TAGACACOGCATTTG 9270 
PPSIG-cDNA TAGTTGCTGGCACAT AGTCAAACTGAGTTA CGAOQCTGGGCAGTG CTOGCACCQOCCTTT AACCCCAOCACTCM^ AAOGCAGGQGCAGAC 2433 
PPSIG-genomic TAGTTGCTGGCACAT AGTCAAACTGAGTTA CGAGGCTGGGCAGTG CTGGCACCQGCCTTT AACCCCAGCACTCAG AAGGCAGGGGCAGAC 9360 
‘ PPSIG-cDNA AGAGCTCTGTOAATC TGAAGCCAQAACTAG TTTATQAAGCAAGTC CAQGGCAGCCAGAGC TCTGTTATACAQAGA AACCCTGTCTTQAAA 2523 
PPSIG-genomic AGAGCTCTGTGAATC TGAAGCCAGAACTAG TTTATGAAGCAAGTC CAGOGCAGCCAGAGC TCTOTTATACAGAGA AACCCTCTCTTGAAA 9450 
PPSIG-cDNA AACAAAACAAAACAA AACAAAACCTGAGTA TTGTTTrCTAAAATG CTTGGAGTCAGAATT CTTTCAGATTTTGTG GTATrTGCATACXCa' 2613 
PPSIG-genomic AACAAAACAAAACAA AAOUVAACCTQAOTA TTOTTTTCTAAAATO CTTOaAOTCAGAATT CTTTCAGATrTTOTA QTATTTQCATACACA 9540 
PPSIG-cDNA TQAGATAACCTGOGQ AATGGGTCOCAGAAC TAAACCACAAATTCA TrTGTTTCATATGTA TAGACCAOGCACAAC ATCTTATOTAATACT 2703 
PPSIG-genomic TGAGATAACCTGGGG AATGGGTCOCAGAAC TAAACCACMATTCA TTTGTTrCATATGTA TAQACCAGGCACAAC ATCrrATGTAATACT 9630 
PPSIG-cDNA TTGAAAAACTGAGCA. TTCTGACCTGTCACA TGAGTCCATGCTATA ATTTAAAAAGCTTGC TTTCATTTTAGAATA GOGATGCTTrACCTA 2793 
PPSIG-genomic TTGAAAAACTCSAGCA TTCTOACCTGTCACA TGAOTCCATOCTATA ATTTAAAAAOCTTOC TTTQATTTCAaAATA QOGATGCTTTACCTA 9720 
PPSIG-cDNA TATGAOTAAATGAOA AQGTGGATAAAAAIT AAAAACCTTTCACTT ATOTTAAACAAGTQC TAATTTTAGTCTGTT TAAATATAOTATTAA 2883 
PPSIG-genomic TATGAOTAAATGAGA AQGTGGATAAAAATT AAAAACClTTTACTT ATGTTAAACAAGTGC TAATTTTAGTCTGTT TAAATATAGTATTAA 9610 
PPSIG-cDNA TACATGTAATGTTTC 2898 
PPSIG-genomic TACATGTAATGTTTC 9825 
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3.2.3.1 Comparison of PPSIG, Riken cDNA 0610039N19 and 
aII-trans-13,14-dihydroretinol saturase genomic sequence 
The full-length PPSIG genomic sequence was compared with the genomic 
sequences of Riken cDNA 0610039N19 and RetSat (Figure 3.15). The two in-frame 
ATG were found in PPSIG exon 1 and exon 6，respectively, but both Riken cDNA 
0610039N19 and RetSat regarded the ATG in exon 1 as the only start codon. All of 
the three genomic sequences contained 11 exons and 10 introns. It was found that 
except exon 1 and exon 11, all the other exons and introns were identical (Table 3.1). 
The size variations in exon 1 and exon 11 were due to different start and stop 
positions of the genomic sequences of PPSIG, Riken cDNA 0610039N19 and RetSat. 
The start location of PPSIG was 26 bp upstream of the start codon, while the genomic 
sequence of Riken cDNA 0610039N19 and RetSat began at the start codon. For the 3’ 
end, the stop position of PPSIG genomic sequence was 1042 bp downstream of the 
stop codon, while Riken cDNA 0610039N19 and RetSat ended at 106 and 21 bp 
downstream of the stop codon, respectively. The differences in start and stop location 
of the genomic sequences leaded to variation in their total length. The sizes of 
genomic sequences of PPSIG, Riken cDNA 0610039N19 and RetSat were 9825, 8860 
and 8775 bp, respectively. 
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Figure 3.15 Comparison of the genomic sequences of PPSIG cDNA, Riken 
cDNA 0610039N19 and RetSat 
The three genomic sequences were highly similar except six mismatched nucleotides 
were found in the PPSIG genomic sequence as indicated by * and highlighted in 
grey. All the three sequences contained 11 exons (uppercase letter and highlighted in 
yellow) and 10 introns (lowercase letter). Two in-frame ATG were found in PPSIG 
exon 1 and exon 6, respectively, but both Riken cDNA 0610039N19 and RetSat 
regarded the ATG in exon 1 as the only start codon. 
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SxoQ 1 1st Start codon 
PPSIG GCGGTCTTCCGAGCC CTGGCAGCAACXTOT QC5ATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTOG 90 
Riken ATGT QGATCACTGCTCTGC TQCTQGCCGTGCTOC TQCTGOTGATCCTCC ACAGGGTCTACGTGG 64 
RetSat ATOT QGATCACTGCTCTGC TQCTQOCCGTGCTOC TGCTGGTGATOCTCC ACAOOGTCTACGTGG 64 
PPSIG GCCTTTACGCTOCAA GTTCCCOGAACCCCT TCQCCGAOGATOTCA AGCQACCQCCTGAAC CCCTGGTGACCGACA AGGAOGCTAOGAAGA 180 
Riken GCCTTTACGCTGCAA GTTCCCOGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 154 
RetSat GCCTTTACGCTGCAA GTTCCCOGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTOAAC CCCTGGTGACCGACA AGOAOGCTAGGAAGA 154 
PPSIG AAGTTCTCAAACAAG gtcaactgatgggtt tcaggcctgctctcg ggccttctgctcatg tctccccattagtaa agtgctgggaaaact 270 
Riken AAGTTCTCAAACAAG gtcaactgatgggtt tcaggcctgctctcg ggccttctgctcatg tctccccattagtaa agtgctgggaaaact 244 
RetSat AAGTTCTCAAACAAG gtcaactgatgggtt tcaggcctgctctcg ggccttctgctcatg tctccccattagtaa agtgctgggaaaact 244 
PPSIG tctcttgcacacaga ggttccataatttag tgttctttgcttctg aaagggtgcaggcat tacccttggcacgcc aaattccagccccgc 360 
Riken tctcttgcacacaga ggttccataatttag tgttctttgcttctg aaagggtgcaggcat cacccttggcacgcc aaattccagccccgc 334 
RetSat tctcttgcacacaga ggttccataatttag tgttctttgcttctg aaagggtgcaggcat tacccttggcacgcc aaattccagccccgc 334 
PPSIG cagCtggaatctttt cagctcdcggcttac acagaataagagacc tttcccctacttggg tctggagccaacttt tccctatacttctgt 450 
Riken cagttggaatcttCt cagctcacggcttac acagaataagagacc tttcccctacttggg tctggagccaacttt tccctatacttctgt 424 
RetSat cagttggaatctttt cagctcacggcttac acagaataagagacc tttcccctacttggg tctggagccaacttt tccctatacttctgt 424 
PPSIG gcaCgctcgggggca cagggaagcagcact gaaagttttcctaac aagcgggttgcaggc aaaatgtagtccagt tcatagaacCgaagc 540 
Riken gcatgctcgggggca cagggaagcagcact gaaagttttcctaac aagcgggttgcaggc aaaatgtagtccagt tcatagaactgaagc 514 
RetSat gcatgctcgggggca cagggaagcagcact gaaagttttcctaac aagcgggttgcaggc aaaatgtagtccagt tcatagaactgaagc 514 
PPSIG ttgataataacttcg gaatttcagtactgg ctagggataagaact ccactctccagtgaa ccatctctaaagcac gtgtagagtgctccc 630 
Riken ttgataataacttcg gaatttcagtactgg ctagggataagaact ccactctccagtgaa ccatctctaaagcac gtgtagagtgctccc 604 
RetSat ttgataataacttcg gaatttcagtactgg ctagggataagaact ccactctccagtgaa ccatctctaaagcac gtgtagagtgccccc 604 
PPSIG aaggtttgtgttttt gagactggtctcact tttgtactggagctg gctttgaactctctt cgcagcccaggctca aacccggagcagccc 720 
Riken aaggtttgtgttttt gagactggtctcact ttCgtactggagttg gctttgaactctctt cgcagcccaggctca aacccggagcagccc 694 
RetSat aaggtttgtgttttt gagactggtctcact tttgtactggagctg gctttgaactctctt cgcagcccaggctca aacccggagcagccc 694 
PPSIG tcttcttctgtcccc agcatgatgagatag attacaagcatgcac cagcatgtctgcctt cc&acgttttacgga agtgttggagctggg 810 
Riken tcttcttctgtcccc agcatgatgagatag attacaagcatgcac cagcatgtctgcctt CcaacgLtttacgga agtgttggagctggg 784 
RetSat tcttcttctgtcccc agcatgatgagatag attacaagcatgcac cagcatgtctgcctt tcaacgttttacgga agtgttggagctggg 764 
PPSIG catagtggtgcaaca atttaattccagttt ggactacacaatgag accctgtctaaatgc acacatcaaacccca aaacaaccaaaaccc 900 
Riken catagtggtgcaaca atttaattccagttt ggactacacaatgag accctgtctaaatgc acacatcaaacccca aaacaaccaaaaccc 874 
RetSat catagtggtgcaaca atttaattccagttt ggactacacaatgag accctgtctaaatgc acacatcaaacccca aaacaaccaaaaccc 874 
PPSIG ccaaatgcaaaactt tcaaaaaacaaacaa ggatcacctctttga cctccaggagcctct gacttgtaaatttta gccaagcctaggcta 990 
Riken ccaaatgcaaaactt tcaaaaaacaaacaa ggatcacctctttga cctccaggagcctct gacttgtaaatttta gccaagcctaggcta 964 
RetSat ccaaatgcaaaactt tcaaaaaacaaacaa ggatcacctctttga cctccaggagcctct gacttgtaaatttta gccaagcctaggcta 964 
PPSIG gccttaactgcacta tttcttggggactga ctCtgaactcctgat ccttgtgcctctact tcct:aagaggcacca cacccagtcatttta 1080 
Riken gccttaactgcacta ttttttggggactga ctttgaactcctgat ccttgtgcctctact tcctaagaggcacca cacccagttatttta 1054 
RetSat gccttaactgcacta ttttttggggactga ctttgaactcctgat ccttgtgcctctact tcctaagaggcacca cacccagttatttta 1054 
PPSIG ttattgttattgttt gtggattgggggaga ggcaggtcLcatact tgtagcccaggctag cttataacttgctat acaggacaagtgtgt 1170 
Riken ttattgttattgtct gtggattgggggaga ggcaggtctcatact tgtagcccaggctag cttacaacttgctat acaggacaagt9tgt 1144 
RetSat ttattgttattgttt gtggattgggggaga ggcaggtctcatact tgtagcccaggctag cttataacttgctat acaggacaagtgtgt 1144 
PPSIG ctcaaattcacagtg attctccaaccacca tcagcaagagattac aaatggtgggattac agatgtgagccacca tggcttggatggaga 1260 
Riken ctcaaattcacagtg attctccaaccacca tcagcaagagattac aaatggtgggattac agatgtgagccacca tggcttggatggaga 1234 
RetSat ctcaaattcacagtg attctccaaccacca tcagcaagagattac aaatggtgggattac aga tgtgagccacca tggcttggatggaga 1234 
PPSIG ttttttttttatttt attttttttagtttt tagttgtttgagaca gtgtttctctctata gttctagatgtcctg gaacttgctattgcc 1350 
Riken ttttttttttatttt attttttttagtttt tagttgtttgagaca gtgtttctctctata gttctagatgtcctg gaacttgctattgcc 1324 
RetSat ttttttttttatttt attttttttagtttt tagttgtttgagaca gtgtttctctctata gttctagatgtcctg gaacttgctattgct 1324 
PPSIG ataCagaccaggctg gccttgaactcactg agatcctcccacctc agcctcctgagtgct gagactaaagctgtg aacacttggccttgg 1440 
Riken atatagaccaggctg gccttgaactcactg agatcctcccacctc agcctcctgagtgct gagactaaagctgtg aacacttggccttgg 1414 
RetSat atatagaccaggctg gccttgaactcactg agatcctcccacctc agcctcctgagtgct gagac taa age tg tg aacacttggccttgg 1414 
PPSIG gcaatgatgtttaat gagcagatttactgg acatagtggcacatt cctgtgatcccagcg ctggggaggaaaaga caggtggatctctac 1530 
Riken gcaatgatgtttaat gagcagatttactgg acatagtggcacatt cctgtgatcccagcg ctggggaggaaaaga caggtggatctctac 1504 
RetSat gcaatgatgtttaat gagcagatttactgg acatagtggcacatt cctgtgatcccagcg ctggggaggaaaaga caggtggatctctac 1504 
PPSIG atagggagttccagc ccagttagggctaca tgtgtagtgaaaccg tgtgtcttaaaaaac acgaatcaataaaat caaagaaagtaagta 1620 
Riken atagggagttccagc ccagttagggctaca tgtgtagtgaaaccg tgtgtcttaaaaaac acgaatcaataaaat caaagaaagtaagta 1594 
RetSat atagggagttccagc ccagttagggctaca tgtgtagtgaaaccg tgtgtcttaaaaaac acgaatcaataaaat caaagaaagtaagta 1594 
PPSIG aataaaggaggaaag gaagtaaaagactgg gagaaaacaacaaat cccaggCcttgtgtt gaccgtgcattccag tttggttctgtgagg 1710 
Riken aataaaggaggaaag gaagtaaaagactgg gagaaaacaacaaat cccaggtcttgtgtt gaccgtgcattccag tttggttctgtgagg 1664 
RetSat aataaaggaggaaag gaagtaaaagactgg gagaaaacaacaaat cccaggtcctgtgtt gaccgtgcattccag tttggttctgtgagg 1684 
PPSIG ttcccggcacaccaa ccttcctccttttct gaggctggtgccgtg acctctcagagtagc agcctctgagcagct ctgcctgctccaccc 1800 
Riken ttcccggcacaccaa ccttcctccttttct gaggctggtgctgtg acctctcagagtagc agcctctgagcagct ctgcctgctccacct 1774 
RetSat ttcccggcacaccaa ccttcctccttttct gaggctggtgctgtg acctctcagagtagc agcctctgagcagct ctgcctgctccacct 1774 
PPSIG ccgCtggcactcaga gaccttgcttcttcc aaagaaacccagttc cctgaaccaccagcg tccccagcccccacc ccgagccttattgcc 1890 
" Riken ccgttggcactcaga gaccttgcttcttcc aaagaaacccagttc cctgaaccaccagcg tccccagcccccacc ctgagccttattgcc 1664 
RetSat ccgttggcactcaga gaccttgcttcttcc aaagaaacccagttc cctgaaccaccagcg tccccagcccccacc ctgagccttattgcc 1664 
PPSIG ttttctttcctcgct tgcattcacagaact gacgttacagccctg tgcagttgccatctt cctggttttgttcta cagtagetagctgag 1980 
Riken ttttctttcctcgct tgcattcacagaact gacgttacagccctg tgcagttgccatctt cctggttttgttcta cagtagctagctgag 1954 
RetSat ttttctttcctcgct tgcattcacagaact gacgttacagccctg tgcagttgccatctt cctggttttgttcta cagtagctagctgag 1954 
PPSIG tcagtcctacttcct ttgaaaggtatcaaa tccctcaagtacact gtaggggttaagact catcactgcttaacc tgcctgtctggtccg 2070 
Riken tcagtcctacttcct ttgaaaggtatcaaa tccctcaagtacact gtaggggttaagact catcactgcttaacc tgcctgtctggtccg 2044 
RetSat tcagtcctacttcct ttgaaaggtatcaaa tccctcaagtacact gtaggggttaagact catcactgcttaacc tgcctgtctggtccg 2044 
PPSIG aggtattccctggta gaatgttttgagaca tcttagtcaagagta aataaactaccttaa aagaaaggtctgccc tccctcttgttttga 2160 
Riken aggtattccctggta gaatgttttgagaca tcttagtcaagagta aataaactaccttaa aagaaaggtctgccc tccctcttgttttga 2134 
RetSat aggtattccctggta gaatgttttgagaca tcttagtcaagagta aataaactaccttaa aagaaaggtctgccc tccctcttgttttga 2134 
PPSIG gactgggtctaacga gcccaggctggccCc ctgtgggatgatctt ggcctcctaatgcac cCttcaagtgctccc atcacaggagtacac 22B0 
Riken gactgggtctaacga gcccaggctggcctc ctgtgggatgatctt ggcctcctaatgcac ctttcaagtgctccc atcacaggagtacac 2224 
RetSat gactgggtctaacga gcccaggctggcctc ctgtgggatgatctt ggcctcctaatgcac ctttcaagtgctccc atcacaggagtacac 2224 
PPSIG caccatgcccagcag ccgtagagacttctt accgagtacacgtta gagaaggaccccggc ttctttgacttgact ttcctgccctcgtct 2340 
Riken caccatgcccagcag ccgtagagacttctt accgagtacacgtta gagaaggaccccggc ttctttgacttgact ttcctgccctcgtct 2314 
RetSat caccatgcccagcag ccgtagagacttctt accgagtacacgtta gagaaggaccccggc ttctttgacttgact ttcctgccctcgtct 2314 
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Bxon 3 
PPSIG gagaagctcaccctt ctcctcccttcCaca gCTTTCTCAGTCAGC CGAGTACCAGAOAAG CTOGATCCAGTGGTG ATCGOCAGCOGCATT 2430 
Riken gagaagctcaccctt ctcctcccttctaca gCTTTCTCAGTCAGC CGAGTACCAGAGAAG CTGOATGCAaTGGTG ATOSGCAOCaGCATT 2404 
RetSat gagaagctcaccctt ctcctcccttctaca gCTTTCTCAGTCAGC CGAOTACCAGAGAAG CTOOATGCAGTOGTG ATCCXSCAGCOGCATT 2404 
PPSIG QGGGGACTOQCCTCA GCTGCGQTTCTAQCT AAAGCTOOCAAQAGA GTCCTTOTGCTOGAA CAACATACCAAGQ06 aOCOQCTGTTOTCAT 2S20 
RiJcen OGQOGACTOOCCTCA GCTOCOOTTCTAQCT AAAOCTQOCAAOAGA. GTCCrTaTOCrOGAA CAACATACCAAGOOG OGCOGCTGrPOTCAT 2494 
RetSat OaOGOACTOGCCrCA OCTGCQGTTCTAOCT AAA0CTG0CAAGA6A OTCCrTOTGCrOQAA CAACATACCAAG006 aOCaOCTGTTGTCAT 2494 
PPSIG ACCTTTOOOGAAAAT OGCCTTOAATTTQAC ACTOGtaaggcttgt gtgggaaagggttag gagcatggccttgtc tttagatggctaata 2610 
Riken ACCTTTOOOGAAAAT OGCCTTQAATTTOAC ACTOGtaaggcttgt gtgggaaagggttag gagcatggccttgtc tttagatggctaata 2564 
RetSat ACCTTTGGGGAAAAT GGCCTTOAATTTGAC ACTOGtaaggcttgt gtgggaaagggttag gagcatggccttgtc tttagatggctaata 2584 
PPSIG acacacactattgag tgacatgggggcatt ttaatgttcggaggt ctcaacttctctctg ggcacctccatttct gtccgatggcctagt 2700 
Riken acacacactattgag tgacatgggggcatt ttaatgtttggaggt ctcaacttctctctg ggcacctccatttct gtccgatggcctagt 2674 
RetSat acacacactattgag tgacatgggggcatt ttaatgttcggaggt ctcaacttctctctg ggcacctccatttct gtccgatggcctagt 2674 
PPSIG tactgggcaagcatt gggtggtatatgttc tgacttgtttcttat agaaagggtgggcag cccccctctggacat gaacatagccaagca 2790 
Riken tactgggcaagcatt gggtggtatacgttc tgatttgttccttat agaaagggtgggcag cccccctctggacat gaacatagccaagca 2764 
RetSat tactgggcaagcatt gggtggtatatgttc tgacttgtttcttat agaaagggtgggcag cccccctctggacat gaacatagcc«agc« 2764 •xon 1 
PPSIG ggacaacctcttcct tacttggcatatttc cagggcccaatccct Cttatctctatatct cctttcctttgcacc tcccaacJtgOAATTC 2880 
Riken ggacaacctcttcct tacttggcatatttc cagggcccaatccct tttatctctatatct cctttcctttgcacc tcccaacagOMTTC 2854 
RetSat ggacaacctcttcct tacttggcatatttc cagggcccaatccct tttatctctatatct cctttcctttgcacc tcccaacagGBUWTC 2854 
PPSIG ArrATATTOGACGAA TGCOGGAOQGCAACA TrGGCCGTTTTATCT TQQACCAGATCACTG AAGOGCAACTOQACT OaOCCCCCATGOCCT 2970 
Riken ATTATATTGOACGAA TGCGOGAOaGCAACA TTOOCCOTTITATCT TGOACCAGATCACTG AAGQQCAACTQQACT OOaCCCCGATOGOCT 2944 
RetSat ATTATATTOQACGAA TOCGOGAOOGCAACA TraGCCOTTTTATCT TGOACCAGATCACTG AAOGQCAACTOGACT OaOCCCCCATOGCCT 2944 
PPSIG CCCCTTTTOACrTGA TOATACTAQAAGQQC OCAATGOCOGAAAGG AOTTOCCCATGTACA GTGGC3AGQAAAGMT ACATCCAGC3CXXTTA 3060 
RiXen CCCCTTTTOACrraA TGATACTAQAAGQGC 0CAATQ0C06AAAGG AGTTCCCCATXJTACA GTGGOAGGAAAGAAT ACftTCCAOOQCCTTA 3034 
RetSat CCOCTTTTOACTTGA TGATACTAOAAGGOC CCAATGOCOGAAAGG AGTTCCCCATQTACA GTGOGU^GGAAAGMIT ACATCCIlGOQCCrTA 3034 
PPSIG AGAAQAAQTTCCCCA AOGAAGAAGCTGTCA rrOAOlAOTACATGG AGTTOOTTAAGgtag tatgcaccatgatta gcatccctagtttat 31B0 
Riken AGAAQAAQTTCCCCA AOGAAQAAGCrGTCA TTGACAAQTACATOG AGTTGOTTAAGgtag tatgcaccatgatCa gcatccctagtttat 3124 
RetSat AGAAGAAGTTCCCCA AGGAAGAAGCTGTCA TTGACAAGTACATGG AGTTOGTTAAGgtag tacgcaccatgatta gcatccccagctcat 3124 
PPSIG ttccaacaagactgg ccttttcattagtga agaaactggtggggc aggaggagagggctgagttggggaggcagga aggaatggtcacgtc 3240 
Riken ttccaacaagactgg ccttttcattagtga agaaactggtggggt aggaggagagggctgagtcggggaggcagga aggaatggccatgtc 32X5 
RetSat ttccaacaagactgg ccttttcattagtga agaaactggtggggt aggaggagagggctgagttggggaggcagga aggaatggtcaCgtc 321S 
PPSIG tgtcctggttccagt gtaagcttgtgcttg cctgtgccctgctcg gctccccagctgcag tcctcacactggcct ctagatggtaccctt 3330 
Riken tgtcctggttccagt gtaagcttgtgtttg cctgtgccctgcttg gctccccagctgcag tcctcacactggcct ctagatggtaccctt 3305 
RetSat tgtcctggttccagt gtaagcttgcgtttg cctgtgccctgcttg gctccccagctgcag tcctcacactggcct ctagatggtaccctt 3305 
PPSIG gctaagccaggcctt gaggaagttagatgt cctctgagatatgcc agacttttgtgtatt cgaggtagagtctca caatgctgccccggc 3420 
Riken gctaagccaggcctt gaggaagttagatgt cctctgagatatgcc agacttttgtgtatt tgaggtagagtctca caatgctgcccCggc 3395 
RetSat gctaagccaggcttt gaggaagttagatgt cctctgagatatgcc agacttttgtgtatt tgaggtagagtctca c&atgctgccctggc 339& 
PPSIG tggtctggaactcag cagagatccacctgc ctctgccgagcatat gaaatcataacctgc tttctggaccaggat gtttggaaggaatct 3510 
Riken tggtctggaactcag cagagatccacctgc ctctgccgagcatat gaaatcataacctgc tttctggaccaggat gtttggaaggaatct 3485 
RetSat 1991ctggaactcag cagagatccacctgc ctctgccgagcatat gaaatcataacctgc tttctggaccaggat gtttggaaggaatct 348S 
PPSIG gaatgctggggatgt ggctcaggcttagca catacaactctgaat tatatcccaagcacc tcagcatctggatat gatggtgtagcctgt 3600 
Riken gaatgctggggatgt ggctcaggcttagca catacaactctgaat tatatcccaagcacc ttagcatcCggatat gatggtgtagcctgt 3B75 
RetSat gaatgctggggatgt ggctcaggcctagca catacaactctgaat tatatcccaagcacc ttagcatctggatat gatggtgtagcctgt 3575 
PPGIG aatcccagcattggg gaggcagaagcagga agttcaggagttcaa ggtcactggaatatt tggaactctctatat aaaagaaaaacaata 3690 
Riken aatcccagcattggg gaggcagaagcagga agttcaggagttcaa ggtcactggaatatt tggaactctctatat aaaagaaaaacaata 3665 
RetSat aatcccagcattggg gaggcagaagcagga agttcaggagctcaa ggtcactggaatatt tggaactctctatat aaaagaaaaacaata 3665 
PPSIG ctttttggagcatga aatggaagagcaaat agtcctatCtgagtg cgaagaatgagaaaa actcaggacccattt tgttgttgtttcgt^g 3780 
RlKen ctttCtggagcatga aaCggaagagcaaaC agtcctatttgagtg cgaagaatgagaaaa actcaggacccattt tgttgttgttttgtg 3755 
RetSat ctttttggagcatga aatggaagagcaaat agtcctatttgagCg cgaagaatgagaaaa actcaggacccattt tgttgttgttttgtg 3755 
PPSIG gtgaggaagacagct ctactacatagccct ggcttctatgtcagt gtatagctctggttg cccttaaactcatgg caatcctcctgctgt 3870 
Riken gtgaggaagacagct ctactdcatagtcct ggcttctatgtcagt gtatagctctggttg cccttaaactcatgg caatccCcctgctgt 3845 
RetSat gtgaggaagacagct ctactacatagccct ggcttctatgtcagt gtatagctctggttg cccttaaactcatgg caatcctcctgctgt 3845 
PPSIG agcatcccaactgtt gggaccacaggcctg agtctgatcacacac accatgcctaaaaaa aattttcaagtccaa aaattctgagtaagt 3960 
RiXen agcatctcaactgtt gggatcacaggcctg agtctgatcacacac accatgcctaaaaaa aattttcaagtccaa aaattctgagtaagt 3935 
RetSat agcatctcaactgtt gggatcacaggcctg agtctgatcacacac accatgcctaaaaaa aattttcaagtccaa aaattctgagtaagt 3935 
PPSIG gttgctgggctggca gtcagcgctgactgc tgcagcagtaactag gctccagcaccccag agctgagactcactt taccttttttatccc 40S0 
Riken gttgctgggctggca gtcagcgctgactgc tgcagcagtaactag gctccagcaccccag agctgagactcactt taccttttttatccc 4025 
RetSat gttgctgggctggca gtcagcgctgactgc tgcagcagtaactag gctccagcaccccag agctgagactcactt taccttttttatccc 4025 
Bxon 4 
PPSIG aggtOGTGGCCCGTG GAGTCTCTCATGCAG TCCTACTCAAGTTCC TCCCATTGCCCTTGA CTCAGCTCCTCAGCA AGTTTGGGCTACTGR 4140 
Riken aggtOOTOOCCCGTO GAGTCTCTCATGCAG TCCTACTCAAGTTCC TCCCATTGCCCTTGA CTCAOCTCCTCAGCA AGTTTGG0CTACTC3A 411& 
RetSat aggtOQTCSQCCCGTO GAGTCTCTCATGCAG TCCTACTCAAGTTCC TCCCATTGCCCTTGA CTCAOCTCCTCAGCA AaTTTOGOCTACTOA 4115 
PPSIG CTCX5TTTCTCTCCAT TCTGCCGAGCX3TCTA CGCAOAOCCTAGCTG AAQTCCTGCAOCAGC TTGGOaCrTCCOGTG AGCTCCAGOCTGTTC 4230 
Riken CTOOTTTCTCTCCAT TCTGCCGAGOGTCTA OOCAOAOCCTAQCTG AAQTOCTGCAGCAGC TT00G0CTTCCCX5TG AOCTCCXGGCTGTTC 4205 
RetSat CTCXSTTTCrCTCCAT TCTGCCGAGOGTCTA OGCAGAGCCTAGCTG AAGTCCTGCAGCAGC TTGGGGCTTCCOGTG AGCTCCAGGCTGTTC 420S 
PPSIG TCAGCTACATCTTCC CCACTTACOGtgggt ggctatagcccaggc ttttctaggctactg ctctcccagctttgg tctttctttcccatc 4320 
Riken TCAGCTACATCrTCC CCACTTACOGtgggt ggctatagcccaggc ttttctaggctactg ctctcccagctttgg tctttctttcccatc 4295 
‘ R e t S a t TCAGCTACATCTTCC CCACTTACOGtgggt ggctatagcccaggc ttttctaggctactg ctctcccagctttgg tctttctttcccatc 4295 
PPSIG cgcctaactgagaca ggctagaatagcccc aggcctgcaggagtt tgtggatcagggctg agaagtctgacccat gttggactctggcaa 4410 
RDcen tgcctaactgagaca ggctagaatagcccc aggcctgcaggagtt tgtggatcagggctg agaagtctgacccat gttggactctggtaa 4385 
RetSat tgcctaactgagaca ggctagaatagcccc aggcctgcaggagtt tgtggatcagggctg agaagtctgacccat gttggactctggtaa 4385 
PPSIG aaatgatttattatt tactttatggaacgt: tatcttttgttcttc tctcttgtatctttt cttcttcttctgttt cgttttctcttcctt 4500 
Riken aaatgatttattatt tactttatggaacgt tatcttttgttcttc tctcttgtatctttt cttcttcttctgttt tgttttctcttcctC 4475 
RetSat aaatgatttattatt tactttatggaacgt tatcttttgttcttc tctcttgtatctttt cttcttcttctgttt tgttttctcttcctt 4475 
PPSIG tttgaagacaaggtc ttccaggcaagcttt gaactcttgtagttg aggatgtccttaaat tccttatccttctgc ctctaccttcctagt 4590 
Riken tttgaagacaaggtc ttccaggcaagcttt gaactcttgtagttg aggatgtccttaaat tccttatccttctgc ctctaccttcctagt 4565 
RetSat tttgaagacaaggtc ttccaggcaagcttt gaactcttgtagttg aggatgtccttaaat tccttatccttctgc ctctaccttcctagt 4565 
PPSIG gctaggcatgcgcca ccatgtctggggtat gtggtgctggagatc aaatccaggctttca tgcatgttaggaaga catccagctgagccc 4680 
Riken gctaggtatgtgcca ccatgtctggggtat gtggtgctggagatc aaacccaggctttca tgcatgttaggaaga catccagctgagccc 4655 
RetSat gctaggtatgtgcca ccatgtctggggtat gtggtgctggagatc aaatccaggctttca tgcatgttaggaaga catccagctgagccc 4655 
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PPSIG acccaagtgcatttt ctccctgtcccctac acctccaggaaaagt tttgacttcgcccag gcCggtctagatctc tccgtagcttagtat 4770 
Riken acccaagtgcatttt ctccctgtcccctac &cctccaggaa&agt tttgactttgctcag gctggtctagatctc tccgtagcttagtat 4745 
RetSat acccaagtgcatttt ctccctgtcccctac acctccaggaaaagt tttgactttgctcag gctggtctagatctc tccgtagcttagtat 4745 
PP8IG ggctttgaatcaatg atccttctggtgtag cttttgagtgtgaga ttataggcatgtaca ctgctcaaggtCgat ttttctctttagcca 4660 
Riken ggctttgaatcaatg atccttctggtgtag cttttgagCgCgaga ttataggcatgCaca ctgctcaaggttgat ttttctctttagcca 4835 
RetSat ggctttgaatcaatg atccttctggtgtag cttttgagtgtgaga ttataggcatgtaca ctgctcaaggttgat ttttctctttagcca 4835 
PPSIG acagtgtcagtgact tctttggtcttggaa gcataatggttttat attccactaagctca ttftcctaccctgggc ctttgggagcattcc 4960 
Riken acagtgtcagtgact; tctttggtcttggaa gcaCaatggttttat attccactaagctca tcacctaccccgggc ctttgggagcattct 4925 
RetSat acagtgtcagcgACt tctttggtcttggaa gcataatggttttat attccactaagctca ttacctaccctgggc ctttgggagcatcct 492& 
PPSIG catcctaggatggac tcttgtggtccctca caggaagccctattt cttcctgaatggtgc caaatgaccactatg ctcatcttctttcct 5040 
Riken catcctaggatggac tcttgtggtccctca caggaagccctattt cttcctgadtggtgc caaatgaccactatg ctcatcttctttcct 5015 
RdtSat caccctaggatggac tcttgtggtccctca caggaagccctattt cttcctgaatggtgc caaatgaccactAtg ctcatcttctttcct 5015 
BXOD 5 
PPSIG tcfltcctgtagOAQT AACTCCCAOCCACAC OOCCTTTTCCTTGCA TQCTCTGCTOaTTQA CCACTACATACAAGG QQCATATTACCCrCG 5130 
RDcen tcatcctgtagOAOT AACTCCCAOCCACAC OGOTTTTCCTTOCA TGCTCrOCrOGTTaA CCACTACATACAAGG OGCATATTACCCTCG 5105 
Ret£at tcatcctgtagGAOT AACTCCCAGCCXCAC OCKCTTTTCCITGCA TGCTCTGCTGGTTCA CCACTACaTACAAGG QGCXTATTWrCTCG 5105 
PPSIG AOGGGGTTCCAGTGUl GATOGCCTTCCATAC CATCCCTTTGATTCA OCGGGCOGOGGGCOC TGTCCTCACCAOOQC CACTOTACACaOTOT 5220 
Riken AOGGGOTTCCAGTOA QATOOCCTTCOITAC CATCCCTTTGATTCA GCOGGCOGOOQOCQC TGTCCTCACCAGOOC CACrGTACMMOTOT 519& 
RetSat AaQGQGTTCCAGTGA GATOGCCTTCCATAC CATCCCTTTGATTCA C3CQ6QCOGQGOGCGC TGTCCTCACCAGOOC CACTGTACAGAOTGT S195 
PPSIG GCTGCTQGACTCAOC TQGOAGAOOQTOTOg taagagatctgtact gggctgtggggtcag tgggctggggtggaa gccagcctgtttatg 5310 
RiJcen GCTOCTGGACTCAGC TGGGAGACJCJGTGTGg taagagatctgtact gggctgtggggtcag tgggctggggtggaa gccagcctgtttatg 52as 
RetSat OCTOCTOGACTCAOC TQQQAGAGOQTGTGg taagagatctgtACt gggctgtggggtcag tgggctggggtggaa gccagcccgcttatg B285 
PPSIG cacggtaagaggctg gcgtctgagccggtg agaCagctcagtgga taaacggtctagtca ctcaccaaacctgat gatccccacagccta 5400 
Riken CAcggtaagaggctg gcgtctgagccggtg agatagctcagtgga taaatggtctagtca ctcactaaacctgat gatccccacagccta 5375 
RetSat cacggtaagaggctg gcgtctgagccggtg agatagctcagtgga taaatggtctagtca ctcactaaacctgat gatccccacAgcctA 5375 
PPSIG catggtggaaggaga gaact-ctgg-caag ttgtc-ct-ctgacc tccacacatgggctg tAgcactcctacccc caccccccccacaca B490 
Riken catggtggaaggaga gaact-ctgg-caag ttgtc-ct-ctgacc tccacacatgggctg tagcactcctAcccc caccccccccacaca 5461 
RetSat catggtggaaggaga gAact-ctgg-caag ttgtc-ct-ctgacc tccacacatgggctg tagcactcctacccc caccccccccacaca &461 
PPSIG cacacacaatgaagg Aatcaaactacaatt cttacaaaaggtcag gtctgacataatggt tttgtgagtggccag agatgaggttggAca 5580 
Riken cacacacaatgaagg aatcaaaccacaatt ctcacaaaaggtcag gtctgacataatggc tctgtgagcggccag agatg&ggtcggaca 5551 
RetSat cacacacaatgaagg aatcaaactacaatt cttacaaaaggtcag gtctgacataatggc tttgtgagtggccag agatgaggttggaca 5551 
PPSIG cacaggcCtcagtac accacagaagccttg gtgtttcatgaaggt tgagccatctgggga gtactgtagatgtgg aacttggcagcaggg 5670 
RDcen cacaggcttcagtac atcacAgaagccttg gtgtttcatgaaggt tgagtcatctgggga gtactgtagatgtgg aacttggcagcaggg 5641 
RetSat cacaggcttcagtac atcacaga&gccttg gtgtttcatgaaggt tgagtcaCctgggga gtactgtagatgtgg aacttggcagcaggg 5641 
PPSIG aaggaggggctggga ctccatagagccagt gttcttgggacggca gggcgtggctaaggt aagtccatatgggtg ggtaagaagagctag 5760 
Ri}cen aaggaggggctggga ctccatagagccagt gttcttgggacggca gggcgtggctaaggt aagtccatatgggtg ggtaagaagagctag 5731 
RetCat aaggaggggctggga ctccatagagccagt gttcttgggacggca gggcgtggctaaggt aagtccatatgggtg ggtaagaagagctag 5731 
PPSIG agAgggcaagcacag aagcatttgaggcaa gggctaagtgactct gcagtgtgcctggga cctgccttggctgga 99aac11ctaggtcC S650 
RiKen agagggcaagcacag aagcatttgaggcaA gggctaagtgacttt gcagtgtgcctggga cctgctttggctgga ggaactcctaggtct 5821 
RetSat agagggcaagcacag aagcatttgaggcaa gggctaagtgacttt gcagtgtgcctggga cctgctttggctgga ggaacttctaggtct 5821 
PPeiG gagaaaacagggcct accctaggagacatc tggatagtgCggcta t&gacagaactaata ttttgaggcaggatt tcatgtgtttcaggc 5940 
Riken gagaaaacagggcct accctaggagacatc tggatagtgtggcta tagacagaactaata ttttgaggcaggatt tcatgtgtttcaggc &911 
RetSat gagaaaacagggcct accctaggagacatc tggatagtgtggcta tagacagaactaaca ttttgaggcaggatt tcatgtgtttcaggc 5911 
PPSIG tatcctca&actcac tagctagctgaggct gaccttcgaattcct gattatatggcgtct acctcctacatgcta ggattgcaggaacat 6030 
Riken tatcctcaaactcac cagctagctgaggct gaccttcgaactcct gattatatggcgtct acctcctacatgcta ggattgcagga&cat: 6001 
RetSat tatcctcaaACtcac tagctagctgaggct gaccttcgaattcct gattatatggcgtct acctcctacatgcta ggattgcaggaacat 6001 
PPSIG gCcatcatgctgcga ctacagctaatgctt tgagagaaacgtatt tcacactttcctggg ttgtgtttgttctat ggtgggcatggggtg 6120 
Riken gtcatcatgctgcga ctacagctaAtgctC tgagagaaatgtatt tcacactttcctggg ttgtgtttgttttat ggtgggtat9gggtg 6091 
RetSat gtcatcatgctgcga ctacagctaatgctt tgagagaaatgtatt tcacactttcctggg ttgtgtttgttttat ggtgggtatggggtg 6091 
PPSIG cacggaacctagggc ttcatacatgttaga caagcgcttcccacc tgagctgtattccta gcccttaagagggat ctagagaatggtata 6210 
RiXen cacggaacctagggc ttcatacatgctaga caagcgctc tccacc tgagctgtattccta gcccCtaagagggat ctagagaatggtaca 6181 
RetSat cacggaacctagggc ttcatacatgttaga caagcgctttccacc tgagctgtattccta gcccttaagagggat ctagagAAtggtata 6181 
Sxoa 6 
PPeiG ggtcttttttgtttc cacagagctcataga agctcagccanattc ttgtgcctgcaggtO TCI^QTGTGUIAGAAGG QACAAOAOCTOGTaX 6300 
Riken ggtcttttttgtttc cacagagctcataga agctcagccanattc ttgtgcctgcaggcG TCA0T6TQAAGAAGG GACAAGAGCTGGTQJl 6271 
RecSat ggtcttttttgtttc cacagagctCAtaga agctcagccanattc ttgtgcctgcaggtO TCAGTOTGAAGAAGO QAGAAGAGCTGOTGU^ 6271 
2&d 0t巍rt codon 
PPSIG ACATCTACTGCCCAG TTGTCATCTCCAATG CGGGAATGTTCAATA CCTATCAGCACTTOT TGCCAGAGACTGTGC OCCATCTOCCAOgta 6390 
Riken ACATCTACTGCCCAG TTGTCATCTCCAATG CGOGAATGTTCAATA CCTATCAGCACTTGT TGCCAGAGACTGTCC OCCATCTGCtaGgta 6361 
ReC&at ACATCTACrOCCCAO TTGTCATCTCCAATG OQaQAATGTTCAATA CCTATCAGCACTTOT TOCCAOAaACTOTOC OCCATCTOCCAOgta 6361 
PPSIG aaagactgatctttt gaactaatatttcat ctgtgAagcttacat gcccagctgggtggg ctcccctctcctcgg gcagtccgctagctg 6480 
Riken aaagaccgatctttt gaactaat&tttcat ctgCgaagcttacat gcccagctgggtggg ctcccctctccttgg gcagtccgctagctg 6451 
Retfiat aaagactgatctttt gaacCaatatttcat ctgtgaagcttacat gcccagctgggtggg ctcccctctccttgg gcagtccgctagctg 6451 
PPSIG tctctccctagtctg tgctaccaggaacac agcatttatatttgg ggaatctaggactac aggggaagaggagcc cttcacagaggcagt 6570 
Riken tctctctctagtctg tgctaccaggaacat agcatttatatttgg ggaatctaggaccac agggga&gaggagcc cttcacagaggcagt 6541 
Recsac tctctctctagtctg tgctaccaggaacat agcatttatatttgg ggaatccaggactac aggggaagaggagcc cttcacagaggcagt 6541 
PPSIG ggcagagctctgagg actctgttttgtcag atgcaaatgtctatc ttgtacttccgggct gaaaaacacaaccct gtatatttgctttcc £660 
^ RiKen ggcagagctctgagg actctgttttgtcag AtgcaaatgtctaCc ttgtacttccgggct gaaaaacacaaccct gtatatttgctttcc 6631 
RetSat ggcagagctctgagg actctgttttgtcag atgcaaatgcctatc ttgtacttccgggct gaaaaacacaaccct gtatatttgctttcc 6631 
PPSIG tttgccagagaaacc agggctttaatagaa aagactcagttaaat ggcagacaagageta gggatgaagttcagt Cggttagagtgttt^ 6750 
Riken 11tgccagagaaacc agggcttt&atagaa aagACtcagttaaat ggcagacaagagcta gggatgaagttcagt tggctagagtgtttg 6721 
RetSat tttgccagagaaacc agggctttaatagaa aagactCAgttaaat ggcagacaAgagcta gggatgaagttcagt tggttagagtgtttg 6721 
PPSIG catcagccctgggtt tacccagagccaggt aagacaactagagtg gatttggctgtaatc ctagcactcaagagg tgttggcgggaagat £840 
Riken catcagccctgggtt CacctAgagccaggt aagacaactAgAgtg gatttggctgtaatc ct ag ca c t caag ^99 tgttggcgggaagat 6811 
RetSat caCcagcccCgggtt tacccagagccaggt aagacaactagagtg gatttggctgtaaCc cCagcactcaagagg Cgttggcggga&gat 6811 
PPSIG aagaaaCtcaaggtc accgttggctacAca agaccctgcctcaac aaAcaaaggccactg agatggttcagagcg t«dagtc11tgctgc 6930 
Riken aagaaattcaaggtc accgttggctacaca agacccCgcctcaac aaacaaaggccactg agatggttcagagtg taaagtctttgctgc 6901 
RetSat aagaaattcaaggtc accgttggctacaca agaccctgcctcaac aaacaaaggccactg agatggttcagagtg taaagtctttgctgc 6901 
PPSIG ta&atccccagagtg gaagaagatagttgt cttctggcttcttgc acatctagacagacc tttatccatatacat ctataattaacgaaa 7020 
RDcen taaatccccagagtg gaagaagatagttgc cttctggcttcttgc acatctagacagacc ttCatccAtatacat ctAt&attaacgaaa 6991 
RetSat taaatccccagagtg gaagaagatagt tgt cttctggcttcttgc acatctagAcagAcc tttatccacatacat ctataat caacgaaa 6991 
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PPSIG catctaadtgtataa agaggagggttggaa cagcctgattgtcca gaggtgctgtgagtt agctctgctctgaat cagcaggaagccAgc 7110 
Riken catctaaatgtataa agaggagggttggaa cagcctgattgtcca gaggtgctgtgagtt agctctgctccgaat cagcaggaagccagc 7081 
RetSat catctaaatgtataa agaggagggttggaa cagcctgattgtcca gaggtgctgtgagtt agctctgctctgaat cagcaggaagccagc 7081 
PPSIG acctatgactaaggg gacatggggcagagg tggtagagttggaag gaatctgaggctaca tctcacatagccagg acgagacttaagagc 7200 
Riken acctatgactaaggg gacatggggcagagg tggtagagttggaag gaatctgaggcCaca tctcacatagccagg acgagacttaagagc 7171 
RetSat acctatgactaaggg gacatggggcagagg tggtagagttggaag gaatctgaggctaca tctcacatagccagg acgagacttaagagc 7171 
PPSIG aggtctctgccagga tcctatagaaatagt tataaaaccggccag gtctctgtcccagct ggcagctgaggatcg agctacagatcagaa 7290 
Riken aggtctctgccagga tcctatagaaatagt tataaaaccggccag gtctctgtcccagct ggcagctgaggatcg agctacagatcagaa 7261 
RetSat aggtctctgccagga tcctatagaaatagt tataaaaccggccag gtctctgtcccagct ggcagctgaggatcg agctacagatcagaa 7261 
Xxon 7 
PPSIG aagggadcatcctga ggctatcctgacagg ggtggctgtctggct gtaactcctgcacag caatcctcactggct ctctgcagATQTQAA 7380 
Riken aagggaacatcctga ggctatcctgacagg ggtggctgtctggct gtaactcctgcacag caatcctcactggct ctctgcagATOTGAA 7351 
RetSat aagggaacatcctga ggctatcctgacagg ggtggctgtctggct gtaactcctgcacag caatcctcactggct ctctgcagATOTGAA 7351 
PPSIG GAAGCAGCTGGCGAT GGTAAGGCCTGGTCT GAGCATGCTCTCAAT CTTCATCrGTCTOAA AGGCACCAAOGAGGA. CCTGAAGCTTCAGTC 7470 
R i k e n GAAGCAQCTQGCQAT GQTAAGGCCTGGTCT OAGCATQCTCTCAAT CTTCATCrOTCTGAA AQOCACCAAGGAGQA. CCTQAAGCTTCAOTC 7441 
RetSat OAAGOHOCrGGCQ^T QGTAAGGCCrGOTCr OAGCATOCTCTCAAT CTTCATCTOTCTOJJl AOOCACCAAOQAGQA CCTOAAGCnTCAOTC 7441 
PPSIG CACCNACTACTATGT TTATTTTGACACAGA CATGGACAAAGOgta agatgtgaggggtgg ggaagactgatagtg ttgggcctcatccca 7560 
Riken CACCNACTACTATGT TTATTTTGACACAOA CATOGACAAAGOgta agatgtgaggggtgg ggaagactgatagtg ttgggcctcatccca 7531 
RetSat CACCNACTACTATGT TTATTTTQACACAGA CATXSOACAAAOCgta agatgtgaggggtgg ggaagactgatagtg ttgggcctcatccca 7531 
PPSIG caaggtcctgcttcc accctccacacggtt ctaggaatgagaagg atgtgttttgaggga ggaggtgcagtctct aatggacttctagaa 76S0 
Riken caaggtcctgcttcc accctccacacggtt ctaggaatgagaagg atgtgttttgaggga ggaggtgcagtctct aatggacttctagaa 7621 
RetSat caaggtcctgcttcc accctccacacggtt ctaggaatgagaagg atgtgttttgaggga ggaggtgcagtctct eiatggacttctagaa 7€21 
PPSIG aggctttctacacca aagccgtgctgtttt ctcccttgtgggaag tccctggagatgagc ctttgtttgggtagt gctggtggctttgag 7740 
Riken aggctttctacacca aagccgtgctgtttt ctcccttgtgggaag tccctggagatgagc ctttgtttgggtagt gctggtggctttgag 7711 
RetSat aggctttctacacca aagccgtgctgtttt ctcccttgtgggaag tccctggagatgagc ctttgtttgggtagt gctggtggctttgag 7711 
Exon B 
PPSIG gaagaggcctaaaga ttggcagtcacgccc cctccctcatccaca gGATCXSAGCGCTATG TCTCTATGCCCAAOG AAAAGGCTCCAGAAC 7830 
Riken gaagaggcctaaaga ttggcagtcacgccc cctccctcatccaca gOATOQAQCGCTATG TCTCTATQCCCAAGG AAAAGQCTCCAGAAC 7801 
RetSat gaagaggcctaaaga ttggcagtcacgccc cctccctcatccaca gGATOGAGCGCTATO TCTCTATGCCCAAOG AAAAGGCTCCAGJUkC 7801 
PPSIG ACATTCCCCTTCTCT TCATTGCCTTCCCAT CAAQCAAGGATCCAA CCTGOGAGGAGCGAT TCCCAGgtagggctt gaagtccagggaagt 7920 
Riken ACATTCCCCTTCTCT TCATTGCCTTCCCAT CAAQCAAGGATCCAA CCTGOQAOQAGOGAT TCCCAGgtagggctt gaagtccagggaagt 7891 
RetSat ACATTCCCCTTCTCT TCATTGCCTTCCCAT CAAGCAAGGATCCAA CCTGOGAOGJWSCOAT TCCCAGgtagggctt gaagtccagggaagt 7891 
Bxon 9 
PPSIG tgggtgtagggcaag gcagggccaaatagc aataacatggcctta tacccacagACCGAT CCACAATGACTOCGC TGGTACCCATQGCCT BOlO 
Riken tgggtgtagggcaag gcagggccaaatagc aataacatggcctta t a cc c a cagACOOXT CCACAATQACTGCOC T0GTACCCATCX5CCT 7981 
RetSat tgggtgtagggcaag gcagggccaaatagc aataacatggcctta tacccacagACOQAT CCACAATOACTQCGC T00TACCCATQC3CCT 7981 
PPSIG TTGAATGGTTCGAGG AGTGGCAGGAGGAGC CAAAGOGCAAGOGTG GTGTTGACTATGAGA CCCTCAAAAATGCCT TCGTQGAAGCCTCTA 8100 
Riken TTQAATGQTTCGAGG AGTOGCAOOAQQAGC CAAAQGOCMIQOGTO QTQTTQACTATQAGA. CCCTCAAAAATGCCT TCOTOGAAGCCTCTA 8071 
RetSat TTOAATaGTrCGAGO AGTGOCAOGAGGAGC CAAAGGGCAAQOOTG GTGTTGACTATGAQA CCCTCMAAATOCCT TCGTOGAAGCCTCTA 8071 
PPSIG TGTCOGTOATCATGA AACTGTTCOCACAGC TGOAOOQCAAGgtag gggctgacatacagt gctggaggtgacaat gcatccctCaactgt 8190 
Riken TGTCGGTGATCATGA AACTGTTCCCACAGC TQaAGGOCAAOgtag gggctgacatacagt gctggaggtgacaat gcatcccttaactgt 8161 
RetSat TGTCGGTGATCATGA AACTGTTCOCACAGC TOQAOOGCAAOgtag gggctgacatacagt gctggaggtgacaat gcatcccttaactgt 8161 
BXOQ 10 
PPSIG cttcttccatacagg gacaaagcctgcggt aacaagagtcccaca gtcccttgttcaccc ttgccttgcccttCt gtttcctcagGTQGA 8280 
Riken cttcttccatacagg gacaaagcctgcggt aacaagagtcccaca gtcccttgttcaccc tcgccttgccctttt gtttcctcagGTOQA 8251 
RetSat cttcttccatacagg gacaaagcctgcggt aacaagagtcccaca gtcccttgttcaccc ttgccttgccctttt gtttcctcagGTOGA 8251 
PPSIG OAGTQTOACTGGAGG OTCACCACTGACCAA CCAGTACTATCTQQC TGCACCOCGAGGAOC TACCTATQGAGCTGA CCATGACTTGOCTOG B370 
Riken QAOTOTOACTOGAOO OTCACCACTQACCAA CCAOTACTATCTQOC TGCACCCCOAGQAGC TACCTATQGAGCTGA CaVTOACTTOaCTOO 8341 
RetSat OAQTOTQACTOGAOa OTCACCACTGACCAA CCAOTACTATCTGQC TGCACCCCOAOGAOC TACCTATOGAfiCTGA CCATGACTTOGCTCG 8341 
PPSIG OCTGCATCCTCATGC AATGGCTTOCATAAG AOCCCAAACCCCCAT CCCCAAOCTCTACCT QACAGgtacactgcc tcactttgccagaat 8460 
Riken GCTGCATCCTCATGC AATGGCTTOCATAAG AGOCCAAACCCCCAT CCCCAAOCTCTACCT QACAGgtacactgcc tcactttgccagaat 8431 
RetSat OCTGCATCCTCATOC AATGGCTTCCATAAG AGOCCAAACCCCCAT CCCCAAGCTCTACCT GACAGgtacactgcc tcactttgccagaat B431 
PPSIG ctggacttccctggc atagtcttctgttct cgtcctcaagcctac accaggagctgggct gccttggctattgtc ctgggttctatctga 8B50 
Riken ctggacttccctggc atagtcttctgttct cgtcctcaagcctac accaggagctgggct gccttggctattgtc ctgggttctatctga 8521 
RetSat ctggacttccctggc atagtcttctgttct cgtcctcaagcctac accaggagctgggct gccttggctattgtc ctgggttctatctga 8521 
PPSIG ggctgtctctctttg ggtggccttgatatg gagggacgaacacaa gaacccttgttaccc ccatcttcatgggtc actgcttttgctttc 8640 
Riken ggctgtctctctttg ggtggccttgatatg gagggatgaacacaa gaacccttgttaccc ccatcttcatgggtc acLgcttttgctttc 8611 
RetSat ggctgtctctctttg ggtggccttgatatg gagggacgaacacaa gaacccttgttaccc ccatcttcatgggtc actgcttttgctttc 6611 
Exon 11 
PPSIG tagGCCAAGATATCT TCACCTOTGOOCTGA TGOaGGCCCTaCAGG GGGCCTTGCTGTOCA GCAGTOCCATCCTQA AACX3GAACTTOTACT 6730 
Riken tagGCCAAGATATCT TCACCTQTGGGCTGA TQGGGGCCCTGCAGG QGGCCTTGCTGTGCA GCAGTGCCATCCTGA AA0CX3AACTTGTACT 8701 
RetSat tagGCCAAGATATCT TCACTTGTGGGCTGA TGGGGGCCCTGCAOG GGGCCTPGCTGTOCA GCAGTGCCATCCTGA AAOOGAACTTGTACT 8701 
Stop codoc 
PPSIG CAQATCTGCAGGCTC TTC30CTCAAA0GTCA AGGCACAAAAGAAGA AGATOTAOTCCGTTC AGAGAAGAGCCAGAG QAAAGGCACCTCCCC 8620 
Riken CAGATCTOCAGGCTC TTGOCTCAAAQGTCA AOOCACAAAAGAAQA AGATOTAOTCCGTTC AGAGAAGAGCCAGAG OAAAGGCXCCTCCCC 8791 
RetSat CAGATCTOCAGGCTC TTGGCTCAAAGGTCA AGGCACAAAAGAAGA AGATGTACTCCGTTC AGAGAAQAGCCAGA 8775 
- PPSIG AACTTCTOGTGGTGT CCTOCCTCCTACAGC AAITCCTTGCACATA TAAACAAAAACCATT TTGTTTCTGATTAGT 0TT3TTAAGTCAAQA 8910 
Riken AACTTCTCOTOGTGT CCTCCCTCCTACAOC AATTCCTTGCACATA TAAACAAAAACCATT TTGTTTCTO - 8860 
PPSIG GTTCTTTACCTTGCA TTCTACTTAAGGCCT AGTGTGAACTACATA GCCTTGATOCCTCAT GAAGWVTGCTCCCAT GCCmCCTACACCC 9000 
PPSIG AACTCCAAQCTATQG TCAOGCACOCAOAAC CCCTGOOGTOTTQaC TACTOQAATAOCTTO GTTCAGTCCTACCCT GAAOCTTTTTQTTCC 9090 
PPSIG TCCTCACTCTCGTGT TGTGATOCTCTATAC ATGGAAAAGTGTGOG CTTOQAGTAGCAACT CTCTCAAAGTQCCAS ACCTAAGJUAACCCT 9180 
PPSIG CAGGTCTAAGTTTTA TCCTGATAGAAGTGG GTTAAAGGAACACAC CAAAAGATACCACTG CCGATGACCCAAGCC TAGACACOGCATTTG 9270 
PPSIG TAQTTOCTGGCACAT AQTCAAACTGAGTTA CGAQQCTGGQCAGTQ CTGGCACCOGCCTTT AACCCOIGCACTCAG AAOQCAGQGQCAGAC 9360 
PPSIG AGWSCTCTGTOAATC TQAAGCCAGAACTAG TTTATQAAGCAAOTC CAGGQCAQCCAGAQC TCTGTTATACRGAGA AACCCTGTCTTQAAA 9450 
PPSIG AACAAAACAAAACAA AACAAAACCTGAGTA TTGTTTTCTAAAATG CTTGGAGTCAGAATT CTTTCAGATTTTGTA GTATTTGCATACACA 9B40 
PPSIG TGAGATAACCTGQGG AATGGGTCOCAGAAC TAftACCACAAATTCA TrTGTTTCATATOTA TAGACCAGGCACAAC ATCTTATGTAATACT 9630 
PPSIG TTGAAAAACTGAGCA TTCTGACCTGTCACA TC3A0TCCATGCTATA ATTTAAAAAGCTTQC TTTGATTTCAGAATA QQGATGCT1TACCTA 9720 
PPSIG TATGAGTAAATGAGA AQGTGGATAAAAATT AAAAACCTTTTACTT ATGTTAAACAAGTGC TAATTTTAGTCTGTT TAAATATAGTATTAA 9810 
PPS IG TACATGTAATGTTTC 98 2 S 
Figure 3.15 Comparison of the genomic sequences of PPSIG cDNA, Riken 
cDNA 0610039N19 and RetSat (continued) 
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Table 3.1 Comparison of exons and introns of PPSIG, Riken cDNA 
0610039N19 and RetSat 
PPSIG Riken cDNA RetSat 
(bp) 0610039N19 (bp) 
(M 
Exon 1 195 169 169 
Intron 1 2176 2176 2176 
E x o n 2 183 183 183 
Intron 2 320 320 320 
Exon 3 242 242 242 
Intron 3 937 937 937 
Exon 4 202 202 202 
Intron 4 797 797 797 
Exon 5 198 198 198 
Intron 5 1014 1014 1014 
Exon 6 120 120 120 
Intron 6 986 986 986 
Exon 7 139 139 139 
Intron 7 274 274 274 
Exon 8 110 110 110 
Intron 8 78 78 78 
Exon 9 167 167 167 
Intron 9 134 134 134 
Exon 10 160 160 160 
Intron 10 208 208 208 
Exon 11 1182 246 161 
Total 9 8 2 2 � 8775 
183 
3.3 Characterization of the 5，-flanking region of PPSIG 
The � 3 0 0 0 bp nucleotide sequence upstream of the ATG start codon was 
analyzed using the Matlnspector software. The start codon was denoted as 
nucleotide +1. A TATA box at position -56 to -50 (Figure 3.23) was identified. GC 
box and TRE site which bind with stimulating protein 1 (Spl) and activator protein 
1 (AP-1) were also found at positions -71 to -66 and -128 to -122, respectively. The 
prediction of these factors suggested that the 5'-flanking region of PPSIG was a 
potential promoter that contributed to its transcription. No PPRE was predicted by 
the software in this region. 
To prepare the PPSIG-promoter construct for examining whether the 
5'-flanking region possesses any promoter activity, a 3055 bp PPSIG fragment from 
-2936 to +119 was amplified (Figure 3.24) and subcloned in a pGL3-Basic vector to 
produce a 7864 bp pGL3-PPSIG (-2936/+119) reporter construct. The construct was 
confirmed by Not l/Hind III digestion (Figure 3.25) and DNA sequencing (Appendix 
^ Dl). The pGL3-PPSIG (-2936/+119) reporter construct was transfected into a 
NIH-3T3 cell line and the transfection experiment was monitored using the 
pGL3-Control plasmid containing the SV40 promoter. Transient transfection assays 
of pGL3-Control revealed a significant 5.9-fold induction of relative luciferase 





































































































































































































































































































































































































































































































































































































1 kb FP(-2936)/ 
Marker RP(+119) 
l i P — P l l ^ l l ^ 
4072 bp 
3054 bp ^ ^3055 bp 
bp 
Figure 3.24 PCR product of PPSIG S'-flanking region amplified from -2936 
to +119 region 
PPSIG 5'-flanking region from -2936 to +119 was amplified by forward and reverse 
primer PPSIG-FP(-2936) and PPSIG-RP(+119), respectively. Based on the genomic 
sequence of Riken cDNA 0610039N19, the expected PCR product size was 3055 bp. 
The amplified products showed a band at -3000 bp, indicating that the PPSIG 
5'-flanking region was successfully amplified. 
186 
pGLS-
PPSIG 1 kb 
(-2936/+119) Marker 
5090 bp 
i S ) ' ^ i n j ^ g j — bp 
-3266 bp • [ 3054 bp 
2036 bp 
Figure 3.25 Not l/Hind III digestion to screen the pGL3-PPSIG (-2936/+119) 
promoter reporter construct recombinant 
‘ The construct pGL3-PPSIG (-2936/+119) was screened by Not VHind III digestion. 
The digested products showed expected sizes of 3266 and 4598 bp, indicating that the 
pGL3-PPSIG (-2936/+119) was successfully produced. 
�+ 
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system was able to examine the promoter activity of the reporter constructs. A 
significant increase (10.3-fold) in reporter activity was also detected in pGL3-PPSIG 
(-2936/+119) construct compared with the pGL3-Basic and pGL3-Control (Figure 
3.26). These results suggested that the 5'-flanking region of PPSIG (-2936 to +119) of 
PPSIG possessed promoter activity. 
To map the minimal PPSIG promoter region essential for its promoter activity, 
three 5’ deletion constructs including pGL3-PPSIG (-1534/+119), pGL3-PPSIG 
(-879/+119) and pGL3-PPSIG (-375/+119) were prepared from the parental reporter 
construct pGL3-PPSlG (-2936/+119). Different restriction enzyme digestions were 
performed to remove the targeted fragments from the parental construct pGL3-PPSIG 
(-2936/+119) ill order to generate the deletion constructs (Figure 3.27). The deletion 
construct subclones were confirmed by Not VHind III digestions (Figure 3.28) and 
DNA sequencing (Appendix Dl). 
The parental pGL3-PPSIG (-2936/+119) and deletion constructs were transient 
� transfected into NIH-3T3, HepG2 and AML-12 cells. It was shown that both the 
parental and three deletion constructs showed a significant induction in luciferase 
activity when compared to the pGL3-Basic in all the three cell lines examined (Figure 
3.29). In the NIH-3T3 cells, the parental pGL3-PPSIG (-2936/+119) construct showed 
a significant 9.4-fold induction in luciferase activity compared with that of the 
188 
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0 “‘ 
pGL3-Basic pGLS-PPSIG pGL3-Control 
(-2396/+119) 
Figure 3.26 PPSIG 5’-flanking region from -2936 to +119 possessed promoter 
activity 
PPSIG-promoter reporter construct pGL3-PPSIG (-2936/+119) was transient 
transfected into NIH-3T3 cells. The pGL3-Basic vector was included in the 
transfection experiment to determine the basal level of luciferase activity, while 
pGL3-Control vector (luciferase gene driven by SV40 promoter) was used as a 
positive control to monitor the transfection procedures. In all transfections, pRL-TK 
was co-transfected to correct for transfection efficiency. Transfections were done in 
triplicate. The relative luciferase activity of the constructs was normalized to the 
activity of pRL-TK vector and expressed as fold induction compared with the activity 
- of pGL3-Basic. Results are shown as means 土 S.E.M. (n=3) *P<0.05 and *** 
PO.OOl, empty construct (pGL3-Basic) versus reporter construct. The Student's Mest 
was used to examine the difference and a difference of P<0.05 was considered 
significant. All statistical analyses were carried out using the SigmaStat version 2.03 
software system (Systat Software, Inc., USA). 
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A 1 kb Uncut Nhe \INsi\ 
Marker plasmid digested 
m m m m 
U n c u t p l a s m i d 
7 1 2 6 bp - 6 4 6 2 b p ( f r a g m e n t r e m a i n e d ) 
5090 bp W ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ M M K t j m 
3054 bp 
2036 bp 
~ 1 4 0 2 b p 
bp 
B 1 kb Nhe \ISac II Nhe ilSnaB I 
Marker digested digested 
6108 bp . ' ^ . . . J W a i p l l l M ^ ^ ^ ^ ^ ^ B < 5 8 0 7 b p ( f r a g m e n t r e m a i n e d ) 
5090 bp I I I " . " ^ H H ^ ^ ^ H - ^ - 5 3 0 3 b p ( f r a g m e n t r e m a i n e d ) 
3054 bp 
2 5 6 1 b p ( f r a g m e n t r e m o v e d ) 
2036 bp 2 0 5 7 b p ( f r a g m e n t r e m o v e d ) 
bp 
1018 bp 
Figure 3.27 Restriction enzyme digestions of the pGL3-PPSIG (-2936/+119) 
- parental construct to produce the 5，deletion constructs 
Three 5' deleted constructs (A) pGL3-PPSIG (-1534/+119) and (B) pGL3-PPSIG 
(-879/+119) and pGL3-PPSIG (-375/+119) were prepared from the parental construct 
pGL3-PPSIG (-2936/+119) by Nhe VNsi I，Nhe VSnaB I and Nhe VSac II，respectively. 
The uncut plasmid of pGL3-PPSIG (-2936/+119) was included for comparison. For 
Nhe VNsi I digestion, the largest band of -8000 bp was due to incomplete digestion as 
its size was similar to one of the uncut plasmid band. All the restriction enzyme 
digestion products showed expected size, indicating that the targeted fragments were 
successfully removed to produce the deletion constructs. 
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pGL3- pGL3- pGL3- pGL3-
PPSIG PPSIG PPSIG PPSIG 
1 kb (-2936/ (-879/ �-375/ (-1534/ 
marker +119) +119) +119) +119) 
5 0 9 0 b p - 4 5 9 8 b p 
b p ^ ^ ^ ^ j ^ ^ ^ i m m i l l i m i l l l ^ ^ 3 2 6 6 b p 
3 0 5 4 b p 
b p — b p 




Figure 3.28 Not l/Hind III restriction enzyme digestion to check the 5，-deletion 
constructs pGL3-PPSIG (-879/+119), pGL3-PPSIG (-375/+119) and 
pGL3-PPSIG (-1534/+119) 
The 5'-deletion constructs were digested with Not l/Hind III to check their insert sizes. 
The parental construct pGL3-PPSIG (-2936/+119) was included for comparison. All 
‘ the Not UHind III restriction enzyme digested products showed expected sizes, 
indicating that the deletion constructs pGL3-PPSIG (-879/+119), pGL3-PPSIG 
(-375/+119) and pGL3-PPSIG (-1534/+119) were successfully produced. 
� ‘ 
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pGL3-Basic. Significant induction was also observed in the three 5'-deletion 
constructs including pGL3-PPSIG (-1534/+119) (12.4-fold), pGL3-PPSIG (-879/+119) 
(11.5-fold) and pGL3-PPSIG (-375/+119) (12.9-fold). These results suggested that the 
promoter activity was retained in the 5'-deletion constructs. Similar results were 
obtained in HepG2 and AML-12 cells. The parental and deletion constructs all 
revealed a significantly higher relative lufierase activity compared with pGL3-Basic 
in both HepG2 (19.6- to 28.1-fold) and AML-12 (10.0- to 12.8-fold) cells. These 
results indicated that all the deletion constructs possessed promoter activity. As the 
deletion construct pGL3-PPSIG (-375/+119) contained the shortest PPSIG 5'-flanking 
fragment, the minimal essential region for inducing PPSIG promoter activity was 
located at -375 to +119. These results appeared to support the computer prediction 
using Matlnspector software that the transcription factors AP-1 (-129 bp), Spl (-74 bp) 
and TATA box (-56 bp) were found within the -375 to +119 region in the PPSIG 
fragment. 
‘ To produce the pSG5-PPARa and pSG5-RXRa expression plasmids for PPRE 
studies, a -1451 bp PPARa and a -1606 RXRa full-length coding sequences were 
amplified (Figure 3.30) and subcloned in a pSG5-expression vector. The orientations 
of PPARa and RXRa cDNA inserts in the vectors were identified by Stu I restriction 
enzyme digestions (Figure 3.31) and the sequences of expression pasmids 
192 



























































































































































































































































































































































































































































































































































































































































































































































were confirmed by DNA sequencing (Appendices D2 and D3). 
To prepare the positive control for monitoring the transfection experiment, a 
� 3 4 7 bp malonyl-CoA decarboxylase (MCD) promoter fragment which contains two 
functional PPREs was amplified (Figure 3.32) and subcloned in a pGL3-Basic vector 
to produce the pGL3-MCD reporter construct. The pGL3-MCD construct was 
confirmed by Not UHind III digestions (Figure 3.33) and DNA sequencing (Appendix 
D4). 
It was found that co-transfection of pSG5-PPARa and pSG5-RXRa with 
pGL3-MCD reporter construct revealed a significant 5-fold increase in reporter 
activity compared with the activity of reporter construct alone (Figure 3.34). The 
induction was further increased to 7.2-fold by the addition of ligands (50 |aM 
Wy-14,643 for PPARa and 1 |aM 9-cis-retinoic acid for RXRa). 
For pGL3-Basic, there was no significant induction of relative luciferase 
activity by co-transfection of pSG5-PPARa and pSG5-RXRa and ligand treatment 
� (Figure 3.34). However, a small (1.22-fold) but significant induction of luciferase 
activity was observed in the presence of pSG5-PPARa and pSG5-RXRa, showing 
thai co-transfection of pSG5-PPARa and pSG5-RXRa might slightly alter the 
luciferase activity of pGL3-Basic vector alone. This alteration was also reported by 
































































































































































































































1048 b^398 (5527 bp) 
( P P A I l a { 1 4 5 1 bp). 1 kb Stu I 
Sui � marker digested 
Stu 
C V Right y 
orientation y / B i H H H I i l ^ ^ ^ ^ H I H 
4479 bp 5090 bp 1 J • -4479 bp 
1801 bp ^ ^ 2 1 5 1 
1636 bp 
^^nf ^ PPARa {14S1 bp) • • • I ^ H H M 
\ 1018 bp bp 
//sfu I \ I ^ B ^ ^ ^ H 
(I ] 506bp ^mam^^^^m 
Wrong J 
ntatjoijx^ ^ ^ ^ ^ ^ H B B 
3726 bp Nv 
B pSG5-RXRa 
1063bp^ 1413 (5682 bp) 
( RXR (1606 bp) 1 kb Stu I 
S u I \ marker digested 
Right J 
orlentaion ^ ^ • 
4619 bp \ j ^ j j J J J j i i J J I ^ ^ ^ ^ ^ I 
1955 b D ^ 2305 1636 bp W ^ ^ Z S P m 
, 丄 I \ 
^ Wrong J 
D^orientaion 
3727 bp 
- Figure 3.31 Stu I digestion to check the orientation of PPARa and 
RXRa inserts in the expression plasmids 
Stu I digestion was performed to check the orientation of (A) PPARa and (B) RXRa 
insert in the expression plasmids, which was important for their protein expression. 
The Stu I digested products of both pSG5-PPARa and pSG5-RXRa showed sizes 
matched with the expected sizes of right orientation, indicating that PPARa and 






400 bp ^ ^ ^ ^ ^ ^ • -^347 
b p 
Figure 3.32 PCR products of MCD promoter fragment containing two 
functional PPREs 
‘ The MCD promoter fragment from -303 to +30 with reference to the transcription 
start site which contained two functional PPREs was amplified by MCD-FP(-311) and 
MCD-RP(+36). The PCR product showed size matched with expected size, 









506 bp � 5 3 1 bp 
Figure 3.33 Not l/Hind III restriction enzyme digestion to check thie reporter 
construct pGL3-MCD 
Not VHind III restriction enzyme digestion was used to check the pGL3-MCD 
construct. The Not VHind III digested products showed sizes matched with the 
expected sizes, indicating that the pGL3-MCD construct was successfully produced. 
199 
12 1 
^ ^ None 
I I PPARa and RXRa 
> 10 - ^ m PPARa, RXRa, 
Wy-14,643 and 9-cis-retinoic acid 
• • * 
n3 8 -
� (fi • • • 
0 6 - ** f l a: 2 - 嫩 ** 
e l ^ • ^ 
pGL3-Basic pGLS-PPSIG pGL3-MCD 
(-2936/+119) 
Figure 3.34 PPSIG 5'-flanking region from -2936 to +119 did not contain PPRE 
pGL3-PPSlG (-2936/+119) was transient transfected into NIH-3T3 cells, with or 
without the co-transfection of pSG5-PPARa and pSG5-RXRa expression plasmids. 
pSG5 empty vector was used to maintain equal DNA amount in all transfection 
conditions. Cells were either treated with ligands (50 |iM Wy-14,643 and 1 |aM 
9-cis-retinoic acid), or untreated in which DMSO and absolute ethanol were added. 
pGL3-MCD and pGL3-Basic were included as positive and negative controls, 
respectively and pRL-TK was used to correct for transfection efficiency. Transfections 
were done in triplicate. The relative luciferase activity of the constructs was 
normalized to the activity of pRL-TK vector and expressed as fold induction 
compared with the activity of reporter construct alone. Results are shown as means 土 
S.E.M. (n=3) *P<0.05, **P<0.01 and ***P<0.001, reporter alone versus 
pSG5-PPARa and pSG5-RXRa co-transfected with/without ligands. The Student's 
/-test was used to examine the difference and a difference of P<0.05 was considered 
significant. All statistical analyses were carried out using SigmaStat version 2.03 
software system (Systat Software, Inc., USA). 
•V 
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Co-transfection of pSG5-PPARa and pSG5-RXRa with the PPSIG promoter 
construct pGL3-PPSIG (-2936/+119) with or without ligands resulted in a significant 
1.6- and 1.5-fold inductions in reporter activity, respectively (Figure 3.34), which 
were statistically significant. Such induction was similar to that observed in the 
pGL3-Basic but was much lower than that of pGL3-MCD, indicating that no PPRE 
was present within this promoter region. This result matched with the Matlnspector 
prediction that no PPRE was predicted in the PPSIG promoter region. 
3.4 Identification of a functional PPRE in the intron 1 of 
PPSIG gene 
In order to locate the putative PPRE, the whole PPSIG genomic sequence was 
analyzed using the Matlnspector software. Two direct repeats of the DR-1 type 
showing similarity to the consensus PPRE sequence (TGACCTNTGACCT) at 
positions +375 to +387 (AGACCTTTCCCCT) and +402 to +414 
‘ (CCAACTTTTCCCT) were found in intron 1 of the PPSIG gene (Figure 3.35). These 
two sequences were named as putative PPRE 1 and PPRE 2，respectively. 
To prepare the PPSIG-PPRE reporter constructs for studying whether the 
intronic PPREs 1 and 2 were functional, four different PPSIG fragments which 




































































































































































































































































































































































































































































































pGL3-Basic vectors. Two of them [pGL3-PPSlG (-229/+435) and pGL3-PPSIG 
(-229/+3031)] contained the essential promoter elements, while the other two 
constructs [pGL3-PPSIG (+94/ +435) and pGL3-PPSIG (+94/+3031)] included the 
sequences after the ATG start codon in exon 1. Not VHind III restriction enzyme 
digestion was performed to check the PPSIG-PPRE reporter constructs (Figure 3.37) 
and the DNA sequences of all the reporter constructs were confirmed by sequencing 
(Appendices D5-D8). • 
To prepare a positive control reporter construct which contained an intronic 
PPRE, a � 1 3 7 1 bp acyl-CoA binding protein (ACBP) fragment which contained a 
functional intronic PPRE was amplified (Figure 3.38) and subcloned in pGL3-Basic 
vector to serve as a positive control. Not VHind III restriction enzyme digestion was 
performed to check the pGL3-ACBP reporter construct (Figure 3.38) and the DNA 
sequence of the pGL3-ACBP reporter construct was confirmed by sequencing 
(Appendix D9). 
The reporter activity of two positive reporter constructs (pGL3-MCD and 
pGL3-ACBP) and the pGL3-Basic was firstly analyzed by transient transfection into 
NIH-3T3, HepG2 and AML-12 mammalian cell lines. Transient transfection of 
pGL3-MCD and pGL3-ACBP constructs in NIH-3T3 cells in the presence of ligands 
























































































































































































































































































































































PPSIG PPSIG 1 kb 
{-229/+435)(+94/+435) Marker 
-4598 bp 5090 bp 
(Vector) 4072 bp 
H ^ ^ ^ ^ I ^ H ^ ^ I 3054 bp 
100 bp 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ Marker 
-858 b p — ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ K S S S m 900 bp 
-536 b p — 600 bp 
500 bp 
B pGL3- pGL3-
1 kb PPSIG PPSIG 
Marker (-229/+3031)(+94/-»'3031) 
『 ‘ 、 1 薩 • 垂 
I j ^ ^ m j / m 
二 | = 4 丨 丨 置 ] 一 二 
3054 bp ^ ^ ^ ^ • • • H H M I I M 
… . 邏 . . . .1 • - -2383 bp 
bp ^ ^ ^ ^ ^ ^ H H H ^ m i l ^ (insert) 
m m m 
1018 bp bp 
506 bp 
‘ Figure 3.37 Not VHind III restriction enzyme digestions to check the 
PPSIG-PPRE reporter constructs that containing putative 
PPREs 1 and 2 
Not VHind III restriction enzyme digestions were used to check the PPSIG-PPRE 
reporter constructs (A) pGLS-PPSIG (-229/+435) and pGL3-PPSIG (+94/+435) and 
(B) pGL3-PPSIG (-229/+3031) and pGL3-PPSIG (+94/+3031). The product sizes 
matched with the expected size, indicating that these contmcts were successfully 
produced. One extra band was observed in both pGL3-PPSIG (-229/+3031) and 
pGLS-PPSIG (+94/+3031), as there was a Hind III site at +512 of PPSIG. 
205 
A 1 kb 
Marker 
IP_i|_ililiii|iillii|i III 
B v i ^ m i i i i m 
B 1 kb 
Marker 
l ^ l ^ m ^ H H I l f (Vector) 
bp 
16：16 bp 令-1S6S bp 
bp 
Figure 3.38 Cloning of acyl-CoA binding protein (ACBP) reporter construct 
which contained an intronic PPRE 
(A) PCR product of ACBP-FP(-392)/ACBP-RP(+979). The ACBP intronic fragment 
which contained an intronic PPRE was amplified by ACBP-FP(-392) and 
ACBP-RP(+979). The PCR product showed size matched with expected size, 
suggesting that it was successfully amplified. (B) Not VHind III restriction enzyme � 
digestions was used to check the pGL3-ACBP reporter construct. The digested 
product showed sizes matched with the expected size, indicating that the pGL3-ACBP 
reporter contruct was successfully produced. 
206 
compared with the reporter construct alone (Figure 3.39). Co-transfection of 
pSG5-PPARa and pSG5-RXRa significantly increased the reporter activity of 
pGL3-MCD and pGL3-ACBP by 4.5- and 4.9-fold, respectively while addition of 
ligands in co-transfected cells further increased the reporter activity to 7.3- and 
9.4-fold for pGL3-MCD and pGL3-ACBP, respectively. Similar trends were observed 
in HepG2 and AML-12 cells. In both cells, addition of ligands to cells transfected 
with pGL3-MCD and pGL3-ACBP signicantly induced their reporter activity (1.4- to 
1.6-fold). When co-transfected with pSG5-PPARa and pSG5-RXRa in both HepG2 
and AML-12 cells, a significant induction was observed for both pGL3-MCD (5.0- to 
5.9-fold) and pGL3-ACBP (4.2- to 4.3-fold). In the presence of ligands, the fold 
activations were further enhanced for pGL3-MCD (17.3-fold in HepG2 and 17.6-fold 
ill AML-12) and pGL3-ACBP (9.5-fold in HepG2 and 10.5-fold in AML-12) 
(Figure 3.39). A small but significant induction (< 2-fold) was also observed in 
pGL3-Basic in some treatment conditions in the three cell lines examined. 
The luciferase activity of PPSIG-PPRE reporter constructs pGL3-PPSlG (-229/+435), 
pGL3-PPSIG (+94/+435), pGL3-PPSIG (-229/+3031) and pGL3-PPSIG (+94/+3031) 
was then studied by transient transfection in NIH-3T3, HepG2 and AML-12. In 
NIH-3T3 cells, except pGL3-PPSIG (+94/+3031) showed a small (1.1-fold) but 
significant induction in the presence of ligands only (50 jiM Wy-14,643 and 1 |iM 
207 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































9-cis-retinoic acid), the other PPSIG-PPRE reporter construct did not show significant 
induction by ligand treatment only (Figure 3.39). However, significant induction of 
luciferase activity was observed when pSG5-PPARa and pSG5-RXRa were 
co-transfected and this induction was further enhanced by the addition of ligands. 
Maximal induction (14.3-fold) was observed in pGL3-PPSIG (+94/+435) construct 
co-transfected with pSG5-PPARa and pSG5-RXRa and treated with ligands, while 
only 2.3- to 2.8-fold induction was observed in the other three constructs 
[pGL3-PPSIG (-229/+435), pGL3-PPSIG (-229/+3031) and pGL3-PPSIG (+94/ 
+3031)] receiving the same treatment (Figure 3.39). The fold induction observed in 
the pGL3-PPSlG (+94/+435) construct was even higher than that in the positive 
controls. Similar trends were observed in HepG2 cells. Maximal induction (30.2-fold) 
was found in pGL3-PPSIG (+94/+435), while 9.4- to 14.0-fold induction was 
observed in the other three reporter constructs co-transfected with pSG5-PPARa and 
pSG5-RXRa and treated with ligands. Similar to the result obtained in NIH-3T3 and 
HepG2 cell lines, maximal induction (35.2-fold) was found in pGL3-PPSIG 
(+94/+435) construct co-transfected with pSG5-PPARa and pSG5-RXRa in the 
presence of ligands. However, only a 4.7-fold induction was found in pGL3-PPSIG 
(-229/+435) construct, while a lower but significant (1.6- to 1.9-fold) induction was 
reported in pGL3-PPSIG (-229/+3031) and pGL3-PPSIG (+94/+3031) constructs in 
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the presence of pSG5-PPARa, pSG5-RXRa and ligands. Thus, it was clear that the 
highest PPRE activity was found within +94 and +435 in intron 1 of the PPSIG gene 
and the PPRE activity was inhibited by the presence of some unknown factors within 
the -229 to +93 and +436 to +3031 regions. 
A deletion construct pGL3-PPSIG (+94/+190) which excluded the putative 
PPRE 1 (+375/+387) and PPRE 2 (+402/+414) was prepared from the parental 
construct pGL3-PPSIG (+94/+435) and studied in transfection experiments. To 
produce the pGL3-PPSIG (+94/+190) deletion construct, a 245 bp (+191/+435) 
fragment was removed from the parental construct pGL3-PPSIG (+94/+435) by Stu I 
and Xho I digestions (Figure 3.40) and then the remaining fragment was religated to 
produce the pGL3-PPSIG (+94/+190) construct. The deletion construct was screened 
by Not UHind III digestions (Figure 3.41) and its DNA sequence was confirmed by 
sequencing (Appendix D6). 
The reporter activity of the parental pGL3-PPSIG (+94/+435) and deletion 
pGL3-PPSIG (+94/+190) constructs was compared by transient transfection in three 
mammalian cells including NIH-3T3, HepG2 and AML-12 in order to confirm that 
the increase in luciferase activity in pGL3-PPSIG (+94/+435) construct was due to the 
presence of the functional PPREs 1 and 2. It was shown that the fold induction of 
reporter activity of the pGL3-PPSIG (+94/+190) deletion construct co-transfected 
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Figure 3.40 Stu VXho I digestion of the pGL3-PPSIG (+947+435) parental 
. construct to produce the deletion construct pGL3-PPSIG 
(+94/+190) 
Stu VXho I digestion was performed to remove a target fragment (+191/+435) from 
the parental construct pGL3-PPSIG (+94/+435) to generate the deletion constructs 
pGL3-PPSIG (+94/+190). The restriction enzyme digested products were 
electrophoresed in (A) 0.7% and (B) 2% agarose gels. The uncut product of 
pGL3-PPSIG (+94/+435) was included for comparison. The restriction enzyme 
digestion products showed expected sizes, indicating that the target fragment 
(+191/+435) was successfully removed. 
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Figure 3.41 Not VHind III restriction enzyme digestions to check the PPSIG 
PPRE reporter constructs that containing putative PPREs 1 and 2 
Not VHind III restriction enzyme digestions were used to check the PPSIG-PPRE 
deletion construct pGL3-PPSIG (+94/+190) and the restriction enzyme digested 
products were resolved in (A) 0.7% and (B) 2% agarose gels. The product sizes 
气 ， 
matched with the expected size, indicating that the deletion contract was successfully 
produced. 
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with pSG5-PPARa and pSG5-RXRa with or without ligand treatment (1.2- to 
2.6-fold) was significantly lower compared to the parental construct pGL3-PPSIG 
(+94/+435) in all the three cell lines examined (Figure 3.42). This result indicated that 
PPSIG fragment from +191 to +435 was essential for the transcriptional activation by 
PPARa and RXRa heterodimer. As putative PPRE 1 (+375/+387) and PPRE 2 
(+402/+414) were located within this region, these results supported that at least one 
or both of them were functional. . 
To examine whether both PPREs 1 and 2 or either one of them was functional, 
three PPRE-deletion constructs [pGL3-PPSIG (APPRE 1), pGL3-PPSIG (APPRE 2) 
and pGL3-PPSIG (APPREs 1 and 2)] and three PPRE-mutation constructs [pGL3-
PPSIG (mutPPRE 1)，pGL3-PPSIG (mutPPRE 2) and pGL3-PPSIG (mutPPREs 1 and 
2)] were produced. These PPRE-deletion and mutation constructs were generated by 
amplification of the left and right halves of the parental construct pGL3-PPSIG 
(+94/+435) using specific combinations of primers designed (Figure 3.43) in which 
the targeted deletion or mutation was introduced. The PPRE-deletion constructs and 
PPRE-mutation constructs were distinguished from the parental construct by EcoR I 
digestion, since EcoK I site was introduced in the PCR-generated constructs (Figure 
3.44). The introduced PPRE deletion and mutation of the PPRE-deletion and 
PPRE-mutation constructs were confirmed by sequencing (Appendix DIO). 
214 . 
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Figure 3.42 PPRE was present in PPSIG intronic fragment from +191 to +435 
pGL3-PPSIG (+94/+435) and pGL3-PPSIG (+94/+190) constructs were transient 
tranfected into NIH-3T3, HepG2 and AML-12 cells, with or without co-transfection 
of pSG5-PPARa and pSG5-RXRa expression plasmids. pSG5 vector was used to 
adjust to equal DNA load. Cells were either treated with ligands (50 |aM Wy-14,643 
and 1 \jiM 9-cis-retinoic acid), or untreated in which DMSO and absolute ethanol were 
added. pGL3-Basic was included as negative control. pRL-TK was introduced to 
correct for transfection efficiency. Transfections were done in triplicate. The relative 
luciferase activity was normalized to the activity of pRL-TK vector and expressed as 
fold induction compared with the activity of reporter construct alone. Results are 
shown as means 土 S.EM, (n > 3) ***P<0.001, parental construct [pGL3-PPSIG 
(+94/4-435)] versus deletion construct [pGL3-PPSIG (+94/+190)] receiving the same 
treatment. The Student's r-test was used to examine the difference and a difference of 
厂<0.05 was considered significant. All statistical analyses were carried out using 
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Transient transfection experiment was performed in AML-12 cells to compare 
the reporter activity of the parental construct pGL3-PPSIG (+94/+435) and the PPRE-
deletion constructs (Figure 3.45). It was found that the relative luciferase activity of 
the parental construct showed a 12.1-fold increase in the presence of pSG5-PPARa 
and pSG5-RXRa expression plasmids and such induction was further increased to 
33.4-fold when ligands were added (50 mM Wy-14,643 and 1 mM 9-cis-retinoic acid). 
However, such transcriptional inductions were significantly reduced to 1.5- to 2.1-fold 
when PPRE 1 or both PPREs 1 and 2 were deleted, suggesting that only PPRE 1 was 
functional for transcriptional activation by PPARa/RXRa heterodimer. This result 
was further supported by the data obtained from the experiment using the 
PPSIG-PPRE-deletion construct pGL3-PPSIG (APPRE 2) to study the responsiveness 
to PPARa/RXRa heterodimer. It was found that the construct with deletion of PPRE 
2 still retained its responsiveness to pSG5-PPARa and pSG5-RXRa co-transfection 
(24.2-fold) and the induction was further increased by ligand treatment (61-fold). 
Surprisingly, the fold induction observed in the PPRE 2-deleted construct was 
significantly higher than that observed in the parental construct, suggesting that the 
presence of PPRE 2 might affect J h e binding of PPARa/RXRa heterodimer to the 
PPRE 1 sequence. 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































PPRE-mutation constructs was also compared (Figure 3.45). Similar to the results 
obtained from the transfection experiments with PPRE-deletion construct, the induced 
luciferase activity by PPARa and RXRa heterodimer with or without ligand treatment 
was significantly reduced to less than 1.6-fold when the sequences of PPRE 1 or both 
PPREs 1 and 2 were mutated. As expected, the pGL3-PPSIG (mutPPRE 2) construct 
with mutated PPRE 2 still retained its PPARa/RXRa responsiveness, showing that 
PPRE 2 was not required for the transcriptional activation by PPARa/RXRa 
heterodimer (Figure 3.45). These results further supported that only PPRE 1 was 
functional and the sequence of PPRE 1 was important for its transactivation. 
Moreover, similar to the result observed from construct with PPRE 2 deletion, it was 
found that the luciferase activity induced by PPARa/RXRa heterodimer with or 
without ligands was significantly higher when PPRE 2 was mutated. 
3.5 Gel shift analysis of PPARa/RXRa heterodimer to 
PPSIG-PPRE 
To determine whether the PPARa/RXRa heterodimer indeed binds to the 
putative PPRE 1 in intron 1 of tKe mouse PPSIG, EMSAs were performed using in 
vitro transcribed/translated PPARa and RXRa proteins (Figure 3.46). The binding 
































































































































































































































































































































































the functional PPRE of rat acyl-CoA oxidase (AOX) (Osada et al. 1997) were studied 
(Figure 3.47). A unique retarded band was observed when AOX-PPRE was incubated 
with both PPARa and RXRa, but this band was not observed in the absence of 
PPARa and RXRa, indicating that the retarded band was due to the formation of 
PPARa/RXRa/PPRE complex. No retarded band was observed for PPSIG-PPRE 2 
incubated with both PPARa and RXRa, suggesting that no binding activity occurred 
between the PPSIG-PPRE 2 and the PPARa/RXRa heterodimer. In contrast, a 
retarded band was observed when PPSIG-PPRE 1 was incubated with both 
PPARa and RXRa, showing that the PPARa/RXRa heterodimer bound to the 
PPSIG-PPRE 1 sequence. The signal intensity of the retarded band decreased when 
10-fold excess of unlabeled wild-type PPSIG-PPRE 1 was added to the mixture and 
the signal totally disappeared when 100-fold excess of the same competitor was added, 
indicating that the unlabeled wild-type PPRE 1 oligonucleotides competed with the 
DIG-labeled wild-type PPRE 1 for the binding of PPARa/RXRa heterodimer. In 
contrast, no effect on the signal intensity of the retarded band was noted when 10- or 
100-fold excess of the mutated PPRE 1 was used to compete with DIG-labeled PPRE 
1, showing that PPARa/RXRa heterodimer did not bind to the mutated PPRE 1 
sequence. Taken together, these results showed that PPARa/RXRa heterodimer 
indeed bound to PPSIG-PPRE 1 and the PPSIG-PPRE 1 sequence was specific for 
_ 224 



























































































































































































































































































































































































































































































































































































































































































































































































PPARa and RXRa heterodimer binding. 
Nuclear proteins extracted from AML-12 cells were also used to study the 
binding of PPARa and RXRa on the PPREs 1 and 2 of PPSIG. DIG-labeled 
dimerized oligonucleotides of PPSIG-PPRE 1, PPSIG-PPRE 2 and AOX-PPRE were 
incubated with nuclear extracts from AML-12 cells which were treated with either 50 
).iM Wy-14,643 or DMSO for 24 h (Figure 3.48). A unique band was retarded for 
AOX-PPRE in the presence of either treated or untreated AML-12 nuclear extracts 
and this band was not observed in the absence of nuclear extracts, confirming that 
some AML-12 nuclear proteins, possibly the PPARa/RXRa protein, bound to the 
AOX-PPRE sequence. The signal intensity of the retarded bands was similar for 
nuclear extracts obtained from both treated and untreated cells, suggesting that 
nuclear proteins that bound to AOX-PPRE were more or less the same in both extracts. 
Similar results were obtained for the binding reaction between PPSIG-PPRE 1 and the 
nuclear extract. In the competition assays, it was shown that the signal intensity of the 
retarded band decreased when 10-fold excess of unlabeled wild-type PPRE 1 
oligonucleotides was added to the mixture and the signal intensity was further 
diminished when 100-fold excess of the same competitor was added, indicating that 
the unlabeled wild-type PPRE 1 oligonucleotides competed with the DIG-labeled 
PPRE 1 for the binding to the nuclear proteins. Surprisingly, it was also found that the 
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signal intensity decreased when 10- or 100-fold mutated PPRE 1 oligonucleotides 
were added as competitors, suggesting that both the wild-type or mutated PPRE 1 
could compete with the DIG-labeled PPRE 1 for binding to the proteins extracted 
from the nuclear extracts. This result was in contrast to that obtained in the EMSA 
experiment using in vitro transcribed/translated PPARa and RXRa proteins in which 
mutated PPRE 1 did not compete with the DIG-labeled PPRE 1 for binding to the 
PPARa and RXRa heterodimer. Thus, it appeared that the retarded band observed in 
the EMSA experiments with nuclear extracts was not only due to the complex 
formation of PPARa/RXRa/PPRE, since AML-12 nuclear extracts might contain 
many other transcription factors such as PPARp or PPARy that could bind to similar 
DR-1 type recognition site. Furthermore, a reduction in signal intensity in the retarded 
band when using mutated PPRE 1 as a competitor, suggesting that mutated PPRE 1 
competed with the DIG-labeled PPRE 1 for the binding to the other transcription 
factors. This speculation was further supported by the observation that a unique 
retarded band was also observed for PPSIG-PPRE 2 in the presence of nuclear 
extracts. From these results it seemed that the unexpected binding activities obtained 
between nuclear proteins and the PPREs 1 and 2 might be due to the binding of other 
transcription factors present in the nuclear extract. To determine whether other PPAR 
isoforms such as PPARp and PPARy can form heterodimer with RXRa and bind to 
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PPSIG-PPRE 1 and/or PPRE 2 sequence, EMSA experiments were performed using 
in vitro transcribed/translated PPARp and PPARy proteins. As shown in Figure 3.49, 
AOX-PPRE displayed a strong retarded band in the presence of PPARa and RXRa as 
well as PPARy and RXRa. A weaker retarded band was also observed when 
AOX-PPRE was incubated with PPARp and RXRa. These results showed that 
besides PPARa/RXRa heterodimer, PPARp/RXRa and PPARy/RXRa heterodimer 
also bound to AOX-PPRE. It is known that AOX is regulated by both PPARa and 
PPARy (Marcus et al. 1993), but whether AOX is also regulated by PPARp has not 
been reported. Similar results were obtained for PPSIG-PPRE 1. A retarded band was 
found in the presence of PPARa/RXRa, PPARp/RXRa and PPARy/RXRa, 
suggesting that both PPARa/RXRa, PPARp/RXRa and PPARy/ RXRa heterodimers 
bound to PPSIG-PPRE 1. No retarded band was observed for PPSIG-PPRE 2， 
suggesting that neither PPARa/RXRa, PPARp/RXRa nor PPARy/RXRa heterodimer 
bound to PPSIG-PPRE 2. Taken together, these results showed that PPRE 1 not only 
^ bound to PPARa/RXRa but also to PPARp/RXRa and PPARy/RXRa heterodimers. 
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Chapter 4 Discussion 
PPSIG was firstly identified as a novel gene in our laboratory during a research 
project using fluorescent differential display method and PPARa-null mice model to 
screen for novel PPARa target genes. In the Northern blot analysis, it was found that 
the transcription of PPSIG was up-regulated in wild-type mice after treatment with 
PPs or starved for 72 h. Such induction was not observed in PPARa-null mice, 
suggesting that the transcriptional regulation of PPSIG was mediated by PPARa and 
that PPSIG is a putative PPARa target gene. The aim of this research project was to 
identify the functional PPRE of PPSIG that was responsible for transcriptional 
activation by PPARa and to confirm that PPSIG is a novel PPARa target gene. 
As a first step to analyze the PPSIG gene, 5' and 3’ RACE was performed to 
obtain its full-length cDNA. The 5' and 3’ RACED results revealed that the open 
reading frame (ORF) of PPSIG was 1830 bp, using the ATG at 27 bp downstream of 
the TSS as the start codon and TAG at +1856 bp downstream of the TSS as the stop 
‘ codon. This ORF was also identified in Riken cDNA 0610p39N19 and 
all-trans-13,14-dihydroretinol saturase (Moise et al. 2004). However, based on the 
analysis of PPSIG cDNA sequence, there is a second in-frame ATG start codon at 
+ 1089 bp downstream of the TSS and no stop codon in between the two start codon, 
which revealed another 768 bp ORF using this start codon and the same stop codon. 
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As it was not able to unambiguously assign the initiator methionine, experiments are 
being conducted in our laboratory to identify the functional ORF(s). 
PPSIG cDNA hybridized to three transcripts of 2000, 3000 and 3500 bp. The 
presence of multiple transcripts could be due to (i) the selection of alternative 
polyadenylation sites, (ii) the use of alternate transcription start sites and (iii) the 
differential splicing of pre-mRNA (Qu et al. 2002). In this thesis, one predominant 
product was obtained from 5' RACE while three products were obtained from 3’ 
RACE. The sequencing results of these RACED products demonstrated that there 
were three PPSIG transcripts (1962，2845 and 2898 bp). The isolation of three 
different 3' RACED cDNAs which differ in the 3’ UTR and poly(A) tails, in 
conjunction with the presence of only one 3000 bp transcript on Northern blot when 
using probe corresponding to 2233 to 2385 bp of the 3’ UTR, suggesting that the 
presence of multiple transcripts was due to alternative polyadenylation. The 3000 bp 
transcript in mouse liver was present at relatively lower levels on most Northern blots. 
This result could reflect an intrinsic instability due to sequences in the 3，UTR. 
PPSIG genomic sequence was studied and compared with the genomic 
sequences of Riken cDNA 0610039N19 and RetSat. PPSIG showed 99% sequence 
similarity with Riken cDNA 0610039N19 and RetSat, suggesting that these genomic 
sequences were in fact corresponding to the same gene. Alignment of the cDNA and 
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genomic sequences of PPSIG revealed that PPSIG contained 11 exons and 10 introns 
spanning 9825 bp. The first and second ATG start codons were observed in exon 1 
and 6, respectively. The TAG stop codon was at the last exon. The genomic sequence 
of PPSIG showed an extension in the 5' and 3' ends compared to that of Riken cDNA 
0610039N19 and RetSat, indicating that PPSIG carried the longest genomic sequence. 
Analysis of the 2700 bp 5, flanking region of PPSIG indicated that a TATA box, 
Spl and AP-1 were found at -56, -74 and -129 bp, respectively, with reference to the 
translation start codon. The identification of these factors suggested that the 2700 bp 
5' flanking region contained a putative promoter. In agreement with this prediction, 
strong promoter activity was localized at -375 to +119 of the 5'flanking region of 
PPSIG. 
No consensus PPRE sequence as well as transactivation by PPARa/RXRa 
heterodimer was found in the 2700 bp 5' flanking region of PPSIG, suggesting that 
PPRE of PPSIG is outside the promoter region. In agreement with this finding, two 
PPRE sequences at +375/+387 (PPRE 1) and +402/+414 (PPRE 2) in intron 1 of 
PPSIG were identified by computer prediction. Results from the transfection 
experiments indicated that a minimal PPSIG fragment +94/+435 allowed the 
transcriptional activation by PPARa/RXRa heterodimer and the deletion of this 
fragment abolished such activation, suggesting that PPRE 1 and/or PPRE 2 was 
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functional. 
Site-directed mutagenesis was performed to study whether both PPREs 1 and 2 
were functional. It was shown that deletion of PPRE 1 abolished the responsiveness to 
PPARa/RXRa heterodimer and such abolishment was not observed for deletion of 
PPRE 2. This result suggested that only PPRE 1 was functional. In addition, mutation 
of the sequences of the second motif of PPRE 1 from TCCCCT to TttttT abolished the 
transcriptional activation by PPARa/RXRa heterodimer, while such activation still 
existed in reporter construct with mutated PPRE 2. Taken together, these results 
indicated that only PPRE 1 was functional and the sequence of PPRE 1 was specific 
for transcriptional activation by PPARa/RXRa heterodimer. 
EMSAs using in vitro transcribed/translated PPARa and RXRa proteins further 
demonstrated the direct binding of PPARa/RXRa heterodimer to PPSIG-PPRE 1. It 
was shown that PPARa/RXRa heterodimer only bound to PPSIG-PPRE 1, but not 
PPSIG-PPRE 2 and PPSIG-mutated PPRE 1. Moreover, it was found that only 
PPARa or RXRa alone did not form complex with PPSIG-PPRE 1. From these 
results, it was confirmed that PPARa/RXRa heterodimer indeed bound to 
PPSIG-PPRE 1. Though computer software predicted that the sequence of PPRE 2 
was a putative PPRE, results from both transfection experiments and EMSAs 
indicated that it was not functional for PPARa/RXRa heterodimer transcriptional 
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activation. This was not an exceptional case, as in malonyl-CoA decarboxylase, three 
putative PPREs were predicted but only PPREs 2 and 3 were found functional (Lee et 
al. 2004). 
It was unexpectedly discovered that PPARp and PPARy also bound with PPRE 
1 as a heterodimer with RXRa. This finding raises a question that the transcription of 
PPSIG might be also regulated by PPARp and PPARy. Similar results were found in 
the transcriptional regulation of the lipoprotein lipase gene (Schoonjans et al. 1996a). 
It was shown that the transcription of the lipoprotein gene was differentially regulated 
by PPARa and PPARy. Treatment of PPARa ligands induced lipoprotein lipase gene 
expression exclusively in rat liver and such induction was not observed by treatment 
of PPARy ligands. In contrast, treatment of PPARy ligands induced lipoprotein lipase 
gene expression in rat adipose tissue. The inducibility of lipoproein lipase gene 
correlated well with the tissue distribution of the respective PPARs: PPARa was 
expressed predominantly in liver while PPARy was highly expressed in adipose tissue. 
These evidences suggested that the transcription of a PPARa target gene might be 
also regulated by PPARy in certain tissue(s). Therefore, it is necessary to study 
whether PPARy as well as PPARp played a role in regulating the transcription of 
PPSIG in different tissues. 
Retarded bands were observed for both PPRE 1 and PPRE 2 using nuclear 
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proteins extracted from AML-12 cells either treated with DMSO or 50 |iM Wy-14,643. 
Since PPARa/RXRa, PPARp/RXRa and PPARy/RXRa heterodimers did not bind to 
PPRE 2, the retarded band observed in EMSA using AML-12 nuclear extracts was 
belived to be formed by other nuclear proteins binding to the PPRE sequences. 
Moreover, addition of ligand did not strongly induce the PPRE activity in the 
transfection experiment in AML-12 cells, suggesting that the amount of endogenous 
PPARa and RXRa in AML-12 cells was limited and other nuclear factors might be 
more abundant, which could bound to the PPRE sequences. Several other nuclear 
hormone receptors have been shown to bind to PPREs and differentially modulate 
PPAR function. These include chicken ovalbumin upstream promoter transcription 
factor (COUP-TF) (Miyata et al. 1993), hepatocyte nuclear factor-4 (HNF-4) 
(Hansmannel et al. 2003), thyroid hormone receptor (TR) (Hunter et al. 1996) and 
retinoid Z receptor (RZR) family [also known as the retinoid orphan receptor (ROR) 
family] (Winrow et al. 1998). Transcriptional regulation via PPREs is thus a net 
aggregate response manifested in part by the availability of PPARs and other factors 
that bind to PPREs, the complexity of response elements and the interplay of PPARs 
with other nuclear hormone receptors and cofactors (Winrow et al 1998). Further 
experiments such as supershift assay could be performed to examine which other 
nuclear proteins could bind to PPRE 1 and/or PPRE 2 and regulate the transcription of 
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PPSIG. 
Identification of a functional PPRE in intron 1 of PPSIG further proved that 
PPRE is not restricted in the promoter region of a gene. PPRE was firstly identified in 
the promoter region of rat acyl-CoA oxidase (Tugwood et al. 1992) in 1992. Since 
then PPREs were identified in the promoter region of many PPARa target genes. 
There was a common belief that PPREs were located proximally to the transcriptional 
initiation site. Until 2002, a PPRE was firstly identified in the intron 1 of rat acyl-CoA 
binding protein (Helledie et al 2002). Another PPRE was found in intron 3 of the rat 
peroxisomal thiolase B gene (Hansmannel et al. 2003) the following year. In 2004, a 
PPRE was located 8400 bp downstream of the mouse P E X l l a gene (Shimizu et al. 
2004). In these three genes, the PPREs are believed to functions as an enhancer by 
serving as binding sites for transcription factors that regulate transcription. Enhancers 
often function irrespective of position relative to the promoter and distance from the 
transcriptional initiation site (Banerji et al. 1981). Similarly, it is possible that the 
PPRE 1 identified in PPSIG in the present study acted as an enhancer to regulate 
PPSIG transcription. 
In conclusion, PPSIG was confirmed as a novel PPARa target gene in this 
study and that the transcriptional activation of PPSIG by PPs or during 72 h starvation 
is regulated by the binding of PPARa to the PPRE 1 in intron 1. 
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Chapter 5 Future studies 
From the results obtained in this project, PPARa was found to activate the 
transcription of PPSIG through PPRE 1 in intron 1，confirming that PPSIG is a new 
PPARa target gene. However, the biological function of PPSIG is still not known. 
Characterization of the function of PPSIG is a critical step in identifying its role 
in PPARa-regulating mechanisms. Based on the information obtained in this thesis, 
transcription of PPSIG was induced by both starvation and Wy-14,643 treatment in 
wild-type mice but not in PPARa-null mice, suggesting that this novel gene might 
play a role in fatty acid metabolism. From the results of other researchers in our 
laboratory, mice treated with high fat diet did not show induction in PPSIG mRNA 
expression. These results indicate that PPSIG is more likely to be involved in fatty 
acid catabolism. To find out the function of PPSIG, in vitro study will be performed 
by over-expression of PPSIG in mammalian cells and observe if there are any changes 
in morphology and proliferation of the cells. Its role in fatty acid metabolism will also 
‘ be examined by treating with different ligands. In vivo study will also be introduced 
by constructing PPSIG-null mouse and examining using different phenotypes upon 
starvation and Wy-14,643 treatment. The comparison of long term Wy-14,643 
treatment effect on wild-type and PPSIG-null mouse might show us whether PPSIG is 
related to cancer. These results obtained might provide more information on how 
241 
PPARa mediates its toxicological as well as physiological roles. 
To examine whether the transcriptional regulation of PPSIG is PPARp and 
PPARy dependent in different tissues, in vivo study could be performed. Firstly, two 
groups of mice will be treated with PPARp and PPARy ligands and the PPSIG RNA 
level in untreated and treated mice will be compared. An induction in PPSIG suggests 
that the transcription of PPSIG is activated by PPARp and PPARy ligands. Assuming 
it is the case, transfection experiments could be performed to study whether PPARp 
and PPARy regulate PPSIG transcription through PPRE 1. 
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Appendix A: Seating plan of transfection experiments (24-wells) 
A l . Transfect ion experiment to study PPSIG-promoter reporter constructs 
Plate 1 
Ti |T2 r n r o r n iTe 
200 ngpGL3-PPSlG 200 pOL3-Pt'SIG 200 rtgpGL3-l|>SlG 200 ng pGL3-Basic 200 ng pGL3-Basic 200 ng pCiL3-Basic 
(-2936/+119) (-2936/+119) (-2936/+119) 20 ng pRL-TK 20 ng pRL-TK 20 ngpRl.-TK 
20 ng pRL-TK 20 ng pRl.-TK 20 ng pRL-TK 100 ng pSG5-PPARa 100 ng pSG5-PPARa 100 ng pSG5-PPARa 
lOOng pSG5-PPARa 100 ng pSG5-PPARa 100 ng pSG5-PPARa 100 iig pSG5-RXRa 丨00 ng pSG5-RXRa 100 iig pSGS-RXKa 
100 ng pSG5-RXRa 100 ng pSG5-RXRa 100 ng pSG5-RXRa Ligands Ligands Ligands 
Ligands Ligands Ligands (50 Wy-14.643 & (5(UiM Wy-I4.643 & (50 灿 1 Wy-I4.M3 & 
(50 jiM Wy-14,643 & (50 pM Wy-14,643 & (50 nM Wy-14,643 & I nM 9-cis-ielinoic acid) I |.iM 9-cis-retinoic acid) 1 nM 9-cis-retinoic acid) 
uM 9-cis-relinoic acid) I (.iM 9-cis-ieliiioic acid) I |.iM 9-cis-ietinoic acid) 
2.1 2.2 2.3 ~2A 15 1 6 
200 ng pGL3-PPSlG 200 ngpGLS-PPSlG 200 ng pGLS-lfSlG 200 ng pGL3-Basic 200 ng pGL3-Basic 200 na pGL3-Basic 
(-2936/+119) (-2936/+119) (-2936/+119) 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 
20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 100 ng pSG5-PPARa 100 ng pSG5-PPARa 100 ng pSG5-PPAR(x 
100iigpSG5-PPARa 100 ng pSG5-PPARa 100 ng pSG5-PPARa 100 ng pSG5-RXRa lOOng pSG5-RXRa 100 iig pSG5-RXRa 
100 ng pSG5-RXRa 100 ng pSG5-RXRa 100 ng pSG5-RXRa No ligands No ligands No ligands 
_No l igands N o l igands N o l igands 
3.1 3.2 3.3 l 4 1 5 1 6 
200ngpOL3-PPSIG 200ngpGU-PPSIG 200ngpGL3-lfSIG 200ngpGL3-Basic 200 ngpOL3-Basic 200 ne pGL3-Basic 
(-2936/+119) (-2936/+11$) (-2936/+119) 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 
20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 200 ng pSG5 vector 200 ng pSG5 vector 200 ng pSGS vector 
vector 200 ag pS05 vwtOT 200 ^ pS05 vfctor No ligands Na ligands No ligands 
No ligands No ligands No ligands 
“42 TH 4~5 47, 
/ Z / / 
, z / z z 
/ z Z 
z / ,, . 
, / / y 
^ L L Li L:： I 
— 
Plate 2 
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A2. Transfect ion experiment to study the PPSIG-promoter deletion constructs 
n ^ r o [m m [76 
2W«fpGL3-PPSIG 200 ngpGL3.PP§IG 200 ngpGL3彿SIG 200 ng pGL3-Basic 200 ng pGL3-Basic 200 ns pGL3-Bas.c 
("2936/+U9) (•2936/+119) (-2936/+1I9) 20ngpRL-TK 20ng pRL-TK 20 ng^Rl -TK 
？P P'^ L-TK 20 ng pRL-TK 20 ng pRL-TK 200 rigpSGS vector 200ilgpS05 vector 2bO ng pSG5 vector 
m M f S Q S v c c t o r 200 rtgpSO^ v«aot 200'ngpS<35 vfctor No ligands No ligands No ligands 
No ligands No ligands No ligands 
P Ts Ta "Ts T6 
200 ng pGL3-PP$IG 200 ngpOL3-PPSrG 200 ng pGL3-lf SIG 
(-375/+119) (-375/+119) {-375/+119) / 
20 »gpRL-TK 20 ng pRL-TK 20 ng pRL-TK / 掷(MlgpS<35 vector 200 ng pSGl vector 200ng^0s \f:tor / 
Mo ligands No ligands XRa No ligands 
"34 
200 ng pGL3-PPSI0 20G ng pGL3-PPSIG 200 ng pGL3-PPSIG X 
(-879/+119) (-879/+119) (-879/+119) , , 
20 >ig pRL-TK 20 ng pRL-TK 20 ng pRL-TK '' 
200 iig p$Q5 vector 200 ng p$05 vector 200 紐旅05 victor 
No ligands No ligands No ligands 
4.1 43 H 
200 ng pGL3-PPSIG 200 ng pGL3-PPSI0 200 ng pGLS-PPSIG •“ 
(-1845/+119) (-1845/+119) (-1845/+119) , 
^ngpRL-TK 20 ng pRL-TK 20 ng pRL-TK Z 
^OagpSGS vector 200 ng pSGS v^tor 2Q0iig pSG5 victor / Z 
No ligands No ligands No ligands 
L Iz [ / 
• 
2 5 9 
A3. Transfect ion experiment to study the PPSIG-PPRE reporter constructs 
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100 ng pSG5-RXRa 100 ng pSG5-RXRa 100 ng pSG5-RXRa 100 ng pSG5-RXRa 100 ng pSG5-RXRa 100 ng pSG5-RXRtt 
Ligands Ligands Ligands Ligands Ligands Ligands 
(50pM Wy-I4.643 & (50 pM Wy-14,643 & <5(HiM Wy-14,643 & (50 pM Wy-14,643 & (50 pM Wy-14.643 & (50 jiM \Vy-14.(>43 & 
I ).LM 9-cis-ietinoic acid) I (.iM 9-cis-retinoic acid) 1 ^M 9-cis-retiiioic acid) I nM 9-cis-ietinoic acid) I |iM 9-cis-ietiiioic acid) I t-iM '>-cis-ielmoic acid) 
2.1 2.2 2.3 2.4 2.5 2,6 
200ngpGU-PPSIG 2命 iig pG'U-PPSlG 200 ngpGLS-lf SIG 200 ng pGL3-PPSIG 200 ngpGL3-PPSlG 200 ng pGL3-PPSICi 
(-229/+435) (-229/t435) (-229/+435) (+947+435) (+94/+435) (+94/+435) 
20 ng pRL-TK 20 ng pRL-TK 20ngpRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 
100 ng pSG5-PPARa 100 iig pSG5-PPARa 100 ng pSG5-PPARa 100 ng pSG5-PPARa 100 iig pSG5-PPARa 100 ng pSG5-PI)ARa 
100 ng pSG5-r<XRa 100 ng pSG5-RXRa 100 ng pSG5-RXRa 100 ng pSG5-RXRa 100 iig pSG5-RXRa 100 ng pSG5-RXRa 
. No ligands No ligands No ligands No ligands No ligands No ligands 
3.1 3.2 3.3 3.4 3 . 5 3.6 
200tlgpGL3-PPSlG 200 ng pGL3-PPSIG 200 ng pGL3-Ff SIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSlG 200 ne pGL3-PPSiG 
(-229/+435) (-2297+435) (-229/+43S) (+947+435) (+94/+435) (+94/+435) 
20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ngpRL-TK 
200 tig p$05 vector 200 ngpSGS vector 200 ng pSGS vfafol 200 ngpSGS vector 200 ngpSG5 vector 200 ng pSG5 vector 
No I.igands Ligands Ligands Ligands Ligands Ligands 
(50 pM Wy-14’643 & (SOpM Wy-14,643 & (SOpM Wy-14.643 & (SOpM Wy-14.643 & (SOpM Wy-I4’643 & (50 & 
nM 9-cis-retiiioic acid) I pM 9-cis-retinoic acid) 1 ^ iM 9-cis-retinoic acid) I nM 9-cis-ietinoic acid) I pM 9-cis-retiiioic acid) I nM 9-cis-retinoic acid) 
4.1 4.2 4.3 4 .4 4.5- 4.6 
200 ngpGL3-PPSIG 200 ng pOO-PPSIG aoFng pGL3-F|>SIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSlG 200 ng pGL3-PPSlG 
(-229/+435) ( -229^35) (-229/+435) (+94/+435) (+94/+435) (+947+435) 
20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 
200iigp$G5vect6r 200 ng pSG5 vector 200 ng pSG5 vfcStor 200 ftgpSGS vector 200 ng pSG5 vector 200 ng pSOS vector 
No ligands No ligands No ligands No ligands No ligands No ligands 
I 
Plate 2 
^ \j2 i n \JA [ H [Tb 
200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSlG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 
(-229/+3031) (-229/+3031) (-229/+3031) (+94/+3031) (+94/+3031) (+94/+3()31) 
20 ng pRL-TK 20 iig pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRl.- TK 
•00 ng pSG5-PPARa 100 ng pSG5-PPARa 100 ng pSG5-PPARa 100 ng pSGSFTARa 100 ng pSG5-PPARa 100 ng pSG5-PPARu 
•00 ng pSG5-RXRa 100 iig pSG5-RXRa 100 ng pSG5-RXRa 100 ng pSG5-RXRc( 100 n^ pSG5-RXRa 100 ng pSG5-RXRu 
Ligands I.igands Ligands Ligands Ligands Ligands 
(SOpM Wy-14,643 & (SOpM Wy-14.643 & <50 pM Wy-I4’643 & (SOpM Wy-14’643 & (SOpM Wy-14,643 & (SO^iM Wy-I4.(>43 & 
-LliM 9-cis-ietinoic acid) I ).[M 9-cis-ietinoic acid) 1 |.iM 9-cis-retinoic acid) I |JM 9-cis-retinoic acid) I ^M 9-cis-retinoic acid) I pM 9-cis-ietinoic acid) 
6.2 6.3 6.4 6.5 6.6 
200 ng PGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSlG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 
(-229/+3031) (-229/+3031) (-229/+3031) (+94/+3031) (+94/+3031) (+94/+3031) 
20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ngpRl.-TK 
•O^ng pSG5-PPARa 100 iig pSG5-丨)l)ARa 100 ng pSG5-PPARa 100 ng pSG5-PPARa 100 ng pSG5-PPARa l()() iig pSG5-l)l)ARu 
ng pSG5-RXRa 100 iig pSG5-RXR(x 100 ng pSG5-RXRa 100 ng pSG5-RXRa 100 ng pSG5-RXR.tt 100 ne pSG5-RXRa 
No ligands No ligands No ligands No ligands No ligands No ligands 
7.1 l2 TA ~5 TZ 
200 ng PGL3-PPSIG 200 ng pGL3-PPSlG 200 ng pGL3-PPSlG 200 ng pGL3-PPSlG 200 ngpGL3-PPSIG 200 ng pGL3-PPSIG 
(-229/+303I) (-229/+3031) (-229/+3031) (+94/+3031) (+94/+3031) (+94/+3()31) 
gOiigpRL-TK 20 ng pRL-TK 20 ng pRL-TK 20np pRL-TK 20 ng pRL-TK 20 ng pRL- TK 
产总ngpSGS vector 200 t i | p S < l 5 ^ d f 200ngpSG5 victor iJgp^GS vector 2O0ttgpSG5 vector 200 ngpSG5 vector 
Ligands 丨-igands L i g a n d s L i g a n d s L i g a n d s U g a i i d s 
W H 4 , 6 4 3 & (M)mM Wy-14’643 & (5(HiM Wy-14,643 & (SOpM Wy-14,643 & (50 Wy-14.643 & (mTmM \Vy-|4.()43 & 
--~ti^9-cis-retinoic acid) I |iM 9-cis-ielinoic acid) I nM 9-cis-retinoic acid) 1 (.iM 9-cis-retinoic acid) I |.iM 9-cis-ietinoic acid) I |.iM 9-cis-ieiinoic acid) 
8.2 8.3 8,4 8.5 8.6 
；OOng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSlG 200 ng pGL3-PPSIG 200 ng pGL3-PPSlG 200 ng pGL3-PPSlG 
(-229/+3031) (-229/+3031) (-229/+3031) (+94/+3031) (+94/+3031) (+94/+3031) 
盆 ngpRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 
^00 ng pSG 5 vector 200 ligpfGS vector 200 ngpS05 v |aor 100 ng pSG5 m m t 2 # n g pSG 5 vector 200 ng pSG5 vector 




[92 r^ IT5 IT6 
200 ngpGL3-MCD 200 ngpGL3-MCD 200 ng pGL3-MCD 200 ng pGL3-ACBP 200 ngpGL3-ACBP 200 ngpGL3-ACBP 
20 ngpRL-TK 20 ng pRL-TK 20 ngpRL-TK 20 ngpRL-TK 20 ngpRL-TK 20 ng pRL-TK 
100ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ng pSG5-PPARa 100 ngpSG5-PPARa 
100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 
Ligands Ligands Ligands Ligands Ligands Ligands 
(50 nM Wy-14’643 & (50 pM Wy-14’643 & (50 nM Wy-14’643 & (50 pM Wy-14’643 & (50 jiM Wy-14’643 & (50 nM Wy-14’643 & 
1 (iM 9-cis-retinoic acid) 1 nM 9-cis-retinoic acid) 1 |iM 9-cis-retinoic acid) 1 nM 9-cis-rerinoic acid) 1 |iM 9-cis-retinoic acid) 1 )iM 9-cis-retinoic acid) 
m 103 m 
200 ngpGL3-MCD 200 ng pGL3-MCD 200 ng pGL3-MCD 200 ng pGL3-ACBP 200 ngpGL3-ACBP 200 ngpGL3-ACBP 
20 ng pRL-TK 20 ng pRL-TK 20 ngpRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ngpRL-TK 
100 ng pSG5-PPARa 100ngpSG5-PPARa 100 ngpSG5-PPARa 100 ng pSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 
100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ng pSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 
No ligands No ligands No ligands No ligands No ligands No ligands 
T u f u l u iT4 iTs l u 
200 ngpGL3-MCD 200 ngpGL3-MCD 200 ngpGL3-MCD 200 ng pGL3-ACBP 200 ng pGL3-ACBP 200 ngpGLS-ACBP 
20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 
200 ngpSGS vector 200 ng pSG5 vector 200 ng pSG5 vector 200 ng pSG5 vector 200 ngpSG5 vector 200 ngpSGS vector 
Ligands Ligands Ligands Ligands Ligands Ligands 
(50 nM Wy-14’643 & (50 pM Wy-14’643 & (50 nM Wy-14’643 & (50 nM Wy-14’643 & (50 nM Wy-14’643 & (50 nM Wy-14’643 & 
1 nM 9-cis-retinoic acid) 1 nM 9-cis-rerinoic acid) 1 nM 9-cis-retinoic acid) 1 nM 9-cis-retinoic acid) 1 nM 9-cis-retinoic acid) 1 nM 9-cis-retinoic acid) 
"TTi \22 123 ]2A lis 
200 ngpGL3-MCD 200 ng pGL3-MCD 200 ngpGL3-MCD 200 ng pGL3-ACBP 200ngpGL3-ACBP 200 ngpGL3-ACBP 
20 ngpRL-TK 20 ng pRL-TK 20 ngpRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ngpRL-TK 
200 ngpSGS vector 200 ng pSG5 vector 200 ng pSG5 vector 200 ng pSG5 vector 200ngp$GS v e c ^ 2|0l&ngpSGS vector 
No ligands No ligands No ligands No ligands No ligands No ligands 
Plate 4 
nil \~iJ3 [uA [ui, rii6 
200ngpGL3-Basic 200 ng pGL3-Basic 200 ng pGL3-Basic 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 
20 ngpRL-TK 20 ng pRL-TK 20 ngpRL-TK (+94/+190) (+94/+190) (+94/+190) 
100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 
100 ngpSG5-RXRa 100 ng pSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 
Ligands Ligands Ligands 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 
(50|_im Wy-14’643 & (50 nM Wy-14’643 & (50 pM Wy-14’643 & Ligands Ligands Ligands 
1 HM 9-cis-retinoic acid) 1 nM 9-cis-retinoic acid) 1 |iM 9-cis-retinoic acid) (50 nM Wy-14,643 & (50 l^M Wy-14,643 & (50 nM Wy-14,643 & 
1 nM 9-cis-rerinoic acid) 1 txM 9-cis-retinoic acid) 1 nM 9-cis-retinoic acid) 
14.1 l 4 2 143 14.4 14.5 14.6 
200ngpGL3-Basic 200 ng pGL3-Basic 200 ng pGL3-Basic 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 
20 ng pRL-TK 20 ng pRL-TK 20 ngpRL-TK (+94/+190) (+94/+190) (+94/+190) 
l00ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 20 ngpRL-TK 20 ngpRL-TK 20 ng pRL-TK 
100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ng pSG5-PPARa 100 ngpSG5-PPARa 100 ng pSG5-PPARa 
No ligands No ligands No ligands 100 ng pSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 
No ligands No ligands No ligands 
15.1 I 5 2 153 15^ i s l 15^ 
^00ngpGL3-Basic 200 ng pGL3-Basic 200 ngpGL3-Basic 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSK5 
20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK (+94/+190) (+94/+190) (+94/+190) 
J ^ n g p S G S vector 200 ngpSGS vector 200 ngpSGS vector 20 ngpRL-TK 20 ng pRL-TK 20 ngpRL-TK 
ligands Ligands Ligands 200 ng pSGS vector 200iigpSG5 vectra- 2 0 0 i i i g | ^ S v«ct(Mr 
(iSOuM Wy-14,643 & (50 nM Wy-14’643 & (50 (iM Wy-i4t643 & Ligands Ligands Ligands 
UM 9-cis-retinoic acid) 1 nM 9-cis-retinoic acid) 1 jiM 9-cis-retinoic acid) (50 nM Wy-14’643 & (50 pM Wy-14’643 & (50 pM Wy-14’643 & 
— 1 txM 9-cis-rerinoic acid) 1 幽 9-cis-retinoic acid) 1 tiM 9-cis-retinoic acid) 
J6.1 i o 16.4 16.5 16.6 
200ngpGL3-Basic 200 ng pGL3-Basic 200 ng pGL3-Basic 200 ng pGL3-PPSIG 2Q0 ng pGL3-PPSIG 200ngpGL3-PPSlG 
20ngpRL-TK 20,ngpRL-TK 20 ngpRL-TK (+94/+190) (+94/+190) (+94/+190) 
^ n g p S G S vector 200 ngpSGS vector 200ngpSGS vector 20 ngpRL-TK 20 ng pRL-TK 20 ngpS:-TK 
No ligands No ligands No ligands 200 ng pSG5 vector 200 ng pSG5 v^ptor 200 ngpSGSjmm 
No ligands No ligands No ligands 
- , 
2 6 1 
A4. Transfection experiment to study PPSIG-PPRE-deletion and PPSIG-PPRE-mutation constructs 
Plate 1 
Ti \T2 [ u [\A PTS pTe 
2»OngpGL3-PPSIG 200 ng pGL3-PPSK3 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSK3 
(+94/+435) (+94/+435) (+94/4435) (+94/+435) (+94/4435) (+94/+43® 
20 ngpRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ngpRL-TK 20 ng pRL-TK 20 ng pRL-TK 
100 ngpSG5-PPARa lOOng pSG5-PPARa 100 ng pSG5-PPARa 200 ngpSGS vector 200 ngpSGS vector 200 ngpSGS vector 
100 ng pSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa No ligands No ligands No ligands 
Ligands Ligands Ligands 
(50 nM Wy-14,643 & (50 pM Wy-14,643 & (50 pM Wy-14,643 & 
_ 1 uM 9-cis-rerinoic acid) 1 tiM 9-cis-rerinoic acid) 1 uM 9-cis-retinoic acid) 
2.1 2.2 2.3 "24 2 3 2.6 
200ngpGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-Basic- 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 
(+94/+435) (+947+435) PPSIG (-229/+435) (APPRE 1) (APPRE 1) (APPRE 1) 
20ngpRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ngpRL-TK 20ngpRL-TK 20 ng pRL-TK 
100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ng pSG5-PPARa 100 ngpSG5-PPARa 
100 ng pSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 
No ligands No ligands No ligands Ligands Ligands Ligands 
(50 nM Wy-14,643 & (50 l^M Wy-14,643 & (50 jxM Wy-14’643 & 
1 ^M 9-cis-retinoic acid) 1 ^M 9-cis-rerinoic acid) 1 uM 9-cis-retinoic acid) 
T i 3 2 1 3 3.4 3.5 3.6 
200ngpGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 
(+94/4-435) (+94/+435) (+947+435) (APPRE 1) (APPRE 1) (APPRE 1) 
20ngpRL-TK 20 ng pRL-TK 20 ngpRL-TK 20 ngpRL-TK 20 ngpRL-TK 20ngpRL-TK 
100 ngpSG5-PPARa 100 ng pSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 
100 ng pSG5 100 ngpSGS lOOngpSGS 100 ng pSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 
Jjo Ligands No Ligands No Ligands No ligands No ligands No ligands 
4.1 T 2 ^ 4.4 4.5 4.6 
200ngpGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 2200 ng pGL3-PPSIG 
(+94/+43.5) (+947+435) (+94/4435) (APPRE 1) (APPRE 1) (APPRE 1) 
20 ngpRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ngpRL-TK 20ngpRL-TK 20 ngpRL-TK 
100 ngpSGS 100 ngpSGS 100 ngpSGS 100 ngpSG5-PPARa 100 ng pSG5-PPARa 100 ngpSG5-PPARa 
100 ng pSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ng pSG5 100 ngpSGS 100 ngpSGS 
ligands No ligands No ligands No Ligands No Ligands | No Ligands 
P l a ^ 
^ [52 [53 r^ ITs |T6 
200ngpGL3-PPSIG 200 ngpGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ngpGL3-PPSIG 
(APPRE 1) (APPRE 1) (APPRE 1) (APPRE 2) (APPRE 2) (APPRE 2) 
20 ngpRL-TK 20 ng pRL-TK 20 ngpRL-TK 20 ngpRL-TK 20 ng pRL-TK 20 ngpRL-TK 
100 ngpSGS 100 ngpSGS 100 ngpSGS 100 ngpSG5-PPARa 100 ng pSG5-PPARa 100 ngpSG5-PPARa 
100 ngpSG5-RXRa lOOng pSG5-RXRa 100 ng pSG5-RXRa 100 ngpSGS 100 ng pSG5 100 ngpSGS 
•HHigands No ligands No ligands No Ligands No Ligands No Ligands 
6.2 6.3 6.4 6.5 6.6 
200ngpGL3.PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 
(APPRE 1) (APPRE 1) (APPRE 1) (APPRE 2) (APPRE 2) (APPRE 2) 
20 ng pRL-TK 20 ng pRL-TK 20 ngpRL-TK 20 ngpRL-TK 20 ng pRL-TK 20 ng pRL-TK 
物—诚G 5 v e c t o r 200 ngpSGS vector 200 ngpSGS vector 100 ng pSG5 100 ng pSG5 100 ng pSG5 
No ligands No ligands No ligands 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 
- No ligands No ligands No ligands 
~12 73 7.4 7.5 7.6 
f»ngpGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200ngpGL3-PPSIG 
gPPRE 2) (APPRE 2) (APPRE 2) (APPRE 2) (APPRE 2) •• (APPRE 2) 
ngpRL-TK 20 ng pRL-TK 20 ngpRL-TK 20 ng pRL-TK 20 ngpRL-TK 20ngpRL-TK 
100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 200 ngpSGS vector 2 0 0 v e c t o r 20&9g^GS Vector 
J00 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa No ligands No ligands No ligands 
Ligands Ligands Ligands 
(I^ O hM Wy-14,643 & (50 nM Wy-14’643 & (50 pM Wy-14,643 & 
—.ii^l^cis-retinoic acid) 1 jiM 9-cis-retinoic acid) 1 nM 9-cis-retinoic acid) 
3丄 ~82 O ^ ^ 
^ngpGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 2DOngpGL3-PPSIG 200ngpGL3-PPS!G 
tAPpRE 2) (APPRE 2) (APPRE 2) (mutPPRE 1) (mutPPRE 1) (mutPPRE i j 
ngpRL-TK ？0 ng pRL-TK 20 ng pRL-TK 20 ngpRL-TK 20ngpRL-TK 20 ng pRL-TK 
J^ O ngpSG5-PPARa 100 ng pSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100ngpSG5-PPARa 
ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ng pSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 
° ligands No ligands No ligands Ligands Ligands Ligands 
(50 HM Wy-14’643 & (50 (iM Wy-14,643 & (50 jiM Wy-14,643 & 
^ ‘ 1 ^M 9-cis-rerinoic acid) 1 ^M 9-cis-retinoic acid) | 1 tiM 9-cis-retmoic acid) 
2 6 2 
Plate 3 
9.2 9.3 9.4 9 5 9.5 
20OngpGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200ngpGL3- PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 
(mutPPRE 1) (mutPPRE 1) (mutPPRE 1) (mutPPRE 2) (mutPPRE 2) (mutPPRE 2) 
20 ng pRL-TK 20 ng pRL-TK 20 ngpRL-TK 20 ng pRL-TK 20ngpRL-TK 20 ngpRL-TK 
100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ng pSG5-PPARa 100 ng pSG5-PPARa 100 ngpSG5-PPARa 
100 ng pSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ng pSG5-RXRa 100 ngpSG5-RXRa 
No ligands No ligands No ligands Ligands Ligands Ligands 
(50 nM Wy-14,643 & (50 nM Wy-14,643 & (50 nM Wy-14,643 & 
1 nM 9-cis-retinoic acid) 1 tiM 9-cis-retinoic acid) 1 txM 9-cis-retinoic acid) 
l ^ n m K i 10.4 10.5 10.6 
200ngpGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGLS-PPSIG 200 ngpGL3- PPSIG 200 ng pGL3-PPSIG 200 ng pGL3- PPSIG 
(mutPPRE 1) (mutPPRE 1) (mutPPRE 1) (mutPPRE 2) (mutPPRE 2) (mutPPRE 2) 
20 ngpRL-TK 20 ng pRL-TK 20 ngpRL-TK 20 ngpRL-TK 20 ngpRL-TK 20 ng pRL-TK 
100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ng pSG5-PPARa 
100 ng pSG5 lOOngpSGS 100 ngpSG5 100 ng pSG5-RXRa 100 ng pSG5-RXRa 100 ngpSG5-RXRa 
No Ligands No Ligands No Ligands No ligands No ligands No ligands 
T u Ul lU IM VL5 iT6 
20(>ngpGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200ngpGL3- PPSIG 200 ngpGL3-PPSIG 200 ng pGL3-PPSIG 
(mutPPRE 1) (mutPPRE 1) (mutPPRE 1) (mutPPRE 2) (mutPPRE 2) (mutPPRE 2) 
20 ng pRL-TK 20 ng pRL-TK 20 ngpRL-TK 20 ngpRL-TK 20 ng pRL-TK 20 ngpRL-TK 
100 tig pSG5 lOOng pSG5 100 ngpSGS 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 
100 ng pSG5-RXRa 100 ngpSG5-RXRa 100 ng pSG5-RXRa 100 ng pSG5 100 ng pSG5 100 ng pSG5 
No ligands No ligands No ligands No Ligands No Ligands No Ligands 
i l 2 \23 VIA i l 5 116 
200ngpGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ngpGL3- PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 
(mutPPRE 1) (mutPPRE 1) (mutPPRE 1) (mutPPRE 2) (mutPPRE 2) (mutPPRE 2) 
20ngpRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ngpRL-TK 20 ng pRL-TK 20 ngpRL-TK 
200 ^ p S G 5 vector 200 ngpSGS vector 200 ngpSGS vector 100 ng pSG5 lOOngpSGS 100 ng pSG5 
No ligands No ligands No ligands 100 ng pSG5-RXRa 100 ng pSG5-RXRa 100 ng pSG5-RXRa 
No ligands No ligands No ligands 
P!ate_4 
^ rii2 r m rii4 n i s 13.6 
200 ngpGL3- PPSIG 200ngpGL3- PPSIG 200 ngpGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGLS-PPSIG 200 ng pGL3-PPSIG 
(mutPPRE 2) (mutPPRE 2) (mutPPRE 2) (APPREs 1&2) (APPREs 1&2) (APPREs 1&2) 
20 ngpRL-TK 20 ng pRL-TK 20 ngpRL-TK 20 ngpRL-TK 20 ngpRL-TK 20 ngpRL-TK 
^ n g p S G S vector 200ngpSGS vector 200ngpSGS vector 100 ng pSG5 100 ngpSG5 100 ngpSG5 
No ligands No ligands No ligands 100 ng pSG5-RXRa 100 ng pSG5-RXRa 100 ng pSG5-RXRa 
No ligands No ligands No ligands 
14.1 l 4 2 143 144 1 4 l 
200ngpGL3-PPSIG 200 ngpGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGLS-PPSIG 200 ng pGL3-PPSIG 200 ngpGL3-PPSIG 
(APPRES 1&2) (APPREs 1&2) (APPREs 1&2) (APPREs 1&2) (APPREs 1&2) (APPREs 1&2) 
20 ngpRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ngpRL-TK 
100 ng pSG5-PPARa lOOng pSG5-PPARa 100 ngpSG5-PPARa 200ngpSGS vector 200ngpSGS vector 2 0 0 s g f ^ S vector 
l?0ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa No ligands No ligands No ligands 
Ligands Ligands Ligands 
(50 nM Wy-14,643 & (50 nM Wy-14,643 & (50 jiM Wy-14,643 & 
~j~U^9-cis-rerinoic acid) 1 nM 9-cis-retinoic acid) 1 txM 9-cis-rerinoic acid) 
15.1 15.2 15.3 1 5 A 15：6 
200ngpGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200ngpGU-PPSlG 200 ngpGL3-PPSIG 
(APPRES 1&2) (APPREs 1&2) (APPREs 1&2) (mutPPREs 1&2) (mutPPREs 1&2) (mutPPREs 1&2) 
20 ng pRL-TK 20 ng pRL-TK 20 ngpRL-TK 20 ngpRL-TK 20 ng pRL-TK 20 ngpRL-TK 
l00ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 100 ngpSG5-PPARa 
JpO ng pSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 
No ligands No ligands No ligands�,. Ligands Ligands Ligands 
” (50 nM Wy-14,643 & (50 jiM Wy-14’643 & (50 jiM Wy-14,643 & 
1 liM 9-cis-rerinoic acid) 1 uM 9-cis-rerinoic acid) 1 tiM 9-cis-retinoic acid) 
；6.1 l 6 ! 2 i ^ l 16.4 16.5 16.6 
200 ngpGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSIG 200 ng pGL3-PPSl<5 200 ng pGL3-PPSlG 200 ng pGLS-PPSIS 
( A P P R E S 1&2) (4PPRES 1&2) (APPREs 1&2) (mutPPREs 1&2) OnutPPREs 1&2) (mutPPREs 1&2) 
ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 20 ng pRL-TK 
j00ngpSG5-PPARa 100 ngpSG5-PPARa 100 ng pSG5-PPARa 100 ngpSG5-PPARa 100 ng pSG5-PPARa 100 ng pSG5-PPARa 
JpO ngpSGS 100ngpSG5 100 ngpSGS 100 ngpSG5-RXRa 100 ngpSG5-RXRa 100 ngpSG5-RXRa 
-!!2ijgands No Ligands No Ligands No ligands No ligands No ligands 
2 6 3 
Plate 3 
r r ^ n ^ ITTA rvTs pTf^ 
200 ng PGL3-PPSIG 200 ng pGU-PPSIG 200 ng pGL3-lfslG 
(mutPPREs 1&2) (mutPPREs 1&2) (mutPPREs 1 减） 
20 ng pRL-TK 20 iig pRL-TK 20 ng pRL-TK / 
lOOng pSG5-PPARa 100 ng pSG5-PPARo(丨00 ng pSG5-PPAR(x 
100 ng pSG5 100 ng pSG5 100iigpSG5 
No Ligands No Ligands No Ligands / 
ilTfi 
200ngpGL3-PPSlQ 200 ngpGL3-PPSIG 200 ng p G U . # S l G / 
(mutPPREs 1&2) (mutPPREs 1&2) (mutPPREs / ' , 
20 ng pRL-TK 20 ng pRL-TK 20 ngpRL-TK / -
100 ngpSG5 l()0ngpSG5 100ngpSG5 , Z 
100 ng pSG5-RXRa 100 iig pSG5-RXRa 100 ng pSG5-RXRa / 
No ligands No ligands No ligands 
If J ^ ITa i9l m, 
2p0iigpGL3-PPSlG 200ngpGL3-PPSIG 200 ng pGL3-lf SIG 
(mutPPREs 1&2) (mutPPREs 1&2) (mutPPREs \ s l ) 
20 ng pRL-TK 2()ngpRL-TK 20 ng pRL-TK / , , 
^OangpSOS vector 200 ng pS65 vectot 200ngpSG5,v|sor / 
Mo ligands No ligands No ligands , , / 
^ ； / 丨 20.2 / l ^ ^Tol 
,z z / ‘, 
/ z / / 
‘ / , 
, z ‘ 
^ V. L t__ 
•s-
2 6 4 
Appendix B: Alignment result of RACE clone cDNAs 
Appendix B l : Alignment result of 5’#7 
1 15 16 30 31 45 4 6 60 61 75 7 6 90 
4 R e t S a t + C h r o m o s G C G G T C T T C C G A G C C C T G G C A G C A A C A T G T G G A T C A C T G C T C T G C T G C T G G C C G T G C T G C T G C T G G T G A T C C T C C A C A G G G T C T A C G T G G 90 
5 5 # 7 G C G G T C T T C C G A G C C C T G G C A G C A A C A T G T G G A T C A C T G C T C T G C T G C T G G C C G T G C T G C T G C T G G T G A T C C T C C A C A G G G T C T A C G T G G 90 
91 1 0 5 1 0 6 1 2 0 1 2 1 1 3 5 1 3 6 1 5 0 1 5 1 1 6 5 1 6 6 1 8 0 
4 R e t S a t + C h r o m o s G C C T T T A C G C T G C A A G T T C C C C G A A C C C C T T C G C C G A G G A T G T C A A G C G A C C G C C T G A A C C C C T G G T G A C C G A C A A G G A G G C T A G G A A G A 180 
5 5#7 G C C T T T A C G C T G C A A G T T C C C C G A A C C C C T T C G C C G A G G A T G T C A A G C G A C C G C C T G A A C C C C T G G T G A C C G A C A A G G A G G C T A G G A A G A 180 
1 8 1 1 9 5 1 9 6 2 1 0 2 1 1 2 2 5 2 2 6 2 4 0 2 4 1 2 5 5 2 5 6 2 7 0 
4 R e t S a t + C h r o m o s A A G T T C T C A A A C A A G C T T T C T C A G T C A G C C G A G T A C C A G A G A A G C T G G A T G C A G T G G T G A T C G G C A G C G G C A T T G G G G G A C T G G C C T C A G 2 7 0 
5 5 # 7 A A G T T C T C A A A C A A G C T T T C T C A G T C A G C C G A G T A C C A G A G A A G C T G G A T G C A G T G G T G A T C G G C A G C G G C A T T G G G G G A C T G G C C T C A G 2 7 0 
2 7 1 2 8 5 2 8 6 3 0 0 3 0 1 3 1 5 3 1 6 3 3 0 3 3 1 3 4 5 3 4 6 3 6 0 
4 R e t S a t + C h r o m o s C T G C G G T T C T A G C T A A A G C T G G C A A G A G A G T C C T T G T G C T G G A A C A A C A T A C C A A G G C G G G C G G C T G T T G T C A T A C C T T T G G G G A A A A T G 3 6 0 
5 5#7 C T G C G G T T C T A G C T A A A G C T G G C A A G A G A G T C C T T G t G C T G G A A C A A C A T A C C A A G G C G G G C G G C T G T T G T C A T A C C T T T G G G G A A A A T G 3 6 0 
3 6 1 3 7 5 3 7 6 3 9 0 3 9 1 4 0 5 4 0 6 4 2 0 4 2 1 4 3 5 4 3 6 4 5 0 
3 5tt7-257 4 M A R 0 6 G C C T T G A A T T T G A C A C T G G A A T T C A T T A T A T T G G A C I A A T G C G G G A G G G C A A C A T T G G C C G T T T T A T C T T G G A C C A G A T C A C T G A A G G G C 1 1 2 
^ R e t S a t + C h r o m o s G C C T T G A A T T T G A C A C T G G A A T T C A T T A T A T T G G A C G A A T G C G G G A G G G C A A C A T T G G C C G T T T T A T C T T G G A C C A G A T C A C T G A A G G G C 4 5 0 
5 5#7 G C C T T G A A T T T G A C A C T G G A A T T C A T T A T A T T G G A C G A A T G C G G G A G G G C A A C A T T G G C C G T T T T A T C T T G G A C C A G A T C A C T G A A G G G C 4 5 0 
4 5 1 4 6 5 4 6 6 4 8 0 4 8 1 4 9 5 4 9 6 5 1 0 5 1 1 5 2 5 5 2 6 5<!0 
3 5 # 7 - 2 5 7 4 M A R 0 6 A A C T G G A C T G G G C C C C C A T G G C C T C C C C T T T T G A C T f G A T G A T A C T A G A A G G G C C C A A T G G C C G A A A G G A G T T C C C C A T G T A C A G T G G G A 2 0 2 
^ R e t S a t + C h r o m o s A A C T G G A C T G G G C C C C C A T G G C C T C C C C T T T T G A C T T G A T G A T A C T A G A A G G G C C C A A T G G C C G A A A G G A G T T C C C C A T G T A C A G T G G G A 54 0 
= A A C T G G A C T G G G C C C C C A T G G C C T C C C C T T T T G A C T T G A T G A T A C T A G A A G G G C C C A A T G G C C G A A A G G A G T T C C C C A T G T A C A G T G G G A 54 0 
5 4 1 5 5 5 5 5 6 5 7 0 5 7 1 5 8 5 5 8 6 6 0 0 6 0 1 6 1 5 6 1 6 6 3 0 
3 5 # 7 - 2 5 7 4 M A R 0 6 G G A A A G A A T A C A T C C A G G G C C T T A A G — A A G A A G T T C C C C A A G G A A G A A - G C T G T C A T T G A C A A G T A C A T G G A G T T G G T T A A G G T G G T G G 2 8 9 
^ R e t S a t + C h r o m o s G G A A A G A A T A C A T C C A G G G C C T T A A G - - A A G A A G T T C C C C A A G G A A G A A - G C T G T C A T T G A C A A G T A C A T G G A G T T G G T T A A G G T G G T G G 6 : 7 
。 G G A A A G A A T A C A T C C A G G G G C C T T A A G A A A G A A G T T C C C C A A G G A A G A A C G C T G T C A T T G A C A A G T A C A T G G A G T T G G T T A A G G T G G T G G 6 3 0 
3 6 3 1 6 4 5 6 4 6 6 6 0 6 6 1 6 7 5 6 7 6 6 9 0 6 9 1 7 0 5 7 0 6 7 2 0 
. ⑷ - 2 5 7 4 M A R 0 6 C C C G T G G A G T C T C T C A T G C A G T T C T A C T C A A G T T C C f C C C A T T G C C C T T G A C T C A G C T C C T C A G C A A G T T T G G G C T A C T G A C T C G T T T C T 3 ^ 9 
. R e t S a t + C h r o m o s C C C G T G G A G T C T C T C A T G C A G T T C T A C T C A A G T T C C T C C C A T T G C C C T T G A C T C A G C T C C T C A G C A A G T T T G G G C T A C T G A C T C G T T T C T 7 1 7 
… C C C G T G G A G T C T C T C A T G C A G T T C T A C T C A A G T T C C T C C C A T T G C C C T T G A C T C A G C T C C T C A G C A A G T T T G G G C T A C T G A C T C G T T T C T 7 2 0 
3 7 2 1 7 3 5 7 3 6 7 5 0 7 5 1 7 6 5 7 6 6 7 8 0 7 8 1 7 9 5 7 9 6 8 1 0 
彳 ” 7 - 2 5 7 她 R 0 6 C T C C A T T C T G C C G A G C G T C T A C G C A G A G C C T A G C T G M G T C C T G C A G C A G C T T G G G G C T T C C C G T G A G C T C C A G G C T G T T C T C A G C T A C A 4 6 9 
5 R e t S a t + C h r o m o s C T C C A T T C T G C C G A G C G T C T A C G C A G A G C C T A G C T G A A G T C C T G C A G C A G C T T G G G G C T T C C C G T G A G C T C C A G G C T G T T C T C A G C T A C A 8 0 7 
⑷ C T C C A T T C T G C C G A G C G T C T A C G C A G A G C C T A G C T G A A G T C C T G C A G C A G C T T G G G G C T T C C C G T G A G C T C C A G G C T G T T C T C A G C T A C A 8 1 0 
3 8 1 1 8 2 5 8 2 6 8 4 0 8 4 1 8 5 5 8 5 6 8 7 0 8 7 1 8 8 5 8 8 6 9 0 0 
^ ”"7 - 2 5 7 4 M A R 0 6 T C T T C C C C A C T T A C G G A G T A A C T C C C A G C C A C A C C G C C T T T T C C T T G C A T G C T C T G C T G G T T G A C C A C T A C A T A C A A G G G G C A T A T T A C C 5 5 9 
5 ^ ® t S a t + C h r o m o s T C T T C C C C A C T T A C G G A G T A A C T C C C A G C C A C A C C G C C T T T T C C T T G C A T G C T C T G C T G G T T G A C C A C T A C A T A C A A G G G G C A T A T T A C C 8 9 7 
如 T C T T C C C C A C T T A C G G A G T A A C T C C C A G C C A C A C C G C C T T T T C C T T G C A T G C T C T G C T G G T T G A C C A C T A C A T A C A A G G G G C A T A T T A C C 9 0 0 
3 9 0 1 9 1 5 9 1 6 9 3 0 9 3 1 9 4 5 9 4 6 9 6 0 9 6 1 9 7 5 9 7 6 9 9 0 
4 €”- 2 5 7 4 M A R 0 6 C T C G A G G G G G T T C C A G T G A G A T C G C C T T C C A T A C C A f C C C T T T G A T T C A G C G G G C C G G G G G C G C T G T C C T C A C C A G G G C C A C T G T A C A G A 64 9 
5 t S a t + C h r o m o s C T C G A G G G G G T T C C A G T G A G A T C G C C T T C C A T A C C A T C C C T T T G A T T C A G C G G G C C G G G G G C G C T G T C C T C A C C A G G G C C A C T G T A C A G A 9 8 7 
C T C G A G G G G G T T C C A G T G A G A T C G C C T T C C A T A C C A T C C C T T T G A T T C A G C G G G C C G G G G G C G C T G T C C T C A C C A G G G C C A C T G T A C A G A 9 9 0 
3 9 9 1 1 0 0 5 1 0 0 6 1 0 2 0 1 0 2 1 1 0 3 5 1 0 3 6 1 0 5 0 1 0 5 1 1 0 6 5 1 0 6 6 1 0 8 0 
4 广 - 2 5 7 4 M A R 0 6 G T G T G C T G C T G G A C T C A G C T G G G A N A G C G T G T G G T G T C A G T G T G A A - A A N G G A C A A N A G C T G G T G A - C A T C T A C T G C C C A G T T G T C A T C T 7 3 7 
s $ = t S a t + C h r o n i o s G T G T G C T G C T G G A C T C A G C T G G G A G A G C G T G T G G T G T C A G T G T G A A G A A G G G A C A A G A G C T G G T G A A C A T C T A C T G C C C A G T T G T C A T C T 1 0 7 7 
G T G T G C T G C T G G A C T C A G C T G G G A G A G C G T G T G G T G f C A G T G T G A A G A A G G G A C A A G A G C T G G T G A A C A T C T A C T G C C C A G T T G T C A T C T l O b O 
3 5 1 0 8 1 1 0 9 5 1 0 9 6 1 1 1 0 1 1 1 1 1 1 2 5 1 1 2 6 1 1 4 0 1 1 4 1 1 1 5 5 1 1 6 6 1 1 7 0 
4 广 " 2 5 7 她 R 0 6 C C A A T G C G G G A A T G T T C A A T A C C T A T C A G C A C T T G T T G C C A N A G A C T G T C C G C C A T C T G C C A A A T G T G A A N A A A C A N C T G G C G A T G N T A N 8 2 7 
5 $ : t S a t + C h r o m o s C C A A T G C G G G A A T G T T C A A T A C C T A T C A G C A C T T G T T G C C A G A G A C T G T C C G C C A T C T G C C A G A T G T G A A G A A G C A G C T G G C G A T G G T A A 116"' 
刚 C C A A T G C G G G A A T G T T C A A T A C C T A T C A G C A C T T G T f G C C A G A G A C T G T C C G C C A T C T G C C A G A T G T G A A G A A G C A G C T G G C G A T G G T A A 1 1 7 0 
2 5 1 1 7 1 1 1 8 5 1 1 8 6 1 2 0 0 1 2 0 1 1 2 1 5 1 2 1 6 1 2 3 0 1 2 3 1 1 2 4 5 1 2 4 6 1 2 6 0 
3 5 ^ ^ ~ 6 4 3 3 M A R 0 6 G G C C T G g T C T G A G C A T G C T C T C A A T C T T C A C C T G T C f G A A A G G C A C C A A G G A G G A C C T G A A G C T T C A G T C C A C C A A C T A C T A T G T T T A T T 1 3 8 
4 2 5 7 4 M A R 0 6 G N C - T G G T C T G A A C A T G C T C T C A A T C T T C A C C T G T C T G A A A G G C - C C N A G G A N G A C T G A A - - C N T C N G T C C - C C A C C T A C T A T G T T T N T T 9 1 2 
5 5 ® ^ S a t + C h r o m o s G G C C T G G T C T G A G C A T G C T C T C A A T C T T C A T C T G T C T G A A A G G C A C C A A G G A G G A C C T G A A G C T T C A G T C C A C C A A C T A C T A T G T T T A T T 1 2 5 7 
G G C C T G G T C T G A G C A T G C T C T C A A T C T T C A C C T G T C T G A A A G G C A C C A A G G A G G A C C T G A A G C T T C A G T C C A C C A A C T A C T A T G T T T A T T 1 2 6 0 
265 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
2 !5#7-64 33MAR06 TTGACACAGACATGG GCAAAGCGATGGAGC GCTATGTCTCTATGC CCAAGGAAAAGGCTC CAGAACACATTCCCC TTCTCTTCATTGCCT 228 
3 5#7-2574MAR06 TGACNAAAAT GGNAANCGATGGAGC CTTTTCT TNT GCCAAGNAAAGGTCN AAANATTCCCTCTTT CNTGCTNCNTNAGAN 99：' 
4 RetSat+Chromos TTGACACAGACATGG ACAAAGCGATGGAGC GCTATGTCTCTATGC CCAAGGAAAAGGCTC CAGAACACATTCCCC TTCTCTTCATTGCCT 1347 
5 5#7 TTGACACAGACATGG GCAAAGCGATGGAGC GCTATGfCTCTATGC CCAAGGAAAAGGCTC CAGAACACATTCCCC TTCTCTTCATTGCCT 13S0 
1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
2 5#7-6433MAR06 T C C C A T C M G C M G G ATCCAACCTGGGAGG AGCGATtCCCAGACC GATCCACAATGACTG CGCTGGTACCCATGG CCTTTGAATGGTTCG 318 
3 5#7-2574MAR06 NNTCACCGGGAGAGN TTCCAACNTT CNAANCNGCNGGC CAGGCTTNANGTCAG ANGNNNNGACNAGGN ACGGGNTAANAANCC 107D 
4 RetSat-fChromos TCCCATCAAGCAAGG ATCCAACCTGGGAGG AGCGATTCCCAGACC GATCCACAATGACTG CGCTGGTACCCATGG CCTTTGAATGGTTCG 1437 
5 5#7 TCCCATCAAGCAAGG ATCCAACCTGGGAGG AGCGATTCCCAGACC GATCCACAATGACTG CGCTGGTACCCATGG CCTTTGAATGGTTCG 14 40 
U41 1455 1456 1470 1471 1485 1486 1500 1501 1615 1516 1530 
2 5#7-6433MAR06 AGGAGTGGCAGGAGG AGCCAAAGGGCAAGC GTGGTGfTGACTATG AGACCCTCAAAAATG CCTTCGTGGAAGCCT CTATGTCGGTGATCA 408 
3 ！5tt7-2574MAR06 AAANCTNGGANCNTN NGGAAAAAANTCCCC NGGGGAGGGANNNGN GGGNCCTGCCCNNNT GGNNCCNGAACNNGN NANANTGGGNGCNCC 1165 
^ RetSat+Chromos AGGAGTGGCAGGAGG AGCCAAAGGGCAAGC GTGGTGTTGACTATG AGACCCTCAAAAATG CCTTCGTGGAAGCCT CTATGTCGGTGATCA 1527 
5 5#7 AGGAGTGGCAGGAGG AGCCAAAGGGCAAGC GTGGTGTTGACTATG AGACCCTCAAAAATG CCTTCGTGGAAGCCT CTATGTCGGTGATCA 1530 
1531 1545 1546 1560 1561 1575 1576 1590 1591 1605 1606 1620 
2 ⑷ 3 M A R 0 6 TGAAACTGTTCCCAC AGCTGGAGGGCAAGG TGGAGA^TGTGACTG GAGGGTCACCACTGA CCAACCAGTACTATC TGGCTGCACCCCGAG 498 
3 5 n - 2 5 7 4 M A R 0 6 NNGNCNAAACCCCCC CCTTTAGNAANTNNN GGGNGGCNGGGNTNN AACNNAAATTTTATN NNNNNANNNAAAAAA TN 1242 
^ RetSat+Chromos TGAAACTGTTCCCAC AGCTGGAGGGCAAGG TGGAGAGTGTGACTG GAGGGTCACCACTGA CCAACCAGTACTATC TGGCTGCACCCCGAG 161'' 
5 5#7 TGAAACTGTTCCCAC AGCTGGAGGGCAAGG TGGAGAGTGTGACTG GAGGGTCACCACTGA CCAACCAGTACTATC TGGCTGCACCCCGAG 161^0 
1621 1635 1636 1650 1651 1665 1666 1680 1681 1695 1696 1710 
2 5i^7-6433MAR06 GAGCTACCTATGGAG CTGACCATGACTTGG CTCGGCtGCATCCTC ATGCAATGGCTTCCA TAAGAGCCCAAACCC CCATCCCCAACCTCT 588 
^ RetSat+Chromos GAGCTACCTATGGAG CTGACCATGACTTGG CTCGGCTGCATCCTC ATGCAATGGCTTCCA TAAGAGCCCAAACCC CCATCCCCAACCTCT 1707 
5 GAGCTACCTATGGAG CTGACCATGACTTGG CTCGGCTGCATCCTC A T G C A A T G G C T T C C A TAAGAGCCCAAACCC CCATCCCCAACCTCT 1710 
1711 1725 1726 1740 1741 1755 1756 1770 1771 1785 1786 1800 
1 5#7-84 54MAR06 ACCTGACAGGCCAAG ATATCTTCACCTGTG GGCTGATGGGGGCCC TGCAGGGGGCCTTGC TGTGCAGCAGTGCCA TCCTGAAACGGAACT 144 
2 5幷7-64 33MAR06 ACCTGACAGGCCAAG ATATCTTCACCTGTG GGCTGAfGGGGGCCC TGCAGGGGGCCTTGC T G T G C A G C A G T G C C A TCCTGAAACGGAACT 678 
^ RetSat+Chromos ACCTGACAGGCCAAG ATATCTTCACCTGTG GGCTGATGGGGGCCC TGCAGGGGGCCTTGC T G T G C A G C A G T G C C A TCCTGAAACGGAACT 1797 
5 5#7 ACCTGACAGGCCAAG ATATCTTCACCTGTG GGCTGATGGGGGCCC TGCAGGGGGCCTTGC TGTGCAGCAGTGCCA TCCTGAAACGGAACT 1800 
1801 1815 1816 1830 1831 1845 1846 1860 1861 1875 1876 1890 
1 5#7-84 54MAR〇6 TGTACTCAGATCTGC AGGCTCTTGGCTCAA AGGTCAAGGCACAAA AGAAGAAGATGTAGT CCGTTCAGAGAAGAG CCAGAGGAAAGGCAC 234 
2 5ft7-6433MAR06 TGTACTCAGATCTGC AGGCTCTTGGCTCAA AGGTCANGGACAAAA AAAA--AGATGTAGT CCGTTCANAGAAAAN CCAAAGAAANGNACC 766 
^ RetSat+Chromos TGTACTCAGATCTGC AGGCTCTTGGCTCAA AGGTCAAGGCACAAA AGAAGAAGATGTAGT CCGTTCAGAGAAGAG CCAGAGGAAAGGCAC 
^ TGTACTCAGATCTGC AGGCTCTTGGCTCAA AGGTCAAGGCACAAA AGAAGAAGATGTAGT CCGTTCAGAGAAGAG CCAGAGGAAAGGCAC 1890 
_ —_ 
1891 1905 1906 1920 1921 1935 1936 1950 1951 1965 1966 1980 
^ - C T C C C C A A C ^ ^ ^ ^ ^ J j ^ B B H ^ C 腦 G G C G A A T T CCAGCACACTGGCGG C C G T T A C T A G T G G A T CCGAGCTCGGTACCA 323 
… - 6 4 3 3 M A R 0 6 --TCCCCAACTTCTC GNGGTGNCCTCCCTC CTACANGGGN-AATT CCAGCCCACTGGCGG CCGTTNCTAGTGGAT CCNANCTCGGTACCA 853 
RetSat+Chromos -CTCCCCAACTTCTC GTGGTGTCCTCCCTC CTAC 1921 
5括7 -CTCCCCAACTTCTC GTGGTGTCCTCCCTC CTAC 
5 ' - G S P l 
266 
Appendix B5: Alignment result of 5，#20 
361 375 376 390 391 405 406 420 421 435 436 450 
1 5ttll-8454MAR06 GNNCTTC CNTAAGAGCCCAAAC CCCCATCCCCAACCT 37 
2 5#11-5244MAR06 GNCCCCANNGGANGG ANNTTGCNGANTNNC CNTTGGNTGGNGCCN GGGNCCNTGCCNNGN CTGANGGGTAGAAAG CGTTTTTCNGAGCC- -4<19 
4 5#ii G CGGTCTTCCGAGCC- 15 
5 RetSat+Chromos G CGGTCTTCCGAGCC- 15 
451 465 466 480 481 495 496 510 511 525 526 540 
1 5#11-8 4 54MAR06 CTACCTGACAGGCCA AGATATCTTCACCTG TGGGCTGATGGGGGC CCTGCAGGGGGCCTT GCTGTGCAGCAGTGC CATCCTGAAACGGAA 127 
2 5#11-5244MAR06 NNG-CAG CAACATG-GGATCAN TGTT-TGNTGCNG-C CNNGCTGCTGCTGG- GATCNTCCACAGG-- -TCTACGGGGCNTTA 
4 5#11 rjTGGCAG CAACATGTGGATCAC TGCTCTGCTGCTGGC CGTGCTGCTGCTGGT GATCCTCCACAGGGT CTACGTGGGCCTTTA a-, 
5 RetSat+Chromos CTGGCAG CAACATGTGGATCAC TGCTCTGCTGCTGGC CGTGCTGCTGCTGGT GATCCTCCACAGGGT ^TAf^GTGGGi^^TTTA .17 
541 555 556 570 571 585 586 600 601 615 616 630 
1 5#11-84 5 碰 豪 CTTGTACTCAGATCT GCAGGCTCTTGGCTC AAAGGTCAGGGCACA AAAGAAGAAGATGTA GTCCGTTCAGAGAAG AGCCAGAGGAAAGGC 217 
2 5#11-52 4 4MAR06 CGCTGCA-GTTCCCC GAACCC-TTNGCCGA GGA-GTCAAGCGACC GCCTGAACCCCTG-T GACCGACAAG--GAG GCTAGGAAGAAAGTT 607 
Sttll CGCTGCAAGTTCCCC GAACCCCTTCGCCGA GGATGTCAAGCGACC GCCTGAACCCCTGGT G A C C G A C A A G — G A G GCTAGGAAGAAAGTT 185 
5 RetSat+Chromos CGCTGCAAGTTCCCC GAACCCCTTCGCCGA GGATGTCAAGCGACC GCCTGAACCCCTGGT GACCGACAAG--GAG GCTAGGAAGAAAGTT 185 
631 645 646 660 661 675 676 690 691 705 706 720 
1 5#11-84 54MAR06 ACCTCCCCAACTTCT CGTGGTGTCCTCCCT CCTACAAGGGCGAAT TCCAGCACACTGGCG GCCGTTACTAGTGGA TCCGAGCTCGGTACC 307 
2 5#:L1-5244MAR06 CTCAAACNAGCTTTC TCAGTCAGCCGAGTA CCAGAGAAGCTGGAT GCAGTGGTGATCGGC AGCGGCATTGGGGGA CTGGCTTCAGCTGCG 697 
^ 5#11 CTCAAACAAGCTTTC TCAGTCAGCCGAGTA CCAGAGAAGCTGGAT GCAGTGGTGATCGGC AGCGGCATTGGGGGA CTGGCCTCAGCTGCG 275 
5 RetSat+Chromos CTCAAACAAGCTTTC TCAGTCAGCCGAGTA CCAGAGAAGCTGGAT GCAGTGGTGATCGGC AGCGGCATTGGGGGA CTGGCCTCAGCTGCG 275 
721 735 736 750 751 765 766 780 781 795 796 810 
1 5#11-8454MAR06 AAGCTTGATGCA--T AGCTTGAGTATTCTA TAGTGTCACCTAAAT AGCTTGGCGTAATCA TG--GTCATAGCTGT TTCCTGTGTGAAATT 393 
2 5 m - 5 2 4 4 M A R 0 6 GTTCTAGCTAAAGCT GGCAAGAGAGTCCTT GTGCTG6AACAACAT ACCAAGGCGGGCGGC TGTTGTCATACCTTT GGGGAAAATGGCCTT ISl 
3 5#11-2574MARC)6 GNGGGNGGC TGTTGTCATACCTTT GGGGAAAATGGCCTT 39 
4 5#11 GTTCTAGCTAAAGCT GGCAAGAGAGTCCTT GTGCTGGAACAACAT ACCAAGGCGGGCGGC TGTTGTCATACCTTT GGGGAAAATGGCCTT 365 
5 RetSat+Chromos GTTCTAGCTAAAGCT GGCAAGAGAGTCCTT GTGCTGGAACAACAT ACCAAGGCGGGCGGC TGTTGTCATACCTTT GGGGAAAATGGCCTT 365 
811 825 826 840 841 855 856 870 871 ‘ 885 886 900 
1 S # 1 1 - 8 4 5麵 R 0 6 G — - T T A T C C G C T C A CAATTCCACACAACA TACGAGC-CGGAAGC ATAAAGTGTAAAGCC TGGGGTGCCTAATGA GTGAGCTAACTCACA 479 
2 5 # n - 5 2 4 4 M A R 0 6 G-AATTTGACACTGG -AATTCATTATATTG GACGAAfGCGGGAGG GCAACATTGGCCGTT TTATCTTGGACCAGA TCACTGAAGGGCAAC 875 
3 5#11-257 4MAR06 GNAATTTGACACTGG NAATTCATTATATTG GACGAATGCGGGAGG GCAACATTGGCCGTT TTATCTTGGACCAGA TCACTGAAGGGCAAC 129 
^ G-AATTTGACACTGG -AATTCATTATATTG GACGAATGCGGGAGG GCAACATTGGCCGTT TTATCTTGGACCAGA TCACTGAAGGGCAAC 453 
^ RetSat+Chromos G-AATTTGACACTGG -AATTCATTATATTG GACGAATGCGGGAGG GCAACATTGGCCGTT TTATCTTGGACCAGA TCACTGAAGGGCAAC 453 
^ — . — 
901 915 916 930 931 945 946 960 961 975 976 990 
I S#11-8 4 54MAR06 TTAATTGCGTTGCGC TCACTGCCCGCTTTC CAGTCGGGAAACCTG TCGTGCCAGCTGCAT TAATGAATCGGCCAA CGCGCGGGGAGAGGC 569 
^ S#11-52'14MAR06 TGGACTGGGCCCCCA TGGCCTCCCCTTTTG ACTTGATGATACTAG AAGGGCCCAATGGCC GAAAGGAGTTCCCCA TGTACAGTGGGAGGA 965 
5«11-2574MAR06 TGGACTGGGCCCCCA TGGCCTCCCCTTTTG ACTTGATGATACTAG AAGGGCCCAATGGCC GAAAGGAGTTCCCCA TGTACAGTGGGAGGA 219 
TGGACTGGGCCCCCA TGGCCTCCCCTTTTG ACTTGATGATACTAG AAGGGCCCAATGGCC GAAAGGAGTTCCCCA TGTACAGTGGGAGGA 543 
RetSat+Chromos TGGACTGGGCCCCCA TGGCCTCCCCTTTTG ACTTGATGATACTAG AAGGGCCCAATGGCC GAAAGGAGTTCCCCA TGTACAGTGGGAGGA 543 
1 991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
2 S#11-8454MAR06 GGTTTGCGTATTGGG CGCTCTTCCGCTTCC TCGCTCACTGACTCG CTGCGCTCGGTCGTT CGGCTGCGGCGAGCG GTATCAGCTCACTCA 6E,9 
3 ” 1 1 - 5 2 4 4 M A R 0 6 A A G A A T A C A T C C A G G G C C T T A A G A A G A A G T T C C C C M G G A A G A A G C T G T C A T T G A C A A G T A C A T G G A G T T G G T T A A G G T G G T G G C C C G T G 1 0 5 5 
.5#11-2574MAR06 AAGAATACATCCAGG GCCTTAAGAAGAAGT TCCCCAAGGAAGAAG CTGTCATTGACAAGT ACATGGAGTTGGTTA AGGTGGTGGCCCGTG 309 
^ AAGAATACATCCAGG GCCTTAAGAAGAAGT TCCCCAAGGAAGAAG CTGTCATTGACA-GT ACTGGAGTTGGATTA AGGTGGTGGCC-GTG 631 
RetSat+Chromos AAGAATACATCCAGG GCCTTAAGAAGAAGT TCCCCAAGGAAGAAG CTGTCATTGACAAGT ACATGGAGTTGGTTA AGGTGGTGGCCCGTG 633 
J 1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
2 ”11-8454MAR06 AAGGCGGTAATACGG TTATCCACAGAATCA GGGGATAACGCAGGA AAAAACATGTGAGCA AAAGGCCAGCAAAAG GCCNGAACCGTAAAA "M 9 
3 ^•'ll-52'34MAR06 GAGTCTCTCATGCAG TTCTACTCAAGTTCC TCCCATTGCCCTTGA CTCAGCTCCTCAGCA AGTTTGGGCTACTGA CTCGTTTCTCTCCAT 114 5 
^ 11-2574MAR06 GAGTCTCTCATGCAG TTCTACTCAAGTTCC TCCCATTGCCCTTGA CTCAGCTCCTCAGCA AGTTTGGGCTACTGA CTCGTTTCTCTCCAT 399 
5 GAGTCTCTCATGCAG TTCTACTCAAGTTCC TCCCATTGCCCTTGA CTCAGCTCCTCAGCA AGTTTGGGCTACTGA CTCGTTTCTCTCCAT 721 
RetSat+Chromos GAGTCTCTCATGCAG TTCTACTCAAGTTCC TCCCATTGCCCTTGA CTCAGCTCCTCAGCA AGTTTGGGCTACTGA CTCGTTTCTCTCCAT 723 
1 1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 12-4 6 1260 
2 ”11-8454MAR06 NGNCCCGTTGCTG-- GCGTTTTNCNT ANGNNCCGCCCCCCT GACNANATCCNAAAA TCGACGCTCAAGTCN AANGNGGCAAACCCC 833 
3 ^'•U-5244MAR06 TCTGCCGAGCGTCTA CGCAGAGCCTAGCTG AAGTCCfGCAGCAGC TTGGGGCTTCCCGTG AGCTCCAGGCTGTTC TCAGCTACATCTTCC 1135 
4 ”11-2574MAR06 TCTGCCGAGCGTCTA CGCAGAGCCTAGCTG AAGTCCTGCAGCAGC TTGGGGCTTCCCGTG AGCTCCAGGCTGTTC TCAGCTACATCTTCC <389 
5 TCTGCCGAGCGTCTA CGCAGAGCCTAGCTG AAGTCCTGCAGCAGC TTGGGGCTTCCCGTG AGCTCCAGGCTGTTC TCAGCTACATCTTCC 811 
^etSat+Chromos TCTGCCGAGCGTCTA CGCAGAGCCTAGCTG AAGTCCTGCAGCAGC TTGGGGCTTCCCGTG AGCTCCAGGCTGTTC TCAGCTACATCTTCC 613 
1 1261 1275 1276 1290 1291. 1305 1306 1320 1321 1335 1336 1350 
2 ”11-8454MAR06 ACAGGACTTNAANAA CCAGGNGTTNCCCCT GNANCTCCNCGGGGG CTTCCTGNTCCNACC TGCNNTTACNGANAC TGTCCGCNTTTCCCT 923 
3 ^#l l -5244MAR06 CCACT-ACGGAGAAC NCCC 1253 
4 二11-2574MAR06 CCACTTACGGAGTAA CTCCCAGCCACACCG CCTTTTCCTT G CATGCTCTGCTGGTT CmCCACTACATACAA GGGGCATATTACCCT 575 
5 CCACTTACGGAGTAA CTCCCAGCCACACCG CCTTTTCCTT G CATGCTCTGCTGGTT GACCACTACATACAA GGGGCATATTACCCT 
晰Sat+Chromos CCACTTACGGAGTAA CTCCCAGCCACACCG CCTTTTCCTT G CATGCTCTGCTGGTT GACCACTACATACAA GGGGCATATTACCCT 899 
、. 
\ c 1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
2 "11-8454MAR06 TCGGNANGGGGGCNT TCCCAANCCCCNNTN ANGNTCCNATTCGGG GGNGGCNTCNCCCAA NNGGGGNGGGNCAAA CCCCNTTNACCNACN 1013 
3 5JJI-5244MARO6 1253 
4 J J | 1 - 2 5 7 4 M A R 0 6 C G A G G G G G T T C C A G T G A G A T C G C C T T C C A T A C C A T C C C T T T G A T T C A G C G G G C C G G G G G C G C T G T C C T C A C C A G G G C C A C T G T A C A G A G T 6 6 5 
5 11 CGAGGGGGTTCCAGT GAGATCGCCTTCCAT ACCATCCCTTTGATT CAGCGGGCCGGGGGC GCTGTCCTCACCAGG GCCACTGTACAGAGT 987 
®tSat+Chromos CGAGGGGGTTCCAGT GAGATCGCCTTCCAT ACCATCCCTTTGATT CAGCGGGCCGGGGGC GCTGTCCTCACCAGG GCCACTGTACAGAGT 989 
267 
1441 1455 1456 1470 1471 1485 1486 1500 1501 1515 1516 1530 
1 5#11-8454MAR06 GTGNCNTNNCGGNAA NTNNNTNGNNCCCCC GNAAANANNTTNNCC CNGGGNNNCCCGGNA AANNTNNNAAANGGT TTNNGGGGGNCAAAT 1103 
3 5ttll-2574MAR06 GTGCTGCTGGACTCA GCTGGNAAAGCGTGT GGTGTCANTGTGAAN AAGGGACAANAGCTG GTGAACATCTACTGC CCAGTTGTCATCTCC 755 
4 5#11 GTGCTGCTGGACTCA GCTGGGAGAGCGTGT GGTGTCAGTGTGAAG AAGGGACAAGAGCTG GTGAACATCTACTGC CCAGTTGTCATCTCC 1077 
5 RetSat+Chromos GTGCTGCTGGACTCA GCTGGGAGAGCGTGT GGTGTCAGTGTGAAG AAGGGACAAGAGCTG GTGAACATCTACTGC CCAGTTGTCATr-TCC 10-? 
1531 1545 1546 1560 1561 1575 1576 1690 1591 1605 1606 1620 
1 5«1]-8454MAR06 TTTNNNGGGNCCACC CCNCCCNAAAAAANT TTGNTNCNCCCNNAA NNNNNNCCNNAAAAA NNNNTTTTTTCNNAA AAACCNGGGGGGGNT ll^l? 
3 5«1]-2574MAR06 AATGCGGGAATGTTC AATACCTATCANCAC TTGTTGCCANANACT GTCCCCCATCTGCCA AANGTG AA AAANCACCTGGCGAT 
4 AATGCGGGAATGTTC AATACCTATCAGCAC TTGTTGCCAGAGACT GTCCCCCATCTGCCA GATGTG AA GAAGCAGCTGGCGAT 1160 
5 RetSat + Chromos AATGCGGGAATGTTC AATACCTATCAGCAC TTGTTGCCAGAGACT GTCCCCCATCTGCCA GATGTG AA GAAGCAGCTGGCGAT 1! 
1621 1635 1636 1650 1651 1665 1666 1680 1681 1695 1696 1710 
1 5#11-I34 54MAR06 TTTTTNNNNNNANNN CCNAAAANNNNNAAA TTTTTTTTNNGGGNN NNNNGNAAAA 1248 
3 5#11-2574MAR06 GGNANG-CCTGGTCN AA-CATGCTCTCA-T CNTCATCTGNCNAAA GGNCCAGGAAGA CTGAACNTCNTCNC AACTCTATTTTTTTG 921 
4 5#11 GGTAAGGCCTGGTCT GAGCATGCTCTCAAT CTTCATCTGTCTGAA AGGCACCAAGGAGGA CCTGAAGCTTCAGTC CACCAACTACTATGT 1250 
5 RetSat+Chromos GGTAAGGCCTGGTCT GAGCATGCTCTCAAT CTTCATCTGTCTGAA AGGCACCAAGGAGGA CCTGAAGCTTCAGTC CACCAACTACTATGT 1252 
1711 1725 1726 1740 17-31 1755 1756 1770 1771 1785 1786 1 _ 
3 5#11-2574MAR06 ANAAANTGACA AGCGTGAGNNTTG TTTNNGCNAG--AAA GGTCNAAANNTCCCT TCTNNTGCTCCTNAG 988 
4 5 m TTATTTTGACACAGA CATGGACAAAGCGAT GGAGCGeTATGTCTC TATGCCCAAGGAAAA GGCTCCAGAACACAT TCCCCTTCTCTTCAT 1340 
5 RetSat+Chromos TTATTTTGACACAGA CATGGACAAAGCGAT GGAGCGCTATGTCTC TATGCCCAAGGAAAA GGCTCCAGAACACAT TCCCCTTCTCTTCAT 134：.' 
1801 1815 1816 1830 1831 1845 1846 1860 1861 1875 1876 1890 
3 5#11-2574MAR06 ANGANCACTGGAGNN ATCCAACGTCNAAAN GCNGNCCTGCTTATG TCNGANGNGGNACAG GANNGGTNATAACCN AAGCTNGANCTTGGG 1078 
q 5#ll T G — — C C T T C C C A T C AAGCAAGGATCCAAC CTGGGAGGAGCGATT CCCAGACCGATCCAC AATGACTGCGCTGGT ACCCATGGCCTTTGA 1427 
5 RetSat+Chromos TG---CCTTCCCATC AAGCAAGGATCCAAC CTGGGAGGAGCGATT CCCAGACCGATCCAC AATGACTGCGCTGGT ACCCATGGCCTTTGA 1'129 
1891 1905 1906 1920 1921 1935 1936 1950 1951 1965 1966 1980 
3 5#11-2574MAR06 AAAANTCCCNGGGGG GGNGGTGGGNCCGNN NTNTNGNCCNGANNA GNAAANTGNNNCCCN NGNCAaCNCCCCCCC CNNGNANTNNN 1164 
^ 5#11 M G G T T C G A G G A G T G GCAGGAGGAGCCAAA GGGCAAC5CGTGGTGT TGACTATGAC5ACCCT CAAAAATGCCTTCGT GGAAGCCTCTATGTC 1517 . 
5 RetSat+Chromos ATGGTTCGAGGAGTG GCAGGAGGAGCCAAA GGGCAAGCGTGGTGT TGACTATGAGACCCT CAAAAATGCCTTCGT GGAAGCCTCTATGTC 1519 
1981 1995 1996 2010 2011 2025 2026 2040 2041 2055 2056 2070 
^ S#li GGTGATCATGAAACT GTTCCCACAGCTGGA GGGCAAGGTGGAGAG TGTGACTGGAGGGTC ACCACTGACCflACCA GTACTATCTGGCTGC 1607 
5 RetSat+Chromos GGTGATCATGAAACT GTTCCCACAGCTGGA GGGCAAGGTGGAGAG TGTGACTGGAGGGTC ACCACTGACCAACCA GTACTATCTGGCTGC 1609 
2071 2085 2086 2100 2101 2115 2116 2130 2131 2145 2146 2160 
^ ACCCCGAGGAGCTAC CTATGGAGCTGACCA TGACTT|GCTCGGCT GCATCCTCATGCAAT GGCTTCCATAAGAGC CCAAACCCCCATCCC 1697 
5 RetSat+Chromos ACCCCGAGGAGCTAC CTATGGAGCTGACCA TGACTTGGCTCGGCT GCATCCTCATGCAAT GGCTTCCATAAGAGC CCAAACCCCCATCCC 1699 
—— — 
2161 2175 2176 2190 2191 2205 2206 2220 2221 2235 2236 2250 
义 5#11 CAACCTCTACCTGAC AGGCCAAGATATCTT CACCTGtGGGCTGAT GGGGGCCCTGCAGGG GGCCTTGCTGTGCAG CAGTGCCATCCTGAA 1787 
^ '^etSat+Chromos CAACCTCTACCTGAC AGGCCAAGATATCTT CACCTGTGGGCTGAT GGGGGCCCTGCAGGG GGCCTTGCTGTGCAG CAGTGCCATCCTGAA 1789 
2251 2265 2266 2280 2281 2296 2296 2310 2311 2325 2326 2340 
》 地 1 ACGGAACTTCTACTC AGATCTGCAGGCTCT TGGCTCAAAGGTCA| GGCACAAAAGAAGAA GATGTAGTCCGTTCA GAGAAGAG 1870 
奴 S a t + C h r o m o s ACGGAACTTGTACTC AGATCTGCAGGCTCT TGGCTCAAAGGTCAA GGCACAAAAGAAGAA GATGTAGTCCGTTCA GAGAAGAGCCAGAGG 1879 
, 2341 2355 2356 2370 2371 2385 2386 2400 2401 2415 2416 24 30 
；5#11 1870 
•RetSat+Chromos AAAGGCACACTCCCC AACTTCTCGTGGTGT CCTCCCTCCTAC 1921 ‘ 
268 
Appendix B5: Alignment result of 5，#20 
181 195 196 210 211 225 226 240 241 255 256 270 
2 5#12-6437MAR06 GNCNTTAAANNCNNN TNNNCCAGTNGNNCN GNTTGATCCNNAAAN GCCCCANGGGGGANT CCCNTNGNGGNCCNG GGCCNTCCNNGNTGA 270 
3 5#12 GC GGTCTTCCXJAGCCCT 17 
4 RetSat+Chromos GC GGTCTTCCGAGCCCT 17 
271 285 286 300 301 315 316 330 331 345 346 360 
2 5<tl2-6437MAR06 NGNNGGAANNGTTTT CNACCCTGNACNNNA TGGNNNANNTTTNNN NNGGCCGGNNNNNNN GGNATCTCCCCNGGT TNAG---GGGNCTTT 357 
3 5#12 GGCAGCAA CATGTGGATCA CTGCTCTGCTGCTGG CCX5TGCTGCTGCTGG TGATCCTCCACAGGG TCTACGTGGGCCTTT 96 
4 RetSat+Chromos GGCAGCAA CATGTGGATCA CTGCTCTGCTGCTGG CCGTGCTGCTGCTGG TGATCCTCCACAGGG TCTACGTGGGCCTTT 96 
361 375 376 390 391 405 406 420 421 435 436 450 
2 5#12-6437MAR06 NGGNN--AAGTTCCC GAACCCTTTNCGGGG AT TCNAAGGAC CNCNNNACCCCTGGG --ACCGNCAAGGGGN TAGG--ANAAAATTT 437 
3 ACGCTGCAAGTTCCC CGAACCCCTTCGCCG AGGATGTCAAGCGAC CGCCTGAACCCCTGG TGACCGACAAGGAGG CTAGGAAGAAAGTTC 186 
4 RetSat+Chromos ACGCTGCAAGTTCCC CGAACCCCTTCGCCG AGGATGTCAAGCGAC CGCCTGAACCCCTGG TGACCGACAAGGAGG CTAGGAAGAAAGTTC 186 
451 465 466 480 481 495 496 510 511 525 526 540 
2 5#12-6437MAR06 TCAANCAANCTTTTT CANTCAGCNGAGTAC CAGGGAAGCTGGATN CAGTG-TGATCGGCA GCGNCATTGGGGGAC TGGCNTCAGCTGCGG 526 
3 5#12 TCAAACAAGCTTTCT CAGTCAGCCGAGTAC CAGAGAAGCTGGATG CAGTGGTGATCGGCA GCGGCATTGGGGGAC TGGCCTCAGCTGCX3G 276 
4 RetSat+Chromos TCAAACAAGCTTTCT CAGTCAGCCGAGTAC CAGAGAAGCTGGATG CAGTGGTGATCGGCA GCGGCATTGGGGGAC TGGCCTCAGCTGCGG 276 
541 555 556 570 571 585 586 600 601 615 616 630 
2 5#:L2-6437MAR06 TTCTAGCTAAAGCTG GCAAGAGAGTCCTTG TGCTGGAACAACATA CCAAGGCGGGCGGCT GTTGTCATACCTTGG GGAAAAT--GNCCTG 614 
3 5#12 TTCTAGCTAAAGCTG GCAAGAGAGTCCTTG TGCTGGAACAACATA CCAAGGCGGGCGGCT GTTGTCATACCTTTG GGGAAAATGGCCTTG 366 
4 RetSat+Chromos TTCTAGCTAAAGCTG GCAAGAGAGTCCTTG TGCTGGAACAACATA CCAAGGCGGGCGGCT GTTGTCATACCTTTG GGGAAAATGGCCTTG 366 
631 645 646 660 661 675 676 690 691 705 706 720 
1 S#:L2-8454MAR06 -GNNNTGGCT TCCATAAGA--GCCC AAACCCCCATCCCCA ACCTCTACCTGACAG GCCAAGATATCTTCA CCTGTGGGCTGATGG 82 
2 5#12-6437MAR06 AATTTGACACTGGAA TTCATTATATTGGAC GAATGCGGGAGGGCA ACATTGGCCGTTTTA TCTTG-ACCAGATCA CTGAAGGGCAACTGG 703 
3 5#12 AATTTGACACTGGAA TTCATTATATTGGAC GAATGCGGGAGGGCA ACATTGGCCGTTTTA TCTTGGACCAGATCA CTGAAGGGCAACTGG 456 
4 RetSat+Chromos AATTTGACACTGGAA TTCATTATATTGGAC GAATGCGGGAGGGCA ACATTGGCCGTTTTA TCTTGGACCAGATCA CTGAAGGGCAACTGG 456 
721 735 736 750 751 765 766 780 781 •. 795 796 810 
1 5#12-8454MAR06 GGGCCCTGCAGGGGG CCTTGCTGTGCAGCA GTGCCATCCTGAAAC GGAACTTGTACTCAG ATCTGCGGGCTCTTG GCTCAAAGGTCAAGG 172 
2 5#12-6437MAR06 ACTC5GGCCCCCATGG CCTCCCCTTTTGACT TGATGATACTAGAAG GGCCCAATGGCCGAA AGGAGTTCCCCATGT ACAGTGGGAGGAAAG 793 
3 5#12 ACTGGGCCCCCATGG CCTCCCCTTTTGACT TGATGATACTAGAAG GGCCCAATGGCCGAA AGGAGTTCCCCATGT ACAGTGGGAGGAAAG 546 
^ RetSat+Chromos ACTGGGCCCCCATGG CCTCCCCTTTTGACT TGATGATACTAGAAG GGCCCAATGGCCGAA AGGAGTTCCCCATGT ACAGTGGGAGGAAAG 546 
811 825 826 840 841 855 856 870 871 885 886 900 
1 5#12-8454MAR06 CACAAAAG -AAGAAGATGTAGT CCGTTCAGAGAAGAG CCAGAGGAAAGGCAC CTCCCCAACTTCTCG TGGTGTCCTCCCTCC 253 
2 5#12-6437MAR06 AATACATCCAGGGCC TTAAGAAGAAGTTCC CCAAGGAAGAAGCTG TCATTGACAAGTACA TGGAGTTGGTTAAGG TGGTGGCCCGTGGAG 883 
3 5#12 AATACATCCAGGGCC TTAAGAAGAAGTTCC CCAAGGAAGAAGCTG TCATTGACA-GTACT GGAGTTGGATTAAGG TGGTGGCC-GTGGAG 634 
4 RetSat+Chromos AATACATCCAGGGCC TTAAGAAGAAGTTCC CCAAGGAAGAAGCTG TCATTGACAAGTACA TGGAGTTGGTTAAGG TGGTGGCCCGTGGAG 636 
901 915 916 930 931 945 946 960 961 975 976 990 
^ S#12-8454MAR06 TACAAGGGCGAATTC TGCAGATATCCATCA CACTGGCGGCCGCTC GAGCATGCATCTAGA GGGCCCAATTCGCCC TATAGTGAGTCGTAT 343 
^ S#12-6437MAR06 TCTCTCATGCAGTTC TACTCAAGTTCCTCC CATTGCCCTTGACTC AGCTCCTCAGCAAGT TTGGGCTACTGACTC GTTTCCCTCCATTCT 973 
^ TCTCTCATGCAGTTC TACTCAAGTTCCTCC CATTGCCCTTGACTC AGCTCCTCAGCAAGT TTGGGCTACTGACTC GTTTCTCCCCATTCT 724 
RetSat+Chromos TCTCTCATGCAGTTC TACTCAAGTTCCTCC CATTGCCCTTGACTC AGCTCCTCAGCAAGT TTGGGCTACTGACTC GTTTCTCTCCATTCT 726 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
J S#12-8454MAR06 TACAATTCACTGGCC GTCGTTTTACAACGT CGTGACTGGGAAAAC CCTGGCGTTACCCAA CTTAATCGCCTTGCA GCACATCCCCCTTTC 433 
J S#12-6437MAR06 GCCGAGCGTCTACGC AGAG CCTAGCT GAAGTCCTGCAGCAG CTTGGGGCTTCCCGT CJAGCTCCAGGCTGTT -CCCAGCTACATCTT 1058 
^ GCCGAGCGTCTACGC AGAG CCTAGCT GAAGTCCTGCAGCAG CTTGGGGCTTCCCGT GAGCTCCAGGCTGTT -CCCAGCTACATCTT 809 
•RetSat+Chromos GCCGAGCGTCTACGC AGAG CCTAGCT GAAGTCCTGCAGCAG CTTGGGGCTTCCCGT GAGCTCCAGGCTGTT -CTCAGCTACATCTT 811 
1 1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
2 2#12-8454MAR06 GCCAGCTGGCGTAAT AGCGAAGAGGCCCGC ACCGATCGCCCTTCC --CAACAGTTGCGCA GCCTGAATGGCGAAT GGACXSCGCCCTGTAG 521 
3 S#12-6437MAR06 CCCCACTTACGGAGT AACTCCCAGCCACAC CGCCTTTTCCTTGCA TGCTCTGCTGGTTGA CCACTACATACAAGG GGCATATTACCCTCG 1148 
. C C C C A C T T A C G G A G T AACTCCCAGCCACAC CGCCTTTTCCTTGCA TGCTCTGCTGGTTGA CCACTACATACAAGG GGCATATTACCCTCG 899 
•RetSat+Chromos CCCCACTTACGGAGT AACTCCCAGCCACAC CGCCTTTTCCTTGCA TGCTCTGCTGGTTGA CCACTACATACAAGG GGCATATTACCCTCG 901 
, 1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
2 Sk2-8454MAR06 CGGCGCATTAAGCGC GGCGGGTGTGG TGGTTAC GCGCAGCGTGACCGC TACACTTGCCAGCGC CCTAGCGCCCGCTCC 599 
3 ^ #12-6437MAR06 AGGGGGTTCCAGTGA GATCGCCTTCCATAC CATCCCTTTGATTCA GCGGGCCGGGGGCGC TGTCCTCACCAGGGC CACTGTACAGAGTGT 1238 
4 ， A G G G G G T T C C A G T G A GATCGCCTTCCATAC CATCCCTTTGATTCA GCGGGCCGGGGGCGC TGTCCTCACCAGGGC CACTGTACAGAGTGT 989 
RetSat+Chromos AGGGGGTTCCAGTGA GATCGCCTTCCATAC CATCCCTTTGATTCA GCGGGCCGGGGGCGC TGTCCTCACCAGGGC CACTGTACAGAGTGT 991 
1 1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
2 二#12-8454MAR06 TTTCGCTTTCTTCCN TCCTTTCTCGCCACG T-TCGCCGGCTTTCC CCGTCAAGCTCTAAA TCGGGGGCTCCCTTT AGGGTTCCGATTTAG 688 
3 ” 12-6437MAR06 GCTGCTGGANTCA-- - - 1251 
4 ” G C T G C T G G A C T C A G C TGGGAGAGCGTGTGG TGTCAGTGTGAAGAA GGGACAAGAGCTGGT GAACATCTACTGCCC AGTTGTCATCTCCAA 1079 
RetSat+Chromos GCTGCTGGACTCAGC TGGGAGAGCGTGTGG TGTCAGTGTGAAGAA GGGACAAGAGCTGGT GAACATCTACTGCCC AGTTGTCATCTCCAA 1081 
1 1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
3 g^lS-SASAMAROS TGCTTTACGGCACCT CGACCCCAAAAACTT GATTAGGGTGATGGT TCACGTANTGGGCCA TCGCCCTGATANACG G TTTTTCGCCC 774 
4 ”12 TGCGGGAATGTTCAA TACCTATCAGCACTT GTTGCCAGAGACTGT CCGCCATCTGCCAGA TGTGAAGAAGCAGCT GGCGATGGTAAGGCC 1169 
'^®tSat+Chromos TGCGGGAATGTTCAA TACCTATCAGCACTT GTTGCCAGAGACTGT CCGCCATCTGCCAGA TGTGAAGAAGCAGCT GGCGATGGTAAGGCC 1171 
1 G 1 4 4 1 1 4 5 5 1 4 5 6 1 4 7 0 1 4 7 1 1 4 8 5 1 4 8 6 1 5 0 0 1 5 0 1 1 5 1 5 1 5 1 6 1 5 3 0 
3 ^ 12-8454MAR06 TTTGACGTTGGANTC CNCNTTCTTAAAANN GGANTCTTGNTCCAA ACTGGAACANCCTCA NCCTATCCCGGTCTA TTCTTTTGNTTTNAA 864 
4 TGGTCTGAGCATGCT CTCAATCTTCATCTG TCTGAAAGGCACCAA GGAGGACCTGAAGCT TCAGTCCACCAACTA CTATGTTTATTTTGA 1259 
etSat+ChromoB TGGTCTGAGCATGCT CTCAATCTTCATCTG TCTGAAAGGCACCAA GGAGGACCTGAAGCT TCAGTCCACCAACTA CTATGTTTATTTTGA 1261 
269 
1531 1545 1546 1560 1561 1575 1576 1590 1591 1605 1606 1620 
1 5#12-84 54MAR06 GG--GATTTTGCCAA TTCGGNCNNTNGGTN AAAAATGNCTGATTN ACAAAATTTANCNNA NTTTNANAAATTCNG GNCCANGGCTGCTAA 952 
3 5#12 CACAGACATGGACAA AGCG ATGGAG CGCTATGTCTCTATG CCCAAGGAAAAGGCT CCAGAACACATTCCC CTTCTCTTCATTGCC 1344 
4 RetSat + Chromos CACAGACATGGACAA AGCG ATGGAG CGCTATGTCTCTATG CCCAAGGAAAAGGCT CCAGAACACATTCCC CTTCTCTTCATTGCC 1346 
1621 1635 1636 1650 1651 1665 1666 1680 1681 1695 1696 1710 
1 5#12-8454MAR06 NGAANGGAACCTTNA AAGCCCNCCCCAAAN NGGGGNACCCCGAAA ANGNCCCNTTGGGNT TTG--GGNANGNAAA CCNCNCCAAAAAAAC 1040 
3 5#12 TTCCCATCAAGCAAG GATCCAACCTGGGAG GAGCGATTCCCAGAC CX3ATCCACAATGACT GCGCTGGTACCCATG GCCTTTGAATGGTTC 1434 
4 RetSat+Chromos TTCCCATCAAGCAAG GATCCAACCTGGGAG GAGCGATTCCCAGAC CGATCCACAATGACT GCGCTGGTACCCATG GCCTTTGAATGGTTC 1436 
1711 1725 1726 1740 1741 1755 1756 1770 1771 1785 1786 1800 
1 5#12-8454MAR06 NGGGNNTNNNGGGNN TATGGGAAANNAAAN GGGGGTTTNNNAAAA ANNA AAN ANTTCCCTNGGGCCC NTTGGAGGGGGNANC 1122 
3 5#12 GAGGAGTGGCAGGAG GAGCCAAAGGGCAAG CGTGGTGTTGACTAT GAGACCCTCAAAAAT GCCTTCGTGGAAGCC TCTATGTCGGTGATC 1524 
4 RetSat+Chromos GAGGAGTGGCAGGAG GAGCCAAAGGGCAAG CGTGGTGTTGACTAT GAGACCCTCAAAAAT GCCTTCGTGGAAGCC TCTATGTCGGTGATC 1526 
1801 1815 1816 1830 1831 1845 1846 1860 1861 1875 1876 1890 
1 5#12-8454MAR06 CCNAAAAAANGNGGT TTTNNCCCAAGTTTT GGGCGGGGNNANTTT TAAAAAAGGGNGNTT TNCNNTANAAAAANG GNNNCCNNNCCCNNN 1212 
3 5#12 ATGAAAC T GTTCCCACAGCTGGA GGGCAAGGTGGAGAG TGTGACTGGAGGGTC ACCACTGACCAACCA GTACTATCTGGCTGC 1607 
4 RetSat+Chromos ATGAAAC T GTTCCCACAGCTGGA GGGCAAGGTGGAGAG TGTGACTGGAGGGTC ACCACTGACCAACCA GTACTATCTGGCTGC 1609 
1891 1905 1906 1920 1921 1935 1936 1950 1951 1965 1966 1980 
1 5#12-8454MAR06 T GGGGAGNNTT TTTTNNGGGNAAAAA ANTTTTTTNNCCTTT TTTTTNAAANGNCCN TTTTTNAAAANNCNN CCNAAAAAAAAAAAN 1298 
3 5#12 ACCCCGAGGAGCTAC CTATGGAGCTGACCA TGACTTGGCTCGGCT GCATCCTCATGCAAT GGCTTCCATAAGAGC CCAAACCCCCATCCC 1697 
4 RetSat+Chromos ACCCCGAGGAGCTAC CTATGGAGCTGACCA TGACTTGGCTCGGCT GCATCCTCATGCAAT GGCTTCCATAAGAGC CCAAACCCCCATCCC 1699 
1981 1995 1996 2010 2011 2025 2026 2040 2041 2055 2056 2070 
1 5#12-8454MAR06 CNTTTNNG 1306 
3 5#12 CAACCTCTACCTGAC AGGCCAAGATATCTT CACCTGTGGGCTGAT GGGGGCCCTGCAGGG GGCCTTGCTGTGCAG CAGTGCCATCCTGAA 1787 
4 RetSat+Chromos CAACCTCTACCTGAC AGGCCAAGATATCTT CACCTGTGGGCTGAT GGGGGCCCTGCAGGG GGCCTTGCTGTGCAG CAGTGCCATCCTGAA 1789 
2071 2085 2086 2100 2101 2115 2116 2130 2131 2145 2146 2160 
3 ACGGAACTTGTACTC AGATCTGCAGGCTCT TGGCTCAAAGGTCAI GGCACAAAAGAAGAA GATGTAGTCCGTTCA GAGAAGAG - 1870 
4 RetSat+Chromos ACGGAACTTGTACTC AGATCTGCAGGCTCT TGGCTCAAAGGTCAA GGCACAAAAGAAGAA GATGTAGTCCGTTCA GAGAAGAGCCAGAGG 1879 
2161 2175 2176 2190 2191 2205 2206 2220 2221 2235 2236 2250 
1 5#12-8454MAR06 1306 
2 S#12-6437MAR06 1251 
3 5#12 1870 
4 RetSat+Chromos AAAGGCACACTCCCC AACTTCTCGTGGTGT CCTCCCTCCTAC 1921 
v. 
270 
Appendix B4: Alignment result of 5’#16 
541 555 556 570 571 585 586 600 601 615 616 630 
1 5)(16-M13FAPR05 GACTGGAGCACTGAG GACACTGAGCATGGA CTGAAGGAAGAGGCT GGTCTTCCGAGCCCT GGCAGCAACATGTGG ATCACTGCTCTGCTA 19..1 
2 5ttl6-59")RMAY05 GACTGGAGCAC-GAG GACACTGA-CATGGA CTGAAGGAAGAAGC- GGTCTTCCGAGCCCT GGCAGCAACATGTGG ATCACTGCTCTGCT- 321 
3 5#16-2635MAY05 GACTGGAGCAC-GAG GACACTGA-CATGGA CTGAAGGAAGAAGC- GGTCTTCCGAGCCCT GGCAGCAACATGTGG ATCACTGCTCTGCT- 588 
14 RetSat+Chromos GC- GGTCTTCCGAGCCCT GGCAGCAACATGTGG ATCACTGCTCTGCT- 0 
631 645 646 660 661 675 676 690 691 705 706 720 
1 I5#16-M13FAPR05 GCTGGCCGTGCTGCT AGCATGGTGATCCTC CACAGGGTCTACGTG GGCCTTTACGCTGCA AGTTCCCCGAACCCC TTCGCCGAGGATGTC 274 
2 5#16-594RMAY05 GCTGGCCGTGCTGCT -GC-TGGTGATCCTC CACAGGGTCTACGTG GGCCTTTACGCTGCA AGTTCCCCGAACCCC TTCGCCGAGGATGTC 409 
3 5#16-2635MAY05 GCTGGCCGTGCTGCT -GC-TGGTGATCCTC CACAGGtSTCTACGTG GGCCTTTACGCTGCA AGTTCCCCGAACCCC TTCGCCGAGGATGTC 676 
RetSat+Chromos GCTGGCCGTGCTGCT -GC-TGGTGATCCTC CACAGGGTCTACGTG GGCCTTTACGCTGCA AGTTCCCCGAACCCC TTCGCCGAGGATGTC 134 
721 735 736 750 751 765 766 780 781 795 796 810 
1 5#16-M13FAPR05 AAGCGACCGC-TGAG CCCCTGGTGACCGAC AAGGAGGCTAGGAAG AAAGTTCTCAAACAA GCTTTCTCAGTCAGC CGAGTACCAGAGAAG 363 
2 5n6-!594RMM05 AAGCGACCGCCTGAA CCCCTGGTGACCGAC AAGGAGGCTAGGAAG AAMGTTCTCAAACAA GCTTTCTCAGTCAGC CGAGTACCAGAGAAG 499 
9 5t(16-5244MAR06 AAGCGACCGCCTGAA CCC-TGGCGACCGAC AAGG-GGCTAGGAAG AAAGTTTTCAANNA- GCTTTTTCAGTCAGC CGAGTACCAGAGAAG 606 
11 5#16-64 37MAR06 AAGGGNCC-CCTGAA CCCCTGGNGNCNNA- AAGGNGGNTAGNAA- AAANTTTTCAANNAN NTTTT-TCANTCAGC NGANTACCNNGGAAN 503 
3 5#16-2635MAY05 AAGCGACCGCCTGAA CCCCTGGTGACCGAC AAGGAGGCTAGGAAG CCAGTTCTCAAACAA GCTTTCTCAGTCAGC CGAGTACCAGAGAAG 76G 
“ RetSat+Chromos AAGCGACCGCCTGAA CCCCTGGTGACCGAC AAGGAGGCTAGGAAG AAAGTTCTCAAACAA GCTTTCTCAGTCAGC CGAGTACCAGAGAAG 224 
811 825 826 840 841 855 856 870 871 885 886 900 
1 5#16-M13FAPR05 CTGGATGCAGTGGTG ATCGGCAGCGGCATT GGGGGACTGGCCTCA GCTGCGGTTCTAGCT AAAGCTGGCAAGAGA GTCCTTGTGCTGGAA 453 
11 5#16-6437MAR06 CTGGATNCANTG-TN ATCG-CAGCGGCATN GGGG-ACTGGCNTNA GNTGCGGTTCTAGCT AAAGCTGNCAAGAGA GTCCTTNTGCTGNAA 590 
9 5#16-524 4MAR06 CTGGATGCAGTG-TG ATCGGCAGCGGCATT GGGGGACTGGCNTCA GCTGCGGTTCTAGCT AAAGCTGGCAAGAGA GTCCTTGTGCTGGAA 695 
3 5#16-2635MAY05 CTGGATGCAGTGGTG ATCGGCAGCGGCATT GGGG-ACTG-CCTCA GCT-CG TT AAAATGGGTGCAAGA GTC 834 
2 5#16-594RMAY05 CTGGATGCAGTGGTG ATCGGCAGCGGCATT GGGGGAeTGGCCTCA GCTGCGGTTCTAGCT AAAGCTGGCAAGAGA GTCCTTGTGCTGGAA 689 
RetSat+Chromos CTGGATGCAGTGGTG ATCGGCAGCGGCATT GGGGGACTGGCCTCA GCTGCGGTTCTAGCT AAAGCTGGCAAGAGA GTCCTTGTGCTGGAA 314 
901 915 916 930 931 945 946 960 961 975 976 990 
5#16-64 37MAR06 -AANATAACNAGGNG GGC-GGCTGTTGTCA TACCTTN-GGG-AAA ATGGCCTTGAATTTG ACACTGGAATTCATT ATATT-GGACGAATG 675 
5#16-25"74MAR06 GNG GGC-GGCTGTTGTCA TACCTTT-GGGGAAA ATGGCCTTGAATTTG ACACTGGAATTCATT ATATT-GGACGAATG 75 
2 5ttl6-594RMAY05 CAACATACCAAGGCG CCCCAGCTGTTGTCA TACCTTTCGGGGAAA ATGGCCTTGAATTTG ACACTGGAATTCATT ATATT-GTACAGAAT 678 
1 5#16-M13FAPR05 CAACATACCAAGGCG GGC-GGCTGTTGTCA TACCTTATGGGGAAA ATGGCCTTGAATTTG ACACTGGAATTCATT ATATTCGGACGAATG 542 
® 5#16-52 4 4MAR06 CAACATACCAAGGCG GGC-GGCTGTTGTCA TACCTTt-GGGGAAA ATGGCCTTGAATTTG ACACTGGAATTCATT ATATT-GGACGAATG 782 
“ RetSat+Chromos CAACATACCAAGGCG GGC-GGCTGTTGTCA TACCTTT-GGGGAAA ATGGCCTTGAATTTG ACACTGGAATTCATT ATATT-GGACGAATG 401 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
^ 5#16-M13FAPR05 CGCGGAGGGCAACAT TGGCCGTTTA-TCTT GGACCAGATCACTGA AGGGCA-CTGGACTG GGCCCCCATGG-CTC CCCTTTTGA-TTGAT 62S 
^ …6- 5 9 4 R M A Y 0 5 CGCGGGAGGCAACAT CGACCGTTTT-NTAT CGACCGGATCATCGA AGG-CA TCTG TGCCCCC CGGTGTTGA-G 748 
5(n6-l547MAYC15 - G - A G A G A G C A A — — - G G C 16 
5#16-968MAY05 GG AC AC TAC ATACAG CCCAT AT 22 
5#16-5244MAR06 CG-GGAGGGCAACAT TGGCCGTTTTATCTT GGACCAGATCACTGA AGGGCAACTGGACTG GGCCCCCATGGCCTC CCCTTTTGACTTGAT 871 
. 5 # 1 6 - 6 4 3 7 M A R 0 6 CG-GGAGGGCAACAT TGGCCGTTTTATNTT GGACCAGATCACTGA AGGGCAACTGGACTG GGCCCCCATGGCCTC CCCTTTTGACTTGAT 764 
^ 5 # 1 6 - 2 5 7磁 R 0 6 CG-GGAGGGCAACAT TGGCCGTTTTATCTT GGACCASATCACTGA AGGGCAACTGGACTG GGCCCCCATGGCCTC CCCTTTTGACTTGAT 164 
RetSat+Chromos CG-GGAGGGCAACAT TGGCCGTTTTATCTT GGACCAGATCACTGA AGGGCAACTGGACTG GGCCCCCATGGCCTC CCCTTTTGACTTGAT 490 
I 1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
〜5#16-M13FAPR05 GATACTAGAAGGGCC CAATGGCCGAAACGG AGTT 662 
g S#16-968MAY05 TTTACTACAGGGGTC AGTGAGAC 4 5 
g ⑷6- 1 2 0 5 M A Y 0 5 GCC — G T G G T C T A A — — G AAATCCGCCATTGGC AGATGATTGATAGTG ATCA GAGACTG AATAGGATAAGTGCC 69 
5#16-5244MAR06 GATACTAGAAGGGCC CAATGGCCGAAA-GG AGTTCC-CCATGTAC AGTGGGAGGAAAGAA TACATCCAGGGCCTT A--AGAAGAAGTTCC 957 
5*tl6-6437MAR06 GATACTAGAAGGGCC CAATGGCCGAAA-GG AGTTCC-CCATGTAC AGTGGGAGGAAAGAA TACATCCAGGGCCTT A--AGAAGAAGTTCC 860 
J. ^|16-2574MAR06 GATACTAGAAGGGCC CAATGGCCGAAA-GG AGTTCC|CCATGTAC AGTGGGAGGAAAGAA TACATCCAGGGCCTT A--AGAAGAAGTTCC 250 
f^etSat+Chromos GATACTAGAAGGGCC CAATGGCCGAAA-GG AGTTCC-CCATGTAC AGTGGGAGGAAAGAA TACATCCAGGGCCTT A--AGAAGAAGTTCC 576 
9 1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 124 6 1260 
”16-5244MAR06 CCAAGGAAGAAGCTG TCATTGACAAGTACA TGGAGTT--GGTTAA GGTGGTGGCCCGTGG -AGTCTCTCATGCAG TTCTACTCAAGTTCC 1044 
5#16-6437MAR06 CCAAGGAAGAAGCTG TCATTGACAAGTACA TGGAGTT--GGTTAA GGTGGTGGCCCGTGG -AGTCTCTCATGCAG TTCTACTCAAGTTCC 93~l 
13 ”16-684MAY05 AGAAACTG -CTATGACAAGCCNA TGGAGTTTGAGTTAA GGTGGTGGCCCGTGG OAGTCTCTCATGCAG TTCTACTCAAGTTCC 82 
5 « 1 6 - 2 5 7 4 M A R 0 6 C C A A G G A A G A A G C T G T C A T T G A C A A G T A C A T G G A G T F — G G T T A A G G T G G T G G C C C G T G G - A G T C T C T C A T G C A G T T C T A C T C A A G T T C C 3 3 7 
KetSat+Chromos CCAAGGAAGAAGCTG TCATTGACAAGTACA TGGAGTT--GGTTAA GGTGGTGGCCCGTGG -AGTCTCTCATGCAG TTCTACTCAAGTTCC 663 
9 1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
II ^*'16-5244MAR06 TCCCATTGCCCTTGA CTCAGCTCCTCAQCA AGTTTGGGCTACTGA CTCGTTTCTCTCCAT TCTGCCGAGCGTCTA CGCAGAGCCTAGCT- 1133 
\2 ^'•16-6437MAR06 TCCCATTGCCCTTGA CTCAGCTCCTCAGCA AGTTTGGGCTACTGA CTCGTTTCTCTCCAT TCTGCCGAGCGTCTA CGCAGAGCCTAGCTG 1027 
13 ”16-684MAY05 TCCCATTGCCCTTGA CTCAGCTCCTCAGCA AGTTTGGGCTACTGA GTCGTTTCTCTCCAT TCTGCCGAGCGTCTA CGCAGAGCCTAGCTG. 17： 
14 ”16-2574MAR06 TCCCATTGCCCTTGA CTCAGCTCCTCAGCA AGTTTGGGCTACTGA CTCGTTTCTCTCCAT TCTGCCGAGCGTCTA CGCAGAGCCTAGCTG 41^ 7 
他 S a t + C h r o m o s TCCCATJCCCCTTGA CTCAGCTCCTCAGCA AGTTTGGGCTACTGA CTCGTTTCTCTCCAT TCTGCCGAGCGTCTA CGCAGAGCCTAGCTG 753 
1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
丨 l2 ^*16-6437MAR06 AAGTCCTGCAGCAGC TTGGGGCTTCCCGTG AGCTCCAGGCTGTTC TCAGCTACATCTTCC CCACTTACGGAGTAA CTCCCAGCCACACCG 1117 
13 ^''16-684MAY05 AAGTCCTGCAGCAGC TTGGGGCTTCCCGTG AGCTCCAGGCTGTTC TCAGCTACATCTTCC CCACTTACGGAGTAA CTCCCAGCCACACCG 262 
14 P ^6-2574MAR06 AAGTCCTGCAGCAGC TTGGGGCTTCCCGTG AGCTCCAGGCTGTTC TCAGCTACATCTTCC CCACTTACGGAGTAA CTCCCAGCCACACCG 517 
*^®tSat+Chromos AAGTCCTGCAGCAGC TTGGGGCTTCCCGTG AGCTCCAGGCTGTTC TCAGCTACATCTTCC CCACTTACGGAGTAA CTCCCAGCCACACCG 843 
271 , 
1441 1455 1456 1470 1471 1485 1486 1500 1501 1515 1516 1530 
11 5梓16-6437MAR06 CCTTTTCCTTGCATG CTCTGCTGGTTGACC ACTACATACAAGGGG CATATTACCCTCGAG GGGGTTCCAGTGAGA TCGCCTTCCATACCA 1207 
12 5tjl6-684MAY05 CCTTTTCCTTGCACG CTCTGCTGGTTGACC ACTACATACAAGGGG CATATTACCCTCGAG GGGGTTCCAGTGAGA TCGCCTTCCATACCA 3:.2 
13 5幷16-2574MAR06 CCTTTTCCTTGCATG CTCTGCTGGTTGACC ACTACATACAAGGGG CATATTACCCTCGAG GGGGTTCCAGTGAGA TCGCCTTCCATACCA 607 
RetSat+Chromos CCTTTTCCTTGCATG CTCTGCTGGTTGACC ACTACATACAAGGGG CATATTACCCTCGAG GGGGTTCCAGTGAGA TCGCCTTCCATACCA 933 
1531 1545 1546 1560 1561 1575 1676 1S90 1591 1605 1606 16l!0 
7 5#16-968MAY05 TCCCTTTGATTCAGC GGGCCGGGGGCGCTG TCCTCACCAGGGCCA CTGTACAGAGTGTGC TGCTGGACTCAGCTG GGAGAGCGTGTGGTG 150 
B 5#16-1205MAY05 GGGTCGTGAGCG 82 
10 S#16-194 8MAY05 CGGGGGC-CTG TCCTCACCAGGGCCA CTGTACAGAGTGTGC TGCTGGACTCAGCTG GGAGAGCGTGTGGTG 70 
11 5#16-6437MAR06 TCCCTTTGATTCAGC GGGCCGGGGGCGCTG TCCTCACCAGGGCCA CTGTACAGAGNN-GN NNNNGA 1272 
13 5#16-2574MAR06 TCCNTTTGATTCAGC GGGCCGGGGGCGCTG TCCTCACCAGGGCCA CTGTACAGAGTGTGC TGCTGGACTCANCTG GGAAANCGTGTGGTG 697 
12 舰Y05 TCCCTTTGATTCAGC GGGCCGGGGGCGCTG TCCTCACCAGGGCCA CTGTACAGAGTGTGC TGCTGGACTCAGCTG GGAGAGCGTGTGGTG 442 
RetSat+Chromos TCCCTTTGATTCAGC GGGCCGGGGGCGCTG TCCTCACCAGGGCCA CTGTACAGAGTGTGC TGCTGGACTCAGCTG GGAGAGCGTGTGGTG 1023 
1621 1635 1636 1650 1651 1665 1666 1680 1681 1695 1696 1710 
]5ttl6~968MAY05 TCAGTGTGAAGAAGG GACAAGAGCTGGTGA ACATCTACTGCCCAG TTGTCATCTCCAATG CGGGAATGTTCAATA CCTATCAGCACTTGT 'J4 0 
IQ 5n6-1948MAY05 TCAGTGTGAAGAAGG GACAAGAGCTGGTGA ACATCTACTGCCCAG TTGTCATCTCCAATG CGGGAATGTTCAATA CCTATCAGCACTTGT 160 
13 15#16-257 4MAR06 TCANTGTGAAAAANG GACAANANCTGGTGA -CATCTACTGNCCAG TTGTCATCTCCAATG NGGGAATGNTCAATA CCTATCANCACTTGT 7b6 
12 5#16-684MAY05 TCAGTGTGAAGAAGG GACAAGAGCTGGTGA ACATCTACTGCCCAG TTGTCATCTCCAATG CGGGAATGTTCAATA CCTATCAGCACTTGT 532 
“ RetSat+Chromos TCAGTGTGAAGAAGG GACAAGAGCTGGTGA ACATCTACTGCCCAG TTGTCATCTCCAATG CGGGAATGTTCAATA CCTATCAGCACTTGT 1113 
1711 1725 1726 1740 1741 1755 1756 1770 1771 1785 1786 1800 
〕5#16-968MAY05 TGCCAGAGACTGTCC GCCATCTGCCAGATG TGAAGAAGCAGCTGG CGATGGTAAGGCCTG GTCTGAGCATGCTCT CAA--TCTTCATCTG 32i9 
5#16-1948MAY05 TGCCAGAGACTGTCC GCCATCTGCCAGATG TGAAGAAGCAGCTGG CGATGGTAAGGCCTG GTCTGAGCATGCTCT CAA--TCTTCATCTG 248 
” 5#16-2574MAR06 TGCCANAAACTGNCC GCCATCNGCNAANT- TGAAAAAN-ANCTGG CNATGGTA-NGCCTG GTCTNAA-NTGCCC- CNA--NCTN-ANCTG 868 
5ttl6-684MAY05 TGCCAGAGACTGTCC GCCATCTGCCAGATG TGAAGMGCAGCTGG CGATGGTAAGGCCTG GTCTGAGCATGCTCT CAA—TCTTCATCTG 620 
“ RetSat+Chromos TGCCAGAGACTGTCC GCCATCTGCCAGATG TGAAGAAGCAGCTGG CGATGGTAAGGCCTG GTCTGAGCATGCTCT CAA--TCTTCATCTG 1201 
1801 1815 1816 1830 1831 1845 1846 1860 1861 1875 1876 1890 
1 5#16-968MAY05 -TC--TGAAAGGCAC CA-AGGAGGACCTGA A — — G C T - T C A G T C C ACCAA-CTACTATGT -TTATTTTGAC-ACA GACATGGA--CAA-A 404 
8 5ttl6-1205MAY05 GTCGTGAAAGGGCAC CAGAAGAGGACCTGA AAAGGCTATCAGTCC ACCAAGCTACTATGT ATTATTTTGACGACA GACATGGAATCAAGA 194 
” 5#l6-684MAY05 -TC--TGAAAGGCAC CA-AGGAGGACCTGA A — — G C T - T C A G T C C ACCAA-CTACTATGT -TTATTTTGAC-ACA G A C A T G G A — C A A - A 696 
：^  5#16-2574MAR06 -NC--NAAAGGNC-- CA-NGGAGA--CTGA NCN-TC-NNCC CCCA CTANAT -NTTNTTTGAN-NAA NN--TGGN A-A 930 
.0 5#16-1948MAY05 -TC--TGAAAGGCAC CA-AGGAGGACCTGA A—-GCf-TCAGTCC ACCAA-CTACTATGT -TTATTTTGAC-ACA GACATGGA--CAA-A 324 
“ RetSat+Chromos -TC--TGAAAGGCAC CA-AGGAGGACCTGA A——GCT-TCAGTCC ACCAA-CTACTATGT -TTATTTTGAC-ACA GACATGGA--CAA-A 1277 
1891 1905 1906 1920 1921 1935 1936 1950 1951 1965 1966 1980 
^ ^^16-M13RMAY05 ATGTCTC-TATG-CC CAAGGAA-AAGGCTC CAGAACACATTCCCC TTCTCTTCATTGCCT TCC-CATCAAGCAAG 71 
^ 地 6 - 9 6 8 M A Y 0 5 GCGA-TGGAG-CGCT ATGTCTC-TATG-CC CAAGGAA-AAGGCTC CAGAACACATTCCCC TTCTCTTCATTGCCT TCC-CATCAAGCAAG 488 
.… 6 - 1 2 0 5 M A Y 0 5 GCGAATGGAGGCGCT ATGTCTCGTATGACC CAAGGAAGAAGGCTC CAGAACACATTCCCC TTCTCTTCATTGCCT TCC-CATCAAGCAAG 283 
^#16-1948MAY05 GCGA-TGGAG-CGCT ATGTCTC-TATG-CC CAAGGAA-AAGGCTC CAGAACACATTCCCC TTCTCTTCATTGCCT TCC-CATCAAGCAAG 408 
A 5ttl6-2574MAR06 NC-A-TGG GCN NT-TNTT-TTTG-CC --AAGAA-AGGNC-- AAAAANTCCCT T — — C T T C - N T G C - - TCCNCANNANN 992 
“ 5#16-684MAY05 GCGA-TGGAG-CGCT ATGTCTC-TATG*CC CAAGGAA-AAGGCTC CAGAACACATTCCCC TTCTCTTCATTGCCT TCC-CATCAAGCAAG 780 
RetSat+Chromos GCGA-TGGAG-CGCT ATGTCTC-TATG-CC CAAGGAA-AAGGCTC CAGAACACATTCCCC TTCTCTTCATTGCCT TCC-CATCAAGCAAG 1361 
^ 1981 1995 1996 2010 2011 2025 2026 2040 2041 2055 2056 2010 
5ttl6-M13RAPR05 CTTGGGAG GA-CGATTCCCAGAC CGATCCAACAATGAC TGCCGCTGGTACCCA TGGCCTTTGAAATGG TTCGAGGAGTG——G 79 
^ S#l6-M13RMAy05 GATCCAACCTGGGAG GAGCGATTCCCAGAC CGATCCA-CAATGAC TGC-GCTGGTACCCA TGGCCTTTGAA-TGG T T C G A G G A G T G — — G 155 
Q ^^16-968MAY05 GATCCAACCTGGGAG GAGCGATTCCCAGAC CGATCCA-CAATGAC TGC-GCTGGTACCCA TGGCCTTTGAA-TGG T T C G A G G A G T G — — G 572 
13 g样16-1205MAY05 GATCCAACCTGGGAG GAGCGATTCCCAGAC CGATCCA-CAATGAC TGC-GCTGGTACCCA TGGCCTTTGAA-TGG T T C G A G G A G T G — — G 367 
12 ”16-2574MAR06 --TCCN—CTGGG-- —GAGNNTCCAACNN C CNANG-- -NN-GNNGG-ACC-- TGG NTTNANGTNANNNNG 1046 
lO ”16-684MAY05 GATCCAACCTGGGAG GAGCGATTCCCAGAC CGATCCA-CAATGAC TGC-GCTGGTAACCC ATGGCTTTGAA-TGG T T C G A G G A G T G — — G 864 
5幷16-1948MAY05 GATCCAACCTGGGAG GAGCGATTCCCAGAC CGATCCA-CAATGAC TGC-GCTGGTACCCA TGGCCTTTGAA-TGG T T C G A G G A G T G — — G 492 
^®tSat+Chromos GATCCAACCTGGGAG GAGCGATTCCCAGAC CGATCCA-CAATGAC TGC-GCTGGTACCCA TGGCCTTTGAA-TGG T T C G A G G A G T G — — G 14 4 5 
4 2071 2085 2086 2100 2101 2115 2116 2130 2131 2145 214 6 2160 
5 ”16-1547MAY05 ACCGT-GG TGTT-ACTATGAGAC C-TCAAAAATGCCTC CGTGGTAAGC-CTCT ATGTCGGTGATCATG HO 
g ^^16-M13RAPR05 CAGGGAGGAGCCAAA --GGGCAAGCGTGGT TGTTGACTATGAGAC CCTCAAATATGCCTC CGTGG-AAGCTCTCT ATGTCGGTGATCATG 16f" 
7 ^^16-M13RMAY05 CA-GGAGGAGCCAAA --GGGCAAGCGT-GG TGTTGACTATGAGAC CCTCAAAAATGCCTC CGTGG-AAGC-CTCT ATGTCGGTGATCATG 2 
Q ”16-968MAY05 CA-GGAGGAGCCAAA --GGGCAAGCGT-GG TGTTGACTATGAGAC CCTCAAAAATGCCTC CGTGG-AAGC-CTCT ATGTCGGTGATCATG 656 
g 样 1 2 0 5 M A Y 0 5 CA-GGAGGAGCCAAA --GGGCAAGCGT-GG TGTTGACTATGAGAC CCTCAAAAATGCCTC CGTGG-AAGC-CTCT ATGTCGGTGATCATG 4 51 
13 ”16 - 6 8麵 Y 0 5 CAAGGAGGAGCCCAA AGGGCCAAGCGTGGG TGTTGACTATGAGAC CCTCAAAAA 91b 
iQ ^^16-2574MAR06 CG-GGA CNAA --GG——ANCG-GGN T - - - - — — A N A A A A C C N A A A G C — — - - T N G - G A N C - C T T T NGN 1095 
“ CA-GGAGGAGCCAAA —GGGCAAGCGT-GG TGTTGACTATGAGAC CCTCAAAAATGCClf CGTGG-AAGC-CTCT ATGTCGGTGATCATG 576 
^®tSat+Chromos CA-GGAGGAGCCAAA —GGGCAAGCGT-GG TGTTGACTATGAGAC CCTCAAAAATGCCTT CGTGG-AAGC-CTCT ATGTCGGTGATCATG 1529 
4 . 2161 2175 2176 2190 2191 2205 2206 2220 2221 2235 2236 2250 -
5 st…1547MAY05 AAACTGTTCCCACAG CTGGA-GGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CA-ACCAGTACTATC TGGCTGCACCCCGAG 168 
6 二16-M13RAPR05 AAACTGXffCCCACAG CTGGATGGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CAGACCAGTACTATC TGGCTGCACCCCGAG 256 
7 ^^16-M13RMAY05 AAACTGTTCCCACAG CTGGA-GGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CA-ACCAGTACTATC TGGCTGCACCCCGAG 327 
e ^16-968MAY06 AAACTGTTCCCACAG CTGGA-GGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CA-ACCAGTACTATC TGGCTGCACCC 740 
l3 ^16-1205MAY05 AAACTGTTCCCACAG CTGGA-GGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CA-ACCAGTACTATC TGGCTGCACCCCGAG 「)39 
lO ^16-2574MAR06 AAAAANNNCCC CNGGG-GMG 1114 
U 林16-1948MAY05 AAACTGTTCCCACAG CTGGA-GGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CA-ACCAGTACTATC TGGCTGCACCCCGAG 664 
®tSat-fChromos AAACTGTTCCCAC/CG CTGGA-GGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CA-ACCAGTACTATC TGGCTGCACCCCGAG 1617 
272 
2251 2265 2266 2280 2281 2295 2296 2310 2311 2325 2326 2340 
4 5n6-1547MAY0!3 GAGCTACCTATGGAG CTGACCATGACTTGG CTCGGCTGCATCCTC ATGCAATGGCTTCCA TAAGAGCCCAAACCC CCATCCCCAACCTCT 258 
5 5#16-M13RAPR05 GAGCTACCTATGGAG CTGACCATGACTTGG CTCGGCTGCATCCTC ATGCAATGGCTTCCA TAAGAGCCCAAACCC CCATCCCCAACCTCT 346 
6 5#16-M13RMAY05 GAGCTACCTATGGAG CTGACCATGACTTGG CTCGGCTGCATCCTC ATGCAATGGCTTCCA TAAGAGCCCAAACCC CCATCCCCAACCTCT 417 
8 5#16-1205MAY05 GAGCTACCTATGGAG CTGACCATGACTTGG CTCGGCTGCATCCTC ATGCAATGGCTTCCA TAAGAGCCCAAACCC C-ATCCCCAACCTCT 62B 
10 5ttl6-:i948MAY05 GAGCTACCTATGGAG CTGACCATGACTTGG CTCGGCfGCATCCTC ATGCAATGGCTTCCA TAAGAGCCCAAACCC CCATCCCCAACCTCT 7已4 
“ RetSat+Chromos GAGCTACCTATGGAG CTGACCATGACTTGG CTCGGCTGCATCCTC ATGCAATGGCTTCCA TAAGAGCCCAAACCC CCATCCCCAACCTCT 1707 
2341 2355 2356 2370 2371 2385 2386 2400 2401 2415 2416 2430 
4 5#16-:I547MAY05 ACCTGACAGGCCAAG ATATCTTCACCTGTG GGCTGATGGGGGCCC TGCAGGG GGCC TTGCTGTGCA-GCAG TACCATCCTGAAACG 343 
5 5ttl6-M13RAPR05 ACCTGACAGGCCAAG ATATCTTCACCTGTG GGCTGATGGGGGCCC TGCAGGG GGCC TTGCTGTCCA-GCAG TACCATCCTGAAACG 4 31 
6 5#16-M13RMAY05 ACCTGACAGGCCAAG ATATCTTCACCTGTG GGCTGATGGGGGCCC TGCAGGG GGCC TTGCTGTGCACGCAG TACCATCCTGAAACG Sn3 
10 5^tl6-1948MAY05 ACCTGACAGGCCAAG ATATCTTCACCTGTG GGCTGATGGGG——C TGCAGGG GGCC TT-CTGT SI 3 
13 5ttl6-2574MA_ GGANGGGGGGGGCCC NNNNNNNTTNNGNCC 1 川 
B 5#16-1205MAY05 ACCTGACAGGCCAAG ATATCTTCACCTGTG GGCTGAfGGGGGCCC TGCAGGG GGCC TTGCTGTGCA-GCAG TACCATCCTGAAACG 713 
RetSat+Chromos ACCTGACAGGCCAAG ATATCTTCACCTGTG GGCTGATGGGGGCCC TGCAGGG GGCC TTGCTGTGCA-GCAG TGCCATCCTGAAACG 179二 
2431 2445 2446 2460 2461 2475 2476 2490 2491 2505 2506 2520 
^ 5#16-1547MAY05 GAACTTGTACTCAGA TCTGCAGGCTCTTGG CTCAAAGGTCAAGGC ACAAAAGAAGAAGAT GTAGTCCGTTCAGAG AAGAGCCA-GAGGAA 432 
5 5#16-M13RAPR05 GAACTTGTACTCAGA TCTGCAGGCTCTTGG CTCAAAGGTCAAGGC ACAAAAGAAGAAGAT GTAGTCCGTTCAGAG AAGAGCCA-GAGGAA 520 
6 5#16-M13RMAY05 GAACTTGTACTCAGA TCTGCAGGCTCTTGG CTCAAAGGTCAAGGC ACAAAAGAAGAAGAT GTAGTCCGTTCAGAG AAGAGCCA-GAGGAA 592 
” 5#16-2574MAR06 C AAAAAANNNAAAANN GNGGNCC CCNNGNNTAA 1177 
8 5n6-1205MAY05 GAACTTGTACTCAGA TCTGCAGGCTCTTGG CTCAAAGGTCAAGGC ACAAAAGAAGAAGAT GTAGTCCGTTCAGAG AAGAGCCA-GAGGAA 802 
“ RetSat+Chromos GAACTTGTACTCAGA TCTGCAGGCTCTTGG CTCAAAGGTCAAGGC ACAAAAGAAGAAGAT GTAGTCCGTTCAGAG AAGAGCCA-GAGGAA 1861 
2521 2535 2536 2550 2551 2565 2566 2580 2581 2595 2596 2610 
^ 5#16-1547MAY05 AGGCAC-CTCCCCAA CTTCTCGTGGTGTCC TCCCTCCTAC-AAGG GCGAATTCCAG-CAC ACTGGCGGCCGTTAC TAG-TGGATCCGAGC Sly 
5 5#16-M13RAPR05 AGGCAC-CTCCCCAA CTTCTCGTGGTGTCC TCCCTCCTCCCAAGG GCGAATTCCAG-CAC ACTGGCGGCCGTTAC TAG-TGGATCCGAGC 607 
6 S#16-M13RMAY05 AGGCAC-CTCCCCAA CTTCTCGTGGTGTCCTCCCTCCTACCAAGG GCGAATTCCAG-CAC ACTGGCGGCCGTTAC TAG-TGGATCCGAGC 67 9 
8 5#16-1205MAY05 AGGCAC-CTCCCCAA GCGAATTCCAGGCAC ACTGGCGGCCGTTAC TAGGTGGATCCGAGC 890 
- 1948MAY05 --GCACAGTACTCAA CTG GGGGTAC 836 
” 5#,16-2574MAR06 ANNCCCCCCCCNNNG GNANTTNNGGGG 1204 




Appendix B5: Alignment result of 5，#20 
1 15 16 30 31 45 46 60 61 75 76 '叩 
4 5 # 2 0 G C G G T C T T C C G A G C C C T G G C A G C A A C A T G T G G A T C A C T G C T C T G C T G C T G G C C G T G C T G C T G C T G G T G A T C C T C C A C A G C | | T C T A C G T G G H ^ 
5 RetSat+Chromos GCGGTCTTCCGAGCC CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 
91 105 106 120 121 135 136 150 151 165 166 180 
1 5#20-2635MAR06 AAA AAANNCCCCNNNNHN 18 
4 5tt20 GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCC|GGTGACCGACA AGGAGGCTAGGAAGA 178 
5 RetSat+Chromos GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 180 
181 195 196 210 211 225 226 240 241 255 256 210 
1 5#20-2635MAR06 NAANNNNNNAAAANN NTTTTTNNCNNNAAA AANNNCCCCCNGGGG GGNGGGGNNNNTTTT TTNNNNGNNNNNTN TNNTTTTTN 101 
4 5#20 AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACgAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 268 
5 RetSat+Chromos AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 270 
271 285 286 300 301 315 316 330 331 345 346 360 
1 5#20-2635MAR06 NANNTNTNCCCNCNN AANNTGGGGGNAAAN NCCNTTTTTTNGGGN TCCCNCNNNNNGGGN CCCCNGGNNTTTNTT TTTTTTTTNNAAANC IQl 
^ 5#20 CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGtGCTGGAAC AACATACCAAGGCGG GCGGCTGTTGTCATA CCTTTGGGGAAAATG 35b 
5 RetSat+Chromos CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACCAAGGCGG GCGGCTGTTGTCATA CCTTTGGGGAAAATG 360 
361 375 376 390 391 405 -306 420 421 4 35 436 450 
1 5#20-2635MAR06 CCCNTTTTTTTNCCN TNANCCCCCNNANNC CCTTTTTTTTGGGNN NTTTTNCTTNCCNAA NCCCNGNNGGNCNTN TTCGGGTNANCCCTT 281 
^ 5#20 GCCTTGAATTTGACA CTGGAAT TCATTAfATTGGACG AATGCGGGAGGGCAA CATT GGCCGTTTTATCTTG 429 
5 RetSat+Chromos GCCTTGAATTTGACA CTGGAAT TCATTATATTGGACG AATGCGGGAGGGCAA CATT GGCCGTTTTATCTTG 431 
451 465 466 480 481 495 496 510 511 525 526 540 
1 5#20-2635MAR06 TTNGGGNGGGNTTTA AGGNTNCNNTCCTTN NCCCCCNNNNCCCNA AATTNTTAAANNCCG GTAAATTTTTNAANN AGNNCTTTTTNACCN 371 
4 5#20 GACCAGATCACTGAA GGGCAACTGGACTGG GCCCCCaTGGCCTCC CCTTTTGAC -TTGATGATACTAGA AGGGCCCAATGGCCG 512 
5 RetSat+Chromos GACCAGATCACTGAA GGGCAACTGGACTGG GCCCCCATGGCCTCC CCTTTTGAC -TTGATGATACTAGA AGGGCCCAATGGCCG 514 
541 555 556 570 571 585 686 600 601 615 616 630 
1 5#20-2635MAR0e； ANNGNCGAANTTGCN AAATNCNTTAAANNA AAANAANANCCNGAA ANGGNTGAGGTTTTT CCCNTTNGNANCANA NTCCCNTNTTAAAAA J 61 
I 5#20 AAAGGAGTTCCCCAT GTACAGTGGGAGGAA AGAATACATCCAGGG CCTTAAGAAGAAGTT CCCCAAGGAAGAAGC TGTCATTGACAAGTA 60: 
RetSat+Chromos AAAGGAGTTCCCCAT GTACAGTGGGAGGAA AGAATACATCCAGGG CCTTAAGAAGAAGTT CCCCAAGGAAGAAGC TGTCATTGACAAGTA 604 
. \ 、 - _ — 
631 645 646 660 661 675 676 690 691 705 706 720 
5#20-2635MAR06 ANNNGANTCCAACGT CAAAGGGGGAAAACC GTNTNTCAGGGNGAN GGCCCNNTANGGNAC CATCNCCCTAATCAA GTTTTTGGGGTCGGG 551 
\ 5#20 CATGGAGTT GG TTAAGGTGGTGGCCC GT GGA GTCTCTCATGCAGTT CTACTCAAGTTCCTC CCATTGCCCTTGACT 678 
f^etSat+Chromos CATGGAGTT GG TTAAGGTGGTGGCCC GT GGA GTCTCTCATGCAGTT CTACTCAAGTTCCTC CCATTGCCCTTGACT 680 
, 721 735 736 750 751 765 766 780 781 795 796 810 
；5#20-2635MAR06 GNGCCGTAAAGCNCN AATTGGNACCCTAAA GGGANCCCCCGATTT AGAGCTTGACGGGNA AANCCGGCGAACGTG GCG--AGAAAGGAHG 63 9 
. 5 # 2 0 CAGCTCCTCAGCAAG TTTGGGCTACTGACT CGTTTCTCTCCATTC TGCCGAGCG TCTACGCAGAGCCTA GCTGAAGTCCTGCAG 762 
•RetSat+Chromos CAGCTCCTCAGCAAG TTTGGGCTACTGACT CGTTTCTCTCCATTC TGCCGAGCG TCTACGCAGAGCCTA GCTGAAGTCCTGCAG •'64 
J ^ 811 825 626 840 841 855 856 870 871 885 886 900 
.5#20-2635MAR06 GAAGAAAGCGAAAGG AGCGGGCGCTAGGGC GCTGGCAAGTGTAGC GGTCACGCTGC--GC GTAACCACCACACCC GCCGCGCTTAATGCG 727 
5 5TT20 C A G C T T G G G G C T T C C C G T G A G C T C C A G G C T G T T C T C A G C T A C A T C T T C C C C A C T T A C G G A G T A A C T C C C A G C C A C A C C G C C T T T T C C T T G 8 5 2 
RetSat+Chromos CAGCTTGGGGCTTCC CGTGAGCTCCAGGCT GTTCTCAGCTACATC TTCCCCACTTACGGA GTAACTCCCAGCCAC ACCGCCTTTTCCTTG 854 
1 V. 901 915 916 930 931 945 946 960 961 975 976 990 
^ ”20-2635MAR06 CCGCTACAGGGCGCG TCCATTCGCCATTCA GGCTGCGCAACTGTT GGAAGGGCGATCGGT GCGGGCCTCTTCGCT ATTACGCCAGCTGGC 817 
5 CATGCTCTGCTGGTT GACCACTACATACM. GGGGCAfATTACCCT CGAGGGGGTTCCAGT GAGATCGCCTTCCAT ACCATCCCT--TTGA 94 0 
•^etSat+Chromos CATGCTCTGCTGGTT GACCACTACATACAA GGGGCATATTACCCT CGAGGGGGTTCCAGT GAGATCGCCTTCCAT ACCATCCCT--TTGA 942 
1 991 1006 1006 1020 1021 1035 1036 1050 1051 1065 1066 10叩 
4 ” 0 - 2 6 3 5 M A R 0 6 G A A A G G G G G A T G T G C T G C A A G G C G A T T A A G T T G G G T A A C G C C A G G G T T T T C C C A G T C A C G A C G T T G T A A A A C G A C G G C C A G T G A A T T G T A 9 0 7 
5 TTCAGCGGGCCGGGG GCGCTGTCCTCACCA GGGCCACTGTACAGA GTGTGCTGCTGGACT CAGCTGGGAGAGCGT GTGGTGTCAGTGTGA 1030 
RetSat+Chromos TTCAGCGGGCCGGGG GCGCTGTCCTCACCA GGGCCACTGTACAGA GTGTGCTGCTGGACT CAGCTGGGAGAGCGT GTGGTGTCAGTGTGA 103： 
I 1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
4 二20-2635MAR06 ATACGACTCACTATA GGGCGAAT-TGGGCC CTCTAGATGCATGCT CGAGCGGCCGCCAGT GTGATGGATATCTGC AGAATTCGCCC 992 
5 AGAAGGGACAAGAGC TGGTGAACATCTACT GCCCAGtTGTCATCT CCAATGCGGGAATGT TCAATACCTATCAGC ACTTGTTGCCAGAGA 1120 
晰 S a t + C h r o m o s AGAAGGGACAAGAGC TGGTGAACATCTACT GCCCAGTTGTCATCT CCAATGCGGGAATGT TCAATACCTATCAGC ACTTGTTGCCAGAGA 1122 
1 , 1171 、. 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
3 "20-2635MAR06 ——TTCGACTGGAGC ACGAGGACACTGACA TGGACTGAAGGAGTA GAAAGCGGTCTTCCG AGCCCTGGCAGCAAC ATGTGGATCACTGCT 1079 
4 "20-6433MAR06 --GNNNGCCNTCTGC CAGATGTGAAGAAGC AGCTG-GCGATGGTA AGGCCTGGTCTGAGC ATGCTCTCAATCTTC ATCTGTCTGAAAGGC 87 
5 CTGTCCGCCATCTGC CAAATGTGAAGAAGC AGCCCCGCGATGGTA AGGCCTGGTCTGAGC ATGCTCTCAATCTTC ATCTGTCTGAAAGGC 1210 
®tSat+Chromos CTGTCCGCCATCTGC CAGATGTGAAGAAGC AGCTG-GCGATGGTA AGGCCTGGTCTGAGC ATGCTCTCAATCTTC ATCTGTCTGAAAGGC 1211 
274 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
1 5#20-2635MAR06 CTGCTGCTGGCCGTG CTGCTGCTGGTGATC CTCCACAGGGTCTAC GTGGGCCTTTACGCT GCAAGTTCCCCGAAC CCCTTCGCCGAGGAT 116<3 
3 5#20-64 33MAR06 ACCAAGGAGGACCTG AAGCTTCAGTCCACC AACTACfATGTTTAT TTTGACACAGACATG GACAAAGCGATGGAG CGCTATGTCTCTATG 「7 
4 5#20 ACCAAGGAGGACCTG AAGCTTCAGTCCACC AACTACTATGTTTAT TTTGACACAGACATG GACAAAGCGATGGAG CGCTATGTCTCTATG 130n 
5 RetSat+Chromos ACCAAGGAGGACCTG AAGCTTCAGTCCACC AACTACTATGTTTAT TTTGACACAGACATG GACAAAGCGATGGAG CGCTATGTCTCTATG 1301 
1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
1 5tt20-2635MAR06 GTCAAGCGACCGCCT GAACCCCTGGTGACC GACAAGGAGGCTAGG AAGAAAGTTCTCAAA CAAGCTTTCTCAGTC AGCCGAGTACCAGA- 11:58 
3 5#20-64 33MAR06 CCCAAGGAAAAGGCT CCAGAACACATTCCC CTTCTCfTCATTGCC TTCCCATCAAGCAAG GATCCAACCTGGGAG GAGCGATTCCCAGAC 1:67 
4 5#20 CCCAAGGAAAAGGCT CCAGAACACATTCCC CTTCTCTTCATTGCC TTCCCATCAAGCAAG GATCCAACCTGGGAG GAGCGATTCCCAGAC 1390 
5 RetSat+Chromos CCCAAGGAAAAGGCT CCAGAACACATTCCC CTTCTCTTCATTGCC TTCCCATCAAGCAAG GATCCAACCTGGGAG GAGCGATTCCCAGAC 1391 
1441 1455 1456 1470 1471 1485 1486 1500 1501 1515 1516 1530 
1 5#20-2635MAR06 -GAAGCTGGATG-CA GTGGTGATCGGCAGC GGCATTGGGGGANCT GGCNTNCA 1309 
3 5#20-64 33MAR06 CGATCCACAATGACT GCGCTGGTACCCATG GCCTTT6AATGGTTC GAGGAGTGGCAGGAG GAGCCAAAGGGCAAG CGTGGTGTTGACTAT 357 
^ 5#20 CGATCCACAATGACT GCGCTGGTACCCATG GCCTTTGAATGGTTC GAGGAGTGGCAGGAG GAGCCAAAGGGCAAG CGTGGTGTTGACTAT 1480 
5 RetSat+Chromos CGATCCACAATGACT GCGCTGGTACCCATG GCCTTTGAATGGTTC GAGGAGTGGCAGGAG GAGCCAAAGGGCAAG CGTGGTGTTGACTAT 1481 
1531 1545 1546 1560 1561 1575 1576 1590 1591 1605 1606 1620 
3 5#20-64 33MAR06 GAGACCCTCAAAAAT GCCTTCGTGGAAGCC TCTATGfCGGTGATC ATGAAACTGTTCCCA CAGCTGGAGGGCAAG GTGGAGAGTGTGACT “7 
^ 5#20 GAGACCCTCAAAAAT GCCTTCGTGGAAGCC TCTATGTCGGTGATC ATGAAACTGTTCCCA CAGCTGGAGGGCAAG GTGGAGAGTGTGACT 11：70 
5 RetSat+Chromos GAGACCCTCAAAAAT GCCTTCGTGGAAGCC TCTATGTCGGTGATC ATGAAACTGTTCCCA CAGCTGGAGGGCAAG GTGGAGAGTGTGACT 1S71 
1621 1635 1636 1650 1651 1665 1666 1680 1681 1695 1696 1710 
3 5#20-64 33MAR06 GGAGGGTCACCACTG ACCAACCAGTACTAT CTGGCT(3CACCCCGA GGAGCTACCTATGGA GCTGACCATGACTTG GCTCGGCTGCATCCT 537 
4 5#20 GGAGGGTCACCACTG ACCAACCAGTACTAT CTGGCTGCACCCCGA GGAGCTACCTATGGA GCTGACCATGACTTG GCTCGGCTGCATCCT 1660 
5 RetSat+Chromos GGAGGGTCACCACTG ACCAACCAGTACTAT CTGGCTGCACCCCGA GGAGCTACCTATGGA GCTGACCATGACTTG GCTCGGCTGCATCCT 1661 
1711 1725 1726 1740 1741 1755 1756 1770 1771 1785 1786 1800 
2 5#20-84 5 碰 R 0 6 GNNNNNN NTNNNAGCCCANACC CCCATCCCCAACCTC TACCTGACAGGCCAA GATATCTTCACCTGT GGGCTGATGGGGGCC 82 
3 S#20-64 33MAR06 CATGCAATGGCTTCC ATAAGAGCCCAAACC CCCATCC^CCAACCTC TACCTGACAGGCCAA GATATCTTCACCTGT GGGCTGATGGGGGCC 627 
4 5#20 CATGCAATGGCTTCC ATAAGAGCCCAAACC CCCATCCCCAACCTC TACCTGACAGGCCAA GATATCTTCACCTGT GGGCTGATGGGGGCC 1750 
5 RetSat+Chromos CATGCAATGGCTTCC ATAAGAGCCCAAACC CCCATCCCCAACCTC TACCTGACAGGCCAA GATATCTTCACCTGT GGGCTGATGGGGGCC 1751 
1801 1815 1816 1830 1831 1845 1846 1860 1861 1875 1876 1890 
2 5#20-84 54MAR06 CTGCAGGGGGCCTTG CTGTGCAGCAGTGCC ATCCTGAAACGGAAC TTGTACTCAGATCTG CAGGCTCTTGGCTCA AAGGTCAAGGCACAA 172 
3 S#20-64 33MAR06 CTGCAGGGGGCCTTG CTGTGCAGCAGTGCC ATCCTGAAACGGAAC TTGTACTCAGATCTG CAGGCTCTTGGCTCA AAGGTCAAGGCACAA 717 
^ 5#20 CTGCAGGGGGCCTTG CTGTGCAGCAGTGCC ATCCTGAAACGGAAC TTGTACTCAGATCTG CAGGCTCTTGGCTCA AAGGTCAAGGCACAA IS-JO 
S RetSat+Chromos CTGCAGGGGGCCTTG CTGTGCAGCAGTGCC ATCCTGAAACGGAAC TTGTACTCAGATCTG CAGGCTCTTGGCTCA AAGGTCAAGGCACAA 11：(41 
1891 1905 1906 1920 1921 1935 1936 1950 1951 1965 1966 1980 
5#20-8454MAR06 AAGAAGAAGATGTAG TCCGTTCAGAGAAGA GCCAGAGGAAAGGCA r|rTrrrraai |||H|||||||||j||||||||||||j||fzxz^�r:r:广。)ai^T 261 
^ 5#20-64 33MAR06 AAAAAAAA-ATGTAG TCCGTTCAGAGAAAA GCCANAGAAANGGAC C--TCCCCAACTTCT CGNGGNGTCCNCCCC CCTACAAGGGCGAAT 804 
I 5*120 AAGAAGAAGATGTAG TCCGTTCAGAGAAGA GCCAGAGGAAAGGCA C-CTCCCCAACTTCT CGTGGTGTCCTCCCT CCTAC 1919 
RetSat+Chromos AAGAAGAAGATGTAG TCCGTTCAGAGAAGA GCCAGAGGAAAGGCA CACTCCCCAACTTCT CGTGGTGTCCTCCCT CCTAC 1921 
5 ’ - G S P l 
275 
Appendix B6: Alignment result of 5，#31 
181 195 196 210 211 225 226 240 241 255 256 270 
1 5 # 3 1 - 2 6 3 5 M A R 0 6 C N T N N C C N A N C C C N A A G G N C A T T T T C G G G T N A N C C N T T T T G G G N G G N T T T T A N G G T T C N N T C T T T N A N C C C C T N N C C C N N A A 'J47 
4 5#31-64 3 7 M A _ CNNNAAANNNTNNGG NCCCCCNNGNNNNAA TTNNNAANTCCCTTT NGGGGNCNGGGNCNN NCCTGGNNNAGGGNN AAANGGTTTTNNNCC 270 
5 5#31 GCGGTCTT CCGAGCCCTGGCAGC AACATGTGGATCACT GCTCTGCCGCTGGCC 53 
6 RetSat+Chromos GCGGTCTT CCGAGCCCTGGCAGC AACATGTGGATCACT GCTCTGCTGCTGGCC 53 
271 285 286 300 301 315 316 330 331 345 346 360 
1 5#31-2635MAR06 TTNTNAAATNNGGTA AATTTTTAAATANNN CNTTTTNACNAANGG CGNANTGGCAAATCC NTTNAATCAAANAAT NNCCNGAAAGGGTNG 337 
^ 5 T T 3 1 - 6 4 3 7 M A R 0 6 N N G N A A A A N A N G G N A A N N T T T T N C C C N G N C C _ T _ T T _ A T T N C C C A G G G T T A N G G G G C C T T N N G G G A A A T T N C C N N A N C C T T T N C 3F,N 
5 5 m GTGCTGCTGCTGGTG ATCCTCCACAGGGTC TACGTGSGCCTTTAC GCTGCAAGTTCCCCG AACCCC T TCGCCGAGGATGTCA 13。 
6 RetSat+Chromos GTGCTGCTGCTGGTG ATCCTCCACAGGGTC TACGTGGGCCTTTAC GCTGCAAGTTCCCCG AACCCC T TCGCCGAGGATGTCA 135 
361 375 376 390 391 405 406 420 421 435 436 450 
1 5#31-2635MAR06 GGTTGTNCCNTTNGN ACAAGGTTCCNTNTN AAGAACGGGANTCCA NNTCAAAGGGNGAAA ACCNTNTTCAGGGGG ANGCCCNNTANGGNA 4 27 
4 5#31-6437MAR06 GGNGANTNAANGNCC CCNNAACCCNNGNNA CNCCAAGGGGTTNGN AAAAATTTTCAAACA ANTTTTTNT--TNAN CCGANNC.CCANNAAN 448 
5 5#31 AGCGACCGCCTGAAC CCCTGGTGACCG--A CAAGGASGCTAGGAA GAAAGTTCTCAAACA AGCTTTCTCAGTCAG CCGAGTACCAGAGAA 223 
6 RetSat+Chromos AGCGACCGCCTGAAC CCCTGGTGACCG--A CAAGGAGGCTAGGAA GAAAGTTCTCAAACA AGCTTTCTCAGTCAG CCGAGTACCAGAGAA 223 
451 465 466 480 481 495 496 510 511 525 526 540 
1 5tt31-:2635MAR06 CCATCNCCNNATCAA GTTT T TGGGGTGNGGGNC-- --CGNAANCNCTAAN TCGGACCCTAAAGGG AGCCCCCGATTTAGA 503 
4 5#31-6<!37MAR06 NNGATCCANGGTTAT C GCANCGNCAT TGGGGAAT--GNCTN AGNTGGGNTT-TAGN TAAAGN-GGCAANAG AGTCNTT-TGNNNGA 529 
5 5tt31 GCTGGATGCAGTGGT GATCGGCAGCGGCAT TGGGGGACTGGCCTC AGCTGCGGTTCTAGC TAAAGCTGGCAAGAG AGTCCTTGTGCTGGA 313 
6 RetSat+Chromos GCTGGATGCAGTGGT GATCGGCAGCGGCAT TGGGGGACTGGCCTC AGCTGCGGTTCTAGC TAAAGCTGGCAAGAG AGTCCTTGTGCTGGA 313 
541 555 556 570 571 585 586 600 601 615 616 630 
1 5#31-2635MAR06 GCTTGACGGGAAAGC CGGCGAACGTGGCGA GAAAGNAGGGAAGAA AGCGAAAGGAGCGGG CGCTAGGGCGCTG-- GCAAGTG 583 
2 5#31-84 54MAR06 GGCTTCCATAAGA GCCCAAACCCCCATC CCCAACCTCTACCTG 43 
3 5#31-2574MAR06 TGGACACTACCAGGC GGGCGGCTGTTGTCA TACCTTTGGGGAAAA TGGCCTTGAATTTGA CACTGGAATTCATTA TATTGGACGAATGCG 93 
^ 5#31-6437MAR06 ACAACAAACNA-GGN GGGCGGNGGTNGTN- TACCTTTGGGNAAAA -GGCCTTGAATT-GA CACTGNA-TTCATTA TATTGGACGAATGCG 614 
5 5#31 ACAACATACCAAGGC GGGCGGCTGTTGTCA TACCTTfGGGGAAAA TGGCCTTGAATTTGA CACTGGAATTCATTA TATTGGACGAATGCG 403 
® RetSat+Chromos ACAACATACCAAGGC GGGCGGCTGTTGTCA TACCTTTGGGGAAAA TGGCCTTGAATTTGA CACTGGAATTCATTA TATTGGACGAATGCG 403 
631 645 646 660 661 675 676 690 691 705 706 720 
^ 5tt3l-2635MAR06 TAGCGGTCACGCTGC GCGTAACCACCACAC CCGCCGCGCTTAATG CGCCGCTACAGGGCG CGTCCATTCGCCATT CAGGCTGCGCAACTG 673 
^ 5#31-8454MAR06 ACAGGCCAAGATATC TTCACCTGTGGGCTG ATGGGGGCCCTGCAG GGGGCCTTG-CTGTG CAGCAGTGCCATCCT GAAACGGAACTTGTA 132 
^ ^^31-2574MAR06 GGAGGGCAACATTGG CCGTTTTATCTTG-G ACCAGAfCACTGAAG GGCAACTGGACTGGG CCCCCATGGCCTCCC CTTT-TGACTTGATG 181 
S^31-6437MAR06 GGAGGGCAACATTGN CCGTTTNTTTTGG-- ACCAGATCACTGAAG GGCAACTGGACTGGG CCCCCATGGCCTCCC CTTT-TGACTTGATG 701 
… 1 GGAGGGCAACATTGG CCGTTTTATCTTGCG ACCAGATCACTGAAG GGCAACTGGACTGGG CCCCCATGGCCTCCC CTTTATGACTTGATG ^93 
RetSat+Chromos GGAGGGCAACATTGG CCGTTTTATCTTG-G ACCAGATCACTGAAG GGCAACTGGACTGGG CCCCCATGGCCTCCC CTTT-TGACTTGATG 4Q1 
1 721 735 736 750 751 765 766 780 781 795 796 «10 
5#31-2635MAR06 TTGGGAAGGGCGATC GGTGCGGGCCTCTTC GCTATTACGCCAGCT GGCGAAAGGGGGATG TGCTGCAAGGCGATT AAGTTGGGTAACGCC 763 
湘 1 - 8 4 54MAR06 CTCAGATCTGCAGGC TCTTGGCTCAAAGGT CAAGGCACAAAAGAA GAAGATGTAGTCCGT TCAGAGAAGAGCCAG AGGAAAGGCACCTCC 222 
4 5ft3l-2574MAR06 ATACTAGAAGGGCCC A A T G G C C G A A A — G G AGTTCCCCATGTACA GTGGGAGGAAAGAAT ACATCCAGGGCCTTA AGAAGAAGTTCCCCA 269 
^#31-6437MAR06 ATACTAGAAGGGCCC AATGGCCGAAA--GG AGTTCCCCATGTACA GTGGGAGGAAAGAAT ACATCCAGGGCCTTA AGAAGAAGTTCCCCA 789 
G 刚 1 ATACTAGAAGGGCCC AATGGCCAGAAATGG AGTTCCCCATGTACA GTGGGAGGAAAGAAT ACATCCAGGGCCTTA AGAAGAAGTTCCCCA 5 8 3 
RetSat+Chromos ATACTAGAAGGGCCC AATGGCCGAAA--GG AGTTCCCCATGTACA GTGGGAGGAAAGAAT ACATCCAGGGCCTTA AGAAGAAGTTCCCCA 579 
1 - 811 825 826 _ 841 855 856 870 871 886 886 900 
2 ”31-2635MAR06 AGGGTTTTCGCAGTC ACGACGTTGTAAAAC GACGGCCAGTGAATT GTAATACGACTCACT ATAGGGCGAATTGGG CCC.TCTAG-ATGCAT H52 
2 ^**31-8454MAR06 TCAACTTCTCGTGGT GTCCTCCCTCCTACA AGGGCGAATTCCAGC ACACTGGCGGCCGTT ACTAGTGGATCCGAG CTCGGTACCAAGCTT 312 
^ ^**31-2574MAR06 AGGAAGAAGCT-G TCATTGACAAG TACATGSAGTTGGTT AAGGTGGTGGCCCGT G-GAGT CTCTCATGCAGTTCT 341' 
3 ^^31-6437MAR06 AGGAAGAAGCT-G-- TCATTGACAAG TACATGGAGTTGGTT AAGGTGGTGGCCCGT G-GAGT CTCTCATGCAGTTCT M62 
G ” A G G A A G A A G C T T G TCATTGACAAG TACATGGAGTTGGTT AAGGTGGTGGCCCGT GAGAGT C T C T C A T G C A G T T C T 
RetSat+Chromos AGGAAGAAGCT-G-- TCATTGACAAG TACATGGAGTTGGTT AAGGTGGTGGCCCGT G-GAGT CTCTCATGCAGTTCT f>52 
1 901 915 916 930 931 945 946 960 961 975 976 990 
2 ^^31-2635MAR06 GCTCGAGCGGCCGCC AGTGTGATGGAT 879 
3 g#3l-84 54MAR06 GATGCATAGCTTGAG TATTCTATAGTGTCA CCTAAATAGCTTGGC GTAATCATGGTCATA GCTGTTTCCTGTGTG AAATTGTTATCCGCT 402 
4 ”31-2574MAR06 ACTCAAGTTCCTCCC ATTGCCCTTGACTCA GCTCCTg:AGCAAGTT TGGGCTACTGACTCG TTTCTCTCCATTCTG CCGAGCGTCTACGCA 432 
5 ”31-64 37MAR06 ACTCAAGTTCCTCCC ATTGCCCTTGACTCA GCTCCTCAGCAAGTT TGGGCTACTGACTCG TTTCTCTCCATTCTG CCGAGCGTCTACGCA 952 
5 ACTCAAGTTCCTCCC ATTGCCCTTGACTCA GCTCCTCAGCAAGTT TGGGCTACTGACTCG TTTCTCTCCATTCTG CCGAGCGTCTACGCA 748 
晰 S a t + C h r o m o s ACTCAAGTTCCTCCC ATTGCCCTTGACTCA GCTCCTCAGCAAGTT TGGGCTACTGACTCG TTTCTCTCCATTCTG CCGAGCGTCTACGCA 742 
2 r 991 、’ 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
3 ^^1-8454MAR06 CACAATTCCACACAA CATACG--AGCCGGA AGCATAAAGTGTAAA GCCTGGGGTGCCTAA TGAGTGAGCTAACTC ACATTAATTGCGTTG 490 
4 ^31-2574MAR06 GAGCCTAGCCGAAGT CCTGCAGCAGCTTGG GGCTTCCCGTGATCT CCAGGCTGTTCTCAG CTACATCTTCCCCAC TTACGGAGTAN-TCC 521 
5 ^^^1-6437MAR06 G A G C C T A G C ^ A A G T CCTGCAGCAGCTTGG GGCTTCCCGTGATCT CCAGGCTGTTCTCAG CTACATCTTCCCCAC TTACGGAGTAACTCC 10^2 
6 并 G A G C C T A G C C G A A G T CCTGCAGCAGCTTGG GGCTTCCCGTGATCT CCAGGCTGTTCTCAG CTACATCTTCCCCAC TTACGGAGTAACTCC 838 
®tSat+Chromos GAGCCTAGCTGAAGT-CCTGCAGCAGCTTGG GGCTTCCCGTGAGCT CCAGGCTGTTCTCAG CTACATCTTCCCCAC TTACGGAGTAACTCC b31 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
276 
2 5#31-8454MAR06 CGCTCACTGCCCGCT TTCCAGTCGGGAAAC CTGTCGTGCCAGCTG CATTAATGAATCGGC CAACGCGCGGGGAGA NGCG GTTTGC 仍 
3 5#31-2574MAR06 CAGCCACACCGCCTT TTCCTTGCATGCTCT GCTGGTTGANCACTA CATACANGGG-CATA TTACCCTCGAGGGNN TNC-AGTGAAATCGC 609 
4 5#31-6437MAR06 CAGCCACACCGCCTT TTCCTTGCATGCTCT GCTGGTtGACCACTA C A T A C M G G G G C A T A TTACCCTCGAGGGTG TTCCAGTGAGATCGC 1132 
5 5#31 CAGCCACACCGCCTT TTCCTTGCATGCTCT GCTGGTTGACCACTA CATACAAGGGGCATA TTACCCTCGAGGGTG TTCCAGTGAGATCGC 92" 
6 RetSat+Chromos CAGCCACACCGCCTT TTCCTTGCATGCTCT GCTGGTTGACCACTA CATACAAGGGGCATA TTACCCTCGAGGGGG TTCCAGTGAGATCGC 922 
1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
2 5 # 3 1 - 8 4 5 4臓 0 6 GTATTGGGCGCTCTT CCGCTTCCTCGCTCA CTGACTCGCTGCGCT CGGTCGTTCGGCTGC GGCGAGCGTNAT-CA GCTCACTCAAAGGCG G64 
3 5tt3:L-25"MMAR06 NTNCATA--CATCCC TTTGATNANCGGGCC G G G G G N C T G N — — C C CNCCNGGCCCTGTNA AAATGGGNTGCTGAC TCCCTGGAAAANTGG 
4 5#31-64 37MAR06 CTTCCATACCATCCC TTTGATTCAGCGGGC CGGGGGCGCTGTCCT CACCAGGGCCACTGT ACAGAGTGTGCTGNT GGANTCA 1214 
5 5#31 CTTCCATACCATCCC TTTGATTCAGCGGGC CGGGGGCGCTGTCCT CACCAGGGCCACTGT ACAGAGTGTGCTGCT GGACTCAGCTGGGAG 1018 
6 RetSat+Chromos CTTCCATACCATCCC TTTGATTCAGCGGGC CGGGGGCGCTGTCCT CACCAGGGCCACTGT ACAGAGTGTGCTGCT GGACTCAGCTGGGAG 1012 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
2 5#31-84 54MAR06 GTAATACGGNTTTCC ACAGAATCAGGGGAT AACGCAGGA-AANAA CNTGTGANCAAANGN CNGCAAAAGGCCGGA ACCGTAAAANGNCCN 753 
3 5#31-257 4MAR06 GGGNCNTTGGAAAAG GANAAAACTGGGAAN TCCCTGCCAN TNTCTTCCNANGGGN ANGTTAAAACNNANA NCTTNTNNCAAAANT 779 
5 15#31 AGCATGTGGTGTCAG TGTGAAGAAGGGACft AGAGCTdGTGAACRT CTACTGCCCAGTTGT CATCTCCAATGCGGG AATGTTCAATACCTA 1108 
6 RetSat+Chromos AGCGTGTGGTGTCAG TGTGAAGAAGGGACA AGAGCTGGTGAACAT CTACTGCCCAGTTGT CATCTCCAATGCGGG AATGTTCAATACCTA 1102 
1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
2 5#31-84 54MAR06 GTTGCTGG-GNTTTT NCATANGNTCCGCCC CCTGACANAATCAAA AATCGACCCNAANNN AAGGGGNGAANCCNN CGGANT 833 
3 5#31-25"MMAR06 NCCCCCCCCCNAATN NAAAAACCTTGNAAG NAANGCNGNNNAAAT TNTCNNNTTNCNTNT TNANNGNCNAGGGAA CNGANTTTCNCCCCN 869 
5 5#31 TCAGCACTTGTTGGC AGAGACTGTCCGCCA TCTGCCIGATGTGAA GAAGCAGCTGGCGAT G G T A A G G C C T G G T — CTGAGCATGCTCTCA 1196 
6 RetSat+Chromos TCAGCACTTGTTGCC AGAGACTGTCCGCCA TCTGCCAGATGTGAA GAAGCAGCTGGCGAT G G T A A G G C C T G G T — CTGAGCATGCTCTCA 1190 
1441 1455 1456 1470 1471 1485 1486 1500 1501 1515 1516 1530 
2 .5#31-8454MAR06 NAAANNACCAGGGTT NCCCCTGNAANNCCN CGGGGNNCCTNNTNC NNCCTGNNNTTACGG AAACTTNCCCCTTTN 908 
3 5#31-2574MAR06 ATNNTTTTTTTTNCC NAAANGNAAANGGGG NGNNTTTTNTTTCCN ANAAAGGNCAAAAAT TCCCTTCTTTTNTNC CCNAANAGGGNNNCC 959 
5 5 如 ATCTTCATCTGTCTG AAAGGCACCAAGGAG GACCTGftAGCTTCAG T C C A C — C A A C T A C TATGTTTATTTTGAC AC AG AC AT GG AC AAA 1283 
5 RetSat+Chromos ATCTTCATCTGTCTG AAAGGCACCAAGGAG GACCTGAAGCTTCAG T C C A C — — C A A C T A C TATGTTTATTTTGAC ACAGACATGGACAAA 1277 
1531 1545 1546 1560 1561 1575 1576 1590 1591 1605 1606 1620 
2 5#31-84 54MAR06 CCNNNGGAANGGGGG NTTTNCAANCCCCCG NGANGACCCATNCGG GGNGGCNTCCCCAAA GGGGGNGGGNNAAAC CCCNTTACCCANCGN 998 
3 5#31-2574MAR06 GGGGGNGGTNCCCNN NNCNNNANGGCNGGN CCCNGNTTTNNNNNN NAAGGGGGNGAAAAA NNNNNGGGTTNTAAA ACNAAAAAACNNNGN 104 9 
5 5#31 GCG|TGGAGCGCTAT GTCTCTATGCCCAAG GAAAAGSCTCCAGAA CACATTCCCCTTCTC TTCATTGCCTTCCCA TCAAGCAAGGATCCA 1373 
6 RetSat+Chromos GCGATGGAGCGCTAT GTCTCTATGCCCAAG GAAAAGGCTCCAGAA CACATTCCCCTTCTC TTCATTGCCTTCCCA TCAAGCAAGGATCCA 1367 
、 
1621 1635 1636 1650 1651 1665 1666 1680 1681 1695 1696 1710 
^ 5#31-8454MAR06 GNCNTTNNGGAAATT TCTTGNNCNCCCGGA AAAAAATTTNCCCTG GGANCCCNGNNA AAN TNNAAAAAGGNTNNG 1073 
^ 5#31-2574MAR06 ANCNNTTNGGNNAAA ANTCCC--CCNGGGG GGGGGGNNGGGGGGG GGNCCCNNNNNANTT TNNNNCCCNAAAAAA AANNAAAAAANNNNN 1137 
” # 3 1 AGCTGGGAGGAGCGA TTCCCAGACCGATCC ACAATG^CTGCGCTG GTACCCATGGCCTTT GAATGGTTCGAGGAG TGGCAGGAGGAGCCA 1463 
RetSat+Chromos ACCTGGGAGGAGCGA TTCCCAGACCGATCC ACAATGACTGCGCTG GTACCCATGGCCTTT GAATGGTTCGAGGAG TGGCAGGAGGAGCCA 1457 
1711 1725 1726 1740 1741 1755 1756 1770 1771 1785 1786 1800 
^ ⑷1 - 8 4 5 4 M A R 0 6 GGGNCCAAANTNTNA GGGGGCCANNCNCCC CNAAAAAANTTTTTT CCCCNCNNAACNCTT CCCNAAAAATTGTTT TTTNCCNAAAACCCN 1163 
^ S#31-2574MAR06 NNCCCCNNNNGNNAA N 1153 
” # 3 1 AAGGGCAAGCGTGGT GTTGACTATGAGACC C T C A A A M T G C C T T C GTGGAAGCCTCTATG TCGGTGATCATGAAA CTGTTCCCACAGCTG 1553 
奴 S a t + C h r o m o s AAGGGCAAGCGTGGT GTTGACTATGAGACC CTCAAAAATGCCTTC GTGGAAGCCTCTATG TCGGTGATCATGAAA CTGTTCCCACAGCTG 1547 
, 1801 1815 1816 1830 1831 1845 1846 1860 1861 1875 1876 1890 
i 5#31-2635MAR06 ATCTGCAGA ATTCGCCCTTCGACT GGAGCACGAGGACAC TGACATGGACTGAAG 933 
^ ^»31-8454MAR06 GGGGG GGNT TTTTTTNCCCNNTNC CCNAAAANNTCAAAA TTTTTTTTT 1211 
5 ⑷ 1 GAGGGCAAGGTGGAG AGTGTGACTGGftGGG TCACCAljTGACCAAC CAGTACTATCTGGCT GCACCCCGAGGAGCT ACCTATGGAGCTGAC 164 3 
RetSat+Chromos GAGGGCAAGGTGGAG AGTGTGACTGGAGGG TCACCACTGACCAAC CAGTACTATCTGGCT GCACCCCGAGGAGCT ACCTATGGAGCTGAC 1637 
1 、 1891 1905 1906 1920 1921 1935 1936 1950 1951 1965 1966 19b0 
5 5tt3l-2635MAR06 GAGTAGAAAGCGGTC TTCCGAGCCCTGGCA GCAACATGTGGATCA CTGCTCTGCCGCTGG CCGTGCTGCTGCTGG TGATCCTCCACAGGG 1023 
5 如 1 CftTGACTTQGCTCGG CTGCATCCTCATGCA ATGGCTfCCATAAGA GCCCAAACCCCCATC CCCAACCTCTACCTG ACAGGCCAAGATATC 1733 
•RetSat+Chromos CATGACTTGGCTCGG CTGCATCCTCATGCA ATGGCTTCCATAAGA GCCCAAACCCCCATC CCCAACCTCTACCTG ACAGGCCAAGATATC 1727 
1 1981 1995 1996 2010 2011 2025 2026 2040 2041 2055 2056 2070 
5 ” 3 1 - 2 6 3 5 M A R 0 6 T C T A C G T G G G C C T T T A C G C T G C A A G T T C C C C G A A C C C C T T C G C C G A G G A T G T C A A G C G A C C G C C T G A A C C C C T G G T G A C C G A C A A G G A G G 1 1 1 3 
5 TTCACCTGTGGGCTG ATG6GGGCCCTGCAG GGGGCC$TGCTGTGC AGCAGTGCCATCCTG AAACGGAACTTGTAC TCAGATCTGCAGGCT 1823 
RetSat+Chromos TTCACCTGTGGGCTG ATGGGGGCCCTGCAG GGGGCCTTGCTGTGC AGCAGTGCCATCCTG AAACGGAACTTGTAC TCAGATCTGCAGGCT 1817 
1 2071 2085 2086 2100 2101 2115 2116 2130 2131 2145 2146 2160 
5 ”31-2635MAR06 CTAGGAAGAAAGTTC T — — C A A A C A A G C T T TCTCAGTCAGCCGAG TACCAGAGAAGCTGG ATGCAGTGGTGATCG GCAGCGGCATTGGGG 1200 
6 CTTGGCTCAAAGGTC AAGGCACAAAAGAAG A A G A T G I A G T C C G T T CAGAGAAGAG . 1 8 7 8 
RetSat+Chromos CTTGGCTCAAAGGTC AAGGCACAAAAGAAG AAGATGTAGTCCGTT CAGAGAAGAGCCAGA GGAAAGGCACACTCC CCAACTTCTCGTGGT 1907 
1 , 2161 、 2175 2176 2190 2191 2205 2206 2220 2221 2235 2236 2250 
2 二31-2635MAR06 GACTGGCCTCAGCTG CG 1217 
3 ”31-845搬底 1211 
4 二31-2574MAR06 1153 
5 ^»31-6437MAR06 1214 
6 r j l = -- 1878 
®tSat+Chromos GTCCTCCCTCCTAC- -- 1921 
277 . 
Appendix B7: Alignment result of 5'#32 
1 15 16 30 31 45 46 60 61 75 76 叩 
4 5#3:2-8197MAR06 NNN TNNNGNNTNNNNNNN CCNNNNTTNTNNNTN 33 
5 GCGGTCTTCCGAGCC CTGGCAGCAACATGT GGATCAijTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 90 
6 RetSat+Chromos GCGGTCTTCCGAGCC CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 90 
91 105 106 120 121 135 136 150 151 165 166 180 
4 5#32-8197MAR06 NNGNNNAANNNNNNN NAAAANTTTTCCCCN NNNAANNNANTTTTT NGNGNGGNNGGNNNT NCCNNGNNGGGGNTT NNNAATTCCCNCCCN 123 
5 5#32 GCCTTTACGGTGCAA. GTTCCCCGAACCCCT TCGCCGllGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 180 
6 RetSat+Chromos GCCTTTACGGTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 180 
181 195 196 210 211 225 226 240 241 255 256 270 
4 5#32-8197MAR06 NNGGNGNNAAAACCC CCNACCCNNGNNCNA NGGGGGNNAAATTTT NANANTTTTTNTTCC NNNNCCNAAAANNNN NCNTNTTTTCCCCCC 1:13 
5 5#32 AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACSAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 1:70 
6 RetSat+Chromos AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG ：'70 
271 285 286 300 301 315 316 330 331 345 346 360 
4 5#32-8197MAR06 NTGGGGNNCNTNNNN GGGTTTNNAAAANNN CAANGGNNTTTTTGG GAAAAAANCAAGGGG GGGGGTTNT TA CCTTGGGNAAANC-- 297 
5 5#32 CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGIGCTGGAAC AACATACCAAGGCGG GCGGCTGTTGTCATA CCTTTGGGGAAAATG 360 
6 RetSat+Chromos CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACCAAGGCGG GCGGCTGTTGTCATA CCTTTGGGGAAAATG 360 
361 375 376 390 391 405 406 420 421 435 436 450 
4 5#32-8197MAR06 CCNNANTTCCCCGGA NTCNTTTATNGGGGA NGGGGNGGGCACNTN GCCTTTTTTTTGGCC NNATCCNNNAGGGN- 371 
5 5#32 GCCTTGAATTTGACA CTGGAATTCATTATA TTGGAC6AATGCGGG AGGGCAACATTGGCC GTTTTATCTTGGACC AGATCACTGAAGGGC 450 
6 RetSat+Chromos GCCTTGAATTTGACA CTGGAATTCATTATA TTGGACGAATGCGGG AGGGCAACATTGGCC GTTTTATCTTGGACC AGATCACTGAAGGGC 450 
451 465 466 480 481 495 496 510 511 525 526 540 
4 5 T T 3 2 - 8 1 9 7 M A R 0 6 - A N N G G N N N G G N C C C C N A G G C C C C C C T T T N N N N T N A G G A N N N A A - — — A A G G G C C C A A T G N C C - A A A N G N N T T N C C C N N T T N C A G G G G G - ^ 5 4 
5 5tt32 AACTGGACTGGGCCC CCATGGCCTCCCCTT TTGACTTGATGATAC TAGAAGGGCCCAATG GCCGAAAGGAGTTCC CCATGTACAGTGGGA 540 
6 RetSat+Chromos AACTGGACTGGGCCC CCATGGCCTCCCCTT TTGACTTGATGATAC TAGAAGGGCCCAATG GCCGAAAGGAGTTCC CCATGTACAGTGGGA 5<50 
541 555 556 570 571 585 586 600 601 615 616 630 
4 5#32-8197MAR06 GGAAAGAANACNTCC AGGNCCTTAAGANGA NNTTCCCCAAGGGGA AGCTGTCNATNNACA AGTNCATGGAGTTNG NTAAGGTGGTNGCCC 544 
“ # 3 2 GGAAAGAATACATCC AGGGCCTTAAGAAGA AGTTCCGCAAGGAAG AAGCTGTCATTGACA AGTACATGGAGTTGG TTAAGGTGGTGGCCC 630 
® RetSat+Chromos GGAAAGAATACATCC AGGGCCTTAAGAAGA AGTTCCCCAAGGAAG AAGCTGTCATTGACA AGTACATGGAGTTGG TTAAGGTGGTGGCCC 630 
631 645 646 660 661 675 676 690 691 705 706 720 
丨 ^#32-2635MAR06 NTTNNNNCTTTTNGG GNATNNNGNNAAAAA ANCCCCCCCNGGGNT TTNCGGAAANNNNCA NTTTTTNNGNNANGT TNAAAGGGGGNNCAA 98 
St^32-8197MAR06 NGGGAGTNTNTCANG CAGTTTTANTCAAGT TCCTCCCCATGCCCN TGATTNAGNTNNTCA GCAAGTTTGGGCTAN TGACTNGTTTCTTTC 634 
GTGGAGTCTCTCATG CAGTTCTACTCAAGT TCCTCCCATTGCCCT TGACTCAGCTCCTCA GCAAGTTTGGGCTAC TGACTCGTTTCTCTC 720 
RetSat+Chromos GTGGAGTCTCTCATG CAGTTCTACTCAAGT TCCTCCCATTGCCCT TGACTCAGCTCCTCA GCAAGTTTGGGCTAC TGACTCGTTTCTCTC 120 
721 735 736 750 751 765 766 780 781 795 796 810 
”32-2635MAR06 ANTTTTTTNGGGNNG GTTGGGCCCCCTNAA ANTTNGNCCCCCNNA ANCNNTTTTNNANCT TTNCANGGGNNNCCA GGGGAAAANTGNTTT 188 
如 2 - 8 1 9 7 M A R 0 6 CCNTNTGCCGAGCGT TTACGCAGAGCCTAG CTGAAGTCCTGCAGC AGCTTGGGGCTTCCC GTGAGCTCCAGGCTG TTNTCAGCTACATCT 724 
- C A T T C T G C C G A G C G T CTACGCAGAGCCTAG CTGAAGfCCTGCAGC AGCTTGGGGCTTCCC GTGAGCTCCAGGCTG TTCTCAGCTACATCT 810 
^etSat+Chromos CATTCTGCCGAGCGT CTACGCAGAGCCTAG CTGAAGTCCTGCAGC AGCTTGGGGCTTCCC GTGAGCTCCAGGCTG TTCTCAGCTACATCT 810 
1 811 825 826 840 841 855 856 870 871 885 886 900 
^ ^tt32-2635MAR06 NCNGGTGGCCCAAAN AAATTNCCGAAAAGG CCCCNNTGGGTNAAN GGGGT TTT NCCCCNCCCCCNTTG GGNGANNCCCCCCCC 271 
5 ” 3 2 - 8 1 9 7 M A R 0 6 TCCCCACTTACGGAG TAACTCCCAGCCACA CCGCCTTTTCCTTGC A T G C T C T G C T G G T - G AC CAC TACATACAAG GGGCATATTACCCTC 8 1 3 
G •枯32 TCCCCACTTACGGAG TAACTCCCAGCCACA CCGCCTfTTCCTTGC ATGCTCTGCTGGTTG ACCACTACATACAAG GGGCATATTACCCTC 900 
^et^Sat+Chromos TCCCCACTTACGGAG TAACTCCCAGCCACA CCGCCTTTTCCTTGC ATGCTCTGCTGGTTG ACCACTACATACAAG GGGCATATTACCCTC 900 
J 901 915 916 930 931 945 946 960 961 975 976. _ 
^ ”32-2635MAR06 GNATTGNATNCTNCN GGGGNGNTTGGGAAN NCCCCCCNTNCCGAA GGNAAAAGGGGNNAA GTTTCN GTN 3^0 
5 ^^32-8197MAR06 GAGGGGGTTCCAGTG AGATCGCCTTCCATA CCATCCCTTTGATTC AGCGGGCCGGGGGCG CTGTCCTCACCAGGG CCACTGTACAGAGTG 903 
5 g 松 GAGGGGGTTCCAGTG AGATCGCCTTCCATA CCATCCCTTTGATTC AGCGGGCCGGGGGCG CTGTCCTCACCAGGG CCACTGTACAGAGTG 990 
^®tSat+Chromos GAGGGGGTTCCAGTG AGATCGCCTTCCATA CCATCCCTTTGATTC AGCGGGCCGGGGGCG CTGTCCTCACCAGGG CCACTGTACAGAGTG 990 
1 991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 lOHO 
4 ”32-2635MAR06 ANCGNCAGGNNGGAA CNGGAANGNCNCGAG GGGCTTCCAGGGGNA ANNCCNGGNATCTTN NAGTCCNGTCGGGTT TCCCCCCTTTGACTT 430 
5 ^^32-8197MAR06 TGCTGCTGGACTCAG CTGGGAGAGCGTGTG GTGTCA6TGTGAAGA AGGGACAAGAGCTGG TGAACATCTACTGCC CAGTTGTCATCTCCA 993 
G TGCTGCTGGACTCAG CTGGGAGAGCGTGTG GTGTCAGTGTGAAGA AGGGACAAGAGCTGG TGAACATCTACTGCC C A G T T G T C A T C T C C A 1 0 8 0 
晰 S a t + C h r o m o s TGCTGCTGGACTCAG CTGGGAGAGCGTGTG GTGTCAGTGTGAAGA AGGGACAAGAGCTGG TGAACATCTACTGCC CAGTTGTCATCTCPA 1080 
I - 1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
4 ^32-2635MAR06 GAGCGTCC3ATTTTNT GATGCTNGTCAGGGG GGGGAGCCTATGGAA AAACGCCAGCAACGC GGCCTTTTTACGGTT CCTG GC 511 
5 ^32-8197MAR06 ATGCGGGAATGTTCA -ATACCTATCAGCAC TTGTTGGCAGAGACC GTCCGCCATCTGCCA GATGTGAAGAAGCAG CTGGCGATGGTAAGG 1082 
6 ATGCGGGAATGTTCA -ATACCTATCAGCAC TTGTTGCCAGAGACC GTCCGCCATCTGCCA GATGTGAAGAAGCAG CTGGCGATGGTAAGG 1169 
etSat+Chromos ATGCGGGAATGTTCA -ATACCTATCAGCAC TTGTTGCCAGAGACT GTCCGCCATCTGCCA GATGTGAAGAAGCAG CTGGCGATGGTAAGG 1169 
1 ^ 1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
4 2635MAR06 CTTTTGCTGGCCTTf TGCTCA--CATGTTC TTTCCTGCGTTATCC CCTGATTCTGTGGAT AACCGTATTACCGCC TTTGAGTGAGCTGAT 599 
丨 -8197MAR06 CCTGGTCTGAGCATG CTCTCAATCTTCATC T G T C T G j ^ G G C A C C AAGGAGGACCTGAAG CTTCAGTCCACCAAC TACTATGTTTATTTT 1172 
278 
I 
5 5#32 CCTGGTCTGAGCATG CTCTCAATCTTCATC TGTCTGAAAGGCACC AAGGAGGACCTGAAG CTTCAGTCCACCAAC TACTATGTTTATTTT 11:59 
6 RetSat+Chromos CCTGGTCTGAGCATG CTCTCAATCTTCATC TGTCTGAAAGGCACC AAGGAGGACCTGAAG CTTCAGTCCACCAAC TACTATGTTTATTTT 1:'。9 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
1 5#32-2635MAR06 ACCGCTCGCCGCAGC CGAACGACCGAGCGC AGCGAGTCAGTGAGC GAGGAAGCGGAAGAG CGCCCAATACGCAAA CCGCCTCTCCCCGCG 
4 S#32-8197MAR06 GACACAGACGTGGAC AAAGCGATGGAGCGC TATGTCtCTATGCCC AAGGAA AAGGC TCCAGAACACATTCC CCTTCTCTTCATTGC 11'Sh 
5 5 0 2 GACACAGACGTGGAC AAAGCGATGGAGCGC TATGTCTCTATGCCC AAGGAA AAGGC TCCAGAACACATTCC CCTTCTCTTCATTGC i?‘厂’ 
6 RetSat+Chromos GACACAGACATGGAC AAAGCGATGGAGCGC TATGTCTCTATGCCC AAGGAA AAGGC TCCAGAACACATTCC CCTTCTCTTCATTGC H-l ^  
1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 14‘!0 
1 5#32-2635MAR06 CGTTGGCCGATTCAT TAATGCAGC-TGGCA CGACAGGTTTCCCGA CTGGAAAGCGGGCAG TGAGCG CAA CGCAATTAATGTGAG 112 
4 5#32-8197MAR06 CTTCCCATCAAGCAA GGATCCAACCTGGGA GGAGCGATTCCCAGA CCGATCCACAATGAC TGCGCTGGTACCCAT GGCCTNTGAATGGTN 1348 
5 5#32 CTTCCCATCAAGCAA GGATCCAACCTGGGA GGAGCGATTCCCAGA CCGATCCACAATGAC TGCGCTGGTACCCAT GGCCTTTGAATGGTT 1435 
6 RetSat+Chromos CTTCCCATCAAGCAA GGATCCAACCTGGGA GGAGCGATTCCCAGA CCGATCCACAATGAC TGCGCTGGTACCCAT GGCCTTTGAATGGTT 1435 
1441 1455 1456 1470 1471 1485 1486 1500 1501 1515 1516 1530 
1 5 # 3 2 - 2 6 3 5 M A R 0 6 T T A G C T C A C T C A T T A G G C A C C C C A G G C T T T A C A C T T T A T G - - C T T C C G G C T C G T A T G T T G T G T G G A A T T G T G A G C GGATAACAATTTCAC 8 6 0 
4 5#32-8197MAR06 CGAGGA 1354 
5 5tt32 CGAGGAGTGGCAGGA GGAGCCAAAGGGCAA GCGTGGfGTTGACTA TGAGACCCTCAAAAA TGCCTTCGTGGAAGC CTCTATGTCGGTGAT 152 5 
6 RetSat+Chromos CGAGGAGTGGCAGGA GGAGCCAAAGGGCAA GCGTGGTGTTGACTA TGAGACCCTCAAAAA TGCCTTCGTGGAAGC CTCTATGTCGGTGAT 
1531 1545 1546 1560 1561 1575 1576 1590 1591 1605 1606 1620 
1 5#32-2635MAR06 ACAGGAAACAGCTAT GACCATGATTACGCC AAGCTATTTAGGTGA CACTATAGAATACTC AAGCTATGCATCAAG CTTGGTACCGAGCTC 9S0 
3 5#32-8167MAR06 CATGGNAACTGTTCC CACGGNCTGGAGGGC AAGGTGGAGAGTGTG ACTGGAGGGTCACCA CTGACCAACCAGTAC TATCTGGCTGCACCC 125 
5 CATG|-AACTGTTCC CACiG-CTGGAGGGC AAGGTGSAGAGTGTG A C T G G A G G G T C A C C A CTGACCAACCAGTAC TATCTGGCTGCACCC 1613 
6 RetSat+Chromos CATGA-AACTGTTCC CACAG-CTGGAGGGC AAGGTGGAGAGTGTG ACTGGAGGGTCACCA CTGACCAACCAGTAC TATCTGGCTGCACCC 1613 
1621 1635 1636 1650 1651 1665 1666 1680 1681 1695 1696 1710 
1 5#32-2635MAR06 GGATCCACTAGTAAC GGCCGCCAGTGTGCT GGAATTCGCCCTTCG ACTGGAGCACGAGGA CACTGACATGGACTG AAGGAAGTAGAAGCG 1040 
3 5#32-8167MAR06 CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCT^GGCTGCAT C C T C A T G C A — A T G G CTTCCATAAGAGCCC A A A C C C C C A T C C C C A 213 
5 5#32 CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT C C T C A T G C A — A T G G CTTCCATAAGAGCCC A A A C C C C C A T C C C C A 1701 
6 RetSat+Chromos CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT C C T C A T G C A — A T G G CTTCCATAAGAGCCC AAACCCCCATCCCCA 1701 
1711 1725 1726 1740 1741 1755 1756 1770 1771 1785 1786 1800 
1 5#32-2635MAR06 GTCTTCCGAGCCCTG GCAGCAACATGTGGA TCACTGCTCTGCTGC TGGCCGTGCTGCTGC TGGTGATCCTCCACA GGGTCTACGTGGGCC 1130 
2 5#32-84 54MAR06 ACCTCTACCTGACAG GCCAAGATATCTTCA CCTGTGGGCTGATGG GGGCCCTGCAGGGGG C C T T G C T G T G C A G C A GTGCCATCCTGAAAC 122 
3 5#32-816"7MAR06 ACCTCTACCTGACAG GCCAAGATATCTTCA CCTGTGGGCTGATGG GGGCCCTGCAGGGGG C C T T G C T G T G C A G C A GTGCCATCCTGAAAC 303 
5 5#32 ACCTCTACCTGACAG GCCAAGATATCTTCA CCTGTGGGCTGATGG GGGCCCTGCAGGGGG C C T T G C T G T G C A G C A GTGCCATCCTGAAAC 1791 
6 RetSat+Chromos ACCTCTACCTGACAG GCCAAGATATCTTCA CCTGTGGGCTGATGG GGGCCCTGCAGGGGG C C T T G C T G T G C A G C A GTGCCATCCTGAAAC 1791 
、 -
1801 1815 1816 1830 1831 1845 1846 1860 1861 1875 1876 1890 
I 5#32-2635MAR06 TTTACGCTGCAAGTT CCCCGAACCCCTTCG CCGAGGATGTCAAGC GACCGCCTGAACCCC TGGTGACCGACAAGG A G - - - G C T A G G A A G A 1217 
^ 5 # 3 2 - 8 4 5 4 M A R 0 6 GGAACTTGTACTCAG ATCTGCAGGCTCTTG GCTCAAAGGTCAAGG C A C A A A A G A A G A A G A TGTAGTCCGTTCAGA GAAGAGCCAGAGGAA 2 1： 
5#32-8167MAR06 GGAACTTGTACTCAG ATCTGCAGGCTCTTG GCTCAAilCGTCAAGG C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A GAAGAGCCAGAGGAA 393 
I 5#32-8197MAR06 1354 
” # 3 2 GGAACTTGTACTCAG ATCTGCAGGCTCTTG GCTCAAAGGTCAAGG C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A GAAGAGCCAGA 1877 
RetSat+Chromos GGAACTTGTACTCAG ATCTGCAGGCTCTTG GCTCAAAGGTCAAGG CACAAAAGAAGAAGA T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A 1881 
1891 1905 1906 1920 1921 1935 1936 1950 1951 1965 1966 1980 
J 如 2 - 2 6 3 5 M A R 0 6 A A G T T C T C A A A C A A G C T T T C T C A G T C A G C C G A G T A C C A G A G A A G C T G G A T G C A G T G G T G A T C G G C A G C G G C A T T G G G G G A N C T G G C N T C A 1 3 0 7 
^ 5#32-84 5 4 M A R 0 6 A G G C A C - C T C C C C A A 贴 G G G C G A A T T C - - T G C A G A TATCCATCACACTGG CGGCCGCTCGAGCAT 2 9 9 
5#32-8167MAR06 A G G C A C - C T C C C C A A CTTCTCGTGGTGTCC TCCCTCCTACAAGGG CGAATTC--TGCAGA TATCCATCACACTGG CGGCCGCTCGAGCAT 480 
RetSat+Chromos A G G C A C A C T C C C C A A CTTCTCGTGGTGTCC TCCCTCCTAC 19j1 
5 ' - G S P l 
279 







































































































































































































































































































































Appendix B9: Alignment result of all 5' RACE clones consensus sequence 
[Mismatched nucleofiriri arf m m n »n ppeen colour -…， .v'；. 。‘？ 
1 15 16 30 31 45 46 60 61 75 76 90 
1 5#16 GCGGTCTTCCGAGCC CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 90 
2 5#31 GCGGTCTTCCGAGCC CTGGCAGCAACATGT GGATCACTGCTCTGC CGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 90 
3 5#12 GCGGTCTTCCGAGCC CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 90 
4 Sttll GCGGTCTTCCGAGCC CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 90 
5 GCGGTCTTCCGAGCC CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGG|TCTACGTGG 89 
6 5#32 GCGGTCTTCCGAGCC CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 90 
7 5#7 GCGGTCTTCCGAGCC CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 90 
8 5#33 GCGGTCTTCCGAGCC CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 90 
10 5#33 GCGGTCTTCCGAGCC CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 90 
9 RetSat+Chromos GCGGTCTTCCGAGCC CTGGCAGCAACATQT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 90 
TSS of 5' RACE 1" Start codon, start of RetSat 
91 105 106 120 121 135 136 150 151 165 166 180 
1 5#16 GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGC 180 
2 5#31 GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 180 
3 5#12 GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 180 
4 5#11 GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 180 
5 5#20 GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCfGGTGACCGACA AGGAGGCTAGGAAGA 178 
6 5#32 GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 180 
7 5#7 GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 180 
• 8 5#33 GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 180 
‘ 10 5tt33 GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 180 
9 RetSat+Chromos GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 180 
181 195 196 210 211 225 226 240 241 255 256 270 
1 5#16 CAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 270 
2 5#31 AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 270 
3 5#12 AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 270 
4 5#11 AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 270 
5 5#20 AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 268 
6 5#32 AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 270 
7 5#7 AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 270 
8 5#33 AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 270 
10 5#33 AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 270 
9 RetSat+Chromos AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 270 
271 285 286 300 301 315 316 330 331 345 346 360 
1 5#16 CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACCAAGGCGG GC-GGCTGTTGTCAT ACCT-TTGGGGAAAA 358 
2 5#31 CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACCAAGGCGG GC-GGCTGTTGTCAT ACCT-TTGGGGAAAA 358 
3 5#12 CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACCAAGGCGG GC-GGCTGTTGTCAT ACCT-TTGGGGAAAA 358 
4 5#11 CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACCAAGGCGG GC-GGCTGTTGTCAT ACCT-TTGGGGAAAA 358 
5 5#20 CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACCAAGGCGG GC-GGCTGTTGTCAT ACCT-TTGGGGAAAA 356 
6 5#32 CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACCAAGGCGG GC-GGCTGTTGTCAT ACCT-TTGGGGAAAA 358 
7 5#7 CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACCAAGGCGG GC-GGCTGTTGTCAT ACCT-TTGGGGAAAA 358 
8 5#33 CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACCAAGGCGG GC-GGCTGTTGTCAT ACCT-TTGGGGAAAA 358 
10 5#33 CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACCAAGGCGG GC-GGCTGTTGTCAT ACCT-TTGGGGAAAA 360 
9 RetSat+Chromos CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACCAAGGCGG GC-GGCTGTTGTCAT ACCT-TTGGGGAAAA 358 
361 375 376 390 391 405 406 420 421 435 436 450 
1 5#16 TGGCCTTGAATTTGA CACTGGAATTCATTA TATTGGACGAATGCG GGAGGGCAACATTGG CCGTTTTATCTTGGA CCAGATCACTGAAGG 448 
2 5#31 TGGCCTTGAATTTGA CACTGGAATTCATTA TATTGGACGAATGCG GGAGGGCAACATTGG CCGTTTTATCTTGGA CCAGATCACTGAAGG 448 
3 5#12 TGGCCTTGAATTTGA CACTGGAATTCATTA TATTGGACGAATGCG GGAGGGCAACATTGG CCGTTTTATCTTGGA CCAGATCACTGAAGG 448 
4 5#11 TGGCCTTGAATTTGA CACTGGAATTCATTA TATTGGACGAATGCG GGAGGGCAACATTGG CCGTTTTATCTTGGA CCAGATCACTGAAGG 448 
5 5#20 TGGCCTTGAATTTGA CACTGGAATTCATTA TATTGGACGAATGCG GGAGGGCAACATTGG CCGTTTTATCTTGGA CCAGATCACTGAAGG 446 
6 5tt32 TGGCCTTGAATTTGA CACTGGAATTCATTA TATTGGACGAATGCG GGAGGGCAACATTGG CCGTTTTATCTTGGA CCAGATCACTGAAGG 448 
7 5#7 TGGCCTTGAATTTGA CACTGGAATTCATTA TATTGGACGAATGCG GGAGGGCAACATTGG CCGTTTTATCTTGGA CCAGATCACTGAAGG 44 8 
8 5#33 TGGCCTTGAATTTGA CACTGGAATTCATTA TATTGGACGAATGCG GGAGGGCAACATTGG CCGTTTTATCTTGGA CCAGATCACTGAAGG 448 
‘10 5#33 TGGCCTTGAATTTGA CACTGGAATTCATTA TATTGGACGAATGCG GGAGGGCAACATTGG CCGTTTTATCTTGGA CCAGATCACTGAAGG 450 
9 RetSat+Chromos TGGCCTTGAATTTGA CACTGGAATTCATTA TATTGGACGAATGCG GGAGGGCAACATTGG CCGTTTTATCTTGGA CCAGATCACTGAAGG 448 
451 465 466 480 481 495 496 510 511 525 526 540 
1 5#16 GCAACTGGACTGGGC CCCCATGGCCTCCCC TTTTGACTTGATGAT ACTAGAAGGGCCCAA TGGCCGAAAGGAGTT CCCCATGTACAGTGG 538 
2 5#31 GCAACTGGACTGGGC CCCCATGGCCTCCCC TTTTGACTTGATGAT ACTAGAAGGGCCCAA TGGCCGAAAGGAGTT CCCCATGTACAGTGG 538 
3 5ttl2 GCAACTGGACTGGGC CCCCATGGCCTCCCC TTTTGACTTGATGAT ACTAGAAGGGCCCAA TGGCCGAAAGGAGTT CCCCATGTACAGTGG 538 
4 5#11 GCAACTGGACTGGGC CCCCATGGCCTCCCC TTTTGACTTGATGAT ACTAGAAGGGCCCAA TGGCCGAAAGGAGTT CCCCATGTACAGTGG 538 
5 5#20 GCAACTGGACTGGGC CCCCATGGCCTCCCC TTTTGACTTGATGAT ACTAGAAGGGCCCAA TGGCCGAAAGGAGTT CCCCATGTACAGTGG 536 
6 5#32 GCAACTGGACTGGGC CCCCATGGCCTCCCC TTTTGACTTGATGAT ACTAGAAGGGCCCAA TGGCCGAAAGGAGTT CCCCATGTACAGTGG 538 
7 5#7 GCAACTGGACTGGGC CCCCATGGCCTCCCC TTTTGACTTGATGAT ACTAGAAGGGCCCAA TGGCCGAAAGGAGTT CCCCATGTACAGTGG 538 
8 5#33 GCAACTGGACTGGGC CCCCATGGCCTCCCC TTTTGACTTGATGAT ACTAGAAGGGCCCAA TGGCCGAAAGGAGTT CCCCATGTACAGTGG 538 
10 5#33 GCAACTGGACTGGGC CCCCATGGCCTCCCC TTTTGACTTGATGAT ACTAGAAGGGCCCAA TGGCCGAAAGGAGTT CCCCATGTACAGTGG 540 
9 RetSat+Chromos GCAACTGGACTGGGC CCCCATGGCCTCCCC TTTTGACTTGATGAT ACTAGAAGGGCCCAA TGGCCGAAAGGAGTT CCCCATGTACAGTGG 538 
541 555 556 570 571 585 586 600 601 615 616 630 
1 5ttl6 GAGGAAAGAATACAT CCAGGGCCTTAAGAA GAAGTTCCCCAAGGA AGAAGCTGTCATTGA CAAGTACATGGAGTT GGTTAAGGTGGTGGC 628 
2 5#31 GAOUAAAGAATACAT CCAGGGCCTTAAGAA GAAGTTCCCCAAGGA AGAAGCTGTCATTGA CAAGTACATGGAGTT GGTTAAGGTGGTGGC 628 
3 5#12 GAGGAAAGAATACAT CCAGGGCCTTAAGAA GAAGTTCCCCAAGGA AGAAGCTGTCATTGA CAAGTACATGGAGTT GGTTAAGGTGGTGGC 628 
4 5#11 GAGGAAAGAATACAT CCAGGGCCTTAAGAA GAAGTTCCCCAAGGA AGAAGCTGTCATTGA CAAGTACATGGAGTT GGTTAAGGTGGTGGC 628 
5 5#20 GAGGAAAGAATACAT CCAGGGCCTTAAGAA GAAGTTCCCCAAGGA AGAAGCTGTCATTGA CAAGTACATGGAGTT GGTTAAGGTGGTGGC 626 
6 5#32 GAGGAAAGAATACAT CCAGGGCCTTAAGAA GAAGTTCCCCAAGGA AGAAGCTGTCATTGA CAAGTACATGGAGTT GGTTAAGGTGGTGGC 628 
7 GAGGAAAGAATACAT CCAGGGCCTTAAGAA GAAGTTCCCCAAGGA AGAAGCTGTCATTGA CAAGTACATGGAGTT GGTTAAGGTGGTGGC 628 
8 5#33 GAGGAAAGAATACAT CCAGGGCCTTAAGAA GAAGTTCCCCAAGGA AGAAGCTGTCATTGA CAAGTACATGGAGTT GGTTAAGGTGGTGGC 628 
10 5#33 GAGGAAAGAATACAT CCAGGGCCTTAAGAA GAAGTTCCCCAAGGA AGAAGCTGTCATTGA CAAGTACATGGAGTT GGTTAAGGTGGTGGC 630 
9 RetSat+Chromos GAGGAAAGAATACAT CCAGGGCCTTAAGAA GAAGTTCCCCAAGGA AGAAGCTGTCATTGA CAAGTACATGGAGTT GGTTAAGGTGGTGGC 628 
- 287 
631 645 646 660 661 675 676 690 691 705 706 720 
1 5#16 CCGTGGAGTCTCTCA TGCAGTTCTACTCAA GTTCCTCCCATTGCC CTTGACTCAGCTCCT CAGCAAGTTTGGGCT ACTGACTCGTTTCTC 718 
2 5#31 CCGTGGAGTCTCTCA TGCAGTTCTACTCAA GTTCCTCCCATTGCC CTTGACTCAGCTCCT CAGCAAGTTTGGGCT ACTGACTCGTTTCTC 718 
3 5ttl2 CCGTGGAGTCTCTCA TGCAGTTCTACTCAA GTTCCTCCCATTGCC CTTGACTCAGCTCCT CAGCAAGTTTGGGCT ACTGACTCGTTTCTC 718 
4 5ttll CCGTGGAGTCTCTCA TGCAGTTCTACTCAA GTTCCTCCCATTGCC CTTGACTCAGCTCCT CAGCAAGTTTGGGCT ACTGACTCGTTTCTC 718 
5 5#20 CCGTGGAGTCTCTCA TGCAGTTCTACTCAA GTTCCTCCCATTGCC CTTGACTCAGCTCCT CAGCAAGTTTGGGCT ACTGACTCGTTTCTC 716 
6 5#32 CCGTGGAGTCTCTCA TGCAGTTCTACTCAA GTTCCTCCCATTGCC CTTGACTCAGCTCCT CAGCAAGTTTGGGCT ACTGACTCGTTTCTC 717 
7 5#7 CCGTGGAGTCTCTCA TGCAGTTCTACTCAA GTTCCTCCCATTGCC CTTGACTCAGCTCCT CAGCAAGTTTGGGCT ACTGACTCGTTTCTC 718 
8 5#33 CCGTGGAGTCTCTCA TGCAGTTCTACTCAA GTTCCTCCCATTGCC CTTGACTCAGCTCCT CAGCAAGTTTGGGCT ACTGACTCGTTTCTC 718 
10 5#33 CCGTGGAGTCTCTCA TGCAGTTCTACTCAA GTTCCTCCCATTGCC CTTGACTCAGCTCCT CAGCAAGTTTGGGCT ACTGACTCGTTTCTC 720 
9 RetSat+Chromos CCGTGGAGTCTCTCA TGCAGTTCTACTCAA GTTCCTCCCATTGCC CTTGACTCAGCTCCT CAGCAAGTTTGGGCT ACTGACTCGTTTCTC 718 
721 735 736 750 751 765 766 780 781 795 796 810 
1 5#16 TCCATTCTGCCGAGC GTCTACGCAGAGCCT AGCTGAAGTCCTGCA GCAGCTTGGGGCTTC CCGTGATCTCCAGGC TGTTCTCAGCTACAT 753 
2 5#31 TCCATTCTGCCGAGC GTCTACGCAGAGCCT AGCfGAAGTCCTGCA GCAGCTTGGGGCTTC CCGTGATCTCCAGGC TGTTCTCAGCTACAT 808 
3 5#12 CCCATTCTGCCGAGC GTCTACGCAGAGCCT AGCTGAAGTCCTGCA GCAGCTTGGGGCTTC CCGTGAGCTCCAGGC TGTTCCCAGCTACAT 808 
4 5ttll TCCATTCTGCCGAGC GTCTACGCAGAGCCT AGCTGAAGTCCTGCA GCAGCTTGGGGCTTC CCGTGAGCTCCAGGC TGTTCTCAGCTACAT 808 
5 5#20 TCCATTCTGCCGAGC GTCTACGCAGAGCCT AGCTGAAGTCCTGCA GCAGCTTGGGGCTTC CCGTGAGCTCCAGGC TGTTCTCAGCTACAT 806 
6 5#32 TCCATTCTGCCGAGC GTCTACGCAGAGCCT AGCTGAAGTCCTGCA GCAGCTTGGGGCTTC CCGTGAGCTCCAGGC TGTTCTCAGCTACAT 807 
7 5#7 TCCATTCTGCCGAGC GTCTACGCAGAGCCT AGCTGAAGTCCTGCA GCAGCTTGGGGCTTC CCGTGAGCTCCAGGC TGTTCTCAGCTACAT 808 
8 5#33 TCCATTCTGCCGAGC GTCTACGCAGAGCCT AGCTGAAGTCCTGCA GCAGCTTGGGGCTTC CCGTGAGCTCCAGGC TGTTCTCAGCTACAT 808 
10 5#33 TCCATTCTGCCGAGC GTCTACGCAGAGCCT AGCTGAAGTCCTGCA GCAGCTTGGGGCTTC CCGTGAGCTCCAGGC TGTTCTCAGCTACAT 810 
9 RetSat+Chromos TCCATTCTGCCGAGC GTCTACGCAGAGCCT AGCTGAAGTCCTGCA GCAGCTTGGGGCTTC CCGTGAGCTCCAGGC TGTTCTCAGCTACAT 808 
811 825 826 840 841 855 856 870 871 885 886 900 
1 5#16 CTTCCCCACTTACGG AGTAACTCCCAGCCA CACCGCCTTTTCCTT GCATGCTCTGCTGGT TGACCACTACATACA AGGGGCATATTACCC 808 
2 5#31 CTTCCCCACTTACGG AGTAACTCCCAGCCA CACCGCCTTTTCCTT GCATGCTCTGCTGGT TGACCACTACATACA AGGGGCATATTACCC 898 
3 5#12 CTTCCCCACTTACGG AGTAACTCCCAGCCA CACCGCCTTTTCCTT GCATGCTCTGCTGGT TGACCACTACATACA AGGGGCATATTACCC 898 
4 5#11 CTTCCCCACTTACGG AGTAACTCCCAGCCA CACCGCCTTTTCCTT GCATGCTCTGCTGGT TGACCACTACATACA AGGGGCATATTACCC 898 
5 5#20 CTTCCCCACTTACGG AGTAACTCCCAGCCA CACCGCCTTTTCCTT GCATGCTCTGCTGGT TGACCACTACATACA AGGGGCATATTACCC 896 
6 5#32 CTTCCCCACTTACGG AGTAACTCCCAGCCA CACCGCCTTTTCCTT GCATGCTCTGCTGGT TGACCACTACATACA AGGGGCATATTACCC 897 
7 5#7 CTTCCCCACTTACGG AGTAACTCCCAGCCA CACCGCCTTTTCCTT GCATGCTCTGCTGGT TGACCACTACATACA AGGGGCATATTACCC 898 
8 5#33 CTTCCCCACTTACGG AGTAACTCCCAGCCA CACCGCCTTTTCCTT GCATGCTCTGCTGGT TGACCACTACATACA AGGGGCATATTACCC 898 
10 5#33 CTTCCCCACTTACGG AGTAACTCCCAGCCA CACCGCCTTTTCCTT GCATGCTCTGCTGGT TGACCACTACATACA AGGGGCATATTACCC 900 
9 RetSat+Chromos CTTCCCCACTTACGG AGTAACTCCCAGCCA CACCGCCTTTTCCTT GCATGCTCTGCTGGT TGACCACTACATACA AGGGGCATATTACCC 898 
901 915 916 930 931 945 946 960 961 975 976 990 
1 5ttl6 TCGAGGGGGTTCCAG TGAGATCGCCTTCCA TACCATCCCTTTGAT TCAGCGGGCCGGGGG CGCTGTCCTCACCAG GGCCACTGTACAGAG 898 
2 5#31 TCGAGGGTGTTCCAG TGAGATCGCCTTCCA TACCATCCCTTTGAT TCAGCGGGCCGGGGG CGCTGTCCTCACCAG GGCCACTGTACAGAG 988 
3 5#12 TCGAGGGGGTTCCAG TGAGATCGCCTTCCA TACCATCCCTTTGAT TCAGCGGGCCGGGGG CGCTGTCCTCACCAG GGCCACTGTACAGAG 988 
4 5#11 TCGAGGGGGTTCCAG TGAGATCGCCTTCCA TACCATCCCTTTGAT TCAGCGGGCCGGGGG CGCTGTCCTCACCAG GGCCACTGTACAGAG 988 
5 5#20 TCGAGGGGGTTCCAG TGAGATCGCCTTCCA TACCATCCCTTTGAT TCAGCGGGCCGGGGG CGCTGTCCTCACCAG GGCCACTGTACAGAG 986 
6 5#32 TCGAGGGGGTTCCAG TGAGATCGCCTTCCA TACCATCCCTTTGAT TCAGCGGGCCGGGGG CGCTGTCCTCACCAG GGCCACTGTACAGAG 987 
7 5#7 TCGAGGGGGTTCCAG TGAGATCGCCTTCCA TACCATCCCTTTGAT TCAGCGGGCCGGGGG CGCTGTCCTCACCAG GGCCACTGTACAGAG 988 
8 5#33 TCGAGGGGGTTCCAG TGAGATCGCCTTCCA TACCATCCCTTTGAT TCAGCGGGCCGGGGG CGCTGTCCTCACCAG GGCCACTGTACAGAG 988 
10 5tt33 TCGAGGGGGTTCCAG TGAGATCGCCTTCCA TACCATCCCTTTGAT TCAGCGGGCCGGGGG CGCTGTCCTCACCAG GGCCACTGTACAGAG 990 
9 RetSat+Chromos TCGAGGGGGTTCCAG TGAGATCGCCTTCCA TACCATCCCTTTGAT TCAGCGGGCCGGGGG CGCTGTCCTCACCAG GGCCACTGTACAGAG 988 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
1 5#16 TGTGCTGCTGGACTC AGCTGGGAGAGCGTG TGGTGTCAGTGTGAA GAAGGGACAAGAGCT GGTGAACATCTACTG CCCAGTTGTCATCTC 988 
2 5#31 TGTGCTGCTGGACTC AGCTGGGAGAGCATG TGGTGTCAGTGTGAA GAAGGGACAAGAGCT GGTGAACATCTACTG CCCAGTTGTCATCTC 1078 
3 5#12 TGTGCTGCTGGACTC AGCTGGGAGAGCGTG TGGTGTCAGTGTGAA GAAGGGACAAGAGCT GGTGAACATCTACTG CCCAGTTGTCATCTC 1078 
4 5#11 TGTGCTGCTGGACTC AGCTGGGAGAGCGTG TGGTGTCAGTGTGAA GAAGGGACAAGAGCT GGTGAACATCTACTG CCCAGTTGTCATCTC 1078 
5 5#20 TGTGCTGCTGGACTC AGCTGGGAGAGCGTG TGGTGTCAGTGTGAA GAAGGGACAAGAGCT GGTGAACATCTACTG CCCAGTTGTCATCTC 1076 
6 5#32 TGTGCTGCTGGACTC AGCTGGGAGAGCGTG TGGTGTCAGTGTGAA GAAGGGACAAGAGCT GGTGAACATCTACTG CCCAGTTGTCATCTC 1077 
7 5#7 TGTGCTGCTGGACTC AGCTGGGAGAGCGTG TGGTGTCAGTGTGAA GAAGGGACAAGAGCT GGTGAACATCTACTG CCCAGTTGTCATCTC 1078 
8 5#33 TGTGCTGCTGGACTC AGCTGGGAGAGCGTG TGGTGTCAGTGTGAA GAAGGGACAAGAGCT GGTGAACATCTACTG CCCAGTTGTCATCTC 1078 
10 S#33 TGTGCTGCTGGACTC AGCTGGGAGAGCGTG TGGTGTCAGTGTGAA GAAGGGACAAGAGCT GGTGAACATCTACTG CCCAGTTGTCATCTC 1080 
9 RetSat+Chromos TGTGCTGCTGGACTC AGCTGGGAGAGCGTG TGGTGTCAGTGTGAA GAAGGGACAAGAGCT GGTGAACATCTACTG CCCAGTTGTCATCTC 1078 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
1 5ttl6 CAATGCGGGAATGTT CAATACCTATCAGCA CTTGTTGCCAGAGAC TGTCCGCCATCTGCC AGATGTGAAGAAGCA GCTGGCGATGGTAAG 1078 
2 5#31 CAATGCGGGAATGTT CAATACCTATCAGCA CTTGTTGCCAGAGAC TGTCCGCCATCTGCC AGATGTGAAGAAGCA GCTGGCGATGGTAAG 1168 
3 5#12 CAATGCGGGAATGTT CAATACCTATCAGCA CTTGTTGCCAGAGAC TGTCCGCCATCTGCC AGATGTGAAGAAGCA GCTGGCGATGGTAAG 1168 
4 5#11 CAATGCGGGAATGTT CAATACCTATCAGCA CTTGTTGCCAGAGAC TGTCCGCCATCTGCC AGATGTGAAGAAGCA GCTGGCGATGGTAAG 1168 
5 5#20 CAATGCGGGAATGTT CAATACCTATCAGCA CTTGTTGCCAGAGAC TGTCCGCCATCTGCC AAATGTGAAGAAGCA GCTGGCGATGGTAAG 1166 
6 5#32 CAATGCGGGAATGTT CAATACCTATCAGCA CTTGTTGCCAGAGAC CGTCCGCCATCTGCC AGATGTGAAGAAGCA GCTGGCGATGGTAAG 1167 
7 CAATGCGGGAATGTT CAATACCTATCAGCA CTTGTTGCCAGAGAC TGTCCGCCATCTGCC AGATGTGAAGAAGCA GCTGGCGATGGTAAG 1168 
8 5#33 CAATGCGGGAATGTT CAATACCTATCAGCA CTTGTTGCCAGAGAC TGTCCGCCATCTGCC AGATGTGAAGAAGCA GCTGGCGATGGTAAG 1168 
10 5#33 CAATGCGGGAATGTT CAATACCTATCAGCA CTTGTTGCCAGAGAC TGTCCGCCATCTGCC AGATGTGAAGAAGCA GCTGGCGATGGTAAG 1170 
9 RetSat+Chromos CAATGCGGGAATGTT CAATACCTATCAGCA CTTGTTGCCAGAGAC TGTCCGCCATCTGCC AGATGTGAAGAAGCA GCTGGCGATGGTAAG 1168 
� 1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
1 5#16 GCCTGGTCTGAGCAT GCTCTCAATCTTCAT CTGTCTGAAAGGCAC CAAGGAGGACCTGAA GCTTCAGTCCACCAA CTACTATGTTTATTT 1168 
2 5#31 GCCTGGTCTGAGCAT GCTCTCAATCTTCAT CTGTCTGAAAGGCAC CAAGGAGGACCTGAA GCTTCAGTCCACCAA CTACTATGTTTATTT 1258 
3 5#12 GCCTGGTCTGAGCAT GCTCTCAATCTTCAT CTGTCTGAAAGGCAC CAAGGAGGACCTGAA GCTTCAGTCCACCAA CTACTATGTTTATTT 1258 
4 5#11 GCCTGGTCTGAGCAT GCTCTCAATCTTCAT CTGTCTGAAAGGCAC CAAGGAGGACCTGAA GCTTCAGTCCACCAA CTACTATGTTTATTT 1258 
5 5#20 GCCTGGTCTGAGCAT GCTCTCAATCTTCAT CTGTCTGAAAGGCAC CAAGGAGGACCTGAA GCTTCAGTCCACCAA CTACTATGTTTATTT 1256 
6 5#32 GCCTGGTCTGAGCAT GCTCTCAATCTTCAT CTGTCTGAAAGGCAC CAAGGAGGACCTGAA GCTTCAGTCCACCAA CTACTATGTTTATTT 1257 
7 5#7 GCCTGGTCTGAGCAT GCTCTCAATCTTCAC CTGTCTGAAAGGCAC CAAGGAGGACCTGAA GCTTCAGTCCACCAA CTACTATGTTTATTT 1258 
8 5#33 GCCTGGTCTGAGCAT GCTCTCAATCTTCAT CTGTCTGAAAGGCAC CAAGGAGGACCTGAA GCTTCAGTCCACCAA CTACTATGTTTATTT 1258 
10 5#33 GCCTGGTCTGAGCAT GCTCTCAATCTTCAT CTGTCTGAAAGGCAC CAAGGAGGACCTGAA GCTTCAGTCCACCAA CTACTATGTTTATTT 1260 
9 RetSat+Chromos GCCTGGTCTGAGCAT GCTCTCAATCTTCAT CTGTCTGAAAGGCAC CAAGGAGGACCTGAA GCTTCAGTCCACCAA CTACTATGTTTATTT 1258 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
1 5#16 TGACACAGACATGGA CAAAGCGATGGAGCG CTATGTCTCTATGCC CAAGGAAAAGGCTCC AGAACACATTCCCCT TCTCTTCATTGCCTT 1258 
2 5#31 TGACACAGACATGGA CAAAGCG|TGGAGCG CTATGTCTCTATGCC CAAGGAAAAGGCTCC AGAACACATTCCCCT TCTCTTCATTGCCTT 1348 
3 5#12 TGACACAGACATGGA CAAAGCGATGGAGCG CTATGTCTCTATGCC CAAGGAAAAGGCTCC AGAACACATTCCCCT TCTCTTCATTGCCTT 1348 
4 5ttll TGACACAGACATGGA CAAAGCGATGGAGCG CTATGTCTCTATGCC CAAGGAAAAGGCTCC AGAACACATTCCCCT TCTCTTCATTGCCTT 1348 
5 5#20 TGACACAGACATGGA CAAAGCGATGGAGCG CTATGTCTCTATGCC CAAGGAAAAGGCTCC AGAACACATTCCCCT TCTCTTCATTGCCTT 1346 
6 5#32 TGACACAGACGTGGA CAAAGCGATGGAGCG CTATGTCTCTATGCC CAAGGAAAAGGCTCC AGAACACATTCCCCT TCTCTTCATTGCCTT 1347 
7 5#7 TGACACAGACATGGG CAAAGCGATGGAGCG CTATGTCTCTATGCC CAAGGAAAAGGCTCC AGAACACATTCCCCT TCTCTTCATTGCCTT 1348 
8 5#33 TGACACAGACATGGA CAAAGCGATGGAGCG CTATGTCTCTATGCC CAAGGAAAAGGCTCC AGAACACATTCCCCT TCTCTTCATTGCCTT 1348 
10 5#33 TGACACAGACATGGA CAAAGCGATGGAGCG CTATGTCTCTATGCC CAAGGAAAAGGCTCC AGAACACATTCCCCT TCTCTTCATTGCCTT 1350 
9 RetSat+Chromos TGACACAGACATGGA CAAAGCGATGGAGCG CTATGTCTCTATGCC CAAGGAAAAGGCTCC AGAACACATTCCCCT TCTCTTCATTGCCTT 1348 
— 288 
1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
1 5#16 CCCATCAAGCAAGGA TCCAACCTGGGAGGA GCGATTCCCAGACCG ATCCACAATGACTGC GCTGGTACCCATGGC CTTTGAATGGTTCGA 1348 
2 5#31 CCCATCAAGCAAGGA TCCAACCTGGGAGGA GCGATTCCCAGACCG ATCCACAATGACTGC GCTGGTACCCATGGC CTTTGAATGGTTCGA 1438 
3 5#12 CCCATCAAGCAAGGA TCCAACCTGGGAGGA GCGATTCCCAGACCG ATCCACAATGACTGC GCTGGTACCCATGGC CTTTGAATGGTTCGA 1438 
4 5#11 CCCATCAAGCAAGGA TCCAACCTGGGAGGA GCGATTCCCAGACCG ATCCACAATGACTGC GCTGGTACCCATGGC CTTTGAATGGTTCGA 1438 
5 5#20 CCCATCAAGCAAGGA TCCAACCTGGGAGGA GCGATTCCCAGACCG ATCCACAATGACTGC GCTGGTACCCATGGC CTTTGAATGGTTCGA 1436 
6 5#32 CCCATCAAGCAAGGA TCCAACCTGGGAGGA GCGATTCCCAGACCG ATCCACAATGACTGC GCTGGTACCCATGGC CTTTGAATGGTTCGA 1437 
7 5#7 CCCATCAAGCAAGGA TCCAACCTGGGAGGA GCGATTCCCAGACCG ATCCACAATGACTGC GCTGGTACCCATGGC CTTTGAATGGTTCGA 1438 
8 5#33 CCCATCAAGCAAGGA TCCAACCTGGGAGGA GCGATTCCCAGACCG ATCCACAATGACTGC GCTGGTACCCATGGC CTTTGAATGGTTCGA 1438 
10 5#33 CCCATCAAGCAAGGA TCCAACCTGGGAGGA GCGATTCCCAGACCG ATCCACAATGACTGC GCTGGTACCCATGGC CTTTGAATGGTTCGA 1440 
9 RetSat+Chromos CCCATCAAGCAAGGA TCCAACCTGGGAGGA GCGATTCCCAGACCG ATCCACAATGACTGC GCTGGTACCCATGGC CTTTGAATGGTTCGA 1438 
1441 1455 1456 1470 1471 1485 1486 1500 1501 1515 1516 1530 
1 5#16 GGAGTGGCAGGAGGA GCCAAAGGGCAAGCG TGGTGTTGACTATGA GACCCTCAAAAATGC ClfCGTGGAAGCCTC TATGTCGGTGATCAT 1438 
2 5tt31 GGAGTGGCAGGAGGA GCCAAAGGGCAAGCG TGGTGTTGACTATGA GACCCTCAAAAATGC CTTCGTGGAAGCCTC TATGTCGGTGATCAT 1528 
3 5#12 GGAGTGGCAGGAGGA GCCAAAGGGCAAGCG TGGTGTTGACTATGA GACCCTCAAAAATGC CTTCGTGGAAGCCTC TATGTCGGTGATCAT 1528 
4 5 m GGAGTGGCAGGAGGA GCCAAAGGGCAAGCG TGGTGTTGACTATGA GACCCTCAAAAATGC CTTCGTGGAAGCCTC TATGTCGGTGATCAT 1528 
5 5#20 GGAGTGGCAGGAGGA GCCAAAGGGCAAGCG TGGTGTTGACTATGA GACCCTCAAAAATGC CTTCGTGGAAGCCTC TATGTCGGTGATCAT 1526 
6 5#32 GGAGTGGCAGGAGGA GCCAAAGGGCAAGCG TGGTGTTGACTATGA GACCCTCAAAAATGC CTTCGTGGAAGCCTC TATGTCGGTGATCAT 1527 
7 5#7 GGAGTGGCAGGAGGA GCCAAAGGGCAAGCG TGGTGTTGACTATGA GACCCTCAAAAATGC CTTCGTGGAAGCCTC TATGTCGGTGATCAT 1528 
8 5tt33 GGAGTGGCAGGAGGA GCCAAAGGGCAAGCG TGGTGTTGACTATGA GACCCTCAAAAATGC CTTCGTGGAAGCCTC TATGTCGGTGATCAT 1528 
10 5tt33 GGAGTGGCAGGAGGA GCCAAAGGGCAAGCG TGGTGTTGACTATGA GACCCTCAAAAATGC CTTCGTGGAAGCCTC TATGTCGGTGATCAT 1530 
9 RetSat+Chromos GGAGTGGCAGGAGGA GCCAAAGGGCAAGCG TGGTGTTGACTATGA GACCCTCAAAAATGC CTTCGTGGAAGCCTC TATGTCGGTGATCAT 1528 
1531 1545 1546 1560 1561 1575 1576 1590 1591 1605 1606 1620 
1 5#16 GAAACTGTTCCCACA GCTGGAGGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CAACCAGTACTATCT GGCTGCACCCCGAGG 1528 
2 5#31 GAAACTGTTCCCACA GCTGGAGGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CAACCAGTACTATCT GGCTGCACCCCGAGG 16IB 
3 5#12 GAAACTGTTCCCACA GCTGGAGGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CAACCAGTACTATCT GGCTGCACCCCGAGG 1618 
4 5#11 GAAACTGTTCCCACA GCTGGAGGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CAACCAGTACTATCT GGCTGCACCCCGAGG 1618 
5 5#20 GAAACTGTTCCCACA GCTGGAGGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CAACCAGTACTATCT GGCTGCACCCCGAGG 1616 
6 5#32 G|AACTGTTCCCAC| GCTGGAGGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CAACCAGTACTATCT GGCTGCACCCCGAGG 1617 
7 5#7 GAAACTGTTCCCACA GCTGGAGGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CAACCAGTACTATCT GGCTGCACCCCGAGG 1618 
8 5#33 GAAACTGTTCCCACA GCTGGAGGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CAACCAGTACTATCT GGCTGCACCCCGAGG 1618 
10 5#33 GAAACTGTTCCCACA GCTGGAGGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CAACCAGTACTATCT GGCTGCACCCCGAGG 1620 
9 RetSat+Chromos GAAACTGTTCCCACA GCTGGAGGGCAAGGT GGAGAGTGTGACTGG AGGGTCACCACTGAC CAACCAGTACTATCT GGCTGCACCCCGAGG 1618 
1621 1635 1636 1650 1651 1665 1666 1680 1681 1695 1696 1710 
1 5#16 AGCTACCTATGGAGC TGACCATGACTTGGC TCGGCTGCATCCTCA TGCAATGGCTTCCAT AAGAGCCCAAACCCC CATCCCCAACCTCTA 1618 
2 5#31 AGCTACCTATGGAGC TGACCATGACTTGGC TCGGCTGCATCCTCA TGCAATGGCTTCCAT AAGAGCCCAAACCCC CATCCCCAACCTCTA 1708 
3 5#12 AGCTACCTATGGAGC TGACCATGACTTGGC TCGGCTGCATCCTCA TGCAATGGCTTCCAT AAGAGCCCAAACCCC CATCCCCAACCTCTA 1708 
4 5#11 AGCTACCTATGGAGC TGACCATGACTTGGC TCGGCTGCATCCTCA TGCAATGGCTTCCAT AAGAGCCCAAACCCC CATCCCCAACCTCTA 1708 
5 5#20 AGCTACCTATGGAGC TGACCATGACTTGGC TCGGCTGCATCCTCA TGCAATGGCTTCCAT AAGAGCCCAAACCCC CATCCCCAACCTCTA 1706 
6 S#32 AGCTACCTATGGAGC TGACCATGACTTGGC TCGGCTGCATCCTCA TGCAATGGCTTCCAT AAGAGCCCAAACCCC CATCCCCAACCTCTA 1707 
7 5#7 AGCTACCTATGGAGC TGACCATGACTTGGC TCGGCTGCATCCTCA TGCAATGGCTTCCAT AAGAGCCCAAACCCC CATCCCCAACCTCTA 1708 
8 5ft33 AGCTACCTATGGAGC TGACCATGACTTGGC TCGGCTGCATCCTCA TGCAATGGCTTCCAT AAGAGCCCAAACCCC CATCCCCAACCTCTA 1708 
10 5#33 AGCTACCTATGGAGC TGACCATGACTTGGC TCGGCTGCATCCTCA TGCAATGGCTTCCAT AAGAGCCCAAACCCC CATCCCCAACCTCTA 1710 
9 RetSat+Chromos AGCTACCTATGGAGC TGACCATGACTTGGC TCGGCTGCATCCTCA TGCAATGGCTTCCAT AAGAGCCCAAACCCC CATCCCCAACCTCTA 1708 
1711 1725 1726 1740 1741 1755 1756 1770 1771 1785 1786 1800 
1 5#16 CCTGACAGGCCAAGA TATCTTCACCTGTGG GCTGATGGGGGCCCT GCAGGGGGCCTTGCT GTGCAGCAGTACCAT CCTGAAACGGAACTT 1708 
2 5#31 CCTGACAGGCCAAGA TATCTTCACCTGTGG GCTGATGGGGGCCCT GCAGGGGGCCTTGCT GTGCAGCAGTGCCAT CCTGAAACGGAACTT 1798 
3 5#12 CCTGACAGGCCAAGA TATCTTCACCTGTGG GCTGATGGGGGCCCT GCAGGGGGCCTTGCT GTGCAGCAGTGCCAT CCTGAAACGGAACTT 1798 
4 5#11 CCTGACAGGCCAAGA TATCTTCACCTGTGG GCTGATGGGGGCCCT GCAGGGGGCCTTGCT GTGCAGCAGTGCCAT CCTGAAACGGAACTT 1798 
5 5#20 CCTGACAGGCCAAGA TATCTTCACCTGTGG GCTGATGGGGGCCCT GCAGGGGGCCTTGCT GTGCAGCAGTGCCAT CCTGAAACGGAACTT 1796 
6 5#32 CCTGACAGGCCAAGA TATCTTCACCTGTGG GCTGATGGGGGCCCT GCAGGGGGCCTTGCT GTGCAGCAGTGCCAT CCTGAAACGGAACTT 1797 
7 5#7 CCTGACAGGCCAAGA TATCTTCACCTGTGG GCTGATGGGGGCCCT GCAGGGGGCCTTGCT GTGCAGCAGTGCCAT CCTGAAACGGAACTT 1798 
8 5#33 CCTGACAGGCCAAGA TATCTTCACCTGTGG GCTGATGGGGGCCCT GCAGGGGGCCTTGCT GTGCAGCAGTGCCAT CCTGAAACGGAACTT 1798 
10 5#33 CCTGACAGGCCAAGA TATCTTCACCTGTGG GCTGATGGGGGCCCT GCAGGGGGCCTTGCT GTGCAGCAGTGCCAT CCTGAAACGGAACTT 1800 
9 RetSat+Chromos CCTGACAGGCCAAGA TATCTTCACCTGTGG GCTGATGGGGGCCCT GCAGGGGGCCTTGCT GTGCAGCAGTGCCAT CCTGAAACGGAACTT 1798 
1801 1815 1816 1830 1831 1845 1846 1860 1861 1875 1876 1890 
1 5#16 GTACTCAGATCTGCA GGCTCTTGGCTCAAA GGTCAAGGCACAAAA GAAGAAGATGTAGTC CGTTCAGAGAAGAGC CAGAGGAAAGGCAC- 1797 
2 5#31 GTACTCAGATCTGCA GGCTCTTGGCTCAAA GGTCAAGGCACAAAA GAAGAAGATGTAGTC CGTTCAGAGAAGAG 1872 
3 5#12 GTACTCAGATCTGCA GGCTCTTGGCTCAAA GGTCA|GGCACAAAA GAAGAAGATGTAGTC CGTTCAGAGAAGAG- - - 1872 
4 5#11 GTACTCAGATCTGCA GGCTCTTGGCTCAAA GGTCA|GGCACAAAA GAAGAAGATGTAGTC CGTTCAGAGAAGAG- 1872 
5 5#20 GTACTCAGATCTGCA GGCTCTTGGCTCAAA GGTCAAGGCACAAAA GAAGAAGATGTAGTC CGTTCAGAGAAGAGC CAGAGGAAAGGCAC- 1885 
6 5#32 GTACTCAGATCTGCA GGCTCTTGGCTCAAA GGTCAAGGCACAAAA GAAGAAGATGTAGTC CGTTCAGAGAAGAGC CAGAGGAAAGGCAC- 1886 
7 5#7 GTACTCAGATCTGCA GGCTCTTGGCTCAAA GGTCAAGGCACAAAA GAAGAAGATGTAGTC CGTTCAGAGAAGAGC CAGAGGAAAGGCAC- 1887 
8 5#33 GTACTCAGATCTGCA GGCTCTTGGCTCAAA GGTCAAGGCACAAAA GAAGAAGATGTAGTC CGTTCAGAGAAGAGC CAGAGGAAAGGCAC- 1887 
10 5#33 GTACTCAGATCTGCA GGCTCTTGGCTCAAA GGTCAAGGCACAAAA GAAGAAGATGTAGTC CGTTCAGAGAAGAGC CAGAGGAAAGGCAC- 1890 
‘ 9 RetSat+Chromos GTACTCAGATCTGCA GGCTCTTGGCTCAAA GGTCAAGGCACAAAA GAAGAAGATGTAGTC CGTTCAGAGAAGAGC CAGAGGAAAGGCAC- 1887 
1891 1905 1906 1920 1921 1935 1936 1950 1951 1965 1966 1980 
1 5#16 CTCCCCAACTTCTCG TGGTGTCCTCCCTCC TAG 1830 
2 5#31 - 1872 
3 5#12 --- 1872 
4 5#11 1872 
5 5#20 CTCCCCAACTTCTCG TGGTGTCCTCCCTCC TAG 1918 
6 5#32 CTCCCCAACTTCTCG TGGTGTCCTCCCTCC TAG 1919 
7 5#7 CTCCCCAACTTCTCG TGGTGTCCTCCCTCC TAC 1919 
8 5#33 CTCCCCAACTTCTCG TGGTGTCCTCCCTCC TAC 1920 
10 5#33 CTCCCCAACTTCTCG TGGTGTCCTCCCTCC TAC 1923 




Appendix B19: Alignment result of 3，#16 
3'-GSPl 
721 735 736 750 751 765 766 780 781 795 796 810 
1 3#2 AATG CCTTCGTGGAAGCCT CTATGTCGGTGATCA TGAAGACTGTTCCCG GGAGCGTGGAGGGCA AGGTGGAGAGTGTGA 79 
2 3#2-M13F AATTCGCCCTTAATG CCTTCGTGGAAGCCT CTATGTCGGTGATCA TGAA-ACTGTTCCCA C-AGCTGGAGGGNCA AGGTGGAGAGTGTGA H08 
3 3#2-M13R AATTnnrrr:TTai1|BM»fjf|mmiMill_lllMMMp^GGTGATCA TGAA-ACTGTTCCCA C-AGCTGGAGGG-CA AGGTGGAGAGTGTtJA 141 
4 RetSat+Chromos AATG CCTTCGTGGAAGCCT CTATGTCGGTGATCA TGAA-ACTGTTCCCA C-AGCTGGAGGG-CA AGGTGGAGAGTGTGA 76 
811 825 826 840 841 855 856 870 871 885 886 900 
1 3#2 CTGGAGGGTCACCAC TGACCAACCAGTACT ATCTGGCTCGCACCC CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT 169 
2 3#2-M13F CTGGAGGGTCACCAC TGACCAACCAGTACT ATCTGGCT-GCACCC CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT 897 
3 3#2-M13R CTGGAGGGTCACCAC TGACCAACCAGTACT ATCTGG6T-GCACCC CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT 230 
4 RetSat+Chromos CTGGAGGGTCACCAC TGACCAACCAGTACT ATCTGGCT-GCACCC CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT 16:.. 
901 915 916 930 931 945 946 960 961 975 976 990 
1 3#2 CCTCATGCAATGGCT TCCATAAGAGCCCAG GCCCGNATCCCCAAC -TCTACCTGACAGGC CAAGATATCTTCACC GTGTGGGCTGATGGG 258 
2 3#2-M13F CCTCATGCAATGGCT TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC -TGTGGGCTGATGGG 986 
3 3#2-M13R CCTCATGCAATGGCT TCCATAAGAGCCCAA ACCCCCftTCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC -TGTGGGCTGATGGG 319 
4 RetSat+Chromos CCTCATGCAATGGCT TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC -TGTGGGCTGATGGG 254 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
1 3#2 GGCCCTGCAGGGGGC CTTGCTGTGCAGCAG TGCCATCCTGAAACG GAACTTGTACTCAGA TCTGCAGGCTCTTGG CTCAAAGGTCAAGGC 348 
2 3#2-M13F GGCCCTGCAGGGGGC CTTGCTGTGCAGCAG TGCCATCCTGAAACG GAACTTGTACTCAGA TCTGCAGGCTCTTGG CTCAAAGGTCAAGGC 1076 
3 3#2-M13R GGCCCTGCAGGGGGC CTTGCTGTGCAGCAG TGCCATfCTGAAACG GAACTTGTACTCAGA TCTGCAGGCTCTTGG CTCAAAGGTCAAGGC 409 
4 RetSat+Chromos GGCCCTGCAGGGGGC CTTGCTGTGCAGCAG TGCCATCCTGAAACG GAACTTGTACTCAGA TCTGCAGGCTCTTGG CTCAAAGGTCAAGGC 34•！ 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
1 3#2 ACAAAAGAAGAAGAT GTAGTCCGGTCAGAG AAGAGCCAGAGGAAA GGCACCATCCCCCAA CTTCTCGTGGTGTCC TCCCTCCTAACACGC 438 
3 3#2-M13R ACAAAAGAAGAAGAT GTAGTCCGT-CAGAG AAGAGCCAGANGAAA GGCACC--TCCCCAA CTTCTCGTGGTGTCC TCCCTCCTAC--AGC 494 
2 3#2-M13F ACAAAAGAAGAAGAT GTAGTCCGT|CAGAG AAGAGCCAGAGGAAA G G C A C C — T C C C C A A CTTCTCGTGGTGTCC T C C C T C C T A C — A G C llfl 
4 RetSat+Chromos ACAAAAGAAGAAGAT GTAGTCCGTTCAGAG AAGAGCCAGAGGAAA GGCACC--TCCCCAA CTTCTCGTGGTGTCC TCCCTCCTAC--AGC 430 
1171 1185 1186 1200 1201 1215 1216 1230 1231 • 1245 1246 1260 
1 3#2 AAATCCTTGCACATA TAAACAAAAACCATT TTGTTTCTGAAA 480 
2 3#2-M13F AATTCCTTGCACATA TAAACAAAAACCATT TTGTTTNTGAAAAAA AAAAAAAAAAAAAA- CACTGTCA TGCCGTTACGTAGCG 1243 
3 3#2-M13R A-TTCCTTGCACATA TAAACAAAA-CCATT TTGTTTCTGAMSSJ^ M P M P M l ^ M P i CCTGTCA TGCCGTTACNTANCG 571 
4 RetSat+Chromos AATTCCTTGCACATA TAAACAAAAACCATT TTGTTTCTGATTAGT GTTGTTAAGTCAAGA GTTCTTTACCTTGCA TTCTACTTAAGGCCT 520 
Poly(A) tail 
. 290 ‘ 
Appendix B19: Alignment result of 3，#16 
3'-GSPl 
721 735 736 750 751 765 766 780 781 795 796 810 
1 3#3 A A T G C C T T G T T G G A A C C N T C T A T T G C T C G G T G A T C G A T 3h 
2 3#3-M13R A A T A C G A C T C N C T A T A G G G C G A A T T G A A T T TAGCGGNCGCGAANT C G C C C T T A A T G C C T T C G T G G A A G C C T C T A T G - - T C G G T G A T C A T - 807 
3 3#3-M13F TGNATT T A G C G G C C G C G A A T T C G C C C T T t p — P — g ^ O G G T C A T C A T - 63 
4 RetSat+Chromos A A T G C C T T C G T G G A A G C C T C T A T " G--TCGGTGATCAT- 35 
811 825 826 840 841 855 856 870 871 885 886 900 
1 3#3 G G A A A C T G T T C C C C A CAGCTGGAGGCAACG GTGGAGACGTGTGAC TGGAGGGGTCACCAC T G A C C G A T A C C A G T A C T A T C T G G C T G C A C C l^b 
2 3#3-M13R - G A A A C T G T T C C C - A CAGCTGGAGGGCAAG G T G G A G A - G T G T G A C T G G A G G G - T C A C C A C T G A C C A A - - C C A G T A C T A T C T G G C T G C A C C «91 
3 3#3-M13F - G A A A C T G T T C C C - A CAGCTGGAGGGCAAG G T G G A G A - G T G T G A C T G G A G G G - T C A C C A C T G A C C A A — C C A G T A C T A T C T G G C T G C A C C 147 
4 RetSat+Chromos - G A A A C T G T T C C C - A CAGCTGGAGGGCAAG G T G G A G A - G T G T G A C T G G A G G G - T C A C C A C T G A C C A A - - C C A G T A C T A T C T G G C T G C A C C 119 
901 915 916 930 931 945 946 960 961 975 976 990 
1 3ft3 C C G A G G A G C T A C C T A T G G A G C T G A C C A T G A CTTGGCCT CTGGCTG C A T C C T C A T G C A A T G G C T T C C A T A A G T A G C C C A A A C C C C C A T C C C 
2 3#3-M13R C C G A G G A G C T A C C T A T G G A G C T G A C C A T G A C T T G G C - T C - G G C T G C A T C C T C A T G C A A T G G C T T C C A T A A G - A G C C C A A A C C C C C A T C C C 97d 
3 3#3-M13F C C G A G G A G C T A C C T A T G G A G C T G A C C A T G A C T T G G O T C - G G C T G C A T C C T C A T G C A A T G G C T T C C A T A A G - A G C C C A A A C C C C C A T C C C 234 
4 RetSat+Chromos C C G A G G A G C T A C C T A T G G A G C T G A C C A T G A C T T G G C - T C - G G C T G C A T C C T C A T G C A A T G G C T T C C A T A A G - A G C C C A A A C C C C C A T C C C 206 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
1 3#3 C A A C C T C T A C C T G A C A G G C C A A G A T A T C T T C A C C T G T G G G C T G A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A 308 
2 3#3-M13R C A A C C T C T A C C T G A C A G G C C A A G A T A T C T T C A C C T G T G G G C T G A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A 1068 
3 3#3-M13F C A A C C T C T A C C T G A C A G G C C A A G A T A T C T T C A C C T G f G G G C T G A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A 324 
4 RetSat+Chromos C A A C C T C T A C C T G A C A G G C C A A G A T A T C T T C A C C T G T G G G C T G A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A 2 96 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
1 3#3 A C G G A A C T T G T A C T C A G A T T C T G C A G G C T T C C C G T C - C M A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A 397 
2 3#3-M13R A C G G A A C T T G T A C T C A G A T - C T G C A G G C T - C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A 1156 
3 3#3-M13F" A C G G A A C T T G T A C T C A G A T - C T G C A G G C T - C T T G G C f C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A 412 
‘‘RetSat+Chromos A C G G A A C T T G T A C T C A G A T - C T G C A G G C T - C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A 3&4 
1171 1185 1186 1200 1201 1215 1216 1230 1231 ” 1245 1246 1260 
1 3#3 G G A A A G G C A C C T C C C CAACTTCTCGTGGTG T C C T C C C T C - T A C A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C T G A A A - - -584 
2 3#3-M13R G G A A A G G C A C C T C C C CAACTTCTCGTGGTG TCCTCCCT CCTACAG C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T N T G A A A A A 1246 
3 3#3-M13F G G A A A G G C A C C T C C C C A A C T T C T C G T G G T G T C C T C C S T C C T A C A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T TTTGTTTCTGAftAAft 502 
RetSat+Chromos G G A A A G G C A C C T C C C C A A C T T C T C G T G G T G TCCTCCCT CCTACAG C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C T G A T T A G 474 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
1 3#3 484 
2 3#3-M13R A A A A A A A A A A A A A A C A C T G T C A T G C C G T T A C G T A G C G T A T C G T T G A C A G C A A G G G C G A A T T C G T T T A A A C C T G C A G G - - A C T - - A G T C C C 133： 
3 3#3-M13F A C T G T C A T G C C G T T A C G T A G C G T A T C G T T G A C A G C A A G G G C G A A T T C G T T T A A A C C T G C A G G - - A C T - - A G T C C C 5明 
‘‘RetSat+Chromos TGTTGTTA AGT CAAGAG T T C - - T T T A C C T T G C A T T C T A C T T A A G G C C - 519 
L 
t 
. 291 ‘ 
Appendix B12: Alignment result of 3’#4 
3'-GSPl 
721 735 736 750 751 765 766 780 781 795 796 810 
1 3#4 AATGCCTTCGTG GAAGCCTCTATGTCC 
2 3#4-M13FMAR06 CCAAGCTCAGAATTA ACCCTCACTAAAGGG ACTAGTCCTGCAGGT TTAAACGAATTCGCC CTTAATGCCTTCGTG GAAGCCTCTATGTC- 809 
3 3#4-M13RMAR06 TN NCCCTCACTAAAGGG ACTAGTCCTGCAGGT TTAAACGAATTCGCC C T T | H M H M H H M I M I ^ -
4 RetSat+Chromos AATGCCTTCGTG GAAGCCTCTATGTC-
811 825 826 840 841 855 856 870 871 885 886 900 
1 3林4 GGTGATCATGAAACT GTTCCCGGGAGGGTG GAGGGCAAGGTGGAG AGTGTGACTGGAGGG TCACCACTGACCAAC CAGTACTATCGTGGC 1丄―了 
2 3tt4-M13FMAR06 GGTGATCATGAAACT GTTCCCACA--GCTG GAGGGCAAGGTGGAG AGTGTGACTGGAGGG TCACCACTGACCAAC CAGTACTATC-TGGC H96 
3 3ft4-M13RMAR06 GGTGATCATGAAACT GTTCCCACA—GCTG GAGGGC&AGGTGGAG AGTGTGACTGGAGGG TCACCACTGACCAAC CAGTACTATC-TGGC 163 
4 RetSat+Chromos GGTGATCATGAAACT GTTCCCACA--GCTG GAGGGCAAGGTGGAG AGTGTGACTGGAGGG TCACCACTGACCAAC CAGTACTATC-TGGC 113 
901 915 916 930 931 945 946 960 961 975 976 990 
1 TGCACCCCGAGGAGC TACCAGTATGGAGCT GACCATGACTTGGCT CGGCTGCATCCTCAT GCAATGGCTTCCAAT AAGAGCCCGANGACC 207 
2 3#4-M13FMAR06 TGCACCCCGAGGAGC TACC—TATGGAGCT GACCATGACTTGGCT CGGCTGCATCCTCAT GCAATGGCTTCCA-T AAGAGCCCAAACCCC 983 
3 3ttlM13RMAR06 TGCACCCCGAGGAGC TACC—TATGGAGCT GACCATGACTTGGCT CGGCTGCATCCTCAT GCAATGGCTTCCA-T AAGAGCCCAAACCCC 250 
4 RetSat+Chromos TGCACCCCGAGGAGC TACC--TATGGAGCT GACCATGACTTGGCT CGGCTGCATCCTCAT GCAATGGCTTCCA-T AAGAGCCCAAACCCC 200 
991 1005 1006 1020 1021 1035 1036 1050 1061 1065 1066 lOBO 
1 3#4 CGCAATCCCCAAACC TCTACCTGACAGGCC AAGATATCTTCACCG TGTGGGCTGATGGGG GCCCTGCAGGGGGCC TTGCTGTGCAGCGAG 297 
2 3#4-M13FMAR06 CAT CCCCAACC TCTACCTGACAGGCC AAGATATCTTCACC- TGTGGGCTGATGGGG GCCCTGCAGGGGGCC TTGCTGTGCAGC-AG 1067 
3 3#4-M13RMAR06 CAT CCCCAACC TCTACCTGACAGGCC AAGATAfCTTCACC- TGTGGGCTGATGGGG GCCCTGCAGGGGGCC TTGCTGTGCAGC-AG 334 
^ RetSat+Chromos CAT CCCCAACC TCTACCTGACAGGCC AAGATATCTTCACC- TGTGGGCTGATGGGG GCCCTGCAGGGGGCC TTGCTGTGCAGC-AG 2 M 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
1 TGCCATCCTGAAACG GAACTTGTACTCAGA TCTGCAGGCTCTTGG CTCAAAGGTCAAGGC ACAAAAGAAGAAGAT GTAGGTCCGTTCAGA 387 
2 3#4-M13FMAR06 TGCCATCCTGAAACG GAACTTGTACTCAGA TCTGCAGGCTCTTGG CTCAAAGGTCAAGGC ACAAAAGAAGAAGAT GTAG-TCCGTTCAGA 1156 
3 3#4-M13RMAR06 TGCCATCCTGAAACG GAACTTGTACTCAGA TCTGCAGGCTCTTGG CTCAAAGGTCAAGGC ACAAAAGAAGAAGAT GTAG-TCCGTTCAGA 3^23 
^ RetSat+Chromos TGCCATCCTGAAACG GAACTTGTACTCAGA TCTGCAGGCTCTTGG CTCAAAGGTCAAGGC ACAAAAGAAGAAGAT GTAG-TCCGTTCAGA 373 
1171 1185 1186 1200 1201 1215 1216 1230 1231 . 1245 1246 1260 
1 GAAGAGCCAGAGGAA AGGCACCTCCCCCAA CTTCTCGTGGTGTCC TCCCTCCTACAGCAA TTCCTTGCACCATTA TTAAACAAAAAAACC 
2 3#4-M13FMAR06 GAAGAGCCAGAGGAA AGGCACCTCCCC-AA CTTCTCGTGGTGTCC TCCCTCCTACAGCAA TTCCTTGCACATATA AACAAAAAC 1239 
3 3tt4-M13RMAR06 GAAGAGCCAGAGGAA AGGCACCTCCCC-AA CTTCTCGTGGTGTCC TCCCTCCTACAGCAA TTCCTTGCACATATA AACAAAAAC 506 
^ RetSat+Chromos GAAGAGCCAGAGGAA AGGCACCTCCCC-AA CTTCTCGTGGTGTCC TCCCTCCTACAGCAA TTCCTTGCACATATA AACAAAAAC 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
1 ATTGTTGTTTCTGAC 
2 3in-M13FMAR06 CATTTTGTTTCTGAA AAAAAAAAAAAAAAA AACACCGTCATGCCG TTACGTA GCGTATCGTTGACA GCAAGGGCGAATTCG 1320 
3 3#4-M13RMAR06 CATTTTGTTTCTGAA ftC-ACCGTCATGCCG TTACGTA -GCGTATCGTTGACA GCAAGGGCGAATTCG 586 





Appendix B13: Alignment result of 3，#5 
3'-GSPl 
811 825 826 840 841 855 856 870 871 885 886 900 
1 3#5 A A T G C C T T C G T G G A A GCCTCTATGTCGGTG A T C A T G A A G A C T G T T CCCGGGAGGGTGGAG G G C A A G G T G G A G A G T G T G A C T G G A G G G T C A 90 
2 3#5-M13FMAR06 A A T G C C T T C G T G G A A GCCTCTATGTCGGTG A T C A T G A A - A C T G T T CCCA--CAGCTGGAG G G C A A G G T G G A G A G T G T G A C T G G A G G G T C A 897 
3 3#5-M13RMAR06 f ^ ^ ^ ^ ^ M I W H M H M i C G G T G ATCATGftA-ACTGTT C C C A — C A G C T G G A G G G C A A G G T G G A G A G T G T G A C T G G A G G G T C A 114 
4 RetSat+Chromos A A T G C C T T C G T G G A A GCCTCTATGTCGGTG A T C A T G A A - A C T G T T CCCA--CAGCTGGAG G G C A A G G T G G A G A G T G T G A C T G G A G G G T C A h"： 
901 915 916 930 931 945 946 960 961 975 976 990 
1 3#5 CCACTGACCAACCAG TACTATCGTGGCTGC A C C C C G A G G A G C T A C C T A T G G A G C T G A C C A T G A C T T G G C T C G G C T G C A T C C T C A T G C A A T 180 
2 3#5-M13FMAR06 CCACTGACCAACCAG TACTATC-TGGCTGC A C C C C G A G G A G C T A C C T A T G G A G C T G A C C A T G A C T T G G C T C G G C T G C A T C C T C A T G C A A T 986 
3 3#5-M13RMAR06 C C A C T G A C C A A C C A G TACTATC-TGGCTGC A C C C C G I G G A G C T A C C T A T G G A G C T G A C C A T G A C T T G G C T C G G C T G C A T C C T C A T G C A A T 20? 
4 RetSat+Chromos C C A C T G A C C A A C C A G TACTATC-TGGCTGC A C C C C G A G G A G C T A C C T A T G G A G C T G A C C A T G A C T T G G C T C G G C T G C A T C C T C A T G C A A T m 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
1 3#5 G G C T T C C A T A A G A G C CCAGACCCGMATCCC CAAC-TCTACCTGAC A G G C C A A G A T A T C T T C A C C T G T G G G C T G A T G G G G G C C C T G C A G G G 269 
2 3#5-M13FMAR06 G G C T T C C A T A A G A G C CCAAACCCCCATCCC C A A C C T C T A C C T G A C A G G C C A A G A T A T C T T C A C C T G T G G G C T G A T G G G G G C C C T G C A G G G 1076 
3 3#5-M13RMAR06 G G C T T C C A T A A G A G C CCAAACCCCCATCCC C A A C C T S T A C C T G A C A G G C C A A G A T A T C T T C A C C T G T G G G C T G A T G G G G G C C C T G C A G G G 293 
4 RetSat+Chromos G G C T T C C A T A A G A G C CCAAACCCCCATCCC C A A C C T C T A C C T G A C A G G C C A A G A T A T C T T C A C C T G T G G G C T G A T G G G G G C C C T G C A G G G 266 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
1 3#5 G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A C T C A G A T C T G C A G G C T C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A 359 
2 3#5-M13FMAR06 G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A C T C A G A T C T G C A G G C T C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A 1166 
3 3#5-M13RMAR06 G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A C T C A G A T C T G C A G G C T C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A 383 
RetSat+Chromos G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A C T C A G A T C T G C A G G C T C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A 356 
1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
1 3#5 G A T G T A G T C C G T T C A GAGAAGAGCCAGAGG A A A G G C A C C T C C C C A A C T T C T C G T G G T G T C C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T 44 9 
2 3#5-M13FMAR06 G A T G T A G T C C G T T C A GAGAAGAGCCAGAGG A A A G G C A C C T C C C C A A C T T C T C G T G G T G T C C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T 1256 
3 3#5-M13RMAR06 G A T G T A G T C C G T T C A GAGAAGAGCCAGAGG A A A G G C A C C T C C C C A A C T T C T C G T G G T G T C C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T 473 
4 RetSat+Chromos G A T G T A G T C C G T T C A GAGAAGAGCCAGAGG A A A G G C A C C T C C C C A A C T T C T C G T G G T G T C C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T 446 
1261 1275 1276 1290 1291 1305 1306 1320 1 3 2 1 . 1335 1336 1350 
1 3#5 A A A C A A A A A C C A T T T T G T T T C T G A A A A 476 
2 3#5-M13FMAR06 A A A C A A A A A C C A T T T T G T T T C T G A A A A A A A A A A A A A A A A C A C T G T C A T G C C G T - T A C G T A - - G C G T A T C G T - G A C A G C A A G G 1334 
3 3#5-M13RMAR06 A A A C A A A A A C C A T T T T G T T T C T G A ^ ^ ^ P I s ^ P ^ A A C A C T G T C A T G C C G T - T A C G T A — G C G T A T C G T T G A C A G C A A G G 552 
4 RetSat+Chromos A A A C A A A A A C C A T T T TGTTTCTGATTAGTG TTGTTAAGTCAAGAG T T C T T T A C C T T G C A T T C T A C T T A A G G C C T A G T G T G A A C T A C A T A G 536 
L 
- 293 
Appendix B19: Alignment result of 3，#16 
3'-GSPl 
1 15 16 30 31 45 46 60 61 75 76 40 
1 3#6 A A T G C C T T C G T G G A A G C C T C T A T G T C G G T G A T C C A T G A A A CTGTTCCCGGGAGGC S；; 
2 3#6-M13RMAR06 GGACTAGTCCTGCAG G T T T A A A C G A A T T C G。r r T T 1 ^ | p g M t M M i | f f f f f l f P , f P H P p C G G T G A T C - A T G A A A C T G T T C C C A C A G C T G h9 
3 RetSat+Chromos A A T G C C T T C G T G G A A G C C T C T A T G T C G G T G A T C - A T G A A A CTGTTCCCACAGCTG 5 •5 
91 105 106 120 121 135 136 150 151 165 166 180 
1 3#6 G T G G C A G G G C C A A G G TGGAGAGTGTGACTG G A G G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A G G A G C T A C C T A T A G A G 1-5 5 
2 3#6-M13RMAR06 GAGGG CAAGG TGGAGAGTGTGACTG G A G G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A G G A G C T A C C T A T A G A G 174 
3 RetSat+Chromos GAGGG CAAGG TGGAGAGTGTGACTG G A G G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A G G A G C T A C C T A T G G A G 139 
181 195 196 210 211 225 226 240 241 255 256 270 
1 3#6 C T G A C C A T G A C T T G G CTCGGCTGCATCCTC A T G C A A T G G C T T C C A TAAGAGCCCAGGCCG G A A A T C C C C A A C C T C T A C C T G A C A G G C C A A 235 
2 3#6-M13RMAR06 C T G A C C A T G A C T T G G CTCGGCTGCATCCTC A T G C A A I G G C T T C C A T A A G A G C C C A A A C C C C C A - T C C C C A A C C T C T A C C T G A C A G G C C A A 263 
3 RetSat+Chromos C T G A C C A T G A C T T G G CTCGGCTGCATCCTC A T G C A A T G G C T T C C A T A A G A G C C C A A A C C C C C A - T C C C C A A C C T C T A C C T G A C A G G C C A A 229 
271 285 286 300 301 315 316 330 331 345 346 360 
1 3#6 G A T A T C T T C A C C T G T GGGCTGATGGGGGCC C T G C A G G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A C T C A G A T C T 325 
2 3#6-M13RMAR06 G A T A T C T T C A C C T G T GGGCTGATGGGGGCC C T G C A G ® G G G - C C T T G C T G T G C A G C A G T G C CATCCTGAAACGGAA. C T T G T A C T C A G A T C T 352 
3 RetSat+Chromos G A T A T C T T C A C C T G T GGGCTGATGGGGGCC C T G C A G G G G G - C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A C T C A G A T C T 317 
361 375 376 390 391 405 406 420 421 435 436 450 
1 G C A G G C T C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G G C A C C T C C C C A A C T T C T 415 
2 3tt6-M13RMAR06 G C A G G C T C T T G G C T C A A A G G T C A A G G C A C A A A A G A A S A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G G C A C C T C C C C A A C T T C T 442 
3 RetSat+Chromos G C A G G C T C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G G C A C C T C C C C A A C T T C T 4 07 
451 465 466 480 481 495 496 510 511 .. 525 526 540 
1 3#6 C G T G G T G T C C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C TG^^Skfta 481 
2 3#6-M13RMAR06 C G T G G T G T C C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T A A A C A A A A A A A A A A A A A A A A A A A A A A A A C A C T G T C A TGCCG TT 524 
3 RetSat+Chromos C G T G G T G T C C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C T G A T T A G T G T T G T T A A G T C A A G A G T T C T T T 497 
Poly(A) tail 
. 294 ‘ 
Appendix B19: Alignment result of 3，#16 
3'-GSPl 
451 465 466 480 481 495 496 510 511 525 526 540 
7 3#8-9534MAR06 T C C N T T T A A A C N G C C CC C A N N G G N G G G A N T C C C C N T A A A N C C T N G G G N A N N C T T T N T N G G G G G A T T A A G A A A C T T T T C C 529 
8 3#8-M13RMAR06 GTGCTGGAATTCGCC CTT ipiijMMBj||ii||i|||||iif||PPBC GGTGA TCATGAAACTGTTCC 136 
10 3#8-M13FMAR06 N N N N N N G G — G N A N A - -NTTNNCC NGGG 56 
11 3#8-M13FDEC06 N N C C N N A N N N N N N N C CNNTNGNNNAANNNN NNNNNGGNNGNNNC- -NAANNCC NNGGNNN CCANN TNGNNC 177 
9 RetSat+Chromo AATGCC TTCGTGGAAGCCTC- -TATGTC G G T G A T C A T G A A A C T G T T C C 59 
5 4 1 5 5 5 5 5 6 5 7 0 5 7 1 5 8 5 5 8 6 6 0 0 6 0 1 6 1 5 6 1 6 6 3 0 
1 3#8-9534MAR06 C - C A N N T G G - G G G C A A G G N G G G G A N G G - G A NTGGAGGGTCCCC-C N G N C C N A C C A G T A - T N T T T G G G T G C A C C C N G G G N G - - C T C C N T T G 612 
8 3tt8-M13RMAR06 C A C A G C T G G A G G G C A A G G T G G A G A G T G T G A C T G G A G G Q T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A G G A G C T A C C T A T G 226 
10 3#8-M13FMAR06 GGNGGGGGG GGGGGG G N C C C C C C C N N N N T TT TNTNCCCC G G N N A N N N A 10-5 
U 3tt8-m3FDEC06 T T T G G N N A A A T T C C C NGGGGAGGGG GNGGGG G N C C N N C - - N N C N T TT TG-GCCCN G G G N - - - N C :35 
9 RetSat+Chromo C A C A G C T G G A G G G C A A G G T G G A G A G T G T G A C T G G A G G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A G G A G C T A C C T A T G 149 
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^ ^ 
1621 1635 1636 1650 1651 1665 1666 1680 1681 1695 1696 1710 
2 3#8-9382MAY06 G T A G T A T T T G C A T A C A C A T G A G A T A A C C T G G G G A A T G G G T C C C A G A A C T A A A C C A C A A A T T C A T T T G T T T C A T A T G T A T A G A C C A G G C A C 437 
^ 3#8-9382MAR06 G T A G T A T T T G C A T A C A C A T G A G A T A A C C T G G G G A A T G G G T C C C A G A A C T A A A C C A C A A A T T C A T T T G T T T C A T A T G T A T A G A C C A G G C A C 374 
^ 3#8-9382DEC05 G T A G T A T T T G C A T A C A C A T G A G A T A A C C T G G G G A A T G G G T C C C A G A A C T A A A C C A C A A A T T C A T T T G T T T C A T A T G T A T A G A C C A G G C A C 395 
® 3W8-M13RMAR06 N A A T T T T T T T T T N N C NCNAAA---AANCGG GGG NGNNCCA- A A A N C A C - C T T T T T T T T T T T - - - T A T A N C C C — — C M C 1182 
3 # 8 - M 1 3 F M A R 0 6 G T A G T A T T T G C A T A C A C A T G A G A T A A C C T G G G G A A T G G G T C C C A G A A C T A A A C C A C A A A T T C A T T T G T T T C A T A T G T A T A G A C C A G G C A C 1 0 6 9 
^ 3#8-M13FDEC06 G T A G T A T T T G C A T A C A C A T G A G A T A A C C T G G G G A A T G G G T C C C A G A A C T A A A C C A C A A A T T C A T T T G T T T C A T A T G T A T A G A C C A G G C A C 1156 
9 RetSat+Chromo G T A G T A T T T G C A T A C A C A T G A G A T A A C C T G G G G A A T G G G T C C C A G A A C T A A A C C A C A A A T T C A T T T G T T T C A T A T G T A T A G A C C A G G C A C 1204 
1711 1725 1726 1740 1741 1755 1756 1770 1771 1785 1786 1800 
^ 3#8-9382MAY06 A A C A T C T T A T G T A C A T A C T T T G A C A A A A C T G A G C A T T C T G A C C T G T C A C A T G A G T C C A T G C T A T A A T T T A A A A A G C T T G C T T T G A T T T C A 52"? 
3#8-9382MAR06 A A C A T C T T A T G T A - A T A C T T T G A - A A A A C T G A G C A T T C T G A C C T G T C A C A T G A G T C C A T G C T A T A A T T T A A A A A G C T T G C T T T G A T T T C A 462 
^ 3«8-9382DEC05 A A C A T C T T A T G T A - A T A C T T T G A - A A A A C T G A G C A T T C T G A C C T G T C A C A T G A G T C C A T G C T A T A A T T T A A A A A G C T T G C T T T G A T T T C A 483 
. 地 - M 1 3 R M A R 0 6 --CTTTTT TTTTA-AAAAAN N C C C C N N C N - - C C C N C N T N N T A A A A A N N T T T - - T T T N A A A N G G T - - C N T N N A A 1246 
3#8-M13FMAR06 A A C A T C T T A T G T A - A T A C T T T G A - A A A A C T G A G C A T T C T G A C C T G T C A C A T G A G T C C A T G C T A T A A T T T A A A A A G C T T G C T T T G A T T T C A 1157 
3#8-M13FDEC06 A A C A T C T T A T G T A - A T A C T T T G A - A A A A C T G A G C A T T C T G A C C T G T C A C A T G A G T C C A T G C T A T A A T T T A A A A A G C T T G C T T T G A T T T C A 1244 
RetSat+Chromo A A C A T C T T A T G T A - A T A C T T T G A - A A A A C T G A G C A T T C T G A C C T G T C A C A T G A G T C C A T G C T A T A A T T T A A A A A G C T T G C T T T G A T T T C A 12 92 
- 1801 1815 1816 1830 1831 1845 1846 1860 1861 1875 1876 1890 
3 S 8 - 9 3 8 2 M A Y 0 6 G A A T A G G G A T G C T T T A C C T A T A T G A G T A A A T G A G A A G G T G G A T A A A A A T T A A A T A A C C T T T C A C T 
^ 3#8-9382MAR06 G A A T A G G G A T G C T T T A C C T A T A T G A G T A A A T G A G A A G G T G G A T A A A A A T T A A A - A A C C T T T C A C T T A T G T T A A A A A A A A A A A A A A A A A A A 551 
G 3TT8-9382DEC05 G A A T A G G G A T G C T T T A C C T A T A T G A G T A A A T G A G A A G G T G G A T A A A A A T T A A A - A A C C T T T C A C T T A T G T T A A A A A A A A A A A A A A A A A A A S72 
iQ 3tt8-M13RMAR06 A A A A A G G A A A A A - A A C C N N ——CTTA A A A A A A A A A A N N N N N 1283 
3#8-M13FMAR06 G A A T A G G G A T G C T T T A C C T A T A T G A G T A A A T G A G A A G 6 T G G A T A A A A A T T A A A - A A C C T T TCACTTATGTTAAftft A A M A A M A A A A A A A 1246 
g 3#8-M13FDEC06 G A A T A G G G A T G C T T T A C C T A T A T G A G T A A A T G A G A A G G T G G A T A A A A A T T A A A - A A C C T T T C A C T T A T G T T A A A A A A A A A A A A A A A A A A A 1333 




Appendix B16: Alignment result of 3，#10 
3'GSP-l 
721 735 736 750 751 765 766 780 781 795 796 810 
1 3#10 A A T G C C T T C G T G G A A G C C T C T A T G T C G G T G A T C A T G A A A C T G T T C C C A G A G G 52 
2 3#10-M13F A A G G G A C T A G T C C T G CAGGTTTAAACGAAT TCGCCCTTAATGCCT T C G T G G A A G C C T C T A T G T C G G T G A T C A T G A A A C T G T T C C C A C A G C 810 
3 3#10-M13R A A G G G A C T A G T C C T G C A G G T T T A A A C G A A T T C G C C C T T j H | | | | H | H I H | | | H | | | | | | C G G T G A T C A T G A A A C T G T T C C C A C A G C 102 
4 RetSat+Chromos A A T G C C T T C G T G G A A G C C T C T A T G T C G G T G A T C A T G A A A C T G T T C C C A C A G C 52 
811 825 826 840 841 855 856 870 871 885 886 900 
1 3#10 TGGAGGGCAAGGTGG AGAGTGTGACTGGAG G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A G G A G C T A C C T A T G G A G C T G 14: 
2 3#10-M13F T G G A G G G C A A G G T G G AGAGTGTGACTGGAG G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A G G A G CTACCTATGGAGCTG 900 
3 3#10-M13R TGGAGGGCAAGGTGG A G A G T G T G A C T G G A G G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A G G A G C T A C C T A T G G A G C T G 1 …） 
4 RetSat+Chromos TGGAGGGCAAGGTGG AGAGTGTGACTGGAG G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A G G A G C T A C C T A T G G A G C T G 14：; 
901 915 916 930 931 945 946 960 961 975 976 990 
1 3#10 A C C A T G A C T T G G C T C GGCTGCATCCTCATG C A A T G G C T T C C A T A A G A G C C C A A G A G C C G G G A T C C C C A A C C T C T A C C T G A C A G G C C A A G A 232 
2 3#10-M13F A C C A T G A C T T G G C T C GGCTGCATCCTCATG C A A T G G C T T C C A T A A G A G C C C A A A C C C C - - C A T C C C C A A C C T C T A C C T G A C A G G C C A A G A 988 
3 3#10-M13R A C C A T G A C T T G G C T C GGCTGCATCCTCATG C A A T G G C T T C C A T A A G A G C C C A A A C C C C — C A T C C C C A A C C T C T A C C T G A C A G G C C A A G A 280 
4 RetSat+Chromos A C C A T G A C T T G G C T C GGCTGCATCCTCATG C A A T G G C T T C C A T A A G A G C C C A A A C C C C - - C A T C C C C A A C C T C T A C C T G A C A G G C C A A G A 230 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
1 3#10 TATCTTCACCTGTGG G C T G A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A C T C A G A T C T G C A 32：' 
2 3#10-M13F T A T C T T C A C C T G T G G G C T G A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A C T C A G A T N T G C A 1078 
3 3#10-M13R T A T C T T C A C C T G T G G G C T G A T G G G G G C C C T G C A G G G S G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A C T C A G A T C T G C A 370 
4 RetSat+Chromos T A T C T T C A C C T G T G G G C T G A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A C T C A G A T C T G C A 320 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 . 
1 3#10 G G C T C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G G C A C C T C C C C A A C T T C T C G T <112 
2 3#10-M13F G G C T C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G G C A C C T C C C C A A C T T C T C G T 1168 
3 3#10-M13R G G C T C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G G C A C C T C C C C A A C T T C T C G T 460 
4 RetSat+Chromos G G C T C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G G C A C C T C C C C A A C T T C T C G T 410 
1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
1 3#10 G G T G T C C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C T G A A A A A 476 
2 3#10-M13F G G T G T C C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T T T G A M M I H W i i l f f f l r j t l f f i P W i l & C A C：T G 1256 
3 3#10-M13R G G T G T C C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C T G A A N A A N A N N N N N A N A N N N N N W ^ N A A - C A C T G 549 





Appendix B17: Alignment result of3，#n 
3'-GSPl 
721 735 736 750 751 765 766 780 781 795 796 810 
1 3#11 A A T G C C T T C G T G G A A G C C T C T A T G T C G G T G A T C A T G A A A ？9 
2 3#11-M13FMAR06 T T A A C C C T C A C T A A A GGGACTAGTCCTGCA G G T T T A A A C G A A T T C G C C C T T A A T G C C T T C G T G G A A G C C T C T A T G T C G G T G A T C A T G A A A 810 
3 3#11-M13RMAR06 G G N C T A N T C C T G C A G G T T T A A A C G A A T T C G C C C T T | M M I B H M H M M M H i ^ G G T G A T C A T G A A A 74 
4 RetSat+Chromos A A T G C C T T C G T G G A A G C C T C T A T G T C G G T G A T C A T G A A A 39 
811 825 826 840 841 855 856 870 871 885 886 900 
1 3#11 C T G T T C C C A G A G C T G GAGGGCAAGGTGGAG A G T G T G A C T G G A G G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A G G A G C T 129 
2 3#11-M13FMAR06 C T G T T C C C A C A G C T G GAGGGCAAGGTGGAG A G T G T G A C T G G A G G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A G G A G C T 900 
3 3#11-M13RMAR06 C T G T T C C C A C A G C T G GAGGGCAAGGTGGAG A G T G T G A C T G G A G G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A G G A G C T 164 
4 RetSat+Chromos C T G T T C C C A C A G C T G GAGGGCAAGGTGGAG A G T G T G A C T G G A G G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A G G A G C T 129 
901 915 916 930 931 945 946 960 961 975 976 990 
1 A C C T A T G G A G C T G A C CATGACTTGGCTCGG CTGCATCCTCATGCG A T G G C T T C C A T A A G A G C C C A A G A C C C G G A T C C C C A A C C T C T A C C T 119 
2 3#11-M13FMAR06 A C C T A T G G A G C T G A C CATGACTTGGCTCGG C T G C A T C C T C A T G C G A T G G C T T C C A T A A G A G C C C A A - A C C C C C A T C C C C A A C C T C T A C C T 969 
3 3#11-M13RMAR06 A C C T A T G G A G C T G A C CATGACTTGGCTCGG C T G C A T C C T C A T G C G A T G G C T T C C A T A A G A G C C C A A - A C C C C C A T C C C C A A C C T C T A C C T 253 
4 RetSat+Chromos A C C T A T G G A G C T G A C CATGACTTGGCTCGG C T G C A T C C T C A T G C A A T G G C T T C C A T A A G A G C C C A A - A C C C C C A T C C C C A A C C T C T A C C T 218 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 lOBO 
1 3#11 G A C A G G C C A A G A T A T C T T C A C C T G T G G G C T G A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A 309 
2 3 # U - M 1 3 F M A R 0 6 G A C A G G C C A A G A T A T CTTCACCTGTGGGCT G A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A 1079 
3 3#11-M13RMAR06 G A C A G G C C A A G A T A T C T T C A C C T G T G G G C T G A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A 343 
4 RetSat+Chromos G A C A G G C C A A G A T A T CTTCACCTGTGGGCT G A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A 308 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
1 C T C A G A T C T G C A G G C TCTTGGCTCAAAGGT C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G G C A C C T C C 399 
2 3#11-M13FMAR06 C T C A G A T C T G C A G G C TCTTGGCTCAAAGGT C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G G C A C C T C C 1169 
3 3#11-M13RMAR06 C T C A G A T C T G C A G G C T C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G G C A C C T C C 433 
^ RetSat+Chromos C T C A G A T C T G C A G G C TCTTGGCTCAAAGGT C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G G C A C C T C C 398 
1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
1 3 # U C C A A C T T C T C G T G G T G C C C T C C C T C C T A C A G G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C T G A A G A A 476 
2 3#1:L-M13FMAR06 C C A A C T T C T C G T G G T G C C T C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C T G A A A A A A A A A A A A A A A A A A 1159 
3 3#11-M13RMAR06 C C A A C T T C T C G T G G T C ^ C - C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C ATTTTfiTTTr;Tf;A|||;g|||j||^^i|ffjppfft 522 
‘‘Re t S a t + C h r o m o s C C A A C T T C T C G T G G T G T C - C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C T G A T T " A G T G T T G T T P A G T C A 4 8 7 
i 
! ‘ 
. I • 298 
i . 
Appendix B18: Alignment result of 3，#12 
3，-GSPl 
451 465 466 480 481 495 496 510 511 525 526 540 
6 3 # 1 2 - 9 5 3 4 M A R 0 6 G G N C C C C C A - T N T G A G G G A T T T - T G C A N A A T T - N C C C T T A A - G C C T T N G - G G N A N C C T T T A T - T C N G G G A T C A N G A A - C N G T T C C C - C A N 5 3 2 
8 3#12-M13FMAR06 CGGCCGCCAGTGTGA TGGATATCTGCAGAA TTCGCCCTT||(!||H(^^(aB|Bl8(BliaHMiMtrGTCGGTGATCATG AAACTGTTCCCACAG 100 
9 RetSat+Chromo - AATGCC TTCGTGGAAGCCTCT ATGTCGGTGATCATG AAACTGTTCCCACAG 51 
541 555 556 570 571 585 586 600 601 615 616 630 
6 3#12-9534MAR06 CTGG-GGGCAAGNNG -AGAGTN-GACNGGA GGGTCCCC-CTGNCC AACCAGTNNTTT-TG GNTGCNCCCNG-GGN NCTACCTA-GGAGCT 615 
7 3#12-M13RMAR06 GGGG GGGGG GGG GGNNCCCC-CNNTTT TNCC 30 
8 3#12-M13FMAR06 CTGGAGGGCAAGGTG GAGAGTGTGACTGGA GGGTCACCACTGACC AACCAGTACTATCTG GCTGCACCCCGAGGA GCTACCTATGGAGCT 190 
9 RetSat+Chromo CTGGAGGGCAAGGTG GAGAGTGTGACTGGA GGGTCACCACTGACC AACCAGTACTATCTG GCTGCACCCCGAGGA GCTACCTATGGAGCT 141 
631 645 646 660 661 675 676 690 691 705 706 720 
4 3#12-9534APR05 -GACAGGCCCCAGA 13 
6 3#12-9534MAR06 GACCATGACTNGN-T NGGNTGCATCNTCAT GCAATGG-TTNCATA AGAGCCCAAACCCCC ATCCCCAACCTTTAC CTGACAGGCCA-AGA 702 
7 3#12-M13RMAR06 CGGNAAANNNAGNNA NTTTTGTNNTNCAAN TTTNAANNAACCC- - TNC CNTTTNGG GGN 87 
8 3#12-M13FMAR06 GACCATGACTTGGCT CGGCTGCATCCTCAT GCAATGGCTTCCATA AGAGCCCAAACCCCC ATCCCCAACCTCTAC CTGACAGGCCA-AGA 279 
9 RetSat+Chromo GACCATGACTTGGCT CGGCTGCATCCTCAT GCAATGGCTTCCATA AGAGCCCAAACCCCC ATCCCCAACCTCTAC CTGACAGGCCA-AGA 230 
721 735 736 750 751 765 766 780 781 795 796 810 
4 3#12-9534APR05 TATCGTCACCTGT-G GCTGATGGGGGGCCC CTTGCCAGGG-GCCT TCTTGTGCAAGCAGT GCCATCCTGAAACG- GAACTTGTACTCAGA 100 
5 3#12-1833APR05 TGTGG G-TGATGGGGG--CC C--GCAGGTGTGACT TGCTGTGCA-GCAGT GC-ATCCTGAAACGN GAACTTGTACTCAGA 73 
6 3#12-9534MAR06 TATCTTCACCTGTGG GCTGATGGGGG--CC CT-GCAGG-G-GCCN TGCTGTGCA-GCAGT GCCATCCTGAAACG- GAACTTGTACTCAGA 785 
7 3ttl2-M13RMAR06 AANTTT TNTNG G NGGGG--CC CN-G G-GCNT T TNCN-NC——-CC--CCTAAA--G- NATTTTTTNTTNNGT 14 5 
8 3#12-M13FMAR06 TATCTTCACCTGTGG GCTGATGGGGG--CC CT-GCAGGGG-GCCT TGCTGTGCA-GCAGT GCCATCCTGAAACG- GAACTTGTACTCAGA 363 
9 RetSat+Chromo TATCTTCACCTGTGG GCTGATGGGGG--CC CT-GCAGGGG-GCCT TGCTGTGCA-GCAGT GCCATCCTGAAACG- GAACTTGTACTCAGA 313 
811 825 826 840 841 855 856 870 871 885 886 900 
4 3#12-9534APR05 TCTGCAGGCTCTTG- GCTCAAAGGTCAAGG CACAAAAGAAGAAGA TGTAGTCCGTTCAGA GAAGAGCCAGAGGAA GGGCACCTCCCCAAC 189 
5 3#12-1833APR05 TCTGCAGGCTCTTGA GCTCAAAGGTCAAGG CACAAAAGAAGAAGA TGTAGTGCGTTCAGA GAAGAGCCAGAGGAA GGGCACCTCCCCAAC 163 
6 3#12-9534MAR06 TCTGCAGGCTCTTG- GCTCAAAGGTCAAGG CACAAAAGAAGAAGA TGTAGTCCGTTCAGA GAAGAGCCAGAGGAA GGGCACCTCCCCAAC 874 
7 m2-M13RMAR06 NTTN - -TTAAANNANAN- - - -CNAAAAANNAATT TTTTTTANAAAC- - CNAGNGGG CCNNCCNA-- 201 
8 3#12-M13FMAR06 TCTGCAGGCTCTTG- GCTCAAAGGTCAAGG CACAAAAGAAGAAGA TGTAGTCCGTTCAGA GAAGAGCCAGAGGAA GGGCACCTCCCCAAC 452 
9 RetSat+Chromo TCTGCAGGCTCTTG- GCTCAAAGGTCAAGG CACAAAAGAAGAAGA TGTAGTCCGTTCAGA GAAGAGCCAGAGGAA AGGCACCTCCCCAAC 402 
901 915 916 930 931 94 5 946 960 961 975 976 990 
4 3#12-9534APR05 TTCTCGTGGTGTCCT CCCTCCTA-CAGCAA TTCCTTGCACATATA GACAAAAACCATTTT GTTTCTGATTAGTGT TGTTAAGTCAAGAGT 278 
5 3#12-1833APR05 TTCTCGTGGTGTCCT CCCTCCTTGCAGCAA TTCCTTGCACATATA GACAAAAACCATTTT GTTTCTGATTAGTGT TGTTAAGTCAAGAGT 253 
6 3 # 1 2 - 9 5 3 4 M A R 0 6 T T C T C G T G G T G T C C T C C C T C C T A - C A G C A A TTCCTTGCACATATA G A C A A A A A C C A T T T T G T T T C T G A T T A G T G T T G T T A A G T C A A G A G T 9 6 3 
7 3#12-M13RMAR06 -TTTNGNGGT--CC- CCTTCC CAA ANTTNTNCN AA AAAAAAAACCTTTTT TTTAANNG GGNTAAANCAAN-GT 269 
8 3#12-M13FMAR06 TTCTCGTGGTGTCCT CCCTCCTA-CAGCAA TTCCTTGCACATATA GACAAAAACCATTTT GTTTCTGATTAGTGT TGTTAAGTCAAGAGT 541 
9 RetSat+Chromo TTCTCGTGGTGTCCT CCCTCCTA-CAGCAA TTCCTTGCACATATA AACAAAAACCATTTT GTTTCTGATTAGTGT TGTTAAGTCAAGAGT 491 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
4 3#1:2-9534APR05 TCTTTACCTTGCATT CTACTTAAG-GCCTA GTGTGAACTACATAG CCTTGATGCCTCATG AAGAATGCTCCCATG CCTTTCCTACACCCA 367 
5 3#12-1833APR05 TCTTTACCTTGCATT CTACTTGGGTGCCTA GTGTGAACTACATAG CCTTGATGCCTCATG AAGAATGCTCCCATG CCTTTCCTACACCCA 343 
7 3#12-M13RMAR06 TTTTCCCC---CCTT TN--TNAAG-GCCTG GGGN--ACAA--AAN CCTNGGN CNTN AGGAAANTTNCCAT- CCTTTT-TTCCCCCA 343 
8 3#12-M13FMAR06 TCTTTACCTTGCATT CTACTTAAG-GNCTA GTGTGAACTACATAG CCTTGATGCCTCATG AAGAATGCTCCCATG CCTTTCCTACACCCA 630 
6 3#12-9534MAR06 TCTTTACCTTGCATT CTACTTAAG-GCCTA GTGTGAACTACATAG CCTTGATGCCTCATG AAGAATGCTCCCATG CCTTTCCTACACCCA 1052 
9 RetSat+Chromo TCTTTACCTTGCATT CTACTTAAG-GCCTA GTGTGAACTACATAG CCTTGATGCCTCATG AAGAATGCTCCCATG CCTTTCCTACACCCA 580 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
^ 3#12-9534APR05 ACTCCAAGCTCTGGT CAGGCACCCAGAACC CCTGGGGTGTTGGCT ACTGGAATAGGTTGG TTCAGTCCTACCCTG AAGCTTTTTGTTCCT 457 
5 3#12-1833APR0S ACTCCAAGCTATGGT CAGGCACCCAGAACC CCTGRGGTGTTGGCT ACTGGAATAGGTTGG TTCAGTCCTACCCTG AAGCTTTTTGTTCCT 433 
1 3 # 1 2 - M 1 3 R M A R 0 6 N T T C - A A G T T T T G - T T G G G C C C C C - G A A C C C C G G G G N T N - - G G N T C C N G G A A A A G G G - G N T T C A N T C - T C C C C N G A N N - N T T T T N T T C C C 4 2 5 
® 3#12-M13FMAR06 ACTCCAAGCTATGGT CAGGCACCCAGAACC CCTGGGGTGTTGGCT ACTGGAATAGGTTGG TTCAGTCCTACCCTG AAGCTTTTTGTTCCN 720 
6 3#12-9534MAR06 ACTCCAAGCTATGGT CAGGCACCCAGAACC CCTGGGGTGTTGGCT ACTGGAATAGGTTGG TTCAGTCCTACCCTG AAGCTTTTTGTTCCT 1142 
^ RetSat+Chromo ACTCCAAGCTATGGT CAGGCACCCAGAACC CCTGGGGTGTTGGCT ACTGGAATAGGTTGG TTCAGTCCTACCCTG AAGCTTTTTGTTCCT 670 
1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
令 3#12-9534APR05 CC-TCACTCTCGTGT TGTGATGCTCTATAC ATGGAAAAGTGTGGG CTTGGAGTAGCAACT CTCTCAAACGTCCCC AGACCTAAGAAAACC 546 
^ 晰2-1833APR05 CCATCACTCTCGTGT TGTGATGCTCTATAC ATGGAAAAGTGTGGG CTTGGAGTAGCAACT CTCTCAAA-GTGCC- AGACCTAAGAAAACC 521 
7 3^12-M13RMAR06 CC-NCCCTNCCNGGT GGGGNAGNNNTNAAN ANGNAAANGGNGGGG NTTGGNGT-GCNNNT TTTNCAAA-G-GCC- ANCCNTAAGAAAACC 510 
8 3 # 1 2 - M 1 3 F M A R 0 6 C T - T C A C T C T C G N G T T G N G A T G C T C T A T A N A T G G A A A A G T G N G G G C T T G G A G T A A C A N C T C T C T C A A A - G T G N C - N N A N C T A A - A A A A C C 8 0 6 
二 3#12-9534MAR06 CC-TCACTCTCGTGT TGTGATGCTCTATAC ATGGAAAAGTGTGGG CTTGGAGTAGCAACT CTCTCAAA-GTGCC- AGACCTAAGAAAACC 1229 
RetSat+Chromo CC-TCACTCTCGTGT TGTGATGCTCTATAC ATGGAAAAGTGTGGG CTTGGAGTAGCAACT CTCTCAAA-GTGCC- AGACCTAAGAAAACC 757 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
^ 3#12-938;2MAY05 -CAAAAGATAC-AC TGCCGATGAATTCAA GCCTAGACACGGCAT 63 
\ 3#12-9382APR05 AACAC ACCAAAAGATAC-AC TGCCGATGAAC-CAA GCCTAGACACGGCAT 48 
�3#12-9382MAR06 - GGAC-C ACCAAAAGATACCAC TGCCGATGAAC-CAA GCCTAGACACGGCAT 49 
3ttl2-9534APR05 CTCAGGTCTAAGTTT TATCCTGATAGAAGT GGGTTAAAGGAACAC ACCAAAAGATACCAC TGCCGATGAAC-CAA GCTTAGACACGGCAT 635 
^ 3#12-9534MA:R06 CTCAGGTCTAAGTTT TATCCTGATAGAAGT GGGTTAAAGGAACAC ACCAAAAGATACCAC TGCCGAGANNC 1300 
3#12-M13RMAR06 NCCCGGTTTNAGTTT TTTC-TGANAGAAG- GGGNTAAAGGAACCC NCCAAAAGATNCCCC TGCNGATGAAC-NAN GC-TNGACNCGGCAT 596 
® 3#12-M13FMAR06 C-CNGGTCTAANTTT N-NCCTNANAAANG- GGGNTAAAGGAACCC -CCAAAA--TNCC-C TGCCGATNA-C-CAA NCCAAAACN-GGNTT 886 
g ^#12-1833APR05 CTCAGGTCTACGTTT TATCCTGATAGAAGT GGGTTAAAGGAACAC ACCAAAAGATACCAC TGCCGATGAAC-CAA GCCTTGACACGGCAT 610 
RetSat+Chromo CTCAGGTCTAAGTTT TATCCTGATAGAAGT GGGTTAAAGGAACAC ACCAAAAGATACCAC TGCCGATGAAC-CAA GCCTAGACACGGCAT 846 
. 299 
1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
1 3#12-9382MAY05 TCTGTAGTTGCTGGC -ACATAGTCAAACTG AGTTACGAGGCTGGG CAGTGCTGGCACCGG CCTTTAACCCCAGCA CTCAGAAGGCAGGGG 152 
2 3#12-9382APR05 T-TGTAGTTGCTGGC -ACATAGTCAAACTG AGTTACGAGGCTGGG CAGTGCTGGCACCGG CCTTTAACCCCAGCA CTCAGAAGGCAGGGG 136 
5 3#12-1833APR05 T-TGTAGTTGCTGGC CACATAGTCACACTG AGT-ACGAGGCTGGC AKGTGCTGGCACCGG CCTT--AACCCAGCA 681 
8 3ttl2-M13FMAR06 T-TNNTGGNG--GGC --CATA-TCCAANTG ANTT--NAAGNTGGG NAGGG-NGGC-CCGN C-NTTNACCC--NCN CTNAAANGG- -GGGG 961 
7 3#12-M13RMAR06 T-TGTAGTTGNTGGC -ACATAGTCAAACTG AGTTACGAGGNTGGG CAGTGCTGGCACCGG CCTTTAACCCCAGCA CTCAGAAGGCAGGGG 684 
3 3#12-9382MAR06 T-TGTAGTTGCTGGC -ACATAGTCAAACTG AGTTACGAGGCTGGG CAGTGCTGGCACCGG CCTTTAACCCCAGCA CTCAGAAGGCAGGGG 137 
9 RetSat+Chromo T-TGTAGTTGCTGGC -ACATAGTCAAACTG AGTTACGAGGCTGGG CAGTGCTGGCACCGG CCTTTAACCCCAGCA CTCAGAAGGCAGGGG 934 
1441 1455 1456 1470 1471 1485 1486 1500 1501 1515 1516 1530 
1 3ttl2-9382MAY05 CAGACAGAGCTCTGT GAATCTGAAGCCAGA ACTAGTTTATGAAGC AAGTCCAGGGGCAGC CAGAGCTCTGTTATA CAGAGAAACCCTGTC 242 
2 3#12-938;2APR05 CAGACAGAGCTCTGT GAATCTGAAGCCAGA ACTAGTTTATGAAGC AAGTCCAGGG-CAGC CAGAGCTCTGTTATA CAGAGAAACCCTGTC 225 
3 3#12-9382MAR06 CAGACAGAGCTCTGT GAATCTGAAGCCAGA ACTAGTTTATGAAGC AAGTCCAGGG-CAGC CAGAGCTCTGTTATA CAGAGAAACCCTGTC 226 
8 3#12-M13FMAR06 CAANAAAN TNT GNAA-NNNANCCAAA NTTTTTNAAAC A-GNCCGGGN-C--C CAAA TNTTT TAAAAAAANCCTGT- 1031 
7 3#12-M13RMAR06 CAGACAGAGCTCTGT GAATCTGAAGCCAGA ACTAGTTTATGAAGC AAGTCCAGGG-CAGC CAGAGCTCTGTTATA CAGAGAAACCCTGTC 773 
9 RetSat+Chromo CAGACAGAGCTCTGT GAATCTGAAGCCAGA ACTAGTTTATGAAGC AAGTCCAGGG-CAGC CAGAGCTCTGTTATA CAGAGAAACCCTGTC 1023 
1531 1545 1546 1560 1561 1575 1576 1590 1591 1605 1606 1620 
1 3#12-9382MAY05 TTGAAAAACAAAACA AA-ACAAAACAAAAC CTGAGTATTGTTTTC TAAAATGCTTGGAGT CAGAATTCTTTCAGA TTTTGTGGTATTTGC 331 
2 3#12-9382APR05 TTGAAAAACAAAACA GGGACAAAACAAAAC CTGAGTATTGTTTTC TAAAATGCTTGGAGT CAGAATTCTTTCAGA TTTTGTGGTATTTGC 315 
8 3#12-M13FMAR06 -TNNAAAAAAAAAAA AA-AAAAAACGGAAT NNTTC -AAAANG-NTGGNNN AAATTTNCNANTTG- GGGNTNNC 1099 
7 3ttl2_M13RMAR06 TTGAAAAACAAAACA AA-ACAAAACAAAAC CTGAGTATTGTTTTN TAAAATGCTTGGAGT CAGAATTCTTTCAGA TTTTGTGGTATTTGC 862 
3 3#12-9382MAR06 TTGAAAAACAAAACA AA-ACAAAACAAAAC CTGAGTATTGTTTTC TAAAATGCTTGGAGT CAGAATTCTTTCAGA TTTTGTGGTATTTGC 315 
9 RetSat+Chromo TTGAAAAACAAAACA AA-ACAAAACAAAAC CTGAGTATTGTTTTC TAAAATGCTTGGAGT CAGAATTCTTTCAGA TTTTGTAGTATTTGC 1112 
1621 1635 1636 1650 1651 1665 1666 1680 1681 1695 1696 1710 
1 3#12-9;582MAY05 ATACACATGAGATAA CCTGGGGAATGGGTC CCAGAACTAAACCAC AAATTCATTTGTTTC ATATGTATAGACCAG GCACAACATCTTATG 421 
2 3ttl2-9382APR05 ATACACATGAGATAA CCTGGGGAATGGGTC CCAGAACTAAACCAC AAATTCATTTGTTTC ATATGTATAGACCAG GCACAACATCTTATG 405 
3 3#12-9382MAR06 ATACACATGAGATAA CCTGGGGAATGGGTC CCAGAACTAAACCAC AAATTCATTTGTTTC ATATGTATAGACCAG GCACAACATCTTATG 405 
8 3#12-M13FMAR06 CANNNNAAAN CC--GGGAA-GGGCC CAANANC-- C NAATTTTTTTTTTTT TTANCN CCNN NC CNTTNN 1162 
7 3#12-m3RMAR06 ATACACATGAGATAA CCTGGGGAATGGGTC CCAGAACTAAACCAC AAATTCATTTGTTTC ATATGTATAGACCAG GCACAACATCTTATG 952 
9 RetSat+Chromo ATACACATGAGATAA CCTGGGGAATGGGTC CCAGAACTAAACCAC AAATTCATTTGTTTC ATATGTATAGACCAG GCACAACATCTTATG 1202 
1711 1725 1726 1740 1741 1755 1756 1770 1771 1785 1786 1800 
1 3#12-9382MAY05 TAATACTTTGAAAAA CTGAGCATTCT--GA CCTGTCACATGAGTC CATGCTATAATTTAA AAAGCTTGCTTTGAT TTT--AGAATAGGGA 507 
2 3#12-9382APR05 TAATACTTTGAAAAA CTGAGCATTCT--GA CCTGTCACATGAGTC CATGCTATAATTTAA AAAGCTTGCTTTGAT TTT--AGAATAGGGA 491 
3 m2-9382MAR06 TAATACTTTGAAAAA CTGAGCATTCT--GA CCTGTCACATGAGTC CATGCTATAATTTAA AAAGCTTGC-TTGAT TTT--AGAATAGGGA 490 
7 3#12-M13RMAR06 TAATACTTTGAAAAA CTGAGCATTNT-- GA CCTGTCACATGAGTC CATGCTATAATTTAA AAAGCTTGCTTTGAT TTf-- AGAATAGGGA 1038 
9 RetSat+Chromo TAATACTTTGAAAAA CTGAGCATTCT--GA CCTGTCACATGAGTC CATGCTATAATTTAA AAAGCTTGCTTTGAT TTC--AGAATAGGGA 1288 
1801 1815 1816 1830 1831 1845 1846 1860 1861 1875 1876 1890 
1 3#12-9382MAY05 TGCTTTACCTATATG AGTAAATGAGAA- - GGTGGAT 541 
2 3ttl2-9382APR05 TGCTTTACCTATATG AGTAAATGAGAA--- GGTGGATAAAA ATTAAAAACCTTTCG CTT--ATGTTAAAAC AAGTGCTAATTTTAG 572 
3 3#12-9382MAR06 TGCTTTACCTATATG AGTAAATGAGAA-- -GTGGATAAAA TTAAAA--CCNTTCC CTT--ATGTNAA--C AAGTGCTA-NTTTAG 565 
7 3#12-M13RMAR06 TGCTTTACCTATATG AGTAAATGAGAA--- GGTGGATAAAA ATTAAAAACCTTTCG CTT--ATGTTAAA-C AAGTGCTAATTTTAG 1118 
9 RetSat+Chromo TGCTTTACCTATATG AGTAAATGAGAA- GGTGGATAAAA ATTAAAAACCTTTCA CTT--ATGTTAAA-C AAGTGCTAATTTTAG 1368 
1891 1905 1906 1920 1921 1935 1936 1950 1951 1965 1966 1980 
2 3#12-9382APR05 TCTGTTTAACATATA GTATTAATACATGTA ATGTTTCAA - - 611 
3 3#12-9382MAR06 NCGGTTAAA-ATA-- GTATAAAACC--GGA ATGTTCCAAAAAAAA AAAAAAAAN CTGTC-TGCCNTT-C NTANC-TTTCNTTAA 641 
7 3#12-M13RMAR06 TCTGTTTAA-ATATA GTATTAATACATGTA ATGTTTCAAAAAAAA AAAAAAAAAAAAACA CTGTCATGCCGTTAC GTAGCGTATCGTTGA 1207 
9 RetSat+Chromo TCTGTTTAA-ATATA GTATTAATACATGTA ATGTTTCAA 1406 
. 300 
Appendix B19: Alignment result of 3，#16 
3'-GSPl 
1 3#16-M13FMAR05 G A A T G G G C C T C T A G A TGCATGCTCGAGCGG CG--CAGTGTGATGG A T A T C T G C A G A A T T C G C C C T T A A T G C C T T C GTGGAAGCCTCTATG 
5 3 # 1 6 - M 1 3 R M A _ A A T N G G C C C N T T A G A AGCATGNTCGAGCGG CCGCCANTGTGATGG A T T T - T G C A G A A T T C G C C C T T A A N - C C T T N NTGGAAGCCTCTATG ； ^  
4 3#16-M13FMAR06 - T G N G G C C C T C T A G A TGCATGCTCGAGCGG CCGCCAG TGTGATGG A T A T C T G C A G A A T T C G C C C T :輯 驟 C (StOGMGCCTCTftTG 卜9 
3 RetSat+Chromos A A T G C C T T C GTGGAAGCCTCTATG ；；•! 
721 735 736 750 751 765 766 780 781 795 796 ^10 
1 3#16-M13FMAR05 T C G G T G A T C A T G A A A CGGTTCCCACAGCTG GAGGGCAAGGTGGAG A G T G T G A C T G G A G G G T C A C C A C T G A C C A A C C A A G T T T A A C C T T N A 17H 
5 3#16-M13RMAR06 T C G G N G A T C A T G A A A CTGTTCCCACAGCTG GAGGGCAAGGTGGAG A G T G T G A C T G G A G G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T _ 
1 3 # 1 6 - M 1 3 ™ A R 0 6 | C G G T G A T C A T G A A A CTGTTCCCACAGCTG G A G G G C M G G T G G A G A G T G T G A C T G G A G G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T 179 
3 RetSat+Chromos T C G G T G A T C A T G A A A CTGTTCCCACAGCTG GAGGGCAAGGTGGAG A G T G T G A C T G G A G G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T 114 
811 825 826 840 841 855 856 870 871 885 886 900 
1 3#16-M13FMAR05 A T T C C T T G G G C T G C A CCCC 197 
4 3#16-M13FMAR06 G C A C C C C G A G G A G C T ACCTATGGAGCTGAC CATGACTTGGCTCGG C T G C A T C C T C A T G C A A T G G C T T C C A T A A G A G C C C A A A C C C C C A T C 269 
5 3#16-M13RMAR06 G C A C C C C G A G G A G C T A C C T A T G G A G C T G A C C A T G A C T T G G C T C G G C T G C A T C C T C A T G C A A T G G C T T C C A T A A G A GCCCAAACCCCCAT'^ h9H 
3 RetSat+Chromos G C A C C C C G A G G A G C T A C C T A T G G A G C T G A C CATGACTTGGCTCGG C T G C A T C C T C A T G C A A T G G C T T C C A T A A G A G C C C A A A C C C C C A T C _：04 
901 915 916 930 931 945 946 960 961 975 976 990 
4 3#16-M13FMAR06 C C C A A C C T C T A C C T G A C A G G C C A A G A T A T C TTCACCTGTGGGCTG A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G 359 
5 3#16-M13RMAR06 C C C A A C C T C T A C C T G A C A G G C C A A G A T A T C TTCACCfGTGGGCTG A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G 988 
3 RetSat+Chromos C C C A A C C T C T A C C T G A C A G G C C A A G A T A T C TTCACC TGTGGGCTG A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
2 3#16-M13RMAR05 GAACTTGTAC TCAGATCTGCAGGCT C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C C N C C A G A G A A G A G C C A G A 85 
1 3 # 1 6 - M 1 3 ™ A R 0 6 A A A C G G A A C T T G T A C TCAGATCTGCAGGCT C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A 4 49 
5 3#16-M13RMAR06 A A A C G G A A C T T G T A C T C A G A T C T G C A G G C T C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A 1078 
3 RetSat+Chromos A A A C G G A A C T T G T A C T C A G A T C T G C A G G C T C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A 394 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
2 3#16-M13RMAR05 G G A A A G G C A C C T C C C CAACTTCTCGTGGTG TCCTCC CTCCTACAG C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C T G A A A A A 175 
5 3#16-M13RMAR06 G G A A A G G C A C C T C C C CAACTTCTCGTGGTG TCCTCCCTCCTACAG C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T N T G A A A A A 1168 
4 3#16-M13FMAR06 G G A A A G G C A C C T C C C C A A C T T C T C G T G G T G T C C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C T G A A A A A 539 
3 RetSat+Chromos G G A A A G G C A C C T C C C CAACTTCTCGTGGTG TCCTCCCTCCTACAG C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C T G A T T A G 474 
1171 1186 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
2 3#16-M13RMAR05 A A A A A A A A A A A A A C A CTGTCATGCCGTTAC G T A G C G T A T C G C C G A C A A - A G G G C G G A A T T C C A G C A C A C T G G C G G C C G T T A C T A G T G G A T 264 
4 3#16-M13FMAR06 A A A A A A A A A A A A A C A C T G T C A T G C C G T T A C G T A G C G T A T C G T T G A C A G C A A G G G C G A A T T C C A G C A C A C T G G C G G C C G T T A C T A G T G G A T 629 
5 3#16-M13RMAR06 A M m P t A k A P s A M C A C T G T C A T G C C G T T A C G T A G C G T A T C G T T G A C A G C A A G G G C G A A T T C C A G C A C A C T G G C G G C C G T T A C T A G T G G A T 1258 
3 RetSat+Chromos T G T T G T T A A G T C A A G A G T T C T T T A C C T T G C AT T C T A C T T A A G G C C T A G T G T G A A C T A C A T A G C C T T G A T G C C T C A T G A A G A A T G C T 560 
. 301 ‘ 
Appendix B20: Alignment result of 3，#22 
3'-GSPl 
631 645 646 660 661 675 676 690 691 705 706 720 
2 3#22-M13FMAR05 T A - A T G C A T G C T C G A GCGGCCGCCAGTGTG ATGGATATCTTGCAG A A T T C G C C C T T G C T G TC 89 
4 3#22-Ml3RMAR06 T A G A T G C A T G C T C G A GCGGCCGCCAGTGTG A T G G A T A T N T - G C A G A A T T C G C C C T T A A T G C C T T N G N G G A A G C C T C T A T G T C G G T G A T C A 719 
5 3林22-M13FMAR06 T A G A T G C A T G C T C G A GCGGCCGCCAGTGTG A T G G A T A T C T - G C A G A A T T C G C C C T T f | | g H H H M M M H M M H | C G G T G A T C A 98 
3 RetSat+Chromos AATG C C T T C G T G G A A G C C T C T A T G T C G G T G A T C A 34 
721 736 736 750 751 765 766 780 781 795 796 810 
2 3tt22-M13FMAR05 ——AACGATACGCTA C G T A A C G G C A T G A C A GTGTTTT TGGTCGGG G T T T T T T C T C A G A A A C A A A A T G G T T T T T G T T T A T A T G T G C A A G G A 176 
4 3#22-M13RMAR06 T G A A A C T G T T C C C A C AGCTGGAGGGCAANG G T G G A G A G T G T G A C T G G A G G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A 
5 3#22-Ml3FMAR06 T G A A A C T G T T C C C A C AGCTGGAGGGCAA-G G T G G A G A G T G T G A C T G G A G G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A ； 
3 RetSat+Chromos T G A A A C T G T T C C C A C AGCTGGAGGGCAA-G G T G G A G A G T G T G A C T GGAGGGTCACCACTG A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A 1：：3 
811 825 826 840 841 855 856 870 871 885 B86 900 
1 3#22-M13RMAR05 GA GGACACCACGAGAA- T T G G G G A G G T G C C T T T C C T C T G G C T C T T C T C T G A A C G G A C T A C A T C T T C T T C T T T T G T G C 76 
2 3#22—M13FMAR05 A T T G C T G T A G A G G G A GGACACCACGAGAAG TTGGGGAGGTGCCTT T C C T C T G G C T C T T C T C T G A A C G G A C T A C A T C T T C T T C T T T T G T G C 266 
4 3 # 2 2 - M m M A R 0 6 G G A G C T A C C T A T G G A GCTGACCATGAC--- T T G G C T C G G C T G C A T C C T C A T G C A A T G G C T T C C A T A A G A G C C C A A A C C C C C A T C C C C A A C 896 
5 3#22-M13FMAR06 G G A G C T A C C T A T G G A G C T G A C C A T G A C - — T T G G C T e G G C T G C A T C C T C A T G C A A T G G C T T C C A T A A G A G C C C A A A C C C C C A T C C C C A A C 274 
3 RetSat+Chromos G G A G C T A C C T A T G G A G C T G A C C A T G A C — — T T G G C T C G G C T G C A T C C T C A T G C A A T G G C T T C C A T A A G A G C C C A A A C C C C C A T C C C C A A C 210 
901 915 916 930 931 945 946 960 961 975 976 990 
1 3#22-M13RMAR05 C T T G A C C T T T G - A G C C A A G A G C - C T G C A G A T C T G A G T A C A A G T T C C G T T T C A G G A T G G C A C T G C T G C A C A G C A A G G C C C C C T G C A G G G C C 164 
2 3#22—M13FMAR05 C T T G A C C G G G G G A G C C A A G A G C - C T G C A G A T C T G A G T A C A A G T T C C G T T T C A G G A T G G C A C T G C T G C A C A G C A A G G C C C C C T G C A G G G C C 355 
4 3#22-M13RMAR06 C T C T A C C T G A C A G G C CAAGATATCTTCACC TGTGGGC TGATGGGG G C C C T G C G G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G 986 
5 3jl22-M13FMAR06 C T C T A C C T G A C A G G C C A A G A T A T C T T C A C C TGTGGGC TGATGGGG G C C C T G C G G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G 364 
3 RetSat+Chromos C T C T A C C T G A C A G G C CAAGATATCTTCACC TGTGGGCTGATGGGG G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G 300 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
1 3#22-M13RMAR05 C C C A T C A G C C C A C A G GTGAAGATATCTTGG CCT---GTCAGGTAG A G G T T G G G G G T G G G G G T T T G G G C T C T T A T G G A A G C C A T T G C A T G A 251 
2 3#22-M13FMAR05 C C C A T C A G C C C A C A G GTGAAGATATCTTGG C C T - — G T C A G G T A G A G G T T G G G G G T G G G G G T T T G G G C T C T T A T G G A A G C C A T T G C A T G A 442 
4 3#22-M13RMAR06 A A C T T G T A C T C A G A T NTGCAGGCTCTTGGC T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G 1076 
5 3#22-M13FMAR06 A A C T T G T A C T C A G A T C T G C A G G C T C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G 45A 
3 RetSat+Chromos A A C T T G T A C T C A G A T CTGCAGGCTCTTGGC T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G 390 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
1 3#22-M13RMAR05 G G A T G C A G C C G C C C C A A C G T C A T G G T C A G C T C C A T A G G T A G C T C C T C G G G G T G C A G C C A G A T A G T A C T G G T T G G T CAG 329 
2 3#22-M13FMAR05 G G A T G C A G C C G A G C C A A - G T C A T G G T C A G C T C C A T A G G T A G C T C C T C G G G G T G C A G C C A G A T A G T A C T G G T T G G T CAG 519 
^ . 3 # 2 2 - M 1 3 R M A R 0 6 GCACCTCCCCAACTT CTCGTGGTGTCCTCC CTCCTACAGCAATTC CTTGCACATATAAAC A A A A A C C A T T T T G T T TNTGA U S E 
5 3tt22-M13FMAR06 G C A C C T C C C C A A C T T C T C G T G G T G T C C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C T G A i U U W V A A A A A 534 
3 RetSat+Chromos G C A C C T C C C C A A C T T C T C G T G G T G T C C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C T G A T T A G T G T T G T 4«0 
1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
1 3#22-M13RMAR05 TGGTGACCCT C C A G T C A C A C T C T C C A C C T T G C C C T C C A G C T G T G G G A A C A G T T T C A T G A T C A C C G A C A T A 399 
2 3#22-M13FMAR05 TGGTGACCCT C C A G T C A C A C T C T C C ACC H 7 
3 RetSat+Chromos T A A G T C A A G A G T T C T T T A C C T T G C A T T C T A C T T A A G G C C T A G T G T G A A C T A C A T A G C C T T G A T G C C T C A T G A A G A A T G C T C C C A T G C C T T 570 
^ 3#22-M13RMAR06 f ^ M M M G A A A A A A A A A A C A C T G T C A T G C C G T 120n 






Appendix B21: Alignment result of 3，#25 
3'GSPl 
451 465 466 480 481 495 496 510 511 525 526 5'!0 
7 3#25-9534MAR06 NCCGANNNGGNTTCN NTAG---AANGNCCN C C A N G G G G G G G A A T T CNCCCTTAAGCCTTN ---GGGNAGCCTTTN GTCGGNGAT':AHGAA 
8 3025-M13RMAR06 A C C G A G C T C G G A T C C ACTAGTAACGGCCGC CAGTGTGCTGGAATT C G C C C T T — m — — t C G G T G A T C A T C A A 156 
9 RetSat+Chromos A A T G C C T T C G T G G A A G C C T C T A T G T C G G T G A T C A T G A A 38 
541 555 556 570 571 585 586 600 601 615 616 630 
7 3#2：5-9153概R06 A C N N T N C C N - C A G C T G G - G G G C C A G G T G G A GAGTG-G ACTGGAGG GTCACCNCTGNCCAN C C A G T A C T N T N T G G N TGCACCCCGGGGAGC 619 
8 3#25-M13RMAR06 A C T G T T C C C A C A G C T G G A G G G C A A G G T G G A GAGTGTQ ACTGGAGG G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A G G A G C 246 
9 RetSat+Chromos A C T G T T C C C A C A G C T G G A G G G C A A G G T G G A GAGTGTGACTGGAGG G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A G G A G C 128 
631 645 646 660 661 675 676 690 691 705 706 7 20 
7 3#25-9534MAR06 T A C C T A T G G A G C T G A CCATGACTTGGNTNG G C T G C A T C N T C A T G C A A T G G C T T C C A T A A G A G C C C A A A C C C C C A T C C C C A A C C T N T A C C T 709 
8 3#25-M13RMAR06 T A C C T A T G G A G C T G A CCATGACTTGGCTCG G C T G C A T C C T C A T G C A A T G G C T T C C A T A A G A G C C C A A A C C C C C A T C C C C A A C C T C T A C C T 330 
9 RetSat+Chromos TACCTATr,GAGCTGA CCATGACTTGGCTCG G C T G C A T C C T C A T G C A A T G G C T T C C A T A A G A G C C C A A A C C C C C A T C C C C A A C C T C T A C C T "1« 
721 735 736 750 751 765 766 780 781 795 796 HlO 
4 3tt25-1833APR05 CTGTGGGCT G A T G G G G G C C C T G C A G G T G G C T T G C T T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A 
1 3#25-9534MAR06 G A C A G G C C A A G A T A T CTTCACCTGTGGGCT G A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A 
8 3 # 2 5 - M 1 3 R M A R 0 6 G A C A G G C C A A G A T A T C T T C A C C T G T G G G C T G A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A 4 2 6 
9 RetSat+Chromos G A C A G G C C A A G A T A T CTTCACCTGTGGGCT G A T G G G G G C C C T G C A G G G G G C C T T G C T G T G C A G C A G T G C C A T C C T G A A A C G G A A C T T G T A 308 
811 825 826 840 841 855 856 870 871 885 886 900 
4 3#25-1833APR05 C T C A G A T C T T G C A G G CTCTTGGCTCAAAGG T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G G C A C C T C 159 
1 3#25-9534MAR06 C T C A G A T C T - G C A G G CTCTTGGCTCAAAGG T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G G C A C C T C 888 
8 3#25-M13RMAR06 C T C A G A T C T - G C A G G C T C T T G G C T C A A A G G T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A N G A A A G G C A C C T C 515 
9 RetSat+Chromos C T C A G A T C T - G C A G G CTCTTGGCTCAAAGG T C A A G G C A C A A A A G A A G A A G A T G T A G T C C G T T C A G A G A A G A G C C A G A G G A A A G G C A C C T C 397 
901 915 916 930 931 945 946 960 961 975 976 990 
4 3tt25-1833APR05 C C C A A C T T C T C G T G G TGTCCTCCCTCCTAC A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C T G A T T A G T G T T G T T A A G T C A 249 
1 3#25-9534MAR06 C C C A A C T T C T C G T G G TGTCCTCCCTCCTAC A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C T G A T T A G T G T T G T T A A G T C A 978 
8 3#25-M13RMAR06 C C C A A C T T C T C G T G G TGTCCTCCCTCCTAC A G C A N T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T N C T G A T T A G T G N T G T T A A G T C A 605 
9 RetSat+Chromos CCCAACTTCTCGTGG TGTCCTCCCTCCTAC A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T f G T T T C T G A T T A G T G T T G T T A A G T C A 4 87 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
‘‘3#25-1833APR05 A G A G T T C T T T A C C T T GCATTCTACTTAAGG C C T A G T G T G A A C T A C A T A G C C T T G A T G C C T C A T G A A G A A T G C T C C C A T G C C T T T C C T A C A 339 
8 3#25-M13RMAR06 A G A G T T C T T T A C C T T GCATTCTACT-AANG N C T A G T G T G A A C T A C A T A G C C T T G A T G C C T C A T G A A N A A T G C T C C C A T G N C T T T C T T A C - 693 
3#25-9534MAR06 A G A G T T C T T T A C C T T GCATTCTACTTAAGG C C T A G T G T G A A C T A C A T A G C C T T G A T G C C T C A T G A A G A A T G C T C C C A T G C C T T T C C T A C A 1069 
9 RetSat+Chromos A G A G T T C T T T A C C T T GCATTCTACTTAAGG C C T A G T G T G A A C T A C A T A G C C T T G A T G C C T C A T G A A G A A T G C T C C C A T G C C T T T C C T A C A 577 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
1 3#25-9534APR05 C C A T A G C T C C C C G G T TCTAGGCTACCCTAG T A A C C C C T G G G G T G T C G G G C T T A C T G G A A T A G G C T T G G T T C T A G T C T T A C C C T G A A G C T T 105 
4 3#25-1833APR05 C C C A A - C T C C A A G C T A T G G T C A G G C A C C C A G A A C C C C T G G G G T G T T G G C - - T A C T G G A A T A G G T T - G G T T C - A G T C C T A C C C T G A A G C T T 424 
6 3tt25-M13FMAR06 C C C A A - N T T C A A N N T TTGTTGGGCCCCCCG A A C C C C — — G G G G G N T G G G - - N N C N G N A A A N G G T — — G T T T - C T T T N C N C C C N G A N G T T T 469 
8 3#25-M13RMAR06 C C C N A - N T C C A A G C T A T G G T C A G G C N C C N N - A A C C C C T G G G G N G N T G G C - - T A C T G G A A N A A G T T N G G T T C - A N T C C N A C C C T G A A A C T T 778 
3#25-9534MAR06 C C C A A - C T C C A A G C T A T G G T C A G G C A C C C A G A A C C C C T G G G G T G T T G G C — T A C T G G A A T A G G T T - G G T T C - A G T C C T A C C C T G A A G C T T 1153 
9 RetSat+Chromos C C C A A - C T C C A A G C T A T G G T C A G G C A C C C A G A A C C C C T G G G G T G T T G G C - - T A C T G G A A T A G G T T - G G T T C - A G T C C T A C C C T G A A G C T T 6G2 
1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
1 3#25-9534APR05 G T A T T G T T C C T C C T T A C T C T C G T G T T G T G T A T G C T C T A T A C A T G G A A A A G T G T G G G C T T G G A G T A G C T A T A C T T C T 181 
^ 3#25-1833APR05 T T - - T G T T C C T C C T C A C T C T C G T G T T G T G - A T G C T C T A T A C A T G G A A A A G T G T G G G C T T G G A G T A G C A A C T C T C T C A A A G T G C C A G A C C T 511 
6 3#25-M13FMAR06 T T - - N - - T N C N C N N C N C T T C C G G G N G G G G - N G G C T T A A A A A A N N A A A A N G T G G G G C - - T G G G G T A A C A N N N T T N N C A A A G N C C C A N N N - T 551 
® 3#25-M13RMAR06 T T - - T G T N C C N C C N C N C N C C C G G G G T G G G - A G G N C C C T A A N A N G N A A A A N N N G G G C N T N G N A A T A A C A A C N C C C C N A A N N G N C A A A - - C T 663 
‘3#25-9534MAR06 T T - - T G T T C C T C C T C A C T C T C G T G T T G T G - A T G C T C T A T A C A T G G A A A A G T G T G G G C T T G G A G T A G C A A C T C T C T C A A A G T G C C A G A C C T 1240 
9 RetSat+Chromos T T - - T G T T C C T C C T C A C T C T C G T G T T G T G - A T G C T C T A T A C A T G G A A A A G T G T G G G C T T G G A G T A G C A A C T C T C T C A A A G T G C C A G A C C T 749 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
^ 3tt25-9382MAY05 A A T T A T C C T G A T A A C C C C G G G G T T T T T T T G A A A C A C A A A A A G A T A C A C T G C C G A T G A A C C A A G C C T A G A 69 
® 了#25-M13FMAR06 N A G A A A A C C C T C C G G N T T N A G T T T T T T C C T G A N N G A A G - G G G N T N A A G G G A C C C C C C N A A A N A T N C C C C T G C C G A T G A A C C A A G C N T A G A 640 
3 # 2 5 - 9 5 3 4 M A R 0 6 A A G A A A A C C C T C A G G T C T A A G T T T T A T C C T G A T A G A A G T G G G T T A A A G G A A C A C N C C A A A A G A N N N C 1 3 0 7 
® 3f<25-M13RMAR06 A A A A A A A C C C N C N G G T T T A A N T T T T N C C C N G A A A A A A N G G G G T T A A A G N A A C C N C C N A A A A A A - - C C C C T G N N G A N A A A C A A A C C N T A A A 9!：,1 
3«25-9382APR05 C A G N T A G T T A T C T G A T A G A N C T G G G T T A T T G G A A C A C A C - - A A A A G A T A C A C T G C C G A T G A A C C A A G C C T A G A 71 
I 3#25-1833APR06 A A G A A A A C C C T C A G G T C T A A G T T T T A T C C T G A T A G A A G T G G G T T A A A G G A A C A C A C C A A A A G A T A C C A C T G C - G A T G A A C C A A G C C T A A C 600 
RetSat+Chromos A A G A A A A C C C T C A G G T C T A A G T T T T A T C C T G A T A G A A G T G G G T T A A A G G A A C A C A C C A A A A G A T A C C A C T G C C G A T G A A C C A A G C C T A G A HSQ 
1351 1365 1366 1380 1381 1396 1396 1410 1411 1425 1426 1440 
3«25-9382MAY05 C A C G G C A T T T G T A G T T G C T G G C A C A T A G T C A A A C T G A G T T A C G A G G C T G G G C A G G T G C T G G C A C C G G C C T T T A A C C C C A G C A C T C A G A A G 159 
3#25-1833APR05 A C G G C C A T T T G T A G T T G C T G G C A C A T A G T T 630 
^ 3#25-9382MAR06 — C N G N N T T T G N A G T T G C T G G C A C A T A G T C A A A C T G A G T T A C G A G G C T G G G C A G - T G C T G G C A C C G G C C T T T A A C C C C A G C A C T C A G A A G 87 
® 3#25-M13FMAR06 C N C G N C A T T T G T A G T T G C T G G C A C A T N G T C A A A C T G A G T T A C G A G G C T G G G C A G - T G N T G G C A C C G G C C T T T A A C C C C A G C A C T C A G A A G 729 
^ 3ft25-M13RMAR06 A C C G N T T T T N N T T N T T G G G G C C A N N N N N A A A T A A A TTAAAG G G G G G G A N G - G G G G G N C C C C N N T T T N C C C C C C C N C N A A 1029 
3#25-9382APR05 C A C G G C A T T T G T A G T T G C T G G C A C A T A G T C A A A C T G A G T T A C G A G G C T G G G C A G - T G C T G G C A C C G G C C T T T A A C C C C A G C A C T C A G A A G 160 
RetSat+Chromos CACGGC^ATTTGTAGT T G C T G G C A C A T A G T C A A A C T G A G T T A C G A G G C T G G G C A G - T G C T G G C A C C G G C C T T T A A C C C C A G C A C T C A G A A G 928 
1441 1455 1456 1470 1471 1485 1486 1500 1501 1515 1516 1530 
G 3 # 2 5 - 9 3 8 2 M A Y 0 5 G C A G G G G C A G A C A G A G C T C T G T G A A T C T G A A G C C A G A A C T A G T T T A T G A A G C A A G T C C A G G G G C A G C C A G A G C T C T G T T A T A C A G A G A A A 2 4 9 
g 3#25-9382MAR06 G C A G G G G C A G A C A G A G C T C T G T G A A T C T G A A G C C A G A A C T A G T T T A T G A A G C A A G T C C A G G G - C A G C C A G A G C T C T G T T A T A C A G A G A A A 176 
G 3 # 2 5 - M 1 3 F M A R 0 6 G C A G G G G C A G A C A G A G N T C T G T G A A T N T G A A G C C A G A A C T A G T T T A T G A A G C A A G T C C A G G G - C A G C C A G A G N T C T G T T A T A C A G A G A A A 8 1 8 
" 3 # 2 5 - M 1 3 R M A R 0 6 - - A G G G G G G G G N A A A A A N T N N T T T A T T T T A A C C C A A A N TTT T T T A A A A A A N N C C N N G G - N C C C A A N N T N T T T N N A A A A A A 1106 
I G 3 # 2 5 - 9 3 8 2 A P R 0 5 GCAGGGGCAGACAGA GCTCTGTGAATCTGA AGCCAGAACTAGTTT ATGAAGCAAGTCCAG GG-CAGCCAGAGCTC T G T T A T A C A G A G A A A 2 4 9 
'^etSat+Chromos G C A G G G G C A G A C A G A G C T C T G T G A A T C T G A A G C C A G A A C T A G T T T A T G A A G C A A G T C C A G G G - C A G C C A G A G C T C T G T T A T A C A G A G A A A 1017 
, 303 
1531 1545 1546 1560 1561 1575 1576 1590 1591 1605 1606 16：:0 
2 3#25-9382MAY05 C C C T G T C T T G A A A A A CAAAAC-AAACAAAA CAAAACCTGAGTATT G T T T T C T A A A A T G C T T G G A G T C A G A A T T C T TTCAGATTTTGTAGT 33h 
5 3#25-9382MAR06 C C C T G T C T T G A A A A A CAAAACCAAACAAAA CAAAACCTGAGTATT G T T T T C T A A A A T G C T T G G A G T C A G A A T T C T TTCAGATTTTGTAGT .Itf, 
8 3#25-Ml3RMAR06 --CCCTTTTNNAAAA AAAANCAAAAAAAAC CGGG GTTTTTTNAAANGNN G G G G N A A A T T T N T A A TTTNGNTTTTCNCCN 118 3 
3 3 # . ? 5 - 9 3 8 2 A P R 0 5 C C C T G T C T T G A A A A A C A A A A C C A G G C A A A A C A A A A C C T G A G T A T T G T T T T C T A A A A T G C T T G G A G T C A G A A T T C T T T C A G A T T T T G T A G T 3 3 9 
6 3#25-M13FMAR06 C C C T G T C T T G A A A A A C A A A A C f A A A C A A A A C A A A A C e T G A G T A T T G T T T T C T A A A A T G C T T G G A G T C A G A A T T C T T T C A G A T T T T G T A G T 
9 RetSat+Chromos C C C T G T C T T G A A A A A CAAAACAAAACAAAA C A A A A C C T G A G T A T T G T T T T C T A A A A T G C T T G G A G T C A G A A T T C T TTCAGATTTTGTAGT 1107 
1621 1635 1636 1650 1651 1665 1666 1680 1681 1695 1696 1710 
3 3 # 2 5 - 9 3 8 2 A P R 0 5 A T T T G C A T A C A C A T G A G A T A A C C T G G G G A A T G G G T C C C A G A A C T A A A C C A C A A A T T C A T T T G T T T C A T A T G T A T A G A C C A G G C A C A A C A T 4 2 9 
5 3 # 2 5 - 9 3 8 2 M A R 0 6 A T T T G C A T A C A C A T G A G A T A A C C T G G G G A A TGGGTCCCAGAACTA A A C C A C A A A T T C A T T T G T T T C A T A T G T A T A GACCAGGCACAACAT 3 5 6 
6 3 # 2 5 - M 1 3 F m R 0 6 A T T T G C A T A C A C A T G A G A T A A C C T G G G G A A T G G G T C C C A G A A C T A A A C C A C A A A T T C A T T T G T T T C A T A T G T A T A G A C C A G G C A C A A C A T 
8 3#25-M13RMAR06 A A A A - - A A A N G G G A G G G C C C C C A A A A A A C A T T T T T T T T T T T T N T T T A C C C C C C N C T T T T T T N N T T A A A A A A A N C C NCCCCCCNCCCCCCN 1”1 
2 3 # 2 5 - 9 3 8 2 M A Y 0 5 A T T T G C A T A C A C A T G A G A T A A C C T G G G G A A T G G G T C C C A G A A C T A A A C C A C A A A T T C A T T T G T T T C A T A T G T A T A G A C C A G G C A C A A C A T 
9 RetSat+Chromos A T T T G C A T A C A C A T G A G A T A A C C T G G G G A A T G G G T C C C A G A A C T A A A C C A C A A A T T C A T T T G T T T C A T A T G T A T A GACCAGGCACA-EvCAT 11 
1711 1725 1726 1740 1741 1755 1756 1770 1771 1785 1786 1800 
2 3 # 2 5 - 9 3 8 2 M A Y 0 5 C T T A T G T i3： 
5 3#25-9382MAR06 C T T A T G T A A T A C T T T G A A A A A C T G A G C A T T C T G A C C T G T C A C A T G A G T C C A T G C T A T A A T T T A A A A A G C T T G C T T T G A T T T C A G A A T A G G 446 
6 3tt25-M13FMAR06 C T T A T G T A A T A C T T T G A A A A A C T G A G C A T T CTGACCTGTCACATG A G T C C A T G C T A T A A T T T A A A A A G C T T G C T T TGATTTCAGAATAGG 1088 
8 3#25-M13RMAR06 T A A A A A A A N T T T T T T TNAAAAGGTNTCTTN AAAAAAANGG7VNAAA A A A N C C C T T T N A A A N N G N T T T T T N N N A A A A A A A T T T N N N A A A A A - 1360 
3 3 # 2 5 - 9 3 8 2 A P R 0 5 C T T A T G T A A T A C T T T G A A A A A C T G A G C A T T C T G A C C F G T C A C A T G A G T C C A T G C T A T A A T T T A A A A A G C T T G C T T T G A T T T C A G A A T A G G 5 1 9 
9 RetSat+Chromos C T T A T G T A A T A C T T T GAAAAACTGAGCATT C T G A C C T G T C A C A T G A G T C C A T G C T A T A A T T T A A A A A G C T T G C T T TGATTTCAGAATAGG 1287 
1801 1815 1816 1830 1831 1845 1846 1860 1861 1875 1876 1890 
3 3#25-9382APR05 G A T G C T T T A C C T A T A TGAGTAAATGAGAAG G T G G A T A A A A A T T A A A A A C C T T T C A C T T A T G T T A A A C A A G T G C T A A T T T - A G T C T G T T T A 608 
5 3#25-9382MAR06 G A T G C T T T A C C T A T A TGAGTAAATGAGAAG G T G G A T A A A A A T T A A A A A C C T T T C A C T T A T G T T A A A C A A G T G C T A A T T T T A G T C T G T T T A 536 
6 3 # 2 5 - M 1 3 F M A R 0 6 G A T G C T T T A C C T A T A T G A G T A A A T G A G A A G G T G G A T A A A A A T T A A A A A C C T T T C A C T T A T G T T A A A C A A G T G C T A A T T T T A G T C T G T T T A 1 1 7 & 
9 RetSat+Chromos G A T G C T T T A C C T A T A TGAGTAAATGAGAAG G T G G A T A A A A A T T A A A A A C C T T T C A C T T A T G T T A A A C A A G T G C T A A T T T T A G T C T G T T T A 1377 
1891 1905 1906 1920 1921 1935 1936 1950 1951 1965 1966 1980 
3 3#25-9382APR05 A A T A T A G T A T - A A T A CATGTAATGTT 633 
5 3#25-9382MAR06 A A T A T A G T A T T A A T A C A T G T A A T G T T T C A A A A A A A A A A A A A A A A - - C A C T G T C A T G C C G T T A C G T A G C G T A T C G T T G A C A G C A A G G G C G A 624 
6 3#25-M13FMAR06 A A T A T A G T A T T A A T A C A T G T A A T G T T T C A A | g ^ | | | ® ^ P | ^ | | | C A C T G T C A T G C C G T T A C G T A G C G T A T C G T T G A C A G C A A G G G C G A 126& 
9 RetSat+Chromos A A T A T A G T A T T A A T A C A T G T A A T G T T T C A A 1407 
Poly(A) tail 
, 304 • 
































































































































































































A A A C C A T T T T G T T T C T G A ^ ^ i A A i ^ A A A A A A A A A 
>RetSat+Chromosome 
AA TGCCTTCOTGGAAGC CTCTATGTC彿TO ATCATGAAACTGT 
TCCCACAeCTGG A^GGCAAQOT GGAG ^GTGTGACTGGAG 
G G T C A C C A t G A CCAACCAGTAC TATCtrGGCTGCAC 
fCCGAGGAGCTACC TATGGAGCTGA C(|ATGACTTGGCTC 
GGCTGCATCCTCA TGCAATGGCTTCCA |AAGAGCCCAAAC 
CCCCATGCCCAAC CTCTACCTGAGA GG 
CCAAGATATCTTCACCTGTGGbCTGATcfcGGGCCCTGCAGGGG 
GCCTTGCTGTGCA GCAGTGCCATCCTG kAACGGAACTTGTAC 
TCAGATCTGCAGGCjdtTGGCTCAAAGGTCAAGGCACAAAAG 
A A G A A G X t G g A ^ C CGTTCAGAt}AAG4 GCCAGA 
GGA A AGO C ACCTCCCC A ACT TCTCGTGGTGTCCT CCCTCCTACAGCA 
ATTCCTTGCACA TATAAACAAAAA CCATTTTGTTTCTG 
ATTAGTGTTGTTAAG TCAAGAGTTCTTTAC CTTGCATTCTACTTA 
AGGCCTAGTGTGAAC TACATAGCCTTGATG CCTCATGAAGAATGC 
TCCCATGCCTT TCCTACACCCAACTC CAAGCTATGGTCAGG 
CACCCAGAACCCCTG GGGTGTTGGCTACTG GAATAGGTTGGTTCA 
GTCCTACCCTGAAGC TTTTTGTTCCTCCTC ACTCTCGTGTTGTGA 
TGCTCTATACATGGA AAAGTGTGCGCTTGG AGTAGCAACTCTCTC 
AAAGTGCCAGACCTA AGAAAACCCTCAGGT CTAAGTTTTATCCTG 
ATAGAAGTGGGTTA AAGGAACACACCAAA AGATACCACTGCCGA 
TGAACCAAGCCTAGA CACGGCATTTGTAG TTGCTGGCACATAG 
TCAAACTGAGTTACG AGGCTGGGCAGTGCT GGCACCGGCCTTT 
AACCCCAGCACT CAGAAGGCAGGGGC AGACAGAGCTCTGTG 
AATCTGAAGCCAGA ACTAGTTTATGAAGC AAGTCCAGGGCAGCC 
AGAGCTCTGTTATAC AGAGAAACCCTGTCT TGAAAAACAAAACAA 
AACAAAACAAAACC TGAGTATTGTTTTCT AAAATGCTTGGAGTC 
AGAATTCTTTCAGAT TTTGTAGTATTTGCA TACACATGAGATAAC 
CTGGGGAATGGGTCC CAGAACTAAACCACA AATTCATTTGTTTCA 
TATGTATAGACCAGG CACAACATCTTATGT AATACTTTGAAAAAC 
TGAGCATTCTGACCT GTCACATGAGTCCAT GCTATAATTTAAAAA 
GCTTGCTTTGATTTC AGAATAGGGATGCTT TACCTATATGAGTAA 




Appendix B 9 : Alignment result of all 5' RACE clones consensus sequence 
^j^tchcd nucleotides are hicMldilted in Oteen H 
3'GSPl 
1 15 16 30 31 45 46 60 61 75 76 90 
1 3#6 AATGCCTTCGTGGAA GCCTCTATGTCGGTG ATCATGAAACTGTTC CCACAGCTGGAGGGC AAGGTGGAGAGTGTG ACTGGAGGGTCACCA 90 
2 3#5 AATGCCTTCGTGGAA GCCTCTATGTCGGTG ATCATGAAACTGTTC CCACAGCTGGAGGGC AAGGTGGAGAGTGTG ACTGGAGGGTCACCA 90 
3 3#2 AATGCCTTCGTGGAA GCCTCTATGTCGGTG ATCATGAAACTGTTC CCACAGCTGGAGGGC AAGGTGGAGAGTGTG ACTGGAGGGTCACCA 90 
4 3#11 AATGCCTTCGTGGAA GCCTCTATGTCGGTG ATCATGAAACTGTTC CCACAGCTGGAGGGC AAGGTGGAGAGTGTG ACTGGAGGGTCACCA 90 
5 3 A A T G C C T T C G T G G A A GCCTCTATGTCGGTG ATCATGAAACTGTTC CCACAGCTGGAGGGC AAGGTGGAGAGTGTG ACTGGAGGGTCACCA 90 
6 3#16 AATGCCTTCGTGGAA GCCTCTATGTCGGTG ATCATGAAACTGTTC CCACAGCTGGAGGGC AAGGTGGAGAGTGTG ACTGGAGGGTCACCA 90 
7 3#4 AATGCCTTCGTGGAA GCCTCTATGTCGGTG ATCATGAAACTGTTC CCACAGCTGGAGGGC AAGGTGGAGAGTGTG ACTGGAGGGTCACCA 90 
8 3#3 AATGCCTTCGTGGAA GCCTCTATGTCGGTG ATCATGAAACTGTTC CCACAGCTGGAGGGC AAGGTGGAGAGTGTG ACTGGAGGGTCACCA 90 
9 3#10 AATGCCTTCGTGGAA GCCTCTATGTCGGTG ATCATGAAACTGTTC CCACAGCTGGAGGGC AAGGTGGAGAGTGTG ACTGGAGGGTCACCA 90 
10 3#8 AATGCCTTCGTGGAA GCCTCTATGTCGGTG ATCATGAAACTGTTC CCACAGCTGGAGGGC AAGGTGGAGAGTGTG ACTGGAGGGTCACCA 90 
12 3#25 AATGCCTTCGTGGAA GCCTCTATGTCGGTG ATCATGAAACTGTTC CCACAGCTGGAGGGC AAGGTGGAGAGTGTG ACTGGAGGGTCACCA 90 
13 3#12 AATGCCTTCGTGGAA GCCTCTATGTCGGTG ATCATGAAACTGTTC CCACAGCTGGAGGGC AAGGTGGAGAGTGTG ACTGGAGGGTCACCA 90 
11 RetSat + Chromos KK^^j^itQCIfmnSMAA fflWSECSWSRPPCGGTG ATCATGAAACTGTTC CCACAGCTGGAGGGC AAGGTGGAGAGTGTG ACTGGAGGGTCACCA 90 
91 105 106 120 121 135 136 150 151 165 166 180 
1 3#6 CTGACCAACCAGTAC TATCTGGCTGCACCC CGAGGAGCTACCTAT AGAGCTGACCATGAC TTGGCTCGGCTGCAT CCTCATGCAATGGCT 180 
2 3#5 CTGACCAACCAGTAC TATCTGGCTGCACCC CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT CCTCATGCAATGGCT 180 
3 3#2 CTGACCAACCAGTAC TATCTGGCTGCACCC CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT CCTCATGCAATGGCT 180 
4 3#11 CTGACCAACCAGTAC TATCTGGCTGCACCC CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT CCTCATGCGATGGCT 180 
5 3#22 CTGACCAACCAGTAC TATCTGGCTGCACCC CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT CCTCATGCAATGGCT 180 
6 3#16 CTGACCAACCAGTAC TATCTGGCTGCACCC CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT CCTCATGCAATGGCT 180 
7 3#4 CTGACCAACCAGTAC TATCTGGCTGCACCC CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT CCTCATGCAATGGCT 180 
8 3#3 CTGACCAACCAGTAC TATCTGGCTGCACCC CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT CCTCATGCAATGGCT 180 
9 3#10 CTGACCAACCAGTAC TATCTGGCTGCACCC CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT CCTCATGCAATGGCT 180 
10 3#8 CTGACCAACCAGTAC TATCTGGCTGCACCC CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT CCTCATGCAATGGCT 180 
3#25 CTGACCAACCAGTAC TATCTGGCTGCACCC CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT CCTCATGCAATGGCT 180 
13 3#12 CTGACCAACCAGTAC TATCTGGCTGCACCC CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT CCTCATGCAATGGCT 180 
11 RetSat+Chromos CTGACCAACCAGTAC TATCTGGCTGCACCC CGAGGAGCTACCTAT GGAGCTGACCATGAC TTGGCTCGGCTGCAT CCTCATGCAATGGCT 180 
181 195 196 210 211 225 226 240 241 255 256 270 
1 3#6 TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC TGTGGGCTGATGGGG GCCCTGCAGGGGGCC 270 
2 3#5 TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC TGTGGGCTGATGGGG GCCCTGCAGGGGGCC 270 
3 3#2 TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC TGTGGGCTGATGGGG GCCCTGCAGGGGGCC 270 
4 3#11 TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC TGTGGGCTGATGGGG GCCCTGCAGGGGGCC 270 
5 3#22 TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC TGTGGGCTGATGGGG GCCCTGCGGGGGGCC 270 
6 3#16 TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC TGTGGGCTGATGGGG GCCCTGCAGGGGGCC 270 
7 TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC TGTGGGCTGATGGGG GCCCTGCAGGGGGCC 270 
8 3#3 TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC TGTGGGCTGATGGGG GCCCTGCAGGGGGCC 270 
9 3#10 TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC TGTGGGCTGATGGGG GCCCTGCAGGGGGCC 270 
3#8 TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC TGTGGGCTGATGGGG GCCCTGCAGGGGGCC 270 
3#25 TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC TGTGGGCTGATGGGG GCCCTGCAGGGGGCC 270 
3#12 TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC TGTGGGCTGATGGGG GCCCTGCAGGGGGCC 270 
RetSat+Chromos TCCATAAGAGCCCAA ACCCCCATCCCCAAC CTCTACCTGACAGGC CAAGATATCTTCACC TGTGGGCTGATGGGG GCCCTGCAGGGGGCC 270 
271 285 286 300 301 315 316 330 331 345 346 360 
1 3#6 TTGCTGTGCAGCAGT GCCATCCTGAAACGG AACTTGTACTCAGAT CTGCAGGCTCTTGGC TCAAAGGTCAAGGCA CAAAAGAAGAAGATG 360 
2 3#5 TTGCTGTGCAGCAGT GCCATCCTGAAACGG AACTTGTACTCAGAT CTGCAGGCTCTTGGC TCAAAGGTCAAGGCA CAAAAGAAGA-GATG 359 
^ 3#2 TTGCTGTGCAGCAGT GCCATCCTGAAACGG AACTTGTACTCAGAT CTGCAGGCTCTTGGC TCAAAGGTCAAGGCA CAAAAGAAGAAGATG 360 
今 3#11 TTGCTGTGCAGCAGT GCCATCCTGAAACGG AACTTGTACTCAGAT CTGCAGGCTCTTGGC TCAAAGGTCAAGGCA CAAAAGAAGAAGATG 360 
5 3#22 TTGCTGTGCAGCAGT GCCATCCTGAAACGG AACTTGTACTCAGAT CTGCAGGCTCTTGGC TCAAAGGTCAAGGCA CAAAAGAAGAAGATG 360 
6 3#16 TTGCTGTGCAGCAGT GCCATCCTGAAACGG AACTTGTACTCAGAT CTGCAGGCTCTTGGC TCAAAGGTCAAGGCA CAAAAGAAGAAGATG 360 
TTGCTGTGCAGCAGT GCCATCCTGAAACGG AACTTGTACTCAGAT CTGCAGGCTCTTGGC TCAAAGGTCAAGGCA CAAAAGAAGAAGATG 360 
® 3#3 TTGCTGTGCAGCAGT GCCATCCTGAAACGG AACTTGTACTCAGAT CTGCAGGCTCTTGGC TCAAAGGTCAAGGCA CAAAAGAAGAAGATG 360 
9 3#10 TTGCTGTGCAGCAGT GCCATCCTGAAACGG AACTTGTACTCAGAT CTGCAGGCTCTTGGC TCAAAGGTCAAGGCA CAAAAGAAGAAGATG 360 
” 3#8 TTGCTGTGCAGCAGT GCCATCCTGAAACGG AACTTGTACTCAGAT CTGCAGGCTCTTGGC TCAAAGGTCAAGGCA CAAAAGAAGAAGATG 360 
RetSat+Chromos TTGCTGTGCAGCAGT GCCATCCTGAAACGG AACTTGTACTCAGAT CTGCAGGCTCTTGGC TCAAAGGTCAAGGCA CAAAAGAAGAAGATG 360 
” 3林25 TTGCTGTGCAGCAGT GCCATCCTGAAACGG AACTTGTACTCAGAT CTGCAGGCTCTTGGC TCAAAGGTCAAGGCA CAAAAGAAGAAGATG - 360 
3 3#12 TTGCTGTGCAGCAGT GCCATCCTGAAACGG AACTTGTACTCAGAT CTGCAGGCTCTTGGC TCAAAGGTCAAGGCA CAAAAGAAGAAGATG 360 
361 375 376 390 391 405 406 420 421 435 436 450 
^ TAGTCCGTTCAGAGA AGAGCCAGAGGAAAG GCACCTCCCCAACTT CTCGTGGTGTCCTCC CTCCTACAGCAATTC CTTGCACATATAAAC 450 
^ TAGTCCGTTCAGAGA AGAGCCAGAGGAAAG GCACCTCCCCAACTT CTCGTGGTGTCCTCC CTCCTACAGCAATTC CTTGCACATATAAAC 449 
^ TAGTCCGT-CAGAGA AGAGCCAGAGGAAAG GCACCTCCCCAACTT CTCGTGGTGTCCTCC CTCCTACAGCAATTC CTTGCACATATAAAC 449 
” # 1 1 TAGTCCGTTCAGAGA AGAGCCAGAGGAAAG GCACCTCCCCAACTT CTCGTGGTG|CCTCC CTCCTACAGCAATTC CTTGCACATATAAAC 450 
^ TAGTCCGTTCAGAGA AGAGCCAGAGGAAAG GCACCTCCCCAACTT CTCGTGGTGTCCTCC CTCCTACAGCAATTC CTTGCACATATAAAC 450 
® 3#16 TAGTCCGTTCAGAGA AGAGCCAGAGGAAAG GCACCTCCCCAACTT CTCGTGGTGTCCTCC CTCCTACAGCAATTC CTTGCACATATAAAC 450 
= T A G T C C G T T C A G A G A AGAGCCAGAGGAAAG GCACCTCCCCAACTT CTCGTGGTGTCCTCC CTCCTACAGCAATTC CTTGCACATATAAAC 450 
” T A G T C C G T T C A G A G A AGAGCCAGAGGAAAG GCACCTCCCCAACTT CTCGTGGTGTCCTCC CTCCTACAGCAATTC CTTGCACATATAAAC 450 
^ TAGTCCGTTCAGAGA AGAGCCAGAGGAAAG GCACCTCCCCAACTT CTCGTGGTGTCCTCC CTCCTACAGCAATTC CTTGCACATATAAAC 450 
3 T A G T C C G T T C A G A G A AGAGCCAGAGGAAAG GCACCTCCCCAACTT CTCGTGGTGTCCTCC CTCCTACAGCAATTC CTTGCACATATAAAC 450 
； T A G T C C G T T C A G A G A AGAGCCAGAGGAAAG GCACCTCCCCAACTT CTCGTGGTGTCCTCC CTCCTACAGCAATTC CTTGCACATATAAAC 450 
扑 1 2 T A G T C C G T T C A G A G A A G A G C C A G A G G A A G G G C A C C T C C C C A A C T T C T C G T G G T G T C C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T A G A C 4 5 0 
RetSat+Chromos TAGTCCGTTCAGAGA AGAGCCAGAGGAAAG GCACCTCCCCAACTT CTCGTGGTGTCCTCC CTCCTACAGCAATTC CTTGCACATATAAAC 450 
RetSat stops here 
- 310 
A 
451 465 466 480 481 495 496 510 511 525 526 540 
1 AAAAACCATTTTGTT TCTGAAAAAAAAAAA AAAAAAA 473 
2 3#5 AAAAACCATTTTGTT TCTGAAAAAAAAAAA AAA - 482 
3 3#2 AAAAACCATTTTGTT TCTGAAAAAAAAAAA AAAAAAA 486 
4 3#11 AAAAACCATTTTGTT TCTGAAAAAAAAAAA AAAAAAA - 487 
5 3#22 AAAAACCATTTTGTT TCTGAAAAAAAAAAA AAAAAAAAA - 489 
6 AAAAACCATTTTGTT TCTGAAAAAAAAAAA AAAAAAA 487 
7 3#4 AAAAACCATTTTGTT TCTGAAAAAAAAAAA AAAAAAA 487 
8 AAAAACCATTTTGTT TCTGAAAAAAAAAAA AAAAAAAA - 488 
9 3#10 AAAAACCATTTTGTT TTTGAAAAAAAAAAA AAAAAAAAAAAAAAA - 495 
10 3#8 AAAAACCATTTTGTT TTTGATTAGTGTTGT TAAGTCAAGAGTTCT TTACCTTGCATTCTA CTTAAGGCCTAGTGT GAACTACATAGCCTT 540 
11 RetSat+Chromos AAAAACCATTTTGTT TCTGATTAGTGTTGT TAAGTCAAGAGTTCT TTACCTTGCATTCTA CTTAAGGCCTAGTGT GAACTACATAGCCTT 540 
12 3#25 AAAAACCATTTTGTT TCTGATTAGTGTTGT TAAGTCAAGAGTTCT TTACCTTGCATTCTA CTTAAGGCCTAGTGT GAACTACATAGCCTT 540 
13 3#12 AAAAACCATTTTGTT TCTGATTAGTGTTGT TAAGTCAAGAGTTCT TTACCTTGCATTCTA CTTAAGGCCTAGTGT GAACTACATAGCCTT 540 
541 555 556 570 571 585 586 600 601 615 616 630 
10 GATGCCTCATGAAGA ATGCTCCCATGCCTT TCCTACACCCAACTC CAAGCTATGGTCAGG CACCCAGAACCCCTG GGGTGTTGGCTACTG 630 
11 RetSat+Chromos GATGCCTCATGAAGA ATGCTCCCATGCCTT TCCTACACCCAACTC CAAGCTATGGTCAGG CACCCAGAACCCCTG GGGTGTTGGCTACTG 630 
12 3 5 GATGCCTCATGAAGA ATGCTCCCATGCCTT TCCTACACCCAACTC CAAGCTATGGTCAGG CACCCAGAACCCCTG GGGTGTTGGCTACTG 630 
13 3#12 GATGCCTCATGAAGA ATGCTCCCATGCCTT TCCTACACCCAACTC CAAGCTATGGTCAGG CACCCAGAACCCCTG GGGTGTTGGCTACTG 630 
631 645 646 660 661 675 676 690 691 705 706 720 
10 3#8 GAATAGGTTGGTTCA GTCCTACCCTGAAGC TTTTTGTTCCTCCTC ACTCTCGTGTTGTGA TGCTCTATACATGGA AAAGTGTGGGCTTGG 720 
11 RetSat+Chromos GAATAGGTTGGTTCA GTCCTACCCTGAAGC TTTTTGTTCCTCCTC ACTCTCGTGTTGTGA TGCTCTATACATGGA AAAGTGTGGGCTTGG 720 
12 3#25 GAATAGGTTGGTTCA GTCCTACCCTGAAGC TTTTTGTTCCTCCTC ACTCTCGTGTTGTGA TGCTCTATACATGGA AAAGTGTGGGCTTGG 720 
13 3#12 GAATAGGTTGGTTCA GTCCTACCCTGAAGC TTTTTGTTCCTCCTC ACTCTCGTGTTGTGA TGCTCTATACATGGA AAAGTGTGGGCTTGG 720 
721 735 736 750 751 765 766 780 781 795 796 810 
10 AGTAGCAACTCTCTC AAAGTGCCAGACCTA AGAAAACCCTCAGGT CTAAGTTTTATCCTG ATAGAAGTGGGTTAA AGGAACAC--CAAAA 808 
11 RetSat+Chromos AGTAGCAACTCTCTC AAAGTGCCAGACCTA AGAAAACCCTCAGGT CTAAGTTTTATCCTG ATAGAAGTGGGTTAA AGGAACACACCAAAA 810 
12 3#25 AGTAGCAACTCTCTC AAAGTGCCAGACCTA AGAAAACCCTCAGGT CTAAGTTTTATCCTG ATAGAAGTGGGTTAA AGGAACACACCAAAA 810 
13 3#12 AGTAGCAACTCTCTC AAAGTGCCAGACCTA AGAAAACCCTCAGGT CTACGTTTTATCCTG ATAGAAGTGGGTTAA AGGAACACACCAAAA 810 
811 825 826 840 841 855 856 870 871 • 885 886 900 
10 3#8 GATACCACTGCCGAT GAACCAAGCCTAGAC ACGGCATTTGTAGTT GCTGGCACATAGTCA AACTGAGTTACGAGG CTGGGCAGTGCTGGC 898 
11 RetSat+Chromos GATACCACTGCCGAT GAACCAAGCCTAGAC ACGGCATTTGTAGTT GCTGGCACATAGTCA AACTGAGTTACGAGG CTGGGCAGTGCTGGC 900 
12 3#25 GATACCACTGCCGAT GAACCAAGCCTAGAC ACGGCATTTGTAGTT GCTGGCACATAGTCA AACTGAGTTACGAGG CTGGGCAGTGCTGGC 900 
13 GATACCACTGCCGAT GAACCAAGCCTTGAC ACGGCATTTGTAGTT GCTGGCACATAGTCA AACTGAGTTACGAGG CTGGGCAGTGCTGGC 900 
901 915 916 930 931 945 946 960 961 975 976 990 
10 3#8 ACCGGCCTTTAACCC CAGCACTCAGAAGGC AGGGGCAGACAGAGC TCTGTGAATCTGAAG CCAGAACTAGTTTAT GAAGCAAGTCCAGGG 988 
RetSat+Chromos ACCGGCCTTTAACCC CAGCACTCAGAAGGC AGGGGCAGACAGAGC TCTGTGAATCTGAAG CCAGAACTAGTTTAT GAAGCAAGTCCAGGG 990 
12 3#25 ACCGGCCTTTAACCC CAGCACTCAGAAGGC AGGGGCAGACAGAGC TCTGTGAATCTGAAG CCAGAACTAGTTTAT GAAGCAAGTCCAGGG 990 
3#12 ACCGGCCTTTAACCC CAGCACTCAGAAGGC AGGGGCAGACAGAGC TCTGTGAATCTGAAG CCAGAACTAGTTTAT GAAGCAAGTCCAGGG 990 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
IQ 3#8 CAGCCAGAGCTCTGT TATACAGAGAAACCC TGTCTTGAAAAACAA AACAAAACAAAACAA AACCTGAGTATTGTT TTCTAAAATGCTTGG 1078 
CAGCCAGAGCTCTGT TATACAGAGAAACCC TGTCTTGAAAAACAA AACfAAACAAAACAA AACCTGAGTATTGTT TTCTAAAATGCTTGG 1080 
3#12 CAGCCAGAGCTCTGT TATACAGAGAAACCC TGTCTTGAAAAACAA AACAAAACAAAACAA, AACCTGAGTATTGTT TTCTAAAATGCTTGG 1080 
RetSat+Chromos CAGCCAGAGCTCTGT TATACAGAGAAACCC TGTCTTGAAAAACAA AACAAAACAAAACAA AACCTGAGTATTGTT TTCTAAAATGCTTGG 1080 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
10 3#8 AGTCAGAATTCTTTC AGATTTTGTAGTATT TGCATACACATGAGA TAACCTGGGGAATGG GTCCCAGAACTAAAC CACAAATTCATTTGT 1168 
丨1 RetSat+Chromos AGTCAGAATTCTTTC AGATTTTGTAGTATT TGCATACACATGAGA TAACCTGGGGAATGG GTCCCAGAACTAAAC CACAAATTCATTTGT 1170 
” 3#25 AGTCAGAATTCTTTC AGATTTTGTAGTATT TGCATACACATGAGA TAACCTGGGGAATGG GTCCCAGAACTAAAC CACAAATTCATTTGT 1170 
AGTCAGAATTCTTTC AGATTTTGTGGTATT TGCATACACATGAGA TAACCTGGGGAATGG GTCCCAGAACTAAAC CACAAATTCATTTGT 1170 
1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
” 3#8 TTCATATGTATAGAC CAGGCACAACATCTT ATGTAATACTTTGAA AAACTGAGCATTCTG ACCTGTCACATGAGT CCATGCTATAATTTA 1258 
” RetSat+Chromos TTCATATGTATAGAC CAGGCACAACATCTT ATGTAATACTTTGAA AAACTGAGCATTCTG ACCTGTCACATGAGT CCATGCTATAATTTA 1260 
” 3#25 TTCATATGTATAGAC CAGGCACAACATCTT ATGTAATACTTTGAA AAACTGAGCATTCTG ACCTGTCACATGAGT CCATGCTATAATTTA 1260 
^ ^#12 TTCATATGTATAGAC CAGGCACAACATCTT ATGTAATACTTTGAA AAACTGAGCATTNTG ACCTGTCACATGAGT CCATGCTATAATTTA 1260 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
广 AAAAGCTTGCTTTGA TTTCAGAATAGGGAT GCTTTACCTATATGA GTAAATGAGAAGGTG GATAAAAATTAAAAA CeTTTCACTTATGTT 1348 
RetSat+Chromos AAAAGCTTGCTTTGA TTTCAGAATAGGGAT GCTTTACCTATATGA GTAAATGAGAAGGTG GATAAAAATTAAAAA CCTTTCACTTATGTT 1350 
3#25 AAAAGCTTGCTTTGA TTTCAGAATAGGGAT GCTTTACCTATATGA GTAAATGAGAAGGTG GATAAAAATTAAAAA CCTTTCACTTATGTT 1350 
3 3#12 AAAAGCTTGCTTTGA TTT|AGAATAGGGAT GCTTTACCTATATGA GTAAATGAGAAGGTG GATAAAAATTAAAAA CCTTTC|CTTATGTT 1350 
, 1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
11 扑 8 A A A A A A A A A A A A A A A A A A A - 1 3 6 7 
li RetSat+Chromos AAACAAGTGCTAATT TTAGTCTGTTTAAAT ATAGTATTAATACAT GTAATGTTTCAA- - - - 1407 
^ AAACAAGTGCTAATT TTAGTCTGTTTAAAT ATAGTATTAATACAT GTAATGTTTCAAAAA AAAAAAAAAAAAA-- - 1423 




Appendix C: DNA sequencing and alignment result of PPSIG genomic fragments 
Appendix CI: Exon 1 to exon 2 
Template: BAC subclone 1#5, pGIJ-PPSIG (-229/+3031) |SIG3| and pGL3-PPSIG (+94/+3031) |S1G4| 
Matched sequence is highligthed 
701 —00 
M 1 3 R T C G C G C T A G A A C T A C A T T T C C C A T T 
Chromosome TCGCG CTAGAACTAC ATTT'XCATT 
PPSIG-FP(U76) 
801 qOO 
M13R AGGCAATTGA ACTCCTGCTC TGCAAAGATC ATACGGAG6T CCATAATGGA CAATCTTCAT CAGTTTTGAG CAGGCGTGAG TCAAAATGCT TCGGCTCCTC 
RP760 A T G C G G — G T C TGGT -AATCTGCTA CGTGANTTCG TAAGCTTACG T-GNCGNGAT CAAGCTCGTC 
Chromosome AGGCAATTGA ACTCCTGCTC TGCAAAGATC ATACGGAGGT CCATAATGGA CAATCTTCAT CAGTTTTGAG CAGGCGTGAG TCAAAATGCT TCGGCTCCTC 
901 1000 
M13R CAAGTCTGGT ATTACTCCAA GGACGAACTA GAGGGGCGgG GCCTCAGCTA TAAAAGCCGA GCTCAGCGGG GAAAGGACGC GGTCTTCCGA GCCCTGGCAG 
RP760 T C A G N — — G T ATNTCA -GACGAAT-- -AGGGGCGG- --CTC-GCTA TAAAG--CGA GCTCAGCGGG --AAGNACGC G-TCTTCCGA GCNCTG-CAG 
Chromosome CAAGTCTGGT ATTACTCCAA GGACGAACTA GAGGGGCGGG GCCTCAGCTA TAAAAGCCGA GCTCAGCGGG GAAAGGACGC GGTCTTCCGA GCCCTGGCAG 
1001 1100 
M13R CAACATGTGG ATCACTGCTC TGCTGCTGGC CGTGCTGCTG CTGGTGATCC TCCACAGGGT CTACGTGGGC CTTTACGCTG CAAGTTCCCC GAACCCCTTC 
RP760 CAACATGTG- ATCACTGCTC TGCTGCTGG- CGTGCTGCTG CTG-TGATCC TCCACAGG-T CTACGTGGGC CTT-ACGCTG CAAGTTCNCC GAACCCCTTC 
SEQ138 GNNC N--TGCTG-- CGTGCTGCTG CTGGTGATCC TCCACAGGGT CTACGTGGGC CTTTACGCTG CAAGTTCCCC GAACCCCTTC 
Riken ATGTGG ATCACTGCTC TGCTGCTGGC CGTGCTGCTG CTGGTGATCC TCCACAGGGT CTACGTGGGC CTTTACGCTG CAAGTTCCCC GAACCCCTTC 
Chromosome CAACATGTGG ATCACTGCTC TGCTGCTGGC CGTGCTGCTG CTGGTGATCC TCCACAGGGT CTACGTGGGC CTTTACGCTG CAAGTTCCCC GAACCCCTTC 
1101 1200 
M13R GCCGAGGATG TCAAGCGACC GCCTGAACCC CTGGTGACCG ACAAGGAGGC TAGGAAGAAA GTTCTCAAAC AAGGTCAACT GATGGGTTTC AGGCCTGCTC 
RF760 GCCGAGGATG TCAAGCGACC GCCTGNACCC CTGGTGACCG ACAAGGAGGC TAGGAAGAAA GTTCTCAAAC AAGGTCAACT GATGGGTTTC AGGCCTGCTC 
SEQ138 GCCGAGGATG TCAAGCGACC GCCTGAACCC CTGGTGACCG ACAAGGAGGC TAGGAAGAAA GTTCTCAAAC AAGGTCAACT GATGGGTTTC AGGCCTGCTC 
Riken GCCGAGGATG TCAAGCGACC GCCTGAACCC CTGGTGACCG ACAAGGAGGC TAGGAAGAAA GTTCTCAAAC AAGGTCAACT GATGGGTTTC AGGCCTGCTC 
Chromosome GCCGAGGATG TCAAGCGACC GCCTGAACCC CTGGTGACCG ACAAGGAGGC TAGGAAGAAA GTTCTCAAAC AAGGTCAACT GATGGGTTTC AGGCCTGCTC 
1201 1300 
M13R TCNGGCCTTC TGCTCATGTC TNCCCATTAG TAAAGTGCTG GAAAAACTTC TCTTGCACAC AGAGGTTCCA TAATTTAGTG TNCTNNGCTN CTGAAANGGT 
RP760 TCGGGCCTTC TGCTCATGTC TCGCCATTAG T A M G T G C f G GGAAAACTTC TCTTGCACAC AGAGGTTCCA TAATTTAGTG TTCTTTGCTT CTGAAAGGGT 
SEQ138 TCGGGCCTTC TGCTCATGTC TCGCCATTAG TAAAGTGCTG GGAAAACTTC TCTTGCACAC AGAGGTTCCA TAATTTAGTG TTCTTTGCTT CTGAAAGGGT 
Riken TCGGGCCTTC TGCTCATGTC TCGCCATTAG TAAAGTGCTG GGAAAACTTC TCTTGCACAC AGAGGTTCCA TAATTTAGTG TTCTTTGCTT CTGAAAGGGT 
Chromosome TCGGGCCTTC TGCTCATGTC TCGCCATTAG TAAAGTGCTG GGAAAACTTC TCTTGCACAC AGAGGTTCCA TAATTTAGTG TTCTTTGCTT CTGAAAGGGT 
1301 14 00 
M13R GCAGGCATTA CCNTGGGCAC GCCANANTCC AGCCCCGCCA GTGGNANTCN TTTCAGCTCA CNGCNTACAC ANANTANGAN ACCTTCCCNN TACTNNGGTN 
RP760 GCAGGCATTA CCCTTGGCAC GCCAAATTCC AGCCCCGCgA GTTGGAATCT TTTCAGCTCA CGGCTTACAC AGAATAAGAG ACCTTTCCCC TACTTGGGTC 
SEQ138 GCAGGCATTA CCCTTGGCAC GCCAAATTCC AGCCCCGCCA GTTGGAATCT TTTCAGCTCA CGGCTTACAC AGAATAAGAG ACCTTTCCCC TACTTGGGTC 
Riken GCAGGCATTA CCCTTGGCAC GCCAAATTCC AGCCCCGCCA GTTGGAATCT TTTCAGCTCA CGGCTTACAC AGAATAAGAG ACCTTTCCCC TACTTGGGTC 
Chromosome GCAGGCATTA CCCTTGGCAC GCCAAATTCC AGCCCCGCCA GTTGGAATCT TTTCAGCTCA CGGCTTACAC AGAATAAGAG ACCTTTCCCC TACTTGGGTC 
1401 ISOO 
M13R NGNANCCA-C TTTTCCCNAT ACT-CTGT-C ATGCTCGGGN -CAC--NGNA GCAGCACTGN N-GTTNNC-- NACA-GCNGG T-GC 
RP760 TGGAGCCAAC TTTTCCCTAT ACTTCTGTGC ATGCTCGGGC GCACAGGGAA GCAGCACTGA AAGTTTTCCT AACAAGCGGG TTGCAGGCAA NATGTAGTC： 
SEQ138 TGGAGCCAAC TTTTCCCTAT ACTTCTGTGC ATGCTCGGGG GCACANGGAA GCAGCACTGA AAGTNTTCCT AACAAGCNGG TTGCAGGCAA AATGTAGTCC 
Riken TGGAGCCAAC TTTTCCCTAT ACTTCTGTGC ATGCTCGGGG GCACAGGGAA GCAGCACTGA AAGTTTTCCT AACAAGCGGG TTGCAGGCAA AATGTAGTCC 
Chromosome TGGAGCCAAC TTTTCCCTAT ACTTCTGTGC ATGCTCGGGG GCACAGGGAA GCAGCACTGA AAGTTTTCCT AACAAGCGGG TTGCAGGCAA AATGTAGTCC 
1501 1600 
R P 7 6 0 A G T T C A T A G A A C T G A A G C T T G A T A A T A A C T T C G G N A T T T C A G T A C T G G C T A G G G A T N A G A - C T C C A C T C T C C A G T G A C C 
SEQ138 AGTTCATAGA ACTGAAGCTN GATAATAACT TCGGAATTTC AGTACTGGCT AGGGATANGA ACTCCACTCN NCAGTGAACN ATCTCTAAAG CACGTGTAGA 
Riken AGTTCATAGA ACTGAAGCTT GATAATAACT TCGGAATTTC AGTACTGGCT AGGGATAAGA ACTCCACTCT CCAGTGAACC ATCTCTAAAG CACGTGTAGA 
SEQ586 AGTTCATAGA ACTGAAGCTT GATAATAACT TCGGAATTfC AGTACTGGCT AGGGATAAGA ACTCCACTCT CCAGTGAACC ATCTCTAAAG CACGTGTAGA 
Chromosome AGTTCATAGA ACTGAAGCTT GATAATAACT TCGGAATTTC AGTACTGGCT AGGGATAAGA ACTCCACTCT CCAGTGAACC ATCTCTAAAG CACGTGTAGA 
1 6 0 1 I：")!； 
SEQ138 GTGCTCCCAG GNNNTGTGTT NNTGANACTG GTCTCACNTT NGNACNGGAG NTGGGCNTNG ANCTCTCTNC GCAGCCCANG NCTCNAACCC GGNANCAGCC 
Riken GTGCTCCCAA GGTTTGTGTT TTTGAGACTG GTCTCACTTT TGTACTGGAG TTGG-CTTTG AACTCTCTTC GCAGCCCAGG -CTCAAACCC GG-AGCAGCC 
SEQ_I1_586 GTGCTCCCAA GGTTTGTGTT TTTGAGACTG GTCTCACTTT TGTACTGGAG TTGG-CTTTG AACTCTCTTC GCAGCCCAGG -CTCAAACCC GG-AGCAGCC 
Chromosome GTGCTCCCAA GGTTTGTGTT TTTGAGACTG GTCTCACTTT TGTACTGGAG TTGG-CTTTG AACTCTCTTC GCAGCCCAGG -CTCAAACCC GG-AGCAGCC 
1701 “ 1800 
SEQ138 NNNCCTCNTC NGNTCCCCAG CATGNATGNG NATNGAATTA CNANNCANNC NNCNAGCNNN NNTNNNNCNN TCTCNNNCGT TNNTNCGGAA NNNGTTT 
Riken CT-CTTCTTC TG-TCCCCAG CATGATGAGA TAGATTACAA GCATGCACCA GCATGTCTGC CTTTCAACGT TTTACGGAAG TGTTGGAGCT GGGCATAGTG 
SEQ_II_586 CT-CTTCTTC TG-TCCCCAG CATGATGAGA TAGATTACftA GCATGCACCA GCATGTCTGC CTTTCAACGT TTTACGGAAG TGTTGGAGCT GGGCATAGTG 
Chromosome CT-CTTCTTC TG-TCCCCAG CATGATGAGA TAGATTACAA GCATGCACCA GCATGTCTGC CTTTCAACGT TTTACGGAAG TGTTGGAGCT GGGCATAGTG 
SIG3-1492 ；. C TTTTCAACGT TTTACGGAAG TGTTGGAGCT GGGCATAGTG 
1801 1900 
Riken GTGCAACAAT TTAATTCCAG TTTGGACTAC ACAATGAGAC CCTGTCTAAA TGCACACATC AAACCCCAAA ACAACCAAAA CCCCCAAATG CAAAACTTTC 
SEQ_I1_586 G T G C M C A A T TTAATTCCAG TTTGGACTAC ACAATGAGiC CCTGTCTAAA TGCACACATC AAACCCCAAA ACAACCAAAA CCCCCAAATG CAAAACTTTC 
SEQ:I1:14 9 GTGCAACAAT TTAATTCCAG TTNGGACTAC ACNATGAGAC CCTGTCTAAA TGCACACATC ANACCCCAAA CANACCAAAA CCCCCAAATG CAAAACTTTC 
Chromosome GTGCAACAAT TTAATTCCAG TTTGGACTAC ACAATGAGAC CCTGTCTAAA TGCACACATC AAACCCCAAA ACAACCAAAA CCCCCAAATG CAAAACTTTC 
SIG3-1492 GTGCAACAAT TTAATTCCAG TTTGGACTAC ACAATGAGAC CCTGTCTAAA TGCACACATC AAACCCCAAATACAACCAAAA CCCCCAAATG CAAAACTTTC 
” 312 
1901 0^00 
Riken AAAAAACAAA CAAGGATCAC CTCTTTGACC TCCAGGAGCC TCTGACTTGT AAATTTTAGC CAAGCCTAGG CTAGCCTTAA CTGCACTATT TTTTGGGGAC 
SEQ_I1_586 AAAAAACAAA CAAGGATCAC CTCTTTGACC TCCAGGAGHC TCTGACTTGT AAATTTTAGC CAAGCCTANG CTAGCCTTAA CTGCACTATT TTTTGGGGAC 
SEQ:I1:14 9 AAAAAACANA CAAGGATCAC CTCTTTGACC TCCAGGAGCC TCTGACTTGT ANATTTTAGC CAAGCCTAGG CTAGCCTTAA CTGCACTATT TTTTGGGGAC 
Chromosome AAAAAACAAA CAAGGATCAC CTCTTTGACC TCCAGGAGCC TCTGACTTGT AAATTTTAGC CAAGCCTAGG CTAGCCTTAA CTGCACTATT TTTTGGGGAC 
SIG3-1492 AAAAAACAAA CAAGGATCAC CTCTTTGACC TC-AGGAGCC TCTGACTTGT AAATTTTAGC CAAGCCTAGG CTAGCCTTAA CTGCACTATT TTTTGGGGAC 
2001 2100 
Riken TGACTTTGAA CTCCTGATCC TTGTGCCTCT ACTTCCTAAG AGGCACCACA CCCAGTTATT TTATTATTGT TATTGTTTGT GGATTGGGGG AGAGGCAGGT 
SEQ_I1_586 TGACTTNGAA CTCCTGATCC TTGTGCCTCT ACTTCCTAAG AGGCACCACA CCCAGTTATT TTATNATTGT NATTGTTTGT GGATTGGGGG AGAGGCAGGT . 
S E Q : N : 1 4 9 T G A C T T T G A A C T C C T G A T C C T T G T G C C T C T A C T T C C T A A G A G G C A C C A C A C C C A G T T A T T T T A T T A T T G T T A T T G T T T G T G G A T T G G G G G A G A G G C A G G T 
Chromosome TGACTTTGAA CTCCTGATCC TTGTGCCTCT ACTTCCTAAG AGGCACCACA CCCAGTTATT TTATTATTGT TATTGTTTGT GGATTGGGGG AGAGGCAGGT 
SIG3-1492 TGACTTTGAA CTCCTGATCC TTGTGCCTCT ACTTCCTAAG AGGCACCACA CCCAGTTATT TTATTATTGT TATTGTTTGT GGATTGGGGG AGAGGCAGGT 
2101 :':,00 
Riken CTCATACTTG TAGCCCAGGC TAGCTTATAA CTTGCTATAC AGGACAAGTG TGTCTCAAAT TCACAGTGAT TCTCCAACCA CCATCAGCAA GAGATTACAA 
Chromosome CTCATACTTG TAGCCCAGGC TAGCTTATAA CTTGCTATAC AGGACAAGTG TGTCTCAAAT TCACAGTGAT TCTCCAACCA CCATCAGCAA GAGATTACAA 
SEQ_I1_149 CTCATACTTG TAGCCCAGGC TAGCTTATNA CTTGCTATAC AGGACAAGTG TGTCTCAAAT TCACAGTGAT TCTCCAACCA CCATCAGCAA GAGATTACAA 
SIG3-I492 CTCATACTTG TAGCCCAGGC TAGCTTATAA CTTGCTATAC AGGACAAGTG TGTCTCAAAT TCACAGTGAT TCTCCAACCA CCATCAGCAA GAGCTTACAA 
2201 2300 
Riken ATGGTGGGAT TACAGATGTG AGCCACCATG GCTTGGATGG AGATTTTTTT TTTATTTTAT TTTTTTTAGT TTTTAGTTGT TTGAGACAGT GTTTCTCTCT 
Chromosome ATGGTGGGAT TACAGATGTG AGCCACCATG GCTTGGATGG AGATTTTTTT TTTATTTTAT TTTTTTTAGT TTTTAGTTGT TTGAGACAGT GTTTCTCTCT 
SEQ_I1_149 ATGGTGGGAT TACAGATGTG AGCCACCATG GCTTGGATGG AGATTTTTTTTTTTATTTTAT TTTTTTTAGT TTTTAGTTGT TTGAGACAGT GTTTCGTTT 
~ R P T 8 4 5 A N G G G G A A T A A C G A A G G G G G C A C C A A T G G C T N G A A G G G G A A T T T T T T T T T T A T T T T A T T T T T T T T A G T T T T T A G T T G T T T G A G A C A G T G T T T C T C T C T 
SIG3-1492 ATGGTGGGAT TACAGATGTG AGCCACCATG GCTTGGATGG AGATTTTTTT TTTATTTTAT TTTTTTTAGT TTTTAGTTGT TTGAGACAGT GAATCTCTCGT 
2301 1:400 
Riken ATAGTTCTAG ATGTCCTGGA ACTTGCTATT GCTATATAGA CCAGGCTGGC CTTGAACTCA CTGAGATCCT CCCACCTCAG CCTCCTGAGT GCTGAGACTA 
Chromosome ATAGTTCTAG ATGTCCTGGA ACTTGCTATT GCTATATAGA CCAGGCTGGC CTTGAACTCA CTGAGATCCT CCCACCTCAG CCTCCTGAGT GCTGAGACTA 
RP1845 ATAGTTCTAG ATGTCCTGGA ACTTGCTATT GCTATATASA CCAGGCTGGC CTTGAACTCA CTGAGATCCT CCCACCTCAG CCTCCTGAGT GCTGAGACTA 
SEQ_I1_218 CCNTGAGT GCTGAGANCT 
2401 2500 
Riken AAGCTGTGAA CACTTGGCCT TGGGCAATGA TGTTTAATGA GCAGATTTAC TGGACATAGT GGCACATTCC TGTGATCCCA GCGCTGGGGA GGAAAAGACA 
Chromosome AAGCTGTGAA CACTTGGCCT TGGGCAATGA TGTTTAATGA GCAGATTTAC TGGACATAGT GGCACATTCC TGTGATCCCA GCGCTGGGGA GGAAAAGACA 
RP1845 AAGCTGTGNA CACTTGGCCT TGGGCAATGA TGTTTAATGA GCAGATTTAC TGGACATAGT' GGCACATTCC TGTGATCCCA GCGCTGGGGA GGAAAAGACA 
SEQ_I1_218 AAGCTGTGAA CACTTGGCNNTNGNGCAATGA TGTTTAATGA GCAGATTTAC TGNACATAGT GGCACATTCC TGTGATCCCA GCGCTGGGGA GGAAAAGACA 
2501 2600 
Riken GGTGGATCTC TACATAGGGA GTTCCAGCCC AGTTAGGGCT ACATGTGTAG TGAAACCGTG TGTCTTAAAA AACACGAATC AATAAAATCA AAGAAAGTAA 
Chromosome GGTGGATCTC TACATAGGGA GTTCCAGCCC AGTTAGGGCT ACATGTGTAG TGAAACCGTG TGTCTTAAAA AACACGAATC AATAAAATCA AAGAAAGTAA 
S E Q _ N _ 1 6 8 A A A A C N C G A A T C A A T A A A A T C A A A G A A A G T A A 
SEQ~I1~218 GGTGGATCTC TACATAGGGA GTTCCAGCCC AGTTAGGGCT ACATGTGTAG TGAAACCGTG TGTCTTAAAA AACACGAATC AATAAAATCA AAGAAAGTAA 
—RPT84 5 GGTGGATCTC TACATAGGGA GTTCCAGCCC AGTTAGGGCT ACATGTGTAG TGAAACCGTG TGTCTTAAAA AACACGAATC AATAAAATCA AAGAAAGTAA 
2601 2700 
Riken GTAAATAAAG GAGGAAAGGA AGTAAAAGAC TGGGAGAAAA CAACAAATCC CAGGTCTTGT GTTGACCGTG CATTCCAGTT TGGTTCTGTG AGGTTCCCG-
Chromosome GTAAATAAAG GAGGAAAGGA AGTAAAAGAC TGGGAGAAAA CAACAAATCC CAGGTCTTGT GTTGACCGTG CATTCCAGTT TGGTTCTGTG AGGTTCCCG-
SEQ340 TGTAG NNNACGNGTC TAAANNNGAT CATNATCANN GTAGTATAGG GAAGATAAGN CGGNACANNT CCGTTGTGAC GGNNNNTTGT 
RP1845 GTAAATAAAG GAGGAAAGGA AGTAAA-GAC TGGGAGAANA NNCAATCC 
S E Q _ n _ 1 6 8 GTAAATAAAG GAGGAAAGGA AGTAAAAGAC -GGGAGAAAA CAACAAATCC CAGGTCTTGT GTTGACCGTG CATTCCAGTT TGGTTCTGTG AGGTTCCCG-
SEQ:I1:218 GTAAATAAAG GAGGAAAGGA AGTAAAAGAC TGGGAGAAAA CAACAAATCC CAGGTCTTGT GTTGACCGTG CATTCCAGTT TGGTTCTGTG AGGTTCCCG-
2701 2800 
Riken -GCACACCAA CCTTCCTCCT TTTCTGAGGC TGGTGCTGTG ACCTCTCAGA GTAGCAGCCT CTGAGCAGCT CTGCCTGCTC CACCTCCGTT GGCACTCAGA 
Chromosome -GCACACCAA CCTTCCTCCT TTTCTGAGGC TGGTGCTGTG ACCTCTCAGA GTAGCAGCCT CTGAGCAGCT CTGCCTGCTC CACCTCCGTT GGCACTCAGA 
SEQ_I1-168 -GCACACCAA CCTTCCTCCT TTTCTGAGGC TGGTGCTGTG ACCTCTCAGA GTAGCAGCCT CTGAGCAGCT CTGCCTGCTC CACCTCCGTT GGCACTCAGA 
SEQ:I1:218 -GCACACCAA CCTTCCTCCT TTTCTGAGGC TGGTGCTGTG ACCTCTCAGA GTAGCAGCCT CTGAGCAGCT CTGCCTGCTC CACCTCCGTT GGCACTCAGA 
~SEQ34 0 NGNNNNNCNN CNNACCTCTC CTTTCGAG-- CGGNNCTN-G ACCTCTCAGA GTAGCAGCNT CTGAGCAGCT CTGCNNGCTC CACCTCCGTT NGCACTCAGA 
2801 2?00 
Riken GACCTTGCTT CTTCCAAAGA AACCCAGTTC CCTGAACCAC CAGCGTCCCC AGCCCCCACC CTGAGCCTTA TTGCCTTTTC TTTCCTCGCT TGCATTCACA ‘ 
Chromosome GACCTTGCTT CTTCCAAAGA AACCCAGTTC CCTGAACCAC CAGCGTCCCC AGCCCCCACC CTGAGCCTTA TTGCCTTTTC TTTCCTCGCT TGCATTCACA 
SEQ34 0 GACCTTGCTT CTTCCAAAGA NACCCAGTTC CCTGNACCAC CAGCGTCCCC AGCCCCCACC CTGAGCGGTA TTGCCTTTTC TTTCNTCGCT TGCATTCACA 
SEQ_I1_168 GACCTTGCTT CTTCCAAAGA AACCCAGTTC CCTGAACCAC CAGCGTCCCC AGCCCCCACC CTGAGCCTTA TTGCCTTTTC TTTCCTCGCT TGCATTCACA 
SEQ:I1:218 GACCTTGCTT CTTCCAAAGA AACCCAGTTC CCTGAACCAC CAGCGTCCCC AGCCCCCACC CTGAGCCTTA TTGCCTTTTC TTTCCTCGCT TGCATTCACA 
2901 3000 
Riken GAACTGACGT TACAGCCC-T GTGCAGTTGC CATCTTTCTG GTTTTGTTCT ACAGTAGCTA GCTGAGTCAG TCCTACTTCC TTTGAAAGGT ATCAAATCTC 
Chromosome GAACTGACGT TACAGCCC-T GTGCAGTTGC CATCTTTCTG GTTTTGTTCT ACAGTAGCTA GCTGAGTCAG TCCTACTTCC TTTGAAAGGT ATCAAATCCC 
SEQ340 GAACTGACGT TACAGCCCCT GTGCAGTTGC CATCTTTCTG GTTTTGTTCT ACAGTAGCTA GCTGAGTCAG TCCTACTTCC TTTGAAAGGT ATCAAATCCC 
SEQ_I1_168 GAACTGACGT TACAGCCC-T GTGCAGTTGC CATCTTTCTG GTTTTGTTCT ACAGTAGCTA GCTGAGTCAG TCCTACTTCC TTTGAAAGGT ATCAAATCCC 
S E Q ~ I 1 ~ 2 1 8 GAACTGACGT T A C A G C C C - T GTGCAGTTGC C A T C T T T C T G G T T T T G T T C T ACAGTAGCTA GCTGAGTCAG T C C T A C T T C C TTTGAAAGGT ATC 
一 M13F TNTCTG GTTTTGGTTCTACNNTANNTA GCTGAGTCAG TCCTACTTCC TTTGAAAGGT ATCAAATCCC 
SIG3-2635 TGACGT TACAGCCCCT GTGCAGTTGC CATCTTTCTG GTTTTGTTCT ACAGTAGCTA GCTGAGTCAG TCCTACTTCC TTTGAAAGGT ATCAAATCCC 
SIG4-2635 CTGTGC AAGTTGCCAT CTTTGCGTGG TTTTGTTTCT ACAGTAGCTA GCTGAGTCAG TCCTACTTCC TTTGAAAGGT ATCAAATCCC 
3001 3100 
Riken TCAAGTACAC" TGTAGGGGTT AAGACTCATC ACTGCTTAAC CTGCCTGTCT GGTCCGAGGT ATTCCCTGGT AGAATGTTTT GAGACATCTT AGTCAAGAGT 
Chromosome TCAAGTACAC TGTAGGGGTT AAGACTCATC ACTGCTTAAC CTGCCTGTCT GGTCCGAGGT ATTCCCTGGT AGAATGTTTT GAGACATCTT AGTCAAGAGT 
SEQ340 TCAAGTACAC TGTAGGGGTT AAGACTCATC ACTGGTTA&C CTGCCTGTCT GGTCCGAGGT ATTCCCTGGT AGAATGTTTT GAGACATCTT AGTCAAGAGT 
SEQ_I1_168 TCAAGTACAC TGTAGGGGTT AAGACTCATC ACTGCTTAAC CTGCCTGTCT GGTCCGAGGT ATTCCCTGGT AGAATGTTTT GAGACATCTT AGTCAAGAGT 
M13F TCAAGTACAC TGTAGGGGTT AAGACTCATC ACTGCTTNNC NTGCCTGTCT GGTCCGAGGT ATTCCCTGGT AGAATGTTTT GAGACATCTT AGTCAAGAGT 
S1G3-2635 TCAAGTACAC TGTAGGGGTT AAGACTCATC ACTGCTTAAC CTGCCTGTCC GGTCCGAGGT ATTCCCTGGT AGAATGTTTT GAGACATCTT AGTCAAGAGT 
SIG4-2635 TCAAGTACAC TGTAGGGGTT AAGACTCATC ACTGCTTAAC CTGCCTGTCT GGTCCGAGGT ATTCCCTGGT AGAATGTTTT GAGACATCTT AGTCAAGAGT 
- 313 
3101 3200 
Riken AAATAAACTA CCTTAAAAGA AAGGTCTGCC TTCCCTCTTG TTTTGAGACT GGGTCTAACG AGCCCAGGCT GGCCTCCTGT GGGATGATCT TGGCCTCCTA 
Chromosome AAATAAACTA CCTTAAAAGA AAGGTCTGCC TTCCCTCTTG TTTTGAGACT GGGTCTAACG AGCCCAGGCT GGCCTCCTGT GGGATGATCT TGGCCTCCTA 
SEQ340 AAATAAACTA CCTTAAAAGA AAGGTCTGCC NTCCCTCTTG TTTNGAGACT GGGTCTAACG AGCCCAGGCT GGCCTCCTGT GGGANGATCT TGGCCTCCTN 
SEQ_I1_168 AAATAAACTA CCTTAANAGA AAGGTCTGCC CTCCCTCTTG TTTTGAGACT GGNTCTAACG ANCCCANGCT GGCCTCNGNT GGAATGATCT -GGGCTCCTA 
- M 1 3 F ANATANACTA CCTTAAAAGA AAGGTCTGCC CTCCCTCTTG TTTTGAGACT GGGTCTAACG AGCCCAGGCT GGCCTCCTGT GGGATGATCT TGGCCTCCTA 
SIG3-2635 AAATAAACTA CCTTAAAAGA AAGGTCTGCC TTCCCTCTTG TTTTGAGACT GGGTCTAACG AGCCCAGGCT GGCCTCCTGT GGGATGATCT TGGCCTCCTA 
SIG4-2635 AAATAAACTA CCTTAAAAGA AAGGTCTGCC TTCCCTCTTG TTTTGAGACT GGGTCTAACG AGCCCAGGCT GGCCTCCTGT GGGATGATCT TGGCCTCCTA 
3201 3300 . 
Riken ATGCACCTTT CAAGTGCTCC CATCACAGGA GTACACCACC ATGCCCAGCA GCCGTAGAGA CTTCTTACCG AGTACACGTT AGAGAAGGAC CCCGGCTTCT 
Chromosome ATGCACCTTT CAAGTGCTCC CATCACAGGA GTACACCACC ATGCCCAGCA GCCGTAGAGA CTTCTTACCG AGTACACGTT AGAGAAGGAC CC'JGGCTTCT 
SEQ340 ATGCACCTTT CAAGTGCTCC CATCACAGGA GTACACCACC A-GCCCAGCA GCCGTAGAGA CTTCTTACCG AGTACACGTT AGAGAAGNAC CCCGGCTTCN 
SEQ_I1_168 NTGCACCTTN CA-GNGCTCC -AT-ACAAGA GTACNN-ANC ATGCCC-GCA GNNGT-NAGA CNTCT-ANCG AGTAC-CGTT 
- M 1 3 F ATGCACCTTT CAAGTGCTCC CATCACAGGA GTACACCACC ATGCCCAGCA GCCGTAGAGA CTTCTTACCG AGTACACGTT AGAGAAGGAC CCCGGCTTCT 
SIG3-2635 ATGCACCTTT CAAGTGCTCC CATCACAGGA GTACACCACC ATGCCCAGCG GCCGTAGAGA CTTCTTACCG AGTACACGTT AGAGAAGGAC CCCGGCTTCT 
SIG4-2635 ATGCACCTTT CAAGTGCTCC CATCACAGGA ATACACCACC ATGCCCAGCA GCCGTAGAGA CTTCTTACCG AGTACACGTT AGAGAAGGAC CCCGGCTTCT 
3301 3400 
Riken TTGACTTGAC TTTCCTGCCC TCGTCTGAGA AGCTCACCCT TCTCCTCCCT TCTACAGCTT TCTCAGTCAG CCGAGTACCA GAGAAGCTGG ATGCAGTGGT 
Chromosome TTGACTTGAC TTTCCTGCCC TCGTCTGAGA AGCTCACCCT TCTCCTCCCT TCTACAGCTT TCTCAGTCAG CCGAGTACCA GAGAAGCTGG ATGCAGTGGT 
SEQ34 0 N-GACT-GAC TT-CCNGCCC TCGTCTGAG 
M13F TTGACTTGAC TTTCCTGCCC TCGTCTGAGA AGCTCACCCT TCTCCTCCCT TCTACAGCTT TCTCAGTCAG CCGAGTACCA GAGAAGCTGG ATGCAGTGGT 
SIG3-2635 TTGACTTGAC TTTCCTGCCC TCGTCTGAGA AGCTCACCCT TCTCCTCCCT TCTACAGCTT TCTCAGTCAG CCGAGTACCA GAGAAGCTGG ATGCAGTGGT 
SIG4-2635 TTGACTTGAC TTTCCTGCCC TCGTCTGAGA AGCTCACCCT TCTCCTCCCT TCTACAGCTT TCTCAGTCAG CCGAGTACCA GAGAAGCTGG ATGCAGTGGT 
SEQ_I1_215 TTGACT-GAC TTTCCTGCCC TCGTCTGAGA AGCTCACCCT TCTCCTCCCT TCTACAGCTT TCTCAGTCAG CCGAGTACCA GAGAAGCTGG ATGCAGTGGT 
PPSIG-RP2635 
3401 3500 
Riken GATCGGCAGC GGCATTGGGG GACTGGCCTC AGCTGCGGTT CTAGCTAAAG CTGGCAAGAG AGTCCTTGTG CTGGAACAAC ATACCAAGGC GGGC 
Chromosome GATCGGCAGC GGCATTGGGG GACTGGCCTC AGCTGCGGTT CTAGCTAAAG CTGGCAAGAG AGTCCTTGTG CTGGAACAAC ATACCAAGGC GGGC 
M13F GATCGGCAGC GGCATTGGGG GACTGGCCTC AGCTGCGGTT CTAGCTAAAG CTGGCAAGAG AGTCCTTGTG CTGGAACAAC ATACCAAGGC GGGC 
SIG3-2635 GATCGGCAGC GGCATGTGGG GGACTGCCTC AGCTGC 
SIG4-2635 GATCGGCAGC GGCATG-GGG GGACTGCCTC AGCTGCG • 
SEQ_I1_215 GATCNGCAGC GGCATG GGG GACTGGC-TC AGCTGCGGNN --TACTAA-G CTGGCNNANN NCT-GT CTNNACAC-- --TACAGCGN 
- 314 
Appendix C2. Exon 2 to exon 3 
Template: BAC subclone 2U2 and pGL3-PPSIG (+94/+3031) |S1G4| 
PPSIG-FP2574 
3401 3500 
M13R A NN-GCCTNNN GNTNTGNNAN CTGCAGGAGT C--TGTGCTG GA CACA ACCAGGCGGC --GCTGT-GT 
Riken C TGCGGTTCTA GCTAAAGCTG GCAAGAGAGT CCTTGTGCTG GAACAACATA CCAAGGCGGG CGGCTGTTGT 
Chromosome C TGCGGTTCTA GCTAAAGCTG GCAAGAGAGT CCTTGTGCTG GAACAACATA CCAAGGCGGG CGGCTGTTGT 
SEQ535 C TGCGGTTCfA GCTAAAGCTG GCAAGAGAGT CCTTGTGCTG GAACAACATA CCAAGGCGGG CGGCTGTTGT 
3501 3600 
M13R CATACC--TT GGG-GNAA-- TGNCC-T-GA ATTNGACACT GGNA-GGCTN GTGTG-GNNA -GGGTTAGGA GCATGGCNTT GTCTTTAGAT GGCTNATAAC 
Riken CATACC--TT TGG-GGAAAA TGGCC-TTGA ATTTGACACT GGTAAGGCTT GTGTG-GGAA AGGGTTAGGA GCATGGCCTT GTCTTTAGAT GGCTAATAAC 
Chromosome CATACC--TT TGG-GGAAAA TGGCC-TTGA ATTTGACACT GGTAAGGCTT GTGTG-GGAA AGGGTTAGGA GCATGGCCTT GTCTTTAGAT GGCTAATAAC 
SIG4-GL2AP CAGACCCTTT GGGTGGAAAA TGGCCCTTGA ATTTGACGCT GGTAAGGCTT GTGTGTGGAA AGGGTTAGGA GCATGTCCTT GTCTTTAGAT GGCTAATAAC 
SEQ535 CATACC--TT TGG-GGAAAA TGGCC-TTGA ATTTGACAI^T GGTAAGGCTT GTGTG-GGAA AGGGTTAGGA GCATGGCCTT GTCTTTAGAT GGCTAATAAC 
3601 3700 
M13R ACACACTATT GAGTGACATG GGGGCATNTT NATGTTTGG- GGTCTCNACT TCTCTCTGGG CACCTCCATT TCTGTCCGAT GGCNTAGTTA CTGGGCAAGC 
Riken ACACACTATT GAGTGACATG GGGGCATTTT AATGTTTGGA GGTCTCAACT TCTCTCTGGG CACCTCCATT TCTGTCCGAT GGCCTAGTTA CTGGGCAAGC 
Chromosome ACACACTATT GAGTGACATG GGGGCATTTT AATGTTTGGA GGTCTCAACT TCTCTCTGGG CACCTCCATT TCTGTCCGAT GGCCTAGTTA CTGGGCAAGC 
SIG4-GL2AP ACACACTATT GAGTGACATG GGGGCATTTT AATGTTTGGA GGTCTCAACT TCTCTCCGGG CACCTCCATT TCTGTCCGAT GGCCTAGTTA CTGGGCAAGC 
SEQ535 ACACACTATT GAGTGACATG GGGGCATTTT AATGTTTGGA GGTCTCAACT TCTCTCTGGG CACCTCCATT TCTGTCCGAT GGCCTAGTTA CTGGGCAAGC 
3701 3800 
M13R ATTGGGTGGT ATATGTTCTG ATTTGTTTCT TATAGAAAGG GTGGGCAGCC CCCCTCTGGA CATGAACATA GCCAAGCAGG ACAACCTCTT CCTTACTTGG 
Riken ATTGGGTGGT ATATGTTCTG ATTTGTTTCT TATAGAAAGG GTGGGCAGCC CCCCTCTGGA CATGAACATA GCCAAGCAGG ACAACCTCTT CCTTACTTGG 
Chromosome ATTGGGTGGT ATATGTTCTG ATTTGTTTCT TATAGAAAGG GTGGGCAGCC CCCCTCTGGA CATGAACATA GCCAAGCAGG ACAACCTCTT CCTTACTTGG 
SIG^-GL2AP ATTGGGTGGT ATATGTTCTG ATTTGTTTCT TATAGAAAGG GTGGGCAGCC CCCCTCTGGA CATGAACATA GCCAAGCAGG ACAACCTCTT CCTTACTTGG 
SEQ535 ATTGGGTGGT ATATGTTCTG ATTTGTTTCT TATAGAAAGG GTGGGCAGCC CCCCTCTGGA CATGAACATA GCCAAGCAGG ACNACCTCTT CCTTACTTGG 
3801 - 3900 
M13R CATATTTCCA GGGCCCAATC CCTTTTATCT CTATATCTGC TTTCCTTTGC ACCTCCCAAC AGGAATTCAT TATATTGGAC GAATGCGGGA GGGCNACATT 
Riken CATATTTCCA GGGCCCAATC CCTTTTATCT CTATATCTCC TTTCCTTTGC ACCTCCCAAC AGGAATTCAT TATATTGGAC GAATGCGGGA GGGCAACATT 
Chromosome CATATTTCCA GGGCCCAATC CCTTTTATCT CTATATCTCC TTTCCTTTGC ACCTCCCAAC AGGAATTCAT TATATTGGAC GAATGCGGGA GGGCAACATT 
SIG4-GL2AP CATATTTC-A GGGCCCAATC CCTTTTATCT CTATATCItC TTTCCTTTGC ACCTCCCAAC AGGAATTCAT TATATTGGAC GAATGCGGGA GGGCAACATT 
SEQ535 CATATTTCCA GG-CCCNATC CCTTT-ATCT CTATATCTNN N 
^ 
3901 4000 
M13R GGCCGTTTTA TCTTGGACCA GATCACTGAA GGGCAACTdG ACTGGGCCCC CATGGCCTCC CCTTTTGACT TGATGATACT AGAAGGGCCC AATGGCCGAA 
Riken GGCCGTTTTA TCTTGGACCA GATCACTGAA GGGCAACTGG ACTGGGCCCC CATGGCCTCC CCTTTTGACT TGATGATACT AGAAGGGCCC AATGGCCGAA 
Chromosome GGCCGTTTTA TCTTGGACCA GATCACTGAA GGGCAACTGG ACTGGGCCCC CATGGCCTCC CCTTTTGACT TGATGATACT AGAAGGGCCC AATGGCCGAA 
SIG4-GL2AP GGCCGTTTTA TCTTGGACCA GATCACTGAA GGGCAACTGG ACTGGGCCCC CATGGCCTCC CCTTTTGACT TGATGATACT AGAAGGGCCC AATGGCCGAA 
4001 4100 
M13R AGGAGTTCCC CATGTACAGT GGGAGGAAAG NATACATCCA GGGCC 
Riken AGGAGTTCCC CATGTACAGT GGGAGGAAAG AATACATCCA GGGCC 
Chromosome AGGAGTTCCC CATGTACAGT GGGAGGAAAG AATACATCCA GGGCC 




Appendix C3: Exon 3 to exon 4 
Template: BAC subclone 3#1，pGL3-PPSIG (+94/+3031) |SIG41，pGL3-Pro 2 [ProZ] and pGL3-Pro 3 [ProS] 
PPSIG-FP3040 
3901 4000 
Riken GGCCGT TTTATCTTGG ACCAGATCAC TGAAGGGCAA CT--GGACTG GG-CCCCCAT GGCC-TCCCC TTTTGA--CT TGATGATACT 
Chromosome GGCCGT TTTATCTTGG ACCAGATCAC TGAAGGGCAA CT--GGACTG GG-CCCCCAT GGCC-TCCCC TTTTGA--CT TGATGATACT 
RP3545JUN GNCCGT TTATN--TGN ACCAGATCAC TGA-GGGCNA CT--GGACTG GG-CCCCCAT GCC--TCNCC TTTTGA--CT TGATGATACT 
SIG4-GL2AP GGCCGT TTTATCTTGG ACCAGATCAC TGAAGGGCAA CT--GGACTG GG-CCCCCAT GGCC-TCCCC TTTTGA--CT TGATGATACT 
4001 4100 
Riken AGAA--GGGC CC--AATGGC CGAAAGGAGT T--CCC-CAT GTAC---AGT GGG--AGGAA AGAATACATC CAG-GGCCTT AAG--AAGAA GTTCCC---C 
Chromosome AGAA--GGGC CC--AATGGC CGAAAGGAGT T--CCC-CAT GTAC---AGT GGG--AGGAA AGAATACATC CAG-GGCCTT AAG--AAGAA GTTCCC…C 
RP3545JUN AGAA--GGGC CC--AATGGC CGAAAGGAGT T---CCCCAT GTAC---AGT GGG--AGGAA AGAATACATC CAG-GGCCTT AAG--AAGAA GTTCCC——C 
SIG4-GL2AP AGAA--GGGC CC--AATGGC CGAAAGGAGT T——CCCCAT GTAC---AGT GGG--AGGAA AGAATACAT- CAGAGGCCCC GCG--TCGAG ATCTGCGATC 
4101 4200 
-RP3971JUN AGGGAAGAG- ---GCNGTCA NTNNCANGTA CATGGAGNTN GGTT--AGGG TAGTATGCNN NATG--AATA GCATNCCTAG TTT---ATTT NCNNACNAGA 
Pro2-3198J G -NNNATGCAC CNTG--ATTA GCATCCCTAG TT TATT TCCAC-AAGA 
Pro3-3198J G--NTTN NNATCCCTAG TT TATT TCCAC--AGA 
Riken AAGGAAGAA- ---GCTGTCA TTGACAAGTA CATGGAGTTG G--TTAAGGT -AGTATGCAC CATG--ATTA GCATCCCTAG TT TATT TCCAACAAGA 
Chromosome AAGGAAGAA- ——GCTGTCA TTGACAAGTA CATGGAGTTG G--TTAAGGT -AGTATGCAC CATG--ATTA GCATCCCTAG TT TATT TCCAACAAGA 
RP3545JUN AAGGAAGAA- ---GCTGTCA TTGACAAGTA CATGGAGTTG G--TTAAGGT -AGTATGCAC CATG--ATTA GCATCCCTAG TT TATT TCCAACAAGA 
RP3198JUL GTTAAGGT -AGTATGCAC CATG--ATTA GCATCCCTAG TT TATT TCCAACAAGA 
SIG4-GL2AP TAATATAAAN GC-ATTGCCG TACTGTTGTA ACCACCATT 
4201 4300 
-RP3971JUN CT--GGCCTT TTCATTAGTG AAG--AAACT GGTGGG-GTA GGA--GGAGA GGGCT-GAGT --GGGAGNCA GGANGNNATG G--TCATGTC TGTCNTGGTT 
Pro2-3198J CT--GGCCTT TTCATTAGTG AAG--AAACT GGTGGG-GTA GGA--GGAGA GGGCT-GAGT TGGGGAGGCA GGAAGGAATG G--TCATGTC TGTCCTGGTT 
Pro3-3198J CT--GGCCTT TTCATTAGTG AAG--AAACT GGTGGG-GTA GGA--GGAGA GGGCT-GAGT TGGGGAGGCA GGAAGGAATG G--TCATGTC TGTCCTGGTT 
Riken CT--GGCCTT TTCATTAGTG AAG--AAACT GGTGGG-GTA GGA--GGAGA GGGCT-GAGT TGGGGAGGCA GGAAGGAATG G—TCATGTC TGTCCTGGTT 
Chromosome CT--GGCCTT TTCATTAGTG AAG--AAACT GGTGGG-GTA GGA--GGAGA GGGCT-GAGT TGGGGAGGCA GGAAGGAATG G--TCATGTC TGTCCTGGTT 
Pro2-3971J CGTGGGCTTT TTCCNTTNNG AAAGNAACCT GGTTGGTGTA GGAANGAGGA GGGCTTGAAT TGGGGANGCA GGAANGGAAG GGNTNATGTC TTTNCNGGTT 
RP3545JUN CT--GGCCTT TTCATTAGTG AAG--AAACT GGTGGG-GTA GGA--GGAGA GGGCT-GAGT T-GGGAGGCA GGAAGGAATG G--TCATGTC TGTCCTGGTT 
RP3198JUL CT--GGCCTT TTCATTAGTG AAG--AAACT GGTGGG-GTA GGA--GGAGA GGGCT-GAGT T-GGGAGGCA GGAAGGAATG G--TCATGTC TGTCCTGGTT 
4301 4400 
-RP3971JUN -CCAGTGTN- AGCTTGTGTT TGCCTG-TGC CCTGCTTGGC TCCCCAGCTG -CAGTCC-TC A--CACTGGC CT-CTA-GAT GGTACCC-TT GCTAAGTCAG 
Pro2-3198J -CCAGTGTA- AGCTTGTGTT TGCCCGGTGC CCTGCTTGGC TCCCCAGCTG -CAGTCC-TC A--CACTGGC CT-CTA-GAT GGTACCC-TT GCTAAGTCAG 
Pro3-3198J -CCAGTGTA- AGCTTGTGTT TGCCTG-TGC CCTGCTTGGC TCCCCAGCTG -CAGTCC-TC A--CACTGGC CT-CTA-GAT GGTACCC-TT GCTAAGTCAG 
Riken -CCAGTGTA- AGCTTGTGTT TGCCTG-TGC CCTGCTTGGC TCCCCAGCTG -CAGTCC-TC A--CACTGGC CT-CTA-GAT GGTACCC-TT GCTAAGTCAG 
Chromosome -CCAGTGTA- AGCTTGTGTT TGCCTG-TGC CCTGCTTGGC TCCCCAGCTG -CAGTCC-TC A--CACTGGC CT-CTA-GAT GGTACCC-TT GCTAAGTCAG 
Pro2-3971J NCAAGTGTAN GGTTTNTGTT GGCCNG-TNC CCTGNTNGGT TCCCNAGNTG ACNGTCCNTC AGCAACTGGC CTTCTANGAN GGTACCCNTT NNTAAGTCAG 
RP3545JUN -CCAGTGTA- AGCTTGTGTT TGCCTG-TGC CCTGCTTGGC TCCCCAGCTG -CAGTCC-TC A--CACTGGC CT-CTA-GAT GGTACCC-TT GCTAAGTCAG 
RP3198JUL -CCAGTGTA- AGCTTGTGTT TGCCTG-TGC CCTGCTTGGC TCCCCAGCTG -CAGTCC-TC A--CACTGGC CT-CTA-GAT GGTACCC-TT GCTAAGTCAG 
4401 4500 
-RP3 971JUN GCTTT-GAGG AAGTTAGATG TCC-TCTGAG ATATGCCAGA CTTTTGTGTA TTTGAGGTAG AGTCTCACAA T-GCTGCCCT GGCTGGTCTG GNACTCAGCA 
Pro2-3198J GCTTT-GAGG AAGTTAGATG TCC-TCTGAG ATATGCCAGA CTTTTGTGTA TTTGAGGTAG AGTCTCACAA T-GCTGCCCT GGCTGGTCTG GAACTCAGCA 
Pro3-3198J GCTTT-GAGG AAGTTAGATG TCC-TCTGAG ATATGCCAGA CTTTTGTGTA TTTGAGGTAG AGTCTCACAA T-GCTGCCCT GGCTGGTCTG GAACTCAGCA 
Riken GCTTT-GAGG AAGTTAGATG TCC-TCTGAG ATATGCCAGA CTTTTGTGTA TTTGAGGTAG AGTCTCACAA T-GCTGCCCT GGCTGGTCTG GAACTCAGCA 
Chromosome GCTTT-GAGG AAGTTAGATG TCC-TCTGAG ATATGCCAGA CTTTTGTGTA TTTGAGGTAG AGTCTCACAA T-GCTGCCCT GGCTGGTCTG GAACTCAGCA 
Pro2-3971J GCTTTCGAGG AAGTTAGATG TCCCTCCGAG ATATGCCAGA NTTTNGTGTA TTTGAGGTAG AGTNTCACAA TNGCTGCCCT GGCTGGTCTG GAACTCAGCA 
RP3545JUN GCTTT-GAGG AAGTTAGATG TCC-TCTGAG ATAAA 
RP3198JUL GCTTT-GAGG AAGTTAGATG TCC-TCTGAG ATATGCCAGA CTTTTGTGTA TTTGAGGTAG AGTCTCACAA T-GCTGCCCT GGCTGGTCTG GAACTCAGCA 
4501 4600 
-RP3 971JUN GAGATC-CAC CTGCCTCTGC CGAGCATATG AAATCATAAC CTGCTTTCTG GACCAGGATG TTTGGAAGGA ATCTGAATGC TGGGGATGTG GCTCAGGCTT 
Pro2-3198J GAGATC-CAC CTGCCTCTGC CGAGCATATG AAATCATAAC CTGCTTTCTG GACCAGGATG TTTGGAAGGA ATCTGAATGC TGGGGATGTG GCTCAGGCTT 
Pro3-3198J GAGATC-CAC CTGCCTCTGC CGAGCATATG AAATCATAAC CTGCTTTCTG GACCAGGATG TTTGGAAGGA ATCTGAATGC TGGGGATGTG GCTCAGGCTT 
Riken GAGATC-CAC CTGCCTCTGC CGAGCATATG AAATCATAAC CTGCTTTCTG GACCAGGATG TTTGGAAGGA ATCTGAATGC TGGGGATGTG GCTCAGGCTT 
Chromosome GAGATC-CAC CTGCCTCTGC CGAGCATATG AAATCATAAC CTGCTTTCTG GACCAGGATG TTTGGAAGGA ATCTGAATGC TGGGGATGTG GCTCAGGCTT 
Pro2-3971J GAGATNNCAC CNGCCTCTGC CGAGCATATG AAATCATAAC CTGCTTTCTG GACCAGGATG TTNGGAAGGA ATCTGAANGC TGGGGATGTG GCTCAGGCTT 
RP3198JUL GAGATC-CAC CTGCCTCTGC CGAGCATATG AAATCATAAC CTGCTTTCTG GACCAGGATG TTTGG 
4601 4700 
M13RJUN AC TGANGATGTG GTGCGATCAG ATGNAGCGAG 
RP4 376JUL NAATCCC AGCATTGGGG AGGCAGAAGC AGNNAGTTCA 
-RP3971JUN AGCACATACA ACTCTGAATT ATATCCCAAG CACCTTAGCA TCTGGATATG ATGGTGTAGC CTGTAATCCC AGCATTGGGG AGGCAGAAGC AGGAAGTTCA 
Pro2-3198J AGCACATACA ACTCTGAATT ATATCCCAAG CACCTTAGCA TCTGGATATG ATGGTGTAGC CTGTAATCCC AGCATTGGGG AGGCAGAAGC NNGAAGTTCA 
Pro3-3198J AGCACATAtA ACTCTGAATT ATATCCCAAG CACCTTAGCA TCTGGATATG ATGGTGTAGC CTGTAATCCC AGCATTGGGG AGGCAGAAGC AGGAAGTTCA 
Riken AGCACATACA ACTCTGAATT ATATCCCAAG CACCTTAGCA TCTGGATATG ATGGTGTAGC CTGTAATCCC AGCATTGGGG AGGCAGAAGC AGGAAGTTCA 
Chromosome AGCACATACA ACTCTGAATT ATATCCCAAG CACCTTAGCA TCTGGATATG ATGGTGTAGC CTGTAATCCC AGCATTGGGG AGGCAGAAGC AGGAAGTTCA 
E*ro2-3971J AGCACATACA ACTCTGAATT ATATCCCAAG CACNTTAGCA TCTGGATATG ATGGTGTAGC CTGTAATCCC AGCATTGGGG AGGCAGAAGC AGGAAGTTCA 
‘ 316 
4701 4800 
M13RJUN AGAGT-C-AG AGTCAGTACT GNATATTGN- ACN---TNNA NATAAAGAAA ACA-TACTTT T--GAGCAT- AAATGGA-GA GCAAATAGTC CCANTTGAGT 
RP4 376JUL GGAGTTC-AA GGTCACTG-- GNATATTGGG ACTCTCTATA TAAAAGAAAA ACAATACTTT TTGGAGCATG AAATGGAAGA GCAAATAGTC CCATTTGAGT 
-RP3971JUN GGAGTTC-AA GGTCAC-TGG AATATTTGGA ACTCTCTATA TAAAAGAAAA ACAATACTTT TTGGAGCATG AAATGGAAGA GCAA-TAGTC CCATTTGAGT 
Pro2-3198J GGAGTTC-AA GGTCAC-TGG AATATTNG-A ACTCTCTATA TAAAA-AAAA ACAATACTTT TTGGAGCATG AAATGGAANA GCAA-TAGTC TCATTTGAGT 
Pro3-3198J GGAGTTC-AA GGTCAC-TGG AATATTTGGA ACTCTCTATA TAAAAGAAAA ACAATACTTT TTGGAGCATG AAATGGAAGA GCAAATAGTC TCATTTGAGT 
Riken GGAGTTC-AA GGTCAC-TGG AATATTTGGA ACTCTCTATA TAAAAGAAAA ACAATACTTT TTGGAGCATG AAATGGAAGA GCAAATAGTC TCATTTGAGT 
Chromosome GGAGTTC-AA GGTCAC-TGG AATATTTGGA ACTCTCTATA TAAAAGAAAA ACAATACTTT TTGGAGCATG AAATGGAAGA GCAAATAGTC TCATTTGAGT 
Pro2-3971J GGAGTTCNAA GGTCACCTGG AATATTTGGA ACTCTCTATA TAAAAGAAAA ACAATACTTT TTGGAGCATG AAATGGAAGA GCAAATAGTC TCATTTGAGT 
4801 4900 
M13RJUN GCGNAGAATG AGAAANACT- CAGGACCCAT NNTGTTGTTG TTTTGTGGTG AGGAAGACAG CTCTACTACA TAGTCCTGGC -TTCTATGTC AGTGTATAGC 
RP4 3 76JUL GCGAAGAATG AGAAAAACT- CAGGACCCAT TTTGTTGTTG TTTTGTGGTG AGGAAGACAG CTCTACTACA TAGTCCTGGC -TTCTATGTC AGTGTATAGC 
-RP3 971JUN GCGAAGAATG AGAAAAACT- CAGGACCCAT TTTGTTGTTG TTTTGTGGTG AGGAAGACAG CTCTA 
Pro2-3198J GCGAA-AATG AGAAAAACT- CNGGACCC-T TTTGTTGTTG TTTTGTGGTG ANGAA-ANAG CNCTACTACA TAGTCCTGGC -T-CTTAGTC NNTGTTAANC 
Pro3-3198J GCGAAGAATG AGAAAAACT- CAGGACCCAT TTTGTTGTTG TTTTGTGGTG AGGAAGACAG CTCTACTACA TAGTCCTGGC -TTCTATGTC AGTGTATAGC 
Riken GCGAAGAATG AGAAAAACT- CAGGACCCAT TTTGTTGTTG TTTTGTGGTG AGGAAGACAG CTCTACTACA TAGTCCTGGC -TTCTATGTC AGTGTATAGC 
Chromosome GCGAAGAATG AGAAAAACT- CAGGACCCAT TTTGTTGTTG TTTTGTGGTG AGGAAGACAG CTCTACTACA TAGTCCTGGC -TTCTATGTC AGTGTATAGC 
Pro2-3971J GCGAAGAATG AGAAAAANTG CAGGACCCAC TTTGTTGTTG NTN-GTGGTG AGGAAGGCNG TNCNNNNNCN NNNNNGNNAA GNNCGCCNTC NNTNNNNANG 
4901 5000 
M13RJUN TCTGGT-GCC CTTAAACTCA TGGCAATCCT CCTGCTGTAG CATCTCAACT GTTGGGATCA CAGGCNTGAG TCTGATCACA CACACCATGC CTAAAAAAAA 
RP4376JUL TCTGGTTGCC CTTAAACTCA TGGCAATCCT CCTGCTGTAG CATCTCAACT GTTGGGATCA CAGGCCTGAG TCTGATCACA CACACCATGC CTAAAAAAAA 
Pro2-3198J -CTNGNTGNC CTTNA-CTCA TGGNAANC-N CCTGCTGN-N CNT-NCAACT GNNGGGATNN -AGGNCTGAN TTTATNCAC- --CCCCNTGC CTAAAAAA--
Pro3-3198J TCTGGTTGCC CTTAAACTCA TGGCAATCCT CCTGCTGTAG CATCTCANCT GTTGGGATCA CAGGCCTGAG TCTGATCACN C-CACCATGC CTAAAAAAA-
Riken TCTGGTTGCC CTTAAACTCA TGGCAATCCT CCTGCTGTAG CATCTCAACT GTTGGGATCA CAGGCCTGAG TCTGATCACA CACACCATGC CTAAAAAAAA 
Chromosome TCTGGTTGCC CTTAAACTCA TGGCAATCCT CCTGCTGTAG CATCTCAACT GTTGGGATCA CAGGCCTGAG TCTGATCACA CACACCATGC CTAAAAAAAA 
5001 5100 
M13RJUN TTTTCAAGTC CAAAAATTCT GAGTAAGTGT TGCTGGGCTG GCAGTCAGCG CTGACTGCTG CAGCAGTAAC TAGGCTCCAG CACCCCAGAG CTGAGACTCA 
RP4 376JUL TTTTCAAGTC CAAAAATTCT GAGTAAGTGT TGCTGGGCTG GCAGTCAGCG CTGACTGCTG CAGCAGTAAC TAGGCTCCAG CACCCCAGAG CTGAGACTCA 
Pro3-3198J TTTTCAAGTC CAAAA-TTCT GANTAANTGT TGCTGGGCTG GCANTCANCG CTNACTGCTG CANCA--TAC TAGGCTCCAN CNCCCNA-AN CTGAAACNC-
Riken TTTTCAAGTC CAAAAATTCT GAGTAAGTGT TGCTGGGCTG GCAGTCAGCG CTGACTGCTG CAGCAGTAAC TAGGCTCCAG CACCCCAGAG CTGAGACTCA 
Chromosome TTTTCAAGTC CAAAAATTCT GAGTAAGTGT TGCTGGGCTG GCAGTCAGCG CTGACTGCTG CAGCAGTAAC TAGGCTCCAG CACCCCAGAG CTGAGACTCA 
5101 5200 
M13RJUN CTTTACCTTT TTTATCCCAG GTGGTGGCCC GTGGAGTCTC TCATGCAGTC CTACTCAAGT TCCTCCCATT GCCCTTGACT CAGCTCCTCA GCAAGTTTGG 
RP43 76JUL CTTTACCTTT TTTATCCCAG GTGGTGGCCC GTGGAGTCTC TCATGCAGTC CTACTCAAGT TCCTCCCATT GCCCTTGACT CAGCTCCTCA GCAAGTTTGG 
Pro2-3198J CNTTTNNTTT TTN--CCCNG GGGG--GNCC GGGGGNT——NCNAGNNNTT C——CCAANT TCC--CCNTT GCC-TNAACN --NCCCCN-- --NAANTTGG 
Pro3-3198J CTTTACNTTT TTTN--CCNG GNGGTGGCC- NNGGAGTC-C TCNTGCAGTT CNA-TCAAGT -CCNCCC-TT GCC-NTGACN C-NCTC-NCA -CCAGTTTGG 
Pro2-RP437 CTTTACCTTT TTTATCCCAG GTGGTGGCCC GTGGAGTCTC TCATGCAGTT CTACTCAAGT TCCTCCCATT GCCCTTGACT CAGCTCCTCA GCAAGTTTGG 
Pro3-RP437 CTTTACCTTT TTTATCCCAG GTGGTGGCCC GTGGAGTCTC TCATGCAGTT CTACTCAAGT TCCTCCCATT GCCCTTGACT CAGCTCCTCA GCAAGTTTGG 
Riken CTTTACCTTT TTTATCCCAG GTGGTGGCCC GTGGAGTCTC TCATGCAGTT CTACTCAAGT TCCTCCCATT GCCCTTGACT CAGCTCCTCA GCAAGTTTGG 
Chromosome CTTTACCTTT TTTATCCCAG GTGGTGGCCC GTGGAGTCTC TCATGCAGTT CTACTCAAGT TCCTCCCATT GCCCTTGACT CAGCTCCTCA GCAAGTTTGG 
5201 5300 
M13RJUN GCTACTGACT CGTTTCTCTC CATTCTGCCG AGCGTCTACG CAGAGCCTAG CTGAAGTCCT GCAGCAGCTT GGGGCTTCCC GTGAGCTCCA GGCTGTTCTC 
RP4 376JUL GCTACTGACT CGTTTCTCTC CAT-CTGCCG AGCGTCTACG CAGAGCCTAG CTGAAGTCCT GCAGCAGCTT GGG-CTTCCC G 一 
Pro2-RP437 GCTACTGACT CGTTTCTCTC CATTCTGCCG AGCGTCTACG CAGAGCCTAG CTGAAGTCC 
Pro3-RP437 GCTACTGACT CGTTTCTCTC CATTCTGCCG AGCGTCTACG CAGAGCCTAG CTGAAGTCC 
Riken GCTACTGACT CGTTTCTCTC CATTCTGCCG AGCGTCTACG CAGAGCCTAG CTGAAGTCCT GCAGCAGCTT GGGGCTTCCC GTGAGCTCCA GGCTGTTCTC 
Chromosome GCTACTGACT CGTTTCTCTC CATTCTGCCG AGCGTCTACG CAGAGCCTAG CTGAAGTCCT GCAGCAGCTT GGGGCTTCCC GTGAGCTCCA GGCTGTTCTC 
PPSIG-RP4376 
5301 5400 
M13RJUN AGCTACATCT TCCCCA 
Pro2-3198J N NNTT NCCCC---
Pro3-3198J N TAANT TCCCC 
Riken AGCTACATCT TCCCCA 
Chromosome AGCTACATCT TCCCCA 
‘ 317 
Appendix C4: Exon 4 to exon 5 
Template: BAC subclone 4#2, pGL3-Pro 2 |Pro2| and pGL3-Pro 3 |Pro3| 
PPSIG-FP4259 
5101 5200 
Pro2-RP437 GGGC TACTGACTCG TTTCTCTCCA TTCTGCCGAG CGTCTACGCA GAGCCTAGCT GAAGTCC-GC AGCAGCNNGG --CTTCC 
Pro3-RP437 GGGC TACTGACTCG TTTCTCTCCA TTCTGCCGAG CGTCTACGCA GAGCCTAGCT GAAGTCC-N- -GCAGC 
Riken GGGC TACTGACTCG TTTCTCTCCA TTCTGCCGAG CGTCTACGCA GAGCCTAGCT GAAGTCCTGC AGCAGCTTGG GGCTTCCCGT GAGCTCCAGG 
Chromosome GGGC TACTGACTCG TTTCTCTCCA TTCTGCCGAG CGTCTACGCA GAGCCTAGCT GAAGTCCTGC AGCAGCTTGG GGCTTCCCGT GAGCTCCAGG 
FP4259JUL GCCTAGCT GAAGTNCTGC AGCAGCTTGG GGCTTCCCGT GAGCTCCAGG 
5201 5300 
Riken CTGTTCTCAG CTACATCTTC CCCACTTACG GTGGGTGGCT ATAGCCCAGG CTTTTCTAGG CTACTGCTCT CCCAGCTTTG GTCTTTCTTT CCCATCTGCC 
Chromosome CTGTTCTCAG CTACATCTTC CCCACTTACG GTGGGTGGCT ATAGCCCAGG CTTTTCTAGG CTACTGCTCT CCCAGCTTTG GTCTTTCTTT CCCATCTGCC 
FP4259JUL CTGTTCTCAG CTACATCTTC CCCACTTACG GTGGGTGGCT ATAGCCCAGG CTTTTCTAGG CTACTGCTCT CCCAGCTTTG GTCTTTCTTT CCCATCTGCC 
SEQ5063RJU TACG GGGGG-GGAT ——GCCA--G CGTTTNNG-- -TACGGTTCC CGC TTG GTCTTNNTN- --CAT-TGCG 
5301 5400 
Riken TAACTGAGAC AGGCTAGAAT AGCCCCAGGC CTGCAGGAGT TTGTGGATCA GGGCTGAGAA GTCTGACCCA TGTTGGACTC TGGTAAAAAT GATTTATTAT 
Chromosome TAACTGAGAC AGGCTAGAAT AGCCCCAGGC CTGCAGGAGT TTGTGGATCA GGGCTGAGAA GTCTGACCCA TGTTGGACTC TGGTAAAAAT GATTTATTAT 
FP4259JUL TAACTGAGAC AGGCTAGAAT AGCCCCAGGC CTGCAGGAGT TTGTGGATCA GGGCTGAGAA GTCTGACCCA TGTTGGACTC TGG|AAAAAT GATTTATTAT 
SEQ5063RJU TAC--GAGAC CGGCTAGA-T N G C N C — N G N C T G C G G G G — TTGTGATA GGCTGANN- GTNT-ANCCA TGTTG-ACTC -GGCANATAT TATTA 
Pro2-FP425 TAACTGAGAC AGGCTAGAAT AGCCCCAGGC CTGCAGGAGT TTGTGGATCA GGGCTGAGAA. GTCTGACCCA TGTTGGACTC TGGTAAAAAT GATTTATTAT 
BAC1-4259M TAACTGAGAC AGGCTANAAT AGCCCCAGGC CTGCAGGAGT TTGTGGATCG GGGCTGAAAA GTCTGACCCA TGTTGGACTC TGGTAAAAAT GATTTATTAT 
5401 5500 
Riken TTACTTTATG GAACGTTATC TTTTGTTCTT CTCTCTTGTA TCTTTTCTTC TTCTTCTGTT TTGTTTTCTC TTCCTTTTTG AAGACAAGGT CTTCCAGGCA 
Chromosome TTACTTTATG GAACGTTATC TTTTGTTCTT CTCTCTTGTA TCTTTTCTTC TTCTTCTGTT TTGTTTTCTC TTCCTTTTTG AAGACAAGGT CTTCCAGGCA 
FP4259JUL TTACTTTATG GAACGTTATC TTTTGTTCTT CTCTCTTGfA TCTTTTCTTC TTCTTCTGTT TTGTTTTCTC TTCCTTTTTG AAGACAAGGT CTTCCAGGCA 
SEQ5063RJU TTACTT-ATG GA-CGTTATC TTTNN--CNT CTCTCT-GTA TCTNNTCNTC TTCTTCTGTT G-GTTNTCTC TTCCTTTTTG NAGANCAGGT CTTNCAGGCN 
BAC1-4259M TTACTTTATG GAACGTTA 
5501 5500 
Riken AGCTTTGAAC TCTTGTAGTT GAGGATGTCC TTAAATTCCT TATCCTTCTG CCTCTACCTT CCTAGTGCTA GGTATGTGCC ACCATGTCTG GGGTATGTGG 
Chromosome AGCTTTGAAC TCTTGTAGTT GAGGATGTCC TTAAATTCCT TATCCTTCTG CCTCTACCTT CCTAGTGCTA GGTATGTGCC ACCATGTCTG GGGTATGTGG 
FP4259JUL AGCTTTGAAC TCTTGTAGTT GAGGATGTCC TTAAATTCCT TATCCTTCTG CCTCTACCTT CCTAGTGCTA GGTATGTGCC ACCATGTCTG GGGTATGTGG 
S E Q 5 0 6 3 R J U A G C T T T G N A C T C T T G T A G T T G A G G A T G T C C T T A N A T T C C T T A T C C T T C T G C N T C T A C N T T C C T A G T G C T A G G T A T G T G C C A C C A T G T C T G G G G T A T G T G G 
5601 5700 
Riken TGCTGGAGAT CAAATCCAGG CTTTCATGCA TGTTAGGAAG ACATCCAGCT GAGCCCACCC AAGTGCATTT TCTCCCTGTC CCCTACACCT CCAGGAAAAG 
Chromosome TGCTGGAGAT CAAATCCAGG CTTTCATGCA TGTTAGGAAG ACATCCAGCT GAGCCCACCC AAGTGCATTT TCTCCCTGTC CCCTACACCT CCAGGAAAAG 
FP4 259JUL TGCTGGAGAT CAAATCCAGG CTTTCATGCA TGTNAGGAAG ACATCCAGCT GAGCNCACCC AAGTGCATTT TCTCCCTGTC CCCTACACCT CCAGGAAAAG 
SEQ5063RJU TGCTGGAGAT CANATCCAGG CTTTCATGCA TGTTAGGAfiG ACATCCAGCT GAGCCCACCC AAGTGCATTN TCTCCCTGTC CCCTACACCT CCAGGAAAAG 
5701 5800 
Riken TTTTGACTTT GCTCAGGCTG GTCTAGATCT CTCCGTAGCT TAGTATGGCT TTGAATCAAT GATCCTTCTG GTGTAGCTTT TGAGTGTGAG ATTATAGGCA 
Chromosome TTTTGACTTT GCTCAGGCTG GTCTAGATCT CTCCGTAGCT TAGTATGGCT TTGAATCAAT GATCCTTCTG GTGTAGCTTT TGAGTGTGAG ATTATAGGCA 
FP4805JUN NNNN GCTCAGGCTG GTCTAGATCT CTCCGTAGCT TAGTATGGCT TTGAATCAAT GATCCTTCTG GTGTAGCTTT TGAGTGTGAG ATTATAGGCA 
SEQ5063RJU TTTTGACTTT GCTCAGGCTG GTCTAGATCT CTCCGTAGCT TAGTATGGCT TTGAATCAAT GATCCTTCTG GTGTAGCTTT TGAGTGTGAG ATTATAGGCA 
5801 5900 
Riken TGTACACTGC TCAAGGTTGA TTTTTCTCTT TAGCCAACAG TGTCAGTGAC TTCTTTGGTC TTGGAAGCAT AATGGTTTTA TATTCCACTA AGCTCATTA'' 
Chromosome TGTACACTGC TCAAGGTTGA TTTTTCTCTT TAGCCAACAG TGTCAGTGAC TTCTTTGGTC TTGGAAGCAT AATGGTTTTA TATTCCACTA AGCTCATTAC 
FP4805JUN TGTACACTGC TCAAGGTTGA TTTTTCTCTT TAGCCAACftG TGTCAGTGAC TTCTTTGGTC TTGGAAGCAT AATGGTTTTA TATTCCACTA AGCTCATTAC 
SEQ5063RJU NGTACACTGN CTCAAGNNGA TTTGTCTCTT TAGCCAACAG TGTCAGTGAC TTCTTTGGTC T-GNAAGCAT AATG 
" 5901 6000 
Riken CTACCCTGGG'CCTTTGGGAG CATTCTCATC CTAGGATGGA CTCTTGTGGT CCCTCACAGG AAGCCCTATT TCTTCCT6AA TGGTGCCAAA TGACCACTAT 
Chromosome CTACCCTGGG CCTTTGGGAG CATTCTCATC CTAGGATGGA CTCTTGTGGT CCCTCACAGG AAGCCCTATT TCTTCCTGAA TGGTGCCAAA TGACCACTAT 
FP4805JUN CTACCCTGGG CCTTTGGGAG CATTCTCATC CTAGGATGGA CTCTTGTGGT CCCTCACAGG AAGCCCTATT TCTTCCTGAA TGGTGCCAAA TGACCACTAT 
6001 6100 
Riken GCTCATCTTC TTTCCTTCAT CCTGTAGGAG TAACTCCCAG CCACACCGCC TTTTCCTTGC ATGCTCTGCT GGTTGACCAC TACATACAAG GG 
Chromosome GCTCATCTTC TTTCCTTCAT CCTGTAGGAG TAACTCCCAG CCACACCGCC TTTTCCTTGC ATGCTCTGCT GGTTGACCAC TACATACAAG GG 
FP4 805JUN GCTCATCTTC TTTCCTTCAT CCTGTAGGAG TAACTCCCAG CCACACCGCC TTTTCCTTGC ATGCTCTGCT GGTTGACCAC TACAtACftAfi GG 
PPS1G-RP5244 
318 
Appendix C5: Exon 5 to exon 6 
Template: BAC subclone 5#1, pGL3-Pro 2 |Pro21 and pGL3-Pro 4 |Pro41 
PPSIG-FP5198 
6001 6100 
RP5600JUN --CCGCC TTTTCCTTGC ATGCTCTGCT GGTTGACCAC TACATACAAG GGGCATATTA 
Riken CCGCC TTTTCCTTGC ATGCTCTGCT GGTTGACCAC TACATACAAG GGGCATATTA 
Chromosome CCGCC TTTTCCTTGC ATGCTCTGCT GGTTGACCAC TACATACAAG GGGCATATTA 
6101 6200 
RP5600JUN CCCTCGAGGG GGTTCCAGTG AGATCGCCTT CCATACCATC CCTTTGATTC AGCGGGCCGG GGGCGCTGTC CTCACCAGGG CCACTGTACA GAGTGTGCTG 
Riken CCCTCGAGGG GGTTCCAGTG AGATCGCCTT CCATACCATC CCTTTGATTC AGCGGGCCGG GGGCGCTGTC CTCACCAGGG CCACTGTACA GAGTGTGCTG 
Chromosome CCCTCGAGGG GGTTCCAGTG AGATCGCCTT CCATACCATC CCTTTGATTC AGCGGGCCGG GGGCGCTGTC CTCACCAGGG CCACTGTACA GAGTGTGCTG 
6201 6300 
RP6214MAY CTGTTTATG CAC---GGTA 
SEQ5368JAN G GGGTCGTGGG CTGGGGTGGA AG-CCAG—— CCTGTTTATG CAC---GGTA 
Pro4-SEQ53 ATGGCCNACG GGGNTTAANN NAAAGGNCNT GGGGCCGGNT TCN--TGNNA ANCCCGGGGN TGNNAGNATA AGNCCTT--- CAAGNTNGGG NAA---TNAA 
Pro2-SEQ53 G CTGGGGTGGA G——CCG—— CCTGTTTATG CAC---GGTA 
S E Q 5 3 6 8 J U L N T G - N G N G T A C G T G G N N C T G N G G T N G N A N C A C N N G A C C N N T N T A T N G A C N N C G G T A 
SEQ5368MAY GGGCTG-GG GGTCAGTGGG CCCGGGTGTA NAGCAG -CTGTTTATG CAC—-GGTA 
RP5600JUN CTGGACTCAG CTGGGAGAGC GTGTGGTAAG AGATCTGTAC TGGGCTGTGG GGTCAGTGGG CTGGGGTGGA AG-CCAG--- CCTGTTTATG CAC---GGTA 
Riken CTGGACTCAG CTGGGAGAGC GTGTGGTAAG AGATCTGTAC TGGGCTGTGG GGTCAGTGGG CTGGGGTGGA AG-CCAG--- CCTGTTTATG CAC---GGTA 
Chromosome CTGGACTCAG CTGGGAGAGC GTGTGGTAAG AGATCTGTAC TGGGCTGTGG GGTCAGTGGG CTGGGGTGGA AG-CCAG--- CCTGTTTATG CAC---GGTA 
6301 6400 
RP6214MAY A GAGG CCTGGCGTCT GAGCCGGTG- AGATAGC--- -TCAGTGGAT AAATGGT-CT AGT CAC TCACTAAACC TGATGAT-CC CCACAG-CCT 
SEQ5368JAN A GAGG C-TGGCGTCT GANCCGGTGN ANATAGC--- -TCAGTGGAT AAATGGT-CT AGT CAC TCACTAGACC TGATGAT-CC CCACAG-CCT 
Pro4-SEQ53 A ATGG G-NTNC-TNA GNTCCACTT- CNA --CNTNAAAA CCCTGNA-AT GNA TCC CCACAGNCCC TA -CATGG-NTG 
Pro2-SEQ53 A GAGG C-TGGCGTCT GANCCGGCG- ANATAGC--- -TCAGTGGAT AAATGGT-CT AGT CAC TCACTAAACC TGATGAT-CC CCACAG-CCT 
SEQ5368JUL ANNANNGCNN G-NACTATCG ANACCGGTG- ANNATACGAC NNCAGNNGAT AAATGGTACT ANTNCNNTAC NNCTAAANCC TGATGATACC CCACAGACCT 
SEQ5368MAY C GAGG C-TGTCGTCT GAGCCGGTG- AGATAGC--- -TCAGTGGAT AAATGGT-CT AGT CAC TCACTAAACC TGATGAT-CC CCACAG-CCT 
RP5600JUN A GAGG C-TGGCGTCT GAGCCGGTG- AGATAGC--- -TCAGTGGAT AAATGGT-CT AGT CAC TCACTANACC TGANGAT-CC CCACAG-CCT 
Riken A GAGG C-TGGCGTCT GAGCCGGTG- AGATAGC--- -TCAGTGGAT AAATGGT-CT AGT CAC TCACTAAACC TGATGAT-CC CCACAG-CCT 
Chromosome A GAGG C-TGGCGTCT GAGCCGGTG- AGATAGC--- -TCAGTGGAT AAATGGT-CT AGT CAC TCACTAAACC TGATGAT-CC CCACAG-CCT 
6401 6500 
RP6214MAY ACATGGTGGA AGGAGA--GA ACT-CTGGCA AG-TTGT-CC TCTG-ACCTC CACACATGGG CTGT-AGCAC TCCTACCCCC ACCCCCCCCA CACACACACA 
SEQ5368JAN ACATGGTGGA AGGAGA--GA ACT-CTGGCA AG-TTGT-CC TCTG-ACCTC CACACATGGG CTGT-AGCAC TCCTACCCCC ACCCCCCCCA CACACACACA 
Pro4-SEQ53 GNAAGGNAGN AGNAGC TCT-GAGNCA AGNTTGTTCC TCCGNACCTC CACACATGGG CTGTTAGCAC TCCTACCCCC ACCCCCCCCA CACACACACA 
Pro2-SEQ53 ACATGGTGGA AGGAGA--GA ACT-CTGGCA AG-TTGT-CC TCTG-ACCTC CACACATGGG CTGT-AGCAC TCCTACCCCC ACCCCCCCCA CACACACACA 
SEQ5368JUL ACATGGTGGA AGGANGACGA ACTNCTGGAC AAGTTGTCAC TACTGACCTC CACACATGGG ATGT-AGCAC TCCTACCCCC ACCCCCCCCA CACACACACN 
SEQ5368MAY ACATGGTGGA AGGAGA--GA ACT-CTGG-C AAGTTGTC-C T-CTGACCTC CACACATGGG CTGT-AGCAC TCCTACCCCC ACCCCCCCCA CACACACACA 
RP5600JUN ACATGGTGGA AGGAGA---G ACT-CTGGNC AG--TGT-CC TCAAA 
Riken ACATGGTGGA AGGAGA--GA ACT-CTGGCA AG-TTGT-CC TCTG-ACCTC CACACATGGG CTGT-AGCAC TCCTACCCCC ACCCCCCCCA CACACACACA 
Chromosome ACATGGTGGA AGGAGA--GA ACT-CTGGCA AG-TTGT-CC TCTG-ACCTC CACACATGGG CTGT-AGCAC TCCTACCCCC ACCCCCCCCA CACACACACA 
6501 6600 
RP6214iyiAY CAATGAAGGA ATCAAACTAC AATTCTTACA AAAGGTCAGG TCTGACATAA TGGTTTTGTG AGTGGCCAGA GATGAGGTTG GACACACAGG CTTCAGTACA 
SEQ5368JAN CAATGAAGGA ATCAAACTAC AATTCTTACA AAAGGTCAGG TCTGACATAA TGGTTTTGTG AGTGGCCAGA GATGAGGTTG GACACACAGG CTTCAGTACA 
Pro4-SEQ53 CAATGAAGGA ATCAAACTAC AATTCTTACA AAAGGTCAGG TCTGACATAA TGGTTTTGTG AGTGGCCAGA GATGAGGTTG GACACACAGG CTTCAGTACA 
Pro2-SEQ53 CAATGAAGGA ATCAAACTAC AATTCTTACA AAAGGTCAGG TCTGACATAA TGGTTTTGTG AGTGGCCAGA GATGAGGTTG GACACACAGG CTTCAGTACA 
SEQ6214RJU CAATGNANGA ATCAAACTAC AATTCTTACA AAAGGTCAGG TCTGACATAA TGGTTTTGTG AGTGGCCAGA GATGAGGTTG GACACACAGG CTTCAGTACA 
SEQ5368JUL NAATGAAGGA ATCAAACTAC AATTCTTACA AAAGGTCAGG TCTGACATAA TGGTTTTGTG AGTGGCCAGA GATGAGGTTG GACACACAGG CTTCAGTACA 
SEQ5368MAY CAATGAAGGA ATCAAACTAC AATTCTTACA AAAGGTCAGG TCTGACATAA TGGTTTTGTG AGTGGCCAGA GATGAGGTTG GACACACAGG CTTCAGTACA 
Riken CAATGAAGGA ATCAAACTAC AATTCTTACA AAAGGTCAGG TCTGACATAA TGGTTTTGTG AGTGGCCAGA GATGAGGTTG GACACACAGG CTTCAGTACA 
Chromosome CAATGAAGGA ATCAAACTAC AATTCTTACA AAAGGTCAGG TCTGACATAA TGGTTTTGTG AGTGGCCAGA GATGAGGTTG GACACACAGG CTTCAGTACA 
6601 6700 
M13RMAY AC AGGGAAG--G AGGGGCTGGG ACT-CCATAG 
RP6214MAY TCACAGAAGC CTTGGTGTTT CATGAAGGTT GAGTCATCTG GGGAGTACTG TAGATGTGGA ATTTGGCAGC AGGGAAG--G AGGGGCTGGG ACT-CCATAG 
SEQ5368JAN TCACAGAAGC CTTGGTGTTT CATGAAGGTT GAGTCATCTG GGGAGTACTG TAGATGTGGA ACTTGGCAGC AGGGAAG--G AGGGGCTGGG ACT-CCATAG 
PV04-SEQ53 TCACAGAAGC CTTGGTGTTT CATGAAGGTT GAGTCATCTG GGGAGTACTG TAGATGTGGA ACTTGGCAGC AGGGAAG--G AGGGGCTGGG ACT-CCATAG 
Pro2-SEQ53 TCACAGAAGC CTTGGTGTTT CATGAAGGTT GAGTCATCTG GGGAGTACTG TAGATGTGGA ACTTGGCAGC AGGGAAG--G AGGGGCTGGG ACT-CCATAG 
SEQ6214RJU TCACAGAAGC CTTGGTGTTT CATGAAGGTT GAGTCATCTG GGGAGTACTG TAGATGTGGA ATTTGGCAGC AGGGAAG--G AGGGGCTGGG ACT-CCATAG 
SEQ5368JUL TCACAGAAGC CTTGGTGTNT CATGAAGGTN GAGTCATCTG GGGAGTACTG TAGATGTGGA ATT-GGCAGC ANGGAAG--- AGGGGCTGGG ACT-CCATAG 
SEQ5368MAY TCACAGAAGC CTTGGTGTTT CATGAAGGTT GAGTCATCTG GGGAGTACTG TAGATGTGGA ATTTGGCAGC AGGGAAG--G AGGGGCTGGG ACT-CCATAG 
Riken TCACAGAAGC CTTGGTGTTT CATGAAGGTT GAGTCATCTG GGGAGTACTG TAGATGTGGA ACTTGGCAGC AGGGAAG--G AGGGGCTGGG ACT-CCATAG 
Chromosome TCACAGAAGC CTTGGTGTTT CATGAAGGTT GAGTCATCTG GGGAGTACTG TAGATGTGGA ACTTGGCAGC AGGGAAG--G AGGGGCTGGG ACT-CCATAG 
6701 6800 
RP6437JUL NGCCNAGTGT TCTTTGGGAC GGGCAGNGCG TGGCTAAGGG TAAGTCCATA TGGGTGGGTN AC5AAGAGCTA GAGAGGGCAA GCA-CAGAAG CATTTGAGGC 
M13RMAY AGCC-AGTGT TCTT-GGGAC GG-CAGGGCG TGGCTAAGG- TAAGTCCATA TGGGTGGGTA AGAAGAGCTA GAGAGGGCAA GCA-CAGAAG CATTTGAGGC 
RP6214MAY AGCC-AGTGT TCTT-GGGAC GG-CAGGGCG TGGCTAAGG- TAAGTCCATA TGGGTGGGTA AGAAGAGCTA GAGAGGGCAA GCA-CAGAAG CATTTGAGGC 
SEQ5368JAN AGCC-AGTGT TCTT-GGGAC GG-CAGGGCG TGGCTAAGG- TAAGTCCATA TGGGTGGGTA AGAAGAGCTA GAGAGGGCAA GCA-CAGAAG CATTTGAGGC 
Pro4-SEQ53 AGCC-AGTGT TCTT-GGGAC GG-CAGGGCG TGGCTAAGG- TAAGTCCATA TGGGTGGGTA AGAAGAGCTA GAGAGGGCAA GCA-CAGAAG CATTTGAGGC 
Pro2-SEQ53 AGCC-AGTGT TCTT-GGGAC GG-CAGGGCG TGGCTAAGG- TAAGTCCATA TGGGTGGGTA AGAAGAGCTA GAGAGGGCAA GCA-CAGAAG CATTTGAGGC 
SEQ6214RJU AGCC-AGTGT TCTT-GGGAC GG-CAGGGCG TGGCTAAGG- TAAGTCCATA TGGGTGGGTA AGAAGAGCTA GAGAGGGCAA GCA-CAGAAG CATTTGAGGC 
SEQ5368JUL AGCC--GTGT NCT--GGGAC G——CNNGCG TG-CTAAG-- -TAGTC-ATA TGG-TGGNAA AGACAAANNA GCCAANCTTA GCAGCAGNAN NCGGTCGGCC 
SEQ5368MAY AGCC-AGTGT TCTT-GGGAC GG-CAGGGCG TGGCTAAGG- TAAGTCCATA TGGGTGGGTA AGAAGAGCTA GAGAGGGCAA GCA-CAGAAG CATTTGAGGC 
Riken AGCC-AGTGT TCTT-GGGAC GG-CAGGGCG TGGCTAAGG- TAAGTCCATA TGGGTGGGTA AGAAGAGCTA GAGAGGGCAA GCA-CAGAAG CATTTGAGGC 




RP64 37JUL -AAGGGCTAA GTGACTTTGC AGTGTGCCTG GGACCTGCTT TGGCTGGAGG AACTTCTAGG TCTGAGAAAA CAGGGCCTAC CCTAGGAGAC ATCTGGATAG 
M13RMAY -AAGGGCTAA GTGACTTTGC AGTGTGCCTG GGACCTGCTT TGGCTGGAGG AACTTCTAGG TCTGAGAAAA CAGGGCCTAC CCTAGGAGAC ATCTGGATAG 
RP6214MAY CAAGGGCTAA GTGACTTTGC AGTGTGCCTG GGACCTGCTT TGGCTGGAGG AACTTCTAGG TCTGAGAAAA CAGGGCCTAC CCTAGGAGAC ATCTGGATAG 
SEQ5368JAN -AAGGGCTAA GTGACTTTGC AGTGTGCCTG GGACCTGCTT TGGCTGGAGG AACTTCTAGG TCTGAGAAAA CAGGGCCTAC CCTAGGAGAC ATCTGGATAG 
Pro4-SEQ53 -AAGGGCTAA GTGACTTTGC AGTGTGCCTG GGACCTGCTT TGGCTGGAGG AACTTCTAGG TCTGAGAAA- CAGGGCCTAC CCTAGGAGAC ATCTGGATAG 
Pro2-SEQ53 -ANGGGCTAA GTGACTTTGC AGTGTGCCTG GGACCTGCTT TGGCTGGAGG AACTTCTAGG TCTGAGAAAA CAGGGCCTAC CCTAGGAGAC ATCTGGATAG 
S E Q 6 2 1 4 R J U - A A G G G C T A A G T G A C T T T G C A G T G T G C C T G G G A C C T G C T T T G G C T G G A G G A A C T T C T A G G T C T G A G A A A A C A G G G C C T A C C C T A G G A G A C A T C T G G A T A G 
SEQ5368JUL -GTGCGAGAT T GCCAA NNCCCNNAAT TGTTTNNTAA AT TNNGCGTTAT TNNGCTTATC TCT 
SEQ5368MAY -AAGGGCTAA G 
Riken -AAGGGCTAA GTGACTTTGC AGTGTGCCTG GGACCTGCTT TGGCTGGAGG AACTTCTAGG TCTGAGAAAA CAGGGCCTAC CCTAGGAGAC ATCTGGATAG 
Chromosome -AAGGGCTAA GTGACTTTGC AGTGTGCCTG GGACCTGCTT TGGCTGGAGG AACTTCTAGG TCTGAGAAAA CAGGGCCTAC CCTAGGAGAC ATCTGGATAG 
6901 7000 
M13RJUN TGTGGGTATA GACAGNACTA ATATTTTGAG NNAGGATTTC ATGTGTTTCA GGCTATCCTC AAACTCACTA GCTAGCTGAG GCTGACNNTC GAATTCCTGA 
RP64 37JUL TGTGGGTATA GACAGAACTA ATATTTTGAG GCAGGATTTC ATGTGTTTCA GGCTATCCTC AAACTCACTA GCTAGCTGAG GCTGACCTTC GAATTCCTGA 
M13RMAY TGTGGGTATA GACAGAACTA ATATTTTGAG GCAGGATTTC ATGTGTTTCA GGCTATCCTC AAACTCACTA GCTAGCTGAG GCTGACCTTC GAATTCCTGA 
RP6214MAY TGTGGCTA-A TAG-GTACTA GTACTCT--- -CAATATCTA TTGAGCTCTA GG--TTCTTC CATCGTGCTT TCCCAC-GAG TCTAAT -ACCTCCAAW 
SEQ5368JAN TGTGGGTATA GACAGAACTA ATATTTTGAG GCAGGATTTC ATGTGTTTCA GGCTATCCTC AAACTCACTA GCTAGCTGAN GCTGACCTTC -AATTCCTGA 
Pro4-SEQ53 TGTGGGTATA GACAGAACTA ATATTTTGAG GCAGGATTTC ATGTGTTTCA GGCTATCCTC AA-CTCACTA GCTAGCTGAA GCTGACCTTC GAATTCCTGA 
Pro2-SEQ53 TGTGGGTATA GACAGAACTN ATATTTTGAG GCAGGATTTC ATGTGTTTCA GGCTATCCTC AAACTCNCTA GCTAGCTGAN GCTGACCTTC NAATTCCTGA 
SEQ6214RJU TGTGGGTATA GACAGAACTA ATATTTTGAG GCAGGATTTC ATGTGTTTCA GGCTATCCTC ANACTCACTA GCTAGCTGAG GCTGACCTTC GAATTCCTGA 
Riken TGTGGGTATA GACAGAACTA ATATTTTGAG GCAGGATTTC ATGTGTTTCA GGCTATCCTC AAACTCACTA GCTAGCTGAG GCTGACCTTC GAATTCCTGA 
Chromosome TGTGGGTATA GACAGAACTA ATATTTTGAG GCAGGATTTC ATGTGTTTCA GGCTATCCTC AAACTCACTA GCTAGCTGAG GCTGACCTTC GAATTCCTGA 
7001 7100 
M13RJUN TTATATGGCG TCTACNTCNT ACATGCTAGG ATTGCAGGAA CATGTCATCA TGCTGCGACT ACAGCTAATG CTTT-GAGAG AAATGTATTT -CACACTTTC 
RP6437JUL TTATATGGCG TCTACCTCCT ACATGCTAGG ATTGCAGGAA CATGTCATCA TGCTGCGACT ACAGCTAATG CTTT-GAGAG AAATGTATTT -CACACTTTC 
M13RMAY TTATATGGCG TCTACCTCCT ACATGCTAGG ATTGCAGGAA CATGTCATCA TGCTGCGACT ACAGCTAATG CTTT-GAGAG AAATGTATTT -CACACTTTC 
RP6214MAY CTCTACGTCA TCGTTAGCGT GAGTG--AGT ACAGCCCTAT TCAGTAATCC TGATTTANTG ATGGCTTATA CCTCCTCGGC ATGTTTGGTT TGCAGAATGA 
SEQ5368JAN TT-TATGGCG TCTACCTCCT ACATGCTAGG ATTGCAGGAA CATGTCATCA TGCTGCGACT ACNGCTAATG CTTT-GAAAG AA-TGTATTT --CCACTTTC 
Pro4-SEQ53 TTATATGGCG TCTACCTCCT ACATGCTAGG ATTGCAGGAA CATGTCATCA TGCTGCGACT ACAGCTAATG CTTTTGAGAG AAATGTATTT TCACACTTTC 
Pro2-SEQ53 TTAATNGGGN NC-CCCTCCN ACATGCTAGA ATGGGNGNAA -NTGTCNTCN TGCTGCNAAT ANNN-.TTANG CTTT--GNNN AAANGNNTTT --CCNCNTTC 
SEQ6214RJU TTATATGGCG TCTACCTCCT ACATGCTAGG ATTGCAGGAA CATGTCATCA TGCNN 
Riken TTATATGGCG TCTACCTCCT ACATGCTAGG ATTGCAGGAA CATGTCATCA TGCTGCGACT ACAGCTAATG CTTT-GAGAG AAATGTATTT -CACACTTTC 
Chromosome TTATATGGCG TCTACCTCCT ACATGCTAGG ATTGCAGGAA CATGTCATCA TGCTGCGACT ACAGCTAATG CTTT-GAGAG AAATGTATTT -CACACTTTC 
7101 7200 
M13RJUN CTGGGTT--- GTGTTTGTTT TATGGTGGGT AT--GGGGTG -CACGGAA-C CTAGGGC-TT CATACATGTT --AGACAAGC GCTTT-CCAC CTGAG-CTGT 
RP64 37JUL CTGGGTT--- GTGTTTGTTT TATGGTGGGT AT--GGGGTG -CACGGAA-C CTAGGGC-TT CATACATGTT --AGACAAGC GCTTT-CCAC CTGAG-CTGT 
M13RMAY CTGGGTT——GTGTTTGTTT TATGGTGGGT AT--GGGGTG -CACGGAA-C CTAGGGC-TT CATACATGTT --AGACAAGC GCTTT-CCAC CTGAG-CTGT 
RP6214MAY CTAATACAGG GTGATCCTGC CTCATTTGC 
SEQ5368JAN CCGGGNT--N TGTTTG-TTT TANGGGGGGT AN--GGGGTG -CACGAAN-- CTANGGC--T NNTACNTGTT ---AAAAAAC GCTTN--CCC CTGAN-CTTT 
Pro4-SEQ53 CCGGGGTTGN GGTTTGNTTT TATGGGGGGG TNTGGGGGTG NCNCGGAANC CTANGGNNTT CATACNTGNT TAAAAAAAGC GCTTTNCCCC TTGANNCTGT 
Pro2-SEQ53 CNGGGG--GG GNTTT--TTT TNNGGGGGGN AN---GGGGG NCNNGAA--C CNANGGNTNT AANNTNT--- ---AAAAAAG GCTTTNCCCC GGG GT 
Riken CTGGGTT--- GTGTTTGTTT TATGGTGGGT AT--GGGGTG -CACGGAA-C CTAGGGC-TT CATACATGTT --AGACAAGC GCTTT-CCAC CTGAG-CTGT 
Chromosome CTGGGTT--- GTGTTTGTTT TATGGTGGGT AT--GGGGTG -CACGGAA-C CTAGGGC-TT CATACATGTT --AGACAAGC GCTTT-CCAC CTGAG-CTGT 
7201 7300 
M13RJUN ATT-CCTAGC CCTT--AAGA GGGATCT-AG AGAATGGTAT A-GGTCTTTT TTG-TTTCCA CAGAGCTCAT AGAAGC-TCA GCCANATTCT TGTGCCTGC-
RP6437JUL ATT-CCTAGC CCTT--AAGA GGGATCT-AG AGAATGGTAT A-GGTCTTTT T-G-TTTCCA CAGAGCTCAT AGAAGC-TCA GCCANATTCT TGTGCCTGC-
M13RMAY ATT-CCTAGC CCTT--AAGA GGGATCT-AG AGAATGGTAT A-GGTCTTTT TTG-TTTCCA CAGAGCTCAT AGAAGC-TCA GCCAAATTCT TGTGCCTGC-
RP6214MAY 
SEQ5368JAN TT--CCTANC CTT AAA NGGATCN-AN AAAAGGGTA- --AGGCNTTT TTGTTNCCCN NANCN ANAAAACNCN CCCAA-TTCT -GGGCCNGNN 
Pro4-SEQ53 ATTNCCTAGC CCNTTAAAAA GGGATCNNAA AAAANGGTTN ANGGTCTTTT TTGNTTTCCN NAAANCTCAT AAAAACCNCC CCCAANTTCT TGGNCCCGNN 
Pro2-SEQ53 GTTTNCNNNC CCTT---AAA GGGNTNN--A NNAAGGGNNN ---GGNTTTT TTNTTNCCCA ANNCN -TAAAANNNC CCCAA--TTT TNGGCCCCNN 
- Riken ATT-CCTAGC CCTT--AAGA GGGATCT-AG AGAATGGTAT A-GGTCTTTT TTG-TTTCCA CAGAGCTCAT AGAAGC-TCA GCCAAATTCT TGTGCCTGC-
Chromosome ATT-CCTAGC CCTT--AAGA GGGATCT-AG AGAATGGTAT A-GGTCTTTT TTG-TTTCCA CAGAGCTCAT AGAAGCr.TCA GCCAAATTCT TGTGCCTGC-
7301 7400 
M13RJUN AGGTGTCAGT GTGAAGAAGG GACAAGAGCT GGTGAACATC TACTGCCC-
RP6437JUL AGGTGTCAGT GTGA 
M13RMAY AGGTGTCAGT GTGAAGAAGG GACAAGAGCT GGTGAACATC TACTGCCC-
SEQ5368JAN GG--TNCNNT GN--AAAANG GAAAAAA-CT GGNAAA---N TCNCNGCC-- --
Pro4-SEQ53 AGGTTNCATT NGNAAAAANG GAAAAAAACT GGNNAAACTN TTNGNNCC--
Pro2-SEQ53 GG--NTCNTN GN---AAAAA GANAAAAANT GGNA^ "- - - NT NTTCGCCC-- --
Riken AGGTGTCAGT GTGAAGAAGG GACAAGAGCT GGTGAACATC TACTGCCC-
Chromosome AGGTGTCAGT GTGAAGAAGG GACAAGAGCT GGTGAACATC TACTGCCC-
PPSIG-RP6437 
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Appendix Cll: Exon 11 to downstream 
Template: BAC subclone 11#1 
3401 3500 
M13RJUN GNNACTC--- AAGCTATGCA TCAAGCTTGG TACCGAGCTC GGATCACTAG TAACGGCCGC CAGTGTGCTG GA-TNCGCCC TTTGCCCAGT TGTCATCTCC 
M13RJUL GAATACT--- CAGCNATGC- TCNAGCN-GG TAC-GAGNTC G-ANNACTAG TAACG-CCGC CAGTGTGCTG NA-TNCNNCC TTTGCC-AGT NGTCATCTCC 
Riken GAGCTCATAG AAGCTCAGCC AAATTCTTGT GCC--TGCAG GTGTCAGT-G TGAAGAAGGG ACAAGAGCTG GTGAACATCT ACTGCCCAGT TGTCATCTCC 
Chromosome GAGCTCATAG AAGCTCAGCC AAATTCTTGT GCC—TGCAG GTGTCAGT-G TGAAGAAGGG ACAAGAGCTG GTGAACATCT ACTGCCCAGT TGTCATCTC： 
3501 3600 
M13RJUN AATGCGGGAA TGTTCAATAC CTATCAGCA- CTTGTTGCCA GAG-AC-TGT CCGCCAT-CT GCCAGGTAAA AGACTGATCT TTTGAACTAA TATTTCATCT 
M13RJUL A-TGCGGGAN TGTACA-TAC CTATCAGCAN CTTGTTGCCC AANNACGTGT CCGCCCNNCT GCCAGGTAAA AGACTGATCT TT-GAACTAA TATNTCATCT 
Riken AATGCGGGAA TGTTCAATAC CTATCAGCA- CTTGTTGCCA GAG-AC-TGT CCGCCAT-CT GCCAGGTAAA AGACTGATCT TTTGAACTAA TATTTCATCT 
Chromosome AATGCGGGAA TGTTCAATAC CTATCAGCA- CTTGTTGCCA GAG-AC-TGT CCGCCAT-CT GCCAGGTAAA AGACTGATCT TTTGAACTAA TATTTCATCT 
3601 3700 
M13RJUN GTGAAGCTTA CATGCCCAGC TGGGTGGGCT CCCCTCTCCT TGGGCAGTCC GCTAGCTGTC TCTCTCTAGT CTGTGCTACC AGGAACATAG CATTTATATT 
M13RJUL GTGAAGCTTA CATGCCCAGC TGGGTGGGCT CCNCTCTCCT TGGGCAGTCC GCTAGCTGTC TCTCTCTAGT CTGTGCTACC AGGAACATAG CATTTATATN 
Riken GTGAAGCTTA CATGCCCAGC TGGGTGGGCT CCCCTCTCCT TGGGCAGTCC GCTAGCTGTC TCTCTCTAGT CTGTGCTACC AGGAACATAG CATTTATATT 
Chromosome GTGAAGCTTA CATGCCCAGC TGGGTGGGCT CCCCTCTCCT TGGGCAGTCC GCTAGCTGTC TCTCTCTAGT CTGTGCTACC AGGAACATAG CATTTATATT 
3701 3800 
M 1 3 R J U N T G G G G A A T C T A G G A C T A C A G G G G A A G A G G A G C C C T T C 聯 G A G G C A G T G G C A G A G C T C T G A G G A C T C T G T T T T G T C A G A T G C A A A T G T C T A T C T T G T A C T 
M13RJUL TGGGGAATCT AGGACTACAN GGGAAGANGA GCCCTTCACA GANGCAGTGG CAGAGCTCTG AGGACTCTGT TTTGTCAGAT GCAAATGTCT ATCTTGTACT 
Riken TGGGGAATCT AGGACTACAG GGGAAGAGGA GCCCTTCACA GAGGCAGTGG CAGAGCTCTG AGGACTCTGT TTTGTCAGAT GCAAATGTCT ATCTTGTACT 
Chromosome TGGGGAATCT AGGACTACAG GGGAAGAGGA GCCCTTCACA GAGGCAGTGG CAGAGCTCTG AGGACTCTGT TTTGTCAGAT GCAAATGTCT ATCTTGTACT 
3801 3900 
M13RJUN TCCGGGCTGA AAAACACAAC CCTGTATATT TGCTTTCCTT TGCCAGAGAA ACCAGGG-CT NTAATAGAAA AGACTCAGTT AAATGN-AGA CAAGAGCTAG 
M m JUL TCCGGGCTGA AAAACACAAC CCTGTATATT TGCTTTCCTT TGCCAGAGAA ACCAGNG-CT TTAATAGAAA AGACTCAGTT AAATGGCAGA CAAGAGCTAG 
Riken TCCGGGCTGA AAAACACAAC CCTGTATATT TGCTTTCCTT TGCCAGAGAA ACCAGGG-CT TTAATAGAAA AGACTCAGTT AAATGGCAGA CAAGAGCTAG 
Chromosome TCCGGGCTGA AAAACACAAC CCTGTATATT TGCTTTCCTT TGCCAGAGAA ACCAGGG-CT TTAATAGAAA AGACTCAGTT AAATGGCAGA CAAGAGCTAG 
SEQ674 9JUL TTT TGCCAGAGAA ACCAGGGNCT TTAATAGAAA AGACTCAGTT AAATGGCAGA CNAGAGCTAG 
3901 4000 
M 1 3 R J U N GGATGAAGTN - A G T G G G T - A GAGTGNT-GC ATCAGCCCTG - G T N - A N C T - GAGCCAGTAG ACACTNAGTG A T N G C G T A T - - C T ACC CAGAGGT3CG 
M13RJUL GGATGAAGTC CAGTNGGTCA GAGTGTTTGC ATCAGCCCTG NGNN-ACCTA GAGCCAGGTA AGAC AA- -CT A-- G 
RP7571JUL GNATGAANN- CAGTTGGGTA GAGGGTTTGC ATCAGNCCTG GGTTTACCTA GAGNCAGGTN AGACNACTAG AGTGGATTGG GCTGTA-ATC CTAGCACTCN 
Riken GGATGAAGTT CAGTTGGTTA GAGTGTTTGC ATCAGCCCTG GGTTTACCTA GAGCCAGGTA AGACAACTAG AGTGGATTTG GCTGTA-ATC CTAGCACTCA 
Chromosome GGATGAAGTT CAGTTGGTTA GAGTGTTTGC ATCAGCCCTG GGTTTACCTA GAGCCAGGTA AGACAACTAG AGTGGATTTG GCTGTA-ATC CTAGCACTCA 
SEQ674 9JUL GGATGAAGTT CAGTTGGTTA GAGTGTTTGC ATCAGCCCTG GGTTTACCTA GAGCCAGGTA AGACAACTAG AGTGGATTTG GCTGTACATC CTAGCACTCA 
4001 4100 
M13RJUN AGTAAA-TCA GTCGTGCACA ACGCCAACAG AGAGCAGAGT GGTTCAGAAT TTGTNCTACT TTTTATGATA AT 
M13RJUL AGTGGA-TNG GCNGTATCCT AC--CCNCAG AGTGTGG 
RP7571JUL AGAGGTGTTG GCGGGAAGAT NAGNAANTNA GGGTCACCGT TGGCTACACN AGACCCTGCC TCNACANACA AAGGCCACTG AGATGGTTCA GAGTGTAAAG 
Riken AGAGGTGTTG GCGGGAAGAT AAGAAATTCA AGGTCACCGT TGGCTACACA AGACCCTGCC TCAACAAACA AAGGCCACTG AGATGGTTCA GAGTGTAAAG 
Chromosome AGAGGTGTTG GCGGGAAGAT AAGAAATTCA AGGTCACCGT TGGCTACACA AGACCCTGCC TCAACAAACA AAGGCCACTG AGATGGTTCA GAGTGTAAAG 
SEQ674 9JUL AGAGGTGTTG GCGGGAAGAT AAGAAATTCA AGGTCACCGT TGGCTACACA AGACCCTGCC TCAACAAACA AAGGCCACTG AGATGGTTCA GAGTGTAAAG 
4101 4200 
RP7571JUL TCTTTGCTGC TAAATCCCCA GAGTGGAAGA AGATAGTTGT CTTCTGGCTT CTTGCACATC TAGACAGACC TTTATCCATA TACATCTATA ATTAACGAAA 
Riken TCTTTGCTGC TAAATCCCCA GAGTGGAAGA AGATAGTTGT CTTCTGGCTT CTTGCACATC TAGACAGACC TTTATCCATA TACATCTATA ATTAACGAAA 
Chromosome TCTTTGCTGC TAAATCCCCA GAGTGGAAGA AGATAGTTGT CTTCTGGCTT CTTGCACATC TAGACAGACC TTTATCCATA TACATCTATA ATTAACGAAA 
SEQ6749JUL TCTTTGCTGC TAAATCCCCA GAGTGGAAGA AGATAGTTGT CTTCTGGCTT CTTGCACATC TAGACAGACC TTTATCCATA TACATCTATA ATTAACGAAA 
4201 4 300 
RP7571JUL CATCTAAATG TATAAAGAGG AGGGTTGGAA CAGCCTGATT GTCCAGAGGT GCTGTGAGTT AGCTCTGCTC TGAATCAGCA GGAAGCCAGC ACCTATGACT 
Riken CATCTAAATG TATAAAGAGG AGGGTTGGAA CAGCCTGATT GTCCAGAGGT GCTGTGAGTT AGCTCTGCTC TGAATCAGCA GGAAGCCAGC ACCTATGACT 
Chromosome CATCTAAATG TATAAAGAGG AGGGTTGGAA CAGCCTGATT GTCCAGAGGT GCTGTGAGTT AGCTCTGCTC TGAATCAGCA GGAAGCCAGC ACCTATGACT 
S£Q67 4 9JUL CATCTAAATG TT 
4301 •• 4400 
RP7571JUL AAGGGGACAT GGGGCAGAGG TGGTAGAGTT GGAAGGAATC TGAGGCTACA TCTCACATAG CCAGGACGAG ACTTAAGAGC AGGTCTCTGC CAGGATCCTA 
Riken AAGGGGACAT GGGGCAGAGG TGGTAGAGTT GGAAGGAATC TGAGGCTACA TCTCACATAG CCAGGACGAG ACTTAAGAGC AGGTCTCTGC CAGGATCCTA 
Chromosome AAGGGGACAT GGGGCAGAGG TGGTAGAGTT GGAAGGAATC TGAGGCTACA TCTCACATAG CCAGGACGAG ACTTAAGAGC AGGTCTCTGC CAGGATCCTA 
4401 4 500 
R P 7 5 7 1 J U L T A G A A A T A G T T A T A A A A C C G G C C A G G T C T C T G T C C C A G C T G G C A G C T G A G G A T C G A G C T A C A G A T C A G A A A A G G G A A C A T C C T G A G G C T A T C C T G A C A G G 
Riken TAGAAATAGT TATAAAACCG GCCAGGTCTC TGTCCCAGCT GGCAGCTGAG GATCGAGCTA CAGATCAGAA AAGGGAACAT CCTGAGGCTA TCCTGACAGG 
Chromosome TAGAAATAGT TATAAAACCG GCCAGGTCTC TGTCCCAGCT GGCAGCTGAG GATCGAGCTA CAGATCAGAA AAGGGAACAT CCTGAGGCTA TCCTGACAGG 
4501 4600 
RP7571JUL GGTGGCTGTC TGGCTGTAAC TCCTGCACAG CAATCCTClLC TGGCTCTCTG CAGATGTGAA GAAGCAGCTG GCGATGGTAA 
Riken GGTGGCTGTC TGGCTGTAAC TCCTGCACAG CAATCCTCAC TGGCTCTCTG CAGATGTGAA GAAGCAGCTG GCGATGGTAA GGCCTGGTCT GAGCATGCTC 
Chromosome GGTGGCTGTC TGGCTGTAAC TCCTGCACAG CAATCCTCAC TGGCTCTCTG CAGATGTGAA GAAGCAGCTG GCGATGGTAA GGCCTGGTCT GAGCATGCTC 
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Appendix C7: Exon 7 to exon 8 “ 
Template: BAC subclone 7#1 
P P S I G - F r 7 5 2 3 
8301 H^no 
M13RJUN AAGG CCTGGTCTGA GCATGCTCTC 
M13RJUL AAGG CNTGGTCTGA GCATGCTCTC 
RP7939MAY AAGG CCTGGTCTGA GCATGCTCTC 
Riken AAGG CCTGGTCTGA GCAr;CTCTC 
Chromosome AAGG CCTGGTCTGA GCATGCTCTC 
8401 8500 
M13RJUN AATCTTCATC TGTCTGAAAG GCACCAAGGA GGACNTGAAG CTTCAGTCCA CCNACTACTA TGTTTATTTT GACACAGACA TGGACAAAGC GTAAGATGTG 
M13RJUL AATCTTCATC TGTCTGAAAG GCACCAAGGA GNACCTGAAG CTTCAGTCCA CNNACTACTA TGTGTATTTT GACACAGACA TGGACAAAGC GTAAGATGTG 
RP7939MAY AATCTTCATC TGTCTGAAAG GCACCAAGGA GGACCTGAAG CTTCAGTCCA CCAACTACTA TGTTTATTTT GACACAGACA TGGACAAAGC GTCAGATGTG 
Riken AATCTTCATC TGTCTGAAAG GCACCAAGGA GGACCTGAAG CTTCAGTCCA CCAACTACTA TGTTTATTTT GACACAGACA TGGACAAAGC GTAAGATGTG 
Chromosome AATCTTCATC TGTCTGAAAG GCACCAAGGA GGACCTGAAG CTTCAGTCCA CCAACTACTA TGTTTATTTT GACACAGACA TGGACAAAGC GTAAGATGTG 
8501 _ 0 
M13RJUN AGGGGTGGGG AAGACTGATA GTGTTGGGCC TCATCCCACA AGGTCCTGCT TCCACCCTCC ACACGGTTCT AGGAATGAGA AGGATGTGTT TTGAGGGAGG 
M13RJUL AGGGGTGGGG AAGACTGATA GTGTTGGGCN TCATCCCACA AGGTCCTGCT TCCACCCTCC ACACGGTTCT AGGAATGAGA AGGATGTGTT TTGAGGGAGG 
RP7939MAY AGGGGTGGGG AAGACTGATA GTGTTGGGCC TCATCCCACA AGGTCCTGCT TCCACCCTCC ACACGGTTCT AGGAATGAGA AGGATGTGTT TTGAGGGAGG 
Riken AGGGGTGGGG AAGACTGATA GTGTTGGGCC TCATCCCACA AGGTCCTGCT TCCACCCTCC ACACGGTTCT AGGAATGAGA AGGATGTGTT TTGAGGGAGG 
Chromosome AGGGGTGGGG AAGACTGATA GTGTTGGGCC TCATCCCACA AGGTCCTGCT TCCACCCTCC ACACGGTTCT AGGAATGAGA AGGATGTGTT TTGAGGGAGG 
8601 8700 
M13RJUN AGGTGCAGTC TCTAATGGAC TTCTAGAAAG GCTTTCTACA CCAAAGCCGT GCTGTTTTCT CCCTTGTGGG AAGTCCCTGG AGATGAGCCT TTGTTTGGGT 
M13RJUL AGGTGCAGTC TCTAATGGAC TTCTAGAAAG GCTTTCTACA CCAAAGCCGT GCTGTTTTCT CCCTTGTGGG AAGTCCCTGG AGATGAGCCT TTGTTTGGGT 
RP7939MAY AGGTGCAGTC TCTAATGGAC TTCTAGAAAG GCTTTCTACA CCAAAGCCGT GCTGTTTTCT CCCTTGTGGG AAGTCCCTGG AGATGAGCCT TTGTTTGG-T 
Riken AGGTGCAGTC TCTAATGGAC TTCTAGAAAG GCTTTCTACA CCAAAGCCGT GCTGTTTTCT CCCTTGTGGG AAGTCCCTGG AGATGAGCCT TTGTTTGGGT 
Chromosome AGGTGCAGTC TCTAATGGAC TTCTAGAAAG GCTTTCTACA CCAAAGCCGT GCTGTTTTCT CCCTTGTGGG AAGTCCCTGG AGATGAGCCT TTGTTTGGGT 
8701 
M13RJUN AGTGCTGGTG GCTTTGAGGA AGAGGCCTAA AGATTGGCAG TCACGCCCCC TCCCTCATCC ACAGGATGGA GCGCTANGTC TCTATGCCCA AGG 
M13RJUL AGTGCTGGTG GCTTTGAGGA AGAGGCCTAA AGATTGGCAG TCACGCCCCC TCCNTCATCC ACAGGATGGA GCGCTATGTC TCTATGCCCA AGG 
RP7939MAY AGTAATG-TG GCGTTGAGGA AGCAGGCTAA A G A T T A — A A TCAGGCCTCC TC TAC ACGTGG 
Riken AGTGCTGGTG GCTTTGAGGA AGAGGCCTAA AGATTGGCAG TCACGCCCCC TCCCTCATCC ACAGGATGGA GCGCTATGTC TCTATGCCCA AGG 
Chromosome AGTGCTGGTG GCTTTGAGGA AGAGGCCTAA AGATTGGCAG TCACGCCCCC TCCCTCATCC ACAGGATGGA GCGCTATGTC TCTATGCCCA AGG 
P P S I G - R P 7 9 3 9 
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Appendix Cll: Exon 11 to downstream 
Template: BAC subclone 11#1 
PPSIG-FP7916 
8701 
M13R AGCGCTAT GTCTCTATGC CCAAGGAAAA GGCTCCAGAA 
Riken AGCGCTAT GTCTCTATGC CCAAGGAAAA GGCTCCAGAA 
Chromosome — A G C G C T A T GTCTCTATGC CCAAGGAAAA GGCTCCAGAA 
8801 8900 
M13R CACATTCCCC TTCTCTTCAT TGCCTTCCCA TCAAGCAASG ATCCAACCTG GGAGGAGCGA TTCCCAGGTA GGGCTTGAAG TCCAGGGAAG TTGGGTGTAG 
Riken CACATTCCCC TTCTCTTCAT TGCCTTCCCA TCAAGCAAGG ATCCAACCTG GGAGGAGCGA TTCCCAGGTA GGGCTTGAAG TCCAGGGAAG TTGGGTGTAG 
Chromosome CACATTCCCC TTCTCTTCAT TGCCTTCCCA TCAAGCAAGG ATCCAACCTG GGAGGAGCGA TTCCCAGGTA GGGCTTGAAG TCCAGGGAAG TTGGGTGTAG 
8901 9000 
M13R GGCAAGGCAG GGCCAAATAG CAATAACATG GCCTTATACC CACAGACCGA TCCACAATGA CTGCGCTGGT ACCCATGGCC TTTGAATGGT TCGAGGAGTG 
Riken GGCAAGGCAG GGCCAAATAG CAATAACATG GCCTTATACC CACAGACCGA TCCACAATGA CTGCGCTGGT ACCCATGGCC TTTGAATGGT TCGAGGAGTG 
Chromosome GGCAAGGCAG GGCCAAATAG CAATAACATG GCCTTATACC CACAGACCGA TCCACAATGA CTGCGCTGGT ACCCATGGCC TTTGAATGGT TCGAGGAGTG 
9001 9100 
M13R GCAGGAGGAG CCAAAGGGCA AGCGTGGTGT TGACTATGAG ACCC 
Riken GCAGGAGGAG CCAAAGGGCA AGCGTGGTGT TGACTATGAG ACCC 
Chromosome GCAGGAGGAG CCAAAGGGCA AGCGTGGTGT TGACTATGAG ACCC 
PPSIG-RP8197 
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Appendix Cll: Exon 11 to downstream 
Template: B A C subclone 11#1 
PPSIG-FP8167 
9001 9100 
M13R AAGGGC AAGCGTGGTG TTGACTATSA GACCCTCAAA AATGCCTTCG TGGAAGCCTC TATGTCGGTG ATCATGAAAC TGTTCCCACA 
Riken AAGGGC AAGCGTGGTG TTGACTATGA GACCCTCAAA AATGCCTTCG TGGAAGCCTC TATGTCGGTG ATCATGAAAC TGTTCCCACA 
Chromosome AAGGGC AAGCGTGGTG TTGACTATGA GACCCTCAAA AATGCCTTCG TGGAAGCCTC TATGTCGGTG ATCATGAAAC TGTTCCCACA 
9101 9200 
M13R GCTGGAGGGC AAGGTAGGGG CTGACATACA GTGCTGGA(3G TGACAATGCA TCCCTTAACT GTCTTCTTCC ATACAGGGAC AAAGCCTGCG GTAACAAGAG 
Riken GCTGGAGGGC AAGGTAGGGG CTGACATACA GTGCTGGAGG TGACAATGCA TCCCTTAACT GTCTTCTTCC ATACAGGGAC AAAGCCTGCG GTAACAAGAG 
Chromosome GCTGGAGGGC AAGGTAGGGG CTGACATACA GTGCTGGAGG TGACAATGCA TCCCTTAACT GTCTTCTTCC ATACAGGGAC AAAGCCTGCG GTAACAAGAG 
9201 9300 
M13R TCCCACAGTC CCTTGTTCAC CCTTGCCTTG CCCTTTTGfT TCCTCAGGTG GAGAGTGTGA CTGGAGGGTC ACCACTGACC AACCAGTACT ATCTGGCTGC 
Riken TCCCACAGTC CCTTGTTCAC CCTTGCCTTG CCCTTTTGTT TCCTCAGGTG GAGAGTGTGA CTGGAGGGTC ACCACTGACC AACCAGTACT ATCTGGCTGC 
Chromosome TCCCACAGTC CCTTGTTCAC CCTTGCCTTG CCCTTTTGTT TCCTCAGGTG GAGAGTGTGA CTGGAGGGTC ACCACTGACC AACCAGTACT ATCTGGCTGC 
9301 9400 
M13R ACCCCGAGGA GCTACCTATG GAGCTGACCA TGACTTGGCT CGGCTGCATC CTCA|GCAAT |GCTTCCATA AGAGCCC|AA CC 
Riken ACCCCGAGGA GCTACCTATG GAGCTGACCA TGACTTGGCT CGGCTGCATC CTCATGCAAT GGCTTCCATA AGAGCCCAAA CC 
Chromosome ACCCCGAGGA GCTACCTATG GAGCTGACCA TGACTTGGCT CGGCTGCATC CTCATGCAAT GGCTTCCATA AGAGCCCAAA CC 
PPSIG-RP8534 
V. 
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Appendix CIO: Exon 10 to exon 11 
Template: BAC subclone 10#2 
PPSIG-FP8454 
5501 5600 
M13RJUN -CCCCGAGNN GCTACCTATG GAGCTGACCA TGACTTGG€T CGGCTGCATC CTCATGCAAT GGCTTCCATA AGAGCCCAAA CCCCCATCCC CGACCTCTAC 
M13RJUL -CCCCGAGGA GCTACCTATG GAGCTGACCA TGACTTGG€T CGGCTGCATC CTCATGCNAT GGCTTCCATA AGAGCCCANA CCCCCATCCC CAACCTCTAC 
Riken -CCCCGAGGA GCTACCTATG GAGCTGACCA TGACTTGGCT CGGCTGCATC CTCATGCAAT GGCTTCCATA AGAGCCCAAA CCCCCATCCC CAACCTCTAC 
Chromosome -CCCCGAGGA GCTACCTATG GAGCTGACCA TGACTTGGCT CGGCTGCATC CTCATGCAAT GGCTTCCATA AGAGCCCAAA CCCCCATCCC CAACCTCTAC 
5601 5700 
M13RJUN CTGACAGGTA CACTGCCTCA CTTTGCCAGA ATCTGGACTT CCCTGGCATA GTCTTCTGTT CTCGTCCTCA AGCCTACACC AGGAGCTGGG CTGCCTTGGC 
M13RJUL CTGACAGGTA CACTGCCTCA CTTTGCCAGA ATCTGGACTT CCCTGGCATA GTCTTCTGTT CTCGTCCTCA AGCCTACACC AGGAGCTGGG CTGCCTTGGC 
Riken CTGACAGGTA CACTGCCTCA CTTTGCCAGA ATCTGGACTT CCCTGGCATA GTCTTCTGTT CTCGTCCTCA AGCCTACACC AGGAGCTGGG CTGCCTTGGC 
Chromosome CTGACAGGTA CACTGCCTCA CTTTGCCAGA ATCTGGACTT CCCTGGCATA GTCTTCTGTT CTCGTCCTCA AGCCTACACC AGGAGCTGGG CTGCCTTGGC 
5701 5800 
M13RJUN TATTGTCCTG GGTTCTATCT GAGGCTGTCT CTCTTTGG6T GGCCTTGATA TGGAGGGATG AACACAAGAA CCCTTGTTAC CCCCATCTTC ATGGGTCACT 
M13RJUL TATTGTCCTG GGTTCTATCT GAGGCTGTCT CTCTTTGGGT GGCCTTGATA TGGAGGGATG AACACAAGAA CCCTTGTTAC CCCCATCTTC ATGGGTCACT 
Riken TATTGTCCTG GGTTCTATCT GAGGCTGTCT CTCTTTGGGT GGCCTTGATA TGGAGGGATG AACACAAGAA CCCTTGTTAC CCCCATCTTC ATGGGTCACT 
Chromosome TATTGTCCTG GGTTCTATCT GAGGCTGTCT CTCTTTGGGT GGCCTTGATA TGGAGGGATG AACACAAGAA CCCTTGTTAC CCCCATCTTC ATGGGTCACT 
Consensus TATTGTCCTG GGTTCTATCT GAGGCTGTCT CTCTTTGGGT GGCCTTGATA TGGAGGGATG AACACAAGAA CCCTTGTTAC CCCCATCTTC ATGGGTCACT 
5801 5900 
M13RJUN GCTTTTGCTT TCTAGGCCAA GATATCTTCA CCTGTGGGGT GATGGGGGCC CTGCAGGGGG CCTTGCTGTG CAGCAGTGCC ATCCTGAAAC GGAACTTGTA 
M13RJUL GCTTTTGCTT TCTAGGCCAA GATATCTTCA CCTGTGGGCT GATGGGGGCC CTGCAGGGGG CCTTGCTGTG CAGCAGTGCC ATCCTGAAAC GGAACTTGTA 
Riken GCTTTTGCTT TCTAGGCCAA GATATCTTCA CCTGTGGGCT GATGGGGGCC CTGCAGGGGG CCTTGCTGTG CAGCAGTGCC ATCCTGAAAC G G A A C T T G ^ 
Chromosome GCTTTTGCTT TCTAGGCCAA GATATCTTCA CCTGTGGGCT GATGGGGGCC CTGCAGGGGG CCTTGCTGTG CAGCAGTGCC ATCCTGAAAC GGAACTTGTA 
Consensus GCTTTTGCTT TCTAGGCCAA GATATCTTCA CCTGTGGGCT GATGGGGGCC CTGCAGGGGG CCTTGCTGTG CAGCAGTGCC ATCCTGAAAC GGAACTTGTA 
5901 .. 6000 
M13RJUN CTCAGATCTG CAGGCT 
M13RJUL CTCAGATCTG CAGGCT 
Riken CTCAGATCTG CAGGCT 
Chromosome CTCAGATCTG CAGGCT 
Consensus CTCAGATCTG CAGGCT 
PPSIG-RP8868 
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Appendix C l l : Exon 11 to downstream 
Template: BAC subclone 11#1 PPSIG-FP8841 
10601 10700 
M 1 3 R J U N - - -ACGGAAC 
M13RJUL - - - ACGGAAC 
Riken ACGGAAC 
Chromosome --- ACGGAAC 
10701 10800 
M13RJUN TTGTACTCAG ATCTGCAGGC TCTTGGCTCA AAGGTCAAGG CACAAAAGAA GAAGATGTAG TCCGTTCAGA GAAGAGCCAG AGGAAAGGCA CCTCCCCAAC 
Ml3RJUL TTGTACTCAG ATCTGCAGGC TCTTGGCTCA AAGGTCAAGG CACAAAAGAA GAAGATGTAG TCCGTTCAGA GAAGAGCCAG AGGAAAGGCA CCTCCCCAAC 
Riken TTGTACTCAG ATCTGCAGGC TCTTGGCTCA AAGGTCAAGG CACAAAAGAA GAAGATGTAG TCCGTTCAGA GAAGAGCCAG AGGAAAGGCA CCTCCCCAAC 
Chromosome TTGTACTCAG ATCTGCAGGC TCTTGGCTCA AAGGTCAAGG CACAAAAGAA GAAGATGTAG TCCGTTCAGA GAAGAGCCAG AGGAAAGGCA CCTCCCCAAC 
10801 10900 
M13RJUN TTCTCGTGGT GTCCTCCCTC CTACAGCAAT TCCTTGCACA TATAAACAAA AACCATTTTG TTTCTGATTA GTGTTGTTAA GTCAAGAGTT CTTTACCTTG 
Ml3RJUL TTCTCGTGGT GTCCTCCCTC CTACAGCAAT TCCTTGCACA TATAAACAAA AACCATTTTG TTTCTGATTA GTGTTGTTAA GTCAAGAGTT CTTTACCTTG 
Riken TTCTCGTGGT GTCCTCCCTC CTACAGCAAT TCCTTGCACA TATAAACAAA AACCATTTTG TTTCTG 
Chromosome TTCTCGTGGT GTCCTCCCTC CTACAGCAAT TCCTTGCACA TATAAACAAA AACCATTTTG TTTCTGATTA GTGTTGTTAA GTCAAGAGTT CTTTACCTTG 
10901 11000 
M13RJUN CATTCTACTT AAGGCCTAGT GTGAACTACA TAGCCTTGAT GCCTCATGAA GAATGCTCCC ATGCCTTTCC TACACCCAAC TCCAAGCTAT GGTCAGGCAC 
M13RJUL CATTCTACTT AAGGCCTAGT GTGAACTACA TAGCCTTGAT GCCTCATGAA GAATGCTCCC ATGCCTTTCC TACACCCAAC TCCAAGCTAT GGTCAGGCAC 
Chromosome CATTCTACTT AAGGCCTAGT GTGAACTACA TAGCCTTGAT GCCTCATGAA GAATGCTCCC ATGCCTTTCC TACACCCAAC TCCAAGCTAT GGTCAGGCAC 
11001 11100 
M13RJUN CCAGAACCCC TGGGGTGTNG GCTACTGGAA TAGGTTGGTT CAGTCCTACC CTGAAGCTTT TTGTTCCTCC TCACTCTCGT GTTGTGATGC TCTATACATG 
Ml3RJUL CCAGAACCCC TGGGGTGTTG GCTACTGGAA TAGGTTGGTT CAGTCCTACC CTGAAGCTTT TTGTNCCTCC TCACTCTCGT GTTGTGATGC TCTATACATG 
Chromosome CCAGAACCCC TGGGGTGTTG GCTACTGGAA TAGGTTGGTT CAGTCCTACC CTGAAGCTTT TTGTTCCTCC TCACTCTCGT GTTGTGATGC TCTATACATG 
11101 11200 
M13RJUN GAAAAGTGTG CGCTAGGAGT AGCAACTCTC TCAAAGTGCC AGACCTAAGA AAACCCTCAG GTCTAAGTTT TATCCTGATA GAAGTGGGTT AAAGGAACAC 
M13RJUL GAAAAGTGTG GGCTTGGAGT AGCAACTCTC TCAAAGTGCC AGACCTAAGA AAACCCTCAN GTCTAAGTTT NATCCTGATA GANGTGNGTN AANNGANCAC 
SEQ9382JUL GNTGGGTN AAAGGAACAC 
Chromosome GAAAAGTGTG GGCTTGGAGT AGCAACTCTC TCAAAGTGCC AGACCTAAGA AAACCCTCAG GTCTAAGTTT TATCCTGATA GAAGTGGGTT AAAGGAACAC 
11201 11300 
M13RJUN ANCAAAAGAT ACCACTGCCG ATGACCCNAG CCTAGACACG GCATTTGTAG TNGCTGNCAC ATAGTCAAAC TGAGTTACGA NGCTGGGCAG TGCTGNCACC 
M13RJUL ACCAAAAGAT ANCACTGCCG ATGACCCNAG CNTAGACACG GCATTTGTAN TTGCTGGCAC ATAGTNNAAC TGAGTTACGA GGCTGGN-AG TGCTGNCACN 
RP_D263_JU ANNNAT NNCACTGCCG ATGGANCCAG CNTANACACN GCANTTGTAG TTGCTGGCAC ATAGTCNAAC TGAGTTACGN G-CTGGGCAG TGCTGGCACC 
RPD263MAY GAACCAAG CTTAGACACG GCATTTGTAG TTGCTGGCAC ATAGTCAAAC TGAGTTACGA G-CTGGCCAG TGCTGGCACC 
SEQ93 82JUL ACCAAAAGAT ACCACTGCCG ATGAACCAAG C-TAGACACG GCATTTGTAG TTGCTGGCAC NTAGTCAAAC TGAGTTACGA GGCTGGGCAG TGCTGGCACC 
SEQ9382MAY ACAACAAAGA TACACTGC-G ATGAA-CAAG CCTAGACACG GCATTTGTAG TTGCTGGCAC ATAGTCAAAC TGAGTTACGA GGCTGGGCAG TGCTGGCACC 
Chromosome ACCAAAAGAT ACCACTGCCG ATGAACCAAG CCTAGACACG GCATTTGTAG TTGCTGGCAC ATAGTCAAAC TGAGTTACGA GGCTGGGCAG TGCTGGCACC 
11301 11400 
M13RJUN GCCCTN--AN CCCAGCACTC AGA-GGCAGG G-CNGAC-NA GC-CTGTGA- --NNNGANCA GA-CTAGTTA T--GAGCA-G TCCGGG 
M13RJUL GCC-TT--AN CCCAGCA-NC NNA-AGCAGG G-C-AAN-NG NC-TTGTAN- --TNGAGCCN NA-CNANTNA T--AA-CA-G TCAGGCACC AACTCG 
Ml3 FJUL CCAGNGCTCT 
RP一D263-JU GGCCTTTAAC CCCAGCACTC AGAAGGCAGG GGCAGACAGA GCTCTGTGNN TCTGAAGCCA GAACTAGTTT ATGAAGCNAG TNCAGGGCAG CCAGAGCTCT 
RPD263MAY GGCCTTTAAC CCCAGCACTC AGAAGGCAGG GCCAGACAGA GCTCTGTGAA TCTGAAGCCA GAACTAGTTT ATGAAGCAAG TCCAGGGCAG CCAGAGCTCT 
SEQ9382JUL GGCCTTTAAC CCCAGCACTC AGAAGGCAGG GGCAGACAGA GCTCTGTGAA TCTGAAGCCA GAACTAGTTT ATGAAGCAAG TCCAGGGCAG CCAGAGCTCT 
SEQ9382MAY GGCCTTTAAC CCCAGCACTC AGAAGGCAGG GGCAGACAGA GCTCTGTGAA TCTGAAGCCA GAACTAGTTT ATGAAGCAAG TCCAGGGCAG CCAGAGCTCT 
Chromosome GGCCTTTAAC CCCAGCACTC AGAAGGCAGG GGCAGACAGA GCTCTGTGAA TCTGAAGCCA GAACTAGTTT ATGAAGCAAG TCCAGGGCAG CCAGAGCTCT 
11401 11500 
Ml3RJUL TNTANA --AANCN-NG TTGAAACAAA AAAAACA 
Ml3FJUL GTTATANAGA GNNACCN-NG TCNTGNNNAA CCAAACAANA -CCAAACAAA NCCTGAGTAN TGTNNNCTNA AATGCTTGGA GTCAGANTTC TTTCAGATTT 
RP_D263_JU GTTATACAGA GAAACCC-TG TCTTGAAAAA CAAAACAANA -CAAAACAAA ACCTGAGTAT TGTTTTCTAA NATGCTTGGA GTCAGAATTC TTTCAGATTT 
RPD263MAY GTTATACAGA GAAACCCCTG TCTTGAAAAA CAAAACAATA ACAAAACAAA ACCTGAGTAT TGTTTTCTAA AATGCTTGGA GTCAGAATTC TTTCAGATTT 
SEQ9382JUL GTTATACAGA GAAACCC-TG TCTTGAAAAA CAAAACAAAA -CAAAACAAA ACCTGAGTAT TGTTTTCTAA AATGCTTGGA GTCAGAATTC TTTCAGATTT 
SEQ9382MAY GTTATACAGA GAAACCC-TG TCTTGAAAAA CAAAACAAAA GGGGGACAAA ACCTGAGTAT TGTTTTCTAA AATGCTTGGA GTCAGAATTC TTTCAGATTT 
Qhrotnosome GTTATACAGA GAAACCC-TG TCTTGAAAAA CAAAACAAAA -CAAAACAAA ACCTGAGTAT TGTTTTCTAA AATGCTTGGA GTCAGAATTC TTTCAGATTT 
11501 11600 
Ml3FJUL TGTAGTANTT GCATACACAT GAGATNACCT GGGGAATGGG TCCCAGNACT NAACCACAAA TTCA-TTTGT TTCATATGTA TAGACCAGGC ACAACATCTT 
RP_D263_JU TGTAGTATTT GCATACACAT GAGATAACCT GGGGAATGGG TCCCAGAACT AAACCACANA TTCA-TTTGT TTCATATGTA TAGACCAGGC ACAACATCTT 
RPD263MAY TGTAGTATTT GCATACACAT GAGATAACCT GGGGAATGGG TCCCAGAACT AAACCACAAA TTCA-TTTGT TTCATATGTA TAGACCAGGC ACAACATCTT 
SEQ9382JUL TGTAGTATTT GCATACACAT GAGATAACCT GGGGAATGGG TCCCAGAACT AAACCACAAA TTCA-TTTGT TTCATATGTA TAGACCAGGC ACAACATCTT 
SEQ93 82MAY TGTAGTATTT GCATACACAT GAGATAACCT GGGGAATGGG TCCCAGAACT AAACCACAAA TTCAGTTTGT TTCATATGTA TAGACCAGGC ACAACATCTT 
Chromosome TGTAGTATTT GCATACACAT GAGATAACCT GGGGAATGGG TCCCAGAACT AAACCACAAA TTCA-TTTGT TTCATATGTA TAGACCAGGC ACAACATCTT 
11601 11700 
Ml3FJUL ATGTAATACT TTGAAAAACT GAGCATTCTG ACC-TGTCAC ATGAGTCCAT GCTATNATTT AAAAAGCTTG CTTTGATTTC AGAATAGGGA TGCTTTACCT 
RP_D263_JU ATGTAATACT TTGAAAAACT GAGCATTCTG ACC-TGTCAC ATGAGTCCAT GCTATAATTT AAAAAGCTTG CTTTGATTTC AGAATAGGGA TGCTTTACCT 
RPD263MAY ATGTAATACT TTGAAAAACT GAGCATTCTG ACC-TGTCAC ATGAGTCCAT GCTATAATTT AAAAAGCTTG CTTTGATTTC AGAATAGGGA TGCTTTACCT 
SEQ93 82JUL ATGTAATACT TTGAAAAACT GAGCATTCTG ACC-TGTCAC ATGAGTCCAT GCTATAATTT AAAAAGCTTG CTTTGATTTC AGAATAGGGA TGCTTTACCT 
SEQ9382MAY ATGTAATACT TTGAAAAACT GAGCATTCTG ACCCTGTCAC ATGAGTCCAT GCTATAATTT AAAAAGCTTG CTTTGATTTC AGAATAGGGA TGCTTTACCT 
BAC-D263MA ATGTAATACT T-GNAAAACT GAGCATTCTG ACC-TGTCCNCATGAGTCCAT GCTATAATTT AACNAAGCTTTGCTTTGATTTCAGAATAGGGA TGCTTTACCT 
Chromosome ATGTAATACT TTGAAAAACT GAGCATTCTG ACC-TGTCAC ATGAGTCCAT GCTATAATTT AAAAAGCTTG CTTTGATTTC AGAATAGGGA TGCTTTACCT 
. 326 • 
11701 11800 
Ml3FJUL ATATGAGTAA ATGAGAAGG- TGGATAAAAA TTAAAAACCT TTTACTTATG TTAAACAAGT GCTAATTTTA GTCTGTTTAA ATATAGTATT AATACATGTA 
RP-D263-JU ATATGAGTAA ATGAGAAGG- TGGATAAAAA TTAAAAACCT TTfACTTATG TTAAACAAGT GCTAATTTTA GTCTGTTTAA ATATAGTATT AATACATGTA 
RPD263MAY ATATGAGTAA ATGAGCCCGC TGGATAAAAA TTAAAAACCT TTTACTTATG TTAAACAAGT GCTAATTTTA GTCTGTTTAA ATATAGTATT AATACATGTA 
SEQ9382JUL ATATGAGTAA ATGAGAAGG- TGGATAAAAA TNANAA-CCN NTNACTNATG TNAA-CAAGT GCTAATTT-A GTCTGTNTAA -TATAGTATN ANTACATGTA 
SEQ93 82MAy ATATGAGTAA ATGAGAAGG- TGGATAAAAA TTAAAAACCT TTTACTTATG TTAAACAAGT GCTAATTTTA GTCTGTTTAA ATATAGTATT AATACATGTA 
3R8-9382 ATATGAGTAA ATGAGAAGG- TGGATAAAAA TTAAAAACCT TTCACTTATG TTAAACAAGT GCTAATTTTA GTCTGTTTAA ATATAGTATT AATACATGTA 
3R12-9382 ATATGAGTAA ATGAGAAGG- TGGATAAAAA TTAAAAACCT TTCACTTATG TTAAACAAGT GCTAATTTTA GTCTGTTTAA ATATAGTATT AATACATGTA 
3 R 2 5 - 9 3 8 2 A T A T G A G T A A A T G A G A A G G - T G G A T A A A A A T T A A A A A C C T T T C A C T T A T G T T A A A C A A G T G C T A A T T T T A G T C T G T T T A A A T A T A G T A T T A A T A C A T G T A 
BAC-D263MA ATATGAGTAA ATGAGAAGG- TGGATTAAAA TTAAAAACCT TTCACTTATG TTAAACAAGT GCTAATGTTA GTCTGTTTAA ATATAGTATT AATACCCTGT 
Chromosome ATATGAGTAA ATGAGAAGG- TGGATAAAAA TTAAAAACCT TTCACTTATG TTAAACAAGT GCTAATTTTA GTCTGTTTAA ATATAGTATT AATACATGTA 
11801 11900 
Ml3FJUL ATGTTTCAAT GCTTTGATAT CTGAAATTTA TTGATTTCTG TTCAATAATG ACATGAAACT ATGCTATGAT TCCATTTACA GAAGCTCAGT AAAATATACT 
RP_D263_JU ATGTTTCAAT GCTTTGATAT CTGAAATTTA TTGATTTCTG TTCAATAATG ACATGAAACT ATGCTATGAT TCCATTTACA GAAGCTCAGN TAAATATATC 
RPD263MAY ATGTTTCAAT GCTTTGATAT CTGAAATTTA TTGATTTCTG TTCAATAATG ACATGAAACT ATGCTCTGAT TCCATTTACA GAAGCTCAGT AAAATATACT 
SEQ9382JUL NTGTNNCANT GCCTTGATAT CTGAAATTAA TNGATTTCTG TNCAATANTG ACATGAAACT ATGCTATGAT T 
SEQ9382MAY ATGTTTCAAT GC 
BAC-D263MA TAATGTTTGGAATGCTTNGATATCTGAAATTTATTGATTTCTG TTCAATAATG ACATGAAACT ATGCTACTGATTCCATTTCNCNGACAGCCT 
Chromosome ATGTTTCAAT GCTTTGATAT CTGAAATTTA TTGATTTCTG TTCAATAATG ACATGAAACT ATGCTATGAT TCCATTTACA GAAGCTCAGT AAAATATACT 
11901 12000 
Ml3FJUL GA-AAAATAC TTACTATACC ACAGTAAGCT TTAAAAAAAA TAAAATTAAG CCATTACAGT TAAGTTACAA AAAAGGTGAC AATACCAAAC ATGGCTAACA 
RP一D263一JU GTNAAAANAT CNATCATATC ACNNCGAAGT CTATATAAAA NAANNATAAG TATATCCAN- ---AGTCTAG TNANA 
RPD263MAY GA-AAAATAC TTACTATACC ACAGTAAGCT TTAAAAAAGA ATAAAATAAG CCATTACAGT TAAATACCAG GAGTACTTCC AC 
Chromosome GA-AAAATAC TTACTATACC ACAGTAAGCT TTAAAAAAAA TAAAATTAAG CCATTACAGT TAAGTTACAA AAAAGGTGAC AATACCAAAC ATGGCTAACA 
12001 12100 
Ml 3 FJUL QTAQCAATCT JlACTGGCUUl-
Chromosome GTAGCAATCT AACTGGGAA-
P P S I G - R P ( D 2 6 3 ) 
V. 
- 327 















































































































































































































































Appendix C13: The alignment result of all the PPSIG genomic sequence 
Chromosome一6 GGGGGGGATCCCACATCCCCCTTTTCGCGCAGCCGTGCAGTGTCGCCTGTCTCGCGCTAG 780 
FP(U76) 
Exon 1-2 TCGCGCTAG 9 
Chromosome_6 AACTACATTTCCCATTAGGCAATTGAACTCCTGCTCTGCAAAGATCATACGGAGGTCCAT 840 
Exon 1-2 AACTACATTTCCCATTAGGCAATTGAACTCCTGCTCTGCAAAGATCATACGGAGGTCCAT 69 
Chromosome—6 AATGGACAATCTTCATCAGTTTTGAGCAGGCGTGAGTCAAAATGCTTCGGCTCCTCCAAG 900 
Exon 1-2 AATGGACAATCTTCATCAGTTTTGAGCAGGCGTGAGTCAAAATGCTTCGGCTCCTCCAAG 129 
Chromosome_6 TCTGGTATTACTCCAAGGACGAACTAGAGGGGCGGGGCCTCAGCTATAAAAGCCGAGCTC 960 
Exon 1-2 TCTGGTATTACTCCAAGGACGAACTAGAGGGGCGGGGCCTCAGCTATAAAAGCCGAGCTC 189 
Chromosome_6 AGCGGGGAAAGGACGCGGTCTTCCGAGCCCTGGCAGCAACATGTGGATCACTGCTCTGCT 1020 
Exon 1-2 AGCGGGGAAAGGACGCGGTCTTCCGAGCCCTGGCAGCAACATGTGGATCACTGCTCTGCT 249 
Chromosome_6 GCTGGCCGTGCTGCTGCTGGTGATCCTCCACAGGGTCTACGTGGGCCTTTACGCTGCAAG 1080 
Exon 1-2 GCTGGCCGTGCTGCTGCTGGTGATCCTCCACAGGGTCTACGTGGGCCTTTACGCTGCAAG 309 
Chromosome_6 TTCCCCGAACCCCTTCGCCGAGGATGTCAAGCGACCGCCTGAACCCCTGGTGACCGACAA 1140 
Exon 1-2 TTCCCCGAACCCCTTCGCCGAGGATGTCAAGCGACCGCCTGAACCCCTGGTGACCGACAA 369 
Chromosome_6 GGAGGCTAGGAAGAAAGTTCTCAAACAAGGTCAACTGATGGGTTTCAGGCCTGCTCTCGG 1200 
Exon 1-2 GGAGGCTAGGAAGAAAGTTCTCAAACAAGGTCAACTGATGGGTTTCAGGCCTGCTCTCGG 429 
Chromosome_6 GCCTTCTGCTCATGTCTCCCCATTAGTAAAGTGCTGGGAAAACTTCTCTTGCACACAGAG 1260 
Exon 1-2 GCCTTCTGCTCATGTCTCCCCATTAGTAAAGTGCTGGGAAAACTTCTCTTGCACACAGAG 489 
Chromosome_6 GTTCCATAATTTAGTGTTCTTTGCTTCTGAAAGGGTGCAGGCATTACCCTTGGCACGCCA 1320 
Exon 1-2 GTTCCATAATTTAGTGTTCTTTGCTTCTGAAAGGGTGCAGGCATTACCCTTGGCACGCCA 549 
Chromosome_6 AATTCCAGCCCCGCCAGTTGGAATCTTTTCAGCTCACGGCTTACACAGAATAAGAGACCT 1380 
Exon 1-2 AATTCCAGCCCCGCCAGTTGGAATCTTTTCAGCTCACGGCTTACACAGAATAAGAGACCT 609 
Chromosome_6 TTCCCCTACTTGGGTCTGGAGCCAACTTTTCCCTATACTTCTGTGCATGCTCGGGGGCAC 1440 
Exon 1-2 TTCCCCTACTTGGGTCTGGAGCCAACTTTTCCCTATACTTCTGTGCATGCTCGGGGGCAC 669 
Chromosome—6 AGGGAAGCAGCACTGAAAGTTTTCCTAACAAGCGGGTTGCAGGCAAAATGTAGTCCAGTT 1500 
Exon 1-2 AGGGAAGCAGCACTGAAAGTTTTCCTAACAAGCGGGTTGCAGGCAAAATGTAGTCCAGTT 729 
Chromosome_6 CATAGAACTGAAGCTTGATAATAACTTCGGAATTTCAGTACTGGCTAGGGATAAGAACTC 1560 
Exon 1-2 CATAGAACTGAAGCTTGATAATAACTTCGGAATTTCAGTACTGGCTAGGGATAAGAACTC 789 
_ 335 
Chromosome_6 CACTCTCCAGTGAACCATCTCTAAAGCACGTGTAGAGTGCTCCCAAGGTTTGTGTTTTTG 1620 
Exon 1-2 CACTCTCCAGTGAACCATCTCTAAAGCACGTGTAGAGTGCTCCCAAGGTTTGTGTTTTTG 849 
Chromosome_6 AGACTGGTCTCACTTTTGTACTGGAGTTGGCTTTGAACTCTCTTCGCAGCCCAGGCTCAA 1680 
Exon 1-2 AGACTGGTCTCACTTTTGTACTGGAGTTGGCTTTGAACTCTCTTCGCAGCCCAGGCTCAA 909 
Chromosome_6 ACCCGGAGCAGCCCTCTTCTTCTGTCCCCAGCATGATGAGATAGATTACAAGCATGCACC 1740 
Exon 1-2 ACCCGGAGCAGCCCTCTTCTTCTGTCCCCAGCATGATGAGATAGATTACAAGCATGCACC 969 
Chromosome_6 AGCATG-TCTGCCTTTCAACGTTTTACGGAAGTGTTGGAGCTGGGCATAGTGGTGCAACAA 1800 
Exon 1-2 AGCATG-TCTGCCTTTCAACGTTTTACGGAAGTGTTGGAGCTGGGCATAGTGGTGCAACAA 1029 
Chromosome_6 TTTAATTCCAGTTTGGACTACACAATGAGACCCTGTCTAAATGCACACATCAAACCCCAA 1860 
Exon 1-2 TTTAATTCCAGTTTGGACTACACAATGAGACCCTGTCTAAATGCACACATCAAACCCCAA 1089 
Chromosome_6 AACAACCAAAACCCCCAAATGCAAAACTTTCAAAAAACAAACAAGGATCACCTCTTTGAC 1920 
Exon 1-2 AACAACCAAAACCCCCAAATGCAAAACTTTCAAAAAACAAACAAGGATCACCTCTTTGAC 1149 
Chromosome_6 CTCCAGGAGCCTCTGACTTGTAAATTTTAGCCAAGCCTAGGCTAGCCTTAACTGCACTAT 1980 
Exon 1-2 CTCCAGGAGCCTCTGACTTGTAAATTTTAGCCAAGCCTAGGCTAGCCTTAACTGCACTAT 1209 
Chromosome_6 TTTTTGGGGACTGACTTTGAACTCCTGATCCTTGTGCCTCTACTTCCTAAGAGGCACCAC 2040 
Exon 1-2 TTTTTGGGGACTGACTTTGAACTCCTGATCCTTGTGCCTCTACTTCCTAAGAGGCACCAC 1269 
Chromosome_6 ACCCAGTTATTTTATTATTGTTATTGTTTGTGGATTGGGGGAGAGGCAGGTCTCATACTT 2100 
Exon 1-2 ACCCAGTTATTTTATTATTGTTATTGTTTGTGGATTGGGGGAGAGGCAGGTCTCATACTT 1329 
Chromosome_6 GTAGCCCAGGCTAGCTTATAACTTGCTATACAGGACAAGTGTGTCTCAAATTCACAGTGA 2160 
Exon 1-2 GTAGCCCAGGCTAGCTTATAACTTGCTATACAGGACAAGTGTGTCTCAAATTCACAGTGA 
Chromosome_6 TTCTCCAACCACCATCAGCAAGAGATTACAAATGGTGGGATTACAGATGTGAGCCACCAT 2220 
Exon 1-2 TTCTCCAACCACCATCAGCAAGAGATTACAAATGGTGGGATTACAGATGTGAGCCACCAT 1449 
Chromosonie_6 GGCTTGGATGGAGATTTTTTTTTT-ATTTTATTTTTTTTAGTTTTTAGTTGTTTGAGACA 2279 
Exon 1-2 GGCTTGGATGGAGATTTTTTTTTT-ATTTTATTTTTTTTAGTTTTTAGTTGTTTGAGACA 
Chromosome—6 GTGTTTCTCTCTATAGTTCTAGATGTCCTGGAACTTGCTATTGCTATATAGACCAGGCTG 2339 
Exon 1-2 GTGTTTCTCTCTATAGTTCTAGATGTCCTGGAACTTGCTATTGCTATATAGACCAGGCTG 1569 
Chromosome一6 GCCTTGAACTCACTGAGATCCTCCCACCTCAGCCTCCTGAGTGCTGAGACTAAAGCTGTG 2399 
Exon 1-2 GCCTTGAACTCACTGAGATCCTCCCACCTCAGCCTCCTGAGTGCTGAGACTAAAGCTGTG 1629 
Chromosome_6 AACACTTGGCCTTGGGCAATGATGTTTAATGAGCAGATTTACTGGACATAGTGGCACATT 2459 
Exon 1-2 AACACTTGGCCTTGGGCAATGATGTTTAATGAGCAGATTTACTGGACATAGTGGCACATT 1689 
Chromosome_6 CCTGTGATCCCAGCGCTGGGGAGGAAAAGACAGGTGGATCTCTACATAGGGAGTTCCAGC 2519 
Exon 1-2 CCTGTGATCCCAGCGCTGGGGAGGAAAAGACAGGTGGATCTCTACATAGGGAGTTCCAGC 1749 
336 
Chromosome_6 CCAGTTAGGGCTACATGTGTAGTGAAACCGTGTGTCTTAAAAAACACGAATCAATAAAAT 2579 
Exon 1-2 CCAGTTAGGGCTACATGTGTAGTGAAACCGTGTGTCTTAAAAAACACGAATCAATAAAAT 1809 
Chromosome_6 CAAAGAAAGTAAGTAAATAAAGGAGGAAAGGAAGTAAAAGACTGGGAGAAAACAACAAAT 2639 
Exon 1-2 CAAAGAAAGTAAGTAAATAAAGGAGGAAAGGAAGTAAAAGACTGGGAGAAAACAACAAAT 1869 
Chromosome_6 CCCAGGTCTTGTGTTGACCGTGCATTCCAGTTTGGTTCTGTGAGGTTCCCGGCACACCAA 2699 
Exon 1-2 CCCAGGTCTTGTGTTGACCGTGCATTCCAGTTTGGTTCTGTGAGGTTCCCGGCACACCAA 1929 
Chromosome_6 CCTTCCTCCTTTTCTGAGGCTGGTGCTGTGACCTCTCAGAGTAGCAGCCTCTGAGCAGCT 2759 
Exon 1-2 CCTTCCTCCTTTTCTGAGGCTGGTGCTGTGACCTCTCAGAGTAGCAGCCTCTGAGCAGCT 1989 
Chromosome_6 CTGCCTGCTCCACCTCCGTTGGCACTCAGAGACCTTGCTTCTTCCAAAGAAACCCAGTTC 2819 
Exon 1-2 CTGCCTGCTCCACCTCCGTTGGCACTCAGAGACCTTGCTTCTTCCAAAGAAACCCAGTTC 2049 
Chromosome—6 CCTGAACCACCAGCGTCCCCAGCCCCCACCCTGAGCCTTATTGCCTTTTCTTTCCTCGCT 2879 
Exon 1-2 CCTGAACCACCAGCGTCCCCAGCCCCCACCCTGAGCCTTATTGCCTTTTCTTTCCTCGCT 2109 
Chromosome—6 TGCATTCACAGAACTGACGTTACAGCCCTGTGCAGTTGCCATCTTTCTGGTTTTGTTCTA 2939 
Exon 1-2 TGCATTCACAGAACTGACGTTACAGCCCTGTGCAGTTGCCATCTTTCTGGTTTTGTTCTA 2169 
Chromosome_6 CAGTAGCTAGCTGAGTCAGTCCTACTTCCTTTGAAAGGTATCAAATCCCTCAAGTACACT 2999 
Exon 1-2 CAGTAGCTAGCTGAGTCAGTCCTACTTCCTTTGAAAGGTATCAAATCCCTCAAGTACACT 2229 
Chromosome_6 GTAGGGGTTAAGACTCATCACTGCTTAACCTGCCTGTCTGGTCCGAGGTATTCCCTGGTA 3059 
Exon 1-2 GTAGGGGTTAAGACTCATCACTGCTTAACCTGCCTGTCTGGTCCGAGGTATTCCCTGGTA 2289 
Chromosome_6 GAATGTTTTGAGACATCTTAGTCAAGAGTAAATAAACTACCTTAAAAGAAAGGTCTGCCT 3119 
Exon 1-2 GAATGTTTTGAGACATCTTAGTCAAGAGTAAATAAACTACCTTAAAAGAAAGGTCTGCCT 
Chromosome_6 TCCCTCTTGTTTTGAGACTGGGTCTAACGAGCCCAGGCTGGCCTCCTGTGGGATGATCTT 3179 
Exon 1-2 TCCCTCTTGTTTTGAGACTGGGTCTAACGAGCCCAGGCTGGCCTCCTGTGGGATGATCTT 2409 
Chromosome一6 GGCCTCCTAATGCACCTTTCAAGTGCTCCCATCACAGGAGTACACCACCATGCCCAGCAG 3239 
Exon 1-2 GGCCTCCTAATGCACCTTTCAAGTGCTCCCATCACAGGAGTACACCACCATGCCCAGCAG 2469 
Chromosome_6 CCGTAGAGACTTCTTACCGAGTACACGTTAGAGAAGGACCCCGGCTTCTTTGACTTGACT 3299 
Exon 1-2 CCGTAGAGACTTCTTACCGAGTACACGTTAGAGAAGGACCCCGGCTTCTTTGACTTGACT 2529 
Chromosome_6 TTCCTGCCCTCGTCTGAGAAGCTCACCCTTCTCCTCCCTTCTACAGCTTTCTCAGTCAGC 3359 
Exon 1-2 TTCCTGCCCTCGTCTGAGAAGCTCACCCTTCTCCTCCCTTCTACAGCTTTCTCAGTCAGC 2589 
Chromosome_6 CGAGTACCAGAGAAGCTGGATGCAGTGGTGATCGGCAGCGGCAT-TGGGGGACTGGCCTCA 3419 
Exon 1-2 CGAGTACCAGAGAAGCTGGATGCAGTGGTGATCGGCAGCGGCAT-TGGGGGACTGGCCTCA 2649 
337 
Chromosome_6 GCTGCGGTTCTAGCTAAAGCTGGCAAGAGAGTCCTTGTGCTGGAACAACATACCAAGGCG 3479 
RP2635 
Exon 1-2 GCTGCGGTTCTAGCTAAAGCTGGCAAGAGAGTCCTTGTGCTGGAACAACATACCAAGGCG 2709 
FP2574 
Exon 2-3 _CGGTTCTAGCTAAAGCTGGCAAGAGAGTCCTTGTGCTGGMCAACATACCMGGCG 60 
Chromosome_6 GGCGGCTGTTGTCATACCTTTGGGGAAAATGGCCTTGAATTTGACACTGGTAAGGCTTGTG 3539 
Exon 1-2 GGC 2712 
Exon 2-3 GGCGGCTGTTGTCATACCTTTGGGGAAAATGGCCTTGAATTTGACACTGGTAAGGCTTGTG 120 
Chromosome_6 TGGGAAAGGGTTAGGAGCATGGCCTTGTCTTTAGATGGCTAATAACACACACTATTGAGT 3599 
Exon 2-3 TGGGAAAGGGTTAGGAGCATGGCCTTGTCTTTAGATGGCTAATAACACACACTATTGAGT 180 
Chromosome_6 GACATGGGGGCATTTTAATGTTTGGAGGTCTCAACTTCTCTCTGGGCACCTCCATTTCTG 3659 
Exon 2-3 GACATGGGGGCATTTTAATGTTTGGAGGTCTCAACTTCTCTCTGGGCACCTCCATTTCTG 240 
Chromosorae_6 TCCGATGGCCTAGTTACTGGGCAAGCATTGGGTGGTATATGTTCTGATTTGTTTCTTATA 3719 
Exon 2-3 TCCGATGGCCTAGTTACTGGGCAAGCATTGGGTGGTATATGTTCTGATTTGTTTCTTATA 300 
Chromosome_6 GAAAGGGTGGGCAGCCCCCCTCTGGACATGAACATAGCCAAGCAGGACAACCTCTTCCTT 3779 
Exon 2-3 GAAAGGGTGGGCAGCCCCCCTCTGGACATGAACATAGCCAAGCAGGACAACCTCTTCCTT 360 
Chromosome_6 ACTTGGCATATTTCCAGGGCCCAATCCCTTTTATCTCTATATCTCCTTTCCTTTGCACCT 3839 
Exon 2-3 ACTTGGCATATTTCCAGGGCCCAATCCCTTTTATCTCTATATCTCCTTTCCTTTGCACCT 420 
Chromosome_6 CCCAACAGGAATTCATTATATTGGACGAATGCGGGAGGGCAACATTGGCCGTTTTATCTT 3899 
Exon 2-3 CCCAACAGGAATTCATTATATTGGACGAATGCGGGAGGGCAACATTGGCCGTTTTATCTT 
FP3040 
SIG3#1 GGOTTTTTATOT 14 
Chromosome_6 GGACCAGATCACTGAAGGGCAACTGGACTGGGCCCCCATGGCCTCCCCTTTTGACTTGAT 3959 
Exon 2-3 GGACCAGATCACTGAAGGGCAACTGGACTGGGCCCCCATGGCCTCCCCTTTTGACTTGAT 540 
Exon 3-4 GGACCAGATCACTGA-GGGCNACTGGACTGGGCCCCCATG-CCTCNCCTTTTGACTTGAT 72 
Chromosome_6 GATACTAGAAGGGCCCAATGGCCGAAAGGAGTTCCCCATGTACAGTGGGAGGAAAGAATA 4019 
RP3184 
Exon 2-3 GATACTAGAAGGGCCCAATGGCCGAAAGGAGTTCCCCATGTACAGTGGGAGGAMGNATI 600 
Exon 3-4 GATACTAGAAGGGCCCAATGGCCGAAAGGAGTTCCCCATGTACAGTGGGAGGAAAGAATA 132 
Chromosome_6 CATCCAGGGCCTTAAGAAGAAGTTCCCCAAGGAAGAAGCTGTCATTGACAAGTACATGGA 4079 
Exon 2-3 CATCCAGGGCap 611 
Exon 3-4 CATCCAGGGCCTTAAGAAGAAGTTCCCCAAGGAAGAAGCTGTCATTGACAAGtACATGGA 192 
Chromosome_6 GTTGGTTAAGGTAGTATGCACCATGATTAGCATCCCTAGTTTATTTCCAACAAGACTGGC 4139 
Exon 3-4 GTTGGTTAAGGTAGTATGCACCATGATTAGCATCCCTAGTTTATTTCCAACAAGACTGGC 252 
Chromosome—6 CTTTTCATTAGTGAAGAAACTGGTGGGGTAGGAGGAGAGGGCTGAGTTGGGGAGGCAGGA 4199 
Exon 3-4 CTTTTCATTAGTGAAGAAACTGGTGGGGTAGGAGGAGAGGGCTGAGTT-GGGAGGCAGGA 311 
338 
Chromosome_6 AGGAATGGTCATGTCTGTCCTGGTTCCAGTGTAAGCTTGTGTTTGCCTGTGCCCTGCTTG 4259 
Exon 3-4 AGGAATGGTCATGTCTGTCCTGGTTCCAGTGTAAGCTTGTGTTTGCCTGTGCCCTGCTTG 371 
Chromosome_6 GCTCCCCAGCTGCAGTCCTCACACTGGCCTCTAGATGGTACCCTTGCTAAGTCAGGCTTT 4319 
Exon 3-4 GCTCCCCAGCTGCAGTCCTCACACTGGCCTCTAGATGGTACCCTTGCTAAGTCAGGCTTT 431 
Chromosome_6 GAGGAAGTTAGATGTCCTCTGAGATATGCCAGACTTTTGTGTATTTGAGGTAGAGTCTCA 4379 
Exon 3-4 GAGGAAGTTAGATGTCCTCTGAGATATGCCAGACTTTTGTGTATTTGAGGTAGAGTCTCA 491 
Chromosome_6 CAATGCTGCCCTGGCTGGTCTGGAACTCAGCAGAGATCCACCTGCCTCTGCCGAGCATAT 4439 
Exon 3-4 CAATGCTGCCCTGGCTGGTCTGGAACTCAGCAGAGATCCACCTGCCTCTGCCGAGCATAT 551 
Chromosome_6 GAAATCATAACCTGCTTTCTGGACCAGGATGTTTGGAAGGAATCTGAATGCTGGGGATGT 4499 
Exon 3-4 GAAATCATAACCTGCTTTCTGGACCAGGATGTTTGGAAGGAATCTGAATGCTGGGGATGT 611 
Chromosome_6 GGCTCAGGCTTAGCACATACAACTCTGAATTATATCCCAAGCACCTTAGCATCTGGATAT 4559 
Exon 3-4 GGCTCAGGCTTAGCACATACAACTCTGAATTATATCCCAAGCACCTTAGCATCTGGATAT 671 
Chromosome一6 GATGGTGTAGCCTGTAATCCCAGCATTGGGGAGGCAGAAGCAGGAAGTTCAGGAGTTCAA 4619 
Exon 3-4 GATGGTGTAGCCTGTAATCCCAGCATTGGGGAGGCAGAAGCAGGAAGTTCAGGAGTTCAA 731 
Chromosome_6 GGTCACTGGAATATTTGGAACTCTCTATATAAAAGAAAAACAATACTTTTTGGAGCATGA 4679 
Exon 3-4 GGTCACTGGAATATTTGGAACTCTCTATATAAAAGAAAAACAATACTTTTTGGAGCATGA 791 
Chromosome_6 AATGGAAGAGCAAATAGTCTCATTTGAGTGCGAAGAATGAGAAAAACTCAGGACCCATTT 4739 
Exon 3-4 AATGGAAGAGCAAATAGTCTCATTTGAGTGCGAAGAATGAGAAAAACTCAGGACCCATTT 
Chromosome_6 TGTTGTTGTTTTGTGGTGAGGAAGACAGCTCTACTACATAGTCCTGGCTTCTATGTCAGT 4799 
Exon 3-4 TGTTGTTGTTTTGTGGTGAGGAAGACAGCTCTACTACATAGTCCTGGCTTCTATGTCAGT 911 
Chromosome一6 GTATAGCTCTGGTTGCCCTTAAACTCATGGCAATCCTCCTGCTGTAGCATCTCAACTGTT 4859 
Exon 3-4 GTATAGCTCTGGTTGCCCTTAAACTCATGGCAATCCTCCTGCTGTAGCATCTCAACTGTT 971 
Chromosome一6 GGGATCACAGGCCTGAGTCTGATCACACACACCATGCCTAAAAAAAATTTTCAAGTCCAA 4919 
Exon 3-4 GGGATCACAGGCCTGAGTCTGATCACACACACCATGCCTAAAAAAAATTTTCAAGTCCAA 1031 
Chromosome_6 AAATTCTGAGTAAGTGTTGCTGGGCTGGCAGTCAGCGCTGACTGCTGCAGCAGTAACTAG 4979 
Exon 3-4 AAATTCTGAGTAAGTGTTGCTGGGCTGGCAGTCAGCGCTGACTGCTGCAGCAGTAACTAG 1091 
Chromosome_6 GCTCCAGCACCCCAGAGCTGAGACTCACTTTACCTTTTTTATCCCAGGTGGTGGCCCGTG 5039 
Exon 3-4 GCTCCAGCACCCCAGAGCTGAGACTCACTTTACCTTTTTTATCCCAGGTGGTGGCCCGTG 1151 
Chromosome_6 GAGTCTCTCATGCAGTTCTACTCAAGTTCCTCCCATTGCCCTTGACTCAGCTCCTCAGCA 5099 
Exon 3-4 GAGTCTCTCATGCAGTTCTACTCAAGTTCCTCCCATTGCCCTTGACTCAGCTCCTCAGCA 1211 
Chromosome_6 AGTTTGGGCTACTGACTCGTTTCTCTCCATTCTGCCGAGCGTCTACGCAGAGCCTAGCTG 5159 
Exon 3-4 AGTTTGGGCTACTGACTCGTTTCTCTCCATTCTGCCGAGCGTCTACGCAGAGCCTAGCTG 1271 
Exon 4-5 、 CGA-CGT-TA-GCAGAGCCTAGCTG 40 
339 
FP4259 
Chromosome—6 AAGTCCTGCAGCAGCTTGGGGCTTCCCGTGAGCTCCAGGCTGTTCTCAGCTACATCTTCC 5219 
RP4376 
Exon 3-4 AAGTCCTGCAGCAGCTTGGGGCTTCCCGTGAGCTCCAGGCTGTTCTCAGCTACATCTTO 1331 
Exon 4-5 AAGTNCTGCAGCAGCTTGGGGCTTCCCGTGAGCTCCAGGCTGTTCTCAGCTACATCTTCC 100 
Chromosome_6 CCACTTACGGTGGGTGGCTATAGCCCAGGCTTTTCTAGGCTACTGCTCTCCCAGCTTTGG 5279 
Exon 3-4 CCA 1334 
Exon 4-5 CCACTTACGGTGGGTGGCTATAGCCCAGGCTTTTCTAGGCTACTGCTCTCCCAGCTTTGG 160 
Chromosome_6 TCTTTCTTTCCCATCTGCCTAACTGAGACAGGCTAGAATAGCCCCAGGCCTGCAGGAGTT 5339 
Exon 4-5 TCTTTCTTTCCCATCTGCCTAACTGAGACAGGCTAGAATAGCCCCAGGCCTGCAGGAGTT 220 
Chromosome—6 TGTGGATCAGGGCTGAGAAGTCTGACCCATGTTGGACTCTGGTAAAAATGATTTATTATT 5399 
E x o n 4 - 5 TGTGGATCAGGGCTGAGAAGTCTGACCCATGTTGGACTCTGGTAAAAATGATTTATTATT 250 
Chromosome_6 TACTTTATGGAACGTTATCTTTTGTTCTTCTCTCTTGTATCTTTTCTTCTTCTTCTGTTT 5459 
Exon 4-5 TACTTTATGGAACGTTATCTTTTGTTCTTCTCTCTTGTATCTTTTCTTCTTCTTCTGTTT 340 
Chromosome_6 TGTTTTCTCTTCCTTTTTGAAGACAAGGTCTTCCAGGCAAGCTTTGAACTCTTGTAGTTG 5519 
Exon 4-5 TGTTTTCTCTTCCTTTTTGAAGACAAGGTCTTCCAGGCAAGCTTTGAACTCTTGTAGTTG 400 
Chromosome_6 AGGATGTCCTTAAATTCCTTATCCTTCTGCCTCTACCTTCCTAGTGCTAGGTATGTGCCA 5579 
Exon 4-5 AGGATGTCCTTAAATTCCTTATCCTTCTGCCTCTACCTTCCTAGTGCTAGGTATGTGCCA 460 
Chromosome一6 CCATGTCTGGGGTATGTGGTGCTGGAGATCAAATCCAGGCTTTCATGCATGTTAGGAAGA 5639 
Exon 4-5 CCATGTCTGGGGTATGTGGTGCTGGAGATCAAATCCAGGCTTTCATGCATGTTAGGAAGA 520 
Chromosome一6 CATCCAGCTGAGCCCACCCAAGTGCATTTTCTCCCTGTCCCCTACACCTCCAGGAAAAGT 5699 
Exon 4-5 CATCCAGCTGAGCCCACCCAAGTGCATTTTCTCCCTGTCCCCTACACCTCCAGGAAAAGT 580 
Chromosome_6 TTTGACTTTGCTCAGGCTGGTCTAGATCTCTCCGTAGCTTAGTATGGCTTTGAATCAATG 5759 
Exon 4-5 TTTGACTTTGCTCAGGCTGGTCTAGATCTCTCCGTAGCTTAGTATGGCTTTGAATCAATG 640 
Chromosome_6 ATCCTTCTGGTGTAGCTTTTGAGTGTGAGATTATAGGCATGTACACTGCTCAAGGTTGAT 5819 
Exon 4-5 ATCCTTCTGGTGTAGCTTTTGAGTGTGAGATTATAGGCATGTACACTGCTCAAGGTTGAT 700 
Chromosome_6 TTTTCTCTTTAGCCAACAGTGTCAGTGACTTCTTTGGTCTTGGAAGCATAATGGTTTTAT 5879 
Exon 4-5 TTTTCTCTTTAGCCAACAGTGTCAGTGACTTCTTTGGTCTTGGAAGCATAATGGTTTTAT 760 
Chromosome_6 ATTCCACTAAGCTCATTACCTACCCTGGGCCTTTGGGAGCATTCTCATCCTAGGATGGAC 5939 
Exon 4-5 ATTCCACTAAGCTCATTACCTACCCTGGGCCTTTGGGAGCATTCTCATCCTAGGATGGAC 820 
Chromosome_6 TCTTGTGGTCCCTCACAGGAAGCCCTATTTCTTCCTGAATGGTGCCAAATGACCACTATG 5999 
Exon 4-5 TCTTGTGGTCCCTCACAGGAAGCCCTATTTCTTCCTGAATGGTGCCAAATGACCACTATG 880 
Chromosome_6 ^ CTCATCTTCTTTCCTTCATCCTGTAGGAGTAACTCCCAGCCACACCGCCTTTTCCTTGCA 6059 
, 340 
Exon 4-5 CTCATCTTCTTTCCTTCATCCTGTAGGAGTAACTCCCAGCCACACCGCCTTTTCCTTGCA 940 
FP5198 
Exon 5-6 OCGCCTTTTCCTTGai 16 
Chromosome_6 TGCTCTGCTGGTTGACCACTACATACAAGGGGCATATTACCCTCGAGGGGGTTCCAGTGA 6119 
RP5244 
Exon 4-5 TGCTCTGCTGGTTGACCACTACATACAAGGG 971 
Exon 5-6 TGCTCTGCTGGTTGACCACTACATACAAGGGGCATATTACCCTCGAGGGGGTTCCAGTGA 76 
Chromosome—6 GATCGCCTTCCATACCATCCCTTTGATTCAGCGGGCCGGGGGCGCTGTCCTCACCAGGGC 6179 
Exon 5-6 GATCGCCTTCCATACCATCCCTTTGATTCAGCGGGCCGGGGGCGCTGTCCTCACCAGGGC 136 
Chromosome_6 CACTGTACAGAGTGTGCTGCTGGACTCAGCTGGGAGAGCGTGTGGTAAGAGATCTGTACT 6239 
Exon 5-6 CACTGTACAGAGTGTGCTGCTGGACTCAGCTGGGAGAGCGTGTGGTAAGAGATCTGTACT 196 
Chromosome—6 GGGCTGTGGGGTCAGTGGGCTGGGGTGGAAGCCAGCCTGTTTATGCACGGTAAGAGGCTG 6299 
Exon 5-6 GGGCTGTGGGGTCAGTGGGCTGGGGTGGAAGCCAGCCTGTTTATGCACGGTAAGAGGCTG 256 
Chroinosome_6 GCGTCTGAGCCGGTGAGATAGCTCAGTGGATAAATGGTCTAGTCACTCACTAAACCTGAT 6359 
Exon 5-6 GCGTCTGAGCCGGTGAGATAGCTCAGTGGATAAATGGTCTAGTCACTCACTAAACCTGAT 316 
Chromosome_6 GATCCCCACAGCCTACATGGTGGAAGGAGAGAACTCTGGCAAGTTGTCCTCTGACCTCCA 6419 
Exon 5-6 GATCCCCACAGCCTACATGGTGGAAGGAGAGAACTCTGGCAAGTTGTCCTCTGACCTCCA 376 
Chromosome_6 CACATGGGCTGTAGCACTCCTACCCCCACCCCCCCCACACACACACACAATGAAGGAATC 6479 
Exon 5-6 CACATGGGCTGTAGCACTCCTACCCCCACCCCCCCCACACACACACACAATGAAGGAATC 436 
Chromosome_6 AAACTACAATTCTTACAAAAGGTCAGGTCTGACATAATGGTTTTGTGAGTGGCCAGAGAT 6539 
Exon 5-6 AAACTACAATTCTTACAAAAGGTCAGGTCTGACATAATGGTTTTGTGAGTGGCCAGAGAT 496 
Chromosome_6 GAGGTTGGACACACAGGCTTCAGTACATCACAGAAGCCTTGGTGTTTCATGAAGGTTGAG 6599 
Exon 5-6 GAGGTTGGACACACAGGCTTCAGTACATCACAGAAGCCTTGGTGTTTCATGAAGGTTGAG 556 
Chromosome_6 TCATCTGGGGAGTACTGTAGATGTGGAACTTGGCAGCAGGGAAGGAGGGGCTGGGACTCC 6659 
Exon 5-6 TCATCTGGGGAGTACTGTAGATGTGGAACTTGGCAGCAGGGAAGGAGGGGCTGGGACTCC 616 
Chromosome_6 ATAGAGCCAGTGTTCTTGGGACGGCAGGGCGTGGCTAAGGTAAGTCCATATGGGTGGGTA 6719 
Exon 5-6 ATAGAGCCAGTGTTCTTGGGACGGCAGGGCGTGGCTAAGGTAAGTCCATATGGGTGGGTA 676 
Chromosome一6 AGAAGAGCTAGAGAGGGCAAGCACAGAAGCATTTGAGGCAAGGGCTAAGTGACTTTGCAG 6779 
Exon 5-6 AGAAGAGCTAGAGAGGGCAAGCACAGAAGCATTTGAGGCAAGGGCTAAGTGACTTTGCAG 736 
Chroraosome_6 TGTGCCTGGGACCTGCTTTGGCTGGAGGAACTTCTAGGTCTGAGAAAACAGGGCCTACCC 6839 
Exon 5-6 TGTGCCTGGGACCTGCTTTGGCTGGAGGAACTTCTAGGTCTGAGAAAACAGGGCCTACCC 796 
Chromosome_6 TAGGAGACATCTGGATAGTGTGGCTATAGACAGAACTAATATTTTGAGGCAGGATTTCAT 6899 
Exon 5-6 TAGGAGACATCTGGATAGTGTGGCTATAGACAGAACTAATATTTTGAGGCAGGATTTCAT 856 
Chromosome一6 、 GTGTTTCAGGCTATCCTCAAACTCACTAGCTAGCTGAGGCTGACCTTCGAATTCCTGATT 6959 
341 
Exon 5-6 GTGTTTCAGGCTATCCTCAAACTCACTAGCTAGCTGAGGCTGACCTTCGAATTCCTGATT 916 
Chromosome_6 ATATGGCGTCTACCTCCTACATGCTAGGATTGCAGGAACATGTCATCATGCTGCGACTAC 7019 
Exon 5-6 ATATGGCGTCTACCTCCTACATGCTAGGATTGCAGGAACATGTCATCATGCTGCGACTAC 976 
Chromosome_6 AGCTAATGCTTTGAGAGAAATGTATTTCACACTTTCCTGGGTTGTGTTTGTTTTATGGTG 7079 
Exon 5-6 AGCTAATGCTTTGAGAGAAATGTATTTCACACTTTCCTGGGTTGTGTTTGTTTTATGGTG 1036 
Chromosome—6 GGTATGGGGTGCACGGAACCTAGGGCTTCATACATGTTAGACAAGCGCTTTCCACCTGAG 7139 
Exon 5-6 GGTATGGGGTGCACGGAACCTAGGGCTTCATACATGTTAGACAAGCGCTTTCCACCTGAG 1096 
Chromosome_6 CTGTATTCCTAGCCCTTAAGAGGGATCTAGAGAATGGTATAGGTCTTTTTTGTTTCCACA 7199 
Exon 5-6 CTGTATTCCTAGCCCTTAAGAGGGATCTAGAGAATGGTATAGGTCTTTTTTGTTTCCACA 1156 
Chromosome_6 GAGCTCATAGAAGCTCAGCCAAATTCTTGTGCCTGCAGGTGTCAGTGTGAAGAAGGGACA 7259 
Exon 5-6 GAGCTCATAGAAGCTCAGCCAAATTCTTGTGCCTGCAGGTGTCAGTGTGAAGAAGGGACA 1216 
Chroraosome_6 AGAGCTGGTGAACATCTACTGCCCAGTTGTCATCTCCAATGCGGGAATGTTCAATACCTA 7319 
RP6437 
Exon 5-6 AGAGCTGaiGAACATCTAGIOTC 1240 
FP6433 
Exon 6-7 起g]:g^GTj;_T_gt_TGCGGGMTGTTCMTACCTA 41 
Chromosome—6 TCAGCACTTGTTGCCAGAGACTGTCCGCCATCTGCCAGGTAAAAGACTGATCTTTTGAAC 7379 
Exon 6-7 TCAGCACTTGTTGCCAGAGACTGTCCGCCATCTGCCAGGTAAAAGACTGATCTTTTGAAC 101 
Chromosome_6 TAATATTTCATCTGTGAAGCTTACATGCCCAGCTGGGTGGGCTCCCCTCTCCTTGGGCAG 7439 
Exon 6-7 TAATATTTCATCTGTGAAGCTTACATGCCCAGCTGGGTGGGCTCCCCTCTCCTTGGGCAG 161 
Chromosome_6 TCCGCTAGCTGTCTCTCTCTAGTCTGTGCTACCAGGAACATAGCATTTATATTTGGGGAA 7499 
Exon 6-7 TCCGCTAGCTGTCTCTCTCTAGTCTGTGCTACCAGGAACATAGCATTTATATTTGGGGAA 221 
Chromosome_6 TCTAGGACTACAGGGGAAGAGGAGCCCTTCACAGAGGCAGTGGCAGAGCTCTGAGGACTC 7559 
Exon 6-7 _ TCTAGGACTACAGGGGAAGAGGAGCCCTTCACAGAGGCAGTGGCAGAGCTCTGAGGACTC 281 
Chromosome一6 TGTTTTGTCAGATGCAAATGTCTATCTTGTACTTCCGGGCTGAAAAACACAACCCTGTAT 7619 
Exon 6-7 TGTTTTGTCAGATGCAAATGTCTATCTTGTACTTCCGGGCTGAAAAACACAACCCTGTAT 341 
Chromosome_6 ATTTGCTTTCCTTTGCCAGAGAAACCAGGGCTTTAATAGAAAAGACTCAGTTAAATGGCA 7679 
Exon 6-7 ATTTGCTTTCCTTTGCCAGAGAAACCAGGGCTTTAATAGAAAAGACTCAGTTAAATGGCA 401 
、Chromosome_6 GACAAGAGCTAGGGATGAAGTTCAGTTGGTTAGAGTGTTTGCATCAGCCCTGGGTTTACC 7739 
Exon 6-7 GACAAGAGCTAGGGATGAAGTTCAGTTGGTTAGAGTGTTTGCATCAGCCCTG(X;TTTACC 461 
Chromosome_6 TAGAGCCAGGTAAGACAACTAGAGTGGATTTGGCTGTAATCCTAGCACTCAAGAGGTGTT 7799 
Exon 6-7 TAGAGCCAGGTAAGACAACTAGAGTGGATTTGGCTGTAATCCTAGCACTCAAGAGGTGTT 521 
Chromosome_6 GGCGGGAAGATAAGAAATTCAAGGTCACCGTTGGCTACACAAGACCCTGCCTCAACAAAC 7859 
Exon 6-7 GGCGGGAAGATAAGAAATTCAAGGTCACCGTTGGCTACACAAGACCCTGCCTCAACAAAC 581 
342 
Chromosome_6 AAAGGCCACTGAGATGGTTCAGAGTGTAAAGTCTTTGCTGCTAAATCCCCAGAGTGGAAG 7919 
Exon 6-7 AAAGGCCACTGAGATGGTTCAGAGTGTAAAGTCTTTGCTGCTAAATCCCCAGAGTGGAAG 641 
Chromosome_6 AAGATAGTTGTCTTCTGGCTTCTTGCACATCTAGACAGACCTTTATCCATATACATCTAT 7979 
Exon 6-7 AAGATAGTTGTCTTCTGGCTTCTTGCACATCTAGACAGACCTTTATCCATATACATCTAT 701 
Chromosome_6 AATTAACGAAACATCTAAATGTATAAAGAGGAGGGTTGGAACAGCCTGATTGTCCAGAGG 8039 
Exon 6-7 AATTAACGAAACATCTAAATGTATAAAGAGGAGGGTTGGAACAGCCTGATTGTCCAGAGG 761 
Chroniosome_6 TGCTGTGAGTTAGCTCTGCTCTGAATCAGCAGGAAGCCAGCACCTATGACTAAGGGGACA 8099 
Exon 6-7 TGCTGTGAGTTAGCTCTGCTCTGAATCAGCAGGAAGCCAGCACCTATGACTAAGGGGACA 821 
Chromosome_6 TGGGGCAGAGGTGGTAGAGTTGGAAGGAATCTGAGGCTACATCTCACATAGCCAGGACGA 8159 
Exon 6-7 TGGGGCAGAGGTGGTAGAGTTGGAAGGAATCTGAGGCTACATCTCACATAGCCAGGACGA 881 
Chromosome_6 GACTTAAGAGCAGGTCTCTGCCAGGATCCTATAGAAATAGTTATAAAACCGGCCAGGTCT 8219 
Exon 6-7 GACTTMGAGCAGGTCTCTGCCAGGATCCTATAGAAATAGTTATAAAACCGGCCAGGTCT 941 
Chroiiiosome_6 CTGTCCCAGCTGGCAGCTGAGGATCGAGCTACAGATCAGAAAAGGGAACATCCTGAGGCT 8279 
Exon 6-7 CTGTCCCAGCTGGCAGCTGAGGATCGAGCTACAGATCAGAAAAGGGAACATCCTGAGGCT 1001 
Chromosome_6 ATCCTGACAGGGGTGGCTGTCTGGCTGTAACTCCTGCACAGCAATCCTCACTGGCTCTCT 8339 
Exon 6-7 ATCCTGACAGGGGTGGCTGTCTGGCTGTAACTCCTGCACAGCAATCCTCACTGGCTCTCT 1061 
Chromosome_6 GCAGATGTGAAGAAGCAGCTGGCGATGGTAAGGCCTGGTCTGAGCATGCTCTCAATCTTC 8399 
Exon 6-7 GCAGATGTGAAGAAGCAGCTGGCGATGGTAA 1110 
FP7523 
Exon 7-8 ilGGCCTGGTCTGAGCAtGCTCTCAATCTTC 31 
Chromosome_6 ATCTGTCTGAAAGGCACCAAGGAGGACCTGAAGCTTCAGTCCACCAACTACTATGTTTAT 8459 
RTO71 
Exon 6-7 ftfCTGTCTGAAAGGCAOC 
Exon 7-8 ATCTGTCTGAAAGGCACCAAGGAGGACCTGAAGCTTCAGTCCACCAACTACTATGTTTAT 91 
Chromosome_6 TTTGACACAGACATGGACAAAGCGTAAGATGTGAGGGGTGGGGAAGACTGATAGTGTTGG 8519 
Exon 7-8 TTTGACACAGACATGGACAAAGCGTAAGATGTGAGGGGTGGGGAAGACTGATAGTGTTGG 151 
Chromosome_6 GCCTCATCCCACAAGGTCCTGCTTCCACCCTCCACACGGTTCTAGGAATGAGAAGGATGT 8579 
Exon 7-8 GCCTCATCCCACAAGGTCCTGCTTCCACCCTCCACACGGTTCTAGGAATGAGAAGGATGT 211 
Chromosome_6 GTTTTGAGGGAGGAGGTGCAGTCTCTAATGGACTTCTAGAAAGGCTTTCTACACCAAAGC 8639 
Exon 7-8 GTTTTGAGGGAGGAGGTGCAGTCTCTAATGGACTTCTAGAAAGGCTTTCTACACCAAAGC 271 
Chromosome_6 CGTGCTGTTTTCTCCCTTGTGGGAAGTCCCTGGAGATGAGCCTTTGTTTGGGTAGTGCTG 8699 
Exon 7-8 CGTGCTGTTTTCTCCCTTGTGGGAAGTCCCTGGAGATGAGCCTTTGTTTGGGTAGTGCTG 331 
Chromosome_6 GTGGCTTTGAGGAAGAGGCCTAAAGATTGGCAGTCACGCCCCCTCCCTCATCCACAGGAT 8759 
Exon 7-8 、 GTGGCTTTGAGGAAGAGGCCTAAAGATTGGCAGTCACGCCCCCTCCCTCATCCACAGGAT 391 
_ 343 
Chromosome_6 GGAGCGCTATGTCTCTATGCCCAAGGAAAAGGCTCCAGAACACATTCCCCTTCTCTTCAT 8819 
RP7939 
Exon 7-8 GGAGCGCmTGTCTCTATGCCCAAaJ 417 
FP7916 
Exon 8-9 —IGCGCTATGTCTCTATOCCCAAGGAAAAGGCTCCAGAACACATTCCCCTTCTCTTCAT 58 
Chroraosome_6 TGCCTTCCCATCAAGCAAGGATCCAACCTGGGAGGAGCGATTCCCAGGTAGGGCTTGAAG 8879 
Exon 8-9 _ TGCCTTCCCATCAAGCAAGGATCCAACCTGGGAGGAGCGATTCCCAGGTAGGGCTTGAAG 118 
Chromosome_6 TCCAGGGAAGTTGGGTGTAGGGCAAGGCAGGGCCAAATAGCAATAACATGGCCTTATACC 8939 
Exon 8-9 TCCAGGGAAGTTGGGTGTAGGGCAAGGCAGGGCCAAATAGCAATAACATGGCCTTATACC 178 
Chromosome_6 CACAGACCGATCCACAATGACTGCGCTGGTACCCATGGCCTTTGAATGGTTCGAGGAGTG 8999 
Exon 8-9 CACAGACCGATCCACAATGACTGCGCTGGTACCCATGGCCTTTGAATGGTTCGAGGAGTG 238 
Chromosome_6 GCAGGAGGAGCCAAAGGGCAAGCGTGGTGTTGACTATGAGACCCTCAAAAATGCCTTCGT 9059 
RP8197 
Exon 8-9 GCAGGAGGAGCCAAAGGGCAAGCGTGGTGTTGACTATGAGAra 282 
FP8167 
Exon 9-10 lAGGGCAAGCGTGGTGTTGACTATGAGACCCTCAAAAATGCCTTCGT 47 
Chromosome—6 GGAAGCCTCTATGTCGGTGATCATGAAACTGTTCCCACAGCTGGAGGGCAAGGTAGGGGC 9119 
Exon 9-10 GGAAGCCTCTATGTCGGTGATCATGAAACTGTTCCCACAGCTGGAGGGCAAGGTAGGGGC 107 
Chromosome_6 TGACATACAGTGCTGGAGGTGACAATGCATCCCTTAACTGTCTTCTTCCATACAGGGACA 9179 
Exon 9-10 TGACATACAGTGCTGGAGGTGACAATGCATCCCTTAACTGTCTTCTTCCATACAGGGACA 167 
Chromosome_6 AAGCCTGCGGTAACAAGAGTCCCACAGTCCCTTGTTCACCCTTGCCTTGCCCTTTTGTTT 9239 
Exon 9-10 AAGCCTGCGGTAACAAGAGTCCCACAGTCCCTTGTTCACCCTTGCCTTGCCCTTTTGTTT 227 
Chromosome_6 CCTCAGGTGGAGAGTGTGACTGGAGGGTCACCACTGACCAACCAGTACTATCTGGCTGCA 9299 
Exon 9-10 CCTCAGGTGGAGAGTGTGACTGGAGGGTCACCACTGACCAACCAGTACTATCTGGCTGCA 287 
Chromosome_6 CCCCGAGGAGCTACCTATGGAGCTGACCATGACTTGGCTCGGCTGCATCCTCATGCAATG 9359 
Exon 9-10 CCCCGAGGAGCTACCTATGGAGCTGACCATGACTTGGCTCGGCTGCATCCTCANGCAATN 347 
FP8454 
SIG10#2 ^XSQSAGGAGCTACCTATGGAGCTGACCATGACTTGGCTCGGCTGCATCCTCATGCAATG 60 
Chromosome_6 GCTTCCATAAGAGCCCAAACCCCCATCCCCAACCTCTACCTGACAGGTACACTGCCTCAC 9419 
‘ RP8534 
Exon 9-10 GCTPCATAAGAGCCCAAACC 368 
Exon 10-11 GCTTCCATAAGAGCCCAAACCCCCATCCCCAACCTCTACCTGACAGGTACACTGCCTCAC 120 
Chromosome—6 TTTGCCAGAATCTGGACTTCCCTGGCATAGTCTTCTGTTCTCGTCCTCAAGCCTACACCA 9479 
Exon 10-11 TTTGCCAGAATCTGGACftCCCTGGCATAGTCTTCTGTTCTCGTCCTCAAGCCTACACCA 180 
Chromosome_6 GGAGCTGGGCTGCCTTGGCTATTGTCCTGGGTTCTATCTGAGGCTGTCTCTCTTTGGGTG 9539 
Exon 10-11 、 GGAGCTGGGCTGCCTTGGCTATTGTCCTGGGTTCTATCTGAGGCTGTCTCTCTTTGGGTG 240 
_ 344 
Chromosome_6 GCCTTGATATGGAGGGATGAACACAAGAACCCTTGTTACCCCCATCTTCATGGGTCACTG 9599 
Exon 10-11 GCCTTGATATGGAGGGATGAACACAAGAACCCTTGTTACCCCCATCTTCATGGGTCACTG 300 
Chromosome—6 CTTTTGCTTTCTAGGCCAAGATATCTTCACCTGTGGGCTGATGGGGGCCCTGCAGGGGGC 9659 
Exon 10-11 CTTTTGCTTTCTAGGCCAAGATATCTTCACCTGTGGGCTGATGGGGGCCCTGCAGGGGGC 360 
Chromosome_6 CTTGCTGTGCAGCAGTGCCATCCTGAAACGGAACTTGTACTCAGATCTGCAGGCTCTTGG 9719 
RP8868 
Exon 10-11 CTTGCTGTGCAGCAGTGCCATCCTGAAACGGAACTTGrACTCAGATCTGCAfiGCr 415 
FP8841 
Exon 11+ A C G G A A C • 画 • I C T G C A G G C T C T T G G 33 
Chromosome_6 CTCAAAGGTCAAGGCACAAAAGAAGAAGATGTAGTCCGTTCAGAGAAGAGCCAGAGGAAA 9779 
Exon 11+ CTCAMGGTCAAGGCACAAAAGAAGAAGATGTAGTCCGTTCAGAGAAGAGCCAGAGGAAA 93 
Chromosome_6 GGCACCTCCCCAACTTCTCGTGGTGTCCTCCCTCCTACAGCAATTCCTTGCACATATAAA 9839 
Exon 11+ GGCACCTCCCCAACTTCTCGTGGTGTCCTCCCTCCTACAGCAATTCCTTGCACATATAAA 153 
Chromosome_6 CAAAAACCATTTTGTTTCTGATTAGTGTTGTTAAGTCAAGAGTTCTTTACCTTGCATTCT 9899 
Exon 11+ CAAAAACCATTTTGTTTCTGATTAGTGTTGTTAAGTCAAGAGTTCTTTACCTTGCATTCT 213 
Chromosome_6 ACTTAAGGCCTAGTGTGAACTACATAGCCTTGATGCCTCATGAAGAATGCTCCCATGCCT 9959 
Exon 11+ ACTTAAGGCCTAGTGTGAACTACATAGCCTTGATGCCTCATGAAGAATGCTCCCATGCCT 273 
Chromosome_6 TTCCTACACCCAACTCCAAGCTATGGTCAGGCACCCAGAACCCCTGGGGTGTTGGCTACT 10019 
Exon 11+ TTCCTACACCCAACTCCAAGCTATGGTCAGGCACCCAGAACCCCTGGGGTGTTGGCTACT 333 
Chromosome_6 GGAATAGGTTGGTTCAGTCCTACCCTGAAGCTTTTTGTTCCTCCTCACTCTCGTGTTGTG 10079 
Exon 11+ GGAATAGGTTGGTTCAGTCCTACCCTGAAGCTTTTTGTTCCTCCTCACTCTCGTGTTGTG 393 
Chromosome一6 ATGCTCTATACATGGAAAAGTGTGGGCTTGGAGTAGCAACTCTCTCAAAGTGCCAGACCT 10139 
Exon 11+ ATGCTCTATACATGGAAAAGTGTGGGCTTGGAGTAGCAACTCTCTCAAAGTGCCAGACCT 453 
Chromosome_6 AAGAAAACCCTCAGGTCTAAGTTTTATCCTGATAGAAGTGGGTTAAAGGAACACACCAAA 10199 
Exon 11+ AAGAAAACCCTCAGGTCTAAGTTTTATCCTGATAGAAGTGGGTTAAAGGAACACACCAAA 513 
Chromosome_6 AGATACCACTGCCGATGAACCAAGCCTAGACACGGCATTTGTAGTTGCTGGCACATAGTC 10259 
Exon 11+ AGATACCACTGCCGATGAACCAAGCCTAGACACGGCATTTGTAGTTGCTGGCACATAGTC 573 
、Chromosome_6 AAACTGAGTTACGAGGCTGGGCAGTGCTGGCACCGGCCTTTAACCCCAGCACTCAGAAGG 10319 
Exon 11+ AAACTGAGTTACGAGGCTGGGCAGTGCTGGCACCGGCCTTTAACCCCAGCACfCAGAAGG 633 
Chromosome_6 CAGGGGCAGACAGAGCTCTGTGAATCTGAAGCCAGAACTAGTTTATGAAGCAAGTCCAGG 10379 
Exon 11+ CAGGGGCAGACAGAGCTCTGTGAATCTGAAGCCAGAACTAGTTTATGAAGCAAGTCCAGG 693 
Chromosome_6 GCAGCCAGAGCTCTGTTATACAGAGAAACCCTGTCTTGAAAAACAAAACAAAACAAAACA 10439 
Exon 11+ GCAGCCAGAGCTCTGTTATACAGAGAAACCCTGTCTTGAAAAACAAAACAAAACAAAACA 753 
345 
Chroraosome_6 AAACCTGAGTATTGTTTTCTAAAATGCTTGGAGTCAGAATTCTTTCAGATTTTGTAGTAT 10499 
Exon 11+ AAACCTGAGTATTGTTTTCTAAAATGCTTGGAGTCAGAATTCTTTCAGATTTTGTAGTAT 813 
Chromosome_6 TTGCATACACATGAGATAACCTGGGGAATGGGTCCCAGAACTAAACCACAAATTCATTTG 10559 
Exon 11+ TTGCATACACATGAGATAACCTGGGGAATGGGTCCCAGAACTAAACCACAAATTCATTTG 873 
Chromosome_6 TTTCATATGTATAGACCAGGCACAACATCTTATGTAATACTTTGAAAAACTGAGCATTCT 10619 
Exon 11+ TTTCATATGTATAGACCAGGCACAACATCTTATGTAATACTTTGAAAAACTGAGCATTCT 933 
Chromosome_6 GACCTGTCACATGAGTCCATGCTATAATTTAAAAAGCTTGCTTTGATTTCAGAATAGGGA 10679 
Exon 11+ GACCTGTCACATGAGTCCATGCTATAATTTAAAAAGCTTGCTTTGATTTCAGAATAGGGA 993 
Chromosome_6 TGCTTTACCTATATGAGTAAATGAGAAGGTGGATAAAAATTAAAAACCTTTCACTTATGT 10739 
Exon 11+ TGCTTTACCTATATGAGTAAATGAGAAGGTGGATAAAAATTAAAAACCTTTCACTTATGT 1053 
Chromosome_6 TAAACAAGTGCTAATTTTAGTCTGTTTAAATATAGTATTAATACATGTAATGTTTCAATG 10799 
Exon 11+ TAAACAAGTGCTAATTTTAGTCTGTTTAAATATAGTATTAATACATGTAATGTTTCAATG 1113 
Chromosome_6 CTTTGATATCTGAAATTTATTGATTTCTGTTCAATAATGACATGAAACTATGCTATGATT 10859 
Exon 11+ CTTTGATATCTGAAATTTATTGATTTCTGTTCAATAATGACATGAAACTATGCTATGATT 1173 
Chromosome_6 CCATTTACAGAAGCTCAGTAAAATATACTGAAAAATACTTACTATACCACAGTAAGCTTT 10919 
Exon 11+ CCATTTACAGAAGCTCAGTAAAATATACTGAAAAATACTTACTATACCACAGTAAGCTTT 1233 
Chromosome_6 AAAAAAAATAAAATTAAGCCATTACAGTTAAGTTACAAAAAAGGTGACAATACCAAACAT 10979 
Exon 11+ AAAAAAAATAAAATTAAGCCATTACAGTTAAGTTACAAAAAAGGTGACAATACCAAACAT 1293 
Chromosome_6 GGCTAACAGTAGCAATCTAACTGGGAACACAAGACAAGGAAAAAAATTTCAACATTCACT 11039 
RP(D263) 
Exon 11+ GGCTMCAgfAGCMTCTAACTGC^ 1320 
•s-
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Appendix D: DNA sequencing and alignment result of constructs 
Dl. pGL3-PPSIG (-2936/+119)，pGL3-PPSIG (-1534/+119)，pGL3-PPSIG (-879/+119) and pGL3-PPSIG (-375/+119) 
reporter construct DNA sequencing and alignment result 
Matched sequence 
Sequencing primers used* pGL3-RV3 and pGL3-GL2 
1 15 16 30 31 45 46 60 61 75 76 90 
(-2936/+119) -RV3 1-OOTMS 50 PPSIG-FP(-2936) 
91 105 106 120 121 135 136 150 151 165 166 180 
(-2936/+119) -RV3 JSCSBPfAGCTGTTGTT CCTCAGGCTCTGTTC GCCITAATTTTTTGA GACARGATCTCTTTT ATTTGCCTGGAACCA 50 
(-375/+119)-RV3 0 
(-1534/+119)-RV3 0 
(-879/+119)-RV3 0 PPSIG gene SEQ CGGGTGAAGAGGACA ACTTTAGCTGTTGTT CCTCAGGCTCTGTTC GCCTTAATTTTTTGA GACAAGATCTCTTTT ATTTGCCTGGAACCA 180 
181 195 196 210 211 225 226 240 241 255 256 270 
(-2936/+119)-RV3 GATGAGCAGGTTAGG ATGGCCAGCCAGTGA GCTTTAGAGAGCGGC CCATTCTCCTTCCTA ATGTTGGGCTTACAA GTATGTGCTACCACA 50 
(-375/+119)-RV3 0 
(-879/+119)-RV3 0 
(-1534/+119)-RV3 - 0 PPSIG gene SEQ GATGAGCAGGTTAGG ATGGCCAGCCAGTGA GCTTTAGAGAGCTGC CCATTCTCCTTCCTA ATGTTGGGCTTACAA GTATGTGCTACCACA 270 
271 285 286 300 301 315 316 330 331 345 346 360 
(-2936/+119)-RV3 CCCAATTTTTTAAAA AGTGTATTATTTTCA TGGGTGTACTCCTCT GTGTGTGTGTGGGTG TGTGTGGGTGTGTGT GGGTGTGTCTGCCAT 50 
(-375/+119)-RV3 - 0 
{-879/+119)-RV3 0 
(-1534/+119)-RV3 0 
PPSIG gene SEQ CCCAATTTTTTAAAA AGTGTATTATTTTCA TTTGTGTACTCCTCT GTGTGTGTGTGGGTG TGTGTGGGTGTGTGT GGGTGTGTCTGCCAT 360 
361 375 376 390 391 405 406 420 421 • 435 436 450 
(-2936/+119)-RV3 GTATGTGCAGATGTC CATAACACATTGGAT TCCCTGGAGCTGGAG TTACACATGGTTGAG AGCTGCCATGTAGGT GCAGAGAGCCAAATT 50 
(-375/+119)-RV3 0 
(-879/+119)-RV3 - 0 
(-1534/+119)-RV3 0 
PPSIG gene SEQ GTATGTGCAGATGTC CATAACACATTGGAT TCCCTGGAGCTGGAG TTACACATGGTTGAG AGCTGCCATGTAGGT GCAGAGAGCCAAATT 450 
451 465 466 480 481 495 496 510 511 525 526 540 




PPSIG gene SEQ CTGGTCCTCTGCAAG ATGTTCTTAAGTGAG CATCTCTCCAGCCCT TCTCTCTCTCCCCCT CTCTCTCTCCCTCTC TATAAGGACTCAGAT 540 
541 555 556 570 571 585 586 600 601 615 616 630 
(-2936/+119)-RV3 ATACAGAGAAGTTCT TATGGACGTTCTTCA GCCTGGCCTCATCCT TGCTATGTAGCTGAN GCTTGCTTCTACTTC TCANGGGTGGA.GACA 569 
(-375/+119)-RV3 0 
(-879/+119)-RV3 0 
(-1534/+119)-RV3 - 0 
PPSIG gene SEQ ATACAGAGAAGTTCT TATGGACGTTCTTCA GCCTGGCCTCATCCT TGCTATGTAGCTGAG GCTTGCTTCTACTTC TCAAGGGTGGAGACA 630 
631 645 646 660 661 675 676 690 691 705 706 720 




PPSIG gene SEQ AAAGTCCTGTTCTTT CATCTTATGGTGCCT GCCTCAGGAAGAGGG CTGGACAAAGACCCC ATCACATCAAAAGTC TGTGTCACGAGGAGA 720 
721 735 736 750 751 765 766 780 781 795 796 810 




PPSIG gene SEQ CAGCCTTCTCATGAG CGAGCACCTCTAGGT CTTAGGGGGACGGAT TGATGTGAGAGAGTC AAAACAAAACACAAG GCCTGGGATACAGAT 810 
811 825 826 840 841 855 856 870 871 885 886 900 
(-2936/+119)-RV3 CAAANGTAAAN-TNT TGCTTACCACAAGTG AC-TCNGGGTTCAGN CCCC-CANCTGAAAA AAAAAAA-T--AAAN CAGAGATC--CCCNC 826 
(-375/ + 119)-RV3 - 0 
(-879/+119)-RV3 0 
(-1534/+119)-RV3 0 
PPSIG gene SEQ CAGAGGTAAAGCTAT TGCTTACCACAAGTG ACATCTGGGTTCAGT CCCCACAACTGAAAA AAAAAAAATAAAAAC CAGAGATCATCCTCA 900 
901 915 916 930 931 945 946 960 961 975 976 990 
{-2936/+119) -RV3 AC^TGGTGGTGTATG CCCGCATGAATGTAT GCCCAGATTCCTAGA AATCTGGAAGCAGAG GCAGGAGAATCACTG TGTATTTGAGGGCAG 916 
(-375/+119)-RV3 0 
(-879/+119) -RV3 - 0 
(-1534/+119)-RV3 0 
PPSIG gene SEQ ACATGGTGGTGTATG CCCGCATGAATGTAT GCCCAGATTCCTAGA AATCTGGAAGCAGAG GCAGGAGAATCACTG TGTATTTGAGGGCAG 990 
. 347 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
(-2936/+119)-RV3 CCTGATCTACATAGA GTTCCAGGTCAGTTA AGACTACCTAGCAAG ACTCTGTCTCAACAG AAAACAAAGCAAGGG CAGGTGAAATGGCTC 1006 
(-375/ + 119) -RV3 0 
(-879/ + 119) -RV3 0 
(-1534/ + 119) -RV3 - 0 
PPSIG gene SEQ CCTGATCTACATAGA GTTCCAGGTCAGTTA AGACTACCTAGCAAG ACTCTGTCTCAACAG AAAACAAAGCAAGGG CAGGTGAAATGGCTC 1080 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
(-2936/+119)-RV3 AGTGGGTCGAGGTGC TTGCCAGCAAACTTG ATGACCTAAGTTCAG TCCCTAGAGGGACCT AGAAGACTGGTAGAA ATAAAGAAGCAATTG 1096 
(-375/ + 119) -RV3 - 0 
(-879/ + 119)-RV3 0 
(-1534/ + 119) -RV3 0 
PPSIG gene SEQ AGTGGGTCGAGGTGC TTGCCAGCAAACTTG ATGACCTAAGTTCAG TCCCTAGAGGGACCT AGAAGACTGGTAGAA ATAAAGAAGCAATTG 1170 
1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
(-2936/+119)-RV3 TCTTCTGACCTCCAC ACACGCACCATGGCA CACACCGCTCTGCTC ACCCAGATAAAAACC AAAAAAAAAAAAAAA AAAAAACACACACAC 1186 
(-375/ + 119) -RV3 0 
(-879/ + 119) -RV3 0 
(-1534/ + 119) -RV3 0 
PPSIG gene SEQ TCTTCTGACCTCCAC ACACGCACCATGGCA CACACCGCTCTGCTC ACCCAGATAAAAACC AAAAAAAAAAAAAAA AAAAAACACACACAC 1260 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
(-2936/+119)-RV3 ACACAAGGGGCTGGG AAGATGACTCAGTGG GCAGGAGGGCTTGCT TCAGGGTAAAAACCT GAGTTTGGCTCCCTA GCACTCTGGTCGATG 1276 
(-375/ + 119) -RV3 - 0 
(-879/ + 119) -RV3 0 
(-1534/ + 119) -RV3 0 
PPSIG gene SEQ ACACAAGGGGCTGGG AAGATGACTCAGTGG GCAGGAGGGCTTGCT TCAGGGTAAAAACCT GAGTTTGGCTCCCTA GCACTCTGGTCGATG 1350 
1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
(-2936/+119)-RV3 GAATTAAAAGGATTG CTGGTTGCTGGGCCT AGTTCCACATTCAGT CAGAGAAGCAATTCT ACCAACTTCAAAGGT AGAAGGCACAGAGTG 1366 
(-375/ + 119) -RV3 .. 0 
(-879/ + 119) -RV3 - 0 
{-1534/ + 119) -RV3 - 0 
PPSIG gene SEQ GAATTAAAAGGATTG CTGGTTGCTGGGCCT AGTTCCACATTCAGT CAGAGAAGCAATTCT ACCAACTTCAAAGGT AGAAGGCACAGAGTG 1440 
1441 1455 1456 1470 1471 1485 1486 1500 1501 1515 1516 1530 
(-2936/+119)-RV3 ACAGAACAGGCAATT TACAGTCCCCCTGAT CTTTCTGTTCCTATA TC3GGCATGCATSCT- CACACCCACACACCA GA 1366 
(-375/ + 119) -RV3 0 
(-879/ + 119) -RV3 - 0 
(-1534/ + 119) -RV3 TGCTT CACACCCACACACCA GAGAGTCAGTGTGGA 68 
PPSIG gene SEQ ACAGAACAGGCAATT TACAGTCCCCCTGAT CTTTCTGTTCCTATA TGGGCATOCATSCT- CACACCCACACACCA GAGAGTCAGTGTGGA 1529 
NBI I 
1531 1545 1546 1560 1561 1575 1576 1590 1591 1605 1606 1620 
{-2936/ + 119) -RV3 --- 1366 
(-375/ + 119) -RV3 - 0 
(-879/ + 119) -RV3 0 
(-1534/+119)-RV3 AAGGCTGGGACTGTA ACCTAGTGGCAC5CAA AGGAGGCTCAACCCC TGATATCXJAGC5GGGA AAATGAGAGTGGATG GTTCTCACACAACTG 158 
PPSIG gene SEQ AAGGCTGGGACTGTA ACCTAGTGGCAGCAA AGGAGGCTCAACCCC TGATATCGAGGGGGA AAATGAGAGTGGATG GTTCTCACACAACTG 1619 
1621 1635 1636 1650 1651 1665 1666 1680 1681 1695 1696 1710 
(-2936/ + 119) -RV3 1366 
(-375/ + 119) -RV3 - 0 
(-879/ + 119) -RV3 0 
(-1534/+119)-RV3 ACAGTCATACTTCAC AGACTCAGAGGACTA AGTCAGTGGGGAGGC CCTCCACGGAGCCAG TCCTCCACTAGGGGA CTATGATTTACATTC 248 
PPSIG gene SEQ ACAGTCATACTTCAC AGACTCAGAGGACTA AGTCAGTGGGGAGGC CCTCCACGGAGCCAG TCCTCCACTAGGGGA CTATGATTTACATTC 1709 
1711 1725 1726 1740 1741 1755 1756 1770 1771 1785 1786 1800 
(-2936/ + 119) -RV3 1366 
(-375/ + 119) -RV3 0 
t-879/ + 119) -RV3 0 
(-1534/+119)-RV3 CCCGGAGGACTGACT GCCAGTAACAAACAG CTTTTGGGCTCGACG CCTG-CTGCCTGTGA TCTAGAGAGGATGGT GGTAACGTCCTCCCT 337 
PPSIG gene SEQ CCCA-AGGACTGACT GCCAGTAACAAACAG CTTTTGGGCTCGACG CCTGGCTGCCTGTGA TCTAGAGAGGATGGT GGTAACGTCCTCCCT 1798 
1801 1815 1816 1830 1831 1845 1846 1860 1861 1875 1876 1890 
(-2936/ + 119) -RV3 - - 1366 
(-375/+119) -RV3 - --- 0 
(-879/ + 119) -RV3 0 
(-1534/+119)-RV3 GAAACACCCCAGGAA CTAGCTCCCCCCCCC GCTCCCCGAGAACCT CAGCATCTACCTCTC TTTTCCTTTCCTTCC ATCTCGGCCTAAATG 427 
PPSIG gene SEQ GAAACACCCCAGGAA CTAGCTCCCCCCCCC CCTCCCC-AGAACCT CAGCATCTACCTCTC TTTTCCTTTCCTTCC ATCTCGGCCTAAATG 1887 
1891 1905 1906 1920 1921 1935 1936 1950 1951 1965 1966 1980 
(-2936/ + 119) -RV3 1366 
(-375/+119)-RV3 0 
(-879/ + 119) -RV3 - - 0 
(-1534/+119)-RV3 XCAGCATAAGATACA CACACATCAGATAAC CTGGCAGGGTCACAG GTACX5ACTGACAAAG TCTCX3GGAAGGCTCT CCTGTTACTGTGGC5G 517 
PPSIG gene SEQ ACAGCATAAGATACA CACACATCAGATAAC CTGGCAGGGTCACAG GTAGGACTGACAAAG TCTCGGGAAGGCTCT CCTGTTACTGTGGGG 1977 
. 348 
1981 1995 1996 2010 2011 2025 2026 2040 2041 2055 2056 2070 
(-2936/ + 119) -RV3 1366 
(-375/ + 119) -RV3 0 
(-879/ + 119) -RV3 0 
(-1534/+119)-RV3 AAAACGAACCAAGTA GCATAGAAGCATGAC CTGCTTTACATACCXS TGACTGGGGAAGCAA CCGGCTGGGGGCCCT AAAAAACCAGGAACC 607 
PPSIG gene SEQ AAAACGAACCAAGTA GCATAGAAGCATGAC CTGCTTTACATACCG -GACTGG---AGCA- CCG-CTGGGG--CCT AAA--ACAAGGA--C 2055 
2071 2085 2086 2100 2101 2115 2116 2130 2131 2145 2146 2160 
(-2936/ + 119) -RV3 1366 
(-375/ + 119) -RV3 0 
(-879/ + 119) -RV3 - - 0 
(-1534/+119)-RV3 AAAAGACTCAAAAGT TAACGAAGTTCATTC CTCCCTGAATAGTGG GTACCCTGWAGGACA TTGGGCCTCCCTTAC AAACAAATCCCTCTT 681 
PPSIG gene SEQ AAAACACTCAAA-GT TA-CGAAGT-CATTC CTCC-TGA-TAGTGG GTACC-TG-AGGA-A ATGGGCCTCCTATAC AAACAAATCCCTCTT 2137 
2161 2175 2176 2190 2191 2205 2206 2220 2221 2235 2236 2250 
(-2936/ + 119) -RV3 1366 
(-375/ + :U9)-RV3 0 
(-879/+119)-RV3 GTAT TTCAGACCTACTTTC CTCAAAGGGCAACAT TAAGATGGTAGGATA TCTAGACTGTCTGCT GGAGCTTAAACTCTC 129 
(-1534/ + 119) -RV3 AA AGTACGTAT TT-A 681 
PPSIG gene SEQ AAGTCAAGTACGTAT TTCAGACCTACTTTC CTCAAAGGGCAACAT TAAGATGGTAGGATA TCTAGACTGTCTGCT GGAGCTTAAACTCTC 2227 
SnaB I 
2251 2265 2266 2280 2281 2295 2296 2310 2311 2325 2326 2340 
(-2936/ + 119) -RV3 1366 
(-375/ + 119) -RV3 0 
(-879/+119)-RV3 TGAAAAGCTGATTTA GAAGCTGGTGCGTCC TTAAATGCAAATAAA CACACAGGATGATCC TTGACTTAGTCTTTC TTGAGGCTTGTCCTA 219 
(-1534/ + 119) -RV3 681 
PPSIG gene SEQ TGAAAAGCTGATTTA GAAGCTGGTGCGTCC TTAAATGCAAATAAA CACACAGGATGATCC TTGACTTAGTCTTTC TTGAGGCTTGTCCTA 2317 
2341 2355 2356 2370 2371 2385 2386 2400 2401 2415 2416 2430 
(-2936/ + 119) -RV3 - 1366 
(-375/ + 119) -RV3 0 
(-879/ + 119)-RV3 GGTGGCTTGCACTTT GAGAGCCTGATAGAG TAGTTACGATTAGGG GAATCCACCTAGGGA..TAACGTCGGTGTGAG GCTGCCAGTCCTGGG 309 
(-1534/ + 119) -RV3 ‘ - 681 
PPSIG gene SEQ GGTGGCTTGCACTTT GAGAGCCTGATAGAG TAGTTACGATTAGGG GAATCCACCTAGGGA TAACGTCGGTGTGAG GCTGCCAGTCCTGGG 2407 
2431 2445 2446 2460 2461 2475 2476 2490 2491 2505 2506 2520 
(-2936/ + 119) -RV3 - 1366 
(-375/ + 119)-RV3 - 0 
(-879/+119)-RV3 CTGACACAGGTTTAG GAGAGCTCCTGTGCA GGTCTCAACAAGGTC TCAACTCAGATACCC AGACAGAGGCTGTGT GGGCACAGAAACTTT 399 
(-1534/ + 119) -RV3 - 681 
PPSIG gene SEQ CTGACACAGGTTTAG GAGAGCTCCTGTGCA GGTCTCAACAAGGTC TCAACTCAGATACCC AGACAGAGGCTGTGT GGGCACAGAAACTTT 2497 
2521 2535 2536 2550 2551 2565 2566 2580 2581 2595 2596 2610 
(-2936/ + 119) -RV3 - - 1366 
(-375/ + 119) -RV3 0 
(-879/+119)-RV3 GTCACTGCTTGGAAG AGGAGAGGGGAGGAA AGCAATGAACTGCCT CCGAGGTTCCAGCGA ATCCAACACX3GAAAA GGCACCAGAACCCAG 489 
(-1534/ + 119) -RV3 681 
PPSIG gene SEQ GTCACTGCTTGGAAG AGGAGAGGGGAGGAA AGCAATGAACTGCCT CCGAGGTTCCAGCGA ATCCAACACGGAAAA GGCACCAGAACCCAG 2587 
2611 2625 2626 2640 2641 2655 2656 2670 2671 2685 2686 2700 
(-2936/ + 119) -RV3 - --- - 1366 
(-375/ + 119)-RV3 - GGTGGACCAGTTTCCACCATGACAT 43 
(-879/+119)-RV3 GTCTTCTCTGCCTCC CAGACAC3GATCTCTC TCAGACCTGCAACTT TCATCCTTGTTGTGG TCCCGCGCrTG-ACCA-TTTCCACCA-GACAT 577 
(-1534/ + 119) -RV3 681 
PPSIG gene SEQ GTCTTCTCTGCCTCC CAGACAGGATCTCTC TCAGACCTGCAACTT TCATCCTTGTTGTGG TCCCGCGGTG-ACCA-TTTCCACCA-GACAT 2675 
Sac II 
2701 2715 2716 2730 2731 2745 2746 2760 2761 2775 2776 2790 
(-2936/+119)-GL2 CGT-CCTCCGTCACC GCTCAC-CTCCCTCA CCAGACCCCTTGCTC ACCGGACG-CGTCCC CAGCGTTCCGGTAAG GGGGGGATCCCACA- 97 
(-375/+119)-RV3 CGTGCCTCTTGCACC -CTCACGCTCCCTCA CCAGACCCCTTGCTC ACCGGACG-CGTCCC CAGCGTTCCGGTAAG GGGGGGATCCCACA- 130 
{-879/ + 119)-GL2 CCGGGACGGCGTCCC CAGCGTTCCGGTAAG GGGGGGATCCCACAA 4 5 
(-879/+119)-RV3 CGT-CCTCCTCAACC -TTCAC-T--CCTCA C-AGACCC-TTG-TC AC-GGANG-C-T-CC CAG-GTTCCG—TAG GGGGGNT 644 
(-1534/ + 119) -RV3 681 
PPSIG gene SEQ CGT-CCTCCTCA-CC -CTCAC-CTCCCTCA CCAGACCCCTTGCTC ACCGGACG-CGTCCC CAGCGTTCCGGTAAG GGGGGGATCCCACA- 2759 
2791 2805 2806 2820 2821 2835 2836 2850 2851 2865 2866 2880 
{-2936/+119)-GL2 TCCCCCTTTTCGCGC AGCCGTG-CAGTGTC GCCTGTC-TCGCX3CT AGAACTACATTTCCC ATTAGGCAA-TTGAA CTCCTGCTCTGCAAA 184 
(-375/+119)-RV3 TCCCCCTTTTCGCGC AGCCGTG-CAGTGTC GCCTGTC-TCGCGCT AGAACTACATTTCCC ATTAGGCAA-TTGAA CTCCTGCTCTGCAAA 217 
(-879/+119)-GL2 TCCCCCTTTTCGCGC AGCCGTGGCAGTGTC GCCTGTCGTCGCGCT AGAACTACATTTCCC ATTAGGCAAATTGAA CTCCTGCTCTGCAAA 135 
(-1534/ + 119) -RV3 681 
PPSIG gene SEQ TCCCCCTTTTCGCGC AGCCGTG-CAGTGTC GCCTGTC-TCGCGCT AGAACTACATTTCCC ATTAGGCAA-TTGAA CTCCTGCTCTGCAAA 2846 
2881 2895 2896 2910 2911 2925 2926 2940 2941 2955 2956 2970 
{-2936/+119)-GL2 GATCATACGGAGGTC CATAATGGACAATC- TTCATCAGTTTTGAG -CAGGCGTGACTCAA AATGC-TTCGGCTC- CTCCAAGTC-TGGTA 269 
(-375/+119)-RV3 GATCATACGGAGGTC CATAATGGACAATC- TTCATCAGTTTTGAG -CAGGCGTGAGTCAA AATGC-TTCGGCTC- CTCCAACCCCTGGTA 303 
(-879/+119)-GL2 6ATCATACGGAGGTC CATAATGGACAATCG TTCATCAGTTTTGAG TCAGGCGTGAGTCAA AATGCCTTCGGCTC- CTCCAAGTCCTGGTA 224 
(-1534/+119)-GL2 GATCATACGGAGGTC CATAATGGACAATC- TTCATCAGTTTTGAG -CAGGCGTGAGTCAA AATGC-TTCGGCTCA CTCCAAGTCC-GGTA 115 
PPSIG gene SEQ GATCATACGGAGGTC CATAATGGACAATC- TTCATCAGTTTTGAG -CAGGCGTGAGTCAA AATGC-TTCGGCTC- CTCCAAGTC-TGGTA 2931 
, 349 • 
2971 2985 2986 3000 3001 3015 3016 3030 3031 3045 3046 3060 
(-2936/+119)-GL2 TTACTC-CAAGGAC- GAACTAGAGGGGC-G GGGC-CTCA-GCTAT AAAAGCCGAGCTCAG CX3GG-GAA-AGGAC- GCGGTCTTCCGAGCC 351 
(-375/+119)-RV3 TTACTC-CAAGGAC- GAACTAGAGGGGC-G GGGC-CTCA-GCTAT AAAAGCCGAGCTCAG CGGG-GAA-AGGAC- GCGGTCTTCCGAGCC 385 
(-879/+119)-GL2 TTACTC-CAAGGAC- GAACTAGAGGGGC-G GGGCACTCA-GCTAT AAAAGCCGAGCTCAG CGGG-GAA-AGGACA GCGGTCTTCCGAGCC 308 
(-1534/+119)-GL2 TTACTCTCAAGGACA GAACTAGAGGGGCAG GGGCACTCATGCTAT AAAAGCCGAGCTCAG CGGG-GAA-AGGACG CTGGTCTTCCGAGCC 203 
PPSIG gene SEQ TTACTC-CAAGGAC- GAACTAGAGGGGC-G GGGC-CTCA-GCTAT AAAAGCCGAGCTCAG CGGG-GAA-AGGAC- GCGGTCTTCCGAGCC 3013 
3061 3075 3076 3090 3091 3105 3106 3120 3121 3135 3136 3150 
(-2936/+119)-GL2 CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATC-CTC C-CCAGGGTCTACGT GGGC-CTTTACGCTG 438 
(-375/ + 119) -RV3 25 
(-375/+119)-GL2 CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATC-CTC C-CCAGGGTCTACGT GGGC-CTTTACGCTG 472 
(-879/+119)-GL2 CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCACTC CACCAGGGTCTACGT GGGC-CTTTACGCTG 397 
(-1534/+119)-GL2 CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCACTC CACCAGGGTCTACGT GGGCACTTTACGCTG 293 
PPSIG gene SEQ CTGGCAGCAACATGT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATC-CTC C-ACAGGGTCTACGT GGGC-CTTTACGCTG 3100 
3 1 5 1 3 1 6 5 3 1 6 6 3 1 8 0 3 1 8 1 3 1 9 5 3 1 9 6 3 2 1 0 3 2 1 1 3 2 2 5 3 2 2 6 3 2 4 0 
{-2936/+119)-GL2 CAAGTT-CCCCGAAC CCCTTCGCCGAOGAT GTCAAGCGAC-C-GC CCCGC-T-CGAGATC TGC-GATCTAAGTAA A-AATGCAT-GGCCG 520 
(-375/+119)-GL2 CAAGTTTCCCCGAAC CCCTTCGCCGAOGJLT GTCAAGCGACAC-GC CCCGC-T-CGXGATC TGC-GATCTAAGTAA TGAATGCATTGGCCG 558 
(-879/+119)-GL2 CAAGTT-CCCCGAAC CCCTTCGCCGAGGXT GTCAAGCGACACAQC CCCGCGT-CGXGATC TGC-GATCTAAGTA- TAA-TGCA-TGGCC- 468 
(-1534/+119)-GL2 CAAGTT-CCCCGAAC CCCTTCGCCGAOOXT GTCAAGCGA.CM--QC CCCGCGTGCGAGATC TGCTGATCTAAGTA- TAAATGCATTGCCCG 366 
PPSIG gene SEQ CAAGTT-CCCCGAAC CCCTTCGCCGAGGAT GTCAAGCGAC-C-GC - 3182 
PPSIG-RPF+Y.?)： 
3241 3255 3256 3270 3271 3285 3286 3300 3301 3315 3316 3330 
(-2936/ + 119) -GL2 520 
(-375/ + 119)-GL2 -TACTGTTG-TAA-- CCACCAT 576 
(-879/ + 119) -GL2 GTACTGTTG-TAA-G CCA 644 
(-1534/ + 119) -GL2 GTACTGTTG-TA- - - - 681 
PPSIG gene SEQ GTACTGTTGGTAAAG CCACCATGGAAGACG CCAAAAACATAAAGA AAGGCCCGGCGCCAT TCTATCCGCTGGAAG ATGGAACCGCTGGAG 3272 
. 350 
D2. pSG5-PPARa expression plasmid DNA sequencing and alignment result 
Matched sequence 
Sequencing primers used: pSG5-SEQ924, PPARa-SEQ667, PPARa-SEQ1126, PPARa-SEQ1440, pSG5-SEQ1206 
361 375 376 390 391 405 406 420 421 435 436 450 
PPARa-pSG5924 (2) - -GGCACATCCATCC AACATGGTGGACACA 119 
PPARa-pSG5924 (1) -GGCCACATCCATCC AACATGGTGGACACA 29 
PPARa cDNA SEQ TGGCTGGTCAAGTTC GGGAACAAGACGTTG TCATCACAGCTTAGC GCTCTGTGGCCTGCC TGGCCACATCCATCC AAOLTQGTGGACACA 450 
PPAKa-FP423 start codon 
451 465 466 480 481 495 496 510 511 525 526 540 
PPARa-pSG5924(2) GAGAGCCCCATCTGT CCTCTCTCCCCACTG GAGGCAGATGACC-- TG-AAAGTCCCTTAT CTGAAGAATTCTTAC AAGAAATGGGAAACA 208 
PPARa-pSG5924(1) GAGAGCCCCATCTGT CCTCTCTCCCCACTG GAGGCAGATGACC-- TGGAAAGTCCCTTAT CTGAAGAATTCTTAC AAGAAATGGGAAACA 119 
PPARa cDNA SEQ GAGAGCCCCATCTGT CCTCTCTCCCCACTG GAGGCAGATGACC-- TGGAAAGTCCCTTAT CTGAAGAATTCTTAC AAGAAATGGGAAACA 538 
541 555 556 570 571 585 586 600 601 615 616 630 
PPARa-pSG5924(2) TTCAAGAGATTTCTC AGTCCATCGGTGAGG AGAGCTCTGGAAGCT TTGGTTTTGCAGACT ACCAGTACTTAGGAA GCTGTCCGGGCTCCG 298 
PPARa-pSG5924(1) TTCAAGAGATTTCTC AGTCCATCGGTGAGG AGAGCTCTGGAAGCT TTGGTTTTGCAGACT ACCAGTACTTAGGAA GCTGTCCGGGCTCCG 209 
PPARa cDNA SEQ TTCAAGAGATTTCTC AGTCCATCGGTGAGG AGAGCTCTGGAAGCT TTGGTTTTGCAGACT ACCAGTACTTAGGAA GCTGTCCGGGCTCCG 628 
631 645 646 660 661 675 676 690 691 705 706 720 
PPARa-SEQ667 ---CCCCA ACGGACNACCTCCC 20 
PPARa-pSG5924(2) AGGGCTCTGTCATCA CAGACACCCTCTCTC CAGCTTCCAGCCCTT CCTCAGTCAGCTGCC CCGTGATCCCCGCCA GCACGGACGAGTCCC 388 
PPARa-pSG5924(1) AGGGCTCTGTCATCA CAGACACCCTCTCTC CAGCTTCCAGCCCTT CCTCAGTCAGCTGCC CCGTGATCCCCGCCA GCACGGACGAGTCCC 299 
PPARa cDNA SEQ AGGGCTCTGTCATCA CAGACACCCTCTCTC CAGCTTCCAGCCCTT CCTCAGTCAGCTGCC CCGTGATCCCCGCCA GCACGGACGAGTCCC 718 
721 735 736 750 751 765 766 780 781 795 796 810 
PPARa-SEQ667 CGTGCAGTGC-CTGA ACATCGAGTGT-CGA ATAT-GTGGGGACAAGGCCTCAGGGTACCAC TACGGAGTTCACGCA TGTGAAGGCTGTAAG 110 
PPARa-pSG5924 CCGGCAGTGCCCTGA ACATCGAGTGT-CGA ATAT - GTGGGGACAAGGCCTCAGGGTACCAC TACGGAGTTCACGCA TGTGAAGGCTGTAAG 478 
PPARa cDNA SEQ CCGGCAGTGCCCTGA ACATCGAGTGT-CGA ATAT-GTGGGGACAAGGCCTCAGGGTACCAC TACGGAGTTCACGCA TGTGAAGGCTGTAAG 807 
811 825 826 84 0 841 855 856 870 871 885 886 900 
PPARa-SEQ667 GGCTTCTTT—CGGC GAACTATT-CGGCTG AAG-CTGGTGTACGA CAAGTGTGATCGGAG -CTGCAAGATTCAGA AGAAGAACCGGAACA 200 
PPARa-pSG5924 GGCTTCTTT— CGGC GAACTATT-CGGCTG AAG-CTGGTGTACGA CAAGTGTGATCGGAG -CTGCAAGATTCAGA AGAAGAACCGGAACA 568 
PPARa cDNA SEQ GGCTTCTTT--CGGC GAACTATT-CGGCTG AAG-CTGGTGTACGA CAAGTGTGATCGGAG -CTGCAAGATTCAGA AGAAGAACCGGAACA 892 
901 915 916 930 931 945 946 960 961 975 976 990 
PPARa-SEQ667 AATGCCAGTACTGCC GTTTTCACAAGTGCC TGTCTGTCGGGATGT CACACAATGCAATT- CGCTTTGGAAGAATG CCAA-GATCTGAAAA 290 
PPARa-pSG5924 AATGCCAGTACTGCC GTTTTCACAAGTGCC TGTCTGTCGGGATGT CACACAATGCAATT- CGCTTTGGAAGAATG CCAA-GATCTGAAAA 658 
PPARa CDNA SEQ AATGCCAGTACTGCC GTTTTCACAAGTGCC TGTCTGTCGGGATGT CACACAATGCAATT- CGCTTTGGAAGAATG CCAA-GATCTGAAAA 980 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
PPARa-SEQ667 AGCAAAACTGAAAGC AGAAATTCTTACCTG TGAACACGACCTGAA AGATTCGGAAACTGC AGACCTCAAATCTCT GGGCAAGAGAATCCA 380 
PPARa-pSG5924 AGCAAAACTGAAAGC AGAAATTCTTACCTG TGAACACGACCTGAA AGATTCGGAAACTGC AGACCTCAAATCTCT GGGCAAGAGAATCCA 748 
PPARa cDNA SEQ AGCAAAACTGAAAGC AGAAATTCTTACCTG TGAACACGACCTGAA AGATTCGGAAACTGC AGACCTCAAATCTCT GGGCAAGAGAATCCA 1070 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
PPARa-SEQ667 CGAAGCCTACCTGAA GAACTTCAACATGAA CAAGGTCAAGGCCCG GGTCATACTCGCGGG AAAGACCAGCAACAA CCCGCCTTTTGTCAT 468 
PPARa-pSG5924 CGAAGCCTACCTGAA GAACTTCAACATGAA CAAGGTCAAGGCCCGGGCTCATACTCGCGGG AAAGACCAGCAACAA CCG-CTTTTTGTCAT 837 
PPARa CDNA SEQ CGAAGCCTACCTGAA GAACTTCAACATGAA CAAGGTCAAGGCCCG GGTCATACTCGCGGG AAAGACCAGCAACAA CCCGCCTTTTGTCAT 1160 
1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
PPARa-SEQl 126 TGGACCACCTTGGTTTAAGGCCGA -GAAGACGCTTGTGCCCAAGATGTGATGGCCAACGGCGTCGAAGACA AAGAGGCAGAGGTCC 100 
PPARa-SEQ667 ACATGA-CATGGAGACCTTGTGTATGGCCGA -GAAGACGCTTGTGG CCAAGATGGTGGCCA ACGGCGTCGAAGACA AAGAGGCAGAGGTCC 554 
PPARa-pSG5924 ACATGACCATGGAGACCTTGTGTATGGGCGGAGGAAGACGCTTGTGG CCAAGATGGTGGC-- 868 
PPARa CDNA SEQ ACATGA-CATGGAGACCTTGTGTATGGCCGA -GAAGACGCTTGTGG CCAAGATGGTGGCCA ACGGCGTCGAAGACA AAGAGGCAGAGGTCC 1249 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
PPARa-SEQ1126 GATTCTTCCACTGCT GCCAGTGCATGTC-C GTGGAGACCGTCACG GAGCTCACAGAATTT GCCAAGGCTATCCCA GGCTTTGCAAACTTG 190 
PPARa-SEQ667 GATTCTTCCACTGCT GCCAGTGCATGTC-C GTGGAGACCGTCACG GAGCTCACAGAATTT GCCAAGGCTATCCCA GGCTTTGCAAACTTG 644 
PPARa cDNA SEQ GATTCTTCCACTGCT GCCAGTGCATGTC-C GTGGAGACCGTCACG GAGCTCACAGAATTT GCCAAGGCTATCCCA GGCTTTGCAAACTTG 1338 
1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
PPARa-SEQ1126 GACTTGAACGACCAA GTCACCTTGCTAAAG TAGGGTGTGTATGAA G-CCATCTTCACGAT GCTGTCCTCCTTGAT GAACAAAGACGGGAT 280 
^*PARa-SEQ667 GACTTGAACGACCAA GTCACCTTGCTAAAG TAGGGTGTGTATGAA G-CCATCTTCACGAT GCTGTCCTCCTTGAT GAACAAAGACGGGAT 734 
PPARa-pSG5SEQ1206 GA A-GNNTNTTCACGAT GCTGTCNTCCTTGAT GAACNAAGACGGGAT 46 
PPARct cDNA SEQ GACTTGAACGACCAA GTCACCTTGCTAAAG TAGGGTGTGTATGAA G-CCATCTTCACGAT GCTGTCCTCCTTGAT GAACAAAGACGGGAT 1427 
1441 1455 1456 1470 1471 1485 1486 1500 1501 1515 1516 1530 
昨ARa-SEQ1126 GCTGAfCGCGTACGG CAATGGCTTTATCAC ACGCGAGTTCCTTAA GAACCTGAGGAAGCC GTTCTGTGACATCAT GGAACCCAAGTTTGA 370 
^PARa-SEQ667 GCTGATCGCGTACGG CAATGGCTTTATCAC ACGCGAGTTCCTTAA GAACCT 778 
PPARa-SEQ144 0 TGAGGAAGCC GTNCTGTGAC-TCAT GGAACCCAAGNN-GA 38 
^PARa-pSG5SEQ1206 GCTGATCGCGTACGG CNATGGCTTTATCAC ACGCGAGTTCNNTAA GNACNTGAGGAAGCC GTTCTGTGACATCAT GGAACCCAAGTTTGA 136 
^PARa cDNA SEQ GCTGATCGCGTACGG CAATGGCTTTATCAC ACGCGAGTTCCTTAA GAACCTGAGGAAGCC GTTCTGTGACATCAT GGAACCCAAGTTTGA 1517 
— 351 
1531 1545 1546 1560 1561 1575 1576 1590 1591 1605 1606 1620 
PPARa-SEQ1126 CTTCGCTATGAAGTT CAATGCCTTAGAACT GGATGACAGTGACAT TTCCCTGTTTGTC3GC TGCTATAATTTGCTG TGGAGATCGGCCTGG 460 
PPARa-SEQ1440 CTTCGCTATGAAGNN -AATGCCTTAGAACT GGATGACAGTGAC-T NTCCCTGTTTGTGGC TGCTATAATNTGCTG TGGAGATCGGCCTGG 126 
PPARa-pSG5SEQ1206 CTTCGCTATGAAGTT C7VATGCNTTAGNACT GGATGACAGTGACAT TTCCCTGTTTGTGGC TGCTATAATTTGCTG TGGAGATCGGCCTGG 226 
PPARa cDNA SEQ CTTCGCTATGAAGTT CAATGCCTTAGAACT GGATGACAGTGACAT TTCCCTGTTTGTGGC TGCTATAATTTGCTG TGGAGATCGGCCTGG 1607 
1621 1635 1636 1650 1651 1665 1666 1680 1681 1695 1696 1710 
PPARa-SEQ1126 CCTTCTAAACATAGG CTACATTGAGAAGTT GCAGGAGGGGATTGT GCACGTGCTTAAGCT CCACCTGCAGAGCAA CCATCCAGATGACAC 550 
PPARa-SEQ1440 CCTTCTAAACATAGG CTACATTGAGAAGTT GCAGGAGGGGATTGT GCACGTGCTTAAGCT CCACCTGCAGAGCAA CCATCCAGATGACAC 216 
PPARa-pSG5SEQ1206 CCTTCTATACATAGG CTACATTGAGAAGTT GCAGGAGGGGATTGT GCACGTGCTTAAGCT CCACCTGCAGAGCAA CCATCCAGATGACAC 316 
PPARa cDNA SEQ CCTTCTAAACATAGG CTACATTGAGAAGTT GCAGGAGGGGATTGT GCACGTGCTTAAGCT CCACCTGCAGAGCAA CCATCCAGATGACAC 1697 
1711 1725 1726 1740 1741 1755 1756 1770 1771 1785 1786 1800 
PPARa-SEQ1126 CTTCCTCTTCCCAAA GCTCCTTCAAAAAAT GGTGGACCTTCGGCA GCTGGTCACGGAGCA TGCGCAG-CTCGTAC AGGTCATCAAG-AAG 640 
PPARa-SEQ144 0 CTTCCTCTTCCCAAA GCTCCTTCAAAAAAT GGTGGACCTTCGGCA GCTGGTCACGGAGCA TGCGCAG-CTCGTAC AGGTCATCAAG-AAG 304 
PPARa-pSG5SEQ1206 CTTCCTCTTCCCAAA GCTCCTTCAAAAAAT GGTGGACCTTCGGCA GCTGGTCACGGAGCA TGCGCAG-CTCGTAC AGGTCATCAAG-AAG 404 
PPARa cDNA SEQ CTTCCTCTTCCCAAA GCTCCTTCAAAAAAT GGTGGACCTTCGGCA GCTGGTCACGGAGCA TGCGCAG-CTCGTAC AGGTCATCAAG-AAG 1785 
1801 1815 1816 1830 1831 1845 1846 1860 1861 1875 1876 1890 
PPARa-SEQ1126 ACCGAGTCCGACGCA GCGCTGCACCCACTG TTGCAA--GAGATCT ACAG-AGACATGTAC TGATCTT 730 
PPARa-SEQ144 0 ACCGAGTCCGACGCA GCGCTGCACCCACTG TTGCAA- -GAGATCT ACAG-AGACATGTAC TGATCTT 368 
PPARa-pSG5SEQ1206 ACCGAGTCCGACGCA GCGCTGCACCCACTG TTGCAA- -GAGATCT ACAG-AGACATGTAC TGATCTT 468 
PPARa cDNA SEQ ACCGAGTCCGACGCA GCGCTGCACCCACTG TTGCAA -- GAGATCT ACAG-AGACATGTAC TQJITCCT 1872 
PPARa-RP1849 stop codon 
, 352 • 
D3. pSG5-RXRa expression plasmid DNA sequencing and alignment result 
Matched sequence (Yellow) 
Sequencing primers used: pSG5-SEQ924, RXRa-SEQ533, RXRa-SEQ921, RXRa-SEQ1220, pSG5-SEO1206 
1 15 16 30 31 45 46 60 61 75 76 90 
RXRa CDNA SEQ GAATTCfiCGGC广GCG GCGACTTTTGCAACA ACTCGCCGCGCCGCG GCCTCCGCGCGCCGC CGCCGCCGCTGCCGC CGCCGGCTCCCCGCC <30 
91 105 106 120 121 135 136 150 151 165 166 180 
RXRa-pSG5924 (2) CGCAGACATG 10 
RXRa-pSG5924(1) TG -
RXRa CDNA SEQ GCCCGGGCCCCGGGC GGGCCGCGCCGGGGG CCGCCGCGCTGCCGC CCTGCTGCTCCGCCG CCGGCTGGGCATGAG TTAG'XGCAGACATG 160 
RXRa-FP171 
181 195 196 210 211 225 226 240 241 255 256 270 
RXRa-pSG5924(2) GACACCAAACATTTC CTGCCGCCCGACTTC TCTACCCAGGTGAAC TCTTCGTC-CCTCAA CTCTCCAACGGGTCG AGGCTCCATGGCTGT 89 
RXRa-pSG5924(1) GACACCAAACATTTC CTGCCGCCCGACTTC TCTACCCAGGTGAAC TCTTCGTCACCTCAA CTCTCCAACGGGTCG AGGCTCCATGGCTGT 92 
RXRa cDNA SEQ GACACCAAACATTTC CTGCCGCTCGACTTC TCTACCCAGGTGAAC TCTTCGTC-CCTCAA CTCTCCAACGGGTCG AGGCTCCATGGCTGT 269 
271 285 286 300 301 315 316 330 331 345 346 360 
RXRa-pSG5924(2) CCCCTCGCTGCACCC CTCCTTGGGTNCGGG AATCGGCTCT-CCAC TGGGCTCGCCTGGGC AGCTGCACTCT-CCT ATCAGCACCC-TGAG 176 
RXRa-pSG5924(1) CCCCTCGCTGCACCC CTCCTTGGGTCCGGG AATCGGCTCT-CCAC TGGGCTCGCCTGGGC AGCTGCACTCT-CCT ATCAGCACCC-TGAG 17=t 
RXR« cDNA SEQ CCCCTCGCTGCACCC CTCCTTGGGTCCGGG AATCGGCTCT-CCAC TGGGCTCGCCTGGGC AGCTGCACTCT-CCT ATCAGCACCC-TGAG 3o6 
361 375 376 390 391 405 406 420 421 435 436 450 
RXRa-pSG592'! (2) CTCCCCCATCAAT— GGCATGGGTNCGCCC TTCTCTGTCATCAGC TCCCCCATGGGCCCG CACTCCATGTCCGTR CCCACCACACCCACA 264 
RXRa-pSG5924(1) CTCCCCCATCAAT-- GGCATGGGTCCGCCC TTCTCTGTCATCAGC TCCCCCATGGGCC-G CACTCCATGTCGGTA CCC--CACACCCACN 264 
RXRa cDNA SEQ CTCCCCCATCAAT-- GGCATGGGTCCGCCC TTCTCTGTCATCAGC TCCCCCATGGGCCCG CACTCCATGTCGGTA CCCACCACACCCACA 444 
451 465 466 480 481 495 496 510 511 525 526 540 
RXRc(-pSG5924 (1) TNGGGCTNCGGGACT GGTAGC 285 
RXRa-pSG5924(2) TTGGGCTTCGGGACT GGTAGCCCCCAGCTC AATTCACCCATGAAC CCTGTGAGCAGCACT GAGGATATCAAGCCG CCACTAGGCCTCAAT 357 
RXRa cDNA SEQ TTGGGCTTCGGGACT GGTAGCCCCCAGCTC AATTCACCCATGAAC CCTGTGAGCAGCACT GAGGATATCAAGCCG CCACTAGGCCTCAAT 534 
541 555 556 570 571 585 586 600 601 615 616 630 
RXRa-SEQ533 C TGTGCTATCTGTGGG GACCGCTCCTCAGGC 31 
RXRa-pSG5924(2) GGCGTCCTCAAGGTT CCTGCCCATCCCTCA GGAAATATGQCCTCC TTCACCAAGCACATC TGTGCTATCTGTGGG GACCGCTCCTCAGGC 447 
RXRn cDNA SEQ GGCGTCCTCAAGGTT CCTGCCCATCCCTCA GGAAATATGGCCTCC TTCACCAAGCACATC TGTGCTATCTGTGGG GACCGCTCCTCAGGC 624 
I 
k ^ 
631 645 646 660 661 675 676 690 691 705 706 二'0 
, RXRtt-SEQ533 AAACACTATGGGGTA TACAGTTGTGAGGGC TGCAAGGGCTTCTTC AAGAGGACAGTACGC AAAGRCCTGACCTAC ACCTGCCGAGACAAC 120 
I RXRa-pSG5924(2) NAACACTATGGGGTA TACAGTTGTGAGGGC TGCANGGGCTTCTTC AAGANGACAGTACGC AANGACCTGACCTAC ACCTGCCGAGACNNC 537 
RXR(x CDNA SEQ AAACACTATGGGGTA TACAGTTGTGAGGGC TGCAAGGGCTTCTTC AAGAGGACAGTACGC AAAGACCTGACCTAC ACCTGCCGAGACAAC 714 
721 735 736 750 751 765 766 780 781 795 796 810 
RXRa-SEQ533 AAGGACTGCCTGATC GACAAGAGACAGCGG AACCGGTGTCAGTAC TGCCGCTACCAGAAG TGCCTGGCCATGGGC ATGAAGCGGGAAGCT 210 
RXRa-pSG5924(2) AAGGACTGCCTGATC GACNAGANACAGCNG ANCCGGTGTNAGTAC TGCCGCTACCAGANG TGCC 601 
RXRa cDNA SEQ AAGGACTGCCTGATC GACAAGAGACAGCGG AACCGGTGTCAGTAC TGCCGCTACCAGAAG TGCCTGGCCATGGGC ATGAAGCGGGAAGCT 804 
811 825 826 840 841 855 856 870 871 885 886 900 
RXRa-SEQ533 GTGCAGGAGGAGCGG CAGCGGGGCAAGGAC C G G A A T G A G M C G A G GTGGAGTCCACCAGC AGTGCCAACGAGGAC ATGCCTGTAGAGAAG 300 
RXRo cDNA SEQ GTGCAGGAGGAGCGG CAGCGGGGCAAGGAC CGGAATGAGAACGAG GTGGAGTCCACCAGC AGTGCCAACGAGGAC ATGCCTGTAGAGAAG 8 94 
901 915 916 930 931 945 946 960 961 975 976 990 
RXRa-SEQ921 C TCACCAAATGACCCT 16 
RXg.a-SEQ533 ATTCTGGAAGCCGAG CTTGCTGTCGAGCCC AAGACTGAGACATAC GTGGAGGCAAACATG GGGCTGAACTCCAGC TCACCAAATGACCCT 390 
RXRa cDNA SEQ ATTCTGGAAGCCGAG CTTGCTGTCGAGCCC AAGACTGAGACATAC GTGGAGGCAAACATG GGGCTGAACCCCAGC TCACCAAATGACCCT 964 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
RXRa-SEQ921 G T T A C C M C A T C T G T CAAGCAGCAGftCAAG CAGCTCTTCACTCTT GTGGAGTGGGCCAAG AGGATCCCACACTTT TCTGAGCTGCCCCTA lOfc 
R X R A - S E Q 5 3 3 GTTACCAACATCTGT CAAGCAGCAGACAAG C A G C T C T T C A C T C T T GTGGAGTGGGCCAAG A G G A T C C C A C A C T T T TCTGAGCTGCCCCTA 4HO 
RXRa cDNA SEQ GTTACCAACATCTGT CAAGCAGCAGACAAG CAGCTCTTCACTCTT GTGGAGTGGGCCAAG AGGATCCCACACTTT TCTGAGCTGCCCCTA 1074 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
RXRa-SEQ921 GACGACCAGGTCATC C-TGCTACGGGCAGG CTGSAACGAGCTGCT GATCGCCTCCTTCTC CCACCGCTCCATAGC TGTGAAAGATGGGAT 195 
R X R A - S E Q 5 3 3 G A C G A C C N N G T C A T C C C T G C T A C G G G C A G G C T G G A A C G A G C T G C T G A T C G C C T C C T T C T C C A C C C G N N N C C T N G C T G T G A A A G A T G G G A T 6 7 0 
RXRa cDNA SEQ GACGACCAGGTCATC C-TGCTACGGGCAGG CTGGAACGAGCTGCT GATCGCCTCCTTCTC CCACCGCTCCATAGC TGTGAAAGATGGGAT 1163 
1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 12 60 
RXRa-SEQ921 TCTCCTGGCCACCGG CCTGCACGTACACCG GAACAGCGCfCACAG TGCTGGGGTGGGCGC CATCTTTGACAGGGT GCTAACAGAGCTGGT 285 
RXRa-SEQ533 NCTCCTG 577 
RXRa cDNA SEQ TCTCCTGGCCACCGG CCTGCACGTACACCG GAACAGCGCTCACAG TGCTGGGGTGGGCGC CATCTTTGACAGGGT GCTAACAGAGCTGGT 1253 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
RXRa-SEQ1220 CTGGGCT GCCTGCGAGACATTG TN-CTGTTCANCCCT GACTCTAAGGGGCTC 51 
RXRa-SEQ921 GTCTAAGATGCCTGA CATGCAGATGGACAA GACGGAG-CTGGGCT GCCTGCGAGCCATTG TC-CTGTTCAACCCT GACTCTAAGGGGCTC 373 
RXRa cDNA SEQ GTCTAAGATGCGTGA CATGCAGATGGACAA GACGGAG-CTGGGCT GCCTGCGAGCCATTG TC-CTGTTCAACCCT GACTCTAAGGGGCTC 1341 
353 
J 
1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
RXRa-pSG51206 -GGAGAAGGNGTATG CGTCACTANNAGCGT ACTGCAAACACAAGT ACCCTGAGCAGCCNN 5:-> 
RXRa-SEQ1220 NNAAACCCTGCTGA- -GGTGGAGGCGTNGA GGGAGAAGGTGTATG CGTCACTAGAAGCGT ACTGCAAACACAAGT ACCCTGAGCAGCCGG 139 
RXRa-SEQ921 TCAAACCCTGCTGA- -GGTGGAGGCGTTGA GGGAGAAGGTGTATG CGTCACTAGAAGCGT ACTGCAAACACCAGT ACCCTGAGCAGCCGG 4 60 
RXRa cDNA SEQ TCAAACCCTGCTGA- -GGTGGAGGCGTTGA GGGAGAAGGTGTATG CGTCACTAGAAGCGT ACTGCAAACACAAGT ACCCTGAGCAGCCGG 1--129 
1441 1455 1456 1470 1471 1485 1486 1500 1501 1515 1516 1530 
RXR(X-pSG51206 GCAGGTTTGCCNAGC TGCTGCTCCGCNTGC NTGCACTGCGTTCCA TCGGGCTCAAGTGCC TGGAGCACCTGTTCT TCTTCAAGCTCATCG 1-19 
RXRa-SEQ1220 GCAGGTTTGCCAAGC TGCTGCTCCGCCTGC CTGCACTGCSTTCCA TCGGGCTCAAGTGCC TGGAGCACCTGTTCT TCTTCAAGCTCATCG 
RXRa-SEQ921 GCNNGTNTGCCA-GC TGCTGCTCCGCCTGC CTGCACTGCGTTCCA TCGGGCTCAAGTGCC TGNAGCACCTGTNCT CCTTC 539 
RXRa cDNA SEQ GCAGGTTTGCCAAGC TGCTGCTCCGCCTGC CTGCACTGCGTTCCA TCGGGCTCAAGTGCC TGGAGCACCTGTTCT TCTTCAAGCTCATCG 1519 
1531 1545 1546 1560 1561 1575 1576 1590 1591 1605 1606 1620 
RXRa-pSG51206 GGGACACGCCCATCG ACACNTTCCTCATGG AGATGCTGGAGGCAC CACATCAAGCCACCT AGGCCCCCGCCGCCG TGTGCCGGTCCCGTG 239 
RXRa-SEQl220 GGGACACGCCCATCG ACACCTTCCTCATGG AGATGCTGGfeGCAC CACATCAAGCCACCT A G G C C C C C G C C G C C G TGTGCCGGTCCCGTG 319 
RXRa cDNA SEQ GGGACACGCCCATCG ACACCTTCCTCATGG AGATGCTGGAGGCAC CACATCAAGCCACCT A G G C C C C C G C C G C C G TGTGCCGGTCCCGTG 1609 
Stop codon 
1621 1635 1636 1650 1651 1665 1666 1680 1681 1695 1696 1710 
RXRa-pSG51206 CCCTGCCTGGACACA GCTGCTCAGCTCCAG CCCTGCCCCTGCCCT TTCTGATGGCCCGTG TGGATCTTTGGGGTG CAGTGTCCTTATGGG 329 
RXRa-SEQ1220 C C C T G C C T G G A C A C A GCTGCTCAGCTCCAG CCCTGCCCCtGCCCT TTCTGATGGCCCGTG TGGATCTTTGGGGTG CAGTGTCCTTATGGG 409 
RXRa cDNA SEQ CCCTGCCTGGACACA GCTGCTCAGCTCCAG CCCTGCCCCTGCCCT TTCTGATGGCCCGTG TGGATCTTTGGGGTG CAGTGTCCTTATGGG 1699 
1711 1725 1726 1740 1741 1755 1756 1770 1771 1785 1786 IhOO 
RXRa-pSG51206 CCCAAAAGATGCATC ACCATCCTCGCCATG TTTACTCATQCTTGC CTTTGGCC 3'?1 
RXRa-SEQ1220 CCCAAAAGATGCATC ACCATCCTCGCCATG TTTACTCATGCTTGC CTTNGGCC 46:' 
RXRa CDNA SEQ CCCAAAAGATGCATC ACCATCCTCGCCATG T T T A C 縣 . C l S i ^ 鹏 C C A G G G C A TAGCAGAGCTGGTGT GACACCTGGCCAGCT 1789 
354 
J 
D4. pGL3-IMCD reporter constructs DNA sequencing and alignment result 
Matched sequence 
Sequencing primers used: pGL3-RV3 and pGL3-GL2 
181 195 196 210 211 225 226 240 241 255 256 270 
PGL3-MCD-RV3 A 20 
PGL3-MCD-GL2 A 」6] 
MCD gene SEQ A GC 
MCD-FP(-311) 
271 285 286 300 301 315 316 330 331 345 346 360 
PGL3-MCD-RV3 AGCGCGTGCGTAGTG GGGflAAGGGACTGAG GCGGTGACTC-TCAG AACAGGTGTAAGGAT GCAAGCCAAGAGGGC GAGTCA-GGTGCCCC lOvf 
PGL3-MCD-GL2 AGCGCGTGCGTAGTG GGGAAAGGGACTGAG GCGGTGACTC-TCAG AACAGGTGTAAGGAT GCAAGCCAAGAGGGC GAGTCATGGTGCCCC 
MCD gene SEQ AGCGCSSTGCGTAGTG Gf^GAAAGGGACTGAG GCGGTGACTC-TCAG AACAGGTGTAAGGAT GCAAGCCAAGAGGGC GAGTCA-GGTGCCCC 13« 
MCD-PPRE 1 
361 375 376 390 391 405 406 420 421 435 436 450 
PGL3-MCD-RV3 GGGGCTACCGGGTTC CGGGGACCTTTGGCT GCACTTGGCCTCC-G GCCTGAGAAAGCCAC CTCGCCCCTCCCCCG CCGTTCTACCCCCCG 197 
PGL3-MCD-GL2 GGGGCTACCGGGTTC CGGGGACCTTTGGCT GCACTTGGCCTCCCG GCCTGAGAAAGCCAC CTCGCCCCTCCCCCG CCGTTCTACCCCCCG 446 
MCD gene SEQ GGGGCTACCGGGTTC CGGGGACCTTTGGCT GCACTTGGCCTC-CG GCCTGAGAAAGCCAC CTCGCCCCTCCCCCG CCGTTCTACCCCCCG 221 
MCD-PPRE 2 “ 
451 465 466 480 481 495 496 510 511 525 526 540 
PGL3-MCD-RV3 ATTGGCCAATGTCTC CGTCCGCCGTCCGGC -CTCGGCCAATG6G- GCCGGCGAGAA-GGC -GGAAGCCGGAGCCG GAAGCGAGGCAGAGG 2^3 
PGL3-MCD-GL2 ATTGGCCAATGTCTC CGTCCGCCGTCCGGC ACTCGGCCAATGGG- GCCGGCGAGAAACAC AGGAAGCCGGAGCCG GAAGCGAGGCAGAGG 535 
MCD gene SEQ ATTGGCCAATGTCTC CGTCCGCCGTCCGGC -CTCGGCCAATGGG- GCCGGCGAGAAAC-C -GGAAGCCGGAGCCG GAAGCGAGGCAGAGG 313 
541 555 556 570 571 585 586 600 601 615 616 630 
PGL3-MCD-RV3 CCCGCTCTCCA-GTG GC-GTCTCCCGCTAG CAGCTGTCGCGGaGC TGTC-ATGCGAGGCC TC-GGGCCAGGCTTG A G G G C T C — G G C G C - 367 
PGL3-MCD-GL2 CCCGCTCTCCACGTC GCTGTCTCCCGCTAG CAGCTGTCGCGGAGC TGTC-ATGCGAGGCC TCTGGGCCAGGCTTG AGGGCTCTGAGCGC- 624 
MCD gene SEQ CCCGCTCTCCA-GTG GC-GTCTCCCGCTAG CAGCTGTCGCGGAGC TGTC-ATGCGAGGCC TC-GGGC(S、G0OTCS Aa0SCl5e:‘"*«OG<SC- 397 
MCD-RP(+36) 
355 
D5. pGL3-PPSIG (-229/+435) reporter construct DNA sequencing and alignment result 
Match sequence 
Sequencing primers used: pGL3-RV3 and pGL3-GL2 
631 645 646 660 661 675 676 690 691 705 706 720 
(-229/ + 435) -RV3 TCGCGCTAG AACTACATTTCCCAT TAGGCAATTGAACTC CTGCTCTGCAAAGAT CATACGGAGGTCCAT 78 
PPSIG gene SEQ 纖 M t l ^ i ^ X C A T TAGGCAATTGAACTC CTGCTCTGCAAAGAT CATACGGAGGTCCAT 719 ieiii 麵 
721 735 736 750 751 765 766 780 781 795 796 810 
(-229/+435)-RV3 AATGGACAATCTTCA GCAGTTTTGAGCAGG CGTGAGTCAllMTGC TTCGGCTCCTCCAAG TCTGGTATTACTCCA AGGACGAACTAGAGG 168 
PPSIG gene SEQ AATGGACAATCTTCA TCAGTTTTGAGCAGG CGTGAGTCAAAATGC TTCGGCTCCTCCAAG TCTGGTATTACTCCA AGGACGAACTAGAGG _ 
811 825 826 840 841 855 856 870 871 885 886 900 
(-229/+435)-RV3 GGCGGGGCCTCAGCT ATAAAAGCCGAGCTC AGCGGGGAftiiGGACG CGGTCTTCCGAGCCC TGGCAGCAACATGTG GATCACTGCTCTGCT 268 
PPSIG gene SEQ GGCGGGGCCTCAGCT ATAAAAGCCGAGCTC AGCGGGGAAAGGACG CGGTCTTCCGAGCCC TGGCAGCAACATGTG GATCACTGCTCTGCT 899 
901 915 916 930 931 945 946 960 961 975 976 990 
(-229/+435)-GL2 ---GGCCGTGCTGCT GCTGGTGATCCTCCA CAGGGTCTACGTGGG CCTTTACGCTGCAAG TTCCCCGAACCCCTT CGCCGAGGATGTCAA 87 
{-2297+435)-RV3 GCTGGCCGTGCTGCT GCTGGTGATCCTCCA CAGGGTCTA©GTGGG CCTTTACGCTGCAAG TTCCCCGAACCCCTT CGCCGAGGATGTCAA 348 
PPSIG gene SEQ GCTGGCCGTGCTGCT GCTGGTGATCCTCCA CAGGGTCTACGTGGG CCTTTACGCTGCAAG TTCCCCGAACCCCTT CGCCGAGGATGTCAA 989 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
(-2297+435)-GL2 GCGAGCGCCTGAACC CCTGGTGftCCGACAA GGAGGCTAGG^^GAA AGTTCTCAAACAAGG TCAACTGATGGGTTT CAGGCCTGCTCTCGG 177 
(-2297+435)-RV3 GCGACCGCCTGAACC CCTGGTGACCGACAA GGAGGCTAGGAAGAA AGTTCTCAAACAAGG TCAACTGATGGGTTT CAGGCCTGCTCTCGG 436 
PPSIG gene SEQ GCGACCGCCTGAACC CCTGGTGACCGACAA GGAGGCTAGGAAGAA AGTTCTCAAACAAGG TCAACTGATGGGTTT CAGGCCTGCTCTCGG 1079 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
(-229/+435)-GL2 G-CCTTCCGC-TCAT GTCTCCCCATTAGTA AAGTCCTGG(3ftAAAC TCCTCTTGCACACAG AGGTTCCATAATTTA GTGTTCTTTGCTTCT 266 
(-2297+435)-RV3 G-CCTTCTGC-TCAT GTCTCCCCATTAGTA AAGTGCTGGGAAAAC TCCTCTTGCACACAG AGGTTCCATAATTTA GTGTTCTTTGCTTCT 526 
PPSIG gene SEQ G-CCTTCTGC-TCAT GTCTCCCCATTAGTA AAGTGCTGGGAAAAC TTCTCTTGCACACAG AGGTTCCATAATTTA GTGTTCTTTGCTTCT 1167 
1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
{-229/+435)-GL2 GAAAGGGTGCAGGCA TTACCCTTGGCACGC CAAATTCCAGCCCCG CCAG-TTGGAATCTT T-TCAGCTC-ACGGC TTACACAGAATAAGA 355 
(-229/+435)-RV3 GAAAGGGTGCAGGCA TTACCCTTGGCACGC CCAATTCCAGCCC-G CCAG-TTGGAATCTT T 585 
PPSIG gene SEQ GAAAGGGTGCAGGCA TTACCCTTGGCACGC CAAATTCCAGCCCCG CCAG-TTGGAATCTT T-TCAGCTC-ACGGC TTACACAGAATAAGA 1254 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
(-2297+435)-GL2 GACCTTTCCCCTACT TGGGTCTGGAGCCAA CTTTTCCCTATACTT CAGTGCATGCTCGGG- 433 
PPSIG gene SEQ GACCTTTCCCCTACT TGGGTCTGGAGCCAA CTTTTCCCTATACTT CTGIGCAIKSCTCSGQ 134 2 
PPRE 1 PPRE 2 81__，趣歸 
356 
D6. pGL3_PPSIG (+94/+435) and pGL3-PPSIG (+94/+190) reporter constructs DNA sequencing and alignment result 
Matched sequence 
Fragment removed in pGL3-PPSIG (+94/+190) by Stu HXho I digestion 
Sequencing primers used: pGL3-RV3 and pGL3-GL2 
631 645 646 660 661 675 676 690 691 705 706 720 
(+94/+190)-RV3 -TTC-GCCGAGGATG TCAAAGCGACC-GC- CTGAACCCCTGGTGA 77 
( + 94/ + 190) -GL2 -TTC-GCCGAGGATG TCAA-GCGACC-GC- CTGAACCCCTGGTGA 560 
( + 94/ + 435)-GL2 -TTC-GCCGAGGATG TCAA-GCGACC-GC- CTGAACCCCTGGTGA 268 
C+94/+435)-RV3 -TTC-GCCGAGGATG TCAA-GCGACC-GC- CTGAACCCCTGGTGA 70 
PPSIG gene SEQ -TTC-GCCGAGGATG TCAX-OCGACC-GC- CTGAACCCCTGGTGA 690 
PPS10-PP(+94) 
721 735 736 750 751 765 766 780 781 795 796 810 
( + 94/ + 190) -RV3 CCGACAAGGAGGCTA GGAAG-AAAGTTCTC AAACAAGGTCAACTG AGGGGTTTCAGG--- - 133 
C+94/+190)-GL2 CCGACAAGGAGGCTA GGAAG-AAAGTTCTC AAACAAGGTCAACTG ATGGATTTCAGG--- 616 
(+94/+435)-GL2 CCGACAAGGAGGCTA GGAAG-AAAGTTCTC AAACAAGGTCAACTG ATGGGTTTCAGGCCT GCTCTCGGGCCTTCT GCTCATGTCCCCCCA 357 
(+94/+435)-RV3 CCGACAAGGAGGCTA GGAAG-AAAGTTCTC AAACAAGGTCAACTG ATGGGTTTCAGGCCT GCTCTCGGGCCTTCT GCTCATGTCTCCCCA 159 
PPSIG gene SEQ CCGACAAGGAGGCTA GGAAG-AAAGTTCTC AAACAAGGTCAACTG ATGGGTTTCAGGCCT GCTCTCGGGCCTTCT GCTCATGTCTCCCCA 779 
5tu I site 
811 825 826 840 841 855 856 870 871 885 886 900 
( + 94/ + 190) -RV3 133 
( + 94/ + 190) -GL2 616 
(+94/+435)-GL2 TTAGTAAAGTGCTGG GAAAACTTCTCTTGC ACACAGAGGTTCCAT AATTTAGTGTTCTTT GCTTCTGAAAGGGTG CAGGCATTACCCTTG 447 
(+94/+435)-RV3 TTAGTAAAGTGCTGG GAAAACTTCTCTTGC ACACAGAGGTTCCAT AATTTAGTGTTCTTT GCTTCTGAAAGGGTG CAGGCATTACCCTTG 24 9 
PPSIG gene SEQ TTAGTAAAGTGCTGG GAAAACTTCTCTTGC ACACAGAGGTTCCAT AATTTAGTGTTCTTT GCTTCTGAAAGGGTG CAGGCATTACCCTTG 869 
901 915 916 930 931 94 5 946 960 961 975 976 990 
( + 94/ + 190) -RV3 - 133 
( + 94/ + 190) -GL2 616 
( + 94/ + 435) -GL2 GCACGCCAAATTCCA GCCCCGCCAGTTGGA ATCTTTTCAGCTCAC GGCTTACACAGAATA AGAGACCTTTCCCCT ACTTGGGTCTGGAGC 537 
(+94/+435)-RV3 GCACGCCAAATTCCG GCCCCGCCAGTTGGA ATCTTTTCAGCTCAC GGCTTACACAGAATA AGAGACCTTTCCCCT ACTTGGGTCTGGAC^ 339 
PPSIG gene SEQ GCACGCCAAATTCCA GCCCCGCCAGTTGGA ATCTTTTCAGCTCAC GGCTTACACAGAATA AGAGACCTTTCCCCT ACTTGGGTCTGGAGC 959 
“PPRE 1 一 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
( + 94/ + 190) -RV3 TCGAG-- 183 
( + 94/ + 190) -GL2 665 
( + 94/ + 435) -GL2 CAACTTTTCCCTATA CCTCTGTGCATGCTA CGGC 622 
( + 94/+435) -RV3 CAACTTTTCCCTATA CCTCTGTGCATGCT- CGC3GCCGCTCGAG - 426 
PPSIG gene SEQ CAACTTTTCCCTATA CTTCTGTGCATOCT- CGGG - 1046 
PPRE 2 糊lG-RP<+43S》p Xho I site 
, 357 • 
D7. pGL3-PPSIG (-229/+3031) reporter construct DNA sequencing and alignment result 
Match sequence 
Sequencing primers used: pGL3-RV3, pGL3-GL2，PPSIG-SEQ138，PPSIG-RP760, PPSIG-SEQ(I1)1492R, PPSIG-RP1845 and PPSIG-RP2635 
1 15 16 30 31 45 46 60 61 75 76 90 
(-229/ + 3031) -RV3 TCGCG CTAGAACTACATTTC 32 
PPSIG gene SEQ TOGCG CTAGAACTACATTTC 90 
P M I G - P P ( - 2 2 9 ) 
91 105 106 120 121 135 136 150 151 165 166 180 
C-229/+3031)-RV3 CCATTAGGCAATTGA ACTCCTGCTCTGCAA AGATCATACGGAGGT CCATAATGGACAATC TTCAGCAGTTTTGAG CAGGCGTGAGTCAAA 122 
PPSIG gene SEQ CCATTAGGCAATTGA ACTCCTGCTCTGCAA AGATCATACGGAGGT CCATAATGGACAATC TTCATCAGTTTTGAG CAGGCGTGAGTCAAA 180 
181 195 196 210 211 225 226 240 241 255 256 270 
C-229/+3031)-RV3 ATGCTTCGGCTCCTC CAAGTCTGGTATTAC TCCAAGGACGAACTA GAGGGGCGGGGCCTC AGCTATAAAAGCCGA GCTCAGCGGGGAAAG 212 
PPSIG gene SEQ ATGCTTCGGCTCCTC CAAGTCTGGTATTAC TCCAAGGACGAACTA GAGGGGCGGGGCCTC AGCTATAAAAGCCGA GCTCAGCGGGGAAAG 270 
271 285 286 300 301 315 316 330 331 345 346 360 
(-229/+3031)-138 TC TGCTGCTGGC-GTGC TCGTGCTGTTGATCCTCCACAGGGTCTA-CG 46 
(-229/+3031)-RV3 GACGCGGTCTTCCGA GCCCTGGCAGCAACA TGTGGATCACTGCTC TGCTGCTGGCCGTGC TGCTGCTGGTGATCCTCCACAGGGTCTA-CG 302 
(-229/ + 3031) -760 GGTTCTAACG 16 
PPSIG gene SEQ GACGCGGTCTTCCGA GCCCTGGCAGCAACA TGTGGATCACTGCTC TGCTGCTGGCCGTGC TGCTGCTGGTGATCCTCCACAGGGTCTA-CG 360 
361 375 376 390 391 405 406 420 421 435 436 450 
(-229/+3031)-760 TGGCCCCTTTACGCTTGCAAAGTTNCCCCCG WACCCGCTTCGCCCG GAGGGATGTCAAGCG A-CCGCCTGAACCCC TGGTGACCGACAAGG 101 
(-229/+3031)-138 TGGGCC-TTTACGCT-GCAA-GTT--CCCCG AACCC-CTTCGCC-- GAGG-ATGTCAAGCG AGCCGCCTGAACCCC TGGTGACCGRCAAGG 128 
(-229/+3031)-RV3 TGGGCC-TTTACGCT-GCAA-GTT--CCCCG AACCC-CTTCGCC-- GAGG-ATGTCAAGCG A-CCGCCTGAACCCC TGGTGACCGACAAGG 383 
PPSIG gene SEQ TGGGCC-TTTACGCT-GCAA-GTT--CCCCG AACCC-CTTCGCC-- GAGG-ATGTCAAGCG A-CCGCCTGAACCCC TGGTGACCGACAAGG 441 
451 465 466 480 481 495 496 510 511 525 526 54 0 
C-229/+3031)-760 AGGCTAGGAAGAAAG TTCCTCAAACAAGGT CAACTGATGGGTTTC AGGCCTGCTCCTCGG GCCTTCTGCTCATGT CTCCCCATTAGTAAA 191 
(-229/+3031)-138 AGGCTAGGAAGAAAG TTC-TCAAACAAGGT CAACTGATGGGTTTC AGGCCTGCTC-TCGG GCCTTCTGCTCATGT CTCCCCATTAGTAAA 216 
(-229/+3031)-RV3 AGGCTAGGAAGAAAG TTC-TCAAACAAGGT CAACTGATGGGTTTC AGGCCTGCTC-TCGG GCCTTCTGCTCATGT CTCCCCATTAGTAAA 471 
PPSIG gene SEQ AGGCTAGGAAGAAAG TTC-TCAAACAAGGT CAACTGATGGGTTTC AGGCCTGCTC-TCGG GCCTTCTGCTCATGT CTCCCCATTAGTAAA 529 
541 555 556 570 571 585 586 600 601 615 616 630 
C-229/+3031)-760 GTGCTGGGAAAACTT CTCTTGCACACAGAG GTTCCATAATTTAGT GTTCTTTGCTTCTGA AAGGGTGCAGGCATT -ACCCTTGGCACGCC 280 
(-229/+3031)-138 GTGCTGGGAAAACTT CTCTTGCACACAGAG GTTCCATAATTTAGT GTTCTTTGCGGCTGA AAGGGTGCAGGCATT -ACCCTTGGCACGCC 305 
(-229/+3031)-RV3 GTGCTGGGAAAACTT CTCTTGCACACAGAG GTTCCATAATTTAGT GTTCTTTGCTTCTGA AAGGGTGCAGGCATT TACCCTTGGCACGCC 561 
PPSIG gene SEQ GTGCTGGGAAAACTT CTCTTGCACACAGAG GTTCCATAATTTAGT GTTCTTTGCTTCTGA AAGGGTGCAGGCATT -ACCCTTGGCACGCC 618 
631 645 646 660 661 675 676 690 691 705 706 720 
(-229/ + 3031) -760 AAA-TTCCAGCCCCG CCAGTT-GGAATCTT TTCAGCTCA-CGGCT TACAC-AGAATAAGA GACCTTTCCCC-TAC TTGGGTCTGGAGCCA 365 
(-229/+3031)-138 AAA-TTCCAGCCCCG CCAGTT-GGAATCTT TTCAGCTCA-CGGCT TACAC-AGAATAAGA GACCTTTCCCC-TAC TTGGGTCTGGAGCCA 390 
C - 2 2 9 / + 3 0 3 1 ) - R V 3 A A A A T T C C A G C C C C C G C A G T T T G G A A T C T T T T C A G C T C A A C G G C T T A C A C C A G A A T A A G A G A A C T T T C C C C C T A C T - G G G T C T G G A A G C C 6 5 0 
PPSIG gene SEQ AAA-TTCCAGCCCCG CCAGTT-GGAATCTT TTCAGCTCA-CGGCT TACAC-AGAATAAGA GACCTTTCCCC-TAC TTGGGTCTGGAGCCA 703 
PPRE 1 
721 735 736 750 751 765 766 780 781 795 796 810 
“229/+3031)-760 ACTTTTCCCTATACT TCTGTG-CATGCTC- GGGGGCAC-AGGGAA -GCAGCACTGCCAAG TTTTCCTAACAAGCG GGTTGCAGGCAAAAT 451 
(-229/+3031)-138 ACTTTTCCCTATACT TCTGTG-CATGCTC- GGGGGCAC-AGGGAA -GCAGCACTGA-AAG TTTTCCTAACAAGCG GGTTGCAGGCAAAAT 475 
("229/ + 3031)-RV3 ACTTTTCCCTTATAT TCTGTGGCATGCTCC GGGGGCACCAGGGAA AGCAGC-CTGA-AA- TTTTCCTTA 716 
PPSIG gene SEQ ACTTTTCCCTATACT TCTGTG-CATGCTC- GGGGGCAC-AGGGAA -GCAGCACTGA-AAG TTTTCCTAACAAGCG GGTTGCAGGCAAAAT 788 
PPRE 2 
811 825 826 840 841 855 856 870 871 885 886 900 
(-229/+3031)-760 GTAGTCCAGTTCATA GAACTGAAGCTTGAT AATAACTTCGGGATT TCA-GTACT-GGCTA GGTKAAAGA-CTGCA CTCTCCAG 531 
(-229/+3031)-138 GTAGTCCAGTTCATA GAACTGAAGCTTGAT AATAACTTCGGAATT TCA-GTACT-GGCTA GGGATAAGAACTCCA CTCTCCAGTGAAACC 565 
PPSIG gene SEQ GTAGTCCAGTTCATA GAACTGAAGCTTGAT AATAACTTCGGAATT TCA-GTACT-GGCTA GGGATAAGAACTCCA CTCTCCAGTGAA-CC 875 
901 915 916 930 931 945 946 960 961 975 976 990 
(-229/+3031)-138 ATCTCTAAAGCACGT GTAGAGTGCTCCCAA GGTTTGTGTTTTTGA GACTGGTCTCACTTT TGTACTGGAGTTGGC TTTGAACTCTCTTCG 621 
响 I G gene SEQ ATCTCTAAAGCACGT GTAGAGTGCTCCCAA GGTTTGTGTTTTTGA GACTGGTCTCACTTT TGTACTGGAGTTGGC TTTGAACTCTCTTCG 965 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
(-229/-K3031) -138 CAGCCCAGGCTCAAA CCCGG-AGCAGCCCT CTTCTT C-TG TCCCCAG CAT- GATGAGATAGATTA- CAA 698 
(^229/+3031)-1492 -CCCRGGGTTCCATACCCCGGTAGCAGCCC- CTTCTTTCGTTCGTG TCCCCCGAGGCCATT GATGAGATAGATTAN CAAGCATGCAACCAG 89 
彻 I G gene S E Q C A G C C C A G G C T C A A A C C C G G - A G C A G C C C T C T T C T T C - T G T C C C C A G C A T - G A T G A G A T A G A T T A - C A A 6 C A T G C A - C C A G 1041 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
t~229/+3031)-1492 CATGGTTCTGCCCTT TTCAACGTTTTACGG AAGTGTTGGAGCTGG GCATAGTGGTGCAAC AATTTAATTCCAGTT TGGACTACACAATGA 179 昨SIG gene SEQ CATG--TCTGCC--T TTCAACGTTTTACGG AAGTGTTGGAGCTGG GCATAGTGGTGCAAC AATTTAATTCCAGTT TGGACTACACAATGA 1127 
1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
“229/+3031)-1492 GACCCTGTCTAAATG CACACATCAAACCCC AAATACAACCAAAAC CCCCAAATGCAAAAC TTTCAAAAAACAAAC AAGGATCACCTCTTT 269 
昨SIG gene SEQ GACCCTGTCTAAATG CACACATCAAACCCC AAA-ACAACCAAAAC CCCCAAATGCAAAAC TTTCAAAAAACAAAC AAGGATCACCTCTTT 1216 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
(�229/+3031)-1492 GACCTC-AGGAGCCT CTGACTTGTAAATTT TAGCCAAGCCTAGGC TAGCCTTAACTGCAC TATTTTTTGGGGACT GACTTTGAACTCCTG 358 
昨SIG gene SEQ GACCTCCAGGAGCCT CTGACTTGTAAATTT TAGCCAAGCCTAGGC TAGCCTTAACTGCAC TATTTTTTGGGGACT GACTTTGAACTCCTG 1306 
1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
丄、229/+3031)-1492 ATCCTTGTGCCTCTA CTTCCTAAGAGGCAC CACACCCAGTTATTT TATTATTGTTATTGT TTGTGGATTGGGGGA GAGGCAGGTCTCATA 448 
^PSIG gene SEQ ATCCTTGTGCCTCTA CTTCCTAAGAGGCAC CACACCCAGTTATTT TATTATTGTTATTGT TTGTGGATTGGGGGA GAGGCAGGTCTCATA 1396 
1441 1455^1456 1470 1471 1485 1486 1500 1501 1515 1516 1530 
卜229/+3031)-1845 GTCTTATAACTTGCT ATACAGGACAAGTGT GTCTCAAATTCACAG TGATTCTCCGAACCA CCATCAGCAAGAGAT 75 
^-229/+3031)-1492 CTTGTAGCCCAGGCT AGCTTATAACTTGCT ATACAGGACAAGTGT GTCTCAAATTCACAG TGATTCTCC-AACCA CCATCAGCAAGAGCT 537 
^SlG gene SEQ CTTGTAGCCCAGGCT AGCTTATAACTTGCT ATACAGGACAAGTGT GTCTCAAATTCACAG TGATTCTCC-AACCA CCATCAGCAAGAGAT 1485 
, 358 • 
1531 1545 1546 1560 1561 1575 1576 1590 1591 1605 1606 1620 
(-229/+3031)-1845 TACAAATGGTGGGAT TACAGATGTGAGCCA CCATGGCTTGGATGG AGATTTTTTTTTTAT TTTATTTTTTTTAGT TTTTAGTTGTTTGAG 165 
{-229/+3031)-1492 TACAAATGGTGGGAT TACAGATGTGAGCCA CCATGGCTTGGATGG AGATTTTTTTTTTAT TTTATTTTTTTTAGT TTTTAGTTGTTTGAG 627 
PPSIG gene SEQ TACAAATGGTGGGAT TACAGATGTGAGCCA CCATGGCTTGGATGG AGATTTTTTTTTTAT TTTATTTTTTTTAGT TTTTAGTTGTTTGAG 1575 
1621 1635 1636 1650 1651 1665 1666 1680 1681 1695 1696 1710 
(-229/+3031)-1845 ACAGTGTTTCTCTCT ATAGTTCTAGATGTC CTGGAACTTGCTATT GCTATATAGACCAGG CTGGCCTTGAACTCA CTGAGATCCTCCCAC 203 
(-229/+3031)-1492 ACAGTGAATCTCTC- GTAGTTCTAGATGTC CTG--ACTCG 664 
PPSIG gene SEQ ACAGTGTTTCTCTCT ATAGTTCTAGATGTC CTGGAACTTGCTATT GCTATATAGACCAGG CTGGCCTTGAACTCA CTGAGATCCTCCCAC 1665 
1711 1725 1726 1740 1741 1755 1756 1770 1771 1785 1786 1800 
(-229/+3031)-1845 CTCAGCCTCCTGAGT GCTGAGACTAAAGCT GTGAACACTTGGCCT TGGGCAATGATGTTT AATGAGCAGATTTAC TGGACATAGTGGCAC 293 
PPSIG gene SEQ CTCAGCCTCCTGAGT GCTGAGACTAAAGCT GTGAACACTTGGCCT TGGGCAATGATGTTT AATGAGCAGATTTAC TGGACATAGTGGCAC 1755 
1801 1815 1816 1830 1831 1845 1846 1860 1861 1875 1876 1890 
C-229/+3031)-1845 CTCAGCCTCCTGAGT GCTGAGACTAAAGCT GTGAACACTTGGCCT TGGGCAATGATGTTT AATGAGCAGATTTAC TGGACATAGTGGCAC 383 
PPSIG gene SEQ ATTCCTGTGATCCCA GCGCTGGGGAGGAAA AGACAGGTGGATCTC TACATAGGGAGTTCC AGCCCAGTTAGGGCT ACATGTGTAGTGAAA 1845 
1891 1905 1906 1920 1921 1935 1936 1950 1951 1965 1966 1980 
(-229/ + 3031) -1845 CCGTGTGTCT - 393 
{-229/+3031)-2635 CCGTGTGTCTTAAAA AACACGAATCAATAA AATCAAAGAAAGTAA GTAAATAAAGGAGGA AAGGAAGTAAAAGAC TGGGAG-AAACAANA 105 
PPSIG gene SEQ CCGTGTGTCTTAAAA AACACGAATCAATAA AATCAAAGAAAGTAA GTAAATAAAGGAGGA AAGGAAGTAAAAGAC TGGGAGAAAACAACA 1935 
1981 1995 1996 2010 2011 2025 2026 2040 2041 2055 2056 2070 
{-229/+3031)-2635 AATCCCAGGTCTTGT GTTGACCGTGCATTC CAGTTTGGTTCTGTG AGGTTCCNGGCACAC CAACCTTCCTCCTTT TCTGAGGCTGGTGCT 195 
PPSIG gene SEQ AATCCCAGGTCTTGT GTTGACCGTGCATTC CAGTTTGGTTCTGTG AGGTTCCCGGCACAC CAACCTTCCTCCTTT TCTGAGGCTGGTGCT 2025 
2071 2085 2086 2100 2101 2115 2116 2130 2131 2145 2146 2160 
(-229/+3031)-2635 GTGACCTCTCAGAGT AGCAGCNTTTGAGCA GCTCTGCCTGCTCCA CNTCCGT-GGCACTC AGAGACC-TGCTTT- TCCAAAGAAGCCCAG 285 
PPSIG gene SEQ GTGACCTCTCAGAGT AGCAGCCTCTGAGCA GCTCTGCCTGCTCCA CCTCCGTTGGCACTC AGAGACCTTGCTTCT TCCAAAGAAACCCAG 2115 
2161 2175 2176 2190 2191 2205 2206 2220 2221 2235 2236 2250 
(-229/+3031)-2635 TTCCCTGAACCACCA GCGTCCCCAGCCCCC ACCCTGAGCCTTATT GCCTTT-CTTTCCTC GCTTGCATTCACAGA ACTGACGTTACAGCC 375 
PPSIG gene SEQ TTCCCTGAACCACCA GCGTCCCCAGCCCCC ACCCTGAGCCTTATT GCCTTTTCTTTCCTC GCTTGCATTCACAGA ACTGACGTTACAGCC 2205 
2251 2265 2266 2280 2281 2295 2296 2310 2311 . 2325 2326 2340 
{-229/+3031)-2635 C-TGTGCAGTTGCCA TCTTTCTGGTTTTGT TCTACAGTAGCTAGC TGAGTCAGTCCTACT TCCTTTGAAAGGTAT CAAATCCCTCAAGTA 465 
PPSIG gene SEQ C-TGTGCAGTTGCCA TCTTTCTGGTTTTGT TCTACAGTAGCTAGC TGAGTCAGTCCTACT TCCTTTGAAAGGTAT CAAATCCCTCAAGTA 2294 
2341 2355 2356 2370 2371 2385 2386 2400 2401 2415 2416 2430 
(-229/+3031)-2635 CACTGTAGGGGTTAA GACTCATCACTGCTT AACCTGCCTGTCCGG TCCGAGGTATTCCCT GGTAGAATGTTTTGA GACATCTTAGTCAAG 555 
PPSIG gene SEQ CACTGTAGGGGTTAA GACTCATCACTGCTT AACCTGCCTGTCTGG TCCGAGGTATTCCCT GGTAGAATGTTTTGA GACATCTTAGTCAAG 2384 
2431 2445 2446 2460 2461 2475 2476 2490 2491 2505 2506 2520 
(-229/+3031)-2635 AGTAAATAAACTACC TTAAAAGAAAGGTCT GCCTTCCCTCTTGTT TTGAGACTGGGTCTA ACGAGCCCAGGCTGG CCTCCTGTGGGATGA 645 
PPSIG gene SEQ AGTAAATAAACTACC TTAAAAGAAAGGTCT GCCTTCCCTCTTGTT TTGAGACTGGGTCTA ACGAGCCCAGGCTGG CCTCCTGTGGGATGA 2474 
2521 2535 2536 2550 2551 2565 2566 2580 2581 2595 2596 2610 
(-229/+3031)-2635 TCTTGCCCTCCTAAT GCACCTTTCAAGTGC TCCCATCACAGGAGT ACACCACCATGCCCA GCGGCCGTAGAGACT TCTTACCGAGTACAC 735 
PPSIG gene SEQ TCTTGCCCTCCTAAT GCACCTTTCAAGTGC TCCCATCACAGGAGT ACACCACCATGCCCA GCAGCCGTAGAGACT TCTTACCGAGTACAC 2564 
2611 2625 2626 2640 2641 2655 2656 2670 2671 2685 2686 2700 
(-229/+3031)-2635 GTTAGAGAAGGACCC CGGCTTCTTTGACTT GACTTTCCTGCCCTC GTCTGAGAAGCTCAC CCTTCTCCTCCCTTC TACAGCTTTCTCAGT 825 
PPSIG gene SEQ GTTAGAGAAGGACCC CGGCTTCTTTGACTT GACTTTCCTGCCCTC GTCTGAGAAGCTCAC CCTTCTCCTCCCTTC TACAGCTTTCTCAGT 2654 
2701 2715 2716 2730 2731 2745 2746 2760 2761 2775 2776 2790 
(-229/+3031)-2635 CAGCCGAGTACCAGA GAAGCTGGATGCAGT GGTGATCGGCAGCGG CAT-TGGGGGACTGG CCTCAGCTGC 898 
(-229/ + 3031) -GL2 CAT-TGG- -GACTGG CCTCAGCTGCGGTTC TAGCTAAAGCTGGCA 43 
PPSIG gene SEQ CAGCCGAGTACCAGA GAAGCTGGATGCAGT GGTGATCGGCAGCGG CAT-TGGGGGACTGG CCTCAGCTGCGGTTC TAGCTAAAGCTGGCA 2743 
2791 2805 2806 2820 2821 2835 2836 2850 2851 2865 2866 2880 
(-229/+3031)-GL2 AGAGAGTCCTTGTGC TGGAACAACATACCA AGGCGGGCGGCTGTT GTCATACCTTTGGGG AAAATGGCCTTGAAT TTGACACTGGTAAGG 133 
PPSIG gene SEQ AGAGAGTCCTTGTGC TGGAACAACATACCA AGGCGGGCGGCTGTT GTCATACCTTTGGGG AAAATGGCCTTGAAT TTGACACTGGTAAGG 2833 
2881 2895 2896 2910 2911 2925 2926 2940 2941 2955 2956 2970 
(-229/+3031)-GL2 CTTGTGTGGGAAAGGGCTTAGGAGCATGGCC TTGTCTTTAGATGGC TAATAACACACACTA TTGAGTGACATGGGG GCATGTTTAATGTTTG 224 
响 I G gene SEQ CTTGTGTGGGAAAGG GTTAGGAGCATGGCC TTGTCTTTAGATGGC TAATAACACACACTA TTGAGTGACATGGGG GCAT-TTTAATGTTTG 2923 
2971 2985 2986 3000 3001 3015 3016 3030 3031 3045 3046 3060 
(-229/+3031)-GL2 GAGGTCTCAACTTCT CTCTGGGCACCTCC ATTTCTGTCCGATGGC GTAGTTACTGGGCAA GCATTGGGTGGTATA TGTTCTGATTTGTTT 314 
^PSIG gene SEQ GAGGTCTCAACTTCT CTCTGGGCACCTCCA TTTCTGTCCGATGGC CTAGTTACTGGGCAA GCATTGGGTGGTATA TGTTCTGATTTGTTT 3013 
3061 3075 3076 3090 3091 3105 3106 3120 3121 3135 3136 3150 
(-229/ + 3031) -GL2 CTTATAGAAAGGGT GGTCAGCCCCCCTCTG GACATGAACATAGCC AAGCAGGACAACCTCGTTCCTTACTTGGCAT ATTTCAGGGCCCGAA 404 
响 I G gene SEQ CTTATAGAAAGGGTG GGCAGCCCCCCTCTG GACATGAACATAGCC AAGCAGGACAACCTC TTCCTTACTTGGCAT ATTTCCAGGGCCCAA 3103 
3151 3165 3166 3180 3181 ^ 3195 3196 3210 3211 3225 3226 3240 
“229/+3031)-GL2 TCCCGTTTATCTCTA TATCTCCTTTCCTTT GCACCTCCCAACAGG AATTCATTATATTGG ACGAATGCGGGAGGG CAACATTGGCCGTTT 494 
咖 I G gene SEQ TCCCTTTTATCTCTA TATCTCCTTTCCTTT GCACCTCCCAACAGG AATTCATTATATTGG ACGAATGCGGGAGGG CAACATTGGCCGTTT 3193 
3241 3255 3256 3270 3271 3285 3286 3300 3301 3315 3316 3330 
'^229/ + 3031) -GL2 TATCTTGGACCAGAT CACTGAAGGGCAACT GGACTGGGCCCCCAT GGCCTCCCCTTTTGA CTTGATGATACTAGA AGGGCCCAATGGCCG 534 
昨SIG gene SEQ TATCTTGGACCAGAT CACTGAAGGGCAACT GGACTGGGCCCCCAT GGCCTCCCCTTTTGA CTTGATGATACTAGA AGGGCCCAATGGCCG 3283 
3331 3345 3346 3360 3361 3375 3376 3390 3391 3405 3406 3420 
“229/ + 3031)-GL2 AAAGGAGTTCCCCAT GTACAGTGGGA-GAA AGAATACATCCAGGG CC - 591 




D8. pGL3-PPSIG (+94/+3031) reporter construct DNA sequencing and alignment result 
Match sequence (Yellow) 
Sequencing primers used: pGL3-RV3，pGL3-GL2，PPSIG-SEQ(I1)586, PPSIG-RP760, PPS1G-SEQ(I1)1492R, 
PPSIG-RP1845 and PPSIG-RP2635 
631 645 646 660 661 675 676 690 691 705 706 720 
( + 94/ + 3031)-760 ---GG TACCCCGTTCGCCGA GGATGTCAGGCG-AC CGCCTGAACCCCTGG TGACCGACAAGGAGG CTAGGAAGAAAGTTC 138 
( + 94/ + 3031)-RV3 GG TACCC-GTTCGCCGA GGATGTCAGGCGNAC CGCCTGAACCCCTGG TGAC-GACAAGGAGG CTAGGAAGAAAGTTC 48 
PPSIG gene SEQ 66 TACCCCGTTCGCCGA GOATGTCAAGCG-AC CGCCTGAACCCCTGG TGACCGACAAGGAGG CTAGGAAGAAAGTTC 717 
PPFLG-FP(+94) 
721 735 736 750 751 765 766 780 781 795 796 810 
(+94/+3031)-RV3 TCAAACAAGGTCAGC TGAKGGGTTTCAGGC CTGCTCTCGGGCCTT CTGCTCATGTCTCCC CATTAGTAAAGTGCT GGGAAAACTTCTCTT 138 
(+94/+3031)-760 TCAAACAAGGTCAGC TGATGGGTTTCAGGC CTGCTCTCGGGCCTT CTGCTCATGTCTCCC CATTAGTAAAGTGCT GGGAAAACTTCTCTT 228 
PPSIG gene SEQ TCAAACAAGGTCAAC TGATGGGTTTCAGGC CTGCTCTCGGGCCTT CTGCTCATGTCTCCC CATTAGTAAAGTGCT GGGAAAACTTCTCTT 807 
811 825 826 840 841 855 856 870 871 885 886 900 
(+94/+3031)-RV3 GCACACAGAGGTTCC ATAATTTAGTGTTCT TTGCTTCTGAAAGGG TGCAGGCATTACCCC TTGGGCACGCCAAAT TCCAG-CCCCGCCAG 288 
{+94/+3031)-760 GCACACAGAGGTTCC ATAATTTAGTGTTCT TTGCTTCTGAAAGGG TGCAGGCATTACCCT T--GGCACGCCAAAT TCCAG-CCCCGCCAG 255 
PPSIG gene SEQ GCACACAGAGGTTCC ATAATTTAGTGTTCT TTGCTTCTGAAAGGG TGCAGGCATTACCCT T--GGCACGCCAAAT TCCAG-CCCCGCCAG 894 
901 915 916 930 931 945 946 960 961 975 976 990 
(+94/+3031)-760 TTGGAATCTTTTCAG CTCACGGCTTACACA GAATAAGAGACCTTT CCCCTACTTGGGGTC TGGAGCCAACTTTTC CCTATACTTCTGTGC 345 
(+94/+3031)-RV3 TTGGAATCTTTTCAG CTCACGGCTTACACA GAATAAGAGACCTTT CCCCTACTTGGG-TC TGGAGCCAACTTTTC CCTATACTTCTGTGC 344 
PPSIG gene SEQ TTGGAATCTTTTCAG CTCACGGCTTACACA GAATAAGAGACCTTT CCCCTACTTGGG-TC TGGAGCCAACTTTTC CCTATACTTCTGTGC 983 
PPRE 1 PPRE 2 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
(+94/+3031)-760 ATGCTCGGGGGCACA GGGAAGCAGCCCTCC AAGTTTTCCTAACAA GCGGGTTGCAGGCAA AATGTAGTCCAGTTC ATAGAACTGAAGCTT 435 
(+94/+3031)-RV3 ATGCTCGGGGGCACA GGGAAGCAGCACTGA AAGTTTTCCTAACAA GCGGGTTGCAGGCAA AATGTAGTCCAGTTC ATAGAACTGAAGCTT 434 
PPSIG gene SEQ ATGCTCGGGGGCACA GGGAAGCAGCACTGA AAGTTTTCCTAACAA GCGGGTTGCAGGCAA AATGTAGTCCAGTTC ATAGAACTGAAGCTT 1073 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
( + 94/ + 3031) -760 GATAATT^CTTCGGA -TTTCAGTACTGGCT AGG--TAAAGAACGGCACTCTCC 488 
(+94/+3031)-RV3 GATAATAACTTCGGA ATTTCAGTACTGGCT AGGGATAA-GAACTCCACTCTCCAGTGA-AC CATCTCTAAA-GCAC GTGTAGAGTGCTCCC 522 
PPSIG gene SEQ GATAATAACTTCGGA ATTTCAGTACTGGCT AGGGATAA-GAACTCCACTCTCCAGTGA-AC CATCTCTAAA-GCAC GTGTAGAGTGCTCCC 1161 
1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
( + 94/ + 3031) -586 AAGGTTTGT-GTTTT TGA-GACTGGTCTCACTTTT-GTACTGGAGTTGGCTTTGAACTC-TC-TTCGCAGCCCAGGCT-CAAACCCGGAGCA-G 90 
PPSIG gene SEQ AAGGTTTGT-GTTTT TGA-GACTGGTCTCACTTTT-GTACTGGAGTTGGCTTTGAACTC-TC-TTCGCAGCCCAGGCT-CAAACCCGGAGCA-G 1248 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
C + 94/ + 3031) -586 CCCTCTTCTTCTGTTCCCCAGCATTGATGAGATAGATTAAAAGCATGCACCAGCA-TGGTCTGCCTTTCAACGTTTTACGGAAGT-GTTGGAGCT 180 
PPSIG gene SEQ CCCTCTTCTTCTGT-CCCCAGCAT-GATGAGATAGATTACAAGCATGCACCAGCA-TG-TCTGCCTTTCAACGTTTTACGGAAGT-GTTGGAGCT 1338 
1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
( + 94/ + 3031) -1492 GGGCATAGT-GGTGCAACAATTTAATACCAG TTTGGACTACACAAT GAGACCCTGTCTAAA TGCACACATCAAACC CCAAAACAACCAAAA 90 
PPSIG gene SEQ GGGCATAGT-GGTGCAACAATTTAATTCCAG TTTGGACTACACAAT GAGACCCTGTCTAAA TGCACACATCAAACC CCAAAACAACCAAAA 1428 
1441 1455 1456 1470 1471 1485 1486 1500 1501 1515 1516 1530 
( + 94/ + 3031) -1492 CCCCCAAATQCAAAA CTTTCAAGAAAACAA ACAAGGATCACCTCT TTGACCTCCAGQAGC CTCTGACTTGTAAAT TTTAGCCAAGCCTAG 180 
PPSIG gene SEQ CCCCCAAATGCAAAA CTTTCAA-AAAACAA ACAAGGATCACCTCT TTGACCTCCAGGAGC CTCTGACTTGTAAAT TTTAGCCAAGCCTAG 1517 
1531 1545 1546 1560 1561 1575 1576 1590 1591 1605 1606 1620 
(+94/+3031)-1492 GCTAGCCTTAACTGC ACTATTTTTTGGGGA CTGACTTTGAACTCC TGATCCTTGTGCCTC TACTTCCTAAGAGGC ACCACACCCAGTTAT 270 
PPSIG gene SEQ GCTAGCCTTAACTGC ACTATTTTTTGGGGA CTGACTTTGAACTCC TGATCCTTGTGCCTC TACTTCCTAAGAGGC ACCACACCCAGTTAT 1607 
1 15 16 30 31 45 46 60 61 75 76 90 
( + 94/ + 3031) -1492 TTTATTATTGTTATT GTTTGTGGATTGGGG GAGAGGCAGGTCTCA TA-CTTGTAGCCCAG GCTAGCTTAT A ACTTGCTATACAGGA 360 
PPSIG gene SEQ TTTATTATTGTTATT GTTTGTGGATTGGGG GAGAGGCAGGTCTCA TA-CTTGTAGCCCAG GCTAGCTTAT A ACTTGCTATACAGGA 1697 
" 91 105 106 120 121 135 136 150 151 165 166 180 
( + 94/ + 3031) -1845 CAAGTG-TGTCTCAA ATTCACAGTGATTCT CCAACCACCATC-AGCAAGAG-ATTACAAAT GGTGGGATTACAGAT GTGAGCCACCATGGC 90 
PPSIG gene SEQ CAAGTG-TGTCTCAA ATTCACAGTGATTCT CCAACCACCATC-AGCAAGAG-ATTACAAAT GGTGGGATTACAGAT GTGAGCCACCATGGC 1787 
181 195 196 210 211 225 226 240 241 255 256 270 
(+94/+3031)-1845 TTGGATGGAGATTTT TTTTTTATTTTATTT TTTTT-AGTTTTTAGTTGTTTGAGACAGTGT TTCTCTCTATAGTTC TAGATGTCCTGGAAC 180 
PPSIG gene SEQ TTGGATGGAGATTTT TTTTTTATTTTATTT TTTTTAGTTTTTAGT TGTTTGAGACAGTGT TTCTCTCTATAGTTC TAGATGTCCTGGAAC 1877 
271 285 286 300 301 315 316 330 331 345 346 360 
(+94/+3031)-1845 TTGCTATTGCTATAT AGACCAGGCTGGCCT TGAACTCACTGAGAT CCTCCCACCTCAGCC TTCTGAGTGCTGAGA CTAAAGCTGTGAACA 270 
PPSIG gene SEQ TTGCTATTGCTATAT AGACCAGGCTGGCCT TGAACTCACTGAGAT CCTCCCACCTCAGCC TCCTGAGTGCTGAGA CTAAAGCTGTGAACA 1967 
361 375 376 390 391 405 406 420 421 435 436 450 
(+94/+3031)-1845 CTTGGCCTTGGGCAA TGATGTTTAATGAGC AGATTTACTGGACAT AGTGGCACATTCCTG TGATCCCAGCGCTGG GGAGGAAAAGACAGG 360 
PPSIG gene SEQ CTTGGCCTTGGGCAA TGATGTTTAATGAGC AGATTTACTGGACAT AGTGGCACATTCCTG TGATCCCAGCGCTGG GGAGGAAAAGACAGG 2057 
451 465 466 480 481 495 496 510 511 525 526 540 
(+94/+3031)-1845 TGGATCTCTACATAG GGAGTTCCAGCCCAG TTAGGGCTACATGTG TAGTGAAACCGTGTG TCTTAAAAAACACGA ATCAATAAAATCAAA 450 
PPSIG gene SEQ TGGATCTCTACATAG GGAGTTCCAGCCCAG TTAGGGCTACATGTG TAGTGAAACCGTGTG TCTTAAAAAACACGA ATCAATAAAATCAAA 2147 
360 
541 555 556 570 571 585 586 600 601 615 616 630 
C+94/+3031)-1845 GAAAGTAAGTAAATA AAGGAGGAAAGGAAG TAAAAGACTGGGAGA AAACAACAAATCCCA GGTCTTGTGTNGACC GTGCATTCCAGTTTG 54 0 
PPSIG gene SEQ GAAAGTAAGTAAATA AAGGAGGAAAGGAAG TAAAAGACTGGGAGA AAACAACAAATCCCA GGTCTTGTGTTGACC GTGCATTCCAGTTTG 2237 
631 645 646 660 661 675 676 690 691 705 706 720 
(+94/+3031)-2635 GTTCTGTGAGGTTCC CGGCACACCAACCTT CCTCCTTTTCTGAGG CTGGTGCTGTGACCT CTCAGAGTAGCAGCC TCTGAGCAGCTCTGC 90 
PPSIG gene SEQ GTTCTGTGAGGTTCC CGGCACACCAACCTT CCTCCTTTTCTGAGG CTGGTGCTGTGACCT CTCAGAGTAGCAGCC TCTGAGCAGCTCTGC 2327 
721 735 736 750 751 765 766 780 781 795 796 810 
(+94/+3031)-2635 CTGCTCCACCTCCGT TGGCACTCAGAGACC TTGCTTCTTCCAAAG AAACCCAGTTCCCTG AACCACCAGCGTCCC CAGCCCCCACCCTGA 180 
PPSIG gene SEQ CTGCTCCACCTCCGT TGGCACTCAGAGACC TTGCTTCTTCCAAAG AAACCCAGTTCCCTG AACCACCAGCGTCCC CAGCCCCCACCCTGA 2417 
811 825 826 840 841 855 856 870 871 885 886 900 
(+94/+3031)-2635 GCCTTATTGCCTTTT CTTTCCTCGCTTGCA TTCACAGAACTGACG TTACAGCCCTGTGCA -GTTGCCATCTTT-C -TGGTTTTGTT-CTA 270 
PPSIG gene SEQ GCCTTATTGCCTTTT CTTTCCTCGCTTGCA TTCACAGAACTGACG TTACAGCCCTGTGCA -GTTGCCATCTTT-C -TGGTTTTGTT-CTA 2507 
901 915 916 930 931 945 946 960 961 975 976 990 
(+94/+3031)-2635 CAGTAGCTAGCTGAG TCAGTCCTACTTCCT TTGAAAGGTATCAAA TCCCTCAAGTACACT GTAGGGGTTAAGACT CATCACTGCTTAACC 360 
PPSIG gene SEQ CAGTAGCTAGCTGAG TCAGTCCTACTTCCT TTGAAAGGTATCAAA TCCCTCAAGTACACT GTAGGGGTTAAGACT CATCACTGCTTAACC 2597 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
(+94/+3031)-2635 TGCCTGTCTGGTCCG AGGTATTCCCTGGTA GAATGTTTTGAGACA TCTTAGTCAAGAGTA AATAAACTACCTTAA AAGAAAGGTCTGCCT 450 
PPSIG gene SEQ TGCCTGTCTGGTCCG AGGTATTCCCTGGTA GAATGTTTTGAGACA TCTTAGTCAAGAGTA AATAAACTACCTTAA AAGAAAGGTCTGCCT 2687 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
(+94/+3031)-2635 TCCCTCTTGTTTTGA GACTGGGTCTAACGA GCCCAGGCTGGCCTC CTGTGGGATGATCTT GGCCTCCTAATGCAC CTTTCAAGTGCTCCC 540 
PPSIG gene SEQ TCCCTCTTGTTTTGA GACTGGGTCTAACGA GCCCAGGCTGGCCTC CTGTGGGATGATCTT GGCCTCCTAATGCAC CTTTCAAGTGCTCCC 2777 
1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
(+94/+3031)-2635 ATCACAGGAATACAC CACCATGCCCAGCAG CCGTAGAGACTTCTT ACCGAGTACACGTTA GAGAAGGACCCCGGC TTCTTTGACTTGACT 630 
PPSIG gene SEQ ATCACAGGAGTACAC CACCATGCCCAGCAG CCGTAGAGACTTCTT ACCGAGTACACGTTA GAGAAGGACCCCGGC TTCTTTGACTTGACT 2867 
1261 1275 1276 1290 1291 1305 1306 1320 1321 • 1335 1336 1350 
(+94/+3031)-2635 TTCCTGCCCTCGTCT GAGAAGCTCACCCTT CTCCTCCCTTCTACA GCTTTCTCAGTCAGC CGAGTACCAGAGAAG CTGGATGCAGTGGTG 720 
PPSIG gene SEQ TTCCTGCCCTCGTCT GAGAAGCTCACCCTT CTCCTCCCTTCTACA GCTTTCTCAGTCAGC CGAGTACCAGAGAAG CTGGATGCAGTGGTG 2957 
1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
(+94/+3031)-2635 ATCGGCAGCGGCATG GGGGGACTG-CCTCA GCTGCGGTTCTAGCT AAAGCTGGCAAGAGA GTCCTTGTGCTGGAA CAACATACCAAGGCG 810 
PPSIG gene SEQ ATCGGCAGCGGCATT GGGGGACTGGCCTCA GCTGCGGTTCTAGCT AAAGCTGGCAAGAGA GTCCTTGTGCTGGAA CAACATACCAAGGCG 3047 
1441 1455 1456 1470 1471 1485 1486 1500 1501 1515 1516 1530 
(+94/+3031)-GL2 GGCGGCTGGTGTCAG ACCCTTTGGGTGGAA AATGGCCCTTGAATT TGACGCTGGTAAGGC TTGTGTGTGGAAAGG GTTAGGAGCATGTCC 82 
PPSIG gene SEQ GGCGGCTGTTGTCAT ACC-TTTGGG-G-AA AATGGCC-TTGAATT TGACACTGGTAAGGC TTGTGTG-GGAAAGG GTTAGGAGCATGGCC 3137 
1531 1545 1546 1560 1561 1575 1576 1590 1591 1605 1606 1620 
C + 94/ + 3031) -GL2 TTGTCTTTAGATGGC TAATAACACACACTA TTGAGTGACATGGGG GCATTTTAATGTTTG GAGGTCTCAACTTCT CTCCGGGCACCTCCA 172 
PPSIG gene SEQ TTGTCTTTAGATGGC TAATAACACACACTA TTGAGTGACATGGGG GCATTTTAATGTTTG GAGGTCTCAACTTCT CTCTGGGCACCTCCA 3227 
1621 1635 1636 1650 1651 1665 1666 1680 1681 1695 1696 1710 
(+94/+3031)-GL2 TTTCTGTCCGATGGC CTAGTTACTGGGCAA GCATTGGGTGGTATA TGTTCTGATTTGTTT CTTATAGAAAGGGTG GGCAGCCCCCCTCTG 262 
PPSIG gene SEQ TTTCTGTCCGATGGC CTAGTTACTGGGCAA GCATTGGGTGGTATA TGTTCTGATTTGTTT CTTATAGAAAGGGTG GGCAGCCCCCCTCTG 3317 
1711 1725 1726 1740 1741 1755 1756 1770 1771 1785 1786 1800 
(+94/+3031)-GL2 GACATGAACATAGCC AAGCAGGACAACCTC TTCCTTACTTGGCAT ATTTC-AGGGCCCAA TCCCTTTTATCTCTA TATCTCCTTTCCTTT 351 
PPSIG gene SEQ GACATGAACATAGCC AAGCAGGACAACCTC TTCCTTACTTGGCAT ATTTCCAGGGCCCAA TCCCTTTTATCTCTA TATCTCCTTTCCTTT 3407 
1801 1815 1816 1830 1831 1845 1846 1860 1861 1875 1876 1890 
C+94/+3031)-GL2 GCACCTCCCAACAGG AATTCATTATATTGG ACGAATGCGGGAGGG CAACATTGGCCGTTT TATCTTGGACCAGAT CACTGAAGGGCAACT 441 
PPSIG gene SEQ GCACCTCCCAACAGG AATTCATTATATTGG ACGAATGCGGGAGGG CAACATTGGCCGTTT TATCTTGGACCAGAT CACTGAAGGGCAACT 3497 
1891 1905 1906 1920 1921 1935 1936 1950 1951 1965 1966 1980 
(+94/+3031)-GL2 GGACTGGGCCCCCAT GGCCTCCCCTTTTGA CTTGATGATACTAGA AGGGCCCAATGGCCG AAAGGAGTTCCCCAT GTACAGTGGGAGGAA 531 
PPSIG gene SEQ GGACTGGGCCCCCAT GGCCTCCCCTTTTGA CTTGATGATACTAGA AGGGCCCAATGGCCG AAAGGAGTTCCCCAT GTACAGTGGGAGGW. 3537 
1981 1995 1996 2010 2011 2025 2026 2040 2041 2055 2056 2070 
( + 94/ + 3031) -GL2 AGAATACATCAGAGG CC - 一 606 
PPSIG gene SEQ KQKKThCXrCCMQQ CC - - 3554 
PPSIG-RP(+3031) 
361 
D9. pGL3-ACBP reporter construct DNA sequencing and alignment result 
Matched sequence 
Sequencing primers used: pGL3-RV3 and pGL3-GL2 
1 15 16 30 31 45 46 60 61 75 76 90 
PGL3-ACBP-RV3 胁f_^-CTCA0rrfAaS5ACAGCTCCTG CCC-AACTGTCCCGA CCCAGAACATCCACC &9 
ACBP gene SEQ -ATGGTGTTCTCAGT TTCTGCCAGCTCCTG CCC-AACTGTCCCGA CCCAGAACATCCACC 56 
91 105 106 120 121 135 136 150 151 165 166 180 
PGL3-ACBP-RV3 CCACTGCCTATCCTG TCCCCCTCCGCTCGG GACCCCC&CCCCGAA AAAAAAAAACCGTAG CGTGTC-CAACCTGC TCCCAACAGTGCTAC 178 
ACBP gene SEQ CCACTGCCTT-CC-G TCCCCCTCCGCTCCC CACCCCCACCCCGAA AAAAAAAAACCGTAG CGTGTC-CAACCTGC TCCCAAC-GTGCTCC 14 4 
181 195 196 210 211 225 226 240 241 255 256 SIO 
PGL3-ACBP-RV3 GCTCCTCCAC -ATGTGCATGCGCAA TAAACTCiCATCTTG TGTCTGGTGGAATGGGCCGGAGCTCTCTGC CT-AGGATGTGACACG -6b 
ACBP gene SEQ GCGGCTCCTC CCTGTGCATGCGCAA TAAACTCCC-TCTTG TGTCGGGG-AA-GG GCCGGAGCTCTCTGC CT-AGGATG-GACACG 2：'4 
271 285 286 300 301 315 316 330 331 345 346 360 
PGL3-ACBP-RV3 CCCCCGAAGAGGGAG ATTCCGACTTTCTGA ATTGGCTgCCGCCGC TCGCCACGAGCTCAG AAGGAACGCGGGGGT TGTGCTTTT-AAAGG 329 
ACBP gene SEQ CCCCCGAA-AGC-AG A-TCCGACTT-CTGA -TTGGCTGCCGCCGC TCGCC-CGAGCTCAG TAGGAACGCGGGGGT TGTGCTTTT-AAAGG 307 
361 375 376 390 391 405 406 420 421 435 436 450 
pGL3-ACBP-RV3 CGCTAGCCGGTACGC TCTGGAACTTGATTG CTTCCCTCTTCTGAG CTTGCTCCCGCGCTT TCAGCATCCAGGTCA CCTCGCCAGT-ATGT 3J9 
ACBP gene SEQ CGCTAGCCGGTACGC TCTGGAACTTGATTG CTTCCCTCTTCTGAG CTTGCTCCCGCGCTT TCAGCATCCAGGTCA CCTCGCCAGT-ATGT 396 
451 465 466 480 481 495 496 510 511 525 526 540 
P G L 3 - A C B P - R V 3 C T C A G G T A C T G T G C G T G C C C T G C C G G G C C G C G A A G A T G C A G T G G G T T T G G G G G C A T C A G C C G C A G G A A T C C C G T G G A G T C T C T T T C C T G G 4 1 9 
ACBP gene SEQ CTCAGGTACTGTGCG TGCCCTGCCGGGCCG CGAAGATGCAGTGGG TTTGGGGGCATCAGC CGCAGGAATCCCGTG GAGTCTCTTTCCTGG 4 96 
541 555 556 570 571 585 586 600 601 615 616 630 
P G L 3 - A C B F - R V 3 G A T A T C C C G C A G C T G T T C T G G G A T C C G A G C C C A G C T C L ^ T A G C C T G G G G A G C G G A A C T T T T T C C C T T G C A G A T T T C T G A A A C T G C C A C C C A 5 0 9 
ACBP gene SEQ GATATCCCGCAGCTG TTCTGGGATCCGAGC CCAGCTCATAGCCTG GGGAGCGGAACTTTT TCCCTTGCAGATTTC TGAAACTGCCACCCA 576 
631 645 646 660 661 675 676 690 691 705 706 720 
PGL3-ACBP-RV3 CGCCGGAACTGCTAG AGAGTTACGGGTGGG CTGGACTgCTGGGTG AAGCGGGCACAGGGT CCT-GAAAGAAAGAT GGGGCGAAAGGGGGA 599 
ACBP gene SEQ CGCCGGAACTGCTAG AGAGTTACGGGTGGG CTGGACTCCTGGGTG AAGCGGGCACAGGGT CCTCGAAAGAAAGAT GGGGCGAAAGGGGGA 666 
721 7 35 736 750 751 765 766 780 781 795 796 810 
PGL3-ACBP-RV3 TGAAGGACAGGGAAG ATTGAATCTCATATT GAGAAGAACCGAAAG GAATAGAGGGCCACT CAATGGAGGCCCTGG TTGAAGAGCCTGGAG 689 
ACBP gene SEQ TGAAGGACAGGGAAG ATTGAATCTCATATT GAGAAGAACCGAAAG GAATAGAGGGCCACT CAATGGAGGCCCTGG TTGAAGAGCCTGGAG 756 
811 825 826 840 841 855 856 870 871 885 886 900 
PGL3-ACBP-RV3 GTCGGGGAAGGTATT TAGTCTTGAGCCTGG CATGCCCCTGTACAG AAGAGATGCGAGTAG GTGAAGTGGCCCAGA AAC 66& 
pGL3-ACBP-GL2 AAGAGATGCGAGTAG GTGAAGTGGCCCAGA AACCTGTTCCTTCCC 45 
ACBP gene SEQ GTCGGGGAAGGTATT TAGTCTTGAGCCTGG CATGCCCCTGTACAG AAGAGATGCGAGTAG GTGAAGTGGCCCAGA AACCTGTTCCTTCCC H46 
901 915 916 930 931 945 946 960 961 975 976 990 
PGL3-ACBP-GL2 TCAAGTGGAGACCAC TGCCTAGGACTGAGC CCTGTGGQGCGACCT CTGGCTCCTCCCACT TGCCTCTCCCTAATC TGGGCACTGGGACAG 135 
ACBP gene SEQ TCAAGTGGAGACCAC TGCCTAGGACTGAGC CCTGTGGGGCGACCT CTGGCTCCTCCCACT TGCCTCTCCCTAATC TGGGCACTGGGACAG 936 
ACBP-PPRE 
991 1005 1006 1020 1021 1035 1036 1050 1051 1065 1066 1080 
pGL3-ACBP-GL2 AGGTCAACGCTGAAC TCCAGGCCCCAGTAG GAAGGGAeCAGCTGG CACCCGACCCTGGAT TCCACGGCATTCGCG TCCTGAACCCTGATC 225 
^ACBP gene SEQ AGGTCAACGCTGAAC TCCAGGCCCCAGTAG GAAGGGACCAGCTGG CACCCGACCCTGGAT TCCACGGCATTCGCG TCCTGAACCCTGATC 1026 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155..1156 1170 
PGL3-ACBP-GL2 GACTGTTTTGATCAC CCCACATTTCCCCTT ACTGCCCSGTAAATC TCCGCTGATCATAGG TCGGGGCTTTGCTGG W^CCCCAACAGTTGT 315 
ACBP gene SEQ GACTGTTTTGATCAC CCCACATTTCCCCTT ACTGCCCGGTAAATC TCCGCTGATCATAGG TCGGGGCTTTGCTGG AACCCCAACAGTTGT 1116 
1171 1185 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
P G L 3 - A C B P - G L 2 TGGATCTGGGCCAGT GGTGGCCCAGGCAGT T A G T T G A 6 C C C G A A A A T T T T C C A A G G G C A T G T A C T T T T G C T G T G G G C C A A G T C T A T T C C T 4 0 5 
ACBP gene SEQ TGGATCTGGGCCAGT GGTGGCCCAGGCAGT TAGTTGAGCACGAAA ATTTTC-AAGGGCAT GTACTTTTGCTGTGG GCCAAGTCTATTCCT 1205 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
pGL3-ACBP-GL2 AGTACTTGACACAGT GCTGTAACTACATGA GTGGACASGTGGGCC TGTAGAGAATCTTGA CAAGGAGGAGGAGTT TCGGGAGGAGTGCTG 495 
ACBP gene SEQ AGTACTTGACACAGT GCTGTAACTACATGA GTGGACAGGTGGGCC TGTAGAGAATCTTGA CAAGGAGGAGGAGTT -CGGGAGGAGTGCTG 1294 
1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
P G L 3 - A C B P - G L 2 C T T C C C A C C C T T C C C G T G C A T T C C C T G G A C C T C T C C C A C T C A G G C G T C C T G C A T C C C C T T C C T C T C C C T C T C T C T T A G G 5 8 S 
ACBP gene SEQ CTTCCCACC-TTCCC GTGCAT-CCCTGGAC CTCTCCCACTCAGGC GTCCTGCATCCCCTT CTCTCCCTCTGTCT TA6G 1371 
362 
DIO. PPSIG-PPRE-deietion and PPSIG-PPRE-mutation constructs DNA sequencing and alignment result 
1)1: APPRE 1; P2: APPRE 2; P3: mutPPRE 3; P4: m u t P P R E 2 ; P5: APPREs 1&2; mutPPREs 1&2 
Sev^ai 如核Xrfeadi FFRE^eletton & rnmpn |<r!ieiiced 
The辦丨仗tea foi' traiisfection were highlight^ witfi piiik « s 4 r 
(+94/+435): The experimental sequence of pGL3-PPSIG (+94/+435) 
Parental: The expected sequence of pGL3-PPSIG (+94/+435) 
Matched sequence with parental construct 黎. 
Expected deletion or mutation 
Sequecing primers used: pGL3-RV3 and pGL3-GL2 
1081 1095 1096 1110 1111 1125 1126 1140 1141 1155 1156 1170 
29 P1#7-GL2 CTAGCAAAATA GGCTGTCCCCAGTGC AAGTGCAGGTG-CCA GAACATT-TCTCT-A TCGA--TAGGTACCC 369 
7 H 條 職 CT®'rCGi2GAGT(3C AAGTGCAGGTG-CCA GAACATT-TCTCT-A TCGA—TAGGTACCC 5 3 
22 PMl-GId^ CTAGCAAAATA GGGTGTCCeCAGTGC AAGTGCAGGTG-CCA GAACATT-TCTCT-A TCGA--TAGGTACCC 
15 P2#7-RV3 GCAG-TG-C-A GAACATT-TCTCT-A TCGTA-TAGGTACCC 35 
14 P2#8-GL2 CTAGCAAAATA GGCTGTCCCCAGTGC AAGTGCAGGTG-CCA GAACATT-TCTCT-A TCGA--TAGGTACCC 1^9 
]7 P2tt9-GL2 CTAGCAAAATA GGCTGTCCCCAGTGC AAGTGCAGGTG-CCA GAACATT-TCTCT-A TCGA--TAGGTACCC 
10 P3#3-ai.2 TGTqCCGAGTGC AAGTGCAGGTG-CCA GAACATT-TCTCT-A TCGA--TAGGTACCC 52 
11 P3#5-GL2 CTAGCAAAATA GGCTGTCCCCAGTGC AAGTGCAGGTG-CCA GAACATT-TCTCT-A TCGA--TAGGTACCC 67 
1 3 P 3 T T 8 - G L 2 C T A G C A A A A T A G G C T G T C C C C A G T G C A A G T G C A G G T G - C C A G A A C A T T - T C T C T - A T C G A - - T A G G T A C C C 9 6 
9 P4#2-GL2 AAAAATAG-CTGTCCCCAGTGC AAGTGCAGGTGGCCA GAACATTGTCTCT-A TCGA--TAGGTACCC 63 
5 P4#3-GL2 CTAGCAAAATA GGCTGTCCCCAGTGC AAGTGCAGGTG-CCA GAACATT-TCTCT-A TCGA--TAGGTACCC 67 
16 时 CTAGGAAAAm (^TOTCCiCCAGTck； AAGTGCAGGTG-CCA GAACATT-TCTCT-A TCGA—TAGGTACCC 167 
23 PStB-UVS T C - — T T A G G T A C C C 12 
12 P5#9-RV3 G-GCA GAACAT---CTCT-A TCGNW-TAGGTACCC 2 9 
S CTAGCAAAATA GGCrGTCCCCAGTGC AAGTGCAGGTG-CCA GAACATT-TCTCT-A TCGA--TAGGTACCC 514 
(+947+435)-GL2 CTAGCAAAATA GQGTaTGGGCAGTGC AAGTGCAGGTG-CCA GAACATT-TCTCT-A TCGA--TAGGTACCC 240 
P A T S - R V A P P S I G - P P ( + 9 4 ) 
1171 n & 5 1186 1200 1201 1215 1216 1230 1231 1245 1246 1260 
29 P1#7-GL2 C G T T C G C C — G A G G A -TGTCAAGC-G-ACC G--CCTGAACCCCT- G-GTGACCGACAAGG ---AGGC-TAGGAAG AAA-GTTCTCA-AAC 444 
8 P1J8-GL2 CGTTCGCCCGGAGGAATTGTCAAGCCG-ACCCGGCCCTGAACCCCTT GGNTGACCGACAAGG ---AGGC-TAGGAAG AAA-GTTCTCA-AAC 237 
7‘ £>l#9fCfli2 C G T T C G C C — G A G G A -TGTCAAGC-G-ACC G — C C T G M C C C C T - G-GTGACCGACAAGG — A G G C - T A G G A A G AAA-GTTCTCA-AAC 128 
22 iSiJ•，_ C G T T C G C C — G A G G A -TGTCAAGC-G-ACC G--CCTGAACCCCf- G-GTGACCGACAAGG — A G G C - T A G G A A G AAA-GTTCTCA-AAC 337 
15 P2tt7-RV3 -GTTCGCC--GAGGA -TGTCAAGC-G-ACC G--CCTGAACCCCT- G-GTGACCGACAAGG ---AGGC-TAGGAAG AAA-GTTCTCA-AAC 110 
14 P2#8-GL2 C G T T C G C C — G A G G A -TGTCAAGC-G-ACC G--CCTGAACCCCT- G-GTGACCGACAAGG — A G G C - T A G G A A G AAA-GTTCTCA-AAC 264 
17 P2#9-GL2 C G T T C G C C — G A G G A -TGTCAAGC-G-ACC G--CCTGAACCCCT- G-GTGACCGACAAGG ---AGGC-TAGGAAG AAA-GTTCTCA-AAC 269 
10 I • 骑 C G T T C G C C — G A G G A -TGTCAAGC-G-ACC G--CCTGMCCCCT- G-GTGACCGACAAGG — A G G C - T A G G A A G AAA-GTTCTCA-AAC 127 
11 P3tt5_GL2 CGTTCGCC—GAGGA -TGTCAAGC-G-ACC G—CCTGAACCCCT- G-GTGACCGACAAGG — A G G C - T A G G A A G AAA-GTTCTCA-AAC 14 2 
13 P3tt8-GL2 C G T T C G C C — G A G G A -TGTCAAGC-G-ACC G—CCTGAACCCCT- G-GTGACCGACAAGG — A G G C - T A G G A A G AAA-GTTCTCA-AAC 171 
9 P4#2-GL2 C G T T C G C C — G A G G A -TGTCAAGC-G-ACC G--CCTGAACCCCT- G-GTGACCGACAAGG ---AGGCCTAGGAAG AAA-GTTCTCA-AAC 139 
5 P4#3-GL2 C G T T C G C C — G A G G A -TGTCAAGC-G-ACC G---CKGAACCCCT- G-GTGACCGACAAGG ---AGGC-TAGGAAG AAA-GTTCTCA-AAC 140 
16 C G T T C G C C — G A G G A -TGTCAAGC-G-ACC G—GCTGAACCCCt- G-GTGACCGACAAGG — A G G C - T A G G A A G AAA-GTTCTCA-AAC 242 
4 P4#6-GL2 C G T T C G C C — G A G G A -TGTCAAGC-G-ACC G—CCTGAACCCCT- G-GTGACCGACAAGG ---AGGC-TAGGAAG AAA-GTTCTCAGAAC 12 
32 P5#1-RV3 -GTTCGCC--GAGGA -TGTCAAGC-G-ACC G--CCTGAACCC-T- G-GTGACCGACAAGG ---AGGC-TAGGAAG AAA-GTTC:TCA-AAC 102 
23 H m ^ t m -GTTCGCC—GAGGA -TGTCAAGC-G-ACC G—CCTGAACCCCT- G-GTGACCGACAAGG — A G G C - T A G G A A G AAA-GTTCTCA-AAC 86 
12 P5#9-RV3 -GTTCGCC--GAGGA -TGTCAAGC-G-ACC G--CCTGAACCC-T- G-GTGACCGACAAGG - — A G G C - T A G G A A G AAA-GTTCTCA-AAC 102 
1 6#14-GL2 C G T T C G C C — G A G G A -TGTCAAGC-G-ACC G—CCTGAACCCCT- G-GTGACCGACAAGG ---AGGC-TAGGAAG AAA-GTTCTCA-AAC 2 37 
2 6#1-RV3 C G T - C G C — G A G G A -TGTCAAGCTG-ACC G—C-TGAACCCCT- G-GTGAC-GACAAGG — A G G C - T A G G A A G AAA-GTTCTCA-AAC 143 
3 6#6-RV3 CGTTCGC---GAGGCA-TGTCAAGCTTGAC- G--C-TGAACCCCT- G-GTGACCGACAAGG ---AGGC-TAGGAAG AAA-GTTCTCA-AAC 157 
4 6 # 8 - R V 3 CGTTCGCC—GAGGA - T G T C A A G T C T G A C C G - - C - T G A A C C C C T - G-GTGACCGACAAGG - - - A G G C - T A G G A A G A A A - G T T C T C A - A A C 1 5 3 
5 6#22-(3L2 C G T T C G C C — G A G G A -TGTCAAGC-G-ACC GCCTGAAfcCCCT- G-GTGACCGACAAGG — A G G C - T A G G A A G AAA-GTTCTCA-AAC 603 
( + 9 4 / + 4 3 5 ) - G L 2 C Q F T G T S C O ' - G A G G A - T S T G A M C - G - A C C G — C C T G A A C C C C T - G - G T G A C C G A C A A G G - - A G G C - T A G G A A G A A A - G T T C T C A - A A C 
31 Parental --TTCGCC--GAGGA -TGTCAAGC-G-ACC G--CCTGAACCCCT- G-GTGACCGACAAGG ——AGGC-TAGGAAG AAA-GTTCTCA-AAC 1203 
363 
1261 1275 1276 1290 1291 1305 1306 1320 1321 1335 1336 1350 
29 P;U7-GL2 AAGGTCAA-CTGA-T GGGTTTCAGGCCCGC TC-TCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 52 9 
8 Pltt8-GL2 AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TCCTCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 323 
7 gia^s-鄉2 AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TCY-CGGGCCTTCfG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 213 
22 縱 ^ ^ 縫 AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 422 
3 P2#7-GL2 AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 127 
14 P2#8-GL2 AAGGTCAA-CTGA-T GGGTTTCAGGCCCCC TC-TCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 349 
18 P2#9-RV3 AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 169 
10 AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG I'll' 
11 P3tt5-GL2 AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 1'27 
24 P3#8-RV3 AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 192 
9 P4#2-GL2 AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 224 
5 P4#3-GL2 AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTCTG C-TCATGTCCTCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 226 
16 AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTClG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 327 
30 P4#6二RV3 AAGGTCAA-CTGAGT GGGTTTCAGGCCTGC TC-TCGGGCCTTCtG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 195 
32 P5#1-RV3 AAGGTCAAOCTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 187 
23- •"聯 AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTCfG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 172 
12 P5#9-RV3 AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 187 
1 6#14-GL2 AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTCTG C-TCATGTSCTCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 327 
2 6#1-RV3 AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 232 
3 6抖-RV3 AAGGTCAA-CTGAGT GGGTTTCAGGCCTGC TC-TCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 246 
4 6#8-RV3 AAGGTCAA-CTGAGT GGGTTTCAGGCCTGC TC-TCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 242 -
5 W J H S U AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTCtG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 692 
(+9')/+435)-RV3 AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 126 
31 Parental AAGGTCAA-CTGA-T GGGTTTCAGGCCTGC TC-TCGGGCCTTCTG C-TCATGTC-TCCCC ATTAGTAAAGTGCTG GGAAAACTTCTCTTG 1268 
1351 1365 1366 1380 1381 1395 1396 1410 1411 1425 1426 1440 
29 P1#7-GL2 CACAC-AGAG-GTTC C - A T A A - — T T T A G T GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 611 
8 Pl#8-GL2 CACAC-AGAG-GTTC C - A T A A — — T T T A G T GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 405 
7 約 C A C A C - A G A G - G T T C C - A T A A - — T T T A G T GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 295 
2 2 P I F I ' ; 鄉 C A C A C - A G A G - G T T C C - A T A R , — T T T A G T G T T C T T T G C T T C T I 3 R A A G G G T G C A - G G C A T T A C C C T T G G C A C G C C A A A T T C C - A G C C C C G 5 0 4 
3 P 2 n - G L 2 CACAC-AGAG-GTTC C - A T A A — — T T T A G T GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 209 
14 P2#8-GL2 CACAC-AGAG-GTTC C - A T A A — — T T T A G T GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 431 
18 P2#9-RV3 CACAC-AGAG-GTTC C-ATAA---TTTAGT GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 251 
10 • ， 舰 CACAC-AGAG-GTTC C - A T A A — T T T A G T GTTCTTTGCTTCTdft AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 294 
11 P3#5-GL2 CACAC-AGAG-GTTC C - A T A A — — T T T A G T GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 309 
13 P3#8-GL2 CACAC-AGAG-GTTC C - A T A A — — T T T A G T GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 338 
9 P4#2-GL2 CACAC-AGAG-GTTC C - A T A A — — T T T A G T GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 306 
5 P4#3-GL2 CACAC-AGAG-GTTC C-ATAA---TTTAGT GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 308 
16 CACAC-AGAG-GTTC C - A T A A - — T T T A G T GTTCTTTGCTTCTSft AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 409 
4 P4#6-GL2 CACAC-AGAG-GTTC C-ATAA---TTTAGT GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 240 
32 P 5 # 1 - R V 3 C A C A C - A G A G - G T T C C - A T A A - - - T T T A G T G T T C T T T G C T T C T G A AAGGGTGCA-GGCAT TACCCTTGGCACGCC A A A T T C G - A G C C C C G 2 7 0 
23 l>§*a，RV3 CACAC-AGAG-GTTC C - A T A A — T T T A G T GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCG-AGCCCCG 254 
]2 P5#9-RV3 CACAC-AGAG-GTTC C-ATAA---TTTAGT GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCG-AGCCCCG 270 
1 6#14-GL2 CACAC-AGAG-GTTC C-ATAA---TTTAGT GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 416 
2 6#1-RV3 CACAC-AGAG-GTTC C - A T A A — - T T T A G T GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 320 
3 6#6-RV3 CACAC-AGAG-GTTC C-ATAA TTTAGT GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 334 
4 6#8-RV3 CACAC-AGAG-GTTC C - A T A A - ~ T T T A G T GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATGGCCAGCCCCG 331 
5 CACAC-AGAG-GTTC C-ATAA—TTTAGT GTTCTTTGCtTCT敏 AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 780 
( + 9 4 / + 4 3 6 ) - G L 2 C A C A C - A G A G - G T T C C - A T A A - — T T T A G T G T T C T T T G C T T C T G A A A G G G T G C A - G G C A T T A C C C T T G G C A C G C C A A A T T C C - A G C C C C G 4 1 6 
31 Parental CACAC-AGAG-GTTC C-ATAA---TTTAGT GTTCTTTGCTTCTGA AAGGGTGCA-GGCAT TACCCTTGGCACGCC AAATTCC-AGCCCCG 1370 
364 
1441 1455 1456 1470 1471 1485 1486 1500 1501 1515 1516 1530 
29 P1#7-GL2 CCAGCTTCGAAT-CT -TTTCAGCTCACGG- CTTACAC ---GGGT-CTGGAGC CAACTTTTCCCTATA 671 
8 P1#8-GL2 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAA GGGT-CTGGAGC CAACTTTTCCCTATA 468 
7 • 任 C C A G - T T G G A A T - C Y -TTTCAGCTCACGG- CTTACACA-GAA-f- GGGT-CTGGAGC CAACTTTTCCCTATA 
22 P2#:i-狐2 CCAG-TTGGCAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTCCCCTA CTTG A 564 
15 P2#7-RV3 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTCCCCTA 334 
14 P2tt6-GL2 CCAG-TTGGCAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTCCCCTA CTTG A 491 
18 P2#9-RV3 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTCCCCTA 306 
10 _3M3l»2 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTTTTTTA CTTGGGT-CTGGAGC CAACTTTTCCCTATA 378 
11 P3#5-GL2 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTTTT--- ---GGGT-CTGGAGC CAACTTTTCCCTATA 387 
24 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTTTTTTA CTTGGGT-CTGGAGC CAACTTTTCCCTATA 358 
9 刚 2 - G L 2 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTCCCCTA CTTGGGT-CTGGAGC CAACTTTTTTTTATA 390 
5 P4#3-GL2 CCAG-TTGGAAT-CT -TTTCAGCTCACGGG CTTACCCAGAATATA GAGACCTTTCCCCTA CTTGGGT-CTGGAGC CAACTTTTTTTTATA 394 
16 袖级i;i2 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTCCCCTA CTTGGGT-CTGGAGC CAACTTTTTTTTATA 493 
30 P4tt6-RV3 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTCCCCTA CTTGGGT-CTGGAGC CAACTTTTCCCTATA 361 
32 P5#1-RV3 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA 307 
23 I * 綱 C C A G - T T G G A A T - C T -TTTCAGCTCACGG- CTTACACA-GAA- A 292 
12 P5#9-RV3 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAA 307 
1 6 # : H - G L 2 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACTAGAATAA GAGACCTTTTTTTTA CTTGGGT-CTGGAGCCAAACTTTTCCCTATA 416 
2 6#1-RV3 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTTTTTTA CTTGGGT-CTGGAGC CAACTTTTCCCTATA 320 
3 6#6-RV:3 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTTTTTTA CTTGGGT-CTGGAGC CAACTTTTTTTTATA 334 
4 6tt8-RV3 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTTTTTTA CTTGGGT-CTGGAGC CAACTTTTCCCTATA 331 
CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTTTTTTA CTTGGGT-CTGGAGC CAACTTTTTTTTATA 7 8 0 
(+9^+435)-GL2 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTCCCCTA CTTGGGT-CTGGAGC CAACTTTTCCCTATA 506 
( + 9 4 7 + 4 3 5 ) - R V 3 CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTCCCCTA CTTGGGT-CTGGAGC CAACTTTTCCCTATA 306 
31 Parental CCAG-TTGGAAT-CT -TTTCAGCTCACGG- CTTACACA-GAATAA GAGACCTTTCCCCTA CTTGGGT-CTGGAGC CAACTTTTCCCTATA 14 5-4 
_ P P R E 1 PPRE 2 
1531 1545 1546 1560 1561 1575 1576 1590 1591 1605 1606 1620 
29 P1#7-GL2 CCTCTGTGCATGCT- CGG-CCGCGTCGAGA TCTGCGATCTAAGTA TA--ATGGCATGCCG -TACTGTTGTA 738 
8 P1#8-GL2 CCTCTGTGCATGCT- CGG-CCGCTGCGAGA TCTGCGATCTAAGTA AGACATTGCATTGCG -TACTGTTG-T-AAG CCC 542 
卜j 齊 7 CCTCTGTGCATGCT- CGG-CCGCTGCGAGA TCTGCGATCTAAGTA 402 
1 
I 20 P2fl-flV3 CTTCTGTGCATGCT- CGGGCCGCT-CGAGA TCTGCGATCTAAGTA AG-CTTGGCATTCCG GTACTGTTGGTAAAG CCACCATGGAAGACG 397 
,； 15 P2#7-RV3 CTTCTGTGCATGCT- CGGGCCGCT-CGAGA TCTGCGATCTAAGTA AG-CTTGGCATTCCG GTACTGTTGGTAAAG CCACCATGGAAGACG 4 21 
、 19 P2#8-RV3 CTTCTGTGCATGCT- CGGGCCGCT-CGAGA TCTGCGATCTAAGTA AG-CTTGGCATTCCG GTACTGTTGGTAAAG CCACCATGGAAGACG 426 
U 18 P 2 # 9 - R V 3 C T T C T G T G C A T G C T - C G G G C C G C T - C G A G A T C T G C G A T C T A A G T A A G - C T T G G C A T T C C G G T A C T G T T G G T A A A G C C A C C A T G G A A G A C G 3 9 3 
!r , 1 0 ' P 3 # 3 - G L 2 CCTCTGTGCATGCT- CGGGCCGCT-CGAGA TCTGCGATCTAAGTA AG-AATG-CATGCCG - T A ^ 3 6 
25 P3#5-RV3 CCTCTGTGCATGCT- CGGGCCGCT-CGAGA TCTGCGATCTAAGTA AG-CTTGGCATTCCG GTACTGTTGGTAAAG CCACCATGGAAGACG 430 
：r 24 P3#8-RV3 CCTCTGTGCATGCT- CGGGCCGCT-CGAGA TCTGCGATCTAAGTA AG-CTTGGCATTCCG GTACTGTTGGTAAAG CCACCATGGAAGACG 445 
；r 28 P " 2 - R V 3 C-TCTGTGCATGCT- CGGGCCGCT-CGAGA TCTGCGATCTAAGTA AG-CTTGGCATTCCG GTACTGTTGGTAAAG CCACCATGGAAGACG 448 
15 P4#3-GL2 CTTCTGTGCATG 406 16 CTTCTGTGCATGCTA CGGGCCGCG-CGAGA TCTGCGATCTAAGTA 537 
30 P4#6-RV3 CCTCTGTGCATGCT- CGGGCCGCT-CGAGA TCTGCGATCTAAGTA AG-CTTGGCATTCCG GTACTGTTGGTAAAG CCACCATGGAAGACG 448 
；,：• 32 P5#1-RV3 CTTCTGTGCATGCT- CGGGCCGCT-CGAGA TCTGCGATCTAAGTA AG-CTTGGCATTCCG GTACTGTTGGTAAAG CCACCAIJGGAAGACG 394 
：'' 23 CTTCTGTGCATGCT- CGGGCCGCT-CGAGA TCTGCGATCTAAGTA AG-CTTGGCATTCCG GTACTGTTGGTAAAG CCACCATGGAAGACG 37o 
I ‘ 12 P5TT9-RV3 C T T C T G T G C A T G C T - C G G G C C G C T - C G A G A T C T G C G A T C T A A G T A A G - C T T G G C A T T C C G G T A C T G T T G G T A A A G C C A C C A T G G A A G A C G 394 
I ！ 1 6 t t l 4 - G L 2 CCTCTGTGCATGCT- CGG-CCGCTGCGAGA TCTGCGATCTAAGTA AAAAT-AGCAT-GGC GT-C TGT-GT -CACC 503 
‘ 2 6#1-RV3 CCTCTGTGCATGCT- CGGGCCGCT-CGAGA TCTGCGATCTAAGTA AG-CTTGGCATTCCG GTACTGTTGGTAAAG CCACCATGGAAGACG 權 
]？ 3 6#6-RV3 CTTCTGTGCATGCT- CGGGCCGCT-CGAGA TCTGCGATCTAAGTA AG-CTTGGCATTCCG GTACTGTTGGTAAAG CCACCATGGAAGACG 422 
I ^ 4 6 # 8 - R V 3 CCTCTGTGCATGCT- CGGGCCGCT-CGAGA TCTGCGATCTAAGTA AG-CTTGGCATTCCG GTACTGTTGGTAAAG CCACCATGGAAGACG 419 
I 5 名繊"资縱 CTTCTGTGCATGCT- CGGGCCGCTGCGAGA TCTGCGATCTAAGTA A G A A A T - G C A T — G C G T A C T G T — G T A A — -CACCC 867 
(+94/+435)-RV3 CCTCTGTGCATGCT- CGGGCCGCT-CGAGA TCTGCGATCTAAGTA AG-CTTGGCATTCCG GTACTGTTGGTAAAG CCACCATGGAAGACG 397 
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